<SEC-DOCUMENT>0000886163-22-000049.txt : 20220509
<SEC-HEADER>0000886163-22-000049.hdr.sgml : 20220509
<ACCEPTANCE-DATETIME>20220509160833
ACCESSION NUMBER:		0000886163-22-000049
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220509
DATE AS OF CHANGE:		20220509

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33093
		FILM NUMBER:		22904957

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>lgnd-20220331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:63142b59-d50f-422e-a0a8-23b5f0c0b9ee,g:55f2a22c-b472-424e-aeed-2ce3b4861db0,d:24aac44094964d4184ea8d0c77bbf073--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:lgnd="http://www.ligand.com/20220331" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>lgnd-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV8yLTEtMS0xLTU5NTM1_febeb2f3-7da1-45fe-9adc-747d48652405">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV8zLTEtMS0xLTU5NTM1_bb887447-83be-451c-8a02-edbc7efc8540">2022</ix:nonNumeric><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV80LTEtMS0xLTU5NTM1_5bc75c7e-c44e-454e-9966-980e47bb5f31">Q1</ix:nonNumeric><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV81LTEtMS0xLTU5NTM1_a8b70152-8a0e-477b-ab64-d70652f5378f">0000886163</ix:nonNumeric><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV82LTEtMS0xLTU5NTM1_3a47411d-4c76-4381-b23e-ad12eaab5668">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0wLTEtMS03MDA0Mg_e2adfea4-35a8-4671-b333-781072ebc07b">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180Ni9mcmFnOjNjMzk5N2ZmZTI5ZTRmOTJhMDI3ZDYyY2ZjN2I2ODU4L3RhYmxlOjNiZTM1MjBhOGIwNzQ5MGQ4MjVmODY2YzQ3NTAzNWM1L3RhYmxlcmFuZ2U6M2JlMzUyMGE4YjA3NDkwZDgyNWY4NjZjNDc1MDM1YzVfMi0xLTEtMS01OTUzNQ_fe98e1fe-4d14-42a7-bc56-0b38f00a66e7">0.0040244</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i87eb5ec96aa44c22872e02ee5f10ca53_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180Ni9mcmFnOjNjMzk5N2ZmZTI5ZTRmOTJhMDI3ZDYyY2ZjN2I2ODU4L3RhYmxlOjNiZTM1MjBhOGIwNzQ5MGQ4MjVmODY2YzQ3NTAzNWM1L3RhYmxlcmFuZ2U6M2JlMzUyMGE4YjA3NDkwZDgyNWY4NjZjNDc1MDM1YzVfNC0xLTEtMS03MzYyNg_99b2e5e2-808d-4e5f-9b7a-df265860a6db">0.0052317</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="lgnd-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia08cf90d3d0749cba99e0a20f8f8db7f_I20220505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6c4b67ce45734a1488e028d74424a3ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2871262664774e9c93e671bd91fbc05a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28b08e6912b04510a2abbaffe52e8c52_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6af8f3a1ea1147389b4f58ce1a5ce5c3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4bdb647ddf147bd84a8bb24e2666210_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd7481a03054f56837d5f2889064a3e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f315420bac2445db97141e3eb94ecf8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5b05cfdbed34186bc0ca0f9967ff690_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d9dead5c83f404093493fd89aedc1ef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f6c591ca6164e298b702b2e5838de27_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f9217abff4940c09241816ada5b00d7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i745a10c5acc04c8abff6813d0fbcc32c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87c3f0f2b43c4a02a873a348ac60340e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2b8ad2425b94970836064433e1b9c36_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic54fc48630a943be8d51ab84bb6ec9e1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04dfa09c315e4ea8937000c9fbcebd65_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05239c6a6e534a8c889d6057c3a05746_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29e36d3c6bfa46a3aabff2ac65a972b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida954be77ff74c0bbe3dc1fe29aee07d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2349b019bea04c3f8818d90c8e36dfe4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib57655db6c244e568e24627c0da2b0e6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie23dddf73d564cccbeb38cedfbf213d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf1964f2dbc3421fbd584115f1a95eb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea088c6521ae42dabe8f16d54142f236_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40321155ca4046eba9b0de104f5ce8db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8542ff7045c84ed5bbfbe302627e05db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0adfb1eca5a640698b9228529cba9397_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i154f58555d7d4643b2e1f528903985d9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c8f70bcb8544a2d8a2cb58c9207ff0b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c66c5680f12470c9b06b7b32d2062a2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b75c9953264ac2b488a162bfbb1fa7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb955a30fcb449ca1b8aed8ec29365a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0211e1bbe9f44dfebcdf0ebe1dac694e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id709f7f89de844718660a4c1048c1cf3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d1b66ab770745c8ad6850d6dfd97f30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42456cb257354b64b669494c1f8a43e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6bf4f2b14ab4ca4964ed5c7d1fde736_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5f7c3225f742f2837effcd50bb3f07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadcc8e71d6a1438fbd272741cd9b7d95_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07fd099a96414912b8668ce47bea3ec2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee81d901b6a492abb235b3119cc7898_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d5c0bc6f4744e0b51b5d1f8ae76c36_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04011d0026304dbebecfd23dce2351c2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a2afd26bd6c45f79cf4af863d253176_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic21c8159caf94bc9a53b73d289bb1251_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0175e6ce3cf48caadfd1f3b8bb97392_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11d5dea3dcd743feb47922ec6ed01b4b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bf4fc09793f43a9a8d43f9a8f6a5199_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia269861fa92141fcb3d9629f7e926de1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a539e9335924d0aabf0ec4d5b20b5b7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaedc31f3d0524728ab67dc0105f82c05_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032d93aa682241bcb144bf6c5d387a4a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i356debce55094a5f8fb2dd9767f8a65e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ebba23e98694d9baaebf57762ecde39_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7769789917214a24a4c7dfc52ac670e3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0a615c256b74c3cad0d586a69d2c6d0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief27a2dceccf46e7bb26272780283c82_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2873d3d891464c6596099d2f3ceccbc3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10492cd31c0f473a8754fc4b06d6e667_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84aa90196d9044c096cdc13634fd7385_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida69113abe7847e8b5ed94bf90a72132_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94ef9ec786694f06a63d2a1409816900_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ff3f576fac41e7b315329c76a8306c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2155f0c2705b4c408b646add63eb9071_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie11feec6336542d386a98bda4c8dbf00_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7645756406646ca8f1ec3acc081a02c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56582b6df3664f7283828126f810559e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b2a53fb0eb405a93cded08866b0e8d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i285b0c923a6f42c2af32f25b9fb32381_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i774eff23634b4e6f9ce07e67955988f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic258a2744cc743da87ef38a3bdcf1222_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34da59c366e142fbbf562b813abcb5aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20bdb340507b4cc49042547bdf096356_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992d4d8c76a5476194b7e457e109762c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61db617747884bd480b2ae120011bf66_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bdc3319eb85415ea312cb8a112c69ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>lgnd:position</xbrli:measure></xbrli:unit><xbrli:context id="i34997f63ccf047658e1fca662ede1c9f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7807a6ec9b74845a3590b8007c957ba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1c93540126b4a8dadf1d7a4085e4c3f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if722abdc75b34610b6fea0f9483cee81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i518fdba340374fd3a474af40b10ce796_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c4e5dcb4e7746e5bc080a9c25e3bc3c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7464cb7c60b0446cbd43978b90d27c58_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b7531ec2484661a8f1a0b6c44bfdfe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f0ef9c25a614e018c39ce8e9e5101bd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7719a92b270b4a49ac3b46e3e2b46499_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e39b01f1d4d45689cebd1037fe70f27_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb1ea6c6606c481a951f3cc3af50b136_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22a5e6b72c57405abf407349fa1f4137_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i457b420796584b0fb47f7e39b1055c47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7080131f89e444529897ea3dc7448eb2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14d8023b123a4c2faca1a22a3e115e11_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfa8a3f9ab8545b981b3971997972972_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11b4a8c686fc4648be49dc1b9c525045_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ff20198dfd645f89511cf05d55fafd4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a3b49d1a88349509ccd11b907545d6d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8220447fce27459a888de6de4b101be1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e532a1df4c44aa98fe74ecbd0a59126_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fa0529885044a349ec209c5f5442871_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bd6ab61611848b4af19ea870cad707f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a1194575d634ee8956be0aa05025adc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3365559ab448481290ab043d14bce4fe_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b33615ff4dc4786891d338a0cb87ea1_D20220101-20220322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>lgnd:segment</xbrli:measure></xbrli:unit><xbrli:context id="ib574058f498140e08306c67fbbc14b07_D20220323-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-23</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i300e1e912a0842718dbd2b3d456ac8e0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id431bc8ebbfc4087800d10ed11c19272_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic73cc7ba3d4a447d95e5cb30db52d28b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id34fb1dc5fc741d1b93bb6d1fad26056_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie50c79886ca04ee7b85538c7262e1e53_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fb81ef4735243389f30ebb41fc5156c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i598d08a1a5c64f9c9b4aae4b7fea0796_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if798cc5ddaad4b2a80521e5ef4181f09_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2096d791fd444431ae4e6423cf10a908_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic378cdb30a214a6e973eb163729ac9df_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccf94376ac9f41ba9db7e39a6ff00cd2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44fcbfc7c1c64519a0a268ddd50005f9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0260450d8db471abd4488be4a3107e3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id18be33f9e9e4ae7a764cb16fd2d9133_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70be0418e1f249f5998e0e0067145f1b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19419d57f33740be82d4eb6147bb54a5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e48006baa5e40e28df0dfb681b6ae97_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76cb0239f16b43c4bd8d8c1d06dc5cd8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c3151df873d468daa1bc191317f2131_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a30df8c5d044c60a763185ed4b109ee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if634239711ec47bc8fb473be55d194c2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78c295da60c54f4ba4c67de4f2b2fd6a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i919b865fc7e548288c960eb025fa16f6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f961cf3c57944a989b386a120a59e6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie56a23c988fb481eb3895b19408d8f68_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bcc5777b8c04572a90ff8c68c9be3d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f9f85958a8e45c1999e50f7c31144df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28df26f7a1f24146a45927ad3b6e2625_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2da3eb2118b64b948ace0d372c78e131_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0024c5febbb84c33ba537d246bb26b0d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e6326565a2e4955bf81bde2e03ac28b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3ba69f089de4d0aa3b902eb1357efb6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a463045c0434ff28706f0fd5b252da7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eb310903a3649db988222f2672883a4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54984caedea4d4c829399ada8baf52c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6e15e9ecb9c4bb9a73558b076d35394_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5112991c76244ad1b2e61a2afe8efa8b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c833df0e5124025a8cd7e1936222d95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c518e7be0004946a9276b77331674e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c5a1b7c1bd4601ad0e07d638cfde90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i966883907ba441f5a4e24265299fe9b7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17df672b82eb4eff9d83b149a3113829_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8716ee2bef654ec887fa430172b5e0d3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i211899b611f340528eb396eab170056c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b9d133c575a444b97ac9f108fea9d52_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7dc371fd8d4ba9b2de8e1a8d90ca31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06393bae740d414fb55f36d4f43807b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3496b4825a99453d8e14a952b1c8bbf5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aacb0ab6e8a482dbddfa6725169679d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8cd9489185040a7bb4e6b5151d8fb72_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97def60ed00a4e26a90de87178d3202c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfc8aa3e6e1c478c842cc795c7c3484c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc9098fdefa544a68419972c21ec488c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic14bb82805cc494d8b56d377748e728c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c0225f26f5a48b5b92459eaef9fd75e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic54f0bccced74dc6b12384a2e45705e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12aa59424c6e4371bcaeafb801d99844_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f3a5031213d4a2aa5da82aaa404c742_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a32dc635437486483a3be836ab04ada_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2055a011fa7a4a829cad038d7d64c6ae_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90216ed11e8d4bc1b40442168089a1ad_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80f9ef7fb8a04cb59bc97a74159c2874_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0690c7d860e439ab67baac1955afda1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b92158554854b7599487fbbea4b32d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55dc9c881b384a888900e4e677032eef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34e13f0ccb1840b38bbcc52a9b972a65_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idef14e6ec1314de598c64ef1cd3b8fdf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i065018e70379492b9ffac3ef63d44a78_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7f207c7e7074abdbf50e9ac08b78310_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d31d4856a7f4ecdac5cfa9487f3e54e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2afa4c98a64c4a839dbfa0fd81f143_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6ec0e9d18f64f908b3d00d4d1706f84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2069d01c1f64ca7a72f1f7662269e10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e4d6cbded604d18851f0c907cacd012_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i465d2c5e70fe49d68072bca30f76eb6d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied060cacedb645e8952913558fc4a323_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac5865f4bf0c4476a1cdbb41799578ef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6854523039e846ca86b64f3d0452da62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica6972566df3478a9c82f8db3f0f40d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a94d4a2b23c41cbb4633b169200cf02_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dc1ab71740c4970bfbb9630883923ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right"><xbrli:measure>lgnd:contingent_value_right</xbrli:measure></xbrli:unit><xbrli:context id="ib419e06b57b54f5c8f34756ee9797e58_D20100101-20100131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2010-01-01</xbrli:startDate><xbrli:endDate>2010-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contingent_value_right_series"><xbrli:measure>lgnd:contingent_value_right_series</xbrli:measure></xbrli:unit><xbrli:context id="i194dc7eb8286428aa943ce425971b4b8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43db8217ff36458e87356cae1ff73eb4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i921ef3db471b47e886c3c26b72c7c384_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaafd9004e1524a9686d8306a396aa924_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdfc9f4e909742e7b03c3eca98c41196_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica554f22c30d4304a7166e4a018118e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3d63dad091346d4b421cc89bf1e6cf2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>lgnd:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i45c44217a7754fde9db2a176d420d07e_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325334d147084fc3aa258bd786bbca4a_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id01f6fee2fc241329c914948fff4bda7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d94099936a491687dbdd22e65b4761_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2b572383900440a9b8b357255d25c76_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2635945e42ab464987f287db2ac7954c_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf689c5950764536b68fadb81ab2aee0_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="option"><xbrli:measure>lgnd:option</xbrli:measure></xbrli:unit><xbrli:context id="i87eb5ec96aa44c22872e02ee5f10ca53_D20180501-20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-05-01</xbrli:startDate><xbrli:endDate>2018-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba9060814074f5b8b13493a50dcc9ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2c459c7be754d97891d9360f85d4082_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i573a15b797f746cc9687adb9f4c7f519_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia72734fd1bc34d3f98100401134c40ef_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1275fb9984434e01b87ce488fddf54ad_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib33c801b49164b99a9d4646db3085406_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27f53be60bef4e978e550a0a4312773a_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e0901d9e25c46e498905e04372debe7_D20191031-20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-31</xbrli:startDate><xbrli:endDate>2019-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="civil_complaint"><xbrli:measure>lgnd:civil_complaint</xbrli:measure></xbrli:unit><xbrli:context id="ia10c9da04455423daca5e24de07ee725_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000886163</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i24aac44094964d4184ea8d0c77bbf073_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C.  20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8xNzI_b87f1627-cefd-4c14-ae03-700f9b750dff">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.807%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NTY4MjBmM2QyMjA5NDA1MGI4ZDliYzFmNmM4MDk3ODAvdGFibGVyYW5nZTo1NjgyMGYzZDIyMDk0MDUwYjhkOWJjMWY2YzgwOTc4MF8wLTAtMS0xLTU5NTM1_537f7ff8-9df1-49c3-96c6-9d94abbbea68">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Quarterly Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yOTY_4e4101ca-e907-4625-bbbc-4bdfbe8fe09c">March&#160;31, 2022</ix:nonNumeric>  </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">or</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NmNiNzU1ZWIxY2NhNGFlYTliY2QwYTY5OGFjMjdmODAvdGFibGVyYW5nZTo2Y2I3NTVlYjFjY2E0YWVhOWJjZDBhNjk4YWMyN2Y4MF8wLTAtMS0xLTU5NTM1_3436d683-bbb9-4e5d-a750-59ac40f44483">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">For the Transition Period From ______ to ______ .     </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg2_e18948e2-9907-44b3-af11-a21e8bbd1c2c">001-33093</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><img src="lgnd-20220331_g1.jpg" alt="lgnd-20220331_g1.jpg" style="height:86px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8zOTg_ea2eedfa-0b7f-4428-8934-900df0037e9a">LIGAND PHARMACEUTICALS INCORPORATED</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.467%"><tr><td style="width:1.0%"></td><td style="width:39.481%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y18wLTAtMS0xLTU5NTM1_3303d364-11c3-456c-a2ae-c06b24ded4fb">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y18wLTEtMS0xLTU5NTM1_8186cf6f-8022-4c70-8a2f-f28a7540f0f0">77-0160744</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Identification No.)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y18zLTAtMS0xLTU5NTM1_2f1f6936-9101-4a9c-a1f6-dcb8a69bc265">5980 Horton Street, Suite 405</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y180LTAtMS0xLTU5NTM1_cda7b7e3-8532-47c3-aa50-f9f4933777c4">Emeryville</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y181LTAtMS0xLTU5NTM1_99aa19b4-1fda-408f-9e32-eec71468331f">CA</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y181LTEtMS0xLTU5NTM1_179ec2d0-dce7-45b4-ad1d-59bc01825cdf">94608</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg3_9fd27bed-4109-4069-a05c-194c6cfbf0e7">858</ix:nonNumeric>) <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg4_c0a3a1ce-7a25-4b3b-a610-55b6aadc0051">550-7500</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's Telephone Number, Including Area Code) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Securities registered pursuant to Section 12(b) of the Act: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.515%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWVjNzYzZWQyNGY4NGJjNjkwN2M5YjFkMmRkZjZjNWUvdGFibGVyYW5nZTo1ZWM3NjNlZDI0Zjg0YmM2OTA3YzliMWQyZGRmNmM1ZV8xLTAtMS0xLTU5NTM1_df7615e0-1a92-49e3-a2b9-445a53808c28">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWVjNzYzZWQyNGY4NGJjNjkwN2M5YjFkMmRkZjZjNWUvdGFibGVyYW5nZTo1ZWM3NjNlZDI0Zjg0YmM2OTA3YzliMWQyZGRmNmM1ZV8xLTEtMS0xLTU5NTM1_b0e8a85a-be6b-4276-a306-8e67ca61e280">LGND</ix:nonNumeric></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:94%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWVjNzYzZWQyNGY4NGJjNjkwN2M5YjFkMmRkZjZjNWUvdGFibGVyYW5nZTo1ZWM3NjNlZDI0Zjg0YmM2OTA3YzliMWQyZGRmNmM1ZV8xLTItMS0xLTU5NTM1_753b374d-67da-472d-ba03-30551650390e">The Nasdaq Global Market</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">________________________________________________________________________________________</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg5_a403e4ba-fa0b-4e7f-bffa-d7fa60ac6566">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTkw_c4c4bff0-921c-40c1-89cf-7a2121274c92">Yes</ix:nonNumeric>  &#9746;    No  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See definitions of  &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221;  &#8220;smaller reporting company,&#8221; </span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and "emerging growth company" in Rule 12b-2 of the Exchange Act.  (Check one)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.649%"><tr><td style="width:1.0%"></td><td style="width:29.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.742%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.529%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NjAzNDk5MDkwYTBkNDE3N2I3NTc4ZTY0YWRjMGUxZWUvdGFibGVyYW5nZTo2MDM0OTkwOTBhMGQ0MTc3Yjc1NzhlNjRhZGMwZTFlZV8wLTAtMS0xLTU5NTM1_a71f49ea-64c3-46c9-99a8-d176f9a10dd5">Large Accelerated Filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated Filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NjAzNDk5MDkwYTBkNDE3N2I3NTc4ZTY0YWRjMGUxZWUvdGFibGVyYW5nZTo2MDM0OTkwOTBhMGQ0MTc3Yjc1NzhlNjRhZGMwZTFlZV8xLTQtMS0xLTU5NTM1_c33f6e98-5874-4001-acfc-fda348701cd9">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NjAzNDk5MDkwYTBkNDE3N2I3NTc4ZTY0YWRjMGUxZWUvdGFibGVyYW5nZTo2MDM0OTkwOTBhMGQ0MTc3Yjc1NzhlNjRhZGMwZTFlZV8yLTEtMS0xLTU5NTM1_aa67ae40-d6c9-4bb7-890a-4b514de5b92d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTkx_a3e4fab6-b8b0-4c49-9ebc-eaa83c3ad4c0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">    No  &#9746;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of May&#160;5, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="ia08cf90d3d0749cba99e0a20f8f8db7f_I20220505" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTQ5_224c3164-d26d-4f2f-936e-efb3fd0c9121">16,861,339</ix:nonFraction> shares of common stock outstanding.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.040%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.758%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I.  FINANCIAL INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_13">ITEM 1.  Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_16">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_19">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_22">Condensed Consolidated Statements of Comprehensive Income (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_25">Condensed Consolidated Statements of Stockholders' Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_28">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_64">ITEM 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_64">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_76">ITEM 3.  Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_76">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_79">ITEM 4.  Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_79">28</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II.  OTHER INFORMATION</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_85">ITEM 1.  Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_85">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_88">ITEM 1A.  Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_88">29</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_91">ITEM 2.  Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_91">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_94">ITEM 3.  Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_94">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_97">ITEM 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_97">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_100">ITEM 5.  Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_100">32</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_103">ITEM 6.  Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_106">34</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_106">SIGNATURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i24aac44094964d4184ea8d0c77bbf073_106">34</a></span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.170%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">GLOSSARY OF TERMS AND ABBREVIATIONS</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Abbreviation</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definition</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021 Annual Report</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the year ended December&#160;31, 2021, filed with the SEC on February 28, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$750.0 million aggregate principal amount of convertible senior unsecured notes due 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ab Initio Biotherapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amgen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Avista Public Acquisition Corp. II</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ASU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting Standards Update</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent value right</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Crystal Bioscience, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex Pharmaceuticals, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan, as amended and restated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Food and Drug Administration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Generally accepted accounting principles in the United States</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gilead Sciences, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand Pharmaceuticals Incorporated, including subsidiaries</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of March 23, 2022, among APAC, Ligand, OmniAb and Merger Sub</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Merger Sub</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orwell Merger Sub, Inc., a wholly owned subsidiary of APAC</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">OmniAb Business</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Ligand's antibody discovery business</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Pfenex Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q1 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Q1 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's fiscal quarter ended March 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SBC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Separation and Distribution Agreement, dated as of March 23, 2022, among APAC, Ligand and OmniAb</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Travere Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Viking Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">xCella Biosciences, Inc.</span></div></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i24aac44094964d4184ea8d0c77bbf073_13"></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">     Item 1. Condensed Consolidated Financial Statements</span></div><div id="i24aac44094964d4184ea8d0c77bbf073_16"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except par value)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.738%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMy0xLTEtMS01OTUzNQ_0925179b-c929-4069-b3b0-f09feb64f98e">14,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMy0zLTEtMS01OTUzNQ_e3208043-c7b2-4ee3-bf42-ad9ab2624087">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNC0xLTEtMS01OTUzNQ_2286d4af-6eb5-41da-ab62-f469be5d6fe9">189,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNC0zLTEtMS01OTUzNQ_a576f3d3-17ae-49b1-90b1-bd13dd736eb6">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNS0xLTEtMS01OTUzNQ_a3c829f0-0c47-4556-b560-d5c309c154e1">41,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNS0zLTEtMS01OTUzNQ_69ccef75-3b59-41f1-8c3f-df325903ed4f">85,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNi0xLTEtMS01OTUzNQ_11b6c294-b21f-4ed9-859a-aaef5fe58057">25,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNi0zLTEtMS01OTUzNQ_00b76add-9057-49b7-9923-6d0d8802ac22">27,326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNy0xLTEtMS01OTUzNQ_7e8e30e0-6ef6-4fa0-899d-b74f6c523d43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNy0zLTEtMS01OTUzNQ_8e4399f3-4f3e-415f-859e-47df2ac948dc">6,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOC0xLTEtMS01OTUzNQ_64cce4a4-dde4-4d6d-97a1-dad4aac30a49">4,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOC0zLTEtMS01OTUzNQ_a560e878-27b7-4840-8bfb-fbd9856a02b3">4,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOS0xLTEtMS01OTUzNQ_307eb8de-f995-437b-af79-65bb0acf1e35">276,066</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOS0zLTEtMS01OTUzNQ_3a2b7e98-7a7d-47cf-bd89-1e7e03d827bd">464,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTAtMS0xLTEtNTk1MzU_ed245256-2d68-4b23-94c5-3eb76fbd8bac">35,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTAtMy0xLTEtNTk1MzU_606af54f-901b-4817-9c2e-54fcf819fa54">34,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTEtMS0xLTEtNTk1MzU_95a6a1e5-73df-4728-be8f-70484b2c6189">539,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTEtMy0xLTEtNTk1MzU_74a828b3-2fcf-469c-a191-667e68c24df2">551,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTItMS0xLTEtNTk1MzU_43346c98-bee5-4c1a-8ff8-c702bb77dc3b">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTItMy0xLTEtNTk1MzU_cd61290c-76dc-4074-8070-6f32aa3d9404">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commercial license rights, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTMtMS0xLTEtNTk1MzU_69427ab1-f944-4523-9ac8-99b684d2536a">10,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:CommercialLicenseRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTMtMy0xLTEtNTk1MzU_4da0ecf3-a76e-4711-80a7-28e797d8371f">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTQtMS0xLTEtNTk1MzU_27ed2fee-940f-4756-9b1e-29d53f3acb77">24,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTQtMy0xLTEtNTk1MzU_6881f94f-de53-40b3-b8d7-d359dcb6ad0c">20,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTUtMS0xLTEtNTk1MzU_a8e49baa-2eef-46a6-a58c-a1c44a4de946">15,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTUtMy0xLTEtNTk1MzU_eb10662d-fc5a-4191-bf94-7c23733742f5">16,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTYtMS0xLTEtNTk1MzU_3e561f36-8ca5-442f-8678-047a79780339">15,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTYtMy0xLTEtNTk1MzU_e2a3f820-9e20-40aa-ba73-4119ab483584">16,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTctMS0xLTEtNTk1MzU_15b6928a-4e4e-4ec1-b984-0d2fbb5c6cea">6,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTctMy0xLTEtNTk1MzU_013163f4-c780-4fba-811c-6800e77ed5b2">2,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTgtMS0xLTEtNTk1MzU_e7def1c0-b2c8-4dd3-a2c3-fc8fcce31a3a">1,105,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTgtMy0xLTEtNTk1MzU_a81dda23-b9c4-44d2-ac43-23bff84fe090">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accounts payable </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjEtMS0xLTEtNTk1MzU_d5951dd3-04a4-47a2-b36c-2dbb2b65722d">6,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjEtMy0xLTEtNTk1MzU_48e19e82-24bc-4cbd-91a3-dd9cb31c5980">8,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjItMS0xLTEtNTk1MzU_677cf79e-6689-4d17-973d-df664f8b4f04">15,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjItMy0xLTEtNTk1MzU_72bc1f8c-6d35-4aab-88aa-4cdae7ea4d3e">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Income taxes liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMS0xLTEtNzM5Nzc_e049b28b-c4e6-49b9-9673-d223f9a72e2c">5,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMy0xLTEtNzUzMjY_d1396c65-e69c-47e6-b6ff-ea1fc9c6b416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMS0xLTEtNTk1MzU_da753ba9-0f5a-47bf-8ad0-1c15185766fb">1,524</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:CurrentPortionOfLiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMy0xLTEtNTk1MzU_17002867-c4e1-413b-9d90-b65c8bc6f548">2,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjQtMS0xLTEtNTk1MzU_f53d84ab-cf24-42ae-8c18-1c608aad5f83">10,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjQtMy0xLTEtNTk1MzU_0f2d9826-6bb7-4c0e-815f-99b7fca80b39">10,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjUtMS0xLTEtNTk1MzU_2996c09c-e579-44b3-968e-d90e9dc2b1a1">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjUtMy0xLTEtNTk1MzU_8e705d13-85ee-4e7c-a41c-83191915832c">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Current financing lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjYtMS0xLTEtNTk1MzU_6bd5e283-3b18-45c1-92cb-714c3256e778">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjYtMy0xLTEtNTk1MzU_f5eb6a32-3a39-4c17-9e73-c07f603bd7f0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjctMS0xLTEtNTk1MzU_6731568c-4e30-4a5b-943b-524798bfab79">42,578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjctMy0xLTEtNTk1MzU_83ea1a12-8b5e-427c-9cc4-f40311d84ba5">41,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023 convertible senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjgtMS0xLTEtNTk1MzU_9b01b405-ae91-4340-9e37-f099747dcddc">176,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjgtMy0xLTEtNTk1MzU_bbba352d-ba11-474a-8219-d3f1cfa18aa0">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjktMS0xLTEtNTk1MzU_02fc7336-37d6-4639-9da7-8d7b1febe61e">7,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:LiabilityForContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjktMy0xLTEtNTk1MzU_db1577cb-df4b-489b-9405-9915607a2d42">8,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzAtMS0xLTEtNTk1MzU_a559031f-a446-4870-8ebb-f1633207b337">39,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzAtMy0xLTEtNTk1MzU_a115e6e5-ca35-416b-b2f8-bb91fd5074aa">59,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzEtMS0xLTEtNTk1MzU_893df428-4211-4e72-9501-743bc72ac685">16,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzEtMy0xLTEtNTk1MzU_35dd2d70-6ec9-4142-8fde-b7e238144e52">15,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzItMS0xLTEtNTk1MzU_a1a8863d-da7c-4473-85c1-a20e44503318">29,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzItMy0xLTEtNTk1MzU_515feba1-7616-40ec-99df-e6e71ebd2e70">30,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzMtMS0xLTEtNTk1MzU_69a052d4-8d5a-4ab8-8cb1-031777a7b5c9">311,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzMtMy0xLTEtNTk1MzU_e65dc32a-93d7-4ce5-83df-19ff289e403b">476,431</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzQtMS0xLTEtNTk1MzU_b9cc3268-26ee-47e8-b751-196b6d9908bd"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzQtMy0xLTEtNTk1MzU_5e957ab1-ffa7-4273-ac45-79135fd60ed3"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8yNA_b2d4a385-4ce1-4a51-9812-23456d42cea0"><ix:nonFraction unitRef="usdPerShare" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8yNA_b915bc0d-0f09-4342-ab13-5b196a70c1a1">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8zOA_2fb65cce-ca8e-4023-8a9c-a84a9a78d9eb"><ix:nonFraction unitRef="shares" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8zOA_f5f294a2-b738-4c0f-9aa2-61722eda43dc">5,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_02649cfa-e087-435f-9956-b4731f8c3fea"><ix:nonFraction unitRef="shares" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_1409dec6-1049-4400-b33b-dba16c62b94b"><ix:nonFraction unitRef="shares" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_b49bdff1-3af6-43c9-8cc1-2e7831a09729"><ix:nonFraction unitRef="shares" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_be8416e3-aae6-4ba3-b0f5-c624e3b845c4">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMS0xLTEtNTk1MzU_a9a97bd6-01a7-4fa9-a1b0-d053c6d92c7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMy0xLTEtNTk1MzU_31b9d08d-cf60-4ba1-a883-3018004b0c8a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8yMQ_29ae611a-0490-44ef-962c-859f9b49f6ea"><ix:nonFraction unitRef="usdPerShare" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8yMQ_c6323c92-430a-4507-822b-3da30ef21397">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8zNQ_1a22fb23-68e1-4850-a32a-87dc3672b44b"><ix:nonFraction unitRef="shares" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8zNQ_ce870594-8a5f-4943-9f6e-b1f36a5e4e6a">60,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl81Nw_36dde462-6a4b-40c4-aa1e-fc90a33836db"><ix:nonFraction unitRef="shares" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl81Nw_e9dca2ce-1150-48a3-b552-e2cbbe328da3">16,861</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl82NA_1fb77536-3234-4ba3-b2d1-4c67a0b560d5"><ix:nonFraction unitRef="shares" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl82NA_9028f0db-f813-433b-a40b-64816654015d">16,767</ix:nonFraction></ix:nonFraction>  shares issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMS0xLTEtNTk1MzU_ce4cfef7-a121-4bcf-bbb5-b2a1a22e4dde">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMy0xLTEtNTk1MzU_3ba6b5fc-9c21-4db8-b747-8cd821631f84">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzgtMS0xLTEtNTk1MzU_0172bdf7-3079-4fb8-add7-b95dca509f28">325,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzgtMy0xLTEtNTk1MzU_0a49703f-6143-4890-a450-f2346d80bc22">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzktMS0xLTEtNTk1MzU_5139dda8-b1b5-43e1-a47d-657f25f93172">1,031</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzktMy0xLTEtNTk1MzU_ef76113f-270a-42cf-b86c-d70346f36b0b">917</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Retained earnings </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDAtMS0xLTEtNTk1MzU_3fb4e421-d4e4-4aee-829a-1e9643e5bb7c">468,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDAtMy0xLTEtNTk1MzU_a363ea19-705a-4892-917d-e30a25209757">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDEtMS0xLTEtNTk1MzU_a321faa7-cb3a-4348-81a7-bfa4ecb99fd7">793,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDEtMy0xLTEtNTk1MzU_a38b464d-69fa-4292-9b8b-57dfd30836a4">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDItMS0xLTEtNTk1MzU_f2575a3f-3a05-4ea8-8754-b5b13be78ebe">1,105,184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDItMy0xLTEtNTk1MzU_6a61809a-1e50-46cb-8f2f-4563abdcad0e">1,297,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_19"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share amounts)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:69.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.458%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.460%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2871262664774e9c93e671bd91fbc05a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNC0xLTEtMS01OTUzNQ_ccd56c15-f742-4b05-bc17-f2dd1ec97392">13,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28b08e6912b04510a2abbaffe52e8c52_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNC0zLTEtMS01OTUzNQ_85b04152-c09f-4536-a6ee-aff5003b8195">7,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af8f3a1ea1147389b4f58ce1a5ce5c3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNS0xLTEtMS01OTUzNQ_d723f06c-fb1b-42f1-b0be-00fed675a5e7">12,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNS0zLTEtMS01OTUzNQ_86544294-ba61-44c5-a177-85637bf6833a"><ix:nonFraction unitRef="usd" contextRef="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNS0zLTEtMS01OTUzNQ_f2d12651-5c23-4d07-946e-4f02c5b958b3">31,272</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bdb647ddf147bd84a8bb24e2666210_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNi0xLTEtMS01OTUzNQ_8d249bce-9f56-43f5-81df-818747defc38">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd7481a03054f56837d5f2889064a3e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNi0zLTEtMS01OTUzNQ_3b9281e2-e5ac-44f5-9747-22034f341b56">16,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNy0xLTEtMS01OTUzNQ_2521d48a-6940-4c15-ae40-a541a61d84ea">45,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNy0zLTEtMS01OTUzNQ_fd6b88a1-d19e-453b-bf93-cbe41412da84">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Cost of Captisol</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfOS0xLTEtMS01OTUzNQ_f9528704-f63b-470e-88b1-5e8bcea72b94">4,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:CostDirectMaterial" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfOS0zLTEtMS01OTUzNQ_98c27444-571c-4300-8677-80836be345e5">8,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTAtMS0xLTEtNTk1MzU_058038a6-f371-48b6-a22c-f34d2dcb4421">11,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTAtMy0xLTEtNTk1MzU_065a0f06-234e-451d-8b39-d0009785837e">11,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTEtMS0xLTEtNTk1MzU_fd985838-d3b3-4204-b9f9-3126bdf47139">20,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTEtMy0xLTEtNTk1MzU_82980605-7778-4187-8376-bfe2a485aa3c">17,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTItMS0xLTEtNTk1MzU_32aa1f89-f220-47c1-b5c2-ec1f89fb419b">18,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTItMy0xLTEtNTk1MzU_e7a5f942-b72e-49b9-a059-00c127bdc878">12,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTQtMS0xLTEtNTk1MzU_dda246fa-8163-40c4-8ef7-cfee87a84f54">54,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTQtMy0xLTEtNTk1MzU_a3fc28db-0d9b-4377-b111-a6c15e380528">50,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTUtMS0xLTEtNTk1MzU_c3af6b9a-e756-4fe3-b0da-5f259ebab7df">9,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTUtMy0xLTEtNTk1MzU_30b1ad3f-ee28-431c-a7f0-fadd8fe9d307">4,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Gain (loss) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTctMS0xLTEtNTk1MzU_99011954-6975-4c04-9f82-9d3896ab87a2">12,877</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTctMy0xLTEtNTk1MzU_30ed4b70-287a-4c80-adc9-99dfa833bbbc">13,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTgtMS0xLTEtNTk1MzU_539af246-29a1-4a79-97cb-5ab4072ca693">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTgtMy0xLTEtNTk1MzU_ad267946-d5b6-4e00-9573-9ddf2245ab41">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTktMS0xLTEtNTk1MzU_f015af37-750f-4c2e-8b07-c39adef4a796">789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTktMy0xLTEtNTk1MzU_b41d12de-ff66-4b2a-96c4-de2f50a767ff">5,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjAtMS0xLTEtNTk1MzU_284a6762-b186-4352-a120-4f8c1aeb41a8">2,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjAtMy0xLTEtNTk1MzU_25782cc7-4dec-4434-946a-05bc40802eec">6,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjEtMS0xLTEtNTk1MzU_6a6c2140-fdff-46d3-8a15-78834f5c081d">10,834</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjEtMy0xLTEtNTk1MzU_bd33c05c-6c30-44ce-9377-d8bed22a0106">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income (loss)  before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjItMS0xLTEtNTk1MzU_fcc0d40e-7c09-4ffd-b237-30a938317048">20,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjItMy0xLTEtNTk1MzU_7883873f-64ee-4252-8bb5-1b94f7861bac">5,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax benefit </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjMtMS0xLTEtNTk1MzU_59398e9d-8e87-4e4d-b45e-d8c8e4dc5d44">4,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjMtMy0xLTEtNTk1MzU_db8e4978-e715-4869-84b9-6191f2fc01cf">12,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjQtMS0xLTEtNTk1MzU_63ff8a11-30d4-4db0-b8fe-0cb3db83849e">15,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjQtMy0xLTEtNTk1MzU_ca773ac4-6f0b-4448-9982-55d41784cd54">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Basic net income (loss) per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjYtMS0xLTEtNTk1MzU_e56e4731-6feb-4bb9-9931-8519b1be15ea">0.91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjYtMy0xLTEtNTk1MzU_fbbfa53f-2067-4b1d-8c94-eef9f9c81b0b">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in basic per share calculations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjctMS0xLTEtNTk1MzU_b2ca69ee-39b8-4060-a705-db9b9cdbf339">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjctMy0xLTEtNTk1MzU_a3622068-02f9-4a57-b272-1a7f4c56659b">16,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Diluted net income (loss) per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjktMS0xLTEtNTk1MzU_6d23377c-19fc-488a-8c80-4fe87c97b068">0.91</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjktMy0xLTEtNTk1MzU_863d389b-2d14-4b91-9c5b-0cb4817ce5f7">1.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Shares used in diluted per share calculations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMzAtMS0xLTEtNTk1MzU_a4041dc6-e49f-4502-b589-544e4b4e26ee">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMzAtMy0xLTEtNTk1MzU_25535c20-31cf-43e6-9af0-eb462aa7de03">17,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss):</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfMy0xLTEtMS01OTUzNQ_454f4199-e3c4-451d-80b4-c8c568dcfbad">15,385</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfMy0zLTEtMS01OTUzNQ_bc95796b-7d42-4e43-a0bd-6eb4724bc67a">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNC0xLTEtMS01OTUzNQ_f08ada80-33e9-4503-9b40-02f264d7fc2e">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNC0zLTEtMS01OTUzNQ_28c0b150-717d-433d-8f5b-8be2299b6ea3">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNy0xLTEtMS01OTUzNQ_4d6a4865-060d-4ca3-843b-a712dbf1925c">15,499</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNy0zLTEtMS01OTUzNQ_8fa94b05-caa6-42bb-a743-3e6683852339">18,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f315420bac2445db97141e3eb94ecf8_I20211231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi0xLTEtMS01OTUzNQ_72d548e4-465f-4bf8-b4fe-7ed1821951ea">16,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f315420bac2445db97141e3eb94ecf8_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi0yLTEtMS01OTUzNQ_ef723939-dac4-4390-9177-68d309e123c5">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5b05cfdbed34186bc0ca0f9967ff690_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi0zLTEtMS01OTUzNQ_fd023280-40cc-44dd-9175-e4f2d2190b81">372,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d9dead5c83f404093493fd89aedc1ef_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi00LTEtMS01OTUzNQ_6fa0f172-5c07-4b03-847a-4e609d52cff9">917</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6c591ca6164e298b702b2e5838de27_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi01LTEtMS01OTUzNQ_8dffb38f-ba49-4bff-8f6b-1d330be462e8">449,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi02LTEtMS01OTUzNQ_11bb1299-e0d5-44dd-8203-8292eda62b41">821,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0wLTEtMS03MDA0Mg_e2adfea4-35a8-4671-b333-781072ebc07b">ASU 2020-06 adoption, net of tax (Note 1)</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f9217abff4940c09241816ada5b00d7_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0zLTEtMS02OTIyNA_e96d474d-8d86-490d-a6b5-c303c2df7da1">51,130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i745a10c5acc04c8abff6813d0fbcc32c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy01LTEtMS02OTI0OQ_637707a8-c224-4777-914f-72aaf8468f36">35,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87c3f0f2b43c4a02a873a348ac60340e_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy02LTEtMS02OTIzMA_06f83863-3cb4-4064-ab38-ea1eec17ce94">15,997</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2b8ad2425b94970836064433e1b9c36_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0xLTEtMS01OTUzNQ_6a4755ef-9c41-4da2-8528-e14ad5edf7af">94</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic54fc48630a943be8d51ab84bb6ec9e1_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0zLTEtMS01OTUzNQ_d8136749-c072-466a-b70b-5451913ea05e">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy02LTEtMS01OTUzNQ_4e3924f2-586b-43fb-ba4a-5341f4e2bbdc">5,515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54fc48630a943be8d51ab84bb6ec9e1_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNC0zLTEtMS01OTUzNQ_0e623fb8-f715-42e2-be8f-dbc538731f44">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNC02LTEtMS01OTUzNQ_fc5f53cd-f733-42ed-8a08-f64067253cf5">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04dfa09c315e4ea8937000c9fbcebd65_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNS00LTEtMS01OTUzNQ_01eba2d6-5326-4eab-b3cd-96de0bef6cc9">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNS02LTEtMS01OTUzNQ_595a65e2-2f65-4964-934a-84eafdce9130">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05239c6a6e534a8c889d6057c3a05746_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfOS01LTEtMS01OTUzNQ_18c655db-b216-46bd-bb7d-998f4988e4ae">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfOS02LTEtMS01OTUzNQ_77f60b8f-3e69-4b91-b620-521e0190276f">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i29e36d3c6bfa46a3aabff2ac65a972b1_I20220331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtMS0xLTEtNTk1MzU_b0864a3f-5c14-4d29-b821-d4f10f812af4">16,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e36d3c6bfa46a3aabff2ac65a972b1_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtMi0xLTEtNTk1MzU_0e9d021e-38dc-4ee8-b935-b85ac4838274">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida954be77ff74c0bbe3dc1fe29aee07d_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtMy0xLTEtNTk1MzU_154f2dbb-e32b-4df5-bf69-63dd00d0b515">325,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2349b019bea04c3f8818d90c8e36dfe4_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtNC0xLTEtNTk1MzU_f0cec5ae-4b47-480a-8b5c-f0247b23304f">1,031</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib57655db6c244e568e24627c0da2b0e6_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtNS0xLTEtNTk1MzU_c6a33098-b620-4fba-b470-3b7717a0f8ab">468,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtNi0xLTEtNTk1MzU_97146666-7e9a-4df3-8940-6e12f97dfba0">793,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid in capital</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings </span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie23dddf73d564cccbeb38cedfbf213d4_I20201231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi0xLTEtMS01OTUzNQ_c1710298-adcf-4d31-a4a7-7b1df5f1bcda">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23dddf73d564cccbeb38cedfbf213d4_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi0yLTEtMS01OTUzNQ_15e74ed5-3dd4-48f8-bd0d-c96f049a01b8">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf1964f2dbc3421fbd584115f1a95eb8_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi0zLTEtMS01OTUzNQ_459f4790-07ef-4535-82a9-e3606baae8ab">318,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea088c6521ae42dabe8f16d54142f236_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi00LTEtMS01OTUzNQ_e714005d-f04d-4c96-afaa-79364b0db731">801</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40321155ca4046eba9b0de104f5ce8db_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi01LTEtMS01OTUzNQ_e4a716f9-0816-49b2-9c8c-087003cd8c95">391,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8542ff7045c84ed5bbfbe302627e05db_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi02LTEtMS01OTUzNQ_c3ccdee3-4446-4dcb-95ff-26feb1375f1a">709,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0adfb1eca5a640698b9228529cba9397_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy0xLTEtMS01OTUzNQ_860a8e46-7afa-4c78-bed8-ad5be55614c0">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0adfb1eca5a640698b9228529cba9397_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy0yLTEtMS01OTUzNQ_ff0351f9-d82f-44ce-b879-2d01faca67b1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy0zLTEtMS01OTUzNQ_4d49953d-881c-4cd6-8e2a-9dcdc48f65a9">20,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy02LTEtMS01OTUzNQ_99ff4d7b-5c4c-40ae-9a17-abd308fd57ce">20,581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNC0zLTEtMS01OTUzNQ_cd2cd2a3-9b26-4087-844d-c3d218b0d638">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNC02LTEtMS01OTUzNQ_400efa6c-f287-4f9a-97c0-477a035ca79d">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unrealized net loss on available-for-sale securities, net of deferred tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i154f58555d7d4643b2e1f528903985d9_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNi00LTEtMS01OTUzNQ_9e2f38d0-0e1d-46eb-b984-6fdd38404b1d">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNi02LTEtMS01OTUzNQ_02ed1642-7e2e-4e56-99f2-347d31470dde">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant and bond hedge unwind transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNy0zLTEtMS01OTUzNQ_c63da47c-9fa5-4c6a-8a12-61e23dafab80">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNy02LTEtMS01OTUzNQ_6307ca06-8cc6-4f9e-8f52-5ccdd5cfcfbd">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Reacquisition of equity due to 2023 debt extinguishment, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOC0zLTEtMS01OTUzNQ_0e5ba9cb-4091-4540-bde6-6ae7fc53f018">9,086</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOC02LTEtMS01OTUzNQ_7be46f41-c6c1-4860-8279-7a11130bff7a">9,086</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tax effect for 2023 Notes transactions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOS0zLTEtMS02MDIyMA_ce63024a-594f-476e-acd6-849502d013e5">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOS02LTEtMS01OTUzNQ_5e1c775b-6aea-485a-867b-df19d6d6e0e5">2,032</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c8f70bcb8544a2d8a2cb58c9207ff0b_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTAtNS0xLTEtNTk1MzU_8162255e-4209-4013-baf8-4f32a1d14093">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTAtNi0xLTEtNTk1MzU_eab7726c-880f-4aff-aeaf-cb788cbb7a70">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c66c5680f12470c9b06b7b32d2062a2_I20210331" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtMS0xLTEtNTk1MzU_9f341f50-3fe7-4b5d-a8a9-28bb1db5e043">16,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c66c5680f12470c9b06b7b32d2062a2_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtMi0xLTEtNTk1MzU_c82c3b9d-6e83-4c0c-bc0a-acb70c883de1">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b75c9953264ac2b488a162bfbb1fa7_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtMy0xLTEtNTk1MzU_8c78cc15-c922-4351-b88d-370eb1ff56f5">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6fb955a30fcb449ca1b8aed8ec29365a_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtNC0xLTEtNTk1MzU_4b57c46c-5e93-4bb4-893a-96b6c4423ce4">856</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0211e1bbe9f44dfebcdf0ebe1dac694e_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtNS0xLTEtNTk1MzU_9635f0eb-5a27-4cf0-9a26-17b3aec6e406">410,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id709f7f89de844718660a4c1048c1cf3_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtNi0xLTEtNTk1MzU_33653d4a-0f26-40c7-868c-981545da94b4">745,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_28"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) (in thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNC0xLTEtMS01OTUzNQ_c9307c6d-bc7d-4894-84fa-8a8ad3650c7f">15,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNC0zLTEtMS01OTUzNQ_0a927ae9-d973-469c-95a1-60360428f9de">18,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimated fair value of contingent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNi0xLTEtMS01OTUzNQ_7e1f8804-6e70-4104-8a41-40b4ae9bfece">1,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNi0zLTEtMS01OTUzNQ_1835277d-6ba1-4ba8-83f8-4b68f68f2bbc">1,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNy0xLTEtMS01OTUzNQ_97435651-0bb6-447a-8036-125fae613d29">13,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNy0zLTEtMS01OTUzNQ_2792305e-a79e-4acf-b844-d179dc33b4a7">12,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of premium on investments, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOC0xLTEtMS01OTUzNQ_cea00978-b839-446b-892d-a56a47e77879">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOC0zLTEtMS01OTUzNQ_441fccd0-647c-42c1-ba5e-d18421d5cc5c">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of debt discount and issuance fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOS0xLTEtMS01OTUzNQ_2aeb71e6-d3ae-4f1d-9df0-4ec40d3fa1ff">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOS0zLTEtMS01OTUzNQ_ad3172e9-9adf-4ea4-b557-1b3a6043fb97">4,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of commercial license rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTAtMS0xLTEtNTk1MzU_c41271e8-255d-4278-9198-7091e279edda">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTAtMy0xLTEtNTk1MzU_bfdf1ca2-09fd-4582-ad20-5eb88c2c05b3">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) on debt extinguishment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTEtMS0xLTEtNTk1MzU_0e99b910-5fde-4332-8a7c-e7d37fd6cdf1">1,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTEtMy0xLTEtNTk1MzU_784e6ebb-8da0-4afe-8c67-f295cf2946e6">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTItMS0xLTEtNTk1MzU_627a0547-6655-4ec6-951c-3917f5c95f7e">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTItMy0xLTEtNTk1MzU_f605a571-cdf6-4758-8ca2-23f5e549bb5c">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTMtMS0xLTEtNTk1MzU_00f315de-7b91-4b86-9ff5-44fc71426886">16,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTMtMy0xLTEtNTk1MzU_5a1b3bde-951b-48c8-9b7b-c395cdaa8158">12,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Loss (gain) from short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTQtMS0xLTEtNTk1MzU_1952efef-3d7e-4a76-9dff-de6c4c60d566">12,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="lgnd:GainLossOnShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTQtMy0xLTEtNTk1MzU_ee852cb9-9466-4570-975f-24b5b00821b8">13,090</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTUtMS0xLTEtNTk1MzU_0425d4a4-9935-4d9e-a553-52f004f65ccf">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTUtMy0xLTEtNTk1MzU_b66a0f20-1aa1-4cfe-97a3-8e6e377e1875">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTctMS0xLTEtNTk1MzU_8c186891-1d3a-49a3-9c69-e9e43273a201">43,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTctMy0xLTEtNTk1MzU_6033ed4f-b49b-46e7-9fb3-e65722a2b56c">2,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTgtMS0xLTEtNTk1MzU_5479aa00-6b78-4337-8956-58ed265cacb8">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTgtMy0xLTEtNTk1MzU_cc43342b-c279-4645-a567-5c28f4177798">9,670</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Accounts payable and accrued liabilities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTktMS0xLTEtNTk1MzU_42c1733e-5602-431d-b268-1b477b143a48">2,708</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTktMy0xLTEtNTk1MzU_72d8fb90-5ce1-43d3-8f74-28221bfd095e">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Income tax receivable and payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjAtMS0xLTEtNTk1MzU_6c7b374a-0e2f-484a-a1ae-2a5ecf36aa14">11,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjAtMy0xLTEtNTk1MzU_c1ed677b-2f3a-47c6-9a22-bd0ef7980361">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjEtMS0xLTEtNTk1MzU_713f3a6e-b0c5-4ab2-9007-8096d5d961ec">2,453</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjEtMy0xLTEtNTk1MzU_2a31e8e8-bde0-467e-af82-a52ba9e02683">5,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other assets and liabilities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjMtMS0xLTEtNTk1MzU_98214773-c218-4262-92cb-1ebd0682be4c">233</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjMtMy0xLTEtNTk1MzU_0540e126-d4ba-4704-9971-68a958bb2ebd">3,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjQtMS0xLTEtNTk1MzU_405bc98d-b054-4dba-8ff5-a042750bbb4c">52,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjQtMy0xLTEtNTk1MzU_5d3a0b62-ab1e-4455-9f3f-f633ccc9f44b">10,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjctMS0xLTEtNTk1MzU_77cd7d04-c563-41d4-933f-988744d27496">38,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjctMy0xLTEtNTk1MzU_18e20233-bffa-4e2b-a69b-22204df2320e">72,148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from sale of short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjgtMS0xLTEtNTk1MzU_f9349276-275e-43c3-af41-7e6078f02706">132,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjgtMy0xLTEtNTk1MzU_f3cb7b49-b704-4077-875c-d594a26fc208">109,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from maturity of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjktMS0xLTEtNTk1MzU_fad6cce2-b0e4-4479-8b10-e86e0525a9f9">24,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjktMy0xLTEtNTk1MzU_cbc3b7a2-b574-4012-81de-dd2450ac3537">31,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash paid for equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzEtMS0xLTEtNTk1MzU_21a3e377-ec9e-4d9f-88a6-f30fe7b4b4ec">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzEtMy0xLTEtNTk1MzU_9ea033af-acb3-408e-98f0-730ed961bdd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzItMS0xLTEtNTk1MzU_cebf5b76-6d9e-451b-b768-fa6ac45a9fc1">4,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzItMy0xLTEtNTk1MzU_1972165a-8188-4a21-8b67-16d9978fa57b">3,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzMtMS0xLTEtNTk1MzU_0fb0e64e-6608-47bb-9ff9-e763425c5b1a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzMtMy0xLTEtNTk1MzU_d67db43d-2edc-4f1e-97ee-fe09db974241">240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzQtMS0xLTEtNTk1MzU_09a783db-4423-415f-a32e-a539f0b1f77e">113,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzQtMy0xLTEtNTk1MzU_47b14da6-7478-4361-8477-ce5d5ea29691">65,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Repurchase of 2023 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzctMS0xLTEtNTk1MzU_44193261-05d5-40f6-a9ad-94c476e86ace">163,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzctMy0xLTEtNTk1MzU_7b4279b9-5eed-46b1-8a30-c588df44b7b3">108,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments under financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzgtMS0xLTEtNTk1MzU_971f4fa8-2714-42ca-9901-cf39d4e23296">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzgtMy0xLTEtNTk1MzU_75281507-f5b5-4758-b1e7-170675fb1b1f">3,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Proceeds from convertible bond hedge settlement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzktMS0xLTEtNTk1MzU_4dc0b7cc-fa5a-4993-afee-1b59013f51e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromHedgeFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzktMy0xLTEtNTk1MzU_7f22bb7a-e153-4bdf-8ac2-74e1b75e875b">16,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to convertible bond holders for warrant purchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDAtMS0xLTEtNTk1MzU_4efb6b63-4575-45ea-8322-02ee2b1708f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForHedgeFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDAtMy0xLTEtNTk1MzU_3732ce05-7f6a-4d73-82aa-b4cde8df52ff">16,459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net proceeds from stock option exercises and ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDEtMS0xLTEtNTk1MzU_8b804aaa-44ef-4cb1-8965-55c96f310427">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDEtMy0xLTEtNTk1MzU_91d6c66a-0dcf-4369-a4ec-643bcdb5394a">26,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDItMS0xLTEtNTk1MzU_97ec9989-ee67-4b76-bc5c-e36e9907ee72">5,862</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDItMy0xLTEtNTk1MzU_0a7e2feb-0b86-4332-91d6-edc83ea9a1e7">5,901</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Payments to CVR Holders</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDQtMS0xLTEtNTk1MzU_d5998413-6301-4d4b-a80c-13dc6d8672ce">1,416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="lgnd:PaymentsToContingentValueRightHoldersFinancingActivity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDQtMy0xLTEtNTk1MzU_ab37a1d4-8876-4e7d-869e-79bd44fd7a40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDUtMS0xLTEtNTk1MzU_b8ce65f9-2e7d-47a5-9dcf-e8a251f947f8">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDUtMy0xLTEtNTk1MzU_d8786692-ba02-4e9e-923e-2e9e08b4854b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDYtMS0xLTEtNTk1MzU_a290c33e-03af-400c-96e8-b1d6435c1eca">170,421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDYtMy0xLTEtNTk1MzU_f50e6ce6-e82d-4665-bead-6798e1b3dbe5">91,635</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDgtMS0xLTEtNTk1MzU_b6240f4b-a936-427b-a7f5-fb9158a4bce6">4,529</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDgtMy0xLTEtNTk1MzU_5663e044-14c8-457d-86e7-f77879e6b0dd">15,766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDktMS0xLTEtNTk1MzU_f4f7614c-fd2a-477f-af7a-87acb221d304">19,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8542ff7045c84ed5bbfbe302627e05db_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDktMy0xLTEtNTk1MzU_57279c1e-7b35-4bdc-ac6e-4ce5224ac4f1">47,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNTAtMS0xLTEtNTk1MzU_849fd640-c91b-46d1-9312-2620541a29f7">14,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id709f7f89de844718660a4c1048c1cf3_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNTAtMy0xLTEtNTk1MzU_442233e3-4132-49d7-8516-1afd6efa4c29">32,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental disclosure of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMS0xLTEtMS01OTUzNQ_75495cc2-6e5c-4533-afe5-10c637ee9154">359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMS0zLTEtMS01OTUzNQ_097c3843-799e-4b32-8431-1009c6ab56d8">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Taxes paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMi0xLTEtMS01OTUzNQ_064c1804-1d59-4121-93ba-37b3a5dc3bdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMi0zLTEtMS01OTUzNQ_9583f80c-c847-447c-8f17-1af97e7198a4">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Supplemental schedule of non-cash activity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued fixed asset purchases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfOS0xLTEtMS01OTUzNQ_2a9fc8f8-e797-4b55-b282-795aea61eaea">2,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfOS0zLTEtMS01OTUzNQ_26ae9d1d-f984-47e9-9411-8d36f68a97e0">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accrued inventory purchases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTAtMS0xLTEtNTk1MzU_3d332873-b96b-4b65-a62a-12f523324eed">306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="lgnd:AccruedInventoryPurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTAtMy0xLTEtNTk1MzU_9aa18efd-26f6-43a9-aeb5-70895834d9e1">775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrealized loss on AFS investments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTItMS0xLTEtNTk1MzU_3ba0faf2-95ac-4828-876e-9044e11de3ff">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTItMy0xLTEtNTk1MzU_6610d4ce-58e9-4e0a-855c-80bc690f53eb">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:90%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_31"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIGAND PHARMACEUTICALS INCORPORATED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_34"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this report to &#8220;Ligand,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; the &#8220;Company,&#8221; and &#8220;our&#8221; refer to Ligand Pharmaceuticals Incorporated and its consolidated subsidiaries.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">1.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzI_663eefe9-0aac-423b-96fd-d71f6fab3ec3" continuedAt="i8023152dcbfa423f902758009deb9bc8" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8023152dcbfa423f902758009deb9bc8" continuedAt="id6f6a48696f04dcb964916cd5941548d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMjM_679ba35d-eb7b-44a5-91e4-565c5284b178" continuedAt="if6648a423a4e4386ac6069723041ba25" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if6648a423a4e4386ac6069723041ba25">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</ix:continuation>  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTA_984db0cd-3615-422a-89fb-a3dd34c20082" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNzM_5ddfeedc-d8e1-4c48-8c7a-b7ad5e04f0b1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended March 31, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $<ix:nonFraction unitRef="usd" contextRef="i5d1b66ab770745c8ad6850d6dfd97f30_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzYyMg_dae0a0f5-fee4-4d31-91a2-04550b47b890">20.4</ix:nonFraction>&#160;million, reduced deferred tax liabilities by $<ix:nonFraction unitRef="usd" contextRef="i5d1b66ab770745c8ad6850d6dfd97f30_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzY0Mw_bcecc1dc-12da-407f-9113-2c26be0d97d6">4.4</ix:nonFraction>&#160;million, reduced additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="i42456cb257354b64b669494c1f8a43e9_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzY5Mw_2856c1fb-1384-46f5-9f56-739473c66d83">51.1</ix:nonFraction>&#160;million and increased retained earnings by $<ix:nonFraction unitRef="usd" contextRef="ic6bf4f2b14ab4ca4964ed5c7d1fde736_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzczNg_9023d639-505e-4097-b0b5-c242ed42efa9">35.1</ix:nonFraction>&#160;million. The net balance of the 2023 Notes at January 1, 2022 is $<ix:nonFraction unitRef="usd" contextRef="i6d5f7c3225f742f2837effcd50bb3f07_I20211231" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzc1Nw_f82abf1e-d775-4fe7-b2a0-442b07d827c4">341.1</ix:nonFraction>&#160;million which includes an unamortized discount of $<ix:nonFraction unitRef="usd" contextRef="i6d5f7c3225f742f2837effcd50bb3f07_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyNDY1OQ_25ab67eb-95e0-443f-a462-b04a75ff9e67">2.2</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNzA_638d34de-17a8-4d02-b712-965c63cc5f48" continuedAt="i0b766b65ceae4d6bb6857a309fddbf13" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="id6f6a48696f04dcb964916cd5941548d" continuedAt="i9cde3e97cc9a443a8f25fb99cab7712e"><ix:continuation id="i0b766b65ceae4d6bb6857a309fddbf13" continuedAt="i031b0924ac0b44779b39a6e841835352"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9cde3e97cc9a443a8f25fb99cab7712e" continuedAt="ib4926a86621e45c597e4f8876ec26006"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i031b0924ac0b44779b39a6e841835352" continuedAt="i429930c9e646495b86b4fed4e05fc9cf">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i429930c9e646495b86b4fed4e05fc9cf">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</ix:continuation> During the three months ended March&#160;31, 2022 and 2021, the amount recognized as revenue that was previously deferred was $<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzI3NTk0Nw_a4934969-4517-4af9-8dc5-96fd5012e441">3.7</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzI3NTk1MA_8f7363bd-565d-4e4b-a104-3a6191b1613d">7.3</ix:nonFraction>&#160;million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzU_fb1ec2f8-0466-4926-85b3-627de32802a7" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadcc8e71d6a1438fbd272741cd9b7d95_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNC0yLTEtMS01OTUzNQ_ab3314c5-1a73-4c76-9545-04529fa8559b">4,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07fd099a96414912b8668ce47bea3ec2_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNC00LTEtMS01OTUzNQ_9873bcab-2602-4fce-b364-735ad24e4a9d">4,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee81d901b6a492abb235b3119cc7898_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNS0yLTEtMS01OTUzNQ_8c42ca9b-c346-46a0-8919-a9b52c7dbb85">2,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24d5c0bc6f4744e0b51b5d1f8ae76c36_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNS00LTEtMS01OTUzNQ_05c2f955-5864-4ab4-b90f-9fb888e79995">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04011d0026304dbebecfd23dce2351c2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi0xLTEtMS03MjQwMw_00e87fad-a7b0-4bf7-b00e-a292b8a0b754">2,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a2afd26bd6c45f79cf4af863d253176_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi0zLTEtMS03MjQ1OA_993181a4-0c85-4289-bb4e-02a955481a23">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic21c8159caf94bc9a53b73d289bb1251_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy0xLTEtMS03MjQwMw_0af034b8-f52f-4e76-bdc8-750f05162f2d">1,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0175e6ce3cf48caadfd1f3b8bb97392_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy0zLTEtMS03MzU3Nw_aad16230-8ee8-4a46-be91-aa29531533c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d5dea3dcd743feb47922ec6ed01b4b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi0yLTEtMS01OTUzNQ_7fd0ba69-21e0-43d4-8250-400c2f208a21">1,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bf4fc09793f43a9a8d43f9a8f6a5199_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi00LTEtMS01OTUzNQ_5f5d3284-0627-487f-82d4-23b8740d191a">476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2871262664774e9c93e671bd91fbc05a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy0yLTEtMS01OTUzNQ_f765b1b1-036c-4d75-99b5-6b3821766e2f">13,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28b08e6912b04510a2abbaffe52e8c52_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy00LTEtMS01OTUzNQ_6a7cde8e-7088-42ff-8eb0-3f917df24e3a">7,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia269861fa92141fcb3d9629f7e926de1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItMS0xLTEtNzUxNzY_23273650-3b6c-4682-81bb-380f098ad0f9">6,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a539e9335924d0aabf0ec4d5b20b5b7_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItMy0xLTEtNzUxODc_655b097e-f210-4962-84b0-48b4a13f8b84">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaedc31f3d0524728ab67dc0105f82c05_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtMS0xLTEtNzUxNzk_0e70029b-bdee-4071-9936-5fe6a49e2e91">5,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032d93aa682241bcb144bf6c5d387a4a_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtMy0xLTEtNzUxODc_2612711f-e324-44c2-a714-e303df1ac4e8">30,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af8f3a1ea1147389b4f58ce1a5ce5c3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfOS0yLTEtMS01OTUzNQ_004ae346-32f5-4ad2-951f-e010d8ca5d2d">12,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfOS00LTEtMS01OTUzNQ_3112da10-b178-4cee-bcb2-3ae8416c7b23">31,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i356debce55094a5f8fb2dd9767f8a65e_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItMi0xLTEtNTk1MzU_d8694ce1-2e6b-435e-8fb6-7c0d9e7ed017">5,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ebba23e98694d9baaebf57762ecde39_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItNC0xLTEtNTk1MzU_27f46d62-a36d-45de-8ac7-9e648c3092b7">5,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7769789917214a24a4c7dfc52ac670e3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtMi0xLTEtNTk1MzU_40c19776-41e1-48cb-93b1-220e7b04575f">3,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0a615c256b74c3cad0d586a69d2c6d0_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtNC0xLTEtNTk1MzU_681566f1-a5d1-4e00-a90c-a10eb5a9d3a7">1,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief27a2dceccf46e7bb26272780283c82_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTQtMi0xLTEtNTk1MzU_c06b4048-e6ac-4170-9f8a-00c0966045a4">9,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2873d3d891464c6596099d2f3ceccbc3_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTQtNC0xLTEtNTk1MzU_80944ddc-9a3a-40ad-9908-d86c9e5aa105">8,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10492cd31c0f473a8754fc4b06d6e667_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTUtMi0xLTEtNTk1MzU_9fabdac8-bd3a-4ffe-ad0a-05e7d20af2c4">2,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84aa90196d9044c096cdc13634fd7385_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTUtNC0xLTEtNTk1MzU_c5f2acab-adda-4e2e-918f-cd74c71c7ed0">1,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4bdb647ddf147bd84a8bb24e2666210_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTYtMi0xLTEtNTk1MzU_8c1d2513-1c91-4f9a-a12d-99423ddf3b6a">19,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd7481a03054f56837d5f2889064a3e_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTYtNC0xLTEtNTk1MzU_7eae139c-f64c-4253-b89f-47edf6bcfeee">16,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTgtMi0xLTEtNTk1MzU_c6eacb9b-9495-47b5-a573-07b2aab073c5">45,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTgtNC0xLTEtNTk1MzU_f4ad0cb3-7300-48aa-aa9f-4a9d3d9dd72f">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ib4926a86621e45c597e4f8876ec26006" continuedAt="i0582e81355d14f558dee021435a1358c"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="lgnd:ScheduleOfShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTI_523b3ff6-4aee-41f4-951f-b41a57085b57" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:38.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.290%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy0xLTEtMS01OTUzNQ_215870ea-f492-4036-9dd3-36f3cf208f52">6,231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy0zLTEtMS01OTUzNQ_b6d57447-bba4-4df1-a370-dba52887033d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy01LTEtMS01OTUzNQ_ca93b29d-a7d5-4fac-9293-e8c1af50d2cb">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy03LTEtMS01OTUzNQ_b427c31c-bea8-4ee1-82f0-0ef86dfe6def">6,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC0xLTEtMS01OTUzNQ_6325ef97-16d3-49f9-a804-8782bcd68933">4,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC0zLTEtMS01OTUzNQ_3736c76f-a0bc-485a-b469-2e5bb0c0473a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC01LTEtMS01OTUzNQ_47577def-a8d1-478b-9914-817b2373ba12">84</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC03LTEtMS01OTUzNQ_8bce40ca-8f95-4b02-a6ea-9ec3f55551cf">4,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi0xLTEtMS01OTUzNQ_870039fa-6631-4c56-a03d-48aaafca0f26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi0zLTEtMS01OTUzNQ_d9f2d03c-5e34-4cc8-8f3e-47feef1c4f42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi01LTEtMS01OTUzNQ_961dd8c9-f231-4d13-9018-5b9d50b3e5ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi03LTEtMS01OTUzNQ_ba0c5ae9-0bd5-4d78-8874-8882c839946b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy0xLTEtMS01OTUzNQ_c889619e-617a-4488-9155-c5b45b95c49e">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy0zLTEtMS01OTUzNQ_4fcb74a5-2d01-4479-8f61-c84e4b2869f6">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy01LTEtMS01OTUzNQ_a03671bc-e92a-4a3b-9dae-798bccc46c80">3,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy03LTEtMS01OTUzNQ_7cbf6ea3-55c1-409e-a5b9-a712deddb19d">3,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC0xLTEtMS01OTUzNQ_31a68c8b-e1b7-433d-a1c6-83074c392bbc">152,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC0zLTEtMS01OTUzNQ_ec3be043-484f-4eb8-8d9e-f7d01f3d66ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC01LTEtMS01OTUzNQ_6eef6e84-9671-48cc-ae55-f311fa0c2e69">854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC03LTEtMS01OTUzNQ_393f0507-4288-43a2-96d3-626891ed5cca">151,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS0xLTEtMS01OTUzNQ_c74169d9-9ef1-4022-96d5-f9f7ca605238">3,245</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS0zLTEtMS01OTUzNQ_0765d443-3663-4cbc-aca0-4ba23c95748d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS01LTEtMS01OTUzNQ_143e28e5-8a8f-47b8-8181-8974f8cedc20">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS03LTEtMS01OTUzNQ_b413cfad-256c-4af7-9b93-08a74afd8c3c">3,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56582b6df3664f7283828126f810559e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtMS0xLTEtNTk1MzU_0cf39e90-7fb7-462d-80b0-02a1ebddb058">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56582b6df3664f7283828126f810559e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtMy0xLTEtNTk1MzU_4fb6ddb7-5d93-4d20-88d8-2ffe29aee1f4">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56582b6df3664f7283828126f810559e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtNS0xLTEtNTk1MzU_28767e3d-c00b-4a56-8d17-61c3ebcc1d5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56582b6df3664f7283828126f810559e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtNy0xLTEtNTk1MzU_6dd83770-2c65-4ac1-b343-f30344372a54">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtMS0xLTEtNTk1MzU_03015042-fd0a-4dc4-8037-09730d6240c7">172,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtMy0xLTEtNTk1MzU_9e101075-8fb2-4896-8347-bb895b7ebc79">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtNS0xLTEtNTk1MzU_ceca2248-de20-4264-879f-7b5ec6e5782b">4,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtNy0xLTEtNTk1MzU_0099b1ea-660e-4561-9b46-d5b4130fef58">168,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98b2a53fb0eb405a93cded08866b0e8d_I20220331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTItMTAtMS0xLTcyMjQ4_7ba20d5b-ee9c-4d0d-b6a2-704656ab8bb0">20,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTItMTAtMS0xLTczNTg3_3c02fcef-4e78-4398-9dd2-a97da8a87e56">189,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtMS0xLTEtNjk2MTA_3b60b517-8268-4cd6-bb74-a050d1b83761">63,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtMy0xLTEtNjk2MjQ_a3123c58-7819-4de1-a84b-2c2a6e534f1d">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtNS0xLTEtNjk2MjQ_9c769fce-0593-4f4c-b301-2a0a967d59e0">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtNy0xLTEtNjk2MjQ_fd17832a-26df-45e9-a290-06ed2112a388">63,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtMS0xLTEtNjk2MjQ_3cc89d26-684f-4aea-8bf2-2952d68205f5">29,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtMy0xLTEtNjk2MjQ_a6259d70-d208-43de-9d24-7bb1085d6c5f">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtNS0xLTEtNjk2MjQ_5cd6d1d5-2f3a-41c2-92f4-942a8fe25088">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtNy0xLTEtNjk2MjQ_6afd5807-db44-4d30-a90b-30690aa36ae1">29,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctMS0xLTEtNjk2MjQ_894190e8-c1e2-4db3-b7f1-bebc5fe275ba">36,008</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctMy0xLTEtNjk2MjQ_c0901ee8-3962-4b07-b133-be4892edfda8">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctNS0xLTEtNjk2MjQ_3905a028-644a-4060-8817-bc20c178099b">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctNy0xLTEtNjk2MjQ_1032d906-6f40-4a49-a84e-db1e572c6b33">35,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtMS0xLTEtNjk2MjQ_2c4627df-b36e-4c7a-9009-3586173ecaad">5,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtMy0xLTEtNjk2MjQ_689010e2-a25d-4fd3-aead-348cfa4bd492">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtNS0xLTEtNjk2MjQ_7dc43677-4faf-410a-a68a-a9e0ce3b93a3">2,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtNy0xLTEtNjk2MjQ_ef7a5b21-40b9-462d-a10e-41782627fddd">4,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20bdb340507b4cc49042547bdf096356_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktMS0xLTEtNjk2MjQ_37781b73-c902-42b6-8abb-043570bfa6ce">152,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20bdb340507b4cc49042547bdf096356_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktMy0xLTEtNjk2MjQ_cbd80c01-6c77-4c7f-aaa3-4c7aca96a1b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i20bdb340507b4cc49042547bdf096356_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktNS0xLTEtNjk2MjQ_bfd6e13b-6a5d-49de-ba7c-5fbc1f00d65e">249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20bdb340507b4cc49042547bdf096356_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktNy0xLTEtNjk2MjQ_731c8f40-a861-4d74-a279-ffb0041385d6">151,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtMS0xLTEtNjk2MjQ_1fb137ff-2916-484b-8759-c2aa913084b1">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtMy0xLTEtNjk2MjQ_a34957c6-70dd-415c-a7d1-8f8993c15a6f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtNS0xLTEtNjk2MjQ_f4be4a48-4c18-4dea-b622-bd9f7a5a22a9">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtNy0xLTEtNjk2MjQ_0cb0bdbc-fb83-4754-b29b-d5ed219cbd04">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61db617747884bd480b2ae120011bf66_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtMS0xLTEtNjk2MjQ_6e8bb772-5b3c-4f52-bcc4-8ad8d65dc79d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61db617747884bd480b2ae120011bf66_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtMy0xLTEtNjk2MjQ_e602649d-3a62-43f1-8b01-2944b5199e9e">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61db617747884bd480b2ae120011bf66_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtNS0xLTEtNjk2MjQ_71fdad85-0299-4ad2-8e5e-bda23f7206c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61db617747884bd480b2ae120011bf66_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtNy0xLTEtNjk2MjQ_f2378f73-0ea3-463a-b80a-a7e11d5f1ea3">408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItMS0xLTEtNjk2Njc_739823ec-cbb0-4565-84c6-5fc126faa537">292,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItNC0xLTEtNjk2Njg_592316e2-40e1-47fb-846c-49ba59736a6c">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItNy0xLTEtNjk2NzE_cf00ba94-8d93-4f6a-9915-1f2bbd4b0ad3">2,370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItMTAtMS0xLTY5Njcz_964e6ded-bb05-467d-bd35-fe5062b74e35">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdc3319eb85415ea312cb8a112c69ea_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjUtMTAtMS0xLTcyMjcw_e4be8be1-a1a6-4bba-b333-71e4b4770b2f">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjUtMTAtMS0xLTczNTkw_a9fdabf1-91e1-4a2d-af3c-2a05bec53d38">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended March&#160;31, 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzM_68a82262-c156-4760-bfd2-514852e583be" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMi0xLTEtMS01OTUzNQ_e73ed739-6da6-46f0-8c62-b3e40d973db0">10,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMi0zLTEtMS01OTUzNQ_11e20436-0dd5-45bb-83df-615b129d6fdf">10,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMy0xLTEtMS01OTUzNQ_a03857a0-cc7d-4e9e-9159-724779a06608">6,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMy0zLTEtMS01OTUzNQ_e1b3988d-f433-4314-880a-e47c192f6238">6,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfNC0xLTEtMS01OTUzNQ_901777d0-e3bb-481a-a8d4-18cdb88a8789">16,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfNC0zLTEtMS01OTUzNQ_14b29458-dea5-4426-8a5d-4303aff2658d">16,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of <ix:nonFraction unitRef="position" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTAxODQ_f5f37383-af9a-4d7b-bec5-2f4615f8ce7b">13</ix:nonFraction> positions which were in an unrealized loss position as of March&#160;31, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, <ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTA4MDQ_023b3914-12e7-4cc4-a29f-f3f600f59cf7">no</ix:nonFraction> credit losses were recognized for the three months ended March&#160;31, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i0582e81355d14f558dee021435a1358c" continuedAt="ie78e82f039484fbe939281de3f52ec56"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTc_e0a8e23c-0836-4823-82c9-5c3563d3498c" continuedAt="i32bb8951070148cbbaa2de67ccf71ce3" escape="true">Accounts Receivable and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i32bb8951070148cbbaa2de67ccf71ce3">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</ix:continuation> During the three months ended March&#160;31, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-5" sign="-" name="lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTE4Mzk_7ceb7574-0caf-4f63-acf9-3b8bd5dbaf18">0.1</ix:nonFraction>)&#160;million of allowance for credit losses, respectively, as of March&#160;31, 2022.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNjU5NzA2OTgwNTM1NA_a21e8dc3-e06b-4529-aa59-dd1496c225c6" continuedAt="icd755884cad34e0d9ccc67e258a88f02" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icd755884cad34e0d9ccc67e258a88f02">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="i34997f63ccf047658e1fca662ede1c9f_I20220331" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIwNDkwOQ_f67663c7-b8ca-4387-9ce9-2cef8be61a4e">21.1</ix:nonFraction> million, and as of December 31, 2021 inventory consists of Captisol prepayments of $<ix:nonFraction unitRef="usd" contextRef="if7807a6ec9b74845a3590b8007c957ba_I20211231" decimals="-5" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIwNTEwMw_41bc040c-fc9e-4042-b02b-246ce97b49ea">24.6</ix:nonFraction>&#160;million.</ix:continuation> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzc_fd8d05cc-37a5-46cf-88f8-cfc7abfdde73" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMy0xLTEtMS01OTUzNQ_43346c98-bee5-4c1a-8ff8-c702bb77dc3b">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMy0zLTEtMS01OTUzNQ_86159b2e-3634-4bae-9c54-7ac85b5b78f8">181,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c93540126b4a8dadf1d7a4085e4c3f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNS0xLTEtMS01OTUzNQ_5f80841b-a2ce-4187-9ba3-8d3d64e9ef20">281,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if722abdc75b34610b6fea0f9483cee81_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNS0zLTEtMS01OTUzNQ_42654a36-939a-42ed-95e9-25e2d4db847e">280,617</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1c93540126b4a8dadf1d7a4085e4c3f_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNi0xLTEtMS01OTUzNQ_82bc1e29-d434-44bc-a19a-cf3815dd43f0">82,861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if722abdc75b34610b6fea0f9483cee81_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNi0zLTEtMS01OTUzNQ_0bce75a6-7bb9-41d9-bc9e-8e1112935f96">78,991</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518fdba340374fd3a474af40b10ce796_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNy0xLTEtMS01OTUzNQ_d3429b58-0331-43de-8041-7626308c8a4f">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c4e5dcb4e7746e5bc080a9c25e3bc3c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNy0zLTEtMS01OTUzNQ_284465e0-7c73-48b5-860d-07ca96edf90a">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i518fdba340374fd3a474af40b10ce796_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOC0xLTEtMS01OTUzNQ_2f13d378-f71c-4213-a6a7-8964341b8031">1,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c4e5dcb4e7746e5bc080a9c25e3bc3c_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOC0zLTEtMS01OTUzNQ_0ff4609c-e821-4f6e-9e6c-7a46850fa49f">1,444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7464cb7c60b0446cbd43978b90d27c58_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOS0xLTEtMS01OTUzNQ_7afd4a29-6e44-499b-ab83-f14ef29a354d">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b7531ec2484661a8f1a0b6c44bfdfe_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOS0zLTEtMS01OTUzNQ_b62a01d0-1d33-4a4e-80f5-ee9410317ae9">40,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7464cb7c60b0446cbd43978b90d27c58_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTAtMS0xLTEtNTk1MzU_269c1f08-9eca-4632-9186-63b611ca5358">18,934</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54b7531ec2484661a8f1a0b6c44bfdfe_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTAtMy0xLTEtNTk1MzU_b1534d8a-c25d-47e4-a66e-081ff516c0b3">18,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f0ef9c25a614e018c39ce8e9e5101bd_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTEtMS0xLTEtNTk1MzU_924e7fb7-5614-4f56-b95b-8a8495208597">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7719a92b270b4a49ac3b46e3e2b46499_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTEtMy0xLTEtNTk1MzU_1a584f2b-c48c-4627-b5ba-e12f90f2d06d">362,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f0ef9c25a614e018c39ce8e9e5101bd_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTItMS0xLTEtNTk1MzU_f68e5aea-e44d-42e0-ae08-0a554750f1d7">43,460</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7719a92b270b4a49ac3b46e3e2b46499_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTItMy0xLTEtNTk1MzU_1c1b3ee1-4736-46d3-9bbb-93aa279fe0e4">36,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTMtMS0xLTEtNTk1MzU_2cc3b243-9847-4a48-a749-fa31a469e228">720,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetIncludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTMtMy0xLTEtNTk1MzU_aad61d7a-3359-464a-bffc-4d02e6fbb515">732,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="lgnd:CommercialLicenseRightsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNjU5NzA2OTgwNTM1Ng_073dce2c-e553-4a4d-bb86-a88f8b7ab9da" continuedAt="if448194efb104c58a155b8cb411c5805" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDQ_9bc8da58-de2e-45c5-9e21-d992e5cbe3de" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e39b01f1d4d45689cebd1037fe70f27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0yLTEtMS03Mjg4MA_d1f62529-7bb7-4917-b553-a536ede810c4">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1e39b01f1d4d45689cebd1037fe70f27_I20220331" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi00LTEtMS03MjkwMg_eded4634-67ee-48c3-a422-df3f135dfdb9">9,456</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e39b01f1d4d45689cebd1037fe70f27_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi02LTEtMS03MzY1NA_3f786bf8-769d-4114-99e0-99653448a04a">8,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1ea6c6606c481a951f3cc3af50b136_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi04LTEtMS03MjgzNQ_57209a3d-bf77-425c-86c4-d9f6f949501a">17,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb1ea6c6606c481a951f3cc3af50b136_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMC0xLTEtNzI4NDE_4d43616c-52c8-4bb1-a5c1-39fcced6cc63">9,461</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb1ea6c6606c481a951f3cc3af50b136_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMi0xLTEtNzM2NTQ_4432b51d-e9cb-4314-be66-7b5d4fc257d8">8,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a5e6b72c57405abf407349fa1f4137_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0yLTEtMS01OTUzNQ_7295dd91-e096-4e7c-867a-80911cf6e263">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22a5e6b72c57405abf407349fa1f4137_I20220331" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi00LTEtMS01OTUzNQ_0b5767ec-9aad-434d-8a13-84680f8dd9b7">8,721</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22a5e6b72c57405abf407349fa1f4137_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi02LTEtMS01OTUzNQ_cbfcc68d-7cfd-41e1-8aa6-4856c5a2b9db">1,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457b420796584b0fb47f7e39b1055c47_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi04LTEtMS01OTUzNQ_f5bc1df5-af8a-4cc0-8127-40207cd3d58c">10,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i457b420796584b0fb47f7e39b1055c47_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMC0xLTEtNTk1MzU_0d808498-be3d-4eb6-8cba-664974d90e10">8,727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i457b420796584b0fb47f7e39b1055c47_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMi0xLTEtNTk1MzU_d04c00c7-f15f-47a0-b410-a70f0424f404">1,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC0yLTEtMS03MzY1NA_59a05808-0aec-49c7-ac18-68cb5de1e163">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC00LTEtMS03MzY1NA_1383366d-2202-42a2-b589-bbd9891a78fb">18,177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC02LTEtMS03MzY1NA_7f27d777-cdd6-41a6-84a7-4ee90efb08fc">10,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC04LTEtMS03MzY1NA_439c6c80-3ef8-47a9-93c6-13e422b31722">28,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231" decimals="-3" name="lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC0xMC0xLTEtNzM2NTQ_c7cb2c14-9a07-4108-8051-9bbd5f1f7986">18,188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC0xMi0xLTEtNzM2NTQ_fb2016c3-915e-4d21-a7b8-904f7d7a6f6a">10,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODE4NzU4Mg_20db39c4-f944-4e19-85b5-b1c4c681c6e6">11.7</ix:nonFraction>&#160;million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331" decimals="-5" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTI3ODk_68b3e85f-63e1-4eda-8180-9064c12eca90">6.5</ix:nonFraction> million as of March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $<ix:nonFraction unitRef="usd" contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231" decimals="-5" sign="-" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzI3NjAzNw_3dccb52c-d3e2-4807-b2a4-19581aa30824">11.7</ix:nonFraction>&#160;million and credit loss adjustments of $<ix:nonFraction unitRef="usd" contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231" decimals="-5" sign="-" name="lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNjU5NzA2OTgwNTM3Mg_095ee713-ca59-4240-b143-545a1b634696">6.5</ix:nonFraction>&#160;million as of December&#160;31, 2021.</span></div></ix:nonNumeric><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ie78e82f039484fbe939281de3f52ec56" continuedAt="i58ed4574ce60432dbcc3ab8c14ce7391"><ix:continuation id="if448194efb104c58a155b8cb411c5805"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2022.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDE_8917a497-763d-4279-89ee-f15215f57f2f" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMi0xLTEtMS01OTUzNQ_2b639210-33a1-4ffa-a974-b3b014842f2f">3,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMi0zLTEtMS01OTUzNQ_81c7d6e3-faa4-41d1-bee0-580e30fa14e7">6,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMy0xLTEtMS01OTUzNQ_4ebdb9ec-6fa1-414d-b099-09106d32d97d">3,974</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMy0zLTEtMS01OTUzNQ_9bf660e9-4b89-4d5b-8fb5-bf2c5182d033">2,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:LicenseeAccrualCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNC0xLTEtMS01OTUzNQ_2205fc55-0660-4be9-acac-2e924b42efc4">2,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:LicenseeAccrualCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNC0zLTEtMS01OTUzNQ_73cdcf17-8be8-460e-9048-616fed42d5e8">630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNS0xLTEtMS01OTUzNQ_8e16b3be-2560-4c1c-8a98-8bbe8c893760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AccruedRoyaltiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNS0zLTEtMS01OTUzNQ_6180445d-cbdb-41b6-afa1-737dea987d1e">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:ReturnsAccrual" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNi0xLTEtMS01OTUzNQ_4756ee66-e065-480c-9836-dda343e9bdce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:ReturnsAccrual" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNi0zLTEtMS01OTUzNQ_ef0783ab-9675-43b5-bc64-6c916236cd09">2,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNy0xLTEtMS01OTUzNQ_e37e3f18-af72-4109-b893-e70ebcae0119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:AccruedAssetAcquisitionsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNy0zLTEtMS01OTUzNQ_a448cfd4-5d83-4b34-b76e-b5bc490635b6">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOC0xLTEtMS01OTUzNQ_ac12470f-ffb0-4c4e-a390-a328a314d1c8">1,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:AccruedSubcontractorExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOC0zLTEtMS01OTUzNQ_636c5220-5d53-4e41-8938-45bfaef8aff8">1,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOS0xLTEtMS01OTUzNQ_8faf7a1a-bc87-45df-a47a-4a8fb4f114ca">1,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:AccruedSupplierExpensesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOS0zLTEtMS01OTUzNQ_2dfdc42b-0434-49ac-855a-2390bb1b2891">848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTAtMS0xLTEtNTk1MzU_1f5e9245-d71e-4f24-85ca-93fb4818db53">394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTAtMy0xLTEtNTk1MzU_daa1303c-1ce1-4440-94be-79391380a180">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTEtMS0xLTEtNTk1MzU_78a92c13-fde7-4191-a4c9-e93cfb5f99ec">1,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTEtMy0xLTEtNTk1MzU_8392c652-e9ed-4d9c-8dde-e930d37c8c07">1,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTItMS0xLTEtNTk1MzU_5e6adc9b-6d6a-4ccf-ae05-b5fb46201355">15,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTItMy0xLTEtNTk1MzU_414c8e6d-d2f0-4c3d-8d2c-259d98bc028b">17,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNjY_ce0da8a5-4b8f-4c83-9d33-bd2bf3b6ca89" continuedAt="i1b6186db80b7418c8eb309e50473bd92" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDg_bdcf1bb9-0b1e-47e4-b7ef-bd1fc6a3183b" continuedAt="ieb42b786cab7450e868ceacf22d1ca62" escape="true">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</ix:nonNumeric></span></div><div style="text-align:center"><ix:continuation id="ieb42b786cab7450e868ceacf22d1ca62"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7080131f89e444529897ea3dc7448eb2_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfMy0xLTEtMS01OTUzNQ_beb7e667-1479-48fb-b3c7-76745d77ed05">3,914</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14d8023b123a4c2faca1a22a3e115e11_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfMy0zLTEtMS01OTUzNQ_31b57aed-489c-4749-85a0-c948d48e1807">3,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfa8a3f9ab8545b981b3971997972972_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNC0xLTEtMS01OTUzNQ_efbfbf40-668c-47dd-8dbc-da25a6d52936">5,130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11b4a8c686fc4648be49dc1b9c525045_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNC0zLTEtMS01OTUzNQ_0f49c6f0-9e88-4829-ac01-af02abc81676">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNS0xLTEtMS01OTUzNQ_88e8660d-f23c-47d7-ad99-ed56c44900cf">9,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNS0zLTEtMS01OTUzNQ_8c790eb5-4c42-4248-aba4-abac9d66d8e8">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i58ed4574ce60432dbcc3ab8c14ce7391"><ix:continuation id="i1b6186db80b7418c8eb309e50473bd92"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMjg_66a83d2a-bc7a-4344-982b-6380aff06d28" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfMy0xLTEtMS01OTUzNQ_4b1636bf-498f-4cc7-a228-5d4438c78276">1.6</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfMy0zLTEtMS01OTUzNQ_10ac47f5-24aa-45ae-91b7-e65591f97f18">0.5</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNC0xLTEtMS01OTUzNQ_53ac0d7b-8692-4753-97ad-c4f1a6459ff8">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNC0zLTEtMS01OTUzNQ_86f6fa68-a5c7-445c-a8ca-5298bfbd0989">&#8212;</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNS0xLTEtMS01OTUzNQ_5ccc5426-cb58-4429-a96e-3d517551daf8">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNS0zLTEtMS01OTUzNQ_3b5dcb5d-0d0b-454d-8d44-e2d6b4c3708d">63</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNi0xLTEtMS01OTUzNQ_c3aa6fa9-b147-46bc-9680-cba30b56f118">4.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNi0zLTEtMS01OTUzNQ_5b9a1ca3-7092-456e-9c19-e35d24cbb91e">5</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a <ix:nonNumeric contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDA_292ed8eb-3afb-4c9f-a56d-4378cf74b8bf">three-year</ix:nonNumeric> performance period, with a range of <ix:nonFraction unitRef="number" contextRef="i2ff20198dfd645f89511cf05d55fafd4_D20220101-20220331" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTczMjM_1c458157-d24a-4efe-b4e5-18b03c0e436b">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i2a3b49d1a88349509ccd11b907545d6d_D20220101-20220331" decimals="INF" name="lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTczMjk_c521ea5b-e93b-41e7-bf5b-1958434b98ae">200</ix:nonFraction>% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTk_1a6f86ed-f236-4501-9439-e61b39808bb1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDI_39867695-2aa0-4bba-b54c-c3780f5f4d52" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfMy0xLTEtMS01OTUzNQ_e7595ab9-875f-40dc-940d-045120424375">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfMy0zLTEtMS01OTUzNQ_90ecd1ad-0f8c-4e9c-839f-d820d5aa8e0e">16,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8220447fce27459a888de6de4b101be1_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNS0xLTEtMS01OTUzNQ_dd936ad0-bef0-4e3d-bafa-34d4c3f1eedf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9e532a1df4c44aa98fe74ecbd0a59126_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNS0zLTEtMS01OTUzNQ_29c30c6b-b34a-4bdd-ab9c-db416432bbc3">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fa0529885044a349ec209c5f5442871_D20220101-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNi0xLTEtMS01OTUzNQ_2a9fcf2d-6a3f-445d-859a-90e7c6e10e56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9bd6ab61611848b4af19ea870cad707f_D20210101-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNi0zLTEtMS01OTUzNQ_4aded017-e236-46f0-ae12-0814d5fa9984">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNy0xLTEtMS01OTUzNQ_f1f93cf0-6d21-446c-b503-bb7b85ec0999">16,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNy0zLTEtMS01OTUzNQ_0a58c75f-3b39-4b5f-89af-23532ac190b5">17,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfOC0xLTEtMS01OTUzNQ_980a9707-0426-45ca-8623-a11f48b2de8b">6,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfOC0zLTEtMS01OTUzNQ_45566a85-5577-4bc8-888e-0ea6aed0d388">4,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, due to the net loss for the period, all of the <ix:nonFraction unitRef="shares" contextRef="i8a1194575d634ee8956be0aa05025adc_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkxODI_3e1d083c-8cf9-4164-b92a-0b4731b5448d">0.4</ix:nonFraction>&#160;million weighted average equity awards and <ix:nonFraction unitRef="shares" contextRef="i3365559ab448481290ab043d14bce4fe_D20220101-20220331" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzMzNjE1NA_39c97801-e971-4e59-8c81-1d6716331438">1.8</ix:nonFraction>&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_515"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzMjQ_c81d221d-be39-4803-be76-03ced646d405" continuedAt="i93fffa73c7424103bda5d9256726e34d" escape="true">Segment Information</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i93fffa73c7424103bda5d9256726e34d" continuedAt="ibfcece56a8e54ae682dbe7fa78b466e3"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes annual and interim reporting standards for an enterprise&#8217;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed <ix:nonFraction unitRef="segment" contextRef="i2b33615ff4dc4786891d338a0cb87ea1_D20220101-20220322" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzNDE_30d65455-d073-49b4-addc-9e0803bb21b8">one</ix:nonFraction> reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, we have made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operate the following <ix:nonFraction unitRef="segment" contextRef="ib574058f498140e08306c67fbbc14b07_D20220323-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzNDk_9fcf0350-ac47-4375-beac-f3d9c42cb7f1">two</ix:nonFraction> reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzNDA_6210e946-7c6f-4e3f-9e95-13d4b15e1841" continuedAt="i3448b83194524e51a45c89ff855a4c9d" escape="true">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><ix:continuation id="ibfcece56a8e54ae682dbe7fa78b466e3"><ix:continuation id="i3448b83194524e51a45c89ff855a4c9d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.376%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i300e1e912a0842718dbd2b3d456ac8e0_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtMS0xLTEtNzMyOTQ_76de5eb1-4c61-42f9-9455-c7728676a3a7">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id431bc8ebbfc4087800d10ed11c19272_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtMy0xLTEtNzM2MDU_1126754a-3a59-45d4-a0ab-8a20e4d987d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73cc7ba3d4a447d95e5cb30db52d28b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtMS0xLTEtNzMyOTQ_67817445-5773-4292-9a92-3290bbd89415">8,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34fb1dc5fc741d1b93bb6d1fad26056_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtMy0xLTEtNzMzMzc_eb7c1f48-afd8-43b8-9c30-df95f8b7baf4">8,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie50c79886ca04ee7b85538c7262e1e53_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtMi0xLTEtNzA1MTQ_e44879ad-bae5-43fe-9d5d-993248ee7ae2">9,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fb81ef4735243389f30ebb41fc5156c_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtNC0xLTEtNzA1MTQ_2890e464-73df-49f2-85f2-47b61a811f23">8,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i598d08a1a5c64f9c9b4aae4b7fea0796_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzctMS0xLTEtNzMzMDE_ce806d74-5242-45a7-b364-558d453c6145">13,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if798cc5ddaad4b2a80521e5ef4181f09_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzctMy0xLTEtNzMzMTE_ab1708be-2681-4dc4-98e7-2a76861cc3e2">7,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2096d791fd444431ae4e6423cf10a908_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtMS0xLTEtNzQ1NTU_fd56629a-d170-4028-8e49-661b83fd8baa">6,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic378cdb30a214a6e973eb163729ac9df_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtMy0xLTEtNzQ1NjI_cd318d3c-9bea-45d5-8760-b75a3ebb4591">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccf94376ac9f41ba9db7e39a6ff00cd2_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtMi0xLTEtNzA1MTQ_861598f1-f258-42b8-a596-df184c3ee386">5,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44fcbfc7c1c64519a0a268ddd50005f9_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtNC0xLTEtNzA1MTQ_3b9411e5-1230-4dc1-a9c7-932e63a62e1b">30,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0260450d8db471abd4488be4a3107e3_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzUtMS0xLTEtNzExNjE_9d522233-9927-45fe-8c4b-6bdbd85d61f3">10,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id18be33f9e9e4ae7a764cb16fd2d9133_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzUtMy0xLTEtNzExNjE_ba9456b9-2974-459c-bf7b-42ecd6562283">8,207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70be0418e1f249f5998e0e0067145f1b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTEtMS0xLTczNjAx_1521c869-907c-4aae-a426-4be4d4336216">36,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19419d57f33740be82d4eb6147bb54a5_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTMtMS0xLTczNjAx_a044aaa2-bd1a-4dd8-bfec-5b266a701bf0">46,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e48006baa5e40e28df0dfb681b6ae97_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzExLTEtMS0xLTczNjAz_2e0ac865-07b9-462d-b6d3-44237fc69931">45,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cb0239f16b43c4bd8d8c1d06dc5cd8_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzExLTMtMS0xLTczNjAz_8ab97664-545c-4cf4-a8fa-5948a24ef59a">55,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie50c79886ca04ee7b85538c7262e1e53_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE1LTEtMS0xLTczMTMx_ee732b77-d0fb-4c31-9dfe-c9b61e505756">6,189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fb81ef4735243389f30ebb41fc5156c_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE1LTMtMS0xLTczMTMx_d51e65fa-d081-48eb-8335-dadfa502afb9">4,604</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70be0418e1f249f5998e0e0067145f1b_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtMi0xLTEtNzA1MTQ_181d9b95-312b-4cf7-bdf0-4045ff835f97">9,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19419d57f33740be82d4eb6147bb54a5_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtNC0xLTEtNzA1MTQ_2fff4de4-3d69-436d-8f46-c2f057d7e208">18,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e48006baa5e40e28df0dfb681b6ae97_D20220101-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTEtMS0xLTcxMTYx_d77ebaaf-f2ea-4b9a-8f49-7cd9518c8646">3,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76cb0239f16b43c4bd8d8c1d06dc5cd8_D20210101-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTMtMS0xLTcxMTYx_b6eaaa21-475d-4569-be16-252e7f792fef">13,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3151df873d468daa1bc191317f2131_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEzLTItMS0xLTcwNTE0_d112dc13-a926-46b2-ac1f-98bd67bded4a">5,657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEzLTQtMS0xLTcwNTE0_111d844b-d019-4dc4-a5cb-567b6753fb94">4,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3151df873d468daa1bc191317f2131_D20220101-20220331" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE0LTItMS0xLTcwNTE0_0961c369-6c3a-40c2-aa07-1115660a6907">7,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331" decimals="-3" name="us-gaap:OtherCostAndExpenseOperating" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE0LTQtMS0xLTcwNTE0_192a6f63-a720-4076-bcad-bb0ff42dee02">4,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c3151df873d468daa1bc191317f2131_D20220101-20220331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE2LTEtMS0xLTcxMTYx_20ddb69e-1adf-4103-a056-777d02f38a1b">13,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331" decimals="-3" name="us-gaap:OperatingCostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE2LTMtMS0xLTcxMTYx_b79bd949-596a-41e9-a2a0-6818d08210f6">9,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE4LTItMS0xLTcwNTE0_a9f7f08b-a0ee-425e-b676-1c8abeca0c94">9,306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE4LTQtMS0xLTcwNTE0_1f18c3da-ca60-4e57-a4c3-5c516e63b589">4,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjYwMw_6a55196b-17c6-4dba-9cf6-5d534a409719" continuedAt="ib56d69f2101746ae98f75ea900a2fa81" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib56d69f2101746ae98f75ea900a2fa81" continuedAt="idfd2a2f4eebb43958ef8bed8efb30d8b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjYwMA_819df2c7-3c0c-4edd-9015-23518312e7aa" continuedAt="i7300f051fc7d4ec59c7eac5cf896c1c1" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a30df8c5d044c60a763185ed4b109ee_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0yLTEtMS01OTUzNQ_13401a5a-508d-4111-adf1-2da0fa6bdc69">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if634239711ec47bc8fb473be55d194c2_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy00LTEtMS01OTUzNQ_0c5d98a4-4512-4b24-a7d8-6349743d68ee">162,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78c295da60c54f4ba4c67de4f2b2fd6a_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy02LTEtMS01OTUzNQ_86cdd8a7-d797-45c6-b602-7388e4607211">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919b865fc7e548288c960eb025fa16f6_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy04LTEtMS01OTUzNQ_49b79954-e795-4bf8-92f7-76ff4c002d95">168,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f961cf3c57944a989b386a120a59e6a_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xMC0xLTEtNTk1MzU_046d82df-4537-4a09-b551-5eaa61b9533e">9,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56a23c988fb481eb3895b19408d8f68_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xMi0xLTEtNTk1MzU_8ddaa66c-3960-438e-a71f-3e92f977d778">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bcc5777b8c04572a90ff8c68c9be3d2_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xNC0xLTEtNTk1MzU_f497ccfb-6c10-4204-a586-fd9cbaf353d5">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f9f85958a8e45c1999e50f7c31144df_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xNi0xLTEtNTk1MzU_5d480e9e-2d63-4134-9ce6-fda64f1c4d00">290,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98b2a53fb0eb405a93cded08866b0e8d_I20220331" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0yLTEtMS01OTUzNQ_7ba20d5b-ee9c-4d0d-b6a2-704656ab8bb0">20,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28df26f7a1f24146a45927ad3b6e2625_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC00LTEtMS01OTUzNQ_109a31db-bcf0-40e4-a682-c93556b7eb3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da3eb2118b64b948ace0d372c78e131_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC02LTEtMS01OTUzNQ_b1fc78ad-c8b0-419d-8c05-bdcfe371ef66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0024c5febbb84c33ba537d246bb26b0d_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC04LTEtMS01OTUzNQ_e4600ac1-7190-411d-b459-0f139773d0e9">20,145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6326565a2e4955bf81bde2e03ac28b_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xMC0xLTEtNTk1MzU_c904fd21-aedb-402f-8f2f-5a239bc1bfd9">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3ba69f089de4d0aa3b902eb1357efb6_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xMi0xLTEtNTk1MzU_d2fa7661-01d8-4a01-9aee-2bcc756a2604">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a463045c0434ff28706f0fd5b252da7_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xNC0xLTEtNTk1MzU_5ecd47b3-e02d-4df6-8170-83c787b7cfa1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bdc3319eb85415ea312cb8a112c69ea_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xNi0xLTEtNTk1MzU_e4be8be1-a1a6-4bba-b333-71e4b4770b2f">30,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb310903a3649db988222f2672883a4_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0yLTEtMS01OTUzNQ_209da095-c348-4d4d-babf-b003761398d1">26,424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54984caedea4d4c829399ada8baf52c_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi00LTEtMS01OTUzNQ_a7bc40b5-1a66-43ef-9d4b-7bfa75e8398f">162,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e15e9ecb9c4bb9a73558b076d35394_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi02LTEtMS01OTUzNQ_24818f8e-a646-4e47-9647-7a8da1682b21">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5112991c76244ad1b2e61a2afe8efa8b_I20220331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi04LTEtMS01OTUzNQ_b2581eb3-4b10-4ac8-9d06-505065918983">189,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c833df0e5124025a8cd7e1936222d95_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xMC0xLTEtNTk1MzU_c2103317-c6f8-45f9-8629-cf32c72bb89b">40,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c518e7be0004946a9276b77331674e7_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xMi0xLTEtNTk1MzU_31010d26-6d08-4789-bfde-f53e771c5854">280,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c5a1b7c1bd4601ad0e07d638cfde90_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xNC0xLTEtNTk1MzU_07a7398d-aea8-41e0-a253-99b774a3b325">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966883907ba441f5a4e24265299fe9b7_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xNi0xLTEtNTk1MzU_a450d5bb-de1e-4644-9a49-2240051fb742">321,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17df672b82eb4eff9d83b149a3113829_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0yLTEtMS01OTUzNQ_6590ec57-c581-4e8a-958f-c2fd87a5f408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8716ee2bef654ec887fa430172b5e0d3_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS00LTEtMS01OTUzNQ_c16c8f79-2da8-42f6-8ef9-bb82a5a4735d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i211899b611f340528eb396eab170056c_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS02LTEtMS01OTUzNQ_69c5aaa9-c6a7-4610-883d-a87ec6929404">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b9d133c575a444b97ac9f108fea9d52_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS04LTEtMS01OTUzNQ_a5cc078c-de47-4fff-b5e8-2d422fab87ff">334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d7dc371fd8d4ba9b2de8e1a8d90ca31_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xMC0xLTEtNTk1MzU_d553da34-718b-432d-9736-abbc81ba290c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06393bae740d414fb55f36d4f43807b2_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xMi0xLTEtNTk1MzU_4c03029d-ffad-4662-834d-7fe236a4cc29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3496b4825a99453d8e14a952b1c8bbf5_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xNC0xLTEtNTk1MzU_79ca37cd-635c-415a-bcdf-13f54f6af457">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aacb0ab6e8a482dbddfa6725169679d_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xNi0xLTEtNTk1MzU_88527970-603b-469f-b30c-4171982f986b">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8cd9489185040a7bb4e6b5151d8fb72_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMi0xLTEtNTk1MzU_e9dd7bea-35a2-447c-805f-d5ec19baee66">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97def60ed00a4e26a90de87178d3202c_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtNC0xLTEtNTk1MzU_6a7fc369-179d-446f-90ad-2b367827c3a2">2,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfc8aa3e6e1c478c842cc795c7c3484c_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtNi0xLTEtNTk1MzU_298aed38-a2f9-40f6-bfa8-855d833ef170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc9098fdefa544a68419972c21ec488c_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtOC0xLTEtNTk1MzU_4bbab36e-88df-42b0-b326-bb5ea125315c">2,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic14bb82805cc494d8b56d377748e728c_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTAtMS0xLTU5NTM1_bb09fc86-ba15-4a1c-b90a-2ba5f3f238f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c0225f26f5a48b5b92459eaef9fd75e_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTItMS0xLTU5NTM1_a49ee049-c752-482c-9c03-ac07c81cc8d6">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic54f0bccced74dc6b12384a2e45705e1_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTQtMS0xLTU5NTM1_af1049e8-9549-48cf-bb86-b3cdaa646ab6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12aa59424c6e4371bcaeafb801d99844_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTYtMS0xLTU5NTM1_208db8db-1baa-4ecd-9f1e-5f704bce9e0d">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f3a5031213d4a2aa5da82aaa404c742_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMi0xLTEtNTk1MzU_6135dd68-c51b-4e6a-8c99-8149deaae559">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a32dc635437486483a3be836ab04ada_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtNC0xLTEtNTk1MzU_6708f7bc-7874-4dea-9194-3c4f4dfe5ff6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2055a011fa7a4a829cad038d7d64c6ae_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtNi0xLTEtNTk1MzU_fede6773-e2e2-409b-b7d6-efe80e6f78c3">5,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90216ed11e8d4bc1b40442168089a1ad_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtOC0xLTEtNTk1MzU_613843f4-fbc4-4f93-8f8d-986b5fa06acc">5,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80f9ef7fb8a04cb59bc97a74159c2874_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTAtMS0xLTU5NTM1_6d4a22f7-3feb-4a3c-9b7c-f07c1f3f0257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0690c7d860e439ab67baac1955afda1_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTItMS0xLTU5NTM1_5cda2437-119c-446a-9189-9e296a8f4bd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b92158554854b7599487fbbea4b32d3_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTQtMS0xLTU5NTM1_c09c8357-26d7-48f6-8603-9fbea1cbd6a7">7,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55dc9c881b384a888900e4e677032eef_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTYtMS0xLTU5NTM1_8b2d1323-6833-4d92-b51e-4c24c5685a7b">7,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e13f0ccb1840b38bbcc52a9b972a65_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMi0xLTEtNTk1MzU_2449d44f-1976-4c8b-b8a9-624bca178b5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef14e6ec1314de598c64ef1cd3b8fdf_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtNC0xLTEtNTk1MzU_45d6e2a8-40f7-4015-ad4b-2e0d54700fa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i065018e70379492b9ffac3ef63d44a78_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtNi0xLTEtNTk1MzU_fadccdc4-a90e-44e7-b4f8-df7f2e630a41">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f207c7e7074abdbf50e9ac08b78310_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtOC0xLTEtNTk1MzU_2360775e-2e27-4039-b269-61191026fe39">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d31d4856a7f4ecdac5cfa9487f3e54e_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTAtMS0xLTU5NTM1_6e3e4558-a6c8-413a-a805-552a31d1ef68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2afa4c98a64c4a839dbfa0fd81f143_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTItMS0xLTU5NTM1_d662a1d9-8ac1-43c3-9093-facb00b61e1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ec0e9d18f64f908b3d00d4d1706f84_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTQtMS0xLTU5NTM1_e1408f04-4292-449d-b1f0-84ef3bd678bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2069d01c1f64ca7a72f1f7662269e10_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTYtMS0xLTU5NTM1_4c0c4bbc-9964-4653-8c0b-01a54c4f90d7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e4d6cbded604d18851f0c907cacd012_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMi0xLTEtNTk1MzU_eefe57ad-3681-4735-a1da-b0b22bef554a">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i465d2c5e70fe49d68072bca30f76eb6d_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtNC0xLTEtNTk1MzU_f23df037-a645-4520-adef-bdbbdca3175e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied060cacedb645e8952913558fc4a323_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtNi0xLTEtNTk1MzU_511a8c9d-87e2-489e-9839-b12963f38bed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5865f4bf0c4476a1cdbb41799578ef_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtOC0xLTEtNTk1MzU_22c3e2f4-86b9-4a61-89ed-50a87cadf989">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6854523039e846ca86b64f3d0452da62_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTAtMS0xLTU5NTM1_63ce52e1-53a5-4e2a-ae63-792a2933d91d">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica6972566df3478a9c82f8db3f0f40d1_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTItMS0xLTU5NTM1_dcf6ff26-f332-4f85-a716-e6a2dfa98fff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a94d4a2b23c41cbb4633b169200cf02_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTQtMS0xLTU5NTM1_6f93de02-4a9b-420c-b089-05a2ef3a45bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dc1ab71740c4970bfbb9630883923ad_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTYtMS0xLTU5NTM1_4e4c06ee-1460-4db7-b50d-8c5d8acf9fe3">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5eb310903a3649db988222f2672883a4_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMi0xLTEtNTk1MzU_21912544-c0ea-4bf1-a279-48fb8774446b">75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id54984caedea4d4c829399ada8baf52c_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtNC0xLTEtNTk1MzU_83b4c46f-af84-4632-960c-cc32383ccd48">2,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e15e9ecb9c4bb9a73558b076d35394_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtNi0xLTEtNTk1MzU_f7c04beb-2d99-4f7c-8a32-6b03cd218323">6,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5112991c76244ad1b2e61a2afe8efa8b_I20220331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtOC0xLTEtNTk1MzU_58c72dc0-5d6f-49e3-a80b-dba6d5c4d483">9,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c833df0e5124025a8cd7e1936222d95_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTAtMS0xLTU5NTM1_a1229f86-9ed7-44e7-98df-c270be3290e5">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c518e7be0004946a9276b77331674e7_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTItMS0xLTU5NTM1_0d511499-56fb-4a01-bca2-54ae0e171488">3,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30c5a1b7c1bd4601ad0e07d638cfde90_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTQtMS0xLTU5NTM1_f842b271-2933-4c43-aa13-c3e108125740">7,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i966883907ba441f5a4e24265299fe9b7_I20211231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTYtMS0xLTU5NTM1_c8fb17a0-a74f-4bdd-84f9-552c2ee97d98">11,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="idfd2a2f4eebb43958ef8bed8efb30d8b" continuedAt="i28570b312a8a46f2942bf6e393d42912"><ix:continuation id="i7300f051fc7d4ec59c7eac5cf896c1c1" continuedAt="ia92dbdeb2f664f2eb782b1f67f86f7ff"><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders <ix:nonFraction unitRef="contingent_value_right" contextRef="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjQ5Nw_45864de6-0a2c-4ddb-b631-858544931619">four</ix:nonFraction> tradable CVRs, <ix:nonFraction unitRef="contingent_value_right" contextRef="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131" decimals="INF" name="lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjUxNQ_5dc1cc68-1e37-469f-a0aa-e70125cc2049">one</ix:nonFraction> CVR from each of <ix:nonFraction unitRef="contingent_value_right_series" contextRef="ib419e06b57b54f5c8f34756ee9797e58_D20100101-20100131" decimals="INF" name="lgnd:NumberOfContingentValueRightsSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjUzNQ_90902a5a-8a03-44ec-a3bf-23a01997625e">four</ix:nonFraction> respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every <ix:nonNumeric contextRef="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131" name="lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjY3MA_53a5cabd-cae3-45e6-84de-a8dda2069d67">six months</ix:nonNumeric> as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $<ix:nonFraction unitRef="usd" contextRef="i194dc7eb8286428aa943ce425971b4b8_I20220331" decimals="INF" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMzQ3Mg_6c917e04-debc-4c1c-b9af-a6c75092f5a6">375</ix:nonFraction> million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $<ix:nonFraction unitRef="usd" contextRef="i43db8217ff36458e87356cae1ff73eb4_I20220331" decimals="-6" name="us-gaap:ContractWithCustomerAssetGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMzU4Nw_37c7c8a0-6f43-4096-892a-87cc17199e83">10</ix:nonFraction> million payment upon initiation of a Phase 3 clinical trial.  During the three months ended March&#160;31, 2022, we adjusted the balance of the Metabasis CVR liability by $<ix:nonFraction unitRef="usd" contextRef="i921ef3db471b47e886c3c26b72c7c384_D20220101-20220331" decimals="-5" name="us-gaap:LiabilitiesFairValueAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjU5NzA2OTc3OTcxNA_aac60f24-1960-4560-b6e1-b46d9d5c6e5f">0.6</ix:nonFraction>&#160;million to mark to market.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the three months ended March&#160;31, 2022, we paid $<ix:nonFraction unitRef="usd" contextRef="iaafd9004e1524a9686d8306a396aa924_D20220101-20220331" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNDE5OA_cd754d7c-b29a-4496-9734-f2c64eb92de5">1.5</ix:nonFraction>&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div></ix:continuation><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="ia92dbdeb2f664f2eb782b1f67f86f7ff" continuedAt="ic48079d16e1e4f3cb9c84c7eb069e7d0">4.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"><ix:continuation id="ic48079d16e1e4f3cb9c84c7eb069e7d0">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three months ended March&#160;31, 2022, management recorded $<ix:nonFraction unitRef="usd" contextRef="icdfc9f4e909742e7b03c3eca98c41196_D20220101-20220331" decimals="-5" name="lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNTE0Nw_8b1c5048-960d-42e4-a1d9-177adb1ace4d">0.5</ix:nonFraction> million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjYwMQ_0dc7919d-41ec-46f6-8cd3-ca65a1983c51" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of March&#160;31, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica554f22c30d4304a7166e4a018118e6_I20211231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMC0xLTEtMS01OTUzNQ_54ffd7b8-ec06-4556-9ef6-5208f66eaee8">7,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331" decimals="-3" name="lgnd:PaymentsToContingentValueRightHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMS0xLTEtMS01OTUzNQ_d8e47a81-9a57-4c80-8ad0-62ffcbbaa9ba">1,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMi0xLTEtMS01OTUzNQ_8a37df83-2c18-49a3-bb34-f773043079a4">458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331" decimals="-3" name="lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMy0xLTEtMS01OTUzNQ_fe318901-f3e5-48a8-af9b-cc1d4e032eab">480</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March&#160;31, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3d63dad091346d4b421cc89bf1e6cf2_I20220331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfNC0xLTEtMS01OTUzNQ_c7d3fbcd-dac2-4763-813b-41bcc9b6d109">6,190</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the organizational changes to the Company&#8217;s reportable segments, we re-allocated goodwill between the <ix:nonFraction unitRef="reporting_unit" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="INF" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjU5NzA2OTc3OTcyNw_07029b45-5096-4bca-9ed1-df6216f1cf42">two</ix:nonFraction> identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At March 31, 2022, there were no indicators of impairment at either of the reporting units.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="i28570b312a8a46f2942bf6e393d42912">At March 31, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.</ix:continuation> </span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU0Mw_1ef25279-fd11-4492-9937-c10a6be038a8" continuedAt="i42866abf54e947578879e4e1cdd32204" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i42866abf54e947578879e4e1cdd32204" continuedAt="ief9e8259aba142609466df9766caa279"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzg0ODI5MDcxNTM3NA_23b94f7f-f0f5-4f75-ba28-dee7b06e53d1">0.75</ix:nonFraction>%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$<ix:nonFraction unitRef="usd" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfOTk_70445273-39b6-46d9-b089-b7f53591cd2b">750.0</ix:nonFraction>&#160;million&#160;aggregate principal amount of&#160;<ix:nonFraction unitRef="number" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTMy_1e2516f1-2f0c-4d9b-a8d7-34424440a027">0.75</ix:nonFraction>%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $<ix:nonFraction unitRef="usd" contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531" decimals="-5" name="us-gaap:ProceedsFromDebtNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMjg4_a9d7aea3-5bc3-41fb-9922-9258b3f3e8c5">733.1</ix:nonFraction> million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjA5_705fec65-563d-4f47-8cdb-6e63c0d6f8e2">248.48</ix:nonFraction> per share.  The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i325334d147084fc3aa258bd786bbca4a_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4NDY3Nw_480fb869-3e5e-45bb-b984-568904024330">191.14</ix:nonFraction>. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="ief9e8259aba142609466df9766caa279" continuedAt="ibc0e47060b764750983373d29784845f"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least <ix:nonFraction unitRef="d" contextRef="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfOTQy_5ca935f2-bdb2-48bc-9983-fc221df48af4">20</ix:nonFraction> trading days (whether or not consecutive) during the <ix:nonFraction unitRef="d" contextRef="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfOTk4_c47db030-80d3-47df-85cd-7a1699fd4a66">30</ix:nonFraction> consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than <ix:nonFraction unitRef="number" contextRef="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTE5Mw_8b25dd8c-b9a3-4112-92ac-f30e771a50ad">130</ix:nonFraction>% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the <ix:nonFraction unitRef="d" contextRef="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTI1OA_1508c33b-07da-41f3-ac31-9e4236dbab5b">five</ix:nonFraction> business day period immediately following any <ix:nonFraction unitRef="d" contextRef="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTMwNw_f8b5e58e-ef2a-481b-9fd6-74714be5a81d">10</ix:nonFraction> consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than <ix:nonFraction unitRef="number" contextRef="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531" decimals="INF" name="lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTQxNg_2ecd724d-49d9-48b2-bd04-7e1f8d407509">98</ix:nonFraction>% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1NjUyMw_613df7ce-879a-45b5-b641-2699e46c7e28">248.48</ix:nonFraction>. In connection with the issuance of the 2023 Notes, we incurred $<ix:nonFraction unitRef="usd" contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTk5Nw_66131259-a6df-4201-938d-fd4d1cf12e18">16.9</ix:nonFraction> million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the <ix:nonNumeric contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzg0ODI5MDcxMzIwMg_ec8bc548-87f1-4518-b067-e44421bc6144">five year</ix:nonNumeric> expected life of the 2023 Notes, and the effective interest rate as of March 31, 2022 is <ix:nonFraction unitRef="number" contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ0NA_7ad6da96-8c1d-4268-90f7-f91037ab2349">0.5</ix:nonFraction>%.  During the three months ended March 31, 2022 we recognized a total of $<ix:nonFraction unitRef="usd" contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ1MA_f121d9e5-4ed6-49ae-a88f-0a1b378f827e">0.8</ix:nonFraction>&#160;million in interest expense which includes $<ix:nonFraction unitRef="usd" contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ2NA_289663ad-12b8-434b-80c2-1fea2a800757">0.5</ix:nonFraction>&#160;million in contractual interest expense and $<ix:nonFraction unitRef="usd" contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ3OA_4a68aa10-b241-4740-a4e3-291c6c1567e7">0.3</ix:nonFraction>&#160;million in amortized issuance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, we repurchased $<ix:nonFraction unitRef="usd" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ5Mg_e966307c-8eab-4d48-9838-975df90474f0">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjUwOA_d06a05ca-d0b6-4d5a-8a0c-6cd354cd2269">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjUyNA_20bbef93-7923-4451-8bb5-175415083c31">0.3</ix:nonFraction>&#160;million. After the repurchases, approximately $<ix:nonFraction unitRef="usd" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjUzOA_1cf0597e-5a30-4553-8090-58fe9c8e29e6">343.3</ix:nonFraction>&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended March 31, 2022, we repurchased $<ix:nonFraction unitRef="usd" contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjU1NA_679812c8-f1a7-4634-af4c-dbfc4164884f">165.8</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjU3MA_ee64cb38-5ab0-4863-b364-6fa60168fb02">163.7</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjU4Ng_1380ffe0-eb4d-4800-945b-02f7ed9f685c">0.4</ix:nonFraction>&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $<ix:nonFraction unitRef="usd" contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjYwMA_771c721a-d51e-45b5-9483-b10fd0c69d16">1.5</ix:nonFraction>&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended March 31, 2022, and a $<ix:nonFraction unitRef="usd" contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331" decimals="-5" sign="-" name="lgnd:IncreaseDecreaseInDebtDiscount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjYxNA_916acc4c-d2c2-48e5-9f42-853a44d1fd4d">0.9</ix:nonFraction>&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering <ix:nonFraction unitRef="shares" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzI1NQ_1140bfff-097c-44ba-8de1-137d6a1dcad0">3,018,327</ix:nonFraction> shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzUyOQ_c946fce2-fa8e-4107-a55c-c705bb1e57bc">248.48</ix:nonFraction> per share and are exercisable when and if the 2023 Notes are converted. We paid $<ix:nonFraction unitRef="usd" contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531" decimals="-5" name="lgnd:PaymentsForConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzYxMg_5329b2d4-741c-42fb-8b05-f19b29fd72db">140.3</ix:nonFraction> million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately <ix:nonFraction unitRef="shares" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNDUxMg_3fc993c6-aeee-4f90-af2f-7945940bd6de">3,018,327</ix:nonFraction> shares of common stock with an exercise price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNDU3OA_6ee3b968-303b-4a60-8ef8-670490ce13d6">315.38</ix:nonFraction> per share, subject to certain adjustments. We received $<ix:nonFraction unitRef="usd" contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNDYzNg_053a6c5c-4ead-4fff-a9c8-8430dd5ad701">90.0</ix:nonFraction> million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $<ix:nonFraction unitRef="usd" contextRef="i2635945e42ab464987f287db2ac7954c_I20210131" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1Mzk4Mg_f940f855-ce6f-4a3f-aeed-824c9cdaa5ec">20.3</ix:nonFraction>&#160;million in principal of the 2023 Notes for approximately $<ix:nonFraction unitRef="usd" contextRef="icf689c5950764536b68fadb81ab2aee0_D20210101-20210131" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1Mzk1Mw_d237aa45-a621-4757-81a4-8baea367d060">19.1</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="icf689c5950764536b68fadb81ab2aee0_D20210101-20210131" decimals="-5" name="lgnd:RepaymentsOfNotesPayableInterestPortion" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1Mzk2OA_e63f2363-0226-4a58-a940-4641fe41345f">0.1</ix:nonFraction>&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ibc0e47060b764750983373d29784845f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $<ix:nonFraction unitRef="usd" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="-5" name="us-gaap:DebtInstrumentRepurchaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTY3OA_2b62f16c-5af9-4194-8b8a-7e6de6d2256c">152.0</ix:nonFraction>&#160;million in principal of the 2023 Notes for $<ix:nonFraction unitRef="usd" contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTcxNg_21b3fc26-0969-4180-b703-04c9df2cad47">156.0</ix:nonFraction>&#160;million in cash, including accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231" decimals="-5" name="us-gaap:DebtInstrumentIncreaseAccruedInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTc1OA_5fbda0d9-23ae-4459-8cfe-29ac2403888e">0.3</ix:nonFraction>&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $<ix:nonFraction unitRef="usd" contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231" decimals="-5" name="lgnd:PaymentsToUnwindWarrants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjA2Mg_f045084d-3f8f-453a-9b99-05dca1861ecf">18.4</ix:nonFraction>&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from <ix:nonFraction unitRef="shares" contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjE3MQ_1140bfff-097c-44ba-8de1-137d6a1dcad0">3,018,327</ix:nonFraction> to <ix:nonFraction unitRef="shares" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjE3Nw_c5d8bc2d-a711-4845-8795-c349f6420ab5">2,559,254</ix:nonFraction>. We received $<ix:nonFraction unitRef="usd" contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231" decimals="-5" name="lgnd:ProceedsFromUnwindingConvertibleBondHedges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjE5Mw_228c891d-b55e-4e02-bd77-c95c5617b12f">18.9</ix:nonFraction>&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to <ix:nonFraction unitRef="option" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="INF" name="lgnd:NumberOfOptionsUnderConvertibleBondHedges" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjMxNA_bcaad7e8-f55a-4b35-9b98-0bb011e2512a">598,021</ix:nonFraction>. These unwind transactions resulted in a $<ix:nonFraction unitRef="usd" contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjM1OA_fe5f141b-b6d3-4544-b1eb-ff34c7214769">0.5</ix:nonFraction>&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU0MQ_c2148513-10e8-4ced-959a-3d3146767eed" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:67.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.437%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMS0xLTEtMS01OTUzNQ_684135a3-2e8c-4feb-bb12-1da78e0e3418">177,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMS0zLTEtMS01OTUzNQ_be2f3bd4-aaf4-43a3-8c1a-0ae2f959648a">343,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMi0xLTEtMS01OTUzNQ_6d2ce240-49b7-4156-9b40-d0961e2dd189">987</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMi0zLTEtMS01OTUzNQ_d2033fd3-b075-4d6b-87b6-b78223b43823">22,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMy0xLTEtMS01OTUzNQ_c6f0d62b-f540-4a2d-8ffa-5743b2fe37ff">176,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="-3" name="us-gaap:LongTermNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMy0zLTEtMS01OTUzNQ_b54b8c6c-036f-4b85-9e2a-7866ec6d1214">320,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfNi0xLTEtMS01OTUzNQ_d65c5b92-93c6-4cff-bb5f-22ede63a01a7">172,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d94099936a491687dbdd22e65b4761_I20211231" decimals="-3" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfNi0zLTEtMS01OTUzNQ_c3cfe66e-56f5-4b91-9a24-ee4ed5f2fbe6">341,801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180OS9mcmFnOjkyMjNiODljMWJhZjRlZGQ5ODBhNWUxN2Q4ZjU2YjI5L3RleHRyZWdpb246OTIyM2I4OWMxYmFmNGVkZDk4MGE1ZTE3ZDhmNTZiMjlfMTUzOA_15d088b6-71b0-4766-8ae9-932bb61605e8" continuedAt="ibca6a6a82eb4435ba93fd6b7d83f7eed" escape="true">Income Tax</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ibca6a6a82eb4435ba93fd6b7d83f7eed">Our effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended March&#160;31, 2022 and 2021 was <ix:nonFraction unitRef="number" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180OS9mcmFnOjkyMjNiODljMWJhZjRlZGQ5ODBhNWUxN2Q4ZjU2YjI5L3RleHRyZWdpb246OTIyM2I4OWMxYmFmNGVkZDk4MGE1ZTE3ZDhmNTZiMjlfNDI5_63a4c35f-1208-4727-95ca-ad51c68f9c78">23.6</ix:nonFraction>% and (<ix:nonFraction unitRef="number" contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" format="ixt:num-dot-decimal" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180OS9mcmFnOjkyMjNiODljMWJhZjRlZGQ5ODBhNWUxN2Q4ZjU2YjI5L3RleHRyZWdpb246OTIyM2I4OWMxYmFmNGVkZDk4MGE1ZTE3ZDhmNTZiMjlfMTY0OTI2NzQ1NDA2Mw_9343f552-c1f1-4ad6-8ba3-43c05321c31c">214.1</ix:nonFraction>)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period. The variance from the U.S. federal tax rate of 21% for the three months ended March 31, 2021 was significantly impacted by the discrete tax benefit related to the net excess tax windfalls from the share based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</ix:continuation></span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_52"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTU1OQ_84f9b1e6-ceff-4e62-a583-cc403c1a0c02" continuedAt="i7e7ebf2ca7e346979ab4a822654ab254" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7e7ebf2ca7e346979ab4a822654ab254" continuedAt="i2b79a94a1ca547a59fffb6ebfd71c161"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.</span></div><div><span><br/></span></div><div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTU1OA_77d22084-1226-4a0e-ac60-0a43ed67e4b2" escape="true"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTU2MQ_e71074a6-25cb-4a85-908e-a488ac60f399" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ba9060814074f5b8b13493a50dcc9ab_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi0xLTEtMS01OTUzNQ_3ac2d0cb-2675-48cb-8c0b-efe36716ae5d">2,199,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4ba9060814074f5b8b13493a50dcc9ab_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi0zLTEtMS01OTUzNQ_93017605-9900-40bf-b229-2835ad7eda6d">106.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2c459c7be754d97891d9360f85d4082_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi01LTEtMS01OTUzNQ_cf8665fa-0cb9-4eec-8844-096bf1757ee5">264,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia2c459c7be754d97891d9360f85d4082_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi03LTEtMS01OTUzNQ_6c58252b-28c9-474a-ab11-f677fd6647a5">138.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy0xLTEtMS01OTUzNQ_718d4ae7-7711-4502-a0bb-5e5c4be89447">14,100</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy0zLTEtMS01OTUzNQ_90f05c93-97ba-494e-be13-69ef48978c46">114.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy01LTEtMS01OTUzNQ_01f62687-f2a4-4cb9-9c42-b4dd62a68166">24,840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy03LTEtMS01OTUzNQ_60c3ce5a-067e-4e5a-8634-e54b20f7b74a">99.85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC0xLTEtMS01OTUzNQ_7bbafcce-40de-4e99-93f0-c1ce5b60e54a">17,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC0zLTEtMS01OTUzNQ_516d895d-68bb-4f70-a425-fbe405edc714">19.61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC01LTEtMS01OTUzNQ_465250e9-eafa-46c1-8105-1344a7fddd9b">126,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC03LTEtMS01OTUzNQ_a7cc24b3-4045-4adf-8d82-8c6eda775acf">121.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS0xLTEtMS01OTUzNQ_933314c1-d185-4a80-b728-7fef0564ac95">23,285</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS0zLTEtMS01OTUzNQ_450d2b50-9077-44fd-9101-f24295e71bf0">54.49</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS01LTEtMS01OTUzNQ_539feaaa-232d-49bf-839b-f73454512f94">782</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS03LTEtMS01OTUzNQ_fe6b8880-7111-455b-a493-ad0833e0be76">131.95</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i573a15b797f746cc9687adb9f4c7f519_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi0xLTEtMS01OTUzNQ_56d5cbc7-89ba-46e2-87d0-ecf574983321">2,172,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i573a15b797f746cc9687adb9f4c7f519_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi0zLTEtMS01OTUzNQ_602a876a-190b-43ae-943d-1123a348feae">107.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia72734fd1bc34d3f98100401134c40ef_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi01LTEtMS01OTUzNQ_ac2490ad-4f5d-4f9a-8bd8-346a422d0650">162,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia72734fd1bc34d3f98100401134c40ef_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi03LTEtMS01OTUzNQ_6bb47914-0e4e-436e-b93a-678c3acd6ae7">145.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, outstanding options to purchase <ix:nonFraction unitRef="shares" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNDUw_4e9f2f09-adba-4846-a42e-569e58a83014">1.5</ix:nonFraction> million shares were exercisable with a weighted average exercise price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNTQ5NzU1ODE0MDQ1Mw_ef9e13e4-1a01-44e8-9df5-ee58bf2cb645">100.59</ix:nonFraction>.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2b79a94a1ca547a59fffb6ebfd71c161" continuedAt="ic6968fd1b24f46a5b81d6e369831da6e"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to <ix:nonFraction unitRef="number" contextRef="i1275fb9984434e01b87ce488fddf54ad_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNjc4_95158607-f00c-4937-81d0-1fa595c937f0">85</ix:nonFraction>% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i1275fb9984434e01b87ce488fddf54ad_D20220101-20220331" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfODA1_b8565d0e-b161-48d8-baab-68202cbda26c">44,360</ix:nonFraction> shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic6968fd1b24f46a5b81d6e369831da6e">On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $<ix:nonFraction unitRef="usd" contextRef="ib33c801b49164b99a9d4646db3085406_I20190911" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTA4Mw_9f053c23-3999-4f95-8613-fc80bcf65964">500.0</ix:nonFraction> million of our common stock from time to time over the next <ix:nonNumeric contextRef="i27f53be60bef4e978e550a0a4312773a_D20190911-20190911" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTEzOA_fdeeca49-0ebd-4a83-a507-667288b929d4">three years</ix:nonNumeric>. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did <ix:nonFraction unitRef="usd" contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" decimals="INF" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNjU5NzA2OTc2ODYxNg_955b16ff-388f-4ac2-9ca1-3f2ada6c8b52">no</ix:nonFraction>t have any share repurchases during the three months ended March&#160;31, 2022. Authorization to repurchase $<ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTUwNQ_f764817e-f2b2-4a00-8155-3a9ada990292">248.8</ix:nonFraction> million of our common stock remained available as of March&#160;31, 2022.</ix:continuation> </span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181NS9mcmFnOjIzYjA5OWQwYjcyZjQwYzI4ODE0MWJlMjBhYmZlNzEwL3RleHRyZWdpb246MjNiMDk5ZDBiNzJmNDBjMjg4MTQxYmUyMGFiZmU3MTBfMjI4Mw_712a40e4-a39b-4ce5-9d8c-81adfc14391d" continuedAt="i8511b20ff7ce4adabb60df48c7d453cd" escape="true">Commitment and Contingencies: Legal Proceedings</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8511b20ff7ce4adabb60df48c7d453cd"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received <ix:nonFraction unitRef="civil_complaint" contextRef="i9e0901d9e25c46e498905e04372debe7_D20191031-20191031" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181NS9mcmFnOjIzYjA5OWQwYjcyZjQwYzI4ODE0MWJlMjBhYmZlNzEwL3RleHRyZWdpb246MjNiMDk5ZDBiNzJmNDBjMjg4MTQxYmUyMGFiZmU3MTBfMzg0ODI5MDcxOTMwNQ_f96699f1-0945-412a-874c-fdd64a1b0246">three</ix:nonFraction> civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the <ix:nonFraction unitRef="civil_complaint" contextRef="i9e0901d9e25c46e498905e04372debe7_D20191031-20191031" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181NS9mcmFnOjIzYjA5OWQwYjcyZjQwYzI4ODE0MWJlMjBhYmZlNzEwL3RleHRyZWdpb246MjNiMDk5ZDBiNzJmNDBjMjg4MTQxYmUyMGFiZmU3MTBfMzg0ODI5MDcxOTMxNQ_b0940f9a-c85b-48b3-81e5-e130ee10042d">three</ix:nonFraction> complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">overpaid royalties for several years, and seeks both refunds of those overpayment and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#8217;s Counterdemand. On June 30, 2021, the parties held a Preliminary Hearing before the arbitrator. The parties have completed fact discovery, exchanged expert witness statements and completed depositions of the expert witnesses. The arbitration hearing is currently scheduled for late May 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div></ix:continuation><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.  <ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5Mw_abd7c03c-df1b-42dc-b55d-d4abf0b30032" continuedAt="ife171c7ebb954d90a256942693ebef59" escape="true"><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5Mw_eb4cfe7a-8551-4e33-b8cc-169841c9ff08" continuedAt="i029a82a64bf842a0807f64083494a3cf" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ife171c7ebb954d90a256942693ebef59" continuedAt="i8686447d5e014b589b8fc93ceee5aa0e"><ix:continuation id="i029a82a64bf842a0807f64083494a3cf" continuedAt="i4ef8ef8b3edd4e3d876a4a817a9972d7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to <ix:nonNumeric contextRef="ia10c9da04455423daca5e24de07ee725_I20220331" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMTU3_0b05d11d-81cb-40ee-864a-ea0a1160ab78">ten years</ix:nonNumeric>, some of which include options to extend the leases for up to <ix:nonNumeric contextRef="ia10c9da04455423daca5e24de07ee725_I20220331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjIy_ae795a6c-e40a-495c-b840-e157ada2a93e">five years</ix:nonNumeric>. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i8686447d5e014b589b8fc93ceee5aa0e"><ix:continuation id="i4ef8ef8b3edd4e3d876a4a817a9972d7"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="lgnd:AssetsAndLiabilitiesLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5NA_07b58f05-8ab3-43dd-9eec-f2f2879d89b9" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.007%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMS0xLTEtMS01OTUzNQ_2909d7e7-9f74-4a78-9c7e-5895c4d778cd">15,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMS0zLTEtMS01OTUzNQ_0c97e4e1-039a-42d0-9cfa-116e68d2131c">16,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMi0xLTEtMS01OTUzNQ_e771b899-7fac-41a8-9f9c-d8d39f24569e">15,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMi0zLTEtMS01OTUzNQ_35e7c02a-240d-4cbe-918d-0a590c955680">16,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMy0xLTEtMS01OTUzNQ_b44f8344-ea4e-4d03-8702-dd9a4b5dceab">31,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:LeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMy0zLTEtMS01OTUzNQ_6cc4cad8-1224-4382-8d49-6cfe9867f21e">32,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNi0xLTEtMS01OTUzNQ_42f57636-14e9-4f13-ac2a-5427143e3b4a">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNi0zLTEtMS01OTUzNQ_781da294-d17b-4775-adba-5ffad06e4da6">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNy0xLTEtMS01OTUzNQ_118ad398-0f0e-4d08-aed4-7b23ce7d4076">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNy0zLTEtMS01OTUzNQ_6dd6825a-e135-4e2e-89a3-35420a5a3147">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:LeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOC0xLTEtMS01OTUzNQ_a051a78e-cf78-4ab2-860c-05346d4554a9">1,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:LeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOC0zLTEtMS01OTUzNQ_9373d54d-9562-4cf3-88d0-a636f04826a6">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOS0xLTEtMS01OTUzNQ_9e1a8677-bc4a-4b61-b616-a3d55fd03e5f">16,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOS0zLTEtMS01OTUzNQ_646ce963-7819-4ed4-bead-338a072d3681">15,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTAtMS0xLTEtNTk1MzU_0d0d65c9-02ac-4ae3-acde-871ed6f2522f">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTAtMy0xLTEtNTk1MzU_f5c4e99d-de86-4097-9d72-184c17a2d4d4">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTEtMS0xLTEtNTk1MzU_ef510aee-be56-419f-aada-f3852a34d7a1">18,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231" decimals="-3" name="lgnd:LeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTEtMy0xLTEtNTk1MzU_90ddabbd-4fa2-4e0a-bc35-6b971e92f472">17,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5Mg_2a80b417-e8de-4d89-9f81-a95517a00602" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of March 31, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining nine months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfMS0xLTEtMS01OTUzNQ_3ffb2743-d6b1-47d9-ba98-26781e5ecf58">1,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfMi0xLTEtMS01OTUzNQ_4b2f1ff9-8904-4e3f-a95b-0a64e8847459">2,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfMy0xLTEtMS01OTUzNQ_a0e6fec1-c56c-4659-be67-72b7021b4beb">2,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNC0xLTEtMS01OTUzNQ_db17a3d4-76df-4b9a-b105-9e6087ccb901">2,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNS0xLTEtMS01OTUzNQ_ae58ca5a-8dc0-40b3-8169-699ab554609c">2,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNi0xLTEtMS03MTI5Mg_3a96e7bd-759d-4f8c-ba95-a41331c92e94">2,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNi0xLTEtMS01OTUzNQ_c7415568-e776-4111-ac29-2e2dd0146b18">8,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNy0xLTEtMS01OTUzNQ_2a866d55-fabf-463b-a110-fb23f17b4a61">22,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfOC0xLTEtMS01OTUzNQ_99c2b8b8-c6ee-49b4-8593-687be54bb418">3,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfOS0xLTEtMS01OTUzNQ_9ec5855b-0732-47c9-8469-68482e261425">18,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_64"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. &#160;&#160;&#160;&#160;Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;text-decoration:underline">Caution:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">  This discussion and analysis may contain predictions, estimates and other forward-looking statements that involve a number of risks and uncertainties, including those discussed in Part II, Item 1A. Risk Factors. This outlook represents our current judgment on the future direction of our business. These statements include those related to our Captisol-related revenues and manufacturing capacity, our Kyprolis and other product royalty revenues, the impact of COVID-19, product returns, product development, and the potential separation of the OmniAb business. Actual events or results may differ materially from our expectations. For example, there can be no assurance that our revenues or expenses will meet any expectations or follow any trend(s), that we will be able to retain our key employees or that we will be able to enter into any strategic partnerships or other transactions. We cannot assure you that we will receive expected Kyprolis, Captisol and other product revenues to support our ongoing business or that our internal or partnered pipeline products will progress in their development, gain marketing approval or achieve success in the market. In addition, ongoing or future arbitration, litigation or disputes with third parties may have a material adverse effect on us. Such risks and uncertainties, and others, could cause actual results to differ materially from any future performance suggested. We undertake no obligation to make any revisions to these forward-looking statements to reflect events or circumstances arising after the date of this quarterly report. This caution is made under the safe harbor provisions of Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">We use our trademarks, trade names and services marks in this report as well as trademarks, trade names and service marks that are the property of other organizations. Solely for convenience, trademarks and trade names referred to in this report appear without the &#174; and &#8482; symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert its rights, to these trade marks and trade names.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References to &#8220;Ligand Pharmaceuticals Incorporated,&#8221; &#8220;Ligand,&#8221; the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221; include Ligand Pharmaceuticals Incorporated and our wholly-owned subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:54pt"><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. We employ research technologies such as antibody discovery technologies, ion channel discovery technology, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pseudomonas fluorescens </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. We currently have partnerships and license agreements with over 140 pharmaceutical and biotechnology companies. Over 400 programs are in various stages of commercialization, development or research and are fully funded by our collaboration partners and licensees. We have contributed novel research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and postpartum depression, among others. Our collaboration partners and licensees have programs currently in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others. We have over 1,600 issued patents worldwide.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have assembled our large portfolio of fully-funded programs either by licensing our own proprietary drug development programs, licensing our platform technologies such as Captisol or OmniAb to partners for use with their proprietary programs, or acquiring existing partnered programs from other companies. Fully-funded programs are those for which our partners pay all of the development and commercialization costs. For our internal programs, we generally plan to advance drug candidates through early-stage drug development or clinical proof-of-concept and then seek partners to continue development and potential commercialization.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Our goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified and lower-risk business than a typical biotech company. Our business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation and partnering. We partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management and commercialization) to ultimately generate our revenue. We believe that focusing on discovery and early-stage drug development while benefiting from our partners&#8217; development and commercialization expertise will reduce our internal expenses and allow us to have a larger number of drug candidates progress to later stages of drug development.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue consists of three primary elements: royalties from commercialized products, sale of Captisol material, and contract revenue from license, milestone and other service payments. In addition to discovering and developing our own proprietary drugs, we selectively pursue acquisitions to bring in new assets, pipelines, and technologies to aid in generating additional potential new revenue streams.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Update on the OmniAb Separation Process</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, we announced plans to explore multiple paths for OmniAb to become a standalone public company. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb.  Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the closing of the transaction, Avista Capital Partners (&#8220;Avista&#8221;), APAC&#8217;s sponsor has agreed to invest up to $115 million in the combined company, and Ligand will contribute $15 million (less certain transaction and other expenses). The combined company will have an initial pre-money equity valuation of $850 million. Ligand intends to distribute 100% of its equity in OmniAb to Ligand shareholders immediately prior to the business combination with APAC. The transaction is expected to be tax-free to Ligand and its shareholders for U.S. federal income tax purposes. The transaction is expected to close in the second half of 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, OmniAb filed with the SEC a registration statement on Form 10 registering shares of OmniAb common stock and APAC filed with the SEC a registration statement on Form S-4 registering shares of APAC common stock, warrants and certain equity awards. The Form S-4 filed by APAC includes a proxy statement/prospectus in connection with the APAC shareholder vote required for the proposed transaction. The Form 10 filed by OmniAb includes portion of the Form S-4 registration statement filed by APAC which will serve as an information statement/prospectus in connection with the spin-off of OmniAb. Ligand&#8217;s shareholders and other interested persons are advised to read the preliminary and definitive registration statements, and documents incorporated by reference therein, as these materials contain important information about APAC, OmniAb and the proposed business combination. The proxy statement/prospectus contained in APAC&#8217;s registration statement will be mailed to APAC shareholders as of a record date to be established for voting on the proposed business combination.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statements, proxy statement/prospectus/information statement and other documents are also available at www.sec.gov, or by request to Avista Public Acquisition Corp. II, 65 East 55th Street, 18th Floor, New York, NY 10022.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Portfolio Program Updates </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">OmniAb</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Platform Updates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The OmniAb discovery platform provides our pharmaceutical industry partners with access to diverse antibody repertoires and high-throughput screening technologies to enable discovery of next-generation therapeutics. At the heart of the OmniAb platform is the Biological Intelligence</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (BI) of our proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. Over 55 partners have access to OmniAb-derived antibodies and more than 250 programs are being actively developed or commercialized. As of March 31, 2022, there were 25 active clinical- or commercial- stage OmniAb-derived antibodies.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Immunovant held an R&amp;D day, where they highlighted Batoclimab (IMVT-1401), an OmniAb-derived monoclonal antibody targeting the neonatal Fc receptor. Immunovant announced plans to initiate a Phase 3 trial in myasthenia gravis in the first half of 2022 with top-line results expected in 2024. Immunovant further outlined plans to initiate clinical trials in four additional indications in 2022, with two of the indications expected to enter directly into pivotal trials. Batoclimab is also being developed by Harbour BioMed in China and is currently in an ongoing pivotal Phase 3 trial in patients with myasthenia gravis.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aptevo Therapeutics announced that a patient with relapsed/refractory acute myeloid leukemia in an ongoing Phase 1b trial received an allogeneic stem cell transplant after receiving APVO436 and experiencing significant reduction in bone </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">marrow blasts. This follows Aptevo's previous announcement that a patient receiving combination therapy is also moving to transplant after one cycle of therapy.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Q1 2022 and recently, OmniAb entered into new platform licensing agreements with LTZ Therapeutics, Seismic Therapeutics, LifeArc and an undisclosed venture-backed Bay Area immune-oncology company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ligand Core Business Portfolio Updates</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Travere Therapeutics announced the submission of an NDA to the FDA for accelerated approval of sparsentan for IgA nephropathy (IgAN). Travere announced that plans are underway to submit an NDA for accelerated approval to the FDA for focal segmental glomerulosclerosis (FSGS) and a combined IgAN and FSGS Marketing Authorisation Application in Europe in mid-2022.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, Merck announced the FDA granted Breakthrough Designation for V116, a 21-valent pneumococcal vaccine utilizing Ligand&#8217;s CRM197 vaccine carrier protein produced using the Pelican Expression Technology platform. Merck plans to initiate Phase 3 clinical trials for V116 in 2022.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 2, 2022 Jazz Pharmaceuticals announced the submission of a supplemental BLA to the FDA seeking approval for a M/W/F intramuscular dosing schedule for Rylaze&#8482; as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia. Jazz announced on their fourth quarter 2021 earnings call plans to submit regulatory filings for Rylaze in Europe in mid-2022 with potential approval in 2023.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2022, BeiGene, Ltd. announced the launch of KYPROLIS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (carfilzomib) for injection in China for patients with relapsed/refractory (R/R) multiple myeloma. KYPROLIS is licensed to BeiGene in China under a strategic collaboration with Amgen, and was approved in July 2021 by the China National Medical Products Administration (NMPA) in combination with dexamethasone for the treatment of adult patients with R/R multiple myeloma who have received at least two prior therapies, including a proteasome inhibitor and an immunomodulatory agent.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, Outlook Therapeutics announced it submitted a Biologics License Application (BLA) to the FDA for ONS-5010, an investigational ophthalmic formulation of bevacizumab for the treatment of wet age-related macular degeneration that, if approved, will be branded as LYTENAVA&#8482; (bevacizumab-vikg).</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.093%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13,695</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,583&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol - Core</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6,226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Captisol - COVID</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">5,896</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24,123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">19,876</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">45,693</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,457)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total revenue decreased by $(9.5) million, or (17)%, to $45.7 million in Q1 2022 compared to $55.2 million in Q1 2021 primarily due to the $24.1 million decrease in sales of COVID related Captisol that is used in formulation with remdesivir.  Non-COVID Captisol sales increased by $5.0 million, with the increase primarily due to increased demand from Baxter, Fareva Mirabel, and Novartis in Q1 2022 compared to Q1 2021. Royalties and contract revenue increased in Q1 2022 compared to Q1 2021, with the increase primarily attributable to the increase in partner product sales of Kyprolis, Evomela, Teriparatide Injection, and Rylaze.  </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues attributable to the Ligand core business segment and OmniAb business segment were $36.5 million and $9.2 million, respectively, for the first quarter of 2022. Revenues attributable to the Ligand core business segment and OmniAb business segment were $46.6 million and $8.6 million, respectively, for the first quarter of 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Royalty revenue is a function of our partners&#8217; product sales and the applicable royalty rate. Kyprolis royalty rates are under a tiered royalty rate structure with the highest tier being 3.0%. Evomela has a fixed royalty rate of 20%. Teriparatide injection has a tiered royalty between 25% and 40% on sales that have been adjusted for certain deductible items as defined in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">the respective license agreement. The Rylaze royalty rate is tiered between 3% and 5%. Contract revenue includes service revenue, license fees and development, regulatory and sales based milestone payments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents royalty revenue by program (in millions):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022 Royalty Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021 Estimated Partner Product Sales</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Effective Royalty Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021 Royalty Revenue</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">297.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Teriparatide injection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">32.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">50.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">70.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">1.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">440.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">13.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:112%">(1) - Teriparatide injection sales have been adjusted for certain deductible items as defined in the respective license agreement.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Costs and Expenses</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.549%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.653%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cost of Captisol</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,699</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">11,813</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,786&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">20,307</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,879&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">18,180</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total operating costs and expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">54,999</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50,435&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating costs and expenses during Q1 2022 increased by $4.6 million, or 9%, compared to Q1 2021 primarily  attributable to the OmniAb spin-off related transaction costs recorded in Q1 2022. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cost of Captisol decreased primarily due to the decrease in Captisol sales during Q1 2022 compared to Q1 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of intangibles remained steady in Q1 2022 compared to the same period in 2021 as there have been no significant changes to the gross balance of intangible assets over these periods. Amortization of intangibles were $8.8&#160;million and $3.0&#160;million for the Ligand core business segment and OmniAb business segment during Q1 2022, respectively. Amortization of intangibles were $8.8&#160;million and $3.0&#160;million for the Ligand core business segment and OmniAb business segment during Q1 2021, respectively. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At any one time, we are working on multiple R&amp;D programs. As such, we generally do not track our R&amp;D expenses on a specific program basis. Our R&amp;D expenses increased in Q1 2022 compared to the same period in 2021 due to the increase in R&amp;D activities at Icagen, Crystal, and Pfenex, which primarily consisted of salaries and lab costs. Excluding $0.9&#160;million unallocated corporate items, R&amp;D expenses were $8.2&#160;million and $11.2&#160;million for the Ligand core business segment and OmniAb business segment during Q1 2022, respectively. Excluding $0.8&#160;million unallocated corporate items, R&amp;D expenses were $8.0&#160;million and $9.1&#160;million, respectively, for non-OmniAb business segment and OmniAb business segment during Q1 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses increased in Q1 2022 compared to the same period in 2021 primarily attributable to the $4.8 million of OmniAb spin-off related transaction costs incurred compared to no transaction costs being recorded in Q1 2021. Excluding $12.2&#160;million unallocated corporate items, general and administrative expenses were $4.8&#160;million and $1.2&#160;million, respectively, for Ligand core business segment and OmniAb business segment during Q1 2022. Excluding $8.3&#160;million unallocated corporate items, general and administrative expenses were $3.2&#160;million and $1.1&#160;million, respectively, for Ligand core business segment and OmniAb business segment during Q1 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Other Income (Expense)</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.576%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain (loss) from short-term investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(12,877)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25,938)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">134</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(162)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,831)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2,698</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,477)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total other income (expense), net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(10,834)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11,883)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fluctuation in the gain (loss) from short-term investments is primarily driven by the changes in the fair value of our ownership in Viking common stock, contributing an unrealized loss of $10.7 million in Q1 2022 as compared to an unrealized gain of $9.1 million in Q1 2021. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income consists primarily of interest earned on our short-term investments. The decrease over the prior period was due to the decrease in our short-term investment balance.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense includes the 0.75% coupon cash interest expense in addition to the non-cash accretion of discount (including the amortization of debt issuance cost) on our 2023 Notes for the three months ended March&#160;31, 2022. The decrease was primarily due to the adoption of ASU 2020-06 which significantly reduced the debt discount balance subject to amortization. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for detail on ASU 2020-06 adoption. In addition, we carried a lower average debt outstanding balance during Q1 2022 as compared to Q1 2021. During the three months ended March&#160;31, 2022, we repurchased $165.8&#160;million in principal of the 2023 Notes. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes. </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      </span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net, in Q1 2022 increased by $9.2&#160;million as compared to Q1 2021, primarily due to a $1.5&#160;million gain on extinguishment of debt and $1.0&#160;million gain for the fair value adjustment of Metabasis and Icagen CVRs during Q1 2022 compared to a $4.8&#160;million loss on extinguishment of debt and $1.4&#160;million loss for the fair value adjustment of Metabasis and Icagen CVRs during Q1 2021. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 3, Fair Value Measurements.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Benefit (Expense)</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.128%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.868%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(20,140)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,764&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25,904)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">4,755</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12,342&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7,587)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(15,385)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33,491)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(214.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute our income tax provision by applying the estimated annual effective tax rate to income from operations and adding the effects of any discrete income tax items specific to the period. The effective tax rate for the three months ended March&#160;31, 2022 and 2021 was 23.6% and (214.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March 31, 2021 was significantly impacted by discrete tax benefits from share-based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Liquidity and Capital Resources </span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, our cash, cash equivalents, and short-term investments totaled $204.0 million, which decreased by $137.1&#160;million from the end of last year due to factors described in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below. Our primary source of liquidity, other than our holdings of cash, cash equivalents, and short-term investments, has been cash flows from operations. Our ability to generate cash from operations provides us with the financial flexibility we need to meet operating, investing, and financing needs.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have liquidated our short-term investments and/or issued debt and equity securities to finance our business needs as a supplement to cash provided by operating activities. Our short-term investments include U.S. government debt securities, investment-grade corporate debt securities, mutual funds and certificates of deposit. We have established guidelines relative to diversification and maturities of our investments in order to provide both safety and liquidity. These </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. Additionally, we own certain securities which are classified as short-term investments that we received as a result of a milestone and an upfront license payment as well as 6.7 million shares of common stock in Viking.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued an aggregate principal amount of $750.0 million of the 2023 Notes. During the three months ended March&#160;31, 2022, we repurchased $165.8&#160;million in principal of the 2023 Notes for $163.7&#160;million in cash, including accrued interest of $0.4&#160;million. After the repurchases, $177.5 million in principal amount of the 2023 Notes remain outstanding. We may continue to use cash on hand to repurchase additional 2023 Notes through open-market transactions, including through Rule 10b5-1 trading plans to facilitate open-market repurchases, or otherwise, from time to time. The timing and amount of repurchase transactions will be determined by management based on the evaluation of market conditions, trading price of the 2023 Notes, legal requirements and other factors. The 2023 Notes were not convertible as of March&#160;31, 2022. It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 4, Convertible Senior Notes.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing funds, cash generated from operations and existing sources of and access to financing are adequate to fund our need for working capital, capital expenditures, debt service requirements, continued advancement of research and development efforts, potential stock repurchases and other business initiatives we plan to strategically pursue, including acquisitions and strategic investments.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had $9.0 million in fair value of contingent consideration liabilities associated with prior acquisitions to be settled in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow Summary</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:65.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.854%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Q1 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Investing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;Financing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(170,421)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(91,635)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022, we repurchased $165.8&#160;million in principal of the 2023 Notes for $163.7&#160;million in cash, including accrued interest of $0.4&#160;million. During the three months ended March 31, 2021, we repurchased $104.5&#160;million in principal of the 2023 Notes for $109.1&#160;million in cash, including accrued interest of $0.2&#160;million. </span></div><div style="text-indent:18pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our policies require the application of management judgment in making estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Those estimates and assumptions are based on historical experience and various other factors deemed applicable and reasonable under the circumstances. The use of judgment in determining such estimates and assumptions is by nature, subject to a degree of uncertainty. Accordingly, actual results could differ materially from the estimates made. There have been no material changes in our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our 2021 Annual Report, other than the adoption of the Accounting Standards Updates described in Item 1. Condensed consolidated Financial Statements - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to convertible debt.</span></div><div style="text-indent:14pt"><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_76"></div><div><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="text-indent:45pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no substantial changes to our market risks in the three months ended March&#160;31, 2022, when compared to the disclosures in Item 7A of our 2021 Annual Report.</span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_79"></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures, as defined in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures as of March&#160;31, 2022 were effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the quarter ended March&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_82"></div><div style="padding-left:54pt;text-indent:-54pt"><span><br/></span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information that updates the disclosures set forth under Part I. Item 3. Legal Proceedings in our 2021 Annual Report, refer to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 7, Commitment and Contingencies: Legal Proceedings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Condensed Consolidated Financial Statements contained in Part I. Item 1. of this report.</span></div><div><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as set forth below, we do not believe that there have been any material changes to the risk factors disclosed in Part I, Item 1A of our 2021 Annual Report. The risk factors described in our 2021 Annual Report and below are not the only risks we face. Factors we currently do not know, factors that we currently consider immaterial or factors that are not specific to us, such as general economic conditions, may also materially adversely affect our business or our consolidated operating results, financial condition or cash flows.</span></div><div style="text-indent:27pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Merger is subject to the satisfaction of certain conditions, which may not be satisfied on a timely basis, if at all.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consummation of the Merger is subject to customary closing conditions for transactions involving special purpose acquisition companies, including, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">receipt of required consents and approvals from certain governmental authorities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no agreement between Ligand or APAC and any governmental authority pursuant to which Ligand or APAC has agreed not to consummate the Merger shall have been effected;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no governmental authority of competent jurisdiction shall have enacted, issued or granted any law (whether temporary, preliminary or permanent), in each case that is in effect and which has the effect of restraining, enjoining or prohibiting the consummation of the transaction;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">APAC shall have at least $5,000,001 of net tangible assets as of the Closing;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the APAC common stock issuable pursuant to the Merger shall have been approved for listing on Nasdaq, subject to official notice of issuance;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Ligand, OmniAb, APAC and Merger Sub shall each have performed and complied in all material respects with the obligations, covenants and agreements required by the Merger Agreement to be performed or complied with by it at or prior to filing, or a later date as agreed to by the parties;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">customary bring down conditions related to the accuracy of the parties&#8217; respective representations, warranties and pre-closing covenants in the Merger Agreement;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the consummation of the Distribution, Reorganization and other transactions contemplated by the Separation Agreement shall have occurred;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">each of APAC&#8217;s and OmniAb&#8217;s registration statements to be filed with the United States Securities and Exchange Commission shall have become effective;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">APAC&#8217;s shareholder approval; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the receipt by Ligand and APAC of certain tax opinions.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, APAC&#8217;s obligation to consummate the Business Combination is also subject to there having been no &#8220;Material Adverse Effect&#8221; on OmniAb since the date of the Merger Agreement.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the obligations of OmniAb to consummate or cause to be consummated the Merger is subject to the satisfaction of the following additional conditions, any one (1) or more of which may be waived in writing by the OmniAb, among other things:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the completion of the transactions contemplated by the Merger Agreement; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">the resignation of all directors and all executive officers of APAC.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that such closing conditions will be satisfied or waived, or that the Merger will be consummated. Further, we cannot assure you that the approval of APAC&#8217;s stockholders will be obtained. We, OmniAb and APAC may be subject to shareholder lawsuits, or other actions filed in connection with or in opposition to the Merger, which could prevent or delay the consummation of the Merger.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the Distribution, together with certain related transactions, fails to qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), or the Merger fails to qualify as a reorganization under Section 368(a) of the Code, Ligand and its stockholders could incur significant tax liabilities, and APAC and OmniAb could be required to indemnify Ligand for taxes that could be material pursuant to indemnification obligations under the tax matters agreement to be entered into in connection with the closing of the Merger (the &#8220;Tax Matters Agreement&#8221;).</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ligand expects to receive a tax opinion from Latham &amp; Watkins LLP, tax counsel to Ligand, which shall provide that the Distribution will qualify as a reorganization under Sections 355 and 368(a)(1)(D) of the Code and that the Merger will not cause Section 355(e) of the Code to apply to the Distribution. In addition, the obligations of Ligand and OmniAb to complete the Merger are conditioned upon, among other things, Ligand&#8217;s receipt of such tax opinion. The obligation of APAC to complete the Merger is conditioned upon, among other things, receipt of an opinion of Weil, Gotshal &amp; Manges LLP, tax counsel to APAC, that the Merger will be treated as a reorganization under Section 368(a) of the Code. The opinions will be based on, among other things, certain facts, assumptions, representations and undertakings from Ligand, OmniAb and APAC, including those regarding the past and future conduct of the companies&#8217; respective businesses and other matters. If any of these facts, assumptions, representations, or undertakings are incorrect or not satisfied, Ligand may not be able to rely on the opinions, and Ligand and its stockholders could be subject to significant U.S. federal income tax liabilities. In addition, the opinions will not be binding on the IRS or the courts. Notwithstanding the opinions, the IRS could determine on audit that the Distribution or Merger does not qualify as a reorganization if it determines that any of the facts, assumptions, representations or undertakings on which the opinions are based are not correct or have been violated or that the Distribution or Merger should be taxable for other reasons, including as a result of a significant change in stock or asset ownership after the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Distribution, together with certain related transactions, is ultimately determined not to qualify as a reorganization, the Distribution could be treated as a taxable disposition of shares of OmniAb stock by Ligand and as a taxable dividend or capital gain to Ligand&#8217;s stockholders for U.S. federal income tax purposes. If the Merger is ultimately determined not to qualify as a reorganization, the Merger could be treated as a taxable disposition of OmniAb stock by Ligand stockholders. In either such case, Ligand and its stockholders that are subject to U.S. federal income tax could incur significant U.S. federal income tax liabilities. </span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tax Matters Agreement that APAC and OmniAb will enter into with Ligand, APAC and OmniAb will generally be required to indemnify Ligand against taxes incurred by Ligand that arise as a result of certain actions or omissions by APAC or OmniAb that prevent the Distribution, together with certain related transactions, from qualifying as a reorganization under Sections 355 and 368(a)(1)(D) of the Code. Further, even if APAC and OmniAb are not responsible for tax liabilities of Ligand under the Tax Matters Agreement, OmniAb nonetheless could be liable under applicable U.S. federal tax law for such liabilities if Ligand were to fail to pay them. If APAC or OmniAb is required to pay any liabilities under the circumstances set forth in the Tax Matters Agreement or pursuant to applicable tax law, the amounts may be significant. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The anticipated benefits of the Separation and Merger may not be achieved.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to achieve the full strategic and financial benefits expected to result from the Separation and Merger, including the potential that the Separation and Merger Combination will:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">allow each business to pursue its own operational and strategic priorities and more quickly respond to trends, developments and opportunities in its respective markets;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">create two separate and distinct management teams focused on each business&#8217;s unique strategic priorities, target markets and corporate development opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">give each business opportunity and flexibility by pursuing its own investment, capital allocation and growth strategies consistent with its long-term objectives;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">allow investors to separately value each business based on the unique merits, performance and future prospects of each business, providing investors with two distinct investment opportunities;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">enhance the ability of each business to attract and retain qualified management and to better align incentive-based compensation with the performance of each separate business; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">give each of OmniAb and Ligand its own equity currency for use in connection with acquisitions.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not achieve the anticipated benefits of the Separation and Merger for a variety of reasons. Further, such benefits, if ultimately achieved, may be delayed. In addition, the Separation and Merger could materially and adversely affect our business, financial condition and results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Separation and Distribution may expose Ligand and OmniAb to potential liabilities arising out of state and federal fraudulent conveyance laws and legal dividend requirements.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Separation and Distribution are subject to review under various state and federal fraudulent conveyance laws. Fraudulent conveyance laws generally provide that an entity engages in a constructive fraudulent conveyance when (i) the entity transfers assets and does not receive fair consideration or reasonably equivalent value in return; and (ii) the entity: (a) is insolvent at the time of the transfer or is rendered insolvent by the transfer; (b) has unreasonably small capital with which to carry on its business; or (c) intends to incur or believes it will incur debts beyond its ability to repay its debts as they mature. An unpaid creditor or an entity acting on behalf of a creditor (including without limitation a trustee or debtor-in-possession in a bankruptcy by OmniAb or Ligand or any of our respective subsidiaries) may bring an action alleging that the Separation or Distribution or any of the related transactions constituted a constructive fraudulent conveyance. If a court accepts these allegations, it could impose a number of remedies, including without limitation, voiding OmniAb&#8217;s claims against Ligand, requiring the future OmniAb stockholders to return to Ligand some or all of the shares of OmniAb common stock issued in the Distribution, or providing Ligand with a claim for money damages against OmniAb in an amount equal to the difference between the consideration received by Ligand and OmniAb fair market value at the time of the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measure of insolvency for purposes of the fraudulent conveyance laws will vary depending on which jurisdiction&#8217;s law is applied. Generally, an entity would be considered insolvent if (i) the present fair saleable value of its assets is less than the amount of its liabilities (including contingent liabilities); (ii) the present fair saleable value of its assets is less than its probable liabilities on its debts as such debts become absolute and matured; (iii) it cannot pay its debts and other liabilities (including contingent liabilities and other commitments) as they mature; or (iv) it has unreasonably small capital for the business in which it is engaged. We cannot assure you what standard a court would apply to determine insolvency or that a court would determine that OmniAb or Ligand or any of our subsidiaries were solvent at the time of or after giving effect to the Distribution.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Distribution of OmniAb common stock is also subject to review under state corporate distribution statutes. Under the DGCL, a corporation may only pay dividends to its stockholders either (i) out of its surplus (net assets minus capital) or (ii) if there is no such surplus, out of its net profits for the fiscal year in which the dividend is declared or the preceding fiscal year. Although Ligand intends to make the Distribution of OmniAb common stock entirely from surplus, we cannot assure you that a court will not later determine that some or all of the Distribution to Ligand stockholders was unlawful.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The announcement of the proposed Separation and Merger could disrupt OmniAb&#8217;s relationships with its customers, suppliers, business partners and others, as well as its operating results and business generally.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risks relating to the impact of the announcement of the Separation and Merger on OmniAb&#8217;s business include the following:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">its employees may experience uncertainty about their future roles, which might adversely affect OmniAb&#8217;s ability to retain and hire key personnel and other employees;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">customers, suppliers, business partners and other parties with which OmniAb maintains business relationships may experience uncertainty about its future and seek alternative relationships with third parties, seek to alter their business relationships with OmniAb or fail to extend an existing relationship with OmniAb; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">OmniAb has expended and will continue to expend significant costs, fees and expenses for professional services and transaction costs in connection with the proposed Separation and Merger.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the aforementioned risks were to materialize, they could lead to significant costs which may impact the combined company&#8217;s results of operations and cash available to fund its business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will incur transaction costs in connection with the Separation and Merger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OmniAb has both incurred and expects to incur significant, non-recurring costs in connection with consummating the Separation and Merger and operating as a public company following the consummation of the Separation and Merger. OmniAb may also incur additional costs to retain key employees. Although certain transaction expenses incurred in connection with the Merger Agreement, including all legal, accounting, consulting, investment banking and other fees, expenses and costs, will be paid by APAC following the closing of the Merger, OmniAb expects some increased operational costs as well.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will also bear all of OmniAb&#8217;s expenses if the Merger is not consummated.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_91"></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">None.</span></div><div id="i24aac44094964d4184ea8d0c77bbf073_94"></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i24aac44094964d4184ea8d0c77bbf073_97"></div><div><span><br/></span></div><div style="text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">   Item 4.  Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i24aac44094964d4184ea8d0c77bbf073_100"></div><div><span><br/></span></div><div style="text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;Other Information</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i24aac44094964d4184ea8d0c77bbf073_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.  Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Incorporated by Reference</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Description of Exhibit</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Form</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">File Number</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Date of Filing</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Number</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Filed</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Herewith</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000886163/000119312522083443/d337089dex21.htm">2.1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000886163/000119312522083443/d337089dex21.htm">*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Agreement and Plan of Merger, dated as of March, 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated, OmniAb, Inc. and Orwell Merger Sub Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex22.htm">2.2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex22.htm">*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Separation and Distribution Agreement, dated as of March 23, 2022, by and among Avista Public Acquisition Corp. II, Ligand Pharmaceuticals Incorporated and OmniAb, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex23.htm">2.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Sponsor Insider Agreement, dated March 23, 2022, by and among OmniAb, Inc., Avista Public Acquisition Corp. II and the other parties signatory thereto</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex24.htm">2.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amended and Restated Forward Purchase Agreement, dated March 23, 2022, by and among Avista Public Acquisition Corp. II, Avista Acquisition LP II and OmniAb, Inc.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 24, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">2.4</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/0000936392-98-001000.txt">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Amended and Restated Certificate of Incorporation of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">S-4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">333-58823</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">July 9, 1998</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616301000008/0000886163-01-000008-0002.txt">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 14, 2000</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 29, 2001</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.5</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616304000015/ex3-6.txt">3.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated June 30, 2004</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-Q</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">0-20720</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">August 5, 2004</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312510264942/dex31.htm">3.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certificate of Incorporation of the Company, dated November 17, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">November 19, 2010</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616319000157/exhibit36.htm">3.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certificate of Amendment of the Amended and Restated Certification of Incorporation of the Company, dated June 19, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">S-8</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">333-233130</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">August 8, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.6</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616320000116/exhibit31-ligandxfourt.htm">3.6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Fourth Amended and Restated Bylaws of the Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">October 30, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616318000030/lgndexhibi41.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Specimen stock certificate for shares of the common stock of the Company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 1, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616318000076/exhibit41.htm">4.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Indenture, dated as of May 22, 2018, between the Company and Wilmington Trust, National Association, as trustee, including the form of 0.75% Convertible Senior Notes due 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">May 22, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000088616321000050/exhibit43_ligand-descripti.htm">4.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Description of Registered Securities</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">February 24, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/886163/000119312522083443/d337089dex101.htm">10.1*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Employee Matters Agreement, dated as of March 23, 2022, by and among Ligand Pharmaceuticals Incorporated, Avista Public Acquisition Corp. II, OmniAb, Inc. and Orwell Merger Sub Inc.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">8-K</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">001-33093</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 23, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_33122exhibit311.htm">31.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Executive Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_33122exhibit312.htm">31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certification by Principal Financial Officer, Pursuant to Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="lgnd_33122exhibit321.htm">32.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Certifications by Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:9.234%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.298%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">101</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The following financial information from our Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2022, formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets, (ii) Consolidated Condensed Statements of Operations, (iii) Consolidated Condensed Statement of Comprehensive Income, (iv) Consolidated Condensed Statements of Stockholders' Equity, (v) Consolidated Condensed Statements of Cash Flows, and (vi) the Notes to Consolidated Condensed Financial Statements.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March&#160;31, 2022, formatted in Inline XBRL and contained in Exhibit 101.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">X</span></td></tr></table></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">*   Schedules and exhibits omitted pursuant to Item 601(b)(2) of Regulation S-K. Ligand Pharmaceuticals Incorporated agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div id="i24aac44094964d4184ea8d0c77bbf073_106"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Duly Authorized Officer and Principal Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>lgnd_33122exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i68ad1f74fc5f46d9bdf2d1ddc70033c7_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, John L. Higgins, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.064%"><tr><td style="width:1.0%"></td><td style="width:11.711%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.089%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;May&#160;9, 2022 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:54.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John L. Higgins</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:2pt;padding-right:-2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>lgnd_33122exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iea74fce2e9dc4cc3a696a7ee636caaf5_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULE 13a-14(a)&#47;15d-14(a)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">I, Matthew Korenberg, certify that&#58;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this Quarterly Report on Form 10-Q of Ligand Pharmaceuticals Incorporated&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.362%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:72pt;padding-right:-72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">Date&#58;&#160;&#160;&#160;&#160;May&#160;9, 2022 </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.416%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew Korenberg</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President, Finance and Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-right:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>lgnd_33122exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i120c9a97c52e4c449b8fc3d446253ebe_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, John L. Higgins, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.944%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; John L. Higgins</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John L. Higgins<br>Chief Executive Officer <br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:144%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">In connection with the Quarterly Report of Ligand Pharmaceuticals Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March&#160;31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Matthew Korenberg, Executive Vice President, Finance and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:10.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.146%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 9, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Matthew Korenberg</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Matthew Korenberg<br>Executive Vice President, Finance and Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:144%">by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>lgnd-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:63142b59-d50f-422e-a0a8-23b5f0c0b9ee,g:55f2a22c-b472-424e-aeed-2ce3b4861db0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:lgnd="http://www.ligand.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ligand.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="lgnd-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ligand.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS">
        <link:definition>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables">
        <link:definition>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
        <link:definition>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
        <link:definition>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails">
        <link:definition>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
        <link:definition>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
        <link:definition>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails">
        <link:definition>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
        <link:definition>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails">
        <link:definition>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
        <link:definition>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.ligand.com/role/SegmentInformation">
        <link:definition>2114102 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.ligand.com/role/SegmentReportingTables">
        <link:definition>2315302 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationDetails" roleURI="http://www.ligand.com/role/SegmentInformationDetails">
        <link:definition>2416411 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.ligand.com/role/FairValueMeasurements">
        <link:definition>2117103 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.ligand.com/role/FairValueMeasurementsTables">
        <link:definition>2318303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2419412 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
        <link:definition>2420413 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2421414 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes">
        <link:definition>2122104 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables">
        <link:definition>2323304 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNarrativeDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails">
        <link:definition>2424415 - Disclosure - Convertible Senior Notes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNotesPayableDetails" roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails">
        <link:definition>2425416 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://www.ligand.com/role/IncomeTax">
        <link:definition>2126105 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxDetails" roleURI="http://www.ligand.com/role/IncomeTaxDetails">
        <link:definition>2427417 - Disclosure - Income Tax (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.ligand.com/role/StockholdersEquity">
        <link:definition>2128106 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.ligand.com/role/StockholdersEquityTables">
        <link:definition>2329305 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
        <link:definition>2430418 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>2431419 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedings" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings">
        <link:definition>2132107 - Disclosure - Commitment and Contingencies: Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLegalProceedingsDetails" roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails">
        <link:definition>2433420 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.ligand.com/role/Leases">
        <link:definition>2134108 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.ligand.com/role/LeasesTables">
        <link:definition>2335306 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.ligand.com/role/LeasesNarrativeDetails">
        <link:definition>2436421 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails">
        <link:definition>2437422 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails">
        <link:definition>2438423 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1">
        <link:definition>2438423 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="lgnd_CommercialLicenseRights" abstract="false" name="CommercialLicenseRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ConvertibleSeniorNotesDue2023Member" abstract="true" name="ConvertibleSeniorNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_RoyaltyOtherMember" abstract="true" name="RoyaltyOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_CurrentPortionOfLiabilityForContingentValueRights" abstract="false" name="CurrentPortionOfLiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_CommercialLicenseRightsPolicyTextBlock" abstract="false" name="CommercialLicenseRightsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" abstract="true" name="CommercialLicenseAndOtherEconomicRightsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" abstract="false" name="DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ProceedsFromUnwindingConvertibleBondHedges" abstract="false" name="ProceedsFromUnwindingConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_XCellaBiosciencesIncMember" abstract="true" name="XCellaBiosciencesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_TeriparatideInjectionMember" abstract="true" name="TeriparatideInjectionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" abstract="false" name="NonCashChangeInEstimatedFairValueOfContingentValueRights" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" abstract="false" name="ScheduleOfShortTermInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" abstract="true" name="USDistrictCourtForTheNorthernDistrictOfOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MilestoneMember" abstract="true" name="MilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LeaseLiability" abstract="false" name="LeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LigandCoreBusinessSegmentMember" abstract="true" name="LigandCoreBusinessSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_NumberOfContingentValueRightsSeries" abstract="false" name="NumberOfContingentValueRightsSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" abstract="false" name="BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" abstract="false" name="ScheduleOfCommercialLicenseRightsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" abstract="false" name="ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_AziyoAndCorMatrixMember" abstract="true" name="AziyoAndCorMatrixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EvomelaMember" abstract="true" name="EvomelaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MetabasisMember" abstract="true" name="MetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BasisOfPresentationTable" abstract="true" name="BasisOfPresentationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" abstract="true" name="LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_SelexisAndDianomiMember" abstract="true" name="SelexisAndDianomiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" abstract="false" name="FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedSupplierExpensesCurrent" abstract="false" name="AccruedSupplierExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHolders" abstract="false" name="PaymentsToContingentValueRightHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" abstract="true" name="LiabilityForContingentValueRightsCompanyXCellaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_EmployeeStockPurchasePlanAbstract" abstract="true" name="EmployeeStockPurchasePlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_KyprolisMember" abstract="true" name="KyprolisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" abstract="false" name="ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" abstract="true" name="LiabilityForContingentValueRightsCompanyMetabasisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_ContractRevenueMember" abstract="true" name="ContractRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsToUnwindWarrants" abstract="false" name="PaymentsToUnwindWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ReturnsAccrual" abstract="false" name="ReturnsAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedSubcontractorExpensesCurrent" abstract="false" name="AccruedSubcontractorExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_OmniAbTechnologiesSegmentMember" abstract="true" name="OmniAbTechnologiesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_PaymentsForConvertibleBondHedges" abstract="false" name="PaymentsForConvertibleBondHedges" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRights" abstract="false" name="LiabilityForContingentValueRights" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BasisOfPresentationLineItems" abstract="true" name="BasisOfPresentationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" abstract="true" name="EarnoutRightsForPartnerResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_RepaymentsOfNotesPayableInterestPortion" abstract="false" name="RepaymentsOfNotesPayableInterestPortion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" abstract="true" name="DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" abstract="true" name="LiabilityForContingentValueRightsCompanyIcagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" abstract="true" name="LicenseFeesMilestonesAndProductOtherProductOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LicenseFeesMember" abstract="true" name="LicenseFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LeaseLiabilityCurrent" abstract="false" name="LeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedAssetAcquisitionsCurrent" abstract="false" name="AccruedAssetAcquisitionsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" abstract="false" name="PaymentsToContingentValueRightHoldersFinancingActivity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_NumberOfOptionsUnderConvertibleBondHedges" abstract="false" name="NumberOfOptionsUnderConvertibleBondHedges" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_LicenseeAccrualCurrent" abstract="false" name="LicenseeAccrualCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_ContractRevenueServiceMember" abstract="true" name="ContractRevenueServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCoreMember" abstract="true" name="MaterialSalesCaptisolCoreMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" abstract="false" name="BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_AccruedInventoryPurchases" abstract="false" name="AccruedInventoryPurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" abstract="false" name="BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolCOVIDMember" abstract="true" name="MaterialSalesCaptisolCOVIDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_IncreaseDecreaseInDebtDiscount" abstract="false" name="IncreaseDecreaseInDebtDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_LiabilityForContingentValueRightsCompanyCydexMember" abstract="true" name="LiabilityForContingentValueRightsCompanyCydexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" abstract="false" name="AmortizationOfCommercialLicenseAndOtherEconomicRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" abstract="false" name="COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_RylazeMember" abstract="true" name="RylazeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_MaterialSalesCaptisolMember" abstract="true" name="MaterialSalesCaptisolMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_Phase3ClinicalTrialMember" abstract="true" name="Phase3ClinicalTrialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="lgnd_LeaseRightOfUseAsset" abstract="false" name="LeaseRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_GainLossOnShortTermInvestments" abstract="false" name="GainLossOnShortTermInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>lgnd-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:63142b59-d50f-422e-a0a8-23b5f0c0b9ee,g:55f2a22c-b472-424e-aeed-2ce3b4861db0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_68ada9da-6829-45ad-bff1-a921d288c9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_451b928d-f10a-4cc8-b7c9-5a01b7029ae5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68ada9da-6829-45ad-bff1-a921d288c9bc" xlink:to="loc_us-gaap_Liabilities_451b928d-f10a-4cc8-b7c9-5a01b7029ae5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16c1d4c3-b77f-401b-b792-ee77b55c25c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68ada9da-6829-45ad-bff1-a921d288c9bc" xlink:to="loc_us-gaap_StockholdersEquity_16c1d4c3-b77f-401b-b792-ee77b55c25c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_51e8fe5b-b450-4074-b4e2-b5a5d79e17c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_68ada9da-6829-45ad-bff1-a921d288c9bc" xlink:to="loc_us-gaap_CommitmentsAndContingencies_51e8fe5b-b450-4074-b4e2-b5a5d79e17c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0b487224-7a41-4120-8f9a-5eb972d4946a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_Goodwill_0b487224-7a41-4120-8f9a-5eb972d4946a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c8594fa5-bf4e-4ef1-8c22-caca41a47894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c8594fa5-bf4e-4ef1-8c22-caca41a47894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f3f06c35-ca2c-4bc1-930e-1a7050cef006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f3f06c35-ca2c-4bc1-930e-1a7050cef006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0c40f12-7407-42e6-8018-a6bb4032480b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0c40f12-7407-42e6-8018-a6bb4032480b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_98d53305-9800-46b2-8158-34755018e13e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_98d53305-9800-46b2-8158-34755018e13e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_b63fabdc-a704-4d8b-94a4-598a643c5e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_b63fabdc-a704-4d8b-94a4-598a643c5e64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f9227275-d30c-4ea5-b719-4361730232b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_AssetsCurrent_f9227275-d30c-4ea5-b719-4361730232b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_5042f2d9-4de4-4bd9-8531-b7803f84ea90" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseRights"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_lgnd_CommercialLicenseRights_5042f2d9-4de4-4bd9-8531-b7803f84ea90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_abe94516-8d39-4fd1-8d6c-a88e7a4965f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_63eae059-a0e2-4eb3-98b0-ad497d355b2f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_abe94516-8d39-4fd1-8d6c-a88e7a4965f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c2bb75af-8f5a-4c86-9485-a29d9e1fcf88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_df8b4c1d-99b9-4004-93f3-b300c12e0dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c2bb75af-8f5a-4c86-9485-a29d9e1fcf88" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_df8b4c1d-99b9-4004-93f3-b300c12e0dc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f93af061-4e56-486c-bf2b-d2348c660b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c2bb75af-8f5a-4c86-9485-a29d9e1fcf88" xlink:to="loc_us-gaap_CommonStockValue_f93af061-4e56-486c-bf2b-d2348c660b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_48e42573-77bf-48eb-8c6a-dcf7848f7222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c2bb75af-8f5a-4c86-9485-a29d9e1fcf88" xlink:to="loc_us-gaap_AdditionalPaidInCapital_48e42573-77bf-48eb-8c6a-dcf7848f7222" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3a5d7a29-707a-4d02-9d67-519a039ba241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c2bb75af-8f5a-4c86-9485-a29d9e1fcf88" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3a5d7a29-707a-4d02-9d67-519a039ba241" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_7550f649-2538-4de0-9729-17d764d59f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c2bb75af-8f5a-4c86-9485-a29d9e1fcf88" xlink:to="loc_us-gaap_PreferredStockValue_7550f649-2538-4de0-9729-17d764d59f65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ab55bad3-74c9-450e-bcc7-01a1586f754f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ab55bad3-74c9-450e-bcc7-01a1586f754f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_27021226-b333-43b3-8898-cb4a9d391ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_27021226-b333-43b3-8898-cb4a9d391ad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2e38db57-e3c7-45d5-8c06-52b4e71dd82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2e38db57-e3c7-45d5-8c06-52b4e71dd82b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_d6fd6689-d372-4fa4-a5f5-502b60cf6a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_d6fd6689-d372-4fa4-a5f5-502b60cf6a41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_499d4dab-6667-4f29-ba9e-e8a75958ec93" xlink:href="lgnd-20220331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_499d4dab-6667-4f29-ba9e-e8a75958ec93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_667ffda8-92a8-4ae7-89a2-a29818182d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_667ffda8-92a8-4ae7-89a2-a29818182d10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f1770333-5275-454b-a796-12a3e1640b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_73a6ea4b-9f9f-4cfa-8a26-9b8efbb36757" xlink:to="loc_us-gaap_AccountsPayableCurrent_f1770333-5275-454b-a796-12a3e1640b4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6401ef14-98f7-4d6b-89f6-c8af2cd6a70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_11349398-47be-46b0-a34f-879d26f0c746" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6401ef14-98f7-4d6b-89f6-c8af2cd6a70b" xlink:to="loc_us-gaap_LiabilitiesCurrent_11349398-47be-46b0-a34f-879d26f0c746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_907d1596-0f5a-4483-bf60-098778de0e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6401ef14-98f7-4d6b-89f6-c8af2cd6a70b" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_907d1596-0f5a-4483-bf60-098778de0e80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_c5e03f56-821e-42fb-a528-de24ab7b29c1" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6401ef14-98f7-4d6b-89f6-c8af2cd6a70b" xlink:to="loc_lgnd_LiabilityForContingentValueRights_c5e03f56-821e-42fb-a528-de24ab7b29c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7e01e42b-f73c-49ae-a88d-40e8ee0ffa03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6401ef14-98f7-4d6b-89f6-c8af2cd6a70b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_7e01e42b-f73c-49ae-a88d-40e8ee0ffa03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1461b48c-e4c5-4f15-8038-dad72c2907e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6401ef14-98f7-4d6b-89f6-c8af2cd6a70b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1461b48c-e4c5-4f15-8038-dad72c2907e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_30df47c2-8173-4901-bc0a-9cfca78133f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_6401ef14-98f7-4d6b-89f6-c8af2cd6a70b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_30df47c2-8173-4901-bc0a-9cfca78133f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e459f36e-f1b0-41e8-8a06-1a5ec5d86b63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6b1d4854-1451-43fd-9339-0237be3f3b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e459f36e-f1b0-41e8-8a06-1a5ec5d86b63" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6b1d4854-1451-43fd-9339-0237be3f3b47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_85020454-952f-4e0d-9c8b-5bdb2750ae2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e459f36e-f1b0-41e8-8a06-1a5ec5d86b63" xlink:to="loc_us-gaap_ShortTermInvestments_85020454-952f-4e0d-9c8b-5bdb2750ae2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_55d5603c-321f-4867-81fb-e67c826ad19c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e459f36e-f1b0-41e8-8a06-1a5ec5d86b63" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_55d5603c-321f-4867-81fb-e67c826ad19c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_83cc6053-f691-40e8-bcbf-b25068ce5ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e459f36e-f1b0-41e8-8a06-1a5ec5d86b63" xlink:to="loc_us-gaap_InventoryNet_83cc6053-f691-40e8-bcbf-b25068ce5ef9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_53394a4b-be1d-4121-8328-aea6dd3ea05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e459f36e-f1b0-41e8-8a06-1a5ec5d86b63" xlink:to="loc_us-gaap_IncomeTaxesReceivable_53394a4b-be1d-4121-8328-aea6dd3ea05f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ca16b043-07b4-4c00-9bd9-36866ddaa9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e459f36e-f1b0-41e8-8a06-1a5ec5d86b63" xlink:to="loc_us-gaap_OtherAssetsCurrent_ca16b043-07b4-4c00-9bd9-36866ddaa9e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_eb5304f5-3cf4-465c-8461-99bd33c7d4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_da3a4fa9-7460-4f80-b5c1-405e8158c16a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_eb5304f5-3cf4-465c-8461-99bd33c7d4bb" xlink:to="loc_us-gaap_GainLossOnInvestments_da3a4fa9-7460-4f80-b5c1-405e8158c16a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_fe4d6a76-2a64-47df-9c1c-f6bf753b4aee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_eb5304f5-3cf4-465c-8461-99bd33c7d4bb" xlink:to="loc_us-gaap_InvestmentIncomeInterest_fe4d6a76-2a64-47df-9c1c-f6bf753b4aee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_18b945c4-8604-4b7c-adda-01654f3753e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_eb5304f5-3cf4-465c-8461-99bd33c7d4bb" xlink:to="loc_us-gaap_InterestExpense_18b945c4-8604-4b7c-adda-01654f3753e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_bdb17579-3fe2-4dc7-80fa-9175aa43849d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_eb5304f5-3cf4-465c-8461-99bd33c7d4bb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_bdb17579-3fe2-4dc7-80fa-9175aa43849d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2c9f7209-40de-4838-ad54-036442e4c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d166b957-e052-471b-b3ff-df21c7b75539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c9f7209-40de-4838-ad54-036442e4c65e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d166b957-e052-471b-b3ff-df21c7b75539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_e5c3d0b9-791f-4c05-9720-dfdb965f149e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2c9f7209-40de-4838-ad54-036442e4c65e" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_e5c3d0b9-791f-4c05-9720-dfdb965f149e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_bc3d9d92-6943-4d70-9d66-26098f851150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4237535a-c86d-470d-ba74-955d98d65a89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bc3d9d92-6943-4d70-9d66-26098f851150" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_4237535a-c86d-470d-ba74-955d98d65a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8e33ccf2-e298-48b5-ae5e-b0fdc1c342c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bc3d9d92-6943-4d70-9d66-26098f851150" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8e33ccf2-e298-48b5-ae5e-b0fdc1c342c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1114e57e-a272-4b50-872e-bbf7df5fc9f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bc3d9d92-6943-4d70-9d66-26098f851150" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1114e57e-a272-4b50-872e-bbf7df5fc9f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_fd3a082b-a24f-40c9-aaad-36b6c22ea94d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_bc3d9d92-6943-4d70-9d66-26098f851150" xlink:to="loc_us-gaap_CostDirectMaterial_fd3a082b-a24f-40c9-aaad-36b6c22ea94d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7c4d923e-3f55-495a-bfb8-d07b5ce85a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d56deca4-5b7f-464b-9516-aa6e5d0517f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7c4d923e-3f55-495a-bfb8-d07b5ce85a36" xlink:to="loc_us-gaap_OperatingIncomeLoss_d56deca4-5b7f-464b-9516-aa6e5d0517f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a57ff4dd-b399-423e-8290-69d806bf8f6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7c4d923e-3f55-495a-bfb8-d07b5ce85a36" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a57ff4dd-b399-423e-8290-69d806bf8f6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0cef746f-9dbd-4809-aa65-c5d0cc5f0bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8a4c5843-1123-4535-a0cd-db1a122d1c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0cef746f-9dbd-4809-aa65-c5d0cc5f0bb3" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8a4c5843-1123-4535-a0cd-db1a122d1c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7bf85997-9731-4c0f-8572-ee5572049776" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0cef746f-9dbd-4809-aa65-c5d0cc5f0bb3" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_7bf85997-9731-4c0f-8572-ee5572049776" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_16123f71-89e5-4fca-a659-95b2bdc3e93e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5ce2dfd7-c44d-41d7-9b38-85d181163e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_16123f71-89e5-4fca-a659-95b2bdc3e93e" xlink:to="loc_us-gaap_NetIncomeLoss_5ce2dfd7-c44d-41d7-9b38-85d181163e7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_231214a8-cf8e-44be-af37-d1dbb691d42a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_16123f71-89e5-4fca-a659-95b2bdc3e93e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_231214a8-cf8e-44be-af37-d1dbb691d42a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3066f50e-080a-464c-96ec-6557ab1b17f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_56681938-8fee-4b53-b7bd-d43af9ffcbbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3066f50e-080a-464c-96ec-6557ab1b17f2" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_56681938-8fee-4b53-b7bd-d43af9ffcbbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_aa565569-5da0-4407-a594-833cce922bde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3066f50e-080a-464c-96ec-6557ab1b17f2" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_aa565569-5da0-4407-a594-833cce922bde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d2069ecc-5f65-4782-bafb-f7766648ca63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3066f50e-080a-464c-96ec-6557ab1b17f2" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d2069ecc-5f65-4782-bafb-f7766648ca63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9f614196-edcb-4222-99d3-740e47bb19ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3066f50e-080a-464c-96ec-6557ab1b17f2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9f614196-edcb-4222-99d3-740e47bb19ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_feb27c6d-0df6-4dca-b902-99cc8a38e976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3066f50e-080a-464c-96ec-6557ab1b17f2" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_feb27c6d-0df6-4dca-b902-99cc8a38e976" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_ab2f463d-1334-4ff6-bbbe-998b3a9af3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3066f50e-080a-464c-96ec-6557ab1b17f2" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_ab2f463d-1334-4ff6-bbbe-998b3a9af3a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_511a0c13-5d9f-4b18-ae29-e3a9025d5b05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_511a0c13-5d9f-4b18-ae29-e3a9025d5b05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4b6133f1-99db-49d9-909b-db9eaf32ea44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4b6133f1-99db-49d9-909b-db9eaf32ea44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1badf482-fd8b-4d99-bd00-f969dca4298d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1badf482-fd8b-4d99-bd00-f969dca4298d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_797e9382-64ae-495a-be8a-6fdb5cb12b0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_797e9382-64ae-495a-be8a-6fdb5cb12b0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_fbada723-5250-4317-9ae3-fb0dc0e516bc" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_fbada723-5250-4317-9ae3-fb0dc0e516bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9067f6f6-e306-428f-9a2a-e330145253d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9067f6f6-e306-428f-9a2a-e330145253d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_77c5285a-b288-4559-ae74-886bc3d87be5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_77c5285a-b288-4559-ae74-886bc3d87be5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7d1197ce-225c-41a5-97ee-23c7b7a5e2fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_3b309dba-620b-4b28-8885-e10611a4080a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7d1197ce-225c-41a5-97ee-23c7b7a5e2fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aa23ce16-0dcb-4c41-a261-45061d252290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_ProfitLoss_aa23ce16-0dcb-4c41-a261-45061d252290" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_567a6028-e395-4bb2-85bb-9f8256fef17a" xlink:href="lgnd-20220331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_567a6028-e395-4bb2-85bb-9f8256fef17a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_1f979102-d062-47de-b815-ccc0918b8033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_1f979102-d062-47de-b815-ccc0918b8033" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cd6490a2-8b8d-424b-ac78-985b031f762a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_cd6490a2-8b8d-424b-ac78-985b031f762a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_df5fc302-567f-4360-a3bc-871b620d3d95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_df5fc302-567f-4360-a3bc-871b620d3d95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_81b5a52a-6fe8-4e2b-bdd1-45e9af730af3" xlink:href="lgnd-20220331.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_81b5a52a-6fe8-4e2b-bdd1-45e9af730af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d68e84ef-4e89-403f-b866-ceea325820aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_d68e84ef-4e89-403f-b866-ceea325820aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_54ace80d-9e37-44d5-9a5a-8b1abda5c254" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_ShareBasedCompensation_54ace80d-9e37-44d5-9a5a-8b1abda5c254" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c506bc3b-1e9e-40ad-be13-fdaa6568ec0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_c506bc3b-1e9e-40ad-be13-fdaa6568ec0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_47a28533-2588-4637-9ff8-708000a96921" xlink:href="lgnd-20220331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_47a28533-2588-4637-9ff8-708000a96921" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c94b84c1-58aa-498d-abad-7aad720e41ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_c94b84c1-58aa-498d-abad-7aad720e41ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2927eca7-2095-4af2-8464-cd94b523b56e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2927eca7-2095-4af2-8464-cd94b523b56e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_966bb166-9ceb-4545-947b-5f0c4aad4bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_966bb166-9ceb-4545-947b-5f0c4aad4bb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d43489ff-9e3f-4bcc-a845-140e67ac7f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d43489ff-9e3f-4bcc-a845-140e67ac7f1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2d1afa1-c959-4147-863a-a0c27adb9fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2d1afa1-c959-4147-863a-a0c27adb9fe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_43518cb8-0969-47f5-ba0d-088c28afdf04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_43518cb8-0969-47f5-ba0d-088c28afdf04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_85d0f9ab-a43e-44c8-9d83-2963171771a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_82510c77-2294-446f-89b7-b30aff078bcd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_85d0f9ab-a43e-44c8-9d83-2963171771a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b1b4391d-8453-4c0c-ae2c-c84647c474c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_93a72e80-b50d-4d5d-bc56-6fcd6defa10d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b1b4391d-8453-4c0c-ae2c-c84647c474c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_93a72e80-b50d-4d5d-bc56-6fcd6defa10d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6cf13135-57b3-4b32-b043-1380afceb771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b1b4391d-8453-4c0c-ae2c-c84647c474c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6cf13135-57b3-4b32-b043-1380afceb771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_562cf228-1f7f-440a-b64e-c5d989b85f65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b1b4391d-8453-4c0c-ae2c-c84647c474c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_562cf228-1f7f-440a-b64e-c5d989b85f65" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3f8d35b4-ea2d-4135-92b6-58102c9dfa0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_cdefe4a1-45a0-4ada-912f-9bfbcf46f674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3f8d35b4-ea2d-4135-92b6-58102c9dfa0d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_cdefe4a1-45a0-4ada-912f-9bfbcf46f674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_96534e10-56ff-458a-930a-a3b79e07f7ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3f8d35b4-ea2d-4135-92b6-58102c9dfa0d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_96534e10-56ff-458a-930a-a3b79e07f7ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_969d9064-1fa5-43b5-b86c-1a99b67e7725" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3f8d35b4-ea2d-4135-92b6-58102c9dfa0d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_969d9064-1fa5-43b5-b86c-1a99b67e7725" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_21139c58-6033-4665-ab7b-4357c1630c7b" xlink:href="lgnd-20220331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b890575e-3419-4259-b14f-17cfdffebf08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_21139c58-6033-4665-ab7b-4357c1630c7b" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b890575e-3419-4259-b14f-17cfdffebf08" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_e47645db-a5cb-4fc4-bcc8-7fc1e2bbec7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_21139c58-6033-4665-ab7b-4357c1630c7b" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_e47645db-a5cb-4fc4-bcc8-7fc1e2bbec7e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_f63565f8-73fb-4f9a-8d4a-e06bff15cac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_c6348f9e-3942-4738-b4a6-e704a1ff7779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_f63565f8-73fb-4f9a-8d4a-e06bff15cac8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_c6348f9e-3942-4738-b4a6-e704a1ff7779" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_5e381a9a-f748-435c-8440-a982872c3a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_f63565f8-73fb-4f9a-8d4a-e06bff15cac8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_5e381a9a-f748-435c-8440-a982872c3a3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d5d1b7d2-068a-4204-aaa4-ff20a84e9f17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_88241331-d642-4b04-97da-487f2c56ed37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d5d1b7d2-068a-4204-aaa4-ff20a84e9f17" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_88241331-d642-4b04-97da-487f2c56ed37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_662baa1b-ea6b-4b8c-a996-f49e77f9db2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_d5d1b7d2-068a-4204-aaa4-ff20a84e9f17" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_662baa1b-ea6b-4b8c-a996-f49e77f9db2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_298dafd7-62ad-49b5-b3bf-86ffa16fcd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_951ea269-15a7-49b0-a344-5b0a9d674249" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_298dafd7-62ad-49b5-b3bf-86ffa16fcd03" xlink:to="loc_us-gaap_Goodwill_951ea269-15a7-49b0-a344-5b0a9d674249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4f41615a-9353-4401-8e4e-771266c0c914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_298dafd7-62ad-49b5-b3bf-86ffa16fcd03" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_4f41615a-9353-4401-8e4e-771266c0c914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_39652bb9-2d39-4f5a-bef2-6f2fa071033a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_298dafd7-62ad-49b5-b3bf-86ffa16fcd03" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_39652bb9-2d39-4f5a-bef2-6f2fa071033a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8f21f54a-3f17-424e-9634-545aca3afea1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_8f67440f-d2a8-43d4-bda9-502bdd214ec5" xlink:href="lgnd-20220331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8f21f54a-3f17-424e-9634-545aca3afea1" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_8f67440f-d2a8-43d4-bda9-502bdd214ec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ec1862ef-47ad-4fd2-96a2-d110417a2058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8f21f54a-3f17-424e-9634-545aca3afea1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ec1862ef-47ad-4fd2-96a2-d110417a2058" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a7e0ed39-7d4f-4859-89b8-8d7ae7f5fab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_a7e0ed39-7d4f-4859-89b8-8d7ae7f5fab0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_8dd5eeb2-27a3-4ee7-9eb1-2c0bf670e3a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_8dd5eeb2-27a3-4ee7-9eb1-2c0bf670e3a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_e5a645c2-c5bd-44e6-9e70-adf40c8ef653" xlink:href="lgnd-20220331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_lgnd_LicenseeAccrualCurrent_e5a645c2-c5bd-44e6-9e70-adf40c8ef653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_f3c6d0f6-0b52-4062-ad53-446462ec439d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_f3c6d0f6-0b52-4062-ad53-446462ec439d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_f121640d-d68f-448f-8764-07bfc4962183" xlink:href="lgnd-20220331.xsd#lgnd_ReturnsAccrual"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_lgnd_ReturnsAccrual_f121640d-d68f-448f-8764-07bfc4962183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_7d893171-abe3-4122-ac7d-fea5f276debc" xlink:href="lgnd-20220331.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_7d893171-abe3-4122-ac7d-fea5f276debc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_ba9468c6-4290-42fc-8d89-92d67543fee3" xlink:href="lgnd-20220331.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_ba9468c6-4290-42fc-8d89-92d67543fee3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_e6a79356-8b2c-4fef-bc7b-7d0f2ae8724e" xlink:href="lgnd-20220331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_e6a79356-8b2c-4fef-bc7b-7d0f2ae8724e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_8fba30bc-5bcc-4aef-937f-f8240e123edd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_us-gaap_InterestPayableCurrent_8fba30bc-5bcc-4aef-937f-f8240e123edd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2460e713-d659-4cdd-9d15-85bb931200c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_aefbfac4-36cb-4f58-b0fc-539f101146e6" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_2460e713-d659-4cdd-9d15-85bb931200c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6edf4fe-f7ff-40f9-bbc5-a9a6b1b004cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5269f8ca-82a2-450c-b037-5fd9186a25c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6edf4fe-f7ff-40f9-bbc5-a9a6b1b004cb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5269f8ca-82a2-450c-b037-5fd9186a25c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f49b52e-697e-4bb8-9374-ba7f7111c407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b6edf4fe-f7ff-40f9-bbc5-a9a6b1b004cb" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f49b52e-697e-4bb8-9374-ba7f7111c407" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#SegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_29f187b4-50ea-441d-8139-2d120716dd45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_377fe2c5-78d5-451f-beee-d3cf77affe09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_29f187b4-50ea-441d-8139-2d120716dd45" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_377fe2c5-78d5-451f-beee-d3cf77affe09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_1c905caf-a079-49d5-9e85-a7e25631eece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_29f187b4-50ea-441d-8139-2d120716dd45" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_1c905caf-a079-49d5-9e85-a7e25631eece" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_81691bb3-9d4f-427e-86d3-a544f6b27ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b6cbb354-f948-435f-8a6f-5cbfca564693" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_81691bb3-9d4f-427e-86d3-a544f6b27ded" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b6cbb354-f948-435f-8a6f-5cbfca564693" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7cbe27d3-5a00-4f72-abd3-25022398c98d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermNotesPayable_81691bb3-9d4f-427e-86d3-a544f6b27ded" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_7cbe27d3-5a00-4f72-abd3-25022398c98d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_752f6d42-a938-4acb-91fa-a4d561712a52" xlink:href="lgnd-20220331.xsd#lgnd_LeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ebeb07f1-6c79-4ec8-acd7-f754ec919912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_752f6d42-a938-4acb-91fa-a4d561712a52" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ebeb07f1-6c79-4ec8-acd7-f754ec919912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_d7908af6-46c8-46c4-aec3-65193a2b60d9" xlink:href="lgnd-20220331.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_752f6d42-a938-4acb-91fa-a4d561712a52" xlink:to="loc_lgnd_LeaseLiabilityCurrent_d7908af6-46c8-46c4-aec3-65193a2b60d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04f08059-c4bd-4c4f-8a4f-0c65779b0354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiability_752f6d42-a938-4acb-91fa-a4d561712a52" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_04f08059-c4bd-4c4f-8a4f-0c65779b0354" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_73e1ada9-2528-4625-8030-631c1f33cb48" xlink:href="lgnd-20220331.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_930f0982-ccd7-495e-a5e8-4e4f87f9e9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_73e1ada9-2528-4625-8030-631c1f33cb48" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_930f0982-ccd7-495e-a5e8-4e4f87f9e9aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbb7b247-1860-4ff9-9c73-2fbffb6be340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseLiabilityCurrent_73e1ada9-2528-4625-8030-631c1f33cb48" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbb7b247-1860-4ff9-9c73-2fbffb6be340" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_480bdd24-0e34-4ecc-9e04-e547e98d8943" xlink:href="lgnd-20220331.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e2b7503-3eec-4f76-b1f0-b3e646347465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_480bdd24-0e34-4ecc-9e04-e547e98d8943" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0e2b7503-3eec-4f76-b1f0-b3e646347465" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_64deddc5-3e73-4486-9db0-67df8a6c102a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_lgnd_LeaseRightOfUseAsset_480bdd24-0e34-4ecc-9e04-e547e98d8943" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_64deddc5-3e73-4486-9db0-67df8a6c102a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8af0b0b-f498-4374-8965-17c675f05cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1ea0d9d6-1c5c-4739-bef1-426f159e8b28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8af0b0b-f498-4374-8965-17c675f05cf1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1ea0d9d6-1c5c-4739-bef1-426f159e8b28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f03a9c43-3b7e-45bc-b31a-036809bc6ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e8af0b0b-f498-4374-8965-17c675f05cf1" xlink:to="loc_us-gaap_OperatingLeaseLiability_f03a9c43-3b7e-45bc-b31a-036809bc6ae1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_004c70f8-2570-49e8-91e1-f5fb1da37788" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_004c70f8-2570-49e8-91e1-f5fb1da37788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ee69c0ee-6fef-47e9-b414-cb34a54bc8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ee69c0ee-6fef-47e9-b414-cb34a54bc8cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_5ef93f9f-87bf-4a84-8f76-efed620d6da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_5ef93f9f-87bf-4a84-8f76-efed620d6da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_82c2ccaa-3761-4963-a546-f82c4b5b0ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_82c2ccaa-3761-4963-a546-f82c4b5b0ef2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b6b2dfe6-85e5-43d3-a5d0-e580c8809054" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_b6b2dfe6-85e5-43d3-a5d0-e580c8809054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b3ece2ea-5020-4226-b112-ba4daf0ae2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b3ece2ea-5020-4226-b112-ba4daf0ae2a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d6cbdc6f-adbd-4251-af56-1c96cf9576fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_54094a04-8f2a-4c4e-b4dd-c08e5b779795" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d6cbdc6f-adbd-4251-af56-1c96cf9576fc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lgnd-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:63142b59-d50f-422e-a0a8-23b5f0c0b9ee,g:55f2a22c-b472-424e-aeed-2ce3b4861db0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="iaf96e203b53443179de1c0a164ac831b_CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_4f19aaa7-d045-4899-bcae-87912e673ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_RevenuesAbstract_4f19aaa7-d045-4899-bcae-87912e673ad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0a65841-d4d0-44e9-be17-a366105bb23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_4f19aaa7-d045-4899-bcae-87912e673ad4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0a65841-d4d0-44e9-be17-a366105bb23a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_b1cc62af-48b8-4803-b08c-90b0a0dd37df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_CostDirectMaterial_b1cc62af-48b8-4803-b08c-90b0a0dd37df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_0cf504a7-18c4-4a1a-8f45-1ca3fba29e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_0cf504a7-18c4-4a1a-8f45-1ca3fba29e03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d50f38b6-68fe-4242-8412-511afaea9f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d50f38b6-68fe-4242-8412-511afaea9f7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_88d2614e-192e-4795-8ee3-845757f7801b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_88d2614e-192e-4795-8ee3-845757f7801b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_436e4af5-8926-4a7c-abb6-b135664dbbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_436e4af5-8926-4a7c-abb6-b135664dbbc4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_74bd06b1-7a59-4427-893b-92c03836e67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_OperatingIncomeLoss_74bd06b1-7a59-4427-893b-92c03836e67d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_b5e82e29-b1f1-4c96-879a-a451086141c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_GainLossOnInvestments_b5e82e29-b1f1-4c96-879a-a451086141c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9e7d88fa-a40a-414e-b0f6-80ce308ad42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9e7d88fa-a40a-414e-b0f6-80ce308ad42d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_aaadab8d-ca4c-4540-b99e-57550b84415a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_InterestExpense_aaadab8d-ca4c-4540-b99e-57550b84415a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6b23e9f3-fe92-4c56-9c61-6ef2620938e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6b23e9f3-fe92-4c56-9c61-6ef2620938e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6c5f9581-1202-4bd0-bca2-aff01c568c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6c5f9581-1202-4bd0-bca2-aff01c568c8f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73dce3bb-f34a-46cb-9738-05c439191cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73dce3bb-f34a-46cb-9738-05c439191cb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b769d297-e527-41ea-a14b-12f30cf34b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b769d297-e527-41ea-a14b-12f30cf34b7c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0014dffc-d25a-4574-90ad-f7a0f1fa95e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_NetIncomeLoss_0014dffc-d25a-4574-90ad-f7a0f1fa95e8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_234d23f7-d983-4dd6-ba87-d7c7d946ed97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_EarningsPerShareBasic_234d23f7-d983-4dd6-ba87-d7c7d946ed97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e0ec525d-d384-4b7b-a60e-c7a2371b4ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e0ec525d-d384-4b7b-a60e-c7a2371b4ae1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9f0e2197-be46-47ec-87db-e0d9a26043c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9f0e2197-be46-47ec-87db-e0d9a26043c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d03bd0c-8999-441d-8c11-c9a27d01caa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d03bd0c-8999-441d-8c11-c9a27d01caa0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bd96a5df-2685-4fe6-b6c6-89e1b9376ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e0de58ab-2889-4d1c-9142-b76656f882e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_StatementTable_e0de58ab-2889-4d1c-9142-b76656f882e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b4c6ac2d-b337-4a9d-a742-4bd4559eff04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e0de58ab-2889-4d1c-9142-b76656f882e4" xlink:to="loc_srt_ProductOrServiceAxis_b4c6ac2d-b337-4a9d-a742-4bd4559eff04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b4c6ac2d-b337-4a9d-a742-4bd4559eff04_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b4c6ac2d-b337-4a9d-a742-4bd4559eff04" xlink:to="loc_srt_ProductsAndServicesDomain_b4c6ac2d-b337-4a9d-a742-4bd4559eff04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b4c6ac2d-b337-4a9d-a742-4bd4559eff04" xlink:to="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_d4e5b63e-88c3-4d84-8cae-c5a6d55b1a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:to="loc_us-gaap_RoyaltyMember_d4e5b63e-88c3-4d84-8cae-c5a6d55b1a12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_b88535b3-e12b-43ce-9e93-7f5f89a00584" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_b88535b3-e12b-43ce-9e93-7f5f89a00584" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_b3f9d445-c945-44f7-a066-30b07c073400" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:to="loc_lgnd_ContractRevenueMember_b3f9d445-c945-44f7-a066-30b07c073400" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i12effd490f4e4a5889d9f544e8403da5_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3372a257-6df9-406d-b93b-d2ce6c73d301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3372a257-6df9-406d-b93b-d2ce6c73d301" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f0837d6f-cb0a-489c-b273-bb08688eef9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_SharesIssued_f0837d6f-cb0a-489c-b273-bb08688eef9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_93288998-9a5d-4ad1-ab95-a30b5496c37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_StockholdersEquity_93288998-9a5d-4ad1-ab95-a30b5496c37e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8c7577fc-71a7-453b-8932-8a08a0706df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8c7577fc-71a7-453b-8932-8a08a0706df6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f0110f3-bc7e-40d4-bf18-5dabe5a64b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f0110f3-bc7e-40d4-bf18-5dabe5a64b23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3ebbd71d-4e2a-40ae-95f0-e7c601144947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3ebbd71d-4e2a-40ae-95f0-e7c601144947" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f8ff7a6b-b9bd-402f-85f1-2d8354f5e13a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f8ff7a6b-b9bd-402f-85f1-2d8354f5e13a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_d727a928-a4d8-4f24-8510-ebadd6dd8ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_d727a928-a4d8-4f24-8510-ebadd6dd8ab7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_58c26797-8ddb-4c6b-8cd4-4eea22ce6e71" xlink:href="lgnd-20220331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_58c26797-8ddb-4c6b-8cd4-4eea22ce6e71" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_499aff47-21b5-48be-a6d7-023b03ca77fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_499aff47-21b5-48be-a6d7-023b03ca77fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_1da9b2f5-0deb-4caa-a06b-3eab780a793f" xlink:href="lgnd-20220331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_1da9b2f5-0deb-4caa-a06b-3eab780a793f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f3a99a48-6feb-4e2a-a7fd-09e02a2a1f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_NetIncomeLoss_f3a99a48-6feb-4e2a-a7fd-09e02a2a1f26" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ffdf5e2e-a2e6-4cab-88f0-2038ff4ba94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_765b1c8d-e315-4de8-a91b-9fa77cbc7e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3372a257-6df9-406d-b93b-d2ce6c73d301" xlink:to="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7d83f884-631c-49d7-9b7a-8393e174e39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7d83f884-631c-49d7-9b7a-8393e174e39d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7d83f884-631c-49d7-9b7a-8393e174e39d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d83f884-631c-49d7-9b7a-8393e174e39d" xlink:to="loc_us-gaap_EquityComponentDomain_7d83f884-631c-49d7-9b7a-8393e174e39d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d83f884-631c-49d7-9b7a-8393e174e39d" xlink:to="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6fa4faff-3a57-41b3-bed5-d4753c859199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_CommonStockMember_6fa4faff-3a57-41b3-bed5-d4753c859199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_dc988484-8a7b-4be3-9add-e0a86401e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_dc988484-8a7b-4be3-9add-e0a86401e39e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_54659128-a731-4ad8-8595-f4b94d88e3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_54659128-a731-4ad8-8595-f4b94d88e3c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3a49e689-b9f5-4d1e-98bd-3cd3ed95115e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_RetainedEarningsMember_3a49e689-b9f5-4d1e-98bd-3cd3ed95115e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eed61c10-2f7f-4fda-977a-9b270e5111fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eed61c10-2f7f-4fda-977a-9b270e5111fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_eed61c10-2f7f-4fda-977a-9b270e5111fc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eed61c10-2f7f-4fda-977a-9b270e5111fc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_eed61c10-2f7f-4fda-977a-9b270e5111fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_850088a5-5f09-46b4-8b90-9afcfa7c6779" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eed61c10-2f7f-4fda-977a-9b270e5111fc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_850088a5-5f09-46b4-8b90-9afcfa7c6779" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a3ab8a1d-1a12-4f80-b715-8b68234333d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_850088a5-5f09-46b4-8b90-9afcfa7c6779" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a3ab8a1d-1a12-4f80-b715-8b68234333d1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i69769076149844759b5887171f21c62c_BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_b6d6cacc-497b-4496-b08d-3c22f97604e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_ConvertibleNotesPayable_b6d6cacc-497b-4496-b08d-3c22f97604e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_611c9f7e-d4f7-466c-a137-ed96bf5c14c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_611c9f7e-d4f7-466c-a137-ed96bf5c14c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dc5b8973-118b-4e73-89da-ac45cd3ba5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_StockholdersEquity_dc5b8973-118b-4e73-89da-ac45cd3ba5ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_cea0ba5b-60a3-429f-a3af-d7dc037639c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_cea0ba5b-60a3-429f-a3af-d7dc037639c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5f2f4c38-5dc0-4c5b-8ca4-0c7c47f85c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5f2f4c38-5dc0-4c5b-8ca4-0c7c47f85c01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ccbdf751-fd54-4541-8119-099b0b94f1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ccbdf751-fd54-4541-8119-099b0b94f1cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8faef7e3-200d-4039-82de-57c1fd46eee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8faef7e3-200d-4039-82de-57c1fd46eee6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_6749c567-7f1d-4ebf-895f-5a3ebb278d28" xlink:href="lgnd-20220331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_6749c567-7f1d-4ebf-895f-5a3ebb278d28" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1ec2ed19-2605-47d1-b97a-1c98e0ce046a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_InventoryNet_1ec2ed19-2605-47d1-b97a-1c98e0ce046a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_56d89839-04f6-4bb3-a1b7-59873ca0fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_56d89839-04f6-4bb3-a1b7-59873ca0fde1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_848e6024-5bb6-4013-8e58-61b861fb55ce" xlink:href="lgnd-20220331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_848e6024-5bb6-4013-8e58-61b861fb55ce" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84f8d869-5f57-4326-a5f1-1a0f2ae0c2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84f8d869-5f57-4326-a5f1-1a0f2ae0c2ea" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3172c45f-26e3-4711-9745-1d667d715bb2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_srt_RangeAxis_3172c45f-26e3-4711-9745-1d667d715bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3172c45f-26e3-4711-9745-1d667d715bb2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3172c45f-26e3-4711-9745-1d667d715bb2" xlink:to="loc_srt_RangeMember_3172c45f-26e3-4711-9745-1d667d715bb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3172c45f-26e3-4711-9745-1d667d715bb2" xlink:to="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b445d52e-a6e1-4a0d-b08a-5ec0db6384b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:to="loc_srt_MaximumMember_b445d52e-a6e1-4a0d-b08a-5ec0db6384b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fa41298e-0b96-44e9-94bb-c850660fefe1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:to="loc_srt_MinimumMember_fa41298e-0b96-44e9-94bb-c850660fefe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6b723daa-39f5-437e-88dd-4f9b46f89eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_AwardTypeAxis_6b723daa-39f5-437e-88dd-4f9b46f89eb5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b723daa-39f5-437e-88dd-4f9b46f89eb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6b723daa-39f5-437e-88dd-4f9b46f89eb5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6b723daa-39f5-437e-88dd-4f9b46f89eb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b784c68-a1e4-409b-9d52-429f87abf3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6b723daa-39f5-437e-88dd-4f9b46f89eb5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b784c68-a1e4-409b-9d52-429f87abf3e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a5921e81-48d4-46db-a89d-05a642e07b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b784c68-a1e4-409b-9d52-429f87abf3e2" xlink:to="loc_us-gaap_RestrictedStockMember_a5921e81-48d4-46db-a89d-05a642e07b56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7bf148eb-3c8b-40c1-a29a-f4691bd61f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7bf148eb-3c8b-40c1-a29a-f4691bd61f58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7bf148eb-3c8b-40c1-a29a-f4691bd61f58_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7bf148eb-3c8b-40c1-a29a-f4691bd61f58" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7bf148eb-3c8b-40c1-a29a-f4691bd61f58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c66352a-0030-4be4-8886-fe4ab312e229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7bf148eb-3c8b-40c1-a29a-f4691bd61f58" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c66352a-0030-4be4-8886-fe4ab312e229" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_0f87d907-89ac-48c3-8b4b-765142fc7b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c66352a-0030-4be4-8886-fe4ab312e229" xlink:to="loc_us-gaap_StockCompensationPlanMember_0f87d907-89ac-48c3-8b4b-765142fc7b62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0eed9533-3d7d-4b2d-a063-cf618e44f023" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_srt_ProductOrServiceAxis_0eed9533-3d7d-4b2d-a063-cf618e44f023" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0eed9533-3d7d-4b2d-a063-cf618e44f023_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_0eed9533-3d7d-4b2d-a063-cf618e44f023" xlink:to="loc_srt_ProductsAndServicesDomain_0eed9533-3d7d-4b2d-a063-cf618e44f023_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a4a96a2d-b825-4478-b2fc-47eba1004a96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_0eed9533-3d7d-4b2d-a063-cf618e44f023" xlink:to="loc_srt_ProductsAndServicesDomain_a4a96a2d-b825-4478-b2fc-47eba1004a96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_75639643-bea1-4e86-b4da-ab1cbb61de93" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a4a96a2d-b825-4478-b2fc-47eba1004a96" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_75639643-bea1-4e86-b4da-ab1cbb61de93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f184292-e0ae-45dc-8dc7-8462f17199fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f184292-e0ae-45dc-8dc7-8462f17199fc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9f184292-e0ae-45dc-8dc7-8462f17199fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f184292-e0ae-45dc-8dc7-8462f17199fc" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9f184292-e0ae-45dc-8dc7-8462f17199fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_34ab67bb-8cc5-46ab-b3ba-2e2c737b7ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f184292-e0ae-45dc-8dc7-8462f17199fc" xlink:to="loc_us-gaap_TypeOfAdoptionMember_34ab67bb-8cc5-46ab-b3ba-2e2c737b7ae6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_cb54f42e-0f97-405e-b3af-854f342c4e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_34ab67bb-8cc5-46ab-b3ba-2e2c737b7ae6" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_cb54f42e-0f97-405e-b3af-854f342c4e6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_59e27f0c-1633-4cb0-9170-3e51311654e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_59e27f0c-1633-4cb0-9170-3e51311654e1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_59e27f0c-1633-4cb0-9170-3e51311654e1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_59e27f0c-1633-4cb0-9170-3e51311654e1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_59e27f0c-1633-4cb0-9170-3e51311654e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_59e27f0c-1633-4cb0-9170-3e51311654e1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_117fe980-6847-44ff-8c8d-f70f180db339" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_117fe980-6847-44ff-8c8d-f70f180db339" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_23d3dd47-88b3-40f0-b915-d7e4c3c4a565" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_23d3dd47-88b3-40f0-b915-d7e4c3c4a565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e801a577-a20d-4849-8ce3-18b8a348219e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e801a577-a20d-4849-8ce3-18b8a348219e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e801a577-a20d-4849-8ce3-18b8a348219e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e801a577-a20d-4849-8ce3-18b8a348219e" xlink:to="loc_us-gaap_EquityComponentDomain_e801a577-a20d-4849-8ce3-18b8a348219e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e801a577-a20d-4849-8ce3-18b8a348219e" xlink:to="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_beb67482-ba14-4659-8350-cb7104de5afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_beb67482-ba14-4659-8350-cb7104de5afb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cec0f52b-d2b5-4dfd-ae1c-1cff5c3b050f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:to="loc_us-gaap_RetainedEarningsMember_cec0f52b-d2b5-4dfd-ae1c-1cff5c3b050f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended" id="i54b1ae6bea8f427bafff9506664702ab_BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_28a56d39-1b6b-4732-b2a0-8a24350990f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2c39bd8-0284-4eda-9f4a-2316e4a9ff97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_28a56d39-1b6b-4732-b2a0-8a24350990f2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2c39bd8-0284-4eda-9f4a-2316e4a9ff97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ef4586e9-0d0f-4547-a166-485885aeed92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_28a56d39-1b6b-4732-b2a0-8a24350990f2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ef4586e9-0d0f-4547-a166-485885aeed92" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e68848e5-3633-4a4d-9cd4-51858b7754a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef4586e9-0d0f-4547-a166-485885aeed92" xlink:to="loc_srt_ProductOrServiceAxis_e68848e5-3633-4a4d-9cd4-51858b7754a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e68848e5-3633-4a4d-9cd4-51858b7754a0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_e68848e5-3633-4a4d-9cd4-51858b7754a0" xlink:to="loc_srt_ProductsAndServicesDomain_e68848e5-3633-4a4d-9cd4-51858b7754a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_e68848e5-3633-4a4d-9cd4-51858b7754a0" xlink:to="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:to="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_6fcf2c68-2236-4fbf-ad29-059a303933b0" xlink:href="lgnd-20220331.xsd#lgnd_KyprolisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_KyprolisMember_6fcf2c68-2236-4fbf-ad29-059a303933b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_c655ae5a-3b0c-43d9-b659-cdbecbdcd761" xlink:href="lgnd-20220331.xsd#lgnd_EvomelaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_EvomelaMember_c655ae5a-3b0c-43d9-b659-cdbecbdcd761" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_fa5f1dbb-1155-46be-90dd-414e9dbfc2f9" xlink:href="lgnd-20220331.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_TeriparatideInjectionMember_fa5f1dbb-1155-46be-90dd-414e9dbfc2f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_f14ac585-a64e-488e-a4b0-389f578bdc64" xlink:href="lgnd-20220331.xsd#lgnd_RylazeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_RylazeMember_f14ac585-a64e-488e-a4b0-389f578bdc64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_1ff3972d-765b-4a21-9bfe-623ab300f1ac" xlink:href="lgnd-20220331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_RoyaltyOtherMember_1ff3972d-765b-4a21-9bfe-623ab300f1ac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_03fb92ff-3ccd-4452-a35e-13762fcf9287" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_03fb92ff-3ccd-4452-a35e-13762fcf9287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_c062323e-b8d6-4120-b5e4-4ed4df7b04d8" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_c062323e-b8d6-4120-b5e4-4ed4df7b04d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:to="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_5e51dd6a-e30c-422a-819e-caa151c71178" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_ContractRevenueServiceMember_5e51dd6a-e30c-422a-819e-caa151c71178" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_f341116d-3a7f-49db-b404-bc5348c20c5a" xlink:href="lgnd-20220331.xsd#lgnd_LicenseFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_LicenseFeesMember_f341116d-3a7f-49db-b404-bc5348c20c5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_f74aa135-e76b-4356-8f15-c0a367584353" xlink:href="lgnd-20220331.xsd#lgnd_MilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_MilestoneMember_f74aa135-e76b-4356-8f15-c0a367584353" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_95facf77-24c2-4acf-9a9d-e35eae37e2b7" xlink:href="lgnd-20220331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_95facf77-24c2-4acf-9a9d-e35eae37e2b7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended" id="i152cd167c8ad4af287a513385c865ce1_BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f94672a-a386-4695-b55a-e1483dadc269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f94672a-a386-4695-b55a-e1483dadc269" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c26033bf-8ef3-4d9b-938c-4a46faa1c672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c26033bf-8ef3-4d9b-938c-4a46faa1c672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b1f248a-a563-4fa1-b3db-774da6ea6365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b1f248a-a563-4fa1-b3db-774da6ea6365" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0ce818a4-7ab4-4639-84aa-ac0f9203180c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0ce818a4-7ab4-4639-84aa-ac0f9203180c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c653f7c3-55a6-4a14-bd83-4d61f50ce510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c653f7c3-55a6-4a14-bd83-4d61f50ce510" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a1ed7267-a15f-4ecc-b3ac-9c3d282cd5ce" xlink:href="lgnd-20220331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a1ed7267-a15f-4ecc-b3ac-9c3d282cd5ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8c0e0c32-2366-49af-9803-f4e2abb9c6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8c0e0c32-2366-49af-9803-f4e2abb9c6bd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8c0e0c32-2366-49af-9803-f4e2abb9c6bd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_97909151-dad4-46a0-9c6d-4bb908211e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_DemandDepositsMember_97909151-dad4-46a0-9c6d-4bb908211e50" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_9f8dd273-8538-41a1-a6e9-45a4c4de0107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_9f8dd273-8538-41a1-a6e9-45a4c4de0107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c71d0957-559e-47f2-b657-756f83cd5005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_CommercialPaperMember_c71d0957-559e-47f2-b657-756f83cd5005" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_67638b09-638d-4aaf-8e68-6d0f04da2f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_EquitySecuritiesMember_67638b09-638d-4aaf-8e68-6d0f04da2f96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_ff7452f5-d4e5-4dd8-8ccc-e211533c0c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_MutualFundMember_ff7452f5-d4e5-4dd8-8ccc-e211533c0c31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_26a81d04-49c4-4dc6-833d-b84030179a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_26a81d04-49c4-4dc6-833d-b84030179a30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_bf581f3d-b23a-4c44-bcb6-c08518039adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_WarrantMember_bf581f3d-b23a-4c44-bcb6-c08518039adc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9790eee8-92c1-4e5e-945a-091585d2c63d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_CommonStockMember_9790eee8-92c1-4e5e-945a-091585d2c63d" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended" id="i7951986eef094404bf8347ccd892a719_BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0eedccf-cdee-4cc5-bede-923b9af3b174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0eedccf-cdee-4cc5-bede-923b9af3b174" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3790b4a2-99ef-419f-8cec-c8d98bf462a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_Goodwill_3790b4a2-99ef-419f-8cec-c8d98bf462a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab972b33-91f7-4389-be1c-b8106b5566ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab972b33-91f7-4389-be1c-b8106b5566ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f52d3d98-561b-49d7-989b-51d43e728336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f52d3d98-561b-49d7-989b-51d43e728336" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d7f1e916-458b-4d05-8b50-d7edac0830e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d7f1e916-458b-4d05-8b50-d7edac0830e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af5a4f81-34de-4cfb-91f6-08655943f169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0eedccf-cdee-4cc5-bede-923b9af3b174" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af5a4f81-34de-4cfb-91f6-08655943f169" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2499b3f6-0792-463f-b65a-7fc660a88fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af5a4f81-34de-4cfb-91f6-08655943f169" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2499b3f6-0792-463f-b65a-7fc660a88fa8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2499b3f6-0792-463f-b65a-7fc660a88fa8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2499b3f6-0792-463f-b65a-7fc660a88fa8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2499b3f6-0792-463f-b65a-7fc660a88fa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2499b3f6-0792-463f-b65a-7fc660a88fa8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_c90e888d-cb57-4ed1-adb7-b9f93c3cad40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_PatentedTechnologyMember_c90e888d-cb57-4ed1-adb7-b9f93c3cad40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_be1b85f4-e4d0-43fb-af66-dda4c17280b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_TradeNamesMember_be1b85f4-e4d0-43fb-af66-dda4c17280b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5cc65bf0-d778-4ca7-8969-05538297f845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5cc65bf0-d778-4ca7-8969-05538297f845" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_52277a53-8ecb-44b8-ae05-969f355c93a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_ContractualRightsMember_52277a53-8ecb-44b8-ae05-969f355c93a6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended" id="i7d2190a10cc8440a8a29c1ab12b8f6d3_BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ea9790a6-900d-431e-8e89-851c7f4b4e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ea9790a6-900d-431e-8e89-851c7f4b4e9e" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_222c88c1-2829-46c5-bcaa-59e1e94f2afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_222c88c1-2829-46c5-bcaa-59e1e94f2afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a1704e79-6e3f-4d9f-9077-77cc3096cd10" xlink:href="lgnd-20220331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a1704e79-6e3f-4d9f-9077-77cc3096cd10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0944932e-be49-45dc-831e-0238fa67b330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0944932e-be49-45dc-831e-0238fa67b330" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f19eeaf3-fd23-4e0b-958b-32a7f4f80c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f19eeaf3-fd23-4e0b-958b-32a7f4f80c7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_e4631dc0-8ca1-43b0-a386-a43282daf186" xlink:href="lgnd-20220331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_e4631dc0-8ca1-43b0-a386-a43282daf186" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ea9790a6-900d-431e-8e89-851c7f4b4e9e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb61b4d3-f51b-4924-9289-5c4cf2cd912d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb61b4d3-f51b-4924-9289-5c4cf2cd912d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1322ebda-2e2c-4467-aa9c-395cd1e0560e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb61b4d3-f51b-4924-9289-5c4cf2cd912d" xlink:to="loc_us-gaap_LicensingAgreementsMember_1322ebda-2e2c-4467-aa9c-395cd1e0560e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a003f931-7ea3-4656-bf8a-483656a7c9e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:to="loc_srt_CounterpartyNameAxis_a003f931-7ea3-4656-bf8a-483656a7c9e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a003f931-7ea3-4656-bf8a-483656a7c9e4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_a003f931-7ea3-4656-bf8a-483656a7c9e4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a003f931-7ea3-4656-bf8a-483656a7c9e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_a003f931-7ea3-4656-bf8a-483656a7c9e4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_d063ed8c-926c-40b5-9b84-6c877cc3c5f8" xlink:href="lgnd-20220331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_d063ed8c-926c-40b5-9b84-6c877cc3c5f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_480bee99-34cf-4df9-8eac-412b7351772f" xlink:href="lgnd-20220331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:to="loc_lgnd_SelexisAndDianomiMember_480bee99-34cf-4df9-8eac-412b7351772f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended" id="i1613370f6c29498494637ae75e84427f_BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_84b7fe8f-12f6-4679-886f-6f8f342dde50" xlink:href="lgnd-20220331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_39657c13-6fa0-45db-94db-04db5a476ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_BasisOfPresentationLineItems_84b7fe8f-12f6-4679-886f-6f8f342dde50" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_39657c13-6fa0-45db-94db-04db5a476ce7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_3ccd5d17-5be3-4e29-b5a3-a6fa420329b0" xlink:href="lgnd-20220331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_lgnd_BasisOfPresentationLineItems_84b7fe8f-12f6-4679-886f-6f8f342dde50" xlink:to="loc_lgnd_BasisOfPresentationTable_3ccd5d17-5be3-4e29-b5a3-a6fa420329b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_lgnd_BasisOfPresentationTable_3ccd5d17-5be3-4e29-b5a3-a6fa420329b0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3a24df37-6481-4648-9fa5-41debdaf8ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3a24df37-6481-4648-9fa5-41debdaf8ff1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c70c5b4c-c097-4240-8b23-da70a9d92f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c70c5b4c-c097-4240-8b23-da70a9d92f1b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended" id="i6af47ad0bca345559e24dcaa8d1b17e7_BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4060eba7-8d2e-4b40-90f4-1f0489cd35e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4060eba7-8d2e-4b40-90f4-1f0489cd35e7" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_25225399-3744-41e8-adf0-f5c7ee2a2172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_25225399-3744-41e8-adf0-f5c7ee2a2172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bc04146d-3ca1-4ace-9ac9-e749a405700e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bc04146d-3ca1-4ace-9ac9-e749a405700e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f655492-5848-49c1-aee1-ecf14b335b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f655492-5848-49c1-aee1-ecf14b335b9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c2646d72-9480-48f6-be7c-341adf323aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c2646d72-9480-48f6-be7c-341adf323aa7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe45642a-673b-4ea3-9ea4-dc21ce5dc3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4060eba7-8d2e-4b40-90f4-1f0489cd35e7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe45642a-673b-4ea3-9ea4-dc21ce5dc3f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e5dd148f-5272-489b-8c41-6ce7f7e4ffca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe45642a-673b-4ea3-9ea4-dc21ce5dc3f6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e5dd148f-5272-489b-8c41-6ce7f7e4ffca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e5dd148f-5272-489b-8c41-6ce7f7e4ffca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e5dd148f-5272-489b-8c41-6ce7f7e4ffca" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e5dd148f-5272-489b-8c41-6ce7f7e4ffca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e5dd148f-5272-489b-8c41-6ce7f7e4ffca" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_639448d7-9059-4a85-b590-a1e89c0e3e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:to="loc_us-gaap_RestrictedStockMember_639448d7-9059-4a85-b590-a1e89c0e3e22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f692de30-6a63-42ff-82ea-6f0a17947cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f692de30-6a63-42ff-82ea-6f0a17947cde" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#SegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended" id="ie5b37f611ee246ea9827fa15db25371d_SegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fcb42439-f88a-4c36-bc4d-591965c80316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fcb42439-f88a-4c36-bc4d-591965c80316" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96fb04e7-8400-4753-bc34-1eac92c2d4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96fb04e7-8400-4753-bc34-1eac92c2d4e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b726ae9d-fce9-4551-aa9f-94dc276d8f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b726ae9d-fce9-4551-aa9f-94dc276d8f84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_4ae90e3b-75a3-407f-91fd-d12f0af85b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_4ae90e3b-75a3-407f-91fd-d12f0af85b76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_4189a2c1-c142-4613-96fc-385673469062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_4189a2c1-c142-4613-96fc-385673469062" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ad68fd52-a4b2-4606-8fa8-f41acc2c8636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_OperatingIncomeLoss_ad68fd52-a4b2-4606-8fa8-f41acc2c8636" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d3f8b769-5b86-40a7-ac94-d40a450e6627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d3f8b769-5b86-40a7-ac94-d40a450e6627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d3f8b769-5b86-40a7-ac94-d40a450e6627_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d3f8b769-5b86-40a7-ac94-d40a450e6627" xlink:to="loc_us-gaap_SegmentDomain_d3f8b769-5b86-40a7-ac94-d40a450e6627_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d3f8b769-5b86-40a7-ac94-d40a450e6627" xlink:to="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_04cab104-b560-4b30-9440-0e4bff75b63f" xlink:href="lgnd-20220331.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_04cab104-b560-4b30-9440-0e4bff75b63f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_f7f170e9-91fc-4bd6-9268-57cefc79f417" xlink:href="lgnd-20220331.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_f7f170e9-91fc-4bd6-9268-57cefc79f417" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:to="loc_srt_ProductOrServiceAxis_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222" xlink:to="loc_srt_ProductsAndServicesDomain_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222" xlink:to="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_5810266b-993b-48aa-a8ef-8a453336d7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_us-gaap_RoyaltyMember_5810266b-993b-48aa-a8ef-8a453336d7cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_b0206961-6189-4887-86e6-779718a872c7" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_b0206961-6189-4887-86e6-779718a872c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d68d8451-13c4-4b02-a1b5-587456d00314" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d68d8451-13c4-4b02-a1b5-587456d00314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_bbb884db-c7bc-402a-b898-deafc1f91164" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_lgnd_ContractRevenueMember_bbb884db-c7bc-402a-b898-deafc1f91164" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_42684ec3-ed9a-425d-a036-996a93eeaa4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:to="loc_srt_ConsolidationItemsAxis_42684ec3-ed9a-425d-a036-996a93eeaa4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_42684ec3-ed9a-425d-a036-996a93eeaa4e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_42684ec3-ed9a-425d-a036-996a93eeaa4e" xlink:to="loc_srt_ConsolidationItemsDomain_42684ec3-ed9a-425d-a036-996a93eeaa4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_42684ec3-ed9a-425d-a036-996a93eeaa4e" xlink:to="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f64cf0b3-b115-4280-b4a5-e8613d53aafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:to="loc_us-gaap_OperatingSegmentsMember_f64cf0b3-b115-4280-b4a5-e8613d53aafa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e42719f5-b302-4479-8143-86c6e029615b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e42719f5-b302-4479-8143-86c6e029615b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ieefc802e35564647bbc0209047ca44ac_FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7902ae32-ec72-4f57-baa4-d2001f93debe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7902ae32-ec72-4f57-baa4-d2001f93debe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_4c9baa02-7c34-42ec-a9e4-527b9c935116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_4c9baa02-7c34-42ec-a9e4-527b9c935116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_eb330a16-a27f-4fad-bd3b-9ffd7109c3ed" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_eb330a16-a27f-4fad-bd3b-9ffd7109c3ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2afcdaee-256a-45ec-a10d-0cbfb546852a" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2afcdaee-256a-45ec-a10d-0cbfb546852a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_2b128f78-c563-48d3-b46e-c3a941817921" xlink:href="lgnd-20220331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_2b128f78-c563-48d3-b46e-c3a941817921" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_ec0a65bc-fdd6-4b63-9f66-fa41425d8916" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_ec0a65bc-fdd6-4b63-9f66-fa41425d8916" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4d72c635-5cd5-452b-b520-d4d48243ecd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_Investments_4d72c635-5cd5-452b-b520-d4d48243ecd7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_714a0017-7ecf-49ec-afc9-979e42a5ed21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_714a0017-7ecf-49ec-afc9-979e42a5ed21" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_f804ac72-1cea-4e74-8bbb-e419eeeda37d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_f804ac72-1cea-4e74-8bbb-e419eeeda37d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_e2c39f3c-99f8-41f2-b3d4-62600c53d8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_e2c39f3c-99f8-41f2-b3d4-62600c53d8fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_b4088401-d09b-4178-b3b8-44fd72cfa2d1" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_b4088401-d09b-4178-b3b8-44fd72cfa2d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c253507-10e3-498c-9ce5-2ad0f07c9d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c253507-10e3-498c-9ce5-2ad0f07c9d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_12446198-33b8-456b-b2d0-ff7947024c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c253507-10e3-498c-9ce5-2ad0f07c9d82" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_12446198-33b8-456b-b2d0-ff7947024c8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3508a2b4-2712-477a-aa46-ef776b1f180b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3508a2b4-2712-477a-aa46-ef776b1f180b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3508a2b4-2712-477a-aa46-ef776b1f180b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3508a2b4-2712-477a-aa46-ef776b1f180b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3508a2b4-2712-477a-aa46-ef776b1f180b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3508a2b4-2712-477a-aa46-ef776b1f180b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fb644d97-7593-4787-86ef-f3316ca79b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fb644d97-7593-4787-86ef-f3316ca79b94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_beb874bc-bdca-496b-ba4f-d6eca5ab5b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_beb874bc-bdca-496b-ba4f-d6eca5ab5b11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_45bb7d0d-a031-4a71-b77d-7e14f3eddb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_45bb7d0d-a031-4a71-b77d-7e14f3eddb39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_cfa93796-8875-4117-92e9-81b1867b7939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_cfa93796-8875-4117-92e9-81b1867b7939" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cfa93796-8875-4117-92e9-81b1867b7939_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cfa93796-8875-4117-92e9-81b1867b7939" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cfa93796-8875-4117-92e9-81b1867b7939_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cfa93796-8875-4117-92e9-81b1867b7939" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ef03b784-fc8e-4053-adff-541d57e19087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ef03b784-fc8e-4053-adff-541d57e19087" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8768c4e6-c43c-41e6-b37c-775ae54aa5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:to="loc_us-gaap_EquitySecuritiesMember_8768c4e6-c43c-41e6-b37c-775ae54aa5a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_bda04c35-46ba-4b07-a93e-eaead3a6826f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_bda04c35-46ba-4b07-a93e-eaead3a6826f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_bda04c35-46ba-4b07-a93e-eaead3a6826f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_bda04c35-46ba-4b07-a93e-eaead3a6826f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_bda04c35-46ba-4b07-a93e-eaead3a6826f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_bda04c35-46ba-4b07-a93e-eaead3a6826f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_adf0f700-9a6e-40a0-b4f5-e3455f79f21f" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_adf0f700-9a6e-40a0-b4f5-e3455f79f21f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_581e5a7c-d391-4f2f-93e6-44948fe65e8d" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_581e5a7c-d391-4f2f-93e6-44948fe65e8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_04a05411-567a-4491-abd5-9e023761a67c" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_04a05411-567a-4491-abd5-9e023761a67c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_bb28293e-9552-4266-800a-e673b918ebde" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_bb28293e-9552-4266-800a-e673b918ebde" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_4e072833-0699-4a7e-849a-6f1ab02fffd1" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_4e072833-0699-4a7e-849a-6f1ab02fffd1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1094ede0-7556-428f-a20b-93f93d0e7683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1094ede0-7556-428f-a20b-93f93d0e7683" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1094ede0-7556-428f-a20b-93f93d0e7683_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1094ede0-7556-428f-a20b-93f93d0e7683" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1094ede0-7556-428f-a20b-93f93d0e7683_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1094ede0-7556-428f-a20b-93f93d0e7683" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_bcc78c0a-6ff0-49df-a15f-4b9b3da78ce5" xlink:href="lgnd-20220331.xsd#lgnd_MetabasisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:to="loc_lgnd_MetabasisMember_bcc78c0a-6ff0-49df-a15f-4b9b3da78ce5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_9206488e-aadc-4319-883e-8278777efdaa" xlink:href="lgnd-20220331.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_9206488e-aadc-4319-883e-8278777efdaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_srt_RangeAxis_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4" xlink:to="loc_srt_RangeMember_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5351689f-6123-4c89-bd45-c43cad9dd510" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4" xlink:to="loc_srt_RangeMember_5351689f-6123-4c89-bd45-c43cad9dd510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_46ba257f-74d2-4112-bc41-1554c329e6a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_5351689f-6123-4c89-bd45-c43cad9dd510" xlink:to="loc_srt_MaximumMember_46ba257f-74d2-4112-bc41-1554c329e6a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d106c7c3-838f-4d67-a55e-c9d9b63c46fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d106c7c3-838f-4d67-a55e-c9d9b63c46fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_3dfbea6f-19a2-4e11-bfad-f01b45fd7f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d106c7c3-838f-4d67-a55e-c9d9b63c46fa" xlink:to="loc_us-gaap_TransferredOverTimeMember_3dfbea6f-19a2-4e11-bfad-f01b45fd7f9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_542a3c55-1c7d-48e0-8e27-65a135b9d9e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_srt_ProductOrServiceAxis_542a3c55-1c7d-48e0-8e27-65a135b9d9e4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_542a3c55-1c7d-48e0-8e27-65a135b9d9e4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_542a3c55-1c7d-48e0-8e27-65a135b9d9e4" xlink:to="loc_srt_ProductsAndServicesDomain_542a3c55-1c7d-48e0-8e27-65a135b9d9e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_542a3c55-1c7d-48e0-8e27-65a135b9d9e4" xlink:to="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_79918e0c-0da1-412e-9da5-087343f129a2" xlink:href="lgnd-20220331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_79918e0c-0da1-412e-9da5-087343f129a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_fc9b35fc-6f0b-4a41-92be-a4796f9551cf" xlink:href="lgnd-20220331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_fc9b35fc-6f0b-4a41-92be-a4796f9551cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_9e6f4b73-d136-4247-8b86-3dbd29b0b08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_9e6f4b73-d136-4247-8b86-3dbd29b0b08e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9e6f4b73-d136-4247-8b86-3dbd29b0b08e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9e6f4b73-d136-4247-8b86-3dbd29b0b08e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9e6f4b73-d136-4247-8b86-3dbd29b0b08e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e2b05dd7-49e4-4883-9feb-1fcbf164af1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9e6f4b73-d136-4247-8b86-3dbd29b0b08e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e2b05dd7-49e4-4883-9feb-1fcbf164af1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_2cf72448-4cc6-4803-9b02-cb326b2f83cd" xlink:href="lgnd-20220331.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e2b05dd7-49e4-4883-9feb-1fcbf164af1f" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_2cf72448-4cc6-4803-9b02-cb326b2f83cd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended" id="ia45b74839ef04368a9626b5f5c93775e_FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_82353c98-f9ed-4359-8251-b1341c37c072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_82353c98-f9ed-4359-8251-b1341c37c072" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6f259543-ad9b-4dcd-960e-f2607cafb45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6f259543-ad9b-4dcd-960e-f2607cafb45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_3dc9db80-019d-4188-8479-3e7f99ecb8e9" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_3dc9db80-019d-4188-8479-3e7f99ecb8e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4e57d453-3bfc-4842-9a28-516deb204398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4e57d453-3bfc-4842-9a28-516deb204398" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_1ff4732a-4f43-415a-a87a-ec10f346417b" xlink:href="lgnd-20220331.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_1ff4732a-4f43-415a-a87a-ec10f346417b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0f6f6d20-e70e-4fcc-a118-1b94fba10bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6cf9ff85-2de5-411b-930a-f3bb7dd866d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_82353c98-f9ed-4359-8251-b1341c37c072" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6cf9ff85-2de5-411b-930a-f3bb7dd866d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7dde45b-c927-4628-8a05-71446d8bdb80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6cf9ff85-2de5-411b-930a-f3bb7dd866d4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7dde45b-c927-4628-8a05-71446d8bdb80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7dde45b-c927-4628-8a05-71446d8bdb80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7dde45b-c927-4628-8a05-71446d8bdb80" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f7dde45b-c927-4628-8a05-71446d8bdb80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d44632a8-a99a-4e11-9c1a-d8caa0e07752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7dde45b-c927-4628-8a05-71446d8bdb80" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d44632a8-a99a-4e11-9c1a-d8caa0e07752" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1f718e3b-dd8a-4aa4-bb1a-8f4a61cb4eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d44632a8-a99a-4e11-9c1a-d8caa0e07752" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1f718e3b-dd8a-4aa4-bb1a-8f4a61cb4eca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended" id="i7a39e325b94042cc81bd91f041d051b3_ConvertibleSeniorNotesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f1272148-dfa4-437e-8c59-2180feb97fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f1272148-dfa4-437e-8c59-2180feb97fe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_de5e0ddd-f1b0-4141-bc82-f575836ddc37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_de5e0ddd-f1b0-4141-bc82-f575836ddc37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e1182338-2814-4fa8-b8c8-8611b0ed4ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e1182338-2814-4fa8-b8c8-8611b0ed4ff4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_01eb1890-8df7-4fea-8242-f0e45ae83dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_01eb1890-8df7-4fea-8242-f0e45ae83dcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_84e33045-eb14-496b-bd01-70d84035e831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_84e33045-eb14-496b-bd01-70d84035e831" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_ecd3739a-c925-447d-bf39-995cdb140cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_ecd3739a-c925-447d-bf39-995cdb140cec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bbe43a03-6880-454f-ad73-473e543f6a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bbe43a03-6880-454f-ad73-473e543f6a6b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_38b56abd-6a02-47e6-9684-c3a4f6ccf7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_38b56abd-6a02-47e6-9684-c3a4f6ccf7a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_31ca9603-fb67-4a90-b777-7e5cccc50c4e" xlink:href="lgnd-20220331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_31ca9603-fb67-4a90-b777-7e5cccc50c4e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_aaa9d281-116a-4aca-adc6-5126488ad476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_aaa9d281-116a-4aca-adc6-5126488ad476" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9b6958a7-6fa1-4adb-80e6-6f576a51684c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentTerm_9b6958a7-6fa1-4adb-80e6-6f576a51684c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_72c249b3-28ad-4246-a95e-b58e4545168e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_72c249b3-28ad-4246-a95e-b58e4545168e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ae799d9e-0d47-452e-8050-09efe5ae7259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_InterestExpenseDebt_ae799d9e-0d47-452e-8050-09efe5ae7259" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d6d53061-511f-4c4c-8913-f80bdd52ec92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d6d53061-511f-4c4c-8913-f80bdd52ec92" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_98a913ce-211e-4389-88fa-f0f406afcc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_98a913ce-211e-4389-88fa-f0f406afcc85" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_2f483d0c-f348-49aa-a13f-0c44d6b93f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_2f483d0c-f348-49aa-a13f-0c44d6b93f76" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_2fe5965d-2334-4d26-bad5-7c6b5ea8a3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_2fe5965d-2334-4d26-bad5-7c6b5ea8a3cd" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_ee7fdb18-e502-4443-9d5e-3a5b2c812c1c" xlink:href="lgnd-20220331.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_ee7fdb18-e502-4443-9d5e-3a5b2c812c1c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d46073c2-b8c9-4e94-b95d-0e20a3ba5a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d46073c2-b8c9-4e94-b95d-0e20a3ba5a7d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc4a6b73-e68c-4482-95c3-dcc34bc9e4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc4a6b73-e68c-4482-95c3-dcc34bc9e4ee" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_90f434ad-c30a-4136-a196-1b30369cf541" xlink:href="lgnd-20220331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_90f434ad-c30a-4136-a196-1b30369cf541" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_826cb17f-5099-41b1-8d65-19e4046b9992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_826cb17f-5099-41b1-8d65-19e4046b9992" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_fa36f0dc-444b-4c1e-89f5-cb280170386c" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_fa36f0dc-444b-4c1e-89f5-cb280170386c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_96844769-b527-4b4f-9351-2d3258a20087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_96844769-b527-4b4f-9351-2d3258a20087" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_10d73688-9562-4567-a460-16b199c7e930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_10d73688-9562-4567-a460-16b199c7e930" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_0c1805aa-8998-4e1a-bdbf-067eeba14955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_0c1805aa-8998-4e1a-bdbf-067eeba14955" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_76596c11-c6bd-4b46-9ab6-699115794681" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_76596c11-c6bd-4b46-9ab6-699115794681" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_df8f7c78-5226-4f65-9c64-ceac20e72a68" xlink:href="lgnd-20220331.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_df8f7c78-5226-4f65-9c64-ceac20e72a68" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4ed3915e-fa16-4707-a380-817f2614d0f3" xlink:href="lgnd-20220331.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4ed3915e-fa16-4707-a380-817f2614d0f3" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f9837ae7-bc72-45c4-99c0-30c5e9a12468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f9837ae7-bc72-45c4-99c0-30c5e9a12468" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_546950f6-9475-4d1b-a916-160b92a69532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f9837ae7-bc72-45c4-99c0-30c5e9a12468" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_546950f6-9475-4d1b-a916-160b92a69532" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1759116c-dbe2-463a-94b5-8918ea7f5fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_us-gaap_DebtInstrumentAxis_1759116c-dbe2-463a-94b5-8918ea7f5fa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1759116c-dbe2-463a-94b5-8918ea7f5fa0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_1759116c-dbe2-463a-94b5-8918ea7f5fa0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1759116c-dbe2-463a-94b5-8918ea7f5fa0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_71920e99-69ab-404e-8e8b-d8e8243c2faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_1759116c-dbe2-463a-94b5-8918ea7f5fa0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_71920e99-69ab-404e-8e8b-d8e8243c2faf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_a188d5fa-ab6f-44c4-9dfa-44add792c135" xlink:href="lgnd-20220331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_71920e99-69ab-404e-8e8b-d8e8243c2faf" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_a188d5fa-ab6f-44c4-9dfa-44add792c135" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_94c16e26-84bf-4321-ae40-0f01a17d8da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_94c16e26-84bf-4321-ae40-0f01a17d8da1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_72550a4c-4dbe-4fab-90f7-2b21bcfe38a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_72550a4c-4dbe-4fab-90f7-2b21bcfe38a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_57039947-2117-4a80-8b3d-244d1b51d3dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_srt_RangeAxis_57039947-2117-4a80-8b3d-244d1b51d3dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57039947-2117-4a80-8b3d-244d1b51d3dc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_57039947-2117-4a80-8b3d-244d1b51d3dc" xlink:to="loc_srt_RangeMember_57039947-2117-4a80-8b3d-244d1b51d3dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f5369732-a49d-467d-9900-99dc83192004" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_57039947-2117-4a80-8b3d-244d1b51d3dc" xlink:to="loc_srt_RangeMember_f5369732-a49d-467d-9900-99dc83192004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6105e419-5c82-4a4f-8b7e-4e9398d34f08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f5369732-a49d-467d-9900-99dc83192004" xlink:to="loc_srt_MaximumMember_6105e419-5c82-4a4f-8b7e-4e9398d34f08" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended" id="ida583964769344bbb9cd6a94066eec0d_ConvertibleSeniorNotesNotesPayableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_551990f7-d95d-447e-891a-21494215ff59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_551990f7-d95d-447e-891a-21494215ff59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_4c87e5b9-beb3-4fab-bfd2-23710617b48f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_4c87e5b9-beb3-4fab-bfd2-23710617b48f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_9f9f7bc3-ac20-460d-bf76-44bb2f218d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:to="loc_us-gaap_LongTermNotesPayable_9f9f7bc3-ac20-460d-bf76-44bb2f218d17" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_67e49101-c811-4f5d-afab-34aebd6eb0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_67e49101-c811-4f5d-afab-34aebd6eb0aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:to="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e42d7559-696a-4b4e-8b3f-968b8e89795e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e42d7559-696a-4b4e-8b3f-968b8e89795e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e42d7559-696a-4b4e-8b3f-968b8e89795e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e42d7559-696a-4b4e-8b3f-968b8e89795e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e42d7559-696a-4b4e-8b3f-968b8e89795e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f034e554-4aa3-42c9-9515-35a9bc61d5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e42d7559-696a-4b4e-8b3f-968b8e89795e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f034e554-4aa3-42c9-9515-35a9bc61d5ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_dfb2f34c-3f0d-4182-b255-e213d5410ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f034e554-4aa3-42c9-9515-35a9bc61d5ed" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_dfb2f34c-3f0d-4182-b255-e213d5410ac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_068405e4-c9fd-4178-a999-e0ee832105b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:to="loc_us-gaap_DebtInstrumentAxis_068405e4-c9fd-4178-a999-e0ee832105b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_068405e4-c9fd-4178-a999-e0ee832105b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_068405e4-c9fd-4178-a999-e0ee832105b7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_068405e4-c9fd-4178-a999-e0ee832105b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_26acbdae-0708-4151-b677-1624f05bf27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_068405e4-c9fd-4178-a999-e0ee832105b7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_26acbdae-0708-4151-b677-1624f05bf27f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_15c511c7-5760-4e95-b3d7-5bb3cfb2f1ee" xlink:href="lgnd-20220331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_26acbdae-0708-4151-b677-1624f05bf27f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_15c511c7-5760-4e95-b3d7-5bb3cfb2f1ee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended" id="ic6c17635eccd4db2b5fbe195dabbe611_StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f00ce40-d382-437b-96f9-e91639df1c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f00ce40-d382-437b-96f9-e91639df1c39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b74980d-5c6e-4435-818a-b0041cacf7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b74980d-5c6e-4435-818a-b0041cacf7cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5c4f5fe-159f-4735-a306-55f2d369c486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5c4f5fe-159f-4735-a306-55f2d369c486" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_46fc883f-f3d3-4180-9dc7-36fc61da8adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_46fc883f-f3d3-4180-9dc7-36fc61da8adf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d77ca0e5-de08-4887-b2ec-dc8e63d3b70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e4573fb-dec5-41d9-b563-8e5bd26069b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e4573fb-dec5-41d9-b563-8e5bd26069b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1f8dd16f-4b09-480b-ac13-5539f4d1a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1f8dd16f-4b09-480b-ac13-5539f4d1a7c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_61ef4202-be82-426d-84ab-fc8345f3d5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_61ef4202-be82-426d-84ab-fc8345f3d5d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eb95f8a4-21ee-4adf-9a3d-814c59a2c1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eb95f8a4-21ee-4adf-9a3d-814c59a2c1f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a29c9302-a5e6-4c12-8ccc-bee00640d557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_129199c2-2f87-4979-a1d4-1dfbfadec291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_129199c2-2f87-4979-a1d4-1dfbfadec291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_da1ced3c-7bbe-4154-9bf3-3e969d3dbd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_da1ced3c-7bbe-4154-9bf3-3e969d3dbd88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_030d1149-b179-4ade-baa7-73d2fad84a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_030d1149-b179-4ade-baa7-73d2fad84a79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a08e3748-9191-466c-b075-f97da856d914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a08e3748-9191-466c-b075-f97da856d914" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_69768f35-c1ca-4379-ab55-f9706482ccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a5500c55-4652-4df1-833f-736f64706b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a5500c55-4652-4df1-833f-736f64706b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f1970650-ec7b-43b3-9185-e77eb73498e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f1970650-ec7b-43b3-9185-e77eb73498e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c49f3c33-730b-432c-8517-393471bd002c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c49f3c33-730b-432c-8517-393471bd002c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6a0d5e8d-47e8-4dd3-9014-929ff3369dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6a0d5e8d-47e8-4dd3-9014-929ff3369dd1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a609a6e6-e81d-4944-8a60-4428d4f7dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b8eefbf8-2ac9-4879-ad22-04a651ec999e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b8eefbf8-2ac9-4879-ad22-04a651ec999e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e62d5748-b8cc-4f5c-98df-a0309a3cc46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b8eefbf8-2ac9-4879-ad22-04a651ec999e" xlink:to="loc_us-gaap_AwardTypeAxis_e62d5748-b8cc-4f5c-98df-a0309a3cc46c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e62d5748-b8cc-4f5c-98df-a0309a3cc46c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e62d5748-b8cc-4f5c-98df-a0309a3cc46c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e62d5748-b8cc-4f5c-98df-a0309a3cc46c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e62d5748-b8cc-4f5c-98df-a0309a3cc46c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_90a95d31-077f-4490-bda2-175ab5bcab07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_90a95d31-077f-4490-bda2-175ab5bcab07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9794095d-0d47-49c7-a69f-a6d8060fd9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:to="loc_us-gaap_RestrictedStockMember_9794095d-0d47-49c7-a69f-a6d8060fd9ca" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="if6e8e817f58241febe5533d68a88227d_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c6f4f3c7-f022-46ae-a76b-279e638c3e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c6f4f3c7-f022-46ae-a76b-279e638c3e58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e22765b5-75e4-462f-89b7-9eee6b59efcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e22765b5-75e4-462f-89b7-9eee6b59efcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:href="lgnd-20220331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_34bb78f3-61e1-4279-90f4-ce4221c6630d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_34bb78f3-61e1-4279-90f4-ce4221c6630d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_92b6def1-c371-4351-b462-ffba9573bf18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_92b6def1-c371-4351-b462-ffba9573bf18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_120181b8-658c-45a3-8f8d-887528792784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_120181b8-658c-45a3-8f8d-887528792784" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6b60ad42-24e4-4398-b290-2f1d882c32eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6b60ad42-24e4-4398-b290-2f1d882c32eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_fc52371f-8dce-45e1-8203-435b2d054e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_fc52371f-8dce-45e1-8203-435b2d054e3e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cdd23678-c087-4269-a414-92ad90ba374a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cdd23678-c087-4269-a414-92ad90ba374a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_110bf807-4ccb-440d-9283-6763e45421ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_110bf807-4ccb-440d-9283-6763e45421ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_110bf807-4ccb-440d-9283-6763e45421ff" xlink:to="loc_us-gaap_PlanNameAxis_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0" xlink:to="loc_us-gaap_PlanNameDomain_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_629227be-3c47-4c22-925f-518264fba635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0" xlink:to="loc_us-gaap_PlanNameDomain_629227be-3c47-4c22-925f-518264fba635" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_ef9c97f7-faf4-4fca-a1bd-b94ec3b62bff" xlink:href="lgnd-20220331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_629227be-3c47-4c22-925f-518264fba635" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_ef9c97f7-faf4-4fca-a1bd-b94ec3b62bff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended" id="i215ae2008b334b259a94dd381b34fa5f_CommitmentandContingenciesLegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_738e3836-7e6c-4696-9039-901361fc1e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_1cb31d93-3bed-4717-bc08-cc48ba02869f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_738e3836-7e6c-4696-9039-901361fc1e79" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_1cb31d93-3bed-4717-bc08-cc48ba02869f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_01e53e6a-ff61-4bad-a225-b70e2b10bd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_738e3836-7e6c-4696-9039-901361fc1e79" xlink:to="loc_us-gaap_LossContingenciesTable_01e53e6a-ff61-4bad-a225-b70e2b10bd96" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_01e53e6a-ff61-4bad-a225-b70e2b10bd96" xlink:to="loc_srt_LitigationCaseAxis_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9" xlink:to="loc_srt_LitigationCaseTypeDomain_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7c3021f7-646e-49fa-a9e1-0b05c9fb570c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9" xlink:to="loc_srt_LitigationCaseTypeDomain_7c3021f7-646e-49fa-a9e1-0b05c9fb570c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_93c1a790-7986-43ce-bc2d-6e01318ae8c7" xlink:href="lgnd-20220331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7c3021f7-646e-49fa-a9e1-0b05c9fb570c" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_93c1a790-7986-43ce-bc2d-6e01318ae8c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended" id="ibc97e709bc924ba586fcbf224d582832_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b10400d1-4ce2-4a0b-a8a4-ec5f15d78e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b10400d1-4ce2-4a0b-a8a4-ec5f15d78e9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b1e4184b-39c2-47f5-afd5-88a7f9f2ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b1e4184b-39c2-47f5-afd5-88a7f9f2ac1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d44d5456-d41d-4e26-a2cc-840d6e717f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d44d5456-d41d-4e26-a2cc-840d6e717f29" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4079300e-146b-4d97-b980-53ce4fc544b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d44d5456-d41d-4e26-a2cc-840d6e717f29" xlink:to="loc_srt_RangeAxis_4079300e-146b-4d97-b980-53ce4fc544b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4079300e-146b-4d97-b980-53ce4fc544b5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4079300e-146b-4d97-b980-53ce4fc544b5" xlink:to="loc_srt_RangeMember_4079300e-146b-4d97-b980-53ce4fc544b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2c491ac-618c-42f6-9d7c-6e4f5d4fc41f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4079300e-146b-4d97-b980-53ce4fc544b5" xlink:to="loc_srt_RangeMember_f2c491ac-618c-42f6-9d7c-6e4f5d4fc41f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc181993-c97a-47d7-b67f-62d85cca1b1c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f2c491ac-618c-42f6-9d7c-6e4f5d4fc41f" xlink:to="loc_srt_MaximumMember_bc181993-c97a-47d7-b67f-62d85cca1b1c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lgnd-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:63142b59-d50f-422e-a0a8-23b5f0c0b9ee,g:55f2a22c-b472-424e-aeed-2ce3b4861db0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_d38b8242-fc8d-4875-81fc-01fbb5930fb6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_a8f49a87-604e-4402-9e58-1a911d91927f_verboseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_78c45830-472f-4006-8f44-ec7d04eeefcd_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f0435945-0698-494d-8f71-fd9680204ca0_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f2de37bd-d0f1-4187-a84a-93608ca343f7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e3cb26ff-dc33-4d69-89cb-7a226caacaf0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_f9e7c1a4-4dd1-4cab-a0df-15797d28aa44_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss):</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6dfccf3e-c667-4449-8749-99c9a8728516_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_62692673-9a48-4d1a-a9e3-7357e89974a4_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2e5f11fe-1cb0-4910-a75a-5f6af543531e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_9ed218f1-ac87-498c-b5ec-c43eb88d61b2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_e84ce102-4549-44bb-96a2-6b4a7694ff46_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_ff848163-b05a-4b40-9cce-89288268e005_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_3316fb3f-bfea-469f-aa7c-62b38c9ecad3_negatedLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders, Financing Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:to="lab_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_93aa3056-0532-4690-b662-1566ff3fa53b_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6091eb69-972d-4e09-bd5b-9d01111e6eff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization on finite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d9b125ee-7091-4036-b121-bea8c8a553e3_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_e5329e21-7dc1-4f14-a906-5eb01f699ad7_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights [Policy Text Block]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRightsPolicyTextBlock_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:to="lab_lgnd_CommercialLicenseRightsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4540dc30-9e2f-487c-9fbe-eb0f1be1f4f2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_125883a4-ee50-4051-b2b8-debc9e8e051e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_68639eb1-d3df-48f4-a797-e7eac713cc4e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_5b10750c-bc0d-44c2-b28a-4b0d8fe226a3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion price (USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0bc04bde-0e91-47eb-8872-84175f2cdc65_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_976152d7-4ff0-418d-ae4f-673fb7f7eeaa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share purchase price as percent of market price (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_f3a0cd44-f955-4d6b-90a3-a7e39bf4bcf9_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_61f92d87-68c1-4557-b0d6-bdcb897e957e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_84c0635f-3083-4b8c-a7d6-181e4438d01b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_68e790bb-3642-4058-be34-b5d5dbded608_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_b934332b-9ceb-4775-b643-bd099e092d34_verboseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_label_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights [Abstract]</link:label>
    <link:label id="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_documentation_en-US" xlink:label="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License and Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:to="lab_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ee522426-1c6b-40d4-b7a9-949b71e5038f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3aa43ff7-738d-4fa7-8b9a-766b197e5579_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f73964aa-7f8f-447a-8608-97b8a11e0961_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e6bd1440-b4dd-4f79-86e4-7c2427284f9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5232bf18-c553-41c0-a916-c350a63b45cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_63cf7e82-83e9-47dd-9f0b-8efdfe0f734f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_4c37f4d1-9718-48a2-8545-556161668dd5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable and payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_34007c6e-5cc3-4507-a527-32ca54efdea0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments to contingent liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_03b6832a-5d2d-4bdb-91e5-a2deddcf369f_verboseLabel_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Complete technology</link:label>
    <link:label id="lab_us-gaap_PatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_PatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentedTechnologyMember" xlink:to="lab_us-gaap_PatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_e153ffe8-8389-414d-be90-af17cb3b2e46_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_169a84e0-fbc9-4b41-ba8b-c11c1466b360_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_507a2994-f8b8-4542-8fc1-8cb5f89a774d_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized stock repurchase amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7672d52a-91a2-43a5-988f-2653056ee634_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3cb5abe0-72da-4526-a264-39feee9139e1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized that was previously deferred</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b0e9a2b0-2ba8-488e-b523-0ba03e81299d_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - Research and development expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_bd0eba91-b745-4cfe-a6cf-3bcbb16f2d60_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_94ee5c2b-29a9-49ee-b030-f26295bbdd9c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_d7a8ccd1-511c-4fe3-9829-6014fbf7c0e9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_de9aec60-253c-42fd-a7f3-7879617dbbeb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_46a38692-4859-4358-b630-2a9f696a3624_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for convertible bond hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_PaymentsForConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsForConvertibleBondHedges" xlink:to="lab_lgnd_PaymentsForConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c0b451a8-1407-4c4d-996d-0653588257a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_1229a1e4-5f63-45e5-a39f-ba2205d5beff_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of notes payable</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_523f30a3-8781-4511-9beb-7bcedcce52cf_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_3ae5c7a7-231e-48ad-a12a-8a41d89be5d0_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_cdd3a098-f6a9-4cb9-b8cd-498b523905b8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_445c6a51-a2dc-4b5a-b3e1-a3f7455c3c47_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_09c052cd-af77-41a2-bbf1-ced542eee6de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_52b58c4b-4c33-4ba5-a591-272cd2c8b044_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_281a06db-e8b1-492e-95ed-44938ab73448_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ReturnsAccrual_de4551ea-8ab5-4944-9bf7-b23f4eeae897_terseLabel_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return reserve</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_label_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:label id="lab_lgnd_ReturnsAccrual_documentation_en-US" xlink:label="lab_lgnd_ReturnsAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returns Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual" xlink:href="lgnd-20220331.xsd#lgnd_ReturnsAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ReturnsAccrual" xlink:to="lab_lgnd_ReturnsAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_beed1952-81a9-427c-b281-30dbd584562c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a9bbea28-ad92-493d-925f-7fb6ce33a30a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_6aba9872-075e-4b14-8182-7f37cfac33c8_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_5de7897b-1531-46b6-8fd3-c09f188940fa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consecutive trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_76e0f7a9-59c8-404b-9a34-a5c84247ce0f_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_26bb969c-acf7-447e-85ea-534e9fd281f3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_527a1bf1-29fc-4f04-85bc-d4ba8cd37fb2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_6cfea6dc-1e6c-420e-8dc5-36721c5daa68_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0108ba70-fbd3-40b0-b9f2-fcf923394a10_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment and Contingencies: Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_a5cde0dc-c60c-4ef6-baf1-e6fcbd090cf0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_0de733e2-b414-468d-8eb0-fe8c4ce706c5_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Line Items]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationLineItems_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems" xlink:href="lgnd-20220331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationLineItems" xlink:to="lab_lgnd_BasisOfPresentationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_7e6a7160-54a7-48a5-b03c-6037d466fd1a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d37317f1-6aed-4547-871f-cf9c7f31ed76_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued fixed asset purchases</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_a0af2b30-6204-494a-990d-2d39de8dc70b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Increase, Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:to="lab_us-gaap_DebtInstrumentIncreaseAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_e244a111-56bf-444c-8f83-9e8abbc04894_terseLabel_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensees</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_label_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:label id="lab_lgnd_LicenseeAccrualCurrent_documentation_en-US" xlink:label="lab_lgnd_LicenseeAccrualCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensee Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent" xlink:href="lgnd-20220331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseeAccrualCurrent" xlink:to="lab_lgnd_LicenseeAccrualCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_9fcd94ef-7828-45a2-8db9-8148149ba680_totalLabel_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease assets</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_label_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_lgnd_LeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_lgnd_LeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset" xlink:href="lgnd-20220331.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseRightOfUseAsset" xlink:to="lab_lgnd_LeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_d9040c71-429a-413f-b5fb-72a23c8e03d3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_21e386df-e485-401a-9e3c-f8f0e6a676bb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_7fb5373c-6f6c-4e95-a644-733f67cf8a94_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_476e13e3-82c6-4b66-896d-18ed6efe6e23_terseLabel_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies</link:label>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_label_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies Segment [Member]</link:label>
    <link:label id="lab_lgnd_OmniAbTechnologiesSegmentMember_documentation_en-US" xlink:label="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OmniAb Technologies Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember" xlink:href="lgnd-20220331.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_OmniAbTechnologiesSegmentMember" xlink:to="lab_lgnd_OmniAbTechnologiesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_59e509f8-0678-467d-8045-53e0643e1de4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_1a5db138-07a2-4471-ab1c-597314fa56d6_terseLabel_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_label_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]</link:label>
    <link:label id="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_documentation_en-US" xlink:label="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:href="lgnd-20220331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:to="lab_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_010943af-8a0a-4e79-a722-41129388c63f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4450b887-0637-4724-aeb0-89ecac78bf04_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a75584a1-c7ad-4266-b4b2-c9c79904f72a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_20ecc7cf-ea77-4294-bbcb-713e97cb01a4_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of December&#160;31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_cceb227c-c75e-4fd9-9f20-6a788d1e7a4e_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of level 3 financial instruments as of March&#160;31, 2022</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_56bcc87c-0991-42b1-9e6e-f0f3f79fda15_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_e127ef6a-6bff-43fa-ab2f-a6c81978cd11_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_1bc713e7-a75d-4ece-a6b7-db62200d5b7f_negatedLabel_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimated fair value of contingent liabilities</link:label>
    <link:label id="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_label_en-US" xlink:label="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NonCashChangeInEstimatedFairValueOfContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:href="lgnd-20220331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:to="lab_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_22a1e606-3645-45b1-be6e-e5f7b4081a25_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Source</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_832dbf14-43a0-40a6-ba2f-c9cf525eaffd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f3f3203d-2c62-4e18-88e1-0aab11bec85d_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_5c98724b-06a8-4aa3-b669-917c23614617_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_18cf666f-ffd5-4ea7-aca0-339b142f28a2_terseLabel_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from unwinding convertible bond hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unwinding Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:href="lgnd-20220331.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:to="lab_lgnd_ProceedsFromUnwindingConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_38ade63d-5676-4a2b-b8f0-82d8c28ac049_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal amount of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_33c4ad4c-d240-48d7-8e50-f814073c8052_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_5601030b-1b33-4e9c-9e52-11103e5aa64f_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued per acquiree share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_d693d47a-34b0-4f23-9a19-69cded969b87_terseLabel_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_label_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial [Member]</link:label>
    <link:label id="lab_lgnd_Phase3ClinicalTrialMember_documentation_en-US" xlink:label="lab_lgnd_Phase3ClinicalTrialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Phase 3 Clinical Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember" xlink:href="lgnd-20220331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_Phase3ClinicalTrialMember" xlink:to="lab_lgnd_Phase3ClinicalTrialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_13fc777a-27c9-4771-97f3-525781403527_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_3e8e13bb-73ce-4699-8513-3ef47f5484f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_8913dcc5-8116-4e0f-90ea-7834c693775d_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_55209051-55dc-43f4-bc29-634d07593d0a_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c647d6db-3405-4373-b4ae-caec4a3930d7_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_58fa4365-e065-46d3-9fd8-87d94bd4236e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_57988f70-fa88-4d67-80d1-e3017614243c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_6ee9845a-a8e4-4a12-9831-61afa28a1629_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1e10d12f-a647-4c2b-a585-c605bb59695c_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_3df03ac9-29cd-4e45-a296-b4a846cb5767_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_2f3b8e2a-8a3a-4d98-8cd4-c342b2f000ea_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_ddf41bc5-9b42-4e58-8d03-7a180fb5ca84_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_b7576272-1a42-4b8e-8f54-bb7dee94ce23_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_8ae157e7-698b-4338-b3a1-942b1a1ed538_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_efda1a5f-746e-453f-8cbd-ae87fe7e6b14_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ce45feb8-0167-4a4d-8e72-e4c1491424ef_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_2060669d-9447-487c-9947-dc4c7fba7be9_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_b8d66e80-6e44-4a3c-ae77-dc6a14e33922_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_b7712907-ef34-4097-a92c-57bef9de5666_terseLabel_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related liabilities</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_label_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:label id="lab_lgnd_AccruedAssetAcquisitionsCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Asset Acquisitions, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:href="lgnd-20220331.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedAssetAcquisitionsCurrent" xlink:to="lab_lgnd_AccruedAssetAcquisitionsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d52381a8-7e5e-4191-81be-a05798260693_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_de301115-a6e1-475a-a2ac-7c7ceb9fe7a6_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_4cbd0952-4b2a-431e-9125-07d797c045ed_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d2c97720-2b47-4bdf-a3e7-5377b192b24e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_555a7c5c-3123-4265-a580-5e6b242b5355_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_368ef7bf-2165-4245-a1f6-e90d30486e1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_f44dc05b-0e4b-49c2-a7a1-b88dfcb501f1_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contingent liabilities</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRights" xlink:to="lab_lgnd_LiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BasisOfPresentationTable_23fe0382-a348-4be0-a1a3-2583f125c791_terseLabel_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_label_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Table]</link:label>
    <link:label id="lab_lgnd_BasisOfPresentationTable_documentation_en-US" xlink:label="lab_lgnd_BasisOfPresentationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable" xlink:href="lgnd-20220331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BasisOfPresentationTable" xlink:to="lab_lgnd_BasisOfPresentationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7596985f-e11f-48b1-bcc9-7839e9cbd29d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_cedaf64a-a756-4233-8b19-a13c4a7e2153_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial conversion rate (shares per $1,000)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_325fd98b-4ecb-457b-b4c6-d1953f47ecf8_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_9487dfe0-6988-4654-a15b-a44eefd10e0b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_0babea83-fc9c-431c-9b54-01b3b44fc5b0_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4a76eed3-187c-48aa-bb6d-668f61c94a1f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3d8f71c2-fc23-4829-9e40-b80acec436b0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_690e97f0-e225-4299-aabc-3611bcf206f4_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_25a22afd-f415-43a1-b27a-1755e853dc26_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_104da21a-7529-4c99-a76e-0a77495857ab_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_39036a1a-5a8e-4d61-bfb1-026ff5932477_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_e03127a2-01dd-4685-9874-5019d3bdb25a_netLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_84564fa8-404e-4d47-8ecd-71fb97e1aa4f_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_064439bf-4212-4e13-be8f-da64c7671d93_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_da2c06a0-b988-4f55-af14-0fc843cd4266_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding options that are exercisable, weighted average exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_c1c59588-67d0-412f-bb59-f524141aab93_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_2ea2952a-6405-4400-a17e-2a60cad2666f_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_8b762547-e176-4348-b082-979e379952ca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_24d54525-7103-4736-ac6d-5b682b574768_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for contingent consideration liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_1b0b6a22-8312-46b7-9f09-940ee8f9672e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_0397c164-7e91-4fbf-844f-a347efbb079b_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Viking common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_1b57ddd9-66e3-4537-b0b4-115d4e1397ac_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueMember_d7b155b5-ca72-4903-b91f-7afd3d1fbe6b_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueMember" xlink:to="lab_lgnd_ContractRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_581cdc18-0d7c-4482-a72c-b8ac03201b07_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_0e5a80bf-0056-41e0-a76b-94f63e2373a6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_5dc0770b-475f-4628-8d12-c75bbfe9df06_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_bc6151a3-d50c-487d-8001-a65d14173418_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 60,000 shares authorized; 16,861 and 16,767 shares issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_53753a57-6abc-4da2-8ede-b4354ab6caf5_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_a5317651-4372-406d-826f-a21c6772a80b_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (loss), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6e1edaad-633d-4dfa-bf30-7fc8b7b1ffc4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b7079472-7279-4111-80d1-7925623cdb0e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_2e2b3a67-b9c9-4d7c-8e2b-1e0ad0294a15_verboseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_d8f5b842-7553-4a49-a3bb-791a8e28ba10_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_bf3b8930-7515-47e5-9145-f081f98e5622_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual relationships</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_072eb308-aec7-4efd-9a01-5522bf045953_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_617b83bf-328a-466b-b1fd-94ba706f5224_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_7f66997f-6293-4d12-ad55-cb2db100dd92_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e67b4a5c-6a79-4773-b339-51d43c30651e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Debt, Net of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:to="lab_us-gaap_ProceedsFromDebtNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_529cde0f-007f-4ba4-b29b-23cd601bd394_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining nine months ending December 31, 2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_201a6223-930b-4358-aea6-1ae34b92579b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_0de18bc2-9fd5-4f76-b97d-067a1815ada3_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_8815696f-87ad-452d-b9a9-169922922911_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetGross_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetGross" xlink:to="lab_us-gaap_ContractWithCustomerAssetGross" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_541d88f7-b04a-4ef7-a999-29755dd7180c_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_label_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:label id="lab_lgnd_LeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_lgnd_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent" xlink:href="lgnd-20220331.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiabilityCurrent" xlink:to="lab_lgnd_LeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_0d7b459b-66d8-4742-91ec-74fb21e5ff38_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_796bab9f-9f39-4d96-8d6b-6da8d46e7a89_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f463ef74-91b0-4b73-82fa-bf6c406a665f_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_0f00a66f-8b6f-4e6c-aae2-dd30077a6c4b_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subcontractor</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSubcontractorExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Subcontractor Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:href="lgnd-20220331.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSubcontractorExpensesCurrent" xlink:to="lab_lgnd_AccruedSubcontractorExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_b85d4a92-a78a-4359-9d38-e8596dd2c9ab_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Balance</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjusted Balance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_ff0abcf7-c95f-44e3-92fb-5cc41ee5fd26_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options under convertible bond hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_label_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:label id="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges_documentation_en-US" xlink:label="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options under Convertible Bond Hedges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:href="lgnd-20220331.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:to="lab_lgnd_NumberOfOptionsUnderConvertibleBondHedges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b1449b30-66ff-44e3-a964-a15fe833a44e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ef46965a-d6f0-4b50-8180-44c2ed3fea9e_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_be43d590-2fbc-431a-b18b-8d60b98ae2d5_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_24f0b76d-c5c2-4c8b-ab4d-66e2ee6712b6_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_740f531e-99fc-4205-a106-c22f4ef16025_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3cb89707-d637-483d-b5bc-fb94e4df81ac_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_31ade56d-fc44-468a-a06f-d9bc96982f1a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_999cd265-a0d1-4b93-ad01-77b77e0555f7_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees, Milestones, and Product, Other, Product, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:href="lgnd-20220331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:to="lab_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_8b198227-1795-4562-9875-0910b794a9be_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_7a2afd3c-166b-4ca7-a1ae-a25a8574b15c_terseLabel_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide injection</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_label_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection [Member]</link:label>
    <link:label id="lab_lgnd_TeriparatideInjectionMember_documentation_en-US" xlink:label="lab_lgnd_TeriparatideInjectionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Teriparatide Injection</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember" xlink:href="lgnd-20220331.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_TeriparatideInjectionMember" xlink:to="lab_lgnd_TeriparatideInjectionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_70b0a2a4-ef32-445a-9d74-20ce28ae4944_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:href="lgnd-20220331.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8bc86424-edc9-4676-9ab8-6bf14a61146f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_81cf41fc-ed41-459e-9615-42e889b4ba72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_ee035d26-9571-402e-ae37-ab1712aa46a7_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_eeac8a71-cbd8-449b-b321-b68b93b26a0c_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LicenseFeesMember_f05cdc39-edff-42a2-bfcf-d24fb8683760_terseLabel_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_label_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees [Member]</link:label>
    <link:label id="lab_lgnd_LicenseFeesMember_documentation_en-US" xlink:label="lab_lgnd_LicenseFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember" xlink:href="lgnd-20220331.xsd#lgnd_LicenseFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LicenseFeesMember" xlink:to="lab_lgnd_LicenseFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_47da4de7-ccb7-45d1-a987-113f1c9534ca_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible notes payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_f65918c1-8919-4bbf-94d7-dc222d08b817_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_5dd50f2a-d0b6-4069-b794-ad70da2d5efe_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Notes Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableMember" xlink:to="lab_us-gaap_ConvertibleNotesPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_df66486b-8c14-450b-b792-52c062e926ff_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleOfShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4b3b80d5-ea02-401f-bfd9-2809db5557ab_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_d0984c80-019e-4699-9feb-b73972bc577a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_e3ee391a-5d1a-4678-b744-57a7edae9f3e_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d6ae6e27-a731-4dcd-967d-4561f19ce4a8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ef9eb303-a61b-4c0c-a93e-450a3fce3814_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8351b40e-1822-4a04-a7ba-58ff90857546_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_70a8d7f6-0706-436f-b5d0-ee89cca5edff_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVRs issued from each CVR series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_label_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:label id="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:to="lab_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_170ab3e8-d815-439c-aa69-1456c03de302_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_c9d9ed99-cb7c-4487-9ecf-c65727a3b534_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period in force of stock repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_609dca80-697a-44b6-9728-04d5d508fad5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_b0fe0b2f-b976-451d-8d7b-a80f530fa1a5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_1238e3a6-b3b8-4d21-8726-16399c06d055_negatedLabel_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in debt discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_label_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:label id="lab_lgnd_IncreaseDecreaseInDebtDiscount_documentation_en-US" xlink:label="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:href="lgnd-20220331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_IncreaseDecreaseInDebtDiscount" xlink:to="lab_lgnd_IncreaseDecreaseInDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5ad999d2-bcf8-46d2-bf99-1e6ba81bdc99_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_61e07a81-0f4e-40e4-866b-4ce6bd519d43_negatedTerseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect for 2023 Notes transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:href="lgnd-20220331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_48d909ff-6ea6-4129-85f7-9f3ac1f1e166_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_95423258-d814-4613-acf4-3199125fcaaa_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_38755bb7-1a4c-4d06-8925-f673d3d1e57b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_7c34f50e-a05d-4e18-9fc7-7504dde5e492_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d8872761-ba22-4305-a034-8f24ef970e1c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f2714f91-0c83-4189-aa38-0ce2f44ece76_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_aae7f2c7-3b00-4a9e-854b-8172d9f6b268_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_ee511769-0eb5-4026-bc34-5c461af610fa_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_1026fcb5-533d-4846-91fa-b3989b828909_terseLabel_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to unwind warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_label_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:label id="lab_lgnd_PaymentsToUnwindWarrants_documentation_en-US" xlink:label="lab_lgnd_PaymentsToUnwindWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Unwind Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToUnwindWarrants" xlink:to="lab_lgnd_PaymentsToUnwindWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_8d1bf2af-362c-40c2-99ce-a824801864b2_verboseLabel_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current contingent liabilities</link:label>
    <link:label id="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights_label_en-US" xlink:label="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CurrentPortionOfLiabilityForContingentValueRights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:href="lgnd-20220331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:to="lab_lgnd_CurrentPortionOfLiabilityForContingentValueRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_a4837782-7cf2-419f-8a30-615925e7a24d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_95b2bb27-79d1-49f0-bfd3-46ac2ca5cbdd_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants issued in public offering (shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_83c7656a-7658-49c7-8e18-80c4d74b4b3b_negatedTerseLabel_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to CVR holders and other contingent payments</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_label_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:label id="lab_lgnd_PaymentsToContingentValueRightHolders_documentation_en-US" xlink:label="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Contingent Value Right Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_PaymentsToContingentValueRightHolders" xlink:to="lab_lgnd_PaymentsToContingentValueRightHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_048c6d8b-16f5-473e-8651-8d61b55a550c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LeaseLiability_32f6dcf5-5446-4bda-8629-bf736c89965b_totalLabel_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_lgnd_LeaseLiability_label_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:label id="lab_lgnd_LeaseLiability_documentation_en-US" xlink:label="lab_lgnd_LeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability" xlink:href="lgnd-20220331.xsd#lgnd_LeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LeaseLiability" xlink:to="lab_lgnd_LeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_07848e84-f22d-4a5f-a487-02e66fdf6014_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0ab5cab6-a86b-4b55-9394-58a1ac7a1592_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_076a2cc8-dba5-43ca-978c-dc493004d066_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_9f8d55f9-74b3-41f8-a28f-2f7478a2dfd0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9fe0840d-e4c8-43f2-8d28-6739515d634f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_b0cc4014-c7b3-4b2c-8bea-9cbdba52b1b0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_KyprolisMember_57849a5f-dd9a-4672-b879-16fdbe6e9d80_terseLabel_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:label id="lab_lgnd_KyprolisMember_label_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis [Member]</link:label>
    <link:label id="lab_lgnd_KyprolisMember_documentation_en-US" xlink:label="lab_lgnd_KyprolisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kyprolis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember" xlink:href="lgnd-20220331.xsd#lgnd_KyprolisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_KyprolisMember" xlink:to="lab_lgnd_KyprolisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_453cb830-266f-4341-81e9-d66a2c51966a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturity of short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fc95b779-55b9-430b-ba72-1fb043da030e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3d83b048-bdf4-43a8-b839-15efb62f3da3_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d4aa294a-f56e-45f4-b812-ff153b0302ee_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ed3017ac-aeee-4731-a326-9674342121d5_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3db42c2d-906f-4f71-baa7-69935956f9b7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_9927aed9-25da-403d-8de6-b3c7d47e5316_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f6ad5890-10fa-44a7-b79f-593f7825bd4f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3116411a-86be-478d-b627-ee9d4861dce8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_0553e489-12c6-4675-a8a0-85da37d1422f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_63a999f3-daa0-4817-a850-0055c100c9e3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_2c7d2c60-1f2b-4beb-b242-f07103b2d761_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_74a3e735-3ebe-4ec0-812b-a549bac5bf60_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_e857e375-7514-40f0-b318-2e97f34a6f9b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6fafcb94-a93b-4147-a163-fb22190f6ad8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_27753fae-ad3f-4a6e-bbae-3f6530799e44_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_1cf75c52-d3ec-49be-b024-c1dbddc1365e_terseLabel_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payout range (as a percent)</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_label_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:label id="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_documentation_en-US" xlink:label="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:href="lgnd-20220331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:to="lab_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ba46583a-823b-4bba-992e-91e8bfbb14b4_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on debt extinguishment</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e01d2a7d-a094-4f31-9992-2ac2aa42078e_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_4baf7a6b-c607-45fe-bf6a-45466b2b62e7_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_c4058517-8016-4bad-a336-4829033bc30a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_label_en-US" xlink:label="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current and Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:to="lab_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_d44811dd-9706-4338-8997-b27d52541d5a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchased amount of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchaseAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchaseAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_70c7d671-38e5-40b4-95f8-7672559897b6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental schedule of non-cash activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_e1a0312c-9efc-402f-bab1-87fdd26f4828_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_a50dc0dd-4d27-4e62-b8df-3bc597de38ee_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d2183d4a-edf7-4f7c-953a-8e18c2401ffb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_976e1842-913a-4cf3-b2ea-1330033fa0ba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_ac350819-881c-4d2a-8e52-2c121ea0d412_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_379a3199-afe1-4aeb-b023-4770abe218ad_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount of the 2023 Notes outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c95e2f5c-de2d-4422-9ca2-bbd939fc456c_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_d635ba49-7d36-4250-939c-ada1b0252dc9_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_7eb63de7-122c-4041-b527-c385dd07f1df_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e517b5e7-2e8f-4eab-8312-bd78e320324a_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_5e319624-5e90-41bf-9fea-b90cd3ca9716_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_c2cbcc64-3204-4e8f-8c46-c273beea0568_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_f0ddc0fe-fbe1-4547-96fc-1ae9696caa7b_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - xCella</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, xCella</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_19393b0a-0039-4686-843a-485e93d24750_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_609a291f-bb6e-4c57-baee-60335c9b5bbd_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_eb43a797-81ad-415f-9f52-23e92abae3d9_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Revenue from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_f4b4db6b-fdd6-4285-aad9-a6743fd29f61_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining lease term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_e55f864f-0214-45ba-8b87-ef41668e44c3_verboseLabel_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounting for Share-Based Compensation</link:label>
    <link:label id="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:href="lgnd-20220331.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:to="lab_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_c3ddecd7-ec1e-4da7-a6d3-3c6cf90f71fa_verboseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) from short-term investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_CommercialLicenseRights_32590e3c-f150-4c2f-bdc6-8de8df670a58_terseLabel_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial license rights, net</link:label>
    <link:label id="lab_lgnd_CommercialLicenseRights_label_en-US" xlink:label="lab_lgnd_CommercialLicenseRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial License Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_CommercialLicenseRights" xlink:to="lab_lgnd_CommercialLicenseRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_a3cb6d57-4a09-44b4-90ca-a3826d7de8e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_85fac6d3-cfcf-43fc-a87d-4189a3635512_terseLabel_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_label_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc. [Member]</link:label>
    <link:label id="lab_lgnd_XCellaBiosciencesIncMember_documentation_en-US" xlink:label="lab_lgnd_XCellaBiosciencesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">xCella Biosciences, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember" xlink:href="lgnd-20220331.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_XCellaBiosciencesIncMember" xlink:to="lab_lgnd_XCellaBiosciencesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EvomelaMember_247768b5-41ac-4ef2-a307-34d41a673cc4_terseLabel_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:label id="lab_lgnd_EvomelaMember_label_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela [Member]</link:label>
    <link:label id="lab_lgnd_EvomelaMember_documentation_en-US" xlink:label="lab_lgnd_EvomelaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Evomela</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember" xlink:href="lgnd-20220331.xsd#lgnd_EvomelaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EvomelaMember" xlink:to="lab_lgnd_EvomelaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_7905a312-ac43-4191-956d-864823ede466_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US government securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_7953557b-cc2d-477b-8321-0e702dcc8c97_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from convertible bond hedge settlement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_00819c37-882d-47be-8702-62eaa4eab845_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_8f3f8c75-334d-469e-a5d0-7264dd48979a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_bca882dd-cd49-4651-8073-98857b160aaa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Level 3 Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_e18f0777-7692-4d26-b979-ebe007a75801_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from stock option exercises and ESPP</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_b0de0e2d-c8d6-42aa-a397-c4d14f57c4da_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_22f55bd5-a09d-4467-a918-c6a317abc1f7_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3a35121a-7279-445c-bb16-87da6348c1e4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_65d663fc-c2b8-46e7-9397-ab3e19573579_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4a5fffa6-0a16-4ecd-a205-ad3a3bcd8f06_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a8afbea0-1cd9-44ab-8314-63c6d1dd621f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_02dd251c-b2c1-419f-8a57-72ef4ca81052_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_281a20c1-ba7f-4382-bf0f-577740b92b95_terseLabel_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued inventory purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_label_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:label id="lab_lgnd_AccruedInventoryPurchases_documentation_en-US" xlink:label="lab_lgnd_AccruedInventoryPurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Inventory Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases" xlink:href="lgnd-20220331.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedInventoryPurchases" xlink:to="lab_lgnd_AccruedInventoryPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_2fd86d8e-8a2a-44a3-887f-17199c2e52b6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_87a50847-e1a3-46f4-b5ed-9c6e6cb5a2ae_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_8723fcc6-1f4d-4753-9876-5445537e0837_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Frequency of cash payments to CVR holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_label_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:label id="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:to="lab_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ad9cd422-3c64-4396-96c2-edd71bda4f81_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_859e2144-e6fc-4b24-b90f-3f79dc215e77_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_a4556f40-dc6c-4ca4-ad55-70fed1e9a1ca_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_1d28ebfa-3297-4a2d-961c-e7beea42efd6_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_bca34c3d-1118-44de-9f30-bd44312d3109_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_7760dab0-9958-4031-bf97-e5b3153e8880_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_bf249f6d-1190-4757-af73-3f8f804927f4_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_dc24c5dc-553c-4406-87de-1c10fd619129_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_3fb748b8-4ec6-4f50-8e39-3529879b50d6_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_90dea6cb-213c-4f67-b6a1-9dfc4bf29fec_terseLabel_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Operating and Finance Lease Assets and Liabilities</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_label_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases [Table Text Block]</link:label>
    <link:label id="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:href="lgnd-20220331.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:to="lab_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_1258796a-d72a-4549-a70b-072367416683_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_2d1e62e9-dffc-4082-a7c3-f9a84e6c3d43_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time</link:label>
    <link:label id="lab_us-gaap_TransferredOverTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredOverTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred over Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredOverTimeMember" xlink:to="lab_us-gaap_TransferredOverTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_1870407d-ef45-4c6d-b1c8-f0b1a4efff45_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased during period</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_9469bcc8-e07d-4d7b-b03b-5a8f7932365d_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to additional paid-in-capital from warrants</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_cde7f231-efe3-4a6b-9846-50e45a1a7bc8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_0ebe9f0c-1c59-4906-b54a-d567812511b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_a0c89d0b-464c-475b-bc57-66b64575eb73_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - Core</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCoreMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, Core</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCoreMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCoreMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4f6a0d5a-cea7-42cd-b1ca-0da367e34773_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_2d860ccf-59e0-4a23-837f-06123127f966_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_5c4ce8fb-8c08-4a77-9d5f-3dfef81cb890_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ae9d906c-2696-4047-a4b5-9b0071f9b51c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_0e686e88-de95-4f4d-90da-982ac39911ad_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolMember" xlink:to="lab_lgnd_MaterialSalesCaptisolMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ae0963f2-128e-4488-94ef-01f450780d58_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_8639527b-a775-4759-be82-79a44d1e7bca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net loss on available-for-sale securities, net of deferred tax</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e53e5e99-c4c1-42eb-87ce-f688b20063f9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_d5ff38b7-9c01-4b85-b4c6-7d65f5523809_terseLabel_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of CVR Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_label_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:label id="lab_lgnd_NumberOfContingentValueRightsSeries_documentation_en-US" xlink:label="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Contingent Value Rights Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:href="lgnd-20220331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_NumberOfContingentValueRightsSeries" xlink:to="lab_lgnd_NumberOfContingentValueRightsSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_dded613e-7e4a-4988-beab-c2bfb252fe1c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_9d8634f2-dbf3-4439-9298-81b14bb21af8_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6cab2ab7-0c7f-4c05-97ec-eb11cc3233ee_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_11510368-7aa5-4322-9011-ea0c3079c1c3_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_36162c34-f4f9-4de7-bf9c-0ae05b7fa463_terseLabel_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional allowance for credit losses recorded related to COVID-19</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_label_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:label id="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_documentation_en-US" xlink:label="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:href="lgnd-20220331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:to="lab_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_f07327fd-1d39-4fd6-828b-372a62a1a344_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_22cdb1b3-3b44-4944-b4b5-de855a46acde_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_6cd067bf-dbd5-4f75-9f92-edec23449e1a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_d4effbdd-a940-48a8-a16d-1e6ff8ffc230_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34edb244-7b6a-438d-8098-f3852c23e0a3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_63f2e745-e4be-4871-8da7-0bc21d460c62_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanAbstract_documentation_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:href="lgnd-20220331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract" xlink:to="lab_lgnd_EmployeeStockPurchasePlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_a52917a1-08c8-4dec-89e5-3de070fd133e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_83c97107-7b62-4294-860d-fee5ad3d8965_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_0cd1f28f-dca2-4807-a07c-17eb907074e0_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the 2023 Notes outstanding (Level 2)</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_dbb90fdc-4aad-48f4-b563-bc6f40b860c0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_4201ae28-8184-44fb-8222-16405554e3f1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_c1ba3a0b-eaf1-4b0d-9156-20911e0485b7_verboseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - CyDex</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Cydex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyCydexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RoyaltyOtherMember_8ce82da5-028d-470d-b650-695fe44b7d98_terseLabel_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_label_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other [Member]</link:label>
    <link:label id="lab_lgnd_RoyaltyOtherMember_documentation_en-US" xlink:label="lab_lgnd_RoyaltyOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember" xlink:href="lgnd-20220331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RoyaltyOtherMember" xlink:to="lab_lgnd_RoyaltyOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_514404c6-172b-4c14-ba56-e4f76c69014c_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_799bedbd-ba1b-46f4-99eb-8c4f203faf04_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_55cbe4db-bc50-4ee8-80f1-5f9c7e9ccb9c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_55af9b25-831a-4763-8b26-11144fd475d9_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_a0e7f63a-f8a3-4140-85b0-d8ea6a5f1a46_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_153e6d2b-7512-4e8c-a230-34939f9cdb9c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_1bfee85b-0aba-48ab-8353-77a889315329_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_0e7c6ebc-c61d-4eb0-bfa0-7c3511e88fb9_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b073d153-b9a2-40d3-a8c6-541169fe79bb_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_701bdd74-1f41-49dc-9c85-669881f3137c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_990a115f-1f51-4daf-8104-cb00b674c5f0_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8e6ed81c-a077-4c25-9f83-10e29ba643e7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_818363e6-149c-4d0f-a558-4cc8b29f6deb_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_a736bbb6-c242-4426-b146-8ccc53990720_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_53210fba-1bf8-4ee4-86df-82445121297c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_95ac9897-7083-4bd0-8909-202f1fea326b_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_bb81381e-6fac-477f-ba1b-411ae78b5359_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_65b37c20-aa2c-485a-b48c-d4a781e85bf5_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_ac3f5698-7469-45e9-af34-0b4f52d88ed3_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_e434ee87-9212-469c-905c-36f5f2970e90_terseLabel_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_label_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:label id="lab_lgnd_AccruedSupplierExpensesCurrent_documentation_en-US" xlink:label="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Supplier Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:href="lgnd-20220331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AccruedSupplierExpensesCurrent" xlink:to="lab_lgnd_AccruedSupplierExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_0ce62043-1c47-43b4-a18d-68b47dfd3405_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_6dddf150-e293-4500-a061-435786f3ccee_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a6d3f5ec-e259-4036-b22f-c24b49a2cf74_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_420e41c4-8fb9-4843-b710-4c4471064d4e_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future purchases (shares)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_cbdbb657-552b-45dd-9f0c-ead7d063853c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1e667951-5541-4653-9aef-d6a0f2caceef_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1df9a4ac-9124-4d25-980d-edecbddf089c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_45a8ddf8-be8e-4420-9553-ab58df6312bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_f2cc6131-957f-4c23-8b1f-5ca63e4daed1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term of operating leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_acd929bb-5a83-404b-b735-3153ca91ac9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MetabasisMember_7d6bfcdd-1a32-46ba-8810-b237530d734b_terseLabel_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:label id="lab_lgnd_MetabasisMember_label_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_MetabasisMember_documentation_en-US" xlink:label="lab_lgnd_MetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember" xlink:href="lgnd-20220331.xsd#lgnd_MetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MetabasisMember" xlink:to="lab_lgnd_MetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_bda796c5-395e-417b-96a5-183a908c5ef9_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_eb1c4342-0d41-4f92-8f10-70f9e56900ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_35a2c17f-1744-483a-8063-0189ca3f7e38_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_eaeb7ad0-89d0-4909-9853-9cdacc560962_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_8d128500-ac3a-4318-b1db-f139fef47d93_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_2ede7eb8-ba5d-49a8-9f6c-c3682baa1b14_verboseLabel_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of commercial license rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_label_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:label id="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_documentation_en-US" xlink:label="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization Of Commercial License And Other Economic Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:href="lgnd-20220331.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:to="lab_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_d1604a51-30ec-4f79-a342-45906ee9584b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_edc4fd37-dd72-49e2-a18c-921601d2494b_terseLabel_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_label_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development [Member]</link:label>
    <link:label id="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout Rights for Partner Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:href="lgnd-20220331.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:to="lab_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_02e46232-64a0-494f-a4bc-b2a2f9e8ea6e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income (loss) per share (USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9378f4d2-01ba-4d7a-9efb-9b4c118596ba_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in basic per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e007fe0f-5792-4390-8f92-7e62a2d82606_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_7c9dd600-6512-45fb-8d85-8d8b0e73153b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_f281a65e-47ad-438e-a9ae-c997ea63feb0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount and issuance fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_e2907979-b62a-44b3-b0f4-1b24f9f52b3a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price trigger to classify convertible debt as current (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_5b07dc05-93f4-4731-8fa2-3273ef1c628e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_102984a4-3928-4e90-b9cd-00fbd75ae695_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_cab14ff7-009b-4fe6-9dfb-72db3213a3fe_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_47ff0e8c-ac06-4699-b6c1-ee4d5ca0d7de_verboseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on AFS investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9669955e-5e41-48e0-825c-5b6c6aecf98d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_aac25a3b-dc16-4375-b9fe-b15d3ee9cf6f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_49276415-9054-442a-bac0-7647ec137b6a_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_93815c08-a1dd-4bfd-aa4e-1c0a79d6f696_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Metabasis</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Metabasis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_3845f7c1-657e-4307-a316-1a642731d4d5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_a24f5e32-5217-42f9-a07d-8889e6472aec_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other corporate expenses</link:label>
    <link:label id="lab_us-gaap_OtherCostAndExpenseOperating_label_en-US" xlink:label="lab_us-gaap_OtherCostAndExpenseOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost and Expense, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCostAndExpenseOperating" xlink:to="lab_us-gaap_OtherCostAndExpenseOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_c09878bc-2b6a-46b9-a154-64fafdbd5294_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_1cfbecef-7d0b-4951-acfa-ed8f6e5f9a67_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0ae84783-c6d2-40fc-98dd-6abcc82a14b9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ed399147-9dfb-40ac-ae8f-6efe2cc79bfe_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_7f321e3e-018e-477d-8c63-8d4aa359ee85_terseLabel_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant and bond hedge unwind transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_label_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:label id="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_documentation_en-US" xlink:label="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:href="lgnd-20220331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:to="lab_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_123cac52-8220-40a9-8f23-ec59a1e7f411_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2b8ad9e7-6373-4430-b180-c9b19db7201a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_c1ec05e2-9881-4896-977d-0d74730602db_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_0047664a-6787-45a0-af92-f7006274d6fa_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties owed to third parties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_34f97804-ae0b-49bb-b800-9efd1cc4d030_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_039c564f-4e30-425d-a7c4-f68e25aa770d_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_5820b9cb-cbaf-4f55-9c8a-75eb87ae4a1d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a57e4e96-f2c9-43da-84b8-9716f3c7951c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_28e995f9-2a67-4f02-a72b-d67f02e9a506_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RylazeMember_5edb18eb-17e5-4094-bc6f-83c4b3e10a9d_terseLabel_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:label id="lab_lgnd_RylazeMember_label_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze [Member]</link:label>
    <link:label id="lab_lgnd_RylazeMember_documentation_en-US" xlink:label="lab_lgnd_RylazeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rylaze</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember" xlink:href="lgnd-20220331.xsd#lgnd_RylazeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RylazeMember" xlink:to="lab_lgnd_RylazeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_e5a6c0b8-2030-4bed-9ad4-96bef14ae7f4_terseLabel_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnout rights recognized</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_label_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:label id="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_documentation_en-US" xlink:label="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:to="lab_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cc8998df-814e-4125-8334-4282d02a3fd0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_8da90a33-4c51-4434-8b93-398b97d813e2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_a1e72a2a-22a5-4b3e-bb4e-1b5f16068ead_terseLabel_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Investments</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments [Table Text Block]</link:label>
    <link:label id="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:href="lgnd-20220331.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:to="lab_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c6c04b14-f226-4a1c-9c36-3f96c84091b4_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized net loss on available-for-sale securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f2f2b61d-0506-4747-9120-37e83e101e4d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_7a9eb1f1-12dd-4923-886c-284f0c0ccd46_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities - Icagen</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_label_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Contingent Value Rights Company, Icagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:to="lab_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_cc87a1bf-7752-4c57-ae19-9c0c7ee7a174_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b7807d2f-110a-4d19-924c-f5d2c93ce2e9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_afd01ffb-471c-47ea-bbf8-8a3588aff82a_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_4d646b9e-e20d-40b3-9d8c-ac7b22be82a1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_e5cd60e5-56a8-4227-895e-e65110f492f4_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ba466e4b-ae02-4c12-9b98-a7eb52616c1c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7ea7bef0-2abd-4a59-87d7-bf40dfdeb5a5_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_94b1dfe2-d206-41b3-8a3e-e667dd00d424_terseLabel_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts owed to former licensor</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_label_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:label id="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_documentation_en-US" xlink:label="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Restricted Investments Owed to Former Licensees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:to="lab_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_1670dc5c-2dca-4221-af35-61380156b1e8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_09832c36-128a-4123-8b65-6fb054f9e433_terseLabel_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_label_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi [Member]</link:label>
    <link:label id="lab_lgnd_SelexisAndDianomiMember_documentation_en-US" xlink:label="lab_lgnd_SelexisAndDianomiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selexis and Dianomi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember" xlink:href="lgnd-20220331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_SelexisAndDianomiMember" xlink:to="lab_lgnd_SelexisAndDianomiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostDirectMaterial_dec62224-529b-40e3-abee-dfd9bb46cf0c_terseLabel_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Captisol</link:label>
    <link:label id="lab_us-gaap_CostDirectMaterial_label_en-US" xlink:label="lab_us-gaap_CostDirectMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Direct Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostDirectMaterial" xlink:to="lab_us-gaap_CostDirectMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_2bab98b3-d939-4434-9490-d1d3ca0617a0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_63eeb161-f028-4e51-8150-771daeceb298_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_535f7e06-c715-4cac-ad7f-73a2a5dd8274_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_9d190447-2962-4c7e-a77c-10f41a59984f_negatedLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss adjustments of finite-lived intangible assets</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets, Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:href="lgnd-20220331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5b03f9d7-df21-47e9-8981-bb8eb41a586b_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise price (USD per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_0ffebeeb-c248-4665-95bf-0d3dde573207_terseLabel_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_label_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business Segment [Member]</link:label>
    <link:label id="lab_lgnd_LigandCoreBusinessSegmentMember_documentation_en-US" xlink:label="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ligand Core Business Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember" xlink:href="lgnd-20220331.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_LigandCoreBusinessSegmentMember" xlink:to="lab_lgnd_LigandCoreBusinessSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_cd710eff-7e00-4f21-8121-7c5bd9947418_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c79ce3bb-3230-4c82-b974-fbab867110c6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_5ba9abd2-e600-4885-8f59-8d9d629fd6f7_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_36b253ed-9335-4539-a90e-c4a672596ab1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of positions in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_f6bdaa67-d377-4a80-ba16-89c217be0df1_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_46db0ecc-0d1e-4e94-996a-b2ca54a58610_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total goodwill and other identifiable intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Including Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetIncludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_45a8ead6-4570-41f3-a95d-bbd20d887506_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MilestoneMember_0757eaed-e059-4eb1-a316-85bdd75d2da8_terseLabel_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:label id="lab_lgnd_MilestoneMember_label_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone [Member]</link:label>
    <link:label id="lab_lgnd_MilestoneMember_documentation_en-US" xlink:label="lab_lgnd_MilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember" xlink:href="lgnd-20220331.xsd#lgnd_MilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MilestoneMember" xlink:to="lab_lgnd_MilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a947c8b1-7d89-41e7-a8ad-259fe6ae1779_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3858dd8d-5680-4e02-b171-ffb366893b7b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of computation of basic and diluted net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_0254c35e-df74-42ea-895f-2b7843b266b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_df57d30d-8ec1-4607-ba21-05944a43e7a1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mark-to-market adjustment of CVR liability</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueAdjustment" xlink:to="lab_us-gaap_LiabilitiesFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4d25fee2-8401-433b-a5cc-1f6022d5766d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_f6f278b7-ca2c-4d68-9b55-b435431cdd7e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_23d274da-47b4-4c39-8a56-7c2b3c3ddbc6_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_c01e11aa-5020-489b-ad4e-276f2d359c12_terseLabel_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum threshold of debt trading price trigger (as a percent)</link:label>
    <link:label id="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_label_en-US" xlink:label="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:href="lgnd-20220331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:to="lab_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_81b263c2-ccb5-48c1-94e6-1962d57c49b1_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium on investments, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_d40271f9-cfa2-4754-8237-7d8847a459ed_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3c6cd442-02dd-4feb-81a1-137a270d480b_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_792cd514-0f65-47f1-b2bf-884822b31191_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d392bde-3123-457d-a7bd-610f6f5201bf_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_09647c01-ad27-40f8-9dfb-c7c200469eda_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_1c98a597-2316-4c5d-b41c-fb261aa032ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_ec8d5301-7c97-4318-b698-c880724262e8_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_02e8ea14-b3cd-408b-ac55-82ded9b4bd69_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses related to available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_465c0bf4-c6c1-4dac-bc00-af255d15015c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a3971654-11e8-444f-97ae-3ef0d149724d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3d606f15-783d-45cd-971f-ed5d9a9f50d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_147b2d35-58bd-40a5-994b-e73f44466a07_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_d620d653-8510-42e4-a47c-3a6698ec648b_netLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_a68ca854-51b4-4327-adf4-5de12f369a5f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to convertible bond holders for warrant purchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForHedgeFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Hedge, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForHedgeFinancingActivities" xlink:to="lab_us-gaap_PaymentsForHedgeFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_094ef697-e24a-4c98-ab43-1e557221543a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_50104848-f16a-4870-b774-ce2762a61cb0_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_11e9e9fa-cf10-4bcc-8eb1-6aa2cac80cb4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_b0b95336-98c1-4db0-a073-702b2528565f_terseLabel_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023 Convertible Senior Notes</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_label_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023 [Member]</link:label>
    <link:label id="lab_lgnd_ConvertibleSeniorNotesDue2023Member_documentation_en-US" xlink:label="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:href="lgnd-20220331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:to="lab_lgnd_ConvertibleSeniorNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_62196836-6bad-42ae-b8e0-fafa353069a2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in diluted per share calculations (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a4ee69a8-6cd4-4567-9e02-a15498d05f7f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_4ef76bfa-ae83-412e-949e-450baf94ffcf_terseLabel_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_lgnd_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EmployeeStockPurchasePlanMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:href="lgnd-20220331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_EmployeeStockPurchasePlanMember" xlink:to="lab_lgnd_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_58c065ea-bd39-4833-ba37-fa68413f7e8a_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_9fc30d79-6839-4a07-b50a-3b547f4682bd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_c62c3d86-e1a5-41ff-92b0-4366575803cb_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_1cb4232b-acfe-4447-bf13-da630e708bff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period for awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_a246e9fb-d297-4dcd-95e4-bd5cef41f11a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3511414a-3f29-4866-9d18-179b572055d2_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DemandDepositsMember_7aa6c48d-89d0-463a-a459-e1d933636ac5_terseLabel_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank deposits</link:label>
    <link:label id="lab_us-gaap_DemandDepositsMember_label_en-US" xlink:label="lab_us-gaap_DemandDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Demand Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DemandDepositsMember" xlink:to="lab_us-gaap_DemandDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_6c3d1ced-d61e-4a08-ae9e-cbd01a801cf5_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_bda3c9e7-f205-4403-af3d-d8d06e25f16c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_23836ecc-9e22-4686-8d4d-950b9afe1da2_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_0ebe0caf-4db7-4393-9c0d-a32ba80ca4ad_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reacquisition of equity due to 2023 debt extinguishment, net of tax</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_e26dc6db-268d-42f2-bc30-998338b88a70_terseLabel_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_label_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service [Member]</link:label>
    <link:label id="lab_lgnd_ContractRevenueServiceMember_documentation_en-US" xlink:label="lab_lgnd_ContractRevenueServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Revenue, Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_ContractRevenueServiceMember" xlink:to="lab_lgnd_ContractRevenueServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_02468af8-bc67-44da-a9f6-b685881ab9e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for equity method investment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_f59616c5-8351-4663-925b-fb10f3eab414_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_1e5259b9-3a7d-4d66-a11a-08260ff7363c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_faf28694-8407-4718-842a-3b3f13095c5d_verboseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_7b04a9f0-5821-4233-9728-f3ae98d625a9_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_b58b7707-88c5-4a62-a53e-e74d04e1342c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_23524042-44ee-40d8-b022-2190457dc9ce_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6857b931-12ee-40ed-a288-15e957bcee1b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_6f81ccd1-6059-4e52-bd56-8c50e27fce52_negatedLabel_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) from short-term investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_label_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:label id="lab_lgnd_GainLossOnShortTermInvestments_documentation_en-US" xlink:label="lab_lgnd_GainLossOnShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments" xlink:href="lgnd-20220331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_GainLossOnShortTermInvestments" xlink:to="lab_lgnd_GainLossOnShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_7dc2bb65-7590-4859-9809-d88816826a60_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f494741d-b71b-4062-b9bc-7ed420024f51_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_869e0526-e9c2-42d4-b6a6-5f1deb506a08_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SBC - General and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_664ef1b3-cde2-4f75-9b7f-20a1534e82be_terseLabel_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_label_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix [Member]</link:label>
    <link:label id="lab_lgnd_AziyoAndCorMatrixMember_documentation_en-US" xlink:label="lab_lgnd_AziyoAndCorMatrixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aziyo and CorMatrix</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember" xlink:href="lgnd-20220331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_AziyoAndCorMatrixMember" xlink:to="lab_lgnd_AziyoAndCorMatrixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_fb37cbcd-dcb7-4cdd-a24f-86356ff67679_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_20d12602-5058-4f49-8f03-703f27175ad7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_27f96dd4-4bf0-47b3-8d96-a88ff76acbae_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_51ed92c2-5cc7-4c08-abc8-61f5048a6f8c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_f9fb047b-88e1-4464-a746-8bd898e3fb8d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_6051ba08-3189-4274-af85-21b19e38b45d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2d5aa48f-6eba-4bf0-92c3-9ba889410576_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_6bba3ff4-43a8-40c1-99da-ad85ebe48fa3_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_c35f2704-ee5b-4c37-a29c-660d49a207b0_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual fund</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e6cee528-4597-4b6f-94cc-ed034ab86352_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_1618952d-af2a-46ee-9dd8-2ea3c9593eae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6143c679-63b2-4e79-a2b4-0bfdf9a39fcb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Updates, Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_0c7a5a98-0b74-41ab-8b2b-3798daf2c7ae_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive potential common shares:</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract" xlink:to="lab_us-gaap_DilutiveSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_945e2322-17b7-4680-bf3f-79984aa3a03c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_fd2fa564-e437-4f92-b81e-8f43295edded_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of civil complaints filed against entity</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9d0c12ff-0f14-4b7c-9bd2-5a3672b28d59_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_e0020465-aad2-4a41-be9e-d5b6c8a1e254_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_6502e27e-8159-458b-920e-9aed52b15d3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized discount (including unamortized debt issuance cost)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_e1c9ea56-cdc0-4ae2-af4a-17abd498efef_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_8253b236-d1d2-44ac-b3ec-7089a4bf305b_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b45f9763-9ac1-4fc6-8f1c-65e0ae8e50ba_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_55b3de53-245d-41b8-84fb-05fce9de2529_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_452afc2a-1876-4d04-999b-94e726f26515_terseLabel_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liabilities from xCella asset acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_label_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:label id="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_documentation_en-US" xlink:label="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:href="lgnd-20220331.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:to="lab_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_feb3fea0-81e7-4332-811b-0545a353c921_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes liability</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_987c16c8-81e7-4eed-aff0-71b82d97e1b5_terseLabel_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest portion of repurchased amount of debt instrument</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_label_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:label id="lab_lgnd_RepaymentsOfNotesPayableInterestPortion_documentation_en-US" xlink:label="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments Of Notes Payable, Interest Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:href="lgnd-20220331.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:to="lab_lgnd_RepaymentsOfNotesPayableInterestPortion" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_59691780-bcd5-4cc3-94cb-c1e1181cf8dd_terseLabel_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Captisol - COVID</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_label_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID [Member]</link:label>
    <link:label id="lab_lgnd_MaterialSalesCaptisolCOVIDMember_documentation_en-US" xlink:label="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Sales, Captisol, COVID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:to="lab_lgnd_MaterialSalesCaptisolCOVIDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_4aa0a274-7dd0-40d4-a221-ef54d44a64dc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_b3d63374-041c-4c61-81d9-c9d1c58d8ea0_terseLabel_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_label_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio [Member]</link:label>
    <link:label id="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_documentation_en-US" xlink:label="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US District Court for the Northern District of Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:href="lgnd-20220331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:to="lab_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_9a58d650-84fd-44d9-98bb-2558453a9328_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_69b67788-a21c-47ce-880e-3cf15a45b578_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income (loss) to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_2f5187bc-53d3-4917-9593-e73070ed53b1_negatedTerseLabel_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_label_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:label id="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_documentation_en-US" xlink:label="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:href="lgnd-20220331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:to="lab_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_bcf04bf7-06c8-46ff-8a61-105b58d774d7_totalLabel_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term investments</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_label_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:label id="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_documentation_en-US" xlink:label="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:href="lgnd-20220331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:to="lab_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_4a584e65-9067-442e-ad0c-21f6a3d6cd82_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ff06f717-9d58-4606-9fa8-15723de31e5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_3d8ce449-28d6-4e62-b347-c33cca66c930_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair-Value Options Awarded to Employees and Directors</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lgnd-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:63142b59-d50f-422e-a0a8-23b5f0c0b9ee,g:55f2a22c-b472-424e-aeed-2ce3b4861db0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ligand.com/role/Cover" xlink:type="simple" xlink:href="lgnd-20220331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_eed14d08-17e2-4643-b2b7-b1b11c5264cc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_DocumentType_eed14d08-17e2-4643-b2b7-b1b11c5264cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_fbd668fe-a25c-4d5f-9827-c67a97db954b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_DocumentQuarterlyReport_fbd668fe-a25c-4d5f-9827-c67a97db954b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7d02c48b-141d-4449-be5f-34a0898731f6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_DocumentPeriodEndDate_7d02c48b-141d-4449-be5f-34a0898731f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_7086619e-14f5-4e65-8f69-8eb5e660ac3c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_DocumentTransitionReport_7086619e-14f5-4e65-8f69-8eb5e660ac3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_22e5397c-1b6b-4990-a963-35974af4600c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityFileNumber_22e5397c-1b6b-4990-a963-35974af4600c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_bf1411dc-2d93-4831-a387-fe44ff332ed2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityRegistrantName_bf1411dc-2d93-4831-a387-fe44ff332ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_73e2dd0b-9698-4169-b5fe-9aa4dbf3864b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_73e2dd0b-9698-4169-b5fe-9aa4dbf3864b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_e36cde6e-b34a-4515-bdba-1e352b469d2d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityTaxIdentificationNumber_e36cde6e-b34a-4515-bdba-1e352b469d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_799bd29b-e3f3-401d-a9f8-3699100a1600" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityAddressAddressLine1_799bd29b-e3f3-401d-a9f8-3699100a1600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b69632d8-86e2-46d1-8bd2-588334c18d1a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityAddressCityOrTown_b69632d8-86e2-46d1-8bd2-588334c18d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c2622847-6687-4a4e-a9ea-0ce9d78df80c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityAddressStateOrProvince_c2622847-6687-4a4e-a9ea-0ce9d78df80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e07fd35c-4be2-4d1a-a915-ac0fbc8b0bdd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityAddressPostalZipCode_e07fd35c-4be2-4d1a-a915-ac0fbc8b0bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b8ac1568-4086-46ac-9dc8-54fcf7268543" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_CityAreaCode_b8ac1568-4086-46ac-9dc8-54fcf7268543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3409299c-afdd-4ee0-bd84-151758908541" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_LocalPhoneNumber_3409299c-afdd-4ee0-bd84-151758908541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_29f080c6-baa8-4d58-91d5-0c43eb772d46" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_Security12bTitle_29f080c6-baa8-4d58-91d5-0c43eb772d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1218dba2-49d3-43fb-ba63-936d0e4c561a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_TradingSymbol_1218dba2-49d3-43fb-ba63-936d0e4c561a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_6173f2c9-db05-419b-afde-54ed22e2ca55" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_SecurityExchangeName_6173f2c9-db05-419b-afde-54ed22e2ca55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_87d301ea-c730-47e8-94ea-2b1d241f61ee" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityCurrentReportingStatus_87d301ea-c730-47e8-94ea-2b1d241f61ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ca86fb8c-1e8e-49d3-bb01-eee6c88f082f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityInteractiveDataCurrent_ca86fb8c-1e8e-49d3-bb01-eee6c88f082f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_89133e32-7e41-4a6d-ad36-213441a08aa4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityFilerCategory_89133e32-7e41-4a6d-ad36-213441a08aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_4bb86c96-7643-48aa-b0ad-702ee356062f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntitySmallBusiness_4bb86c96-7643-48aa-b0ad-702ee356062f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_50cb23c0-b7bb-45c6-b148-1b797ad89c6a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityEmergingGrowthCompany_50cb23c0-b7bb-45c6-b148-1b797ad89c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_10dc8830-fafd-4738-a4ea-277947b22626" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityShellCompany_10dc8830-fafd-4738-a4ea-277947b22626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_072dda2d-164f-4b45-a4f8-32b95fc6873c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_072dda2d-164f-4b45-a4f8-32b95fc6873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4bf10493-5d34-40a2-94d4-759d45d68e16" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_AmendmentFlag_4bf10493-5d34-40a2-94d4-759d45d68e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_dc90597d-229d-46e4-a8b3-a0c1bd39c2c6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_DocumentFiscalYearFocus_dc90597d-229d-46e4-a8b3-a0c1bd39c2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_30891b0b-7421-4d0c-b1a0-2ab3aadbd300" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_30891b0b-7421-4d0c-b1a0-2ab3aadbd300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d4c8fdd8-039a-4cd9-907e-8fa21a12dc3f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_EntityCentralIndexKey_d4c8fdd8-039a-4cd9-907e-8fa21a12dc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_b4f38a4f-076b-4dc8-a5ac-a20574bcf88d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_14df3d43-e3a6-4e89-80e8-02ba62dd3b6f" xlink:to="loc_dei_CurrentFiscalYearEndDate_b4f38a4f-076b-4dc8-a5ac-a20574bcf88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6a1d66b5-5e98-4bdc-b126-0c1a62e30da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a1d66b5-5e98-4bdc-b126-0c1a62e30da8" xlink:to="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29edb4f2-9241-4394-9780-0cde824c0a24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29edb4f2-9241-4394-9780-0cde824c0a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_470dd5f1-30ea-4b3a-9448-aa09998db7be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:to="loc_us-gaap_ShortTermInvestments_470dd5f1-30ea-4b3a-9448-aa09998db7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_45078849-48bc-4828-a74e-e11c8be56f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_45078849-48bc-4828-a74e-e11c8be56f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f54b4a7e-023d-4523-bacd-44e6bde6922d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:to="loc_us-gaap_InventoryNet_f54b4a7e-023d-4523-bacd-44e6bde6922d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_351b0361-7d69-412e-a41e-4daab438712c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:to="loc_us-gaap_IncomeTaxesReceivable_351b0361-7d69-412e-a41e-4daab438712c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_a3d9462f-9587-445d-9329-99de4477a03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:to="loc_us-gaap_OtherAssetsCurrent_a3d9462f-9587-445d-9329-99de4477a03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_39b9cddb-92c5-4888-8913-23afd67c9d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_94ef8773-fe35-4694-8462-5ebcc6b323b0" xlink:to="loc_us-gaap_AssetsCurrent_39b9cddb-92c5-4888-8913-23afd67c9d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_016d9f1c-1bcb-4bae-926b-dcd7e5b70c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_016d9f1c-1bcb-4bae-926b-dcd7e5b70c9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_419ae82a-48f2-4f67-b7fa-ad9c10b49c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_419ae82a-48f2-4f67-b7fa-ad9c10b49c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3d1ea38c-3acc-4d26-a1f5-6998cfebac91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_Goodwill_3d1ea38c-3acc-4d26-a1f5-6998cfebac91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRights_08789b01-34a6-44d8-a322-ce5bfbcb48f2" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_lgnd_CommercialLicenseRights_08789b01-34a6-44d8-a322-ce5bfbcb48f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c33be076-fb48-4088-aef9-bcccec510af1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_c33be076-fb48-4088-aef9-bcccec510af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_3784708f-7476-4134-9f23-181e29599c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_3784708f-7476-4134-9f23-181e29599c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_daf4102d-3b83-4fa8-a7e5-f66327f32108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_daf4102d-3b83-4fa8-a7e5-f66327f32108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_989beacb-3900-452d-bfb6-d0bc06013398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_989beacb-3900-452d-bfb6-d0bc06013398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_556e6817-56b5-4578-a9f7-47d5887390a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_ddeac0f4-a711-49ef-b3f8-f46aba884023" xlink:to="loc_us-gaap_Assets_556e6817-56b5-4578-a9f7-47d5887390a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6a1d66b5-5e98-4bdc-b126-0c1a62e30da8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2cc8fae7-51c9-4e7a-8c2e-88cb26467a66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_us-gaap_AccountsPayableCurrent_2cc8fae7-51c9-4e7a-8c2e-88cb26467a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b2f47711-8313-4018-adc4-9ab8fe415d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b2f47711-8313-4018-adc4-9ab8fe415d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_56747e51-a719-4b0c-9972-f9e196eb3165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_56747e51-a719-4b0c-9972-f9e196eb3165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_0225f9ca-b2ad-480b-82cc-b03f510ca8a1" xlink:href="lgnd-20220331.xsd#lgnd_CurrentPortionOfLiabilityForContingentValueRights"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_lgnd_CurrentPortionOfLiabilityForContingentValueRights_0225f9ca-b2ad-480b-82cc-b03f510ca8a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f82155e0-7ee7-40b7-aac2-128bfb69b301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f82155e0-7ee7-40b7-aac2-128bfb69b301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2d1d6617-1443-402a-b018-7cc912a05390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2d1d6617-1443-402a-b018-7cc912a05390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1afec1b6-43bd-47cf-a979-eac5bf3f6593" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1afec1b6-43bd-47cf-a979-eac5bf3f6593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d01edbad-a45c-4a90-86fb-dff3706431c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b1a267a9-0c00-4add-80ce-90249879d27b" xlink:to="loc_us-gaap_LiabilitiesCurrent_d01edbad-a45c-4a90-86fb-dff3706431c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_301a1d6e-bf6e-46c5-ba6d-3db68d480e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_301a1d6e-bf6e-46c5-ba6d-3db68d480e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRights_044b9a39-98f6-4644-9a79-e109a6554534" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_lgnd_LiabilityForContingentValueRights_044b9a39-98f6-4644-9a79-e109a6554534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_50aad2ed-f44c-4a99-b992-ffcca4b0ef2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_50aad2ed-f44c-4a99-b992-ffcca4b0ef2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d5425372-87f6-4c74-abcd-3bb73df6b565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d5425372-87f6-4c74-abcd-3bb73df6b565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_eb36c680-4796-470b-ae17-170b126e79ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_eb36c680-4796-470b-ae17-170b126e79ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_54a724f7-a46c-4c71-92fc-c9f1b2192510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_Liabilities_54a724f7-a46c-4c71-92fc-c9f1b2192510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7c1bf727-e0a7-4cea-8ad3-dff002a29015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7c1bf727-e0a7-4cea-8ad3-dff002a29015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f966a789-0668-4de8-948f-70b8bf3fa031" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:to="loc_us-gaap_PreferredStockValue_f966a789-0668-4de8-948f-70b8bf3fa031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_63e62710-a8fb-4195-899a-7840e1b118a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:to="loc_us-gaap_CommonStockValue_63e62710-a8fb-4195-899a-7840e1b118a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_dfcbf8c0-4b55-4bcc-9e3a-d7038f1f3368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_dfcbf8c0-4b55-4bcc-9e3a-d7038f1f3368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_40b61796-6a65-434a-8289-72a89de1c795" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_40b61796-6a65-434a-8289-72a89de1c795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cff25f1c-d433-489d-a3dd-43bf01cacca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cff25f1c-d433-489d-a3dd-43bf01cacca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_80be5463-ba72-41a0-8361-6388815065d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_84d94965-dbd0-46c1-aae0-fd7e52c4fd0c" xlink:to="loc_us-gaap_StockholdersEquity_80be5463-ba72-41a0-8361-6388815065d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8309f3b5-9bab-4f00-8ffe-4690f4ac96af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d01594cf-182a-4a41-b3d1-0c70373cc87d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8309f3b5-9bab-4f00-8ffe-4690f4ac96af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_21624200-99c9-408a-a234-bfb07ae4c321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_21624200-99c9-408a-a234-bfb07ae4c321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_443e6c65-0e21-48db-9091-08ed3e0a89d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_443e6c65-0e21-48db-9091-08ed3e0a89d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_566f7c36-ed73-4b03-a661-d7a676afe331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_PreferredStockSharesIssued_566f7c36-ed73-4b03-a661-d7a676afe331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_49ee46ba-e651-41ed-beaa-6852b15337b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_49ee46ba-e651-41ed-beaa-6852b15337b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_6ac3f27a-1bac-46d6-9e4a-6761a1ca5a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_6ac3f27a-1bac-46d6-9e4a-6761a1ca5a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_f06d0a00-d34f-4dce-ad27-902d8439c69d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_f06d0a00-d34f-4dce-ad27-902d8439c69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d7de96bd-e9d7-4458-98a1-d09bd9efd00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_CommonStockSharesIssued_d7de96bd-e9d7-4458-98a1-d09bd9efd00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bd1f7a36-20ea-4f31-a278-ec47fb62536e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2d273f08-bae2-40c6-9dcb-615b2b97e68b" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bd1f7a36-20ea-4f31-a278-ec47fb62536e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_cdaa43c4-7e4f-42be-a6ee-38c88dc16406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e0de58ab-2889-4d1c-9142-b76656f882e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_cdaa43c4-7e4f-42be-a6ee-38c88dc16406" xlink:to="loc_us-gaap_StatementTable_e0de58ab-2889-4d1c-9142-b76656f882e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b4c6ac2d-b337-4a9d-a742-4bd4559eff04" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e0de58ab-2889-4d1c-9142-b76656f882e4" xlink:to="loc_srt_ProductOrServiceAxis_b4c6ac2d-b337-4a9d-a742-4bd4559eff04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b4c6ac2d-b337-4a9d-a742-4bd4559eff04" xlink:to="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_d4e5b63e-88c3-4d84-8cae-c5a6d55b1a12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:to="loc_us-gaap_RoyaltyMember_d4e5b63e-88c3-4d84-8cae-c5a6d55b1a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_b88535b3-e12b-43ce-9e93-7f5f89a00584" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_b88535b3-e12b-43ce-9e93-7f5f89a00584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_b3f9d445-c945-44f7-a066-30b07c073400" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_7563b380-c8b8-420e-a465-c4c0a744e3dc" xlink:to="loc_lgnd_ContractRevenueMember_b3f9d445-c945-44f7-a066-30b07c073400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e0de58ab-2889-4d1c-9142-b76656f882e4" xlink:to="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_4f19aaa7-d045-4899-bcae-87912e673ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_RevenuesAbstract_4f19aaa7-d045-4899-bcae-87912e673ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0a65841-d4d0-44e9-be17-a366105bb23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_4f19aaa7-d045-4899-bcae-87912e673ad4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0a65841-d4d0-44e9-be17-a366105bb23a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostDirectMaterial_b1cc62af-48b8-4803-b08c-90b0a0dd37df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostDirectMaterial"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_CostDirectMaterial_b1cc62af-48b8-4803-b08c-90b0a0dd37df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_0cf504a7-18c4-4a1a-8f45-1ca3fba29e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_0cf504a7-18c4-4a1a-8f45-1ca3fba29e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d50f38b6-68fe-4242-8412-511afaea9f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d50f38b6-68fe-4242-8412-511afaea9f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_88d2614e-192e-4795-8ee3-845757f7801b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_88d2614e-192e-4795-8ee3-845757f7801b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_436e4af5-8926-4a7c-abb6-b135664dbbc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_b0d74be3-2853-4b31-874e-8539462cd2e2" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_436e4af5-8926-4a7c-abb6-b135664dbbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_74bd06b1-7a59-4427-893b-92c03836e67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_OperatingIncomeLoss_74bd06b1-7a59-4427-893b-92c03836e67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_b5e82e29-b1f1-4c96-879a-a451086141c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_GainLossOnInvestments_b5e82e29-b1f1-4c96-879a-a451086141c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9e7d88fa-a40a-414e-b0f6-80ce308ad42d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9e7d88fa-a40a-414e-b0f6-80ce308ad42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_aaadab8d-ca4c-4540-b99e-57550b84415a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_InterestExpense_aaadab8d-ca4c-4540-b99e-57550b84415a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6b23e9f3-fe92-4c56-9c61-6ef2620938e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6b23e9f3-fe92-4c56-9c61-6ef2620938e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_6c5f9581-1202-4bd0-bca2-aff01c568c8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_6b519aae-f21b-4967-8c6f-cad340d5d6e6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_6c5f9581-1202-4bd0-bca2-aff01c568c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73dce3bb-f34a-46cb-9738-05c439191cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_73dce3bb-f34a-46cb-9738-05c439191cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b769d297-e527-41ea-a14b-12f30cf34b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b769d297-e527-41ea-a14b-12f30cf34b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0014dffc-d25a-4574-90ad-f7a0f1fa95e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_NetIncomeLoss_0014dffc-d25a-4574-90ad-f7a0f1fa95e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_234d23f7-d983-4dd6-ba87-d7c7d946ed97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_EarningsPerShareBasic_234d23f7-d983-4dd6-ba87-d7c7d946ed97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e0ec525d-d384-4b7b-a60e-c7a2371b4ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e0ec525d-d384-4b7b-a60e-c7a2371b4ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9f0e2197-be46-47ec-87db-e0d9a26043c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9f0e2197-be46-47ec-87db-e0d9a26043c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d03bd0c-8999-441d-8c11-c9a27d01caa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_91985b28-45c9-4bf0-afeb-aca45c257a0f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1d03bd0c-8999-441d-8c11-c9a27d01caa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bd96a5df-2685-4fe6-b6c6-89e1b9376ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5dbec3ed-54af-4807-a012-164f1923cab1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bd96a5df-2685-4fe6-b6c6-89e1b9376ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8aaa72e8-38a5-4bab-8efa-52e1f1759633" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2a1d673-fa2a-49a8-ba3d-cc0d70cae1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8aaa72e8-38a5-4bab-8efa-52e1f1759633" xlink:to="loc_us-gaap_NetIncomeLoss_c2a1d673-fa2a-49a8-ba3d-cc0d70cae1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3c4d7215-00f2-4001-b4fa-d31f8990c0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8aaa72e8-38a5-4bab-8efa-52e1f1759633" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3c4d7215-00f2-4001-b4fa-d31f8990c0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5d39b1b4-43f7-46ce-b6b6-715602e174a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_8aaa72e8-38a5-4bab-8efa-52e1f1759633" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_5d39b1b4-43f7-46ce-b6b6-715602e174a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_49550262-9ebb-4818-abf6-db63f65ba82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_49550262-9ebb-4818-abf6-db63f65ba82f" xlink:to="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7d83f884-631c-49d7-9b7a-8393e174e39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7d83f884-631c-49d7-9b7a-8393e174e39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7d83f884-631c-49d7-9b7a-8393e174e39d" xlink:to="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6fa4faff-3a57-41b3-bed5-d4753c859199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_CommonStockMember_6fa4faff-3a57-41b3-bed5-d4753c859199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_dc988484-8a7b-4be3-9add-e0a86401e39e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_dc988484-8a7b-4be3-9add-e0a86401e39e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_54659128-a731-4ad8-8595-f4b94d88e3c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_54659128-a731-4ad8-8595-f4b94d88e3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3a49e689-b9f5-4d1e-98bd-3cd3ed95115e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_be9d65f0-46b1-48ee-880e-e0eade12e793" xlink:to="loc_us-gaap_RetainedEarningsMember_3a49e689-b9f5-4d1e-98bd-3cd3ed95115e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eed61c10-2f7f-4fda-977a-9b270e5111fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eed61c10-2f7f-4fda-977a-9b270e5111fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_850088a5-5f09-46b4-8b90-9afcfa7c6779" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_eed61c10-2f7f-4fda-977a-9b270e5111fc" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_850088a5-5f09-46b4-8b90-9afcfa7c6779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a3ab8a1d-1a12-4f80-b715-8b68234333d1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_850088a5-5f09-46b4-8b90-9afcfa7c6779" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_a3ab8a1d-1a12-4f80-b715-8b68234333d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3372a257-6df9-406d-b93b-d2ce6c73d301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_999115e3-95ea-4ab3-a20a-469259de5276" xlink:to="loc_us-gaap_StatementLineItems_3372a257-6df9-406d-b93b-d2ce6c73d301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3372a257-6df9-406d-b93b-d2ce6c73d301" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f0837d6f-cb0a-489c-b273-bb08688eef9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_SharesIssued_f0837d6f-cb0a-489c-b273-bb08688eef9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_93288998-9a5d-4ad1-ab95-a30b5496c37e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_StockholdersEquity_93288998-9a5d-4ad1-ab95-a30b5496c37e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8c7577fc-71a7-453b-8932-8a08a0706df6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_8c7577fc-71a7-453b-8932-8a08a0706df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f0110f3-bc7e-40d4-bf18-5dabe5a64b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1f0110f3-bc7e-40d4-bf18-5dabe5a64b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3ebbd71d-4e2a-40ae-95f0-e7c601144947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3ebbd71d-4e2a-40ae-95f0-e7c601144947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f8ff7a6b-b9bd-402f-85f1-2d8354f5e13a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f8ff7a6b-b9bd-402f-85f1-2d8354f5e13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_d727a928-a4d8-4f24-8510-ebadd6dd8ab7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_d727a928-a4d8-4f24-8510-ebadd6dd8ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_58c26797-8ddb-4c6b-8cd4-4eea22ce6e71" xlink:href="lgnd-20220331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions_58c26797-8ddb-4c6b-8cd4-4eea22ce6e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_499aff47-21b5-48be-a6d7-023b03ca77fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt_499aff47-21b5-48be-a6d7-023b03ca77fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_1da9b2f5-0deb-4caa-a06b-3eab780a793f" xlink:href="lgnd-20220331.xsd#lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions_1da9b2f5-0deb-4caa-a06b-3eab780a793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f3a99a48-6feb-4e2a-a7fd-09e02a2a1f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_NetIncomeLoss_f3a99a48-6feb-4e2a-a7fd-09e02a2a1f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_ffdf5e2e-a2e6-4cab-88f0-2038ff4ba94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_SharesIssued_ffdf5e2e-a2e6-4cab-88f0-2038ff4ba94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_765b1c8d-e315-4de8-a91b-9fa77cbc7e12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ac746288-dfb3-4ce1-9de6-89fadc5cc522" xlink:to="loc_us-gaap_StockholdersEquity_765b1c8d-e315-4de8-a91b-9fa77cbc7e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b82d2ef7-bb23-4429-a9df-60d22ef0a07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b82d2ef7-bb23-4429-a9df-60d22ef0a07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c08610f3-6fa9-475b-9d36-c941440c2b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b82d2ef7-bb23-4429-a9df-60d22ef0a07b" xlink:to="loc_us-gaap_ProfitLoss_c08610f3-6fa9-475b-9d36-c941440c2b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b82d2ef7-bb23-4429-a9df-60d22ef0a07b" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_882d1628-fcb2-421a-ba46-b01c79676e91" xlink:href="lgnd-20220331.xsd#lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights_882d1628-fcb2-421a-ba46-b01c79676e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_199cee38-663f-4dc2-b3b9-a1dcf1285e48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_199cee38-663f-4dc2-b3b9-a1dcf1285e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b3dc74bb-fd31-4876-ab4f-9f92e2641a86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b3dc74bb-fd31-4876-ab4f-9f92e2641a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b4885c55-9cc5-4e5f-aae0-8a280d2277a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b4885c55-9cc5-4e5f-aae0-8a280d2277a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_f7185f1e-ba91-453c-8a33-648788752cd1" xlink:href="lgnd-20220331.xsd#lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights_f7185f1e-ba91-453c-8a33-648788752cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e3a9de8-a1ea-4c13-b15b-cd689c44054f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e3a9de8-a1ea-4c13-b15b-cd689c44054f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f343a261-ab88-4c09-a0a4-3795042b6aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_us-gaap_ShareBasedCompensation_f343a261-ab88-4c09-a0a4-3795042b6aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f94387c9-26c5-49c1-97a9-30118d925283" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_f94387c9-26c5-49c1-97a9-30118d925283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_GainLossOnShortTermInvestments_6a140f21-71f2-42a5-abf3-f74b274bf1ad" xlink:href="lgnd-20220331.xsd#lgnd_GainLossOnShortTermInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_lgnd_GainLossOnShortTermInvestments_6a140f21-71f2-42a5-abf3-f74b274bf1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_15c0534b-ef7e-43e1-8131-b06470785849" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_31ab6f4d-83f3-4078-b624-0ae8d0bcc923" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_15c0534b-ef7e-43e1-8131-b06470785849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b82d2ef7-bb23-4429-a9df-60d22ef0a07b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_343fe5e9-eeb8-4844-a2f1-8b476bb2b355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_343fe5e9-eeb8-4844-a2f1-8b476bb2b355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_35f004a3-52c1-44fd-92f4-03d4a990a51d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_35f004a3-52c1-44fd-92f4-03d4a990a51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_cdd9819b-8d8a-4517-ad6b-1dc32b7dee3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_cdd9819b-8d8a-4517-ad6b-1dc32b7dee3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_50c286ac-f8e7-4d32-a659-c8c7b2238c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_50c286ac-f8e7-4d32-a659-c8c7b2238c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b51aaeed-8839-4424-bf89-5eac8cb72bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b51aaeed-8839-4424-bf89-5eac8cb72bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d3d10a7b-3845-4c57-8bdb-3a8325ecd08c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_1ee8652a-63cc-40ea-842c-6777ca4be417" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_d3d10a7b-3845-4c57-8bdb-3a8325ecd08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ac59995-9fbd-46fd-9c59-1fe84c8a8535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b82d2ef7-bb23-4429-a9df-60d22ef0a07b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2ac59995-9fbd-46fd-9c59-1fe84c8a8535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_8c5e3da0-ed3c-4b34-85be-141c25929bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_8c5e3da0-ed3c-4b34-85be-141c25929bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1f013418-691f-426a-8b6b-80df8525635e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:to="loc_us-gaap_ProceedsFromSaleOfShortTermInvestments_1f013418-691f-426a-8b6b-80df8525635e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_71ec4112-4ee2-4c09-bd07-0420eca5782b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_71ec4112-4ee2-4c09-bd07-0420eca5782b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7ffef8df-a57c-4bdc-8b13-5e11ab9e46d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_7ffef8df-a57c-4bdc-8b13-5e11ab9e46d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de836a9a-ff2f-4538-a604-0f4f99cc679d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de836a9a-ff2f-4538-a604-0f4f99cc679d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fac5d995-4bf6-4ffa-b94a-2bb7bb3bca43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fac5d995-4bf6-4ffa-b94a-2bb7bb3bca43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1211bff4-f1d1-4d1f-804e-19b88478bf09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_72556009-3a4e-44b2-a74d-1f018ad0b3e4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1211bff4-f1d1-4d1f-804e-19b88478bf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_279d61c2-1709-405f-9c98-31b30547f47a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_279d61c2-1709-405f-9c98-31b30547f47a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_ff84906b-5340-491b-ac75-13912952e420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_ff84906b-5340-491b-ac75-13912952e420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromHedgeFinancingActivities_721c3687-0cdc-42c9-a07b-f620f4e8c688" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromHedgeFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_ProceedsFromHedgeFinancingActivities_721c3687-0cdc-42c9-a07b-f620f4e8c688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForHedgeFinancingActivities_30dec8bd-e745-43e4-9e34-32a2f1e4b1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForHedgeFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_PaymentsForHedgeFinancingActivities_30dec8bd-e745-43e4-9e34-32a2f1e4b1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_fce4b496-d0b4-4549-bf6d-410e8cc92cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_fce4b496-d0b4-4549-bf6d-410e8cc92cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_28a4a7f7-0740-4701-8b86-da691cc9ed93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_28a4a7f7-0740-4701-8b86-da691cc9ed93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_9d9e7c7c-f754-49ec-8acb-5733397bce26" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToContingentValueRightHoldersFinancingActivity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity_9d9e7c7c-f754-49ec-8acb-5733397bce26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_339734a0-5309-424c-872b-6a01d1a2b256" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_339734a0-5309-424c-872b-6a01d1a2b256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_475fa9a0-3e92-4c6e-9fcb-9416c55b647b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1994f223-c047-42aa-89fc-0c90f1319419" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_475fa9a0-3e92-4c6e-9fcb-9416c55b647b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_69fd7366-fc6a-4101-811f-921ffcb6f959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_69fd7366-fc6a-4101-811f-921ffcb6f959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efb2bee3-5612-44ff-8289-0792462abdf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_efb2bee3-5612-44ff-8289-0792462abdf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ca74813-16d6-471a-834f-13a2ef47860e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6ca74813-16d6-471a-834f-13a2ef47860e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_5fad36cc-1d81-47d1-93b8-ff6d606c77f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_5fad36cc-1d81-47d1-93b8-ff6d606c77f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_30a9906c-5db4-4fd7-8cb0-deea6b8b69c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5fad36cc-1d81-47d1-93b8-ff6d606c77f0" xlink:to="loc_us-gaap_InterestPaidNet_30a9906c-5db4-4fd7-8cb0-deea6b8b69c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_ca0ee0aa-8caa-4edf-a876-4eb628a15b47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_5fad36cc-1d81-47d1-93b8-ff6d606c77f0" xlink:to="loc_us-gaap_IncomeTaxesPaid_ca0ee0aa-8caa-4edf-a876-4eb628a15b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_79e3b93f-d892-477a-b2aa-5dab13d1fa39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cc5bba85-94aa-47a2-bfc7-5c0d89eb8cd4" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_79e3b93f-d892-477a-b2aa-5dab13d1fa39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_cb68a023-91cd-4686-a042-11ccde26fdb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_79e3b93f-d892-477a-b2aa-5dab13d1fa39" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_cb68a023-91cd-4686-a042-11ccde26fdb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedInventoryPurchases_eb8da873-5801-46e8-9e90-325d7ac89fa4" xlink:href="lgnd-20220331.xsd#lgnd_AccruedInventoryPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_79e3b93f-d892-477a-b2aa-5dab13d1fa39" xlink:to="loc_lgnd_AccruedInventoryPurchases_eb8da873-5801-46e8-9e90-325d7ac89fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_0fef2d85-7bf6-40e3-874a-393e48288b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_79e3b93f-d892-477a-b2aa-5dab13d1fa39" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_0fef2d85-7bf6-40e3-874a-393e48288b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d381dd5-4753-4b6a-bdff-8243a3d63111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_89684992-24a3-4de6-bc24-e8601f070c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d381dd5-4753-4b6a-bdff-8243a3d63111" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_89684992-24a3-4de6-bc24-e8601f070c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f7e3aaf7-cc73-4b03-a718-35d4b73a14fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f7e3aaf7-cc73-4b03-a718-35d4b73a14fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_f06539d7-502f-4ab7-9272-ab967784e1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_UseOfEstimates_f06539d7-502f-4ab7-9272-ab967784e1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_700d1bfb-e9fb-41af-b59d-655e354d741a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_700d1bfb-e9fb-41af-b59d-655e354d741a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e4c3c5bc-1290-447d-a43a-df43d9131762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e4c3c5bc-1290-447d-a43a-df43d9131762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_755c7dd6-b4ee-4c5e-b354-7567e8bbbbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_755c7dd6-b4ee-4c5e-b354-7567e8bbbbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_bc60e96e-8b27-45c5-a3ba-05c829f24820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_bc60e96e-8b27-45c5-a3ba-05c829f24820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_7bc55b7c-0ef8-40a9-b4e1-1770d46cf889" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseRightsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_lgnd_CommercialLicenseRightsPolicyTextBlock_7bc55b7c-0ef8-40a9-b4e1-1770d46cf889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_69c0ff4f-6dff-4bdd-a688-041f8c8622e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_69c0ff4f-6dff-4bdd-a688-041f8c8622e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_cd6d4691-8d76-4778-af6e-345ae06f579e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6200e4f2-cdd9-4a65-ac87-49e1979d471c" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_cd6d4691-8d76-4778-af6e-345ae06f579e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ef1e33a9-7678-4e67-8a58-68d2bbd698d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_ef1e33a9-7678-4e67-8a58-68d2bbd698d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_3d2e23db-9c9e-47d7-b82b-f120635da33d" xlink:href="lgnd-20220331.xsd#lgnd_ScheduleOfShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock_3d2e23db-9c9e-47d7-b82b-f120635da33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_da2e9fb9-403f-4bd4-a008-90d59d5a5008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_da2e9fb9-403f-4bd4-a008-90d59d5a5008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_5ed0dd94-76dd-4e50-af92-599df0e0c84a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_5ed0dd94-76dd-4e50-af92-599df0e0c84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_9c358b14-67fa-441a-be22-71245ca0540e" xlink:href="lgnd-20220331.xsd#lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock_9c358b14-67fa-441a-be22-71245ca0540e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0d5e6147-3469-4b7f-b4ab-8bbe2f2a301c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_0d5e6147-3469-4b7f-b4ab-8bbe2f2a301c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_6013eba4-b6ea-48bc-b91b-a0b09e2daf2f" xlink:href="lgnd-20220331.xsd#lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock_6013eba4-b6ea-48bc-b91b-a0b09e2daf2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_56d4ff80-3825-4c84-93db-bd7569bb721f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_56d4ff80-3825-4c84-93db-bd7569bb721f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_130bfdb3-055e-4bfb-9249-e0555ffe1752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_752c69d4-22ac-4909-93d7-dac1bbcabc4e" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_130bfdb3-055e-4bfb-9249-e0555ffe1752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63164fd5-4094-4b1a-8e06-90fa6703d94b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_63164fd5-4094-4b1a-8e06-90fa6703d94b" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3172c45f-26e3-4711-9745-1d667d715bb2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_srt_RangeAxis_3172c45f-26e3-4711-9745-1d667d715bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3172c45f-26e3-4711-9745-1d667d715bb2" xlink:to="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b445d52e-a6e1-4a0d-b08a-5ec0db6384b3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:to="loc_srt_MaximumMember_b445d52e-a6e1-4a0d-b08a-5ec0db6384b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_fa41298e-0b96-44e9-94bb-c850660fefe1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4397cc10-45d1-4584-b0e1-dfba8aac5763" xlink:to="loc_srt_MinimumMember_fa41298e-0b96-44e9-94bb-c850660fefe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6b723daa-39f5-437e-88dd-4f9b46f89eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_AwardTypeAxis_6b723daa-39f5-437e-88dd-4f9b46f89eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b784c68-a1e4-409b-9d52-429f87abf3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6b723daa-39f5-437e-88dd-4f9b46f89eb5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b784c68-a1e4-409b-9d52-429f87abf3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a5921e81-48d4-46db-a89d-05a642e07b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9b784c68-a1e4-409b-9d52-429f87abf3e2" xlink:to="loc_us-gaap_RestrictedStockMember_a5921e81-48d4-46db-a89d-05a642e07b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7bf148eb-3c8b-40c1-a29a-f4691bd61f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7bf148eb-3c8b-40c1-a29a-f4691bd61f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c66352a-0030-4be4-8886-fe4ab312e229" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7bf148eb-3c8b-40c1-a29a-f4691bd61f58" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c66352a-0030-4be4-8886-fe4ab312e229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_0f87d907-89ac-48c3-8b4b-765142fc7b62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_5c66352a-0030-4be4-8886-fe4ab312e229" xlink:to="loc_us-gaap_StockCompensationPlanMember_0f87d907-89ac-48c3-8b4b-765142fc7b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_0eed9533-3d7d-4b2d-a063-cf618e44f023" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_srt_ProductOrServiceAxis_0eed9533-3d7d-4b2d-a063-cf618e44f023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a4a96a2d-b825-4478-b2fc-47eba1004a96" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_0eed9533-3d7d-4b2d-a063-cf618e44f023" xlink:to="loc_srt_ProductsAndServicesDomain_a4a96a2d-b825-4478-b2fc-47eba1004a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_75639643-bea1-4e86-b4da-ab1cbb61de93" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a4a96a2d-b825-4478-b2fc-47eba1004a96" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_75639643-bea1-4e86-b4da-ab1cbb61de93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f184292-e0ae-45dc-8dc7-8462f17199fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f184292-e0ae-45dc-8dc7-8462f17199fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_34ab67bb-8cc5-46ab-b3ba-2e2c737b7ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f184292-e0ae-45dc-8dc7-8462f17199fc" xlink:to="loc_us-gaap_TypeOfAdoptionMember_34ab67bb-8cc5-46ab-b3ba-2e2c737b7ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_cb54f42e-0f97-405e-b3af-854f342c4e6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_34ab67bb-8cc5-46ab-b3ba-2e2c737b7ae6" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_cb54f42e-0f97-405e-b3af-854f342c4e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_59e27f0c-1633-4cb0-9170-3e51311654e1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_59e27f0c-1633-4cb0-9170-3e51311654e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_59e27f0c-1633-4cb0-9170-3e51311654e1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_117fe980-6847-44ff-8c8d-f70f180db339" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_117fe980-6847-44ff-8c8d-f70f180db339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_23d3dd47-88b3-40f0-b915-d7e4c3c4a565" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_b9f0dd39-7ed8-41b1-90b1-e9bd5bb75bb9" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember_23d3dd47-88b3-40f0-b915-d7e4c3c4a565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e801a577-a20d-4849-8ce3-18b8a348219e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e801a577-a20d-4849-8ce3-18b8a348219e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e801a577-a20d-4849-8ce3-18b8a348219e" xlink:to="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_beb67482-ba14-4659-8350-cb7104de5afb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_beb67482-ba14-4659-8350-cb7104de5afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cec0f52b-d2b5-4dfd-ae1c-1cff5c3b050f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9f2344ee-1f0a-448b-8a14-6fd856f23b60" xlink:to="loc_us-gaap_RetainedEarningsMember_cec0f52b-d2b5-4dfd-ae1c-1cff5c3b050f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_81271c09-5eb3-41a7-937c-85b5d987b4c0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_b6d6cacc-497b-4496-b08d-3c22f97604e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_ConvertibleNotesPayable_b6d6cacc-497b-4496-b08d-3c22f97604e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_611c9f7e-d4f7-466c-a137-ed96bf5c14c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_611c9f7e-d4f7-466c-a137-ed96bf5c14c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dc5b8973-118b-4e73-89da-ac45cd3ba5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_StockholdersEquity_dc5b8973-118b-4e73-89da-ac45cd3ba5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_cea0ba5b-60a3-429f-a3af-d7dc037639c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_cea0ba5b-60a3-429f-a3af-d7dc037639c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5f2f4c38-5dc0-4c5b-8ca4-0c7c47f85c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5f2f4c38-5dc0-4c5b-8ca4-0c7c47f85c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ccbdf751-fd54-4541-8119-099b0b94f1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_ccbdf751-fd54-4541-8119-099b0b94f1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8faef7e3-200d-4039-82de-57c1fd46eee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_8faef7e3-200d-4039-82de-57c1fd46eee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_6749c567-7f1d-4ebf-895f-5a3ebb278d28" xlink:href="lgnd-20220331.xsd#lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease_6749c567-7f1d-4ebf-895f-5a3ebb278d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1ec2ed19-2605-47d1-b97a-1c98e0ce046a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_InventoryNet_1ec2ed19-2605-47d1-b97a-1c98e0ce046a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_56d89839-04f6-4bb3-a1b7-59873ca0fde1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_56d89839-04f6-4bb3-a1b7-59873ca0fde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_848e6024-5bb6-4013-8e58-61b861fb55ce" xlink:href="lgnd-20220331.xsd#lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent_848e6024-5bb6-4013-8e58-61b861fb55ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84f8d869-5f57-4326-a5f1-1a0f2ae0c2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_8a0ca700-7c3b-4685-91c0-31121eb2eafa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_84f8d869-5f57-4326-a5f1-1a0f2ae0c2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_295d83dd-447c-4158-b7dd-a15225239568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ef4586e9-0d0f-4547-a166-485885aeed92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_295d83dd-447c-4158-b7dd-a15225239568" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ef4586e9-0d0f-4547-a166-485885aeed92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_e68848e5-3633-4a4d-9cd4-51858b7754a0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef4586e9-0d0f-4547-a166-485885aeed92" xlink:to="loc_srt_ProductOrServiceAxis_e68848e5-3633-4a4d-9cd4-51858b7754a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_e68848e5-3633-4a4d-9cd4-51858b7754a0" xlink:to="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:to="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_KyprolisMember_6fcf2c68-2236-4fbf-ad29-059a303933b0" xlink:href="lgnd-20220331.xsd#lgnd_KyprolisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_KyprolisMember_6fcf2c68-2236-4fbf-ad29-059a303933b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EvomelaMember_c655ae5a-3b0c-43d9-b659-cdbecbdcd761" xlink:href="lgnd-20220331.xsd#lgnd_EvomelaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_EvomelaMember_c655ae5a-3b0c-43d9-b659-cdbecbdcd761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_TeriparatideInjectionMember_fa5f1dbb-1155-46be-90dd-414e9dbfc2f9" xlink:href="lgnd-20220331.xsd#lgnd_TeriparatideInjectionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_TeriparatideInjectionMember_fa5f1dbb-1155-46be-90dd-414e9dbfc2f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RylazeMember_f14ac585-a64e-488e-a4b0-389f578bdc64" xlink:href="lgnd-20220331.xsd#lgnd_RylazeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_RylazeMember_f14ac585-a64e-488e-a4b0-389f578bdc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RoyaltyOtherMember_1ff3972d-765b-4a21-9bfe-623ab300f1ac" xlink:href="lgnd-20220331.xsd#lgnd_RoyaltyOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RoyaltyMember_1fd9cc32-292e-4198-9d01-580cfdbf746e" xlink:to="loc_lgnd_RoyaltyOtherMember_1ff3972d-765b-4a21-9bfe-623ab300f1ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:to="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_03fb92ff-3ccd-4452-a35e-13762fcf9287" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_03fb92ff-3ccd-4452-a35e-13762fcf9287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_c062323e-b8d6-4120-b5e4-4ed4df7b04d8" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_MaterialSalesCaptisolMember_62cd6c8b-7bec-44b8-81f5-332cc6ae376b" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_c062323e-b8d6-4120-b5e4-4ed4df7b04d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e099bb7b-0261-42f0-993d-d3b75327a26a" xlink:to="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueServiceMember_5e51dd6a-e30c-422a-819e-caa151c71178" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_ContractRevenueServiceMember_5e51dd6a-e30c-422a-819e-caa151c71178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMember_f341116d-3a7f-49db-b404-bc5348c20c5a" xlink:href="lgnd-20220331.xsd#lgnd_LicenseFeesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_LicenseFeesMember_f341116d-3a7f-49db-b404-bc5348c20c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MilestoneMember_f74aa135-e76b-4356-8f15-c0a367584353" xlink:href="lgnd-20220331.xsd#lgnd_MilestoneMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_MilestoneMember_f74aa135-e76b-4356-8f15-c0a367584353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_95facf77-24c2-4acf-9a9d-e35eae37e2b7" xlink:href="lgnd-20220331.xsd#lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_ContractRevenueMember_1abbc1fd-374c-45f7-9dfd-38a7c138e158" xlink:to="loc_lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember_95facf77-24c2-4acf-9a9d-e35eae37e2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_28a56d39-1b6b-4732-b2a0-8a24350990f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ef4586e9-0d0f-4547-a166-485885aeed92" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_28a56d39-1b6b-4732-b2a0-8a24350990f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2c39bd8-0284-4eda-9f4a-2316e4a9ff97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_28a56d39-1b6b-4732-b2a0-8a24350990f2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2c39bd8-0284-4eda-9f4a-2316e4a9ff97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_73638010-720e-42f8-9c2c-0215e89f743f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8c0e0c32-2366-49af-9803-f4e2abb9c6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_73638010-720e-42f8-9c2c-0215e89f743f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8c0e0c32-2366-49af-9803-f4e2abb9c6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8c0e0c32-2366-49af-9803-f4e2abb9c6bd" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e0b62993-a9e1-4ecf-a0db-dd0dd83dbc92" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DemandDepositsMember_97909151-dad4-46a0-9c6d-4bb908211e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DemandDepositsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_DemandDepositsMember_97909151-dad4-46a0-9c6d-4bb908211e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_9f8dd273-8538-41a1-a6e9-45a4c4de0107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_9f8dd273-8538-41a1-a6e9-45a4c4de0107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_c71d0957-559e-47f2-b657-756f83cd5005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_CommercialPaperMember_c71d0957-559e-47f2-b657-756f83cd5005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_67638b09-638d-4aaf-8e68-6d0f04da2f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_EquitySecuritiesMember_67638b09-638d-4aaf-8e68-6d0f04da2f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_ff7452f5-d4e5-4dd8-8ccc-e211533c0c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_MutualFundMember_ff7452f5-d4e5-4dd8-8ccc-e211533c0c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_26a81d04-49c4-4dc6-833d-b84030179a30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_26a81d04-49c4-4dc6-833d-b84030179a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_bf581f3d-b23a-4c44-bcb6-c08518039adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_WarrantMember_bf581f3d-b23a-4c44-bcb6-c08518039adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9790eee8-92c1-4e5e-945a-091585d2c63d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24b571ca-9cbf-42ff-823e-d5eae981b7c8" xlink:to="loc_us-gaap_CommonStockMember_9790eee8-92c1-4e5e-945a-091585d2c63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8c0e0c32-2366-49af-9803-f4e2abb9c6bd" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f94672a-a386-4695-b55a-e1483dadc269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_8f94672a-a386-4695-b55a-e1483dadc269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c26033bf-8ef3-4d9b-938c-4a46faa1c672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c26033bf-8ef3-4d9b-938c-4a46faa1c672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b1f248a-a563-4fa1-b3db-774da6ea6365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1b1f248a-a563-4fa1-b3db-774da6ea6365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0ce818a4-7ab4-4639-84aa-ac0f9203180c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0ce818a4-7ab4-4639-84aa-ac0f9203180c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_c653f7c3-55a6-4a14-bd83-4d61f50ce510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_c653f7c3-55a6-4a14-bd83-4d61f50ce510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a1ed7267-a15f-4ecc-b3ac-9c3d282cd5ce" xlink:href="lgnd-20220331.xsd#lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_ff2134ee-bf06-465e-81a8-552e5f8a682e" xlink:to="loc_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI_a1ed7267-a15f-4ecc-b3ac-9c3d282cd5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ede41671-8452-4b74-83d3-6c473b020f68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b8e9c4ac-ca23-4458-a7b6-29a8776a3223" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ede41671-8452-4b74-83d3-6c473b020f68" xlink:to="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b8e9c4ac-ca23-4458-a7b6-29a8776a3223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_3626bee5-fbed-4d09-be5d-f7d986d20b19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b8e9c4ac-ca23-4458-a7b6-29a8776a3223" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_3626bee5-fbed-4d09-be5d-f7d986d20b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_94ad86ca-078d-4e6a-9b8e-6402731ac8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b8e9c4ac-ca23-4458-a7b6-29a8776a3223" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis_94ad86ca-078d-4e6a-9b8e-6402731ac8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_1d5f81a2-a112-4645-bed0-d05137f450ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract_b8e9c4ac-ca23-4458-a7b6-29a8776a3223" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_1d5f81a2-a112-4645-bed0-d05137f450ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_d79f43ce-3920-428c-9f81-56d9a98de2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ede41671-8452-4b74-83d3-6c473b020f68" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_d79f43ce-3920-428c-9f81-56d9a98de2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_d33365cc-123a-4cd9-9525-f9d1fcaf2402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_d79f43ce-3920-428c-9f81-56d9a98de2b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_d33365cc-123a-4cd9-9525-f9d1fcaf2402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_b522e357-9ef4-400c-b60c-2646b49e4c55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_d79f43ce-3920-428c-9f81-56d9a98de2b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue_b522e357-9ef4-400c-b60c-2646b49e4c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_c8addf26-9f8b-42c2-8bfc-2bd52a6ba085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract_d79f43ce-3920-428c-9f81-56d9a98de2b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_c8addf26-9f8b-42c2-8bfc-2bd52a6ba085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3a0c3518-7045-46bd-9394-6a6b0242bdec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af5a4f81-34de-4cfb-91f6-08655943f169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3a0c3518-7045-46bd-9394-6a6b0242bdec" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af5a4f81-34de-4cfb-91f6-08655943f169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2499b3f6-0792-463f-b65a-7fc660a88fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af5a4f81-34de-4cfb-91f6-08655943f169" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2499b3f6-0792-463f-b65a-7fc660a88fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2499b3f6-0792-463f-b65a-7fc660a88fa8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentedTechnologyMember_c90e888d-cb57-4ed1-adb7-b9f93c3cad40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_PatentedTechnologyMember_c90e888d-cb57-4ed1-adb7-b9f93c3cad40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_be1b85f4-e4d0-43fb-af66-dda4c17280b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_TradeNamesMember_be1b85f4-e4d0-43fb-af66-dda4c17280b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5cc65bf0-d778-4ca7-8969-05538297f845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5cc65bf0-d778-4ca7-8969-05538297f845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_52277a53-8ecb-44b8-ae05-969f355c93a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5a0d88b-7948-46e0-ba80-ae3748d2da5c" xlink:to="loc_us-gaap_ContractualRightsMember_52277a53-8ecb-44b8-ae05-969f355c93a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0eedccf-cdee-4cc5-bede-923b9af3b174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_af5a4f81-34de-4cfb-91f6-08655943f169" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0eedccf-cdee-4cc5-bede-923b9af3b174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_b0eedccf-cdee-4cc5-bede-923b9af3b174" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3790b4a2-99ef-419f-8cec-c8d98bf462a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_Goodwill_3790b4a2-99ef-419f-8cec-c8d98bf462a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab972b33-91f7-4389-be1c-b8106b5566ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_ab972b33-91f7-4389-be1c-b8106b5566ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f52d3d98-561b-49d7-989b-51d43e728336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f52d3d98-561b-49d7-989b-51d43e728336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d7f1e916-458b-4d05-8b50-d7edac0830e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetIncludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract_3bc5bbc5-0c0f-4e32-94d6-c6ac69ea68aa" xlink:to="loc_us-gaap_IntangibleAssetsNetIncludingGoodwill_d7f1e916-458b-4d05-8b50-d7edac0830e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_583e2b42-0fd5-4a21-8d83-a400463a7f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_583e2b42-0fd5-4a21-8d83-a400463a7f0f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb61b4d3-f51b-4924-9289-5c4cf2cd912d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3c0f5b8a-93b4-4d08-b05a-8471a6a1ebc7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb61b4d3-f51b-4924-9289-5c4cf2cd912d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_1322ebda-2e2c-4467-aa9c-395cd1e0560e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bb61b4d3-f51b-4924-9289-5c4cf2cd912d" xlink:to="loc_us-gaap_LicensingAgreementsMember_1322ebda-2e2c-4467-aa9c-395cd1e0560e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_a003f931-7ea3-4656-bf8a-483656a7c9e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:to="loc_srt_CounterpartyNameAxis_a003f931-7ea3-4656-bf8a-483656a7c9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_a003f931-7ea3-4656-bf8a-483656a7c9e4" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AziyoAndCorMatrixMember_d063ed8c-926c-40b5-9b84-6c877cc3c5f8" xlink:href="lgnd-20220331.xsd#lgnd_AziyoAndCorMatrixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:to="loc_lgnd_AziyoAndCorMatrixMember_d063ed8c-926c-40b5-9b84-6c877cc3c5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_SelexisAndDianomiMember_480bee99-34cf-4df9-8eac-412b7351772f" xlink:href="lgnd-20220331.xsd#lgnd_SelexisAndDianomiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_eda5420e-5ab2-47da-a753-1e4bbda45a93" xlink:to="loc_lgnd_SelexisAndDianomiMember_480bee99-34cf-4df9-8eac-412b7351772f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ea9790a6-900d-431e-8e89-851c7f4b4e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_774dfd9b-799a-46dd-bd57-e96c5ed45c12" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ea9790a6-900d-431e-8e89-851c7f4b4e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:href="lgnd-20220331.xsd#lgnd_CommercialLicenseAndOtherEconomicRightsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ea9790a6-900d-431e-8e89-851c7f4b4e9e" xlink:to="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_222c88c1-2829-46c5-bcaa-59e1e94f2afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_222c88c1-2829-46c5-bcaa-59e1e94f2afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a1704e79-6e3f-4d9f-9077-77cc3096cd10" xlink:href="lgnd-20220331.xsd#lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments_a1704e79-6e3f-4d9f-9077-77cc3096cd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0944932e-be49-45dc-831e-0238fa67b330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0944932e-be49-45dc-831e-0238fa67b330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f19eeaf3-fd23-4e0b-958b-32a7f4f80c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f19eeaf3-fd23-4e0b-958b-32a7f4f80c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_e4631dc0-8ca1-43b0-a386-a43282daf186" xlink:href="lgnd-20220331.xsd#lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract_1dbbab5d-3508-4585-aa3e-c895b4090f1b" xlink:to="loc_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments_e4631dc0-8ca1-43b0-a386-a43282daf186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05f2287d-ccdf-4ade-bca3-fa7b9819c9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_05f2287d-ccdf-4ade-bca3-fa7b9819c9a1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2e227cf9-c80e-4138-af46-ff0ae122b6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_2e227cf9-c80e-4138-af46-ff0ae122b6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_51c8271c-5284-4f5d-a2f0-f95891ac01f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_51c8271c-5284-4f5d-a2f0-f95891ac01f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LicenseeAccrualCurrent_e5a748c0-de23-4a8c-b86f-12344c41e37c" xlink:href="lgnd-20220331.xsd#lgnd_LicenseeAccrualCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_lgnd_LicenseeAccrualCurrent_e5a748c0-de23-4a8c-b86f-12344c41e37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_f6771ee6-4cb8-4959-a6e3-1a2f6cae0008" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_f6771ee6-4cb8-4959-a6e3-1a2f6cae0008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ReturnsAccrual_918a381a-a08d-4b27-a34b-a7183890349f" xlink:href="lgnd-20220331.xsd#lgnd_ReturnsAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_lgnd_ReturnsAccrual_918a381a-a08d-4b27-a34b-a7183890349f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedAssetAcquisitionsCurrent_07f2ba80-0c40-428b-adc3-73d5d14561e8" xlink:href="lgnd-20220331.xsd#lgnd_AccruedAssetAcquisitionsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_lgnd_AccruedAssetAcquisitionsCurrent_07f2ba80-0c40-428b-adc3-73d5d14561e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSubcontractorExpensesCurrent_1d2609d6-8f22-4e9c-a1f6-17c2a0138e71" xlink:href="lgnd-20220331.xsd#lgnd_AccruedSubcontractorExpensesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_lgnd_AccruedSubcontractorExpensesCurrent_1d2609d6-8f22-4e9c-a1f6-17c2a0138e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AccruedSupplierExpensesCurrent_6dcae6e2-f2cb-4a74-b2f6-83be186ac755" xlink:href="lgnd-20220331.xsd#lgnd_AccruedSupplierExpensesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_lgnd_AccruedSupplierExpensesCurrent_6dcae6e2-f2cb-4a74-b2f6-83be186ac755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_db6dd2bf-b277-4f36-9e3b-2cca832a6635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_us-gaap_InterestPayableCurrent_db6dd2bf-b277-4f36-9e3b-2cca832a6635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_87e1747f-1918-43c3-b15b-8b0a401f8d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_87e1747f-1918-43c3-b15b-8b0a401f8d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_33748b12-f586-4e94-835c-8f8dbfece07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract_c6ac67c3-0108-4212-a1df-ce5d43b1cbc5" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_33748b12-f586-4e94-835c-8f8dbfece07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11abc83f-125d-4dbc-9b57-f295459d12eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationTable_3ccd5d17-5be3-4e29-b5a3-a6fa420329b0" xlink:href="lgnd-20220331.xsd#lgnd_BasisOfPresentationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_11abc83f-125d-4dbc-9b57-f295459d12eb" xlink:to="loc_lgnd_BasisOfPresentationTable_3ccd5d17-5be3-4e29-b5a3-a6fa420329b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3ccd5d17-5be3-4e29-b5a3-a6fa420329b0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ae6b6fa0-bcd7-43a5-bc89-8b754cbe04a1" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3a24df37-6481-4648-9fa5-41debdaf8ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_3a24df37-6481-4648-9fa5-41debdaf8ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c70c5b4c-c097-4240-8b23-da70a9d92f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9d428bc1-b604-4602-b1c0-c0e83b389896" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c70c5b4c-c097-4240-8b23-da70a9d92f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BasisOfPresentationLineItems_84b7fe8f-12f6-4679-886f-6f8f342dde50" xlink:href="lgnd-20220331.xsd#lgnd_BasisOfPresentationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationTable_3ccd5d17-5be3-4e29-b5a3-a6fa420329b0" xlink:to="loc_lgnd_BasisOfPresentationLineItems_84b7fe8f-12f6-4679-886f-6f8f342dde50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_39657c13-6fa0-45db-94db-04db5a476ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_BasisOfPresentationLineItems_84b7fe8f-12f6-4679-886f-6f8f342dde50" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_39657c13-6fa0-45db-94db-04db5a476ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d3ce152-23cd-4453-9c21-d47b4b104d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0a90627e-577a-4041-9721-5a9a80427344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d3ce152-23cd-4453-9c21-d47b4b104d2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0a90627e-577a-4041-9721-5a9a80427344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_58f56f6d-61de-4661-a3cf-ce57e901b59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d3ce152-23cd-4453-9c21-d47b4b104d2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_58f56f6d-61de-4661-a3cf-ce57e901b59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2ca54acf-942f-4dfe-ae34-98271e489b91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d3ce152-23cd-4453-9c21-d47b4b104d2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2ca54acf-942f-4dfe-ae34-98271e489b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_246c6806-13cd-46f6-ba46-603735168d28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d3ce152-23cd-4453-9c21-d47b4b104d2e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_246c6806-13cd-46f6-ba46-603735168d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4360ca4b-d813-43e1-bd8e-3dbf76fffd8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe45642a-673b-4ea3-9ea4-dc21ce5dc3f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4360ca4b-d813-43e1-bd8e-3dbf76fffd8c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe45642a-673b-4ea3-9ea4-dc21ce5dc3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e5dd148f-5272-489b-8c41-6ce7f7e4ffca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe45642a-673b-4ea3-9ea4-dc21ce5dc3f6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e5dd148f-5272-489b-8c41-6ce7f7e4ffca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_e5dd148f-5272-489b-8c41-6ce7f7e4ffca" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_639448d7-9059-4a85-b590-a1e89c0e3e22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:to="loc_us-gaap_RestrictedStockMember_639448d7-9059-4a85-b590-a1e89c0e3e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f692de30-6a63-42ff-82ea-6f0a17947cde" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f7b06a28-5cd6-4216-88c4-f7a52f3a4ee1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f692de30-6a63-42ff-82ea-6f0a17947cde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4060eba7-8d2e-4b40-90f4-1f0489cd35e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_fe45642a-673b-4ea3-9ea4-dc21ce5dc3f6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4060eba7-8d2e-4b40-90f4-1f0489cd35e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4060eba7-8d2e-4b40-90f4-1f0489cd35e7" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_25225399-3744-41e8-adf0-f5c7ee2a2172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_25225399-3744-41e8-adf0-f5c7ee2a2172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:to="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bc04146d-3ca1-4ace-9ac9-e749a405700e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bc04146d-3ca1-4ace-9ac9-e749a405700e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f655492-5848-49c1-aee1-ecf14b335b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DilutiveSecuritiesAbstract_1456a4ba-60cb-4493-9148-9c49dea499ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2f655492-5848-49c1-aee1-ecf14b335b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c2646d72-9480-48f6-be7c-341adf323aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_a67f8851-e8fe-4bc5-b735-b06aeacddcf3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c2646d72-9480-48f6-be7c-341adf323aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformation" xlink:type="simple" xlink:href="lgnd-20220331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_64c50a44-9caa-4720-bd70-bf17ac93356c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_76eebf8e-b09f-441e-b8a2-b20179c979f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_64c50a44-9caa-4720-bd70-bf17ac93356c" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_76eebf8e-b09f-441e-b8a2-b20179c979f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="lgnd-20220331.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1a774e23-71c2-4bb0-9b4c-317227e6d29e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_17fe7464-16c6-434f-b23a-53a14cd743fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1a774e23-71c2-4bb0-9b4c-317227e6d29e" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_17fe7464-16c6-434f-b23a-53a14cd743fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#SegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/SegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_6f8887b7-d630-49cf-8ac3-c9c9bbb17c61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b531efc0-ed5f-4642-87ee-e331ab496a62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6f8887b7-d630-49cf-8ac3-c9c9bbb17c61" xlink:to="loc_us-gaap_NumberOfReportableSegments_b531efc0-ed5f-4642-87ee-e331ab496a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_6f8887b7-d630-49cf-8ac3-c9c9bbb17c61" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d3f8b769-5b86-40a7-ac94-d40a450e6627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d3f8b769-5b86-40a7-ac94-d40a450e6627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d3f8b769-5b86-40a7-ac94-d40a450e6627" xlink:to="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_OmniAbTechnologiesSegmentMember_04cab104-b560-4b30-9440-0e4bff75b63f" xlink:href="lgnd-20220331.xsd#lgnd_OmniAbTechnologiesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:to="loc_lgnd_OmniAbTechnologiesSegmentMember_04cab104-b560-4b30-9440-0e4bff75b63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LigandCoreBusinessSegmentMember_f7f170e9-91fc-4bd6-9268-57cefc79f417" xlink:href="lgnd-20220331.xsd#lgnd_LigandCoreBusinessSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8a3b8aa9-ddab-48eb-9e7f-acc28a7dc43a" xlink:to="loc_lgnd_LigandCoreBusinessSegmentMember_f7f170e9-91fc-4bd6-9268-57cefc79f417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:to="loc_srt_ProductOrServiceAxis_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7c9ab60d-97d2-486e-a6a2-2a4a69bf1222" xlink:to="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_5810266b-993b-48aa-a8ef-8a453336d7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_us-gaap_RoyaltyMember_5810266b-993b-48aa-a8ef-8a453336d7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCoreMember_b0206961-6189-4887-86e6-779718a872c7" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCoreMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_lgnd_MaterialSalesCaptisolCoreMember_b0206961-6189-4887-86e6-779718a872c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d68d8451-13c4-4b02-a1b5-587456d00314" xlink:href="lgnd-20220331.xsd#lgnd_MaterialSalesCaptisolCOVIDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_lgnd_MaterialSalesCaptisolCOVIDMember_d68d8451-13c4-4b02-a1b5-587456d00314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ContractRevenueMember_bbb884db-c7bc-402a-b898-deafc1f91164" xlink:href="lgnd-20220331.xsd#lgnd_ContractRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_77ec4d86-f8a9-47ce-9b0b-2196895330d5" xlink:to="loc_lgnd_ContractRevenueMember_bbb884db-c7bc-402a-b898-deafc1f91164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_42684ec3-ed9a-425d-a036-996a93eeaa4e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:to="loc_srt_ConsolidationItemsAxis_42684ec3-ed9a-425d-a036-996a93eeaa4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_42684ec3-ed9a-425d-a036-996a93eeaa4e" xlink:to="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f64cf0b3-b115-4280-b4a5-e8613d53aafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:to="loc_us-gaap_OperatingSegmentsMember_f64cf0b3-b115-4280-b4a5-e8613d53aafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_e42719f5-b302-4479-8143-86c6e029615b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d6a9986b-4bb3-4b0a-aaa5-19f15d3ae578" xlink:to="loc_us-gaap_CorporateNonSegmentMember_e42719f5-b302-4479-8143-86c6e029615b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_a572f670-5e76-4962-b64e-411a7d50f4f3" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fcb42439-f88a-4c36-bc4d-591965c80316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fcb42439-f88a-4c36-bc4d-591965c80316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96fb04e7-8400-4753-bc34-1eac92c2d4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_96fb04e7-8400-4753-bc34-1eac92c2d4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_b726ae9d-fce9-4551-aa9f-94dc276d8f84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_b726ae9d-fce9-4551-aa9f-94dc276d8f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_4ae90e3b-75a3-407f-91fd-d12f0af85b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_4ae90e3b-75a3-407f-91fd-d12f0af85b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_4189a2c1-c142-4613-96fc-385673469062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_4189a2c1-c142-4613-96fc-385673469062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ad68fd52-a4b2-4606-8fa8-f41acc2c8636" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_f8ec56f2-febf-49ab-a288-ffd85dd87288" xlink:to="loc_us-gaap_OperatingIncomeLoss_ad68fd52-a4b2-4606-8fa8-f41acc2c8636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="lgnd-20220331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ccb367a2-a2ee-472e-9c74-9c991aa420c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_068a3ad7-9598-4b17-98bd-9cb4bd6c898c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ccb367a2-a2ee-472e-9c74-9c991aa420c4" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_068a3ad7-9598-4b17-98bd-9cb4bd6c898c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="lgnd-20220331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_43566b69-de2f-4f91-9b35-7b9189fbc30f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_fd0ace6b-3d7f-49a7-ae8c-bea31c26e5af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_43566b69-de2f-4f91-9b35-7b9189fbc30f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_fd0ace6b-3d7f-49a7-ae8c-bea31c26e5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a51281a5-3af0-410d-8519-9cf563c2cb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_43566b69-de2f-4f91-9b35-7b9189fbc30f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_a51281a5-3af0-410d-8519-9cf563c2cb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b4d18713-c2ba-4d86-b292-c49ae6ee950d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b4d18713-c2ba-4d86-b292-c49ae6ee950d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c253507-10e3-498c-9ce5-2ad0f07c9d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_29716bc9-a3b6-4d8e-8b50-297cd2e7ee6b" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c253507-10e3-498c-9ce5-2ad0f07c9d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_12446198-33b8-456b-b2d0-ff7947024c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_3c253507-10e3-498c-9ce5-2ad0f07c9d82" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_12446198-33b8-456b-b2d0-ff7947024c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3508a2b4-2712-477a-aa46-ef776b1f180b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3508a2b4-2712-477a-aa46-ef776b1f180b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3508a2b4-2712-477a-aa46-ef776b1f180b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_fb644d97-7593-4787-86ef-f3316ca79b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_fb644d97-7593-4787-86ef-f3316ca79b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_beb874bc-bdca-496b-ba4f-d6eca5ab5b11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_beb874bc-bdca-496b-ba4f-d6eca5ab5b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_45bb7d0d-a031-4a71-b77d-7e14f3eddb39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_281cb090-4c01-4fe0-8231-b5df6359b7c7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_45bb7d0d-a031-4a71-b77d-7e14f3eddb39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_cfa93796-8875-4117-92e9-81b1867b7939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_cfa93796-8875-4117-92e9-81b1867b7939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cfa93796-8875-4117-92e9-81b1867b7939" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_ef03b784-fc8e-4053-adff-541d57e19087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_ef03b784-fc8e-4053-adff-541d57e19087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_8768c4e6-c43c-41e6-b37c-775ae54aa5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_96a3fd9d-b505-4ce8-b926-9aa98cdbaeb1" xlink:to="loc_us-gaap_EquitySecuritiesMember_8768c4e6-c43c-41e6-b37c-775ae54aa5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_bda04c35-46ba-4b07-a93e-eaead3a6826f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_bda04c35-46ba-4b07-a93e-eaead3a6826f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_bda04c35-46ba-4b07-a93e-eaead3a6826f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_adf0f700-9a6e-40a0-b4f5-e3455f79f21f" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyCydexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyCydexMember_adf0f700-9a6e-40a0-b4f5-e3455f79f21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_581e5a7c-d391-4f2f-93e6-44948fe65e8d" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember_581e5a7c-d391-4f2f-93e6-44948fe65e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_04a05411-567a-4491-abd5-9e023761a67c" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyIcagenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyIcagenMember_04a05411-567a-4491-abd5-9e023761a67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_bb28293e-9552-4266-800a-e673b918ebde" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForContingentValueRightsCompanyXCellaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForContingentValueRightsCompanyXCellaMember_bb28293e-9552-4266-800a-e673b918ebde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_4e072833-0699-4a7e-849a-6f1ab02fffd1" xlink:href="lgnd-20220331.xsd#lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6b417e02-96e4-454a-a6d7-0361706b56d9" xlink:to="loc_lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember_4e072833-0699-4a7e-849a-6f1ab02fffd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1094ede0-7556-428f-a20b-93f93d0e7683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1094ede0-7556-428f-a20b-93f93d0e7683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1094ede0-7556-428f-a20b-93f93d0e7683" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_MetabasisMember_bcc78c0a-6ff0-49df-a15f-4b9b3da78ce5" xlink:href="lgnd-20220331.xsd#lgnd_MetabasisMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:to="loc_lgnd_MetabasisMember_bcc78c0a-6ff0-49df-a15f-4b9b3da78ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_XCellaBiosciencesIncMember_9206488e-aadc-4319-883e-8278777efdaa" xlink:href="lgnd-20220331.xsd#lgnd_XCellaBiosciencesIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9138a6cf-0b33-4f3d-b06d-15a0737304ab" xlink:to="loc_lgnd_XCellaBiosciencesIncMember_9206488e-aadc-4319-883e-8278777efdaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_srt_RangeAxis_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5351689f-6123-4c89-bd45-c43cad9dd510" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fd2e6a4d-62c5-45ad-a6b9-26cb0ddb0bd4" xlink:to="loc_srt_RangeMember_5351689f-6123-4c89-bd45-c43cad9dd510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_46ba257f-74d2-4112-bc41-1554c329e6a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_5351689f-6123-4c89-bd45-c43cad9dd510" xlink:to="loc_srt_MaximumMember_46ba257f-74d2-4112-bc41-1554c329e6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d106c7c3-838f-4d67-a55e-c9d9b63c46fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_23d83943-3ba5-4ae7-b5d4-825f8cbb12b0" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d106c7c3-838f-4d67-a55e-c9d9b63c46fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredOverTimeMember_3dfbea6f-19a2-4e11-bfad-f01b45fd7f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransferredOverTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_d106c7c3-838f-4d67-a55e-c9d9b63c46fa" xlink:to="loc_us-gaap_TransferredOverTimeMember_3dfbea6f-19a2-4e11-bfad-f01b45fd7f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_542a3c55-1c7d-48e0-8e27-65a135b9d9e4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_srt_ProductOrServiceAxis_542a3c55-1c7d-48e0-8e27-65a135b9d9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_542a3c55-1c7d-48e0-8e27-65a135b9d9e4" xlink:to="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_79918e0c-0da1-412e-9da5-087343f129a2" xlink:href="lgnd-20220331.xsd#lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:to="loc_lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember_79918e0c-0da1-412e-9da5-087343f129a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_Phase3ClinicalTrialMember_fc9b35fc-6f0b-4a41-92be-a4796f9551cf" xlink:href="lgnd-20220331.xsd#lgnd_Phase3ClinicalTrialMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad341ee6-d083-4b0f-b0da-c36e19a203b5" xlink:to="loc_lgnd_Phase3ClinicalTrialMember_fc9b35fc-6f0b-4a41-92be-a4796f9551cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_9e6f4b73-d136-4247-8b86-3dbd29b0b08e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_9e6f4b73-d136-4247-8b86-3dbd29b0b08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e2b05dd7-49e4-4883-9feb-1fcbf164af1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9e6f4b73-d136-4247-8b86-3dbd29b0b08e" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e2b05dd7-49e4-4883-9feb-1fcbf164af1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_2cf72448-4cc6-4803-9b02-cb326b2f83cd" xlink:href="lgnd-20220331.xsd#lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e2b05dd7-49e4-4883-9feb-1fcbf164af1f" xlink:to="loc_lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember_2cf72448-4cc6-4803-9b02-cb326b2f83cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_7f21ac8b-6964-4341-8305-0affe30b8767" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7902ae32-ec72-4f57-baa4-d2001f93debe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7902ae32-ec72-4f57-baa4-d2001f93debe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_4c9baa02-7c34-42ec-a9e4-527b9c935116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_4c9baa02-7c34-42ec-a9e4-527b9c935116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_eb330a16-a27f-4fad-bd3b-9ffd7109c3ed" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare_eb330a16-a27f-4fad-bd3b-9ffd7109c3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2afcdaee-256a-45ec-a10d-0cbfb546852a" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries_2afcdaee-256a-45ec-a10d-0cbfb546852a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfContingentValueRightsSeries_2b128f78-c563-48d3-b46e-c3a941817921" xlink:href="lgnd-20220331.xsd#lgnd_NumberOfContingentValueRightsSeries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_NumberOfContingentValueRightsSeries_2b128f78-c563-48d3-b46e-c3a941817921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_ec0a65bc-fdd6-4b63-9f66-fa41425d8916" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders_ec0a65bc-fdd6-4b63-9f66-fa41425d8916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4d72c635-5cd5-452b-b520-d4d48243ecd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_Investments_4d72c635-5cd5-452b-b520-d4d48243ecd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetGross_714a0017-7ecf-49ec-afc9-979e42a5ed21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_ContractWithCustomerAssetGross_714a0017-7ecf-49ec-afc9-979e42a5ed21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueAdjustment_f804ac72-1cea-4e74-8bbb-e419eeeda37d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueAdjustment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_LiabilitiesFairValueAdjustment_f804ac72-1cea-4e74-8bbb-e419eeeda37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_e2c39f3c-99f8-41f2-b3d4-62600c53d8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities_e2c39f3c-99f8-41f2-b3d4-62600c53d8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_b4088401-d09b-4178-b3b8-44fd72cfa2d1" xlink:href="lgnd-20220331.xsd#lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_01f16ee4-12b1-4ed4-acd6-318923bef5da" xlink:to="loc_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency_b4088401-d09b-4178-b3b8-44fd72cfa2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3840c853-e0d8-4abd-a200-19574f2c53d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6cf9ff85-2de5-411b-930a-f3bb7dd866d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3840c853-e0d8-4abd-a200-19574f2c53d7" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6cf9ff85-2de5-411b-930a-f3bb7dd866d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7dde45b-c927-4628-8a05-71446d8bdb80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6cf9ff85-2de5-411b-930a-f3bb7dd866d4" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7dde45b-c927-4628-8a05-71446d8bdb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d44632a8-a99a-4e11-9c1a-d8caa0e07752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f7dde45b-c927-4628-8a05-71446d8bdb80" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d44632a8-a99a-4e11-9c1a-d8caa0e07752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1f718e3b-dd8a-4aa4-bb1a-8f4a61cb4eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d44632a8-a99a-4e11-9c1a-d8caa0e07752" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1f718e3b-dd8a-4aa4-bb1a-8f4a61cb4eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_82353c98-f9ed-4359-8251-b1341c37c072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6cf9ff85-2de5-411b-930a-f3bb7dd866d4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_82353c98-f9ed-4359-8251-b1341c37c072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_82353c98-f9ed-4359-8251-b1341c37c072" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6f259543-ad9b-4dcd-960e-f2607cafb45a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6f259543-ad9b-4dcd-960e-f2607cafb45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToContingentValueRightHolders_3dc9db80-019d-4188-8479-3e7f99ecb8e9" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToContingentValueRightHolders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_lgnd_PaymentsToContingentValueRightHolders_3dc9db80-019d-4188-8479-3e7f99ecb8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4e57d453-3bfc-4842-9a28-516deb204398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_4e57d453-3bfc-4842-9a28-516deb204398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_1ff4732a-4f43-415a-a87a-ec10f346417b" xlink:href="lgnd-20220331.xsd#lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition_1ff4732a-4f43-415a-a87a-ec10f346417b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0f6f6d20-e70e-4fcc-a118-1b94fba10bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_37c86e9f-2a69-4bd6-a26d-70a27455dfee" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0f6f6d20-e70e-4fcc-a118-1b94fba10bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_800a402b-275f-413a-aacf-e48a23685ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_12547f47-6457-4d8a-a219-a124de22bd16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_800a402b-275f-413a-aacf-e48a23685ee8" xlink:to="loc_us-gaap_NumberOfReportingUnits_12547f47-6457-4d8a-a219-a124de22bd16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="lgnd-20220331.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6b290197-34e1-4b5e-8ff8-b7e678e0ce44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_27c7171d-7d82-4136-8eb9-09af1ec17886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6b290197-34e1-4b5e-8ff8-b7e678e0ce44" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_27c7171d-7d82-4136-8eb9-09af1ec17886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="lgnd-20220331.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9cc41ff5-597b-422f-b54a-3501d4408ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_72100678-8cf8-4064-a42f-02528f925aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9cc41ff5-597b-422f-b54a-3501d4408ec7" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_72100678-8cf8-4064-a42f-02528f925aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#ConvertibleSeniorNotesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_59249db5-451b-4170-898b-250d91eadfd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_59249db5-451b-4170-898b-250d91eadfd3" xlink:to="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f9837ae7-bc72-45c4-99c0-30c5e9a12468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_f36ee94a-1fc3-4f40-8f21-7beaf6836ad4" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f9837ae7-bc72-45c4-99c0-30c5e9a12468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_546950f6-9475-4d1b-a916-160b92a69532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f9837ae7-bc72-45c4-99c0-30c5e9a12468" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_546950f6-9475-4d1b-a916-160b92a69532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_1759116c-dbe2-463a-94b5-8918ea7f5fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_us-gaap_DebtInstrumentAxis_1759116c-dbe2-463a-94b5-8918ea7f5fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_71920e99-69ab-404e-8e8b-d8e8243c2faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_1759116c-dbe2-463a-94b5-8918ea7f5fa0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_71920e99-69ab-404e-8e8b-d8e8243c2faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_a188d5fa-ab6f-44c4-9dfa-44add792c135" xlink:href="lgnd-20220331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_71920e99-69ab-404e-8e8b-d8e8243c2faf" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_a188d5fa-ab6f-44c4-9dfa-44add792c135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_000cbe4e-91ac-4363-a9dc-b4bf63dbf1c9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_94c16e26-84bf-4321-ae40-0f01a17d8da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_94c16e26-84bf-4321-ae40-0f01a17d8da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_72550a4c-4dbe-4fab-90f7-2b21bcfe38a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_d1ba916a-0e34-49e8-95e3-aae80b3283cb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_72550a4c-4dbe-4fab-90f7-2b21bcfe38a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_57039947-2117-4a80-8b3d-244d1b51d3dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_srt_RangeAxis_57039947-2117-4a80-8b3d-244d1b51d3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f5369732-a49d-467d-9900-99dc83192004" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_57039947-2117-4a80-8b3d-244d1b51d3dc" xlink:to="loc_srt_RangeMember_f5369732-a49d-467d-9900-99dc83192004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6105e419-5c82-4a4f-8b7e-4e9398d34f08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f5369732-a49d-467d-9900-99dc83192004" xlink:to="loc_srt_MaximumMember_6105e419-5c82-4a4f-8b7e-4e9398d34f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_ed9627b2-7fd0-479c-b5ca-8d9450040245" xlink:to="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f1272148-dfa4-437e-8c59-2180feb97fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f1272148-dfa4-437e-8c59-2180feb97fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_de5e0ddd-f1b0-4141-bc82-f575836ddc37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_de5e0ddd-f1b0-4141-bc82-f575836ddc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e1182338-2814-4fa8-b8c8-8611b0ed4ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDebtNetOfIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_ProceedsFromDebtNetOfIssuanceCosts_e1182338-2814-4fa8-b8c8-8611b0ed4ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_01eb1890-8df7-4fea-8242-f0e45ae83dcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_01eb1890-8df7-4fea-8242-f0e45ae83dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_84e33045-eb14-496b-bd01-70d84035e831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_84e33045-eb14-496b-bd01-70d84035e831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_ecd3739a-c925-447d-bf39-995cdb140cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_ecd3739a-c925-447d-bf39-995cdb140cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bbe43a03-6880-454f-ad73-473e543f6a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_bbe43a03-6880-454f-ad73-473e543f6a6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_38b56abd-6a02-47e6-9684-c3a4f6ccf7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_38b56abd-6a02-47e6-9684-c3a4f6ccf7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_31ca9603-fb67-4a90-b777-7e5cccc50c4e" xlink:href="lgnd-20220331.xsd#lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger_31ca9603-fb67-4a90-b777-7e5cccc50c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_aaa9d281-116a-4aca-adc6-5126488ad476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_aaa9d281-116a-4aca-adc6-5126488ad476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_9b6958a7-6fa1-4adb-80e6-6f576a51684c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentTerm_9b6958a7-6fa1-4adb-80e6-6f576a51684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_72c249b3-28ad-4246-a95e-b58e4545168e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_72c249b3-28ad-4246-a95e-b58e4545168e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_ae799d9e-0d47-452e-8050-09efe5ae7259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_InterestExpenseDebt_ae799d9e-0d47-452e-8050-09efe5ae7259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d6d53061-511f-4c4c-8913-f80bdd52ec92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_d6d53061-511f-4c4c-8913-f80bdd52ec92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_98a913ce-211e-4389-88fa-f0f406afcc85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_98a913ce-211e-4389-88fa-f0f406afcc85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchaseAmount_2f483d0c-f348-49aa-a13f-0c44d6b93f76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchaseAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentRepurchaseAmount_2f483d0c-f348-49aa-a13f-0c44d6b93f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_2fe5965d-2334-4d26-bad5-7c6b5ea8a3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_2fe5965d-2334-4d26-bad5-7c6b5ea8a3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_ee7fdb18-e502-4443-9d5e-3a5b2c812c1c" xlink:href="lgnd-20220331.xsd#lgnd_RepaymentsOfNotesPayableInterestPortion"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_RepaymentsOfNotesPayableInterestPortion_ee7fdb18-e502-4443-9d5e-3a5b2c812c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d46073c2-b8c9-4e94-b95d-0e20a3ba5a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d46073c2-b8c9-4e94-b95d-0e20a3ba5a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc4a6b73-e68c-4482-95c3-dcc34bc9e4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc4a6b73-e68c-4482-95c3-dcc34bc9e4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_IncreaseDecreaseInDebtDiscount_90f434ad-c30a-4136-a196-1b30369cf541" xlink:href="lgnd-20220331.xsd#lgnd_IncreaseDecreaseInDebtDiscount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_IncreaseDecreaseInDebtDiscount_90f434ad-c30a-4136-a196-1b30369cf541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_826cb17f-5099-41b1-8d65-19e4046b9992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_826cb17f-5099-41b1-8d65-19e4046b9992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsForConvertibleBondHedges_fa36f0dc-444b-4c1e-89f5-cb280170386c" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsForConvertibleBondHedges"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_PaymentsForConvertibleBondHedges_fa36f0dc-444b-4c1e-89f5-cb280170386c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_96844769-b527-4b4f-9351-2d3258a20087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_96844769-b527-4b4f-9351-2d3258a20087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_10d73688-9562-4567-a460-16b199c7e930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_10d73688-9562-4567-a460-16b199c7e930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_0c1805aa-8998-4e1a-bdbf-067eeba14955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentIncreaseAccruedInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_us-gaap_DebtInstrumentIncreaseAccruedInterest_0c1805aa-8998-4e1a-bdbf-067eeba14955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_PaymentsToUnwindWarrants_76596c11-c6bd-4b46-9ab6-699115794681" xlink:href="lgnd-20220331.xsd#lgnd_PaymentsToUnwindWarrants"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_PaymentsToUnwindWarrants_76596c11-c6bd-4b46-9ab6-699115794681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_df8f7c78-5226-4f65-9c64-ceac20e72a68" xlink:href="lgnd-20220331.xsd#lgnd_ProceedsFromUnwindingConvertibleBondHedges"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_ProceedsFromUnwindingConvertibleBondHedges_df8f7c78-5226-4f65-9c64-ceac20e72a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4ed3915e-fa16-4707-a380-817f2614d0f3" xlink:href="lgnd-20220331.xsd#lgnd_NumberOfOptionsUnderConvertibleBondHedges"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_629fac37-f68a-431e-9f86-d90e301de8b2" xlink:to="loc_lgnd_NumberOfOptionsUnderConvertibleBondHedges_4ed3915e-fa16-4707-a380-817f2614d0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#ConvertibleSeniorNotesNotesPayableDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_883c60a8-22cc-4e99-8efe-0214bd0f49b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_883c60a8-22cc-4e99-8efe-0214bd0f49b3" xlink:to="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e42d7559-696a-4b4e-8b3f-968b8e89795e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e42d7559-696a-4b4e-8b3f-968b8e89795e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f034e554-4aa3-42c9-9515-35a9bc61d5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e42d7559-696a-4b4e-8b3f-968b8e89795e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f034e554-4aa3-42c9-9515-35a9bc61d5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableMember_dfb2f34c-3f0d-4182-b255-e213d5410ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleNotesPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f034e554-4aa3-42c9-9515-35a9bc61d5ed" xlink:to="loc_us-gaap_ConvertibleNotesPayableMember_dfb2f34c-3f0d-4182-b255-e213d5410ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_068405e4-c9fd-4178-a999-e0ee832105b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:to="loc_us-gaap_DebtInstrumentAxis_068405e4-c9fd-4178-a999-e0ee832105b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_26acbdae-0708-4151-b677-1624f05bf27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_068405e4-c9fd-4178-a999-e0ee832105b7" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_26acbdae-0708-4151-b677-1624f05bf27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_ConvertibleSeniorNotesDue2023Member_15c511c7-5760-4e95-b3d7-5bb3cfb2f1ee" xlink:href="lgnd-20220331.xsd#lgnd_ConvertibleSeniorNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_26acbdae-0708-4151-b677-1624f05bf27f" xlink:to="loc_lgnd_ConvertibleSeniorNotesDue2023Member_15c511c7-5760-4e95-b3d7-5bb3cfb2f1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f71be5c-b97a-4e57-aec6-f69fdf77eaed" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:to="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_551990f7-d95d-447e-891a-21494215ff59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_551990f7-d95d-447e-891a-21494215ff59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_4c87e5b9-beb3-4fab-bfd2-23710617b48f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_4c87e5b9-beb3-4fab-bfd2-23710617b48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_9f9f7bc3-ac20-460d-bf76-44bb2f218d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract_82262845-8b4c-46ee-967d-b55cf0a9bc47" xlink:to="loc_us-gaap_LongTermNotesPayable_9f9f7bc3-ac20-460d-bf76-44bb2f218d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_67e49101-c811-4f5d-afab-34aebd6eb0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a1bac58d-effd-4ec5-bfec-fb9e1fc4029f" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_67e49101-c811-4f5d-afab-34aebd6eb0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTax" xlink:type="simple" xlink:href="lgnd-20220331.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b2161248-6b8d-4e91-a439-2cd0a92adf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_91e78896-2b1e-49cf-8f19-6514035d2dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b2161248-6b8d-4e91-a439-2cd0a92adf2a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_91e78896-2b1e-49cf-8f19-6514035d2dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#IncomeTaxDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/IncomeTaxDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_895abc2f-7321-4b4a-9f3d-fd84a08f9cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d69c2adc-17e2-46a9-a177-5f9a2f4baa96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_895abc2f-7321-4b4a-9f3d-fd84a08f9cb8" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_d69c2adc-17e2-46a9-a177-5f9a2f4baa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquity" xlink:type="simple" xlink:href="lgnd-20220331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d2859808-a616-49f0-a70f-83341f535e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c4c52aad-7e6b-4983-aa7d-184e62099558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d2859808-a616-49f0-a70f-83341f535e19" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c4c52aad-7e6b-4983-aa7d-184e62099558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="lgnd-20220331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5df5370b-25f1-417a-b093-dadf22a64908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_832dd62c-e999-46d6-bcdb-363cc8116d16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5df5370b-25f1-417a-b093-dadf22a64908" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_832dd62c-e999-46d6-bcdb-363cc8116d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_5be093b3-d23c-4c51-9dca-181bd16f1ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5df5370b-25f1-417a-b093-dadf22a64908" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_5be093b3-d23c-4c51-9dca-181bd16f1ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7c508a30-d604-4689-bb89-8937ad49c59f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b8eefbf8-2ac9-4879-ad22-04a651ec999e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7c508a30-d604-4689-bb89-8937ad49c59f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b8eefbf8-2ac9-4879-ad22-04a651ec999e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e62d5748-b8cc-4f5c-98df-a0309a3cc46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b8eefbf8-2ac9-4879-ad22-04a651ec999e" xlink:to="loc_us-gaap_AwardTypeAxis_e62d5748-b8cc-4f5c-98df-a0309a3cc46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e62d5748-b8cc-4f5c-98df-a0309a3cc46c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_90a95d31-077f-4490-bda2-175ab5bcab07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_90a95d31-077f-4490-bda2-175ab5bcab07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9794095d-0d47-49c7-a69f-a6d8060fd9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2ae6de9f-2a30-48f7-98eb-00ec1bd334b2" xlink:to="loc_us-gaap_RestrictedStockMember_9794095d-0d47-49c7-a69f-a6d8060fd9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b8eefbf8-2ac9-4879-ad22-04a651ec999e" xlink:to="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f00ce40-d382-437b-96f9-e91639df1c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4f00ce40-d382-437b-96f9-e91639df1c39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b74980d-5c6e-4435-818a-b0041cacf7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_7b74980d-5c6e-4435-818a-b0041cacf7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5c4f5fe-159f-4735-a306-55f2d369c486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5c4f5fe-159f-4735-a306-55f2d369c486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_46fc883f-f3d3-4180-9dc7-36fc61da8adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_46fc883f-f3d3-4180-9dc7-36fc61da8adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d77ca0e5-de08-4887-b2ec-dc8e63d3b70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_adb591c5-cee3-4ef8-8e77-e22c9ac55ebe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d77ca0e5-de08-4887-b2ec-dc8e63d3b70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e4573fb-dec5-41d9-b563-8e5bd26069b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0e4573fb-dec5-41d9-b563-8e5bd26069b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1f8dd16f-4b09-480b-ac13-5539f4d1a7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1f8dd16f-4b09-480b-ac13-5539f4d1a7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_61ef4202-be82-426d-84ab-fc8345f3d5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_61ef4202-be82-426d-84ab-fc8345f3d5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eb95f8a4-21ee-4adf-9a3d-814c59a2c1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_eb95f8a4-21ee-4adf-9a3d-814c59a2c1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a29c9302-a5e6-4c12-8ccc-bee00640d557" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7b8c2b4e-ce52-4ef8-8938-17c3aba00b8a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a29c9302-a5e6-4c12-8ccc-bee00640d557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_129199c2-2f87-4979-a1d4-1dfbfadec291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_129199c2-2f87-4979-a1d4-1dfbfadec291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_da1ced3c-7bbe-4154-9bf3-3e969d3dbd88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_da1ced3c-7bbe-4154-9bf3-3e969d3dbd88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_030d1149-b179-4ade-baa7-73d2fad84a79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_030d1149-b179-4ade-baa7-73d2fad84a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a08e3748-9191-466c-b075-f97da856d914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a08e3748-9191-466c-b075-f97da856d914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_69768f35-c1ca-4379-ab55-f9706482ccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7771d4f9-ffb4-4d98-be67-e99a6280cdbd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_69768f35-c1ca-4379-ab55-f9706482ccb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8fb75c30-2b2b-4c8f-a031-bc3bc37165e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a5500c55-4652-4df1-833f-736f64706b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a5500c55-4652-4df1-833f-736f64706b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f1970650-ec7b-43b3-9185-e77eb73498e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f1970650-ec7b-43b3-9185-e77eb73498e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c49f3c33-730b-432c-8517-393471bd002c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c49f3c33-730b-432c-8517-393471bd002c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6a0d5e8d-47e8-4dd3-9014-929ff3369dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_6a0d5e8d-47e8-4dd3-9014-929ff3369dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a609a6e6-e81d-4944-8a60-4428d4f7dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6db7fca4-c764-4a41-b8a9-cb50f0efe552" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a609a6e6-e81d-4944-8a60-4428d4f7dfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_532e6794-1999-4915-a189-8a80ab1c1e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_110bf807-4ccb-440d-9283-6763e45421ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_532e6794-1999-4915-a189-8a80ab1c1e7b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_110bf807-4ccb-440d-9283-6763e45421ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_110bf807-4ccb-440d-9283-6763e45421ff" xlink:to="loc_us-gaap_PlanNameAxis_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_629227be-3c47-4c22-925f-518264fba635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c86113dd-fe8d-4e59-a27d-a5bb1bf4bae0" xlink:to="loc_us-gaap_PlanNameDomain_629227be-3c47-4c22-925f-518264fba635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanMember_ef9c97f7-faf4-4fca-a1bd-b94ec3b62bff" xlink:href="lgnd-20220331.xsd#lgnd_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_629227be-3c47-4c22-925f-518264fba635" xlink:to="loc_lgnd_EmployeeStockPurchasePlanMember_ef9c97f7-faf4-4fca-a1bd-b94ec3b62bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_110bf807-4ccb-440d-9283-6763e45421ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c6f4f3c7-f022-46ae-a76b-279e638c3e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c6f4f3c7-f022-46ae-a76b-279e638c3e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e22765b5-75e4-462f-89b7-9eee6b59efcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e22765b5-75e4-462f-89b7-9eee6b59efcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:href="lgnd-20220331.xsd#lgnd_EmployeeStockPurchasePlanAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_34bb78f3-61e1-4279-90f4-ce4221c6630d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate_34bb78f3-61e1-4279-90f4-ce4221c6630d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_92b6def1-c371-4351-b462-ffba9573bf18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_lgnd_EmployeeStockPurchasePlanAbstract_d39f9770-cbd5-4872-bc3b-7492dacda6b9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod_92b6def1-c371-4351-b462-ffba9573bf18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_120181b8-658c-45a3-8f8d-887528792784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_120181b8-658c-45a3-8f8d-887528792784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6b60ad42-24e4-4398-b290-2f1d882c32eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_6b60ad42-24e4-4398-b290-2f1d882c32eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_fc52371f-8dce-45e1-8203-435b2d054e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_fc52371f-8dce-45e1-8203-435b2d054e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cdd23678-c087-4269-a414-92ad90ba374a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_27e71163-e05b-48bc-b477-c16548233551" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_cdd23678-c087-4269-a414-92ad90ba374a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CommitmentandContingenciesLegalProceedings"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6111f40c-e652-49c4-a69e-415d7c9ab5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4cb088fc-ebc2-4f64-8be5-ce5fb1862026" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6111f40c-e652-49c4-a69e-415d7c9ab5e6" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4cb088fc-ebc2-4f64-8be5-ce5fb1862026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#CommitmentandContingenciesLegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_10e79ef5-e1d2-42ca-9752-505f24c068a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_01e53e6a-ff61-4bad-a225-b70e2b10bd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_10e79ef5-e1d2-42ca-9752-505f24c068a1" xlink:to="loc_us-gaap_LossContingenciesTable_01e53e6a-ff61-4bad-a225-b70e2b10bd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_01e53e6a-ff61-4bad-a225-b70e2b10bd96" xlink:to="loc_srt_LitigationCaseAxis_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7c3021f7-646e-49fa-a9e1-0b05c9fb570c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_7d926e0a-e27e-4967-9b58-7e5b22f3e0e9" xlink:to="loc_srt_LitigationCaseTypeDomain_7c3021f7-646e-49fa-a9e1-0b05c9fb570c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_93c1a790-7986-43ce-bc2d-6e01318ae8c7" xlink:href="lgnd-20220331.xsd#lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7c3021f7-646e-49fa-a9e1-0b05c9fb570c" xlink:to="loc_lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember_93c1a790-7986-43ce-bc2d-6e01318ae8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_738e3836-7e6c-4696-9039-901361fc1e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_01e53e6a-ff61-4bad-a225-b70e2b10bd96" xlink:to="loc_us-gaap_LossContingenciesLineItems_738e3836-7e6c-4696-9039-901361fc1e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_1cb31d93-3bed-4717-bc08-cc48ba02869f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_738e3836-7e6c-4696-9039-901361fc1e79" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_1cb31d93-3bed-4717-bc08-cc48ba02869f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/Leases" xlink:type="simple" xlink:href="lgnd-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0240aa51-d622-421b-83d1-612cae979350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_36cfc063-2eac-44ca-b7a9-76f9e339d163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0240aa51-d622-421b-83d1-612cae979350" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_36cfc063-2eac-44ca-b7a9-76f9e339d163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_2f974598-3faf-40cb-936b-efb184207c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0240aa51-d622-421b-83d1-612cae979350" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_2f974598-3faf-40cb-936b-efb184207c35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesTables" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_889c9bd9-f4c4-4ef0-a215-4fc69b061ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_2638091a-571d-4633-808a-399496f22cc7" xlink:href="lgnd-20220331.xsd#lgnd_AssetsAndLiabilitiesLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_889c9bd9-f4c4-4ef0-a215-4fc69b061ea3" xlink:to="loc_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock_2638091a-571d-4633-808a-399496f22cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e40bc900-6b33-4202-abcd-5a9657595631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_889c9bd9-f4c4-4ef0-a215-4fc69b061ea3" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e40bc900-6b33-4202-abcd-5a9657595631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d868fff6-0be3-41ba-951f-bbd23504ef03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d44d5456-d41d-4e26-a2cc-840d6e717f29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d868fff6-0be3-41ba-951f-bbd23504ef03" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d44d5456-d41d-4e26-a2cc-840d6e717f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4079300e-146b-4d97-b980-53ce4fc544b5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d44d5456-d41d-4e26-a2cc-840d6e717f29" xlink:to="loc_srt_RangeAxis_4079300e-146b-4d97-b980-53ce4fc544b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f2c491ac-618c-42f6-9d7c-6e4f5d4fc41f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4079300e-146b-4d97-b980-53ce4fc544b5" xlink:to="loc_srt_RangeMember_f2c491ac-618c-42f6-9d7c-6e4f5d4fc41f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc181993-c97a-47d7-b67f-62d85cca1b1c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f2c491ac-618c-42f6-9d7c-6e4f5d4fc41f" xlink:to="loc_srt_MaximumMember_bc181993-c97a-47d7-b67f-62d85cca1b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d44d5456-d41d-4e26-a2cc-840d6e717f29" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b10400d1-4ce2-4a0b-a8a4-ec5f15d78e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_b10400d1-4ce2-4a0b-a8a4-ec5f15d78e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b1e4184b-39c2-47f5-afd5-88a7f9f2ac1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d69411b7-7b54-4e59-9315-1a3d700bc8f6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_b1e4184b-39c2-47f5-afd5-88a7f9f2ac1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_67230d0a-7b47-4017-a667-233f47064f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b9a85a75-7a2b-4877-9531-2b9aed03c2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67230d0a-7b47-4017-a667-233f47064f22" xlink:to="loc_us-gaap_AssetsAbstract_b9a85a75-7a2b-4877-9531-2b9aed03c2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_010c06ea-1e22-4c57-9bc6-749de69a2a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b9a85a75-7a2b-4877-9531-2b9aed03c2cb" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_010c06ea-1e22-4c57-9bc6-749de69a2a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_c8f2562a-a042-4ab3-914c-060096466f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b9a85a75-7a2b-4877-9531-2b9aed03c2cb" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_c8f2562a-a042-4ab3-914c-060096466f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseRightOfUseAsset_d9ecd1c0-66ce-49bd-8d57-f45a4609cec1" xlink:href="lgnd-20220331.xsd#lgnd_LeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b9a85a75-7a2b-4877-9531-2b9aed03c2cb" xlink:to="loc_lgnd_LeaseRightOfUseAsset_d9ecd1c0-66ce-49bd-8d57-f45a4609cec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_88ee2b8e-47c5-4918-99cc-a579fe821a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67230d0a-7b47-4017-a667-233f47064f22" xlink:to="loc_us-gaap_LiabilitiesAbstract_88ee2b8e-47c5-4918-99cc-a579fe821a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_275f855d-68c0-4d31-ae74-0d5ece3fbc37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_88ee2b8e-47c5-4918-99cc-a579fe821a9e" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_275f855d-68c0-4d31-ae74-0d5ece3fbc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8442b2ee-c045-4a5b-a71b-0a0e92bfcce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_275f855d-68c0-4d31-ae74-0d5ece3fbc37" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8442b2ee-c045-4a5b-a71b-0a0e92bfcce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_4d2cb1b2-68e2-4af5-bba8-93abd5e58910" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_275f855d-68c0-4d31-ae74-0d5ece3fbc37" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_4d2cb1b2-68e2-4af5-bba8-93abd5e58910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiabilityCurrent_c65d4a5f-8886-4497-b062-559377ced74a" xlink:href="lgnd-20220331.xsd#lgnd_LeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_275f855d-68c0-4d31-ae74-0d5ece3fbc37" xlink:to="loc_lgnd_LeaseLiabilityCurrent_c65d4a5f-8886-4497-b062-559377ced74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_ef89963b-c322-4001-a1b4-4e4294412ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_88ee2b8e-47c5-4918-99cc-a579fe821a9e" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_ef89963b-c322-4001-a1b4-4e4294412ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_435a2d29-ecda-4dbc-93e9-3ab7827a6bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_ef89963b-c322-4001-a1b4-4e4294412ebe" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_435a2d29-ecda-4dbc-93e9-3ab7827a6bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fd48b8ca-ce5b-4d16-8c81-722f337e11de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_ef89963b-c322-4001-a1b4-4e4294412ebe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_fd48b8ca-ce5b-4d16-8c81-722f337e11de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_lgnd_LeaseLiability_a0043291-e3e4-41fb-83c6-c92f639781b8" xlink:href="lgnd-20220331.xsd#lgnd_LeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_67230d0a-7b47-4017-a667-233f47064f22" xlink:to="loc_lgnd_LeaseLiability_a0043291-e3e4-41fb-83c6-c92f639781b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_080e1e4c-347f-4ab4-9ffa-4ebfbd89dc13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_080e1e4c-347f-4ab4-9ffa-4ebfbd89dc13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_720ba477-a88b-456e-bda6-31d997751016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_720ba477-a88b-456e-bda6-31d997751016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_179929df-84c6-46f3-8062-342226668d17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_179929df-84c6-46f3-8062-342226668d17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bafab527-faea-42b5-828c-f1732b4e0583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bafab527-faea-42b5-828c-f1732b4e0583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1c1b0bdc-fe1c-4f2b-b4c7-61a2079088b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1c1b0bdc-fe1c-4f2b-b4c7-61a2079088b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_56f9c921-eaa5-4363-ae0b-8f7804e99f95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_56f9c921-eaa5-4363-ae0b-8f7804e99f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9f869cd8-1d46-4628-b10d-62fa93ccd8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_9f869cd8-1d46-4628-b10d-62fa93ccd8f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_23e494b5-7b0f-4d67-a768-796d98cf7fad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_23e494b5-7b0f-4d67-a768-796d98cf7fad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_27ca208b-0054-43d5-8a3f-b47408ca8508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_27ca208b-0054-43d5-8a3f-b47408ca8508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d09a5341-e165-4c5a-ae43-07f4370d355d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f9689f8-a4cc-4904-9497-9c9955ffc4df" xlink:to="loc_us-gaap_OperatingLeaseLiability_d09a5341-e165-4c5a-ae43-07f4370d355d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="lgnd-20220331.xsd#LeasesMaturityofOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>lgnd-20220331_g1.jpg
<TEXT>
begin 644 lgnd-20220331_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!817AI9@  34T *@    @ ! $Q  (
M   1    /E$0  $    ! 0   %$1  0    !   N(U$2  0    !   N(P
M  !!9&]B92!);6%G95)E861Y  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (+!<8# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "ODS]K?_@KKX'_ &:?%U[X9TO3+WQEXDTUS#>PV\PMK2SD'6-Y
MBK$N#C(1& Y!(((KZSK^=+7];N?$VNWNI7DAFO-0G>YG<]7D=BS'\2332 ^R
MO&__  70^*>N3NNBZ'X0T*V/W,V\UU.OU=I A_[X%<1>_P#!87X]W:2"/Q5I
M]L7SM,>BVA,?TW1G]<U\PT55D!],V/\ P5^^/MI#MD\86ETV<[Y=%L@WT^6(
M#]*ZOPG_ ,%O?C'H4R?VA;>$-;B'#BXT]XG8<=#%(H!_ CGI7QW118#]3_V>
M/^"XGA/Q_KMGI/CKP_/X/ENG$0U*"Y^U6"L3P9 55XE[9^<#J2!DC[GAF2YA
M22-UDCD4,K*<A@>A![BOYR:_<G_@F[XBN_%/[#GPXNKV5IITTLVP8DD[(99(
M8QSZ(BC\*30'M]%%%2 4444 %%%% &=XL\6Z9X#\-7NLZS?VNF:5IT1GN;JY
MD$<4"#J6)_R:_-?]K;_@MMK6NZG=:-\)K9-(TR)FC_MV]@$EW=#INBA<%8E/
M4%PS$8.$.17&_P#!7?\ ;<N_C3\5;KX>Z%=M'X1\)7)AN_*?Y=4OD.'9L=4B
M.44=-P9N<KCV_P#X)L_\$WM$^%?P^M_BI\3;"*\U9[4ZE8:;=0^9%H]N%+B:
M2/!WSE1N (.P8XW_ '7;N!\I>'?V9?VD?VU+==7GLO%^O:?>#S4O=<U$V]K(
MO4&,3NH9<]/+4C\JU]8_X)"_'SP=$+ZQT*QO9H0S#^S]8@69,#G&]D))!/"D
MD\^V?M'Q)_P6\^"^ASLEK#XSUE0<![/3(U5NO(\Z6,_IWJGIG_!=#X/7]ZD4
MNC^/[)&.#--IUL43W(2Y9OR!IW8'Q1X,_;8_:"_8J\9)I.M:CXB7[-@R:)XJ
MBEN(I(^@V>8?,5#V:)U!]2*_1W]B'_@HQX1_;)T[[ BCP_XRM8]]SH]Q*&\X
M <R6[\>:@[C 9>XQACM/=?!W_@I5\';JUAN=-\6:0A 8HIAO](E8?*P# 20O
M\IP<88*1\RY%?E!^TU\ /%G_  3Z_:3BM;74;J":PE74O#^M0#RS<Q;CM?N
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MIKEW/?W/A359-+M[B9R\CV_E1RQJS'DE2[*,]%"CM7UM7PQ_P09_Y-T\8_\
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M(UST 29R /0"OV;HI\P'YL? K_@@]?2WD5U\1_%UM#;J06T_05:1Y!GH9Y5
M7W C;KP1BOO[X/\ P4\+? /P7!X?\(Z+9Z)I<'/EP*2\S="\CG+2.?[S$G@<
M\5U-%%P"BBBD!_./1116@!1110 4444 ?JC_ ,$&?^3=/&/_ &,9_P#26&ON
M>OAC_@@S_P FZ>,?^QC/_I+#7W/4/< HHHI %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6#XW^*/AKX:VPF\0Z_HVAQL-RF^O(X-X_V0Q!/X5\?_P#!0/\ X**Z
MCX*\37G@7P#="UO;%C#JVK( SPR=X(>H#+T9^H;(&"":^#]:UR]\2:I-?:C>
M75_>W#;Y;BYE:664^K,Q))^IK\CXH\5\+EV(E@\#3]K.+LVW:*?9;MVZ[+S9
M^Q<*>$6*S+#QQF/J>RA)722O)KHWLHWZ;OR1^KVN?\%'?@QH3LC^-(;B11D+
M;6%U,&^C+&5_6LK_ (>C?!K_ *&"_P#_  57/_Q%?E917P,_&7.F[QITDO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "OYQZ_HXK^<>JB 44450!1110 5^WG_!+S_DPOX=?]><
M_P#Z5S5^(=?MY_P2\_Y,+^'7_7G/_P"E<U*0'OE%%%0 4444 %%%% !1110
M4444 %%%% !1110!_./1116@!1110 4444 ?JC_P09_Y-T\8_P#8QG_TEAK[
MGKX8_P""#/\ R;IXQ_[&,_\ I+#7W/4/< HHHI %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7\X]?T<5_./51 ****H HHHH *_;S_@EY_P F%_#K
M_KSG_P#2N:OQ#K]O/^"7G_)A?PZ_Z\Y__2N:E(#WRBBBH **** "BBB@ HHH
MH **** "BBB@ HHHH _G'HHHK0 HHHH **** /U1_P""#/\ R;IXQ_[&,_\
MI+#7W/7PQ_P09_Y-T\8_]C&?_26&ON>H>X!1112 **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%<AXH_:"\!>!Y3'K7C?PAH[J<%;W6;>W(/T=Q0!U]%
M>/:A_P % _@IIJJ9/B9X2;?T\J]$OY[,X_&C3_\ @H'\%-25C'\3/"2[.OFW
MHB_+?C/X4 >PT5P.A?M6?"_Q.R+IWQ&\"WLCA2(X==M6?GH"H?(/L1FNVTS5
MK76K19[.YM[N!NDD,@D0]^HX[T 6**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BL_P 0>+=*\)VXFU74]/TR
M$\A[NX2%?S8@5PVL_MC_  E\/LRW?Q-\!Q2*0&C&NVSR+D9&55R1Q[4 >DT5
MXU>_\%#/@E83^7)\2_"S,!G,=SYJ_FH(JSIO[>WP7U98S%\3O!J>:VT>=J4<
M.#G'.\C ]S@4 >N45R_A7XW^"_';JNA^+_"^LL^-HL=5@N"V>F-C&NHH ***
M* "BBB@ HHHH *_G'K^CBOYQZJ(!1115 %%%% !7[>?\$O/^3"_AU_UYS_\
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MGFM;JV<2PS0N4DB<'(96'((/((K]9?\ @F)_P4I3]H[3X/ _C6XA@\<V,/\
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M $U^\?X=N-S?GW<W,E[<R332/+-*Q=W=BS.Q.223R23WIE%6D 4444 %%%%
M!1110 4444 %%%% !1110 5H>%?%FI^!?$5GJ^C:A>:5JFGR"6VN[65HIH''
M=6'(_P#KUGT4 ?J+^P1_P6!L?B/)8^$?BI-;:5KS[8;37N(K/4&Z!9QP(9#_
M 'A\C$_P< _>2L&4$$$'D$=Z_G(K[@_X)R?\%5KWX,36'@CXBW<^H>$"5@L=
M4D)DGT0<X5^"TD'08^]&!QE0%$M ?JQ7\X]?T8:1J]IX@TJVOK&Y@O+*\B6>
MWN()!)%-&PRKJPX*D$$$=<U_.?1$ HHHJ@"BBB@ K]O/^"7G_)A?PZ_Z\Y__
M $KFK\0Z_;S_ ()>?\F%_#K_ *\Y_P#TKFI2 ]\HHHJ "BBB@ HHHH ****
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M110 4444 ?SCT445H 4444 %%%% 'ZH_\$&?^3=/&/\ V,9_])8:^YZ^&/\
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M=^TG)\3/@3J'@74KCS-3\#2+]C+M\TEC,6*#GD^7('7T"M&*_)ZOH+_@E_\
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M]I/_ ).+\??]C'J/_I5)7%5H@"BBB@ HHHH **** "BBNK^"_P $_$W[07Q
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M544 ?@-^T3^S'XR_9:\;MH7C#2GLIGRUM=1YDM+] <;X9, ,.F1PPR,@'BN
MK^@[XR_!7PQ\?_ =WX;\6Z3;ZOI-WR4D&'A<9Q)&X^9'&3AE(/)'0D5^0_[>
MO_!-[Q'^Q[J[ZM8&?7O =U*%MM2"CS;)FSB*Y4?=;L' VMQ]TG:+3 ^::***
M8!1110 4444 %%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DP
MOX=?]><__I7-2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT44
M5H 4444 %%%% 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8
MS_Z2PU]SU#W ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQS^SSX$UIFWOJOAZPNW.>=SV\;,#R>02<\GFNTK, HHHH **** /Y_/VD_\
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M110 4444 %%%% !1110 4444 ?S^?M)_\G%^/O\ L8]1_P#2J2N*KM?VD_\
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M HHHH **** -CX?^ -8^*?C73?#N@6$^IZQJ\XM[6VB&6D8_H !DDG@ $D@
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MU:8!1113 **** "OV\_X)>?\F%_#K_KSG_\ 2N:OQ#K]O/\ @EY_R87\.O\
MKSG_ /2N:E(#WRBBBH **** "BBB@ HHHH **** "BBB@ HHHH _G'HHHK0
MHHHH **** /U1_X(,_\ )NGC'_L8S_Z2PU]SU\,?\$&?^3=/&/\ V,9_])8:
M^YZA[@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?_26&ON>H>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MG_TEAK[GJ'N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@L/%>BVNI:7>VFHZ=>QB:WNK:5989T/1E=20P/J#4- 7****0!1110 4444
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M(Y]V/)JO113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#]F/\
M@CO_ ,F&>&/^OR__ /2J2OJ"OE__ (([_P#)AGAC_K\O_P#TJDKZ@J& 4444
M@"BBB@#^?S]I/_DXOQ]_V,>H_P#I5)7%5VO[2?\ R<7X^_[&/4?_ $JDKBJT
M0!1110 4444 ?M5_P23_ .4?/P__ .XC_P"G*ZKZ.KYQ_P""2?\ RCY^'_\
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M<=.5-? WQA^./BSX_>+7USQAKM_KNHL"J/</\D"YSLC086-,_P *@"N4HII
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MO_@YM/\ XNC_ (<[_'K_ *%?3?\ P<VG_P 71<#Y?HKZ@_X<[_'K_H5]-_\
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M% 'ZH_\ !!G_ )-T\8_]C&?_ $EAK[GKX8_X(,_\FZ>,?^QC/_I+#7W/4/<
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MA7>Y520BY R?09(&?<4R@ HHHH **** "BBB@ HHHH **** "BBB@ HH +$
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MX[U3XG^-M5\1:W=O>ZMK5T]W=3/U>1R2<#L!T '   ' K(JT@"BBBF 4444
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M"VABMX(AM2.- B(/0 <"I:*0!1110 4444 %%%% !1110!^$'[=W_)YOQ/\
M^QDO?_1K5Y-7K/[=W_)YOQ/_ .QDO?\ T:U>35H@"BBB@ HHHH _9C_@CO\
M\F&>&/\ K\O_ /TJDKZ@KY?_ ."._P#R89X8_P"OR_\ _2J2OJ"H8!1112 *
M*** /Y_/VD_^3B_'W_8QZC_Z525Q5=K^TG_R<7X^_P"QCU'_ -*I*XJM$ 44
M44 %%%% '[5?\$D_^4?/P_\ ^XC_ .G*ZKZ.KYQ_X))_\H^?A_\ ]Q'_ -.5
MU7T=4, HHHI %%%% !1110 4444 %%%% !1110 4444 ?./_  5L_P"4?/Q
M_P"X=_Z<K6OQ5K]JO^"MG_*/GX@?]P[_ -.5K7XJU<0"BBBF 4444 =K^S9_
MR<7X!_[&/3O_ $JCK^@.OY_/V;/^3B_ /_8QZ=_Z51U_0'4R ****D HHHH
M_-7_ (+]Z:8O$OPPO-J!9[;4H0P^\2CVQP?8>8,?4U^>-?IK_P %]=!^T?#W
MX<ZGLR+/4;RUW;,X\V*)L9[9\GIWQ[5^956M@"BBBF 4444 =I^S?K1\-_M$
M> M1!(-AXCT^Y! R1LN8VZ'KTK^@2OYS+"]?3;Z&XB($MO(LB9&1D'(_E7]%
M.AZO%X@T6SOX#F"]@2XC.<Y5U##]#4R M4445(!1110 4444 %%%% !1110
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MHJ "BBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?\
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M%7P?PUI\N-;OX),KJLZ'(@0CK"C#)/1W QPH+?"-6D 4444P"BBB@ K]O/\
M@EY_R87\.O\ KSG_ /2N:OQ#K]O/^"7G_)A?PZ_Z\Y__ $KFI2 ]\HHHJ "B
MBB@ HHHH **** "BBB@ HHHH **** /YQZ***T **** "BBB@#]4?^"#/_)N
MGC'_ +&,_P#I+#7W/7PQ_P $&?\ DW3QC_V,9_\ 26&ON>H>X!1112 ****
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MW!'_ '[_ -[[OY5W-S)>W,DTTCRS2L7=W8LSL3DDD\DD]ZI(!E%%%4 4444
M%%%% !7[>?\ !+S_ ),+^'7_ %YS_P#I7-7XAU^WG_!+S_DPOX=?]><__I7-
M2D![Y1114 %%%% !1110 4444 %%%% !1110 4444 ?SCT445H 4444 %%%%
M 'ZH_P#!!G_DW3QC_P!C&?\ TEAK[GKX8_X(,_\ )NGC'_L8S_Z2PU]SU#W
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M@_;:_IS0VVL6H6#6=,#Y?3[C![=3&^"4;N,C[RL!Z[68!1110 4444 %%%%
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M:K_@DG_RCY^'_P#W$?\ TY75?1U?./\ P23_ .4?/P__ .XC_P"G*ZKZ.J&
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MDDD)9F8Y+$]23W--HHJ@"BBB@ HHHH **** "OV\_P""7G_)A?PZ_P"O.?\
M]*YJ_$.OV\_X)>?\F%_#K_KSG_\ 2N:E(#WRBBBH **** "BBB@ HHHH ***
M* "BBB@ HHHH _G'HHHK0 HHHH **** /:?V9_V^?B%^R9X4O]%\'W.E0V.I
M7?VV875DL[&38J<$G@84<5Z3_P /I/CA_P __AO_ ,%*?XU\FT4K ?67_#Z3
MXX?\_P#X;_\ !2G^-'_#Z3XX?\__ (;_ /!2G^-?)M%%D!]9?\/I/CA_S_\
MAO\ \%*?XT?\/I/CA_S_ /AO_P %*?XU\FT460'UE_P^D^.'_/\ ^&__  4I
M_C1_P^D^.'_/_P"&_P#P4I_C7R;119 ?67_#Z3XX?\__ (;_ /!2G^-'_#Z3
MXX?\_P#X;_\ !2G^-?)M%%D!]9?\/I/CA_S_ /AO_P %*?XT?\/I/CA_S_\
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MA!)%+$X=)5(R&5AP01W%35^+'[#O_!23Q=^R%JT.FW4EQXB\#ROB?2)I<M:
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M?_*/GX?_ /<1_P#3E=5]'5\X_P#!)/\ Y1\_#_\ [B/_ *<KJOHZH8!1112
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M$UXE10!_0]\.?B'H_P 6? VE^)/#]]%J.C:S;K<VMQ'T=3V(/*L#D%3RI!!
M((K:K\KO^",7[9$GPY^(Y^%VN7)_L+Q3,9-)>1N+*_Q_JQGHLP&,?\] F!\[
M&OU1J&@"BBBD!\@_\%8/V$G_ &E/AXGB_P ,61F\;^%X&!AB7,FKV8RS0@=6
MD0EF0#DY=<$LN/R&=#&Y5@593@@C!!K^C>OSU_X*A?\ !+N?Q;>ZA\2OAM8*
M^H.&N-;T.W0 W1 RUS;J!S(>2Z#ES\PRQ(:DP/S1HITL30R,CJR.A*LK#!4C
ML:;5 %%%% !1110 4444 %%%% !1110 4444 %%%% !76?!/X(>)OVA?B'9>
M&/"FFRZEJEZ>BC$5O&"-TLK]$C7/+'V R2 >[_9 _88\:_MC>*!!H=L=/T"V
ME":AKEU&?LMIW*KT\V3&,(I[C<5!W5^P7[+'[(W@[]D3P&-&\+V1-Q<8:_U.
MX :[U&0?Q.V.%'.U%PJY/&224V!P_P"R5^PQX?\ V,/@?JMO;^3J?BO4]/D.
MKZN4PTIV$^3%GE85/0=6(W'G 'XG5_1-XR_Y%#5?^O.;_P! -?SLTH@%%%%4
M 4444 ?LQ_P1W_Y,,\,?]?E__P"E4E?4%?+_ /P1W_Y,,\,?]?E__P"E4E?4
M%0P"BBBD 4444 ?S^?M)_P#)Q?C[_L8]1_\ 2J2N*KM?VD_^3B_'W_8QZC_Z
M525Q5:( HHHH **** /VJ_X))_\ */GX?_\ <1_].5U7T=7SC_P23_Y1\_#_
M /[B/_IRNJ^CJA@%%%%( HHHH **** "BBB@ HHHH **** "BBB@#YQ_X*V?
M\H^?B!_W#O\ TY6M?BK7[5?\%;/^4?/Q _[AW_IRM:_%6KB 4444P"BBB@#M
M?V;/^3B_ /\ V,>G?^E4=?T!U_/Y^S9_R<7X!_[&/3O_ $JCK^@.ID 4445(
M!1110 4444 %%%% 'YC_ /!6K_@G3)X1U+4/BKX'L0=&NF-QXAT^$<V,K'FZ
MC7_GFQ.7 ^XQW?=)V?G_ %_1K<VT=[;20S1I+#*I1T=0RNI&""#P01VK\P/^
M"C__  2@N?A[+?>.OA?I\UWX?.ZXU/0X07FTWDDR0*!EH?5.J8R,KG928'P3
M1115 %%%% !1110 4444 %%%% !1110 4444 %%%2V%A/JM]#;6L,US<W#B.
M**)"[RL3@*JCDDGH!0!%7U=_P3Y_X)DZW^U;J-OXC\2+=:'\/X7R9P-ESK!!
M(*6^1PF1AI#P.BY.=OM'[!/_  1SDN)++Q=\7[4QQ+B:S\,EOF?NK79!X'?R
M1R>-Y'S(?T<L+"#2K""UM8(;:UMHUBAAB0)'$BC"JJC@    #@ 5+8&?X&\"
MZ/\ #3PG8Z%H&G6FDZ1ID0AMK6V39'$H_F2<DDY))))))-?.O_!8C_DPSQ/_
M -?EA_Z51U]05\O_ /!8C_DPSQ/_ -?EA_Z51TD!^,]%%%6 4444 %?MY_P2
M\_Y,+^'7_7G/_P"E<U?B'7[>?\$O/^3"_AU_UYS_ /I7-2D![Y1114 %%%%
M!1110 4444 %%%% !1110 4444 ?AK_P4.^ =W^SU^UCXKTR6W>+3-5NY-7T
MN0KA);:=V<!3WV,6C/O&:\1K]XOVL_V//"'[8G@1-'\302PWED6DTW4[;"W6
MGR,!DJ2,,C8&Y#PV!T(5A^8WQY_X(_?%[X1:G.^BZ;%XYT9,F.[TIE$^.P>V
M8^8&]DWC_:JTP/E:BO2'_8W^+L;E3\+/B-E3CCPW>$?GY=)_PQU\7?\ HE?Q
M'_\ ":O?_C=,#SBBO1_^&.OB[_T2OXC_ /A-7O\ \;H_X8Z^+O\ T2OXC_\
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M?%FAZ=KVF2\^3=Q!]C8QN1OO(WHRD$>M-,#^>JBOTI_:,_X(56=^]QJ'PO\
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MG>$_"6E^!/#MII&BZ?9Z5I=A&(K>UM85BAA4=E5>!6C114@9OC+_ )%#5?\
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M HHJYH7AW4/%.I)9Z98WFHWDGW(+6%II&^BJ"30!U/[-G_)Q?@'_ +&/3O\
MTJCK^@.ORN_X)R?\$N?&NL_%K0/&_CS2;CPQX>\/746I6]E?)Y=[J,\;!XE,
M)^:.,. 6,@!(&T*0Q*_JC4M@%%%%2 4444 %%%% !1110 4444 ?%_[='_!(
MK0/CQ+>>)_ +6?ACQ=*3+/:%=FG:HW4DA1^YD/\ >4%2>JY)<?E[\6?@WXH^
M!?C"?0?%NB7VAZI!UBN$P)%Z;T<961#V920?6OZ$JY/XP_ OPC\?O"S:-XQT
M#3]>T\Y*+<)^\@8C!:.08>-L?Q(0?>FF!_/G17Z'?M'_ /!"R^L6GU#X7>(4
MOH>6&D:TPCF'M'<*-K>@#JO3ES7Q1\7OV:_'OP$O##XP\)ZWH0#;%GN+<FVD
M/HDRYC?_ ("QJDP.(HHHI@%%%% !1110 444 %B  23T% !17N7P)_X)R?%[
M]H&6"32O"=YI>F38/]I:R#8VH4_Q#>-\B_\ 7-&K[M_9H_X(G^!OAK+;ZGX]
MOI?&^JQX?[&JFWTR-NO*@[Y<?[3!3W0TFP/S_P#V7/V'?B#^UOJX3PSI+0Z1
M&^RYUF]#0V%OZC?@EV']U Q&1D <U^J?[&W_  3=\"?LAVT6H0PCQ'XO*8EU
MJ]B&Z$GJ+>/D0KVR"7.2"Q' ]]T?1K/P]I<%CI]I;6-E:H(X;>WB6**%1T55
M4  #T JS4M@%%%%( KY?_P""Q'_)AGB?_K\L/_2J.OJ"O._VK_@!;?M0? #Q
M%X)N+D6+:Q"IM[K9N%M/&ZR1.1W7>@! Y*DCO0@/P+HKU'XX_L7_ !-_9YU6
MY@\2^$=7AM+9RHU*VMVN+"8=F69 5Y'.&(8=P#Q7EU: %%%% !7[>?\ !+S_
M ),+^'7_ %YS_P#I7-7Y-_ C]B'XG?M%:U;6WA[PGJJV<[#=J=[ ]M80KW8S
M. #@<[5W,>P-?ME\!/A-;? GX+^&?!]K,US%X>T^*S,Q&#.ZCYY,=MSEFQVS
MBID!UU%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 54U?0;'Q!;>3?V5I?0G/[NXA65>>O# BK=% ''7G[._P_U"X::X\"^#IY
M7QN>31;9F; P,DIGI4?_  S7\.?^A \$_P#@CM?_ (BNUHH R- ^'V@>%91)
MI>AZ1IL@  :ULXX3@ @<J!V)'XFM>BB@ HHHH **** "OQL_X*W?M+M\>OVI
M;[2+*X,OA_P+OTFT"GY9+@$?:9?J9!LR."L*GO7ZJ_M3?%Y?@+^SMXQ\7;E6
M?1-,EEMMW1KAALA4^QE9!^-?@3=W4M]=2SS2/+-,Y>1W.6=B<DD]R3510$=%
M%%4 4444 %?IM_P19_8PC\.^&F^+GB"U!U'55>W\/1R+S;6^2LES@]&D(*J>
M,(&/(DX_/_\ 9P^#MQ^T!\=O"W@VV+HVOZA';RR)C=#"/FFD&>NR)7;'^S7[
MZ>&?#=CX-\-Z?I&F6T=GIVEVT=I:P1C"PQ1J%11[!0!4R8%ZBBBI **** "B
MBB@ HHHH **** "BBB@ HHHH **** $=%D0JP#*PP01D$5^(_P#P4L_9GB_9
MA_:GU?3=.@$'A[74&L:2BC"0Q2LP:$>@CD5U Z[0A/6OVYK\]O\ @OEX'CG\
M'?#SQ(J 36MY=:9(XQEUD1)$![\&)\?[QIH#\T****L HHHH *^O_P#@B3XM
M;P_^V<UAO(37M!N[0KDX9D:.<''J!$?S/K7R!7TA_P $D)6C_P""@O@$*S*'
M&HJP!QN']G71P?Q /X4F!^U%%%%0 4444 %%%% !1110!Y;\3_V)?A+\8WED
M\0^ /#=W<3Y\RYAMOLER^>YFAV2$_P# J\)\;_\ !#[X0>)'>32KWQ=X=<_=
MCM[Y)X5^HFC9S_WV*^R**=P/SK\1_P#! 6UD+-I'Q.N(0/NQWFAB3/3JZSKC
MO_":Y>Z_X('>*4N&$/Q!\/R1#[K/83(Q^H#''YU^GE%%V!^6=G_P07\?O< 7
M'C3P?%%W:-;F1A^!C7^=;FB_\$!]:G<?VC\2]+M5R<FVT:2X(&.#\TJ<Y[?_
M *J_3"BB[ ^$_!O_  09\!Z:ZMKWC/Q5JQ4Y*V<4%DK>QW+*<?0U[C\,O^"8
M_P $/A9(DMIX%T[5+E.?.UAWU D^NR4F,?@HKWNBB[ KZ5I-KH>GQ6EE;6]G
M:0#;'#!&(XXQZ!1@ ?2K%%%( HHHH **** "BBB@#$\1?#/PWXP=VU;P_HFJ
M-(-K&[L8IRP]#N4YK%_X9K^'/_0@>"?_  1VO_Q%=K10!R^C_!#P7X=DWZ?X
M0\+V+YW;K?2H(CGU^51S73JH50   . !VI:* "BBB@ HHHH **** "JFKZ#8
M^(+;R;^RM+Z$Y_=W$*RKSUX8$5;HH XZ\_9W^'^H7#37'@7P=/*^-SR:+;,S
M8&!DE,]*C_X9K^'/_0@>"?\ P1VO_P 17:T4 8^A?#W0/"TH?3-#T?3G& &M
M;*.$C ('*@= 3^=;%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% &/KOP]T#Q3*7U/0]'U%SD%KJRCF)R #RP/4 ?E6%_P ,U_#G_H0/
M!/\ X([7_P"(KM:* ./L_P!GGP!IUP);?P-X/@E7@/'HULK#\0E=+I&@V/A^
MV\FPLK2QA&/W=O"L2\=.% %6Z* "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ J*]L8-3M)+>YABN()E*21R('1P>H(/!%2T4 >'_ !._X)O?!3XLRR3:
MCX!TBSNI.3/I>_3GS_>(A*JQ_P!X&O$/&7_!"7X::LSOHOB?QAHSOG"3207<
M2>F!Y:MCZN:^WZ*=P/S;US_@@)=QR,=-^)]M*IR56YT)HROH"RSMGW.!]*YV
M^_X()^-HX,VWCKPK-)G[LMO<1KCZ@-_*OU&HHNP/RYL/^""GC>2$FZ\<^%89
M-W"Q07$@(]<E5YZ\8KJ?#W_! 1O,#:M\3QL!YCM-"Y(_WVGX_P"^37Z.T478
M'QMX"_X(??"+PS)'+K%]XL\2R#&^.XO4MH&QUPL**XS_ +YKZ"^$W[(7PQ^!
MK12>%O!'A_2[J YCN_LPGNU_[;R;I?\ QZO1Z*5P"BBB@ HHHH **** "BBB
M@ K \0_"CPMXM>1M5\-:!J;2_?-WI\,Q?G=SN4YYY^M;]% '%?\ #-?PY_Z$
M#P3_ .".U_\ B*U?#WPG\*^$9$?2?#7A_2WCY5K33H8"O.>-JC'(!^HKH**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#XT_P""X7Q ;PQ^R18:-$Y$GB;7(()%
MSC=#$CS,??$B1?G7Y)5^CO\ P7\UTA/A=IBL=I.I74BXX)_T54/ZO^=?G%5K
M8 HHHI@%%%% 'V?_ ,$-_ 2>)/VL-4UJ9 R>'-!FDA;'*32R1Q _]^S**_6F
MOS8_X(!::LNN?%*\+*'@@TR$+MY(=KHDY]O+'YCTK])ZA[@%%%%( HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *^%/\ @O1=1I^S]X+A+ 2R>(2ZKZJM
MM*"?P+#\Z^ZZ_,W_ (+X?$9+WQO\/_"<4@WZ=97.JW"#OYSK%&3]/(E_[Z^E
M-;@?GS1115@%%%% !7TG_P $B[.2Y_X* ^!G0 K;IJ,DG/1?[/N5_FPKYLK[
M+_X(<^#FU[]KK4=49#Y.A>'[B4/C@222Q1*/Q5I#_P !-)@?K;1114 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\C'_ "RVX/OZ\]:.8#\)**_8GXP?\$O?@5I&@?;;7P'';W#SHA,>K7ZKC:>
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412523912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 05, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LIGAND PHARMACEUTICALS INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">77-0160744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5980 Horton Street, Suite 405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Emeryville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94608<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">550-7500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LGND<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,861,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000886163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412196024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 14,993<span></span>
</td>
<td class="nump">$ 19,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">189,006<span></span>
</td>
<td class="nump">321,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">41,797<span></span>
</td>
<td class="nump">85,453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">25,614<span></span>
</td>
<td class="nump">27,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income taxes receivable</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,193<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">4,656<span></span>
</td>
<td class="nump">4,671<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">276,066<span></span>
</td>
<td class="nump">464,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes, net</a></td>
<td class="nump">35,655<span></span>
</td>
<td class="nump">34,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">539,707<span></span>
</td>
<td class="nump">551,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">181,206<span></span>
</td>
<td class="nump">181,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRights', window );">Commercial license rights, net</a></td>
<td class="nump">10,121<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">24,584<span></span>
</td>
<td class="nump">20,511<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">15,783<span></span>
</td>
<td class="nump">16,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Financing lease right-of-use assets</a></td>
<td class="nump">15,620<span></span>
</td>
<td class="nump">16,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">6,442<span></span>
</td>
<td class="nump">2,741<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,105,184<span></span>
</td>
<td class="nump">1,297,590<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,972<span></span>
</td>
<td class="nump">8,403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">15,877<span></span>
</td>
<td class="nump">17,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes liability</a></td>
<td class="nump">5,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights', window );">Current contingent liabilities</a></td>
<td class="nump">1,524<span></span>
</td>
<td class="nump">2,588<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">10,503<span></span>
</td>
<td class="nump">10,996<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">1,850<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">42,578<span></span>
</td>
<td class="nump">41,665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">2023 convertible senior notes, net</a></td>
<td class="nump">176,540<span></span>
</td>
<td class="nump">320,717<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LiabilityForContingentValueRights', window );">Long-term contingent liabilities</a></td>
<td class="nump">7,448<span></span>
</td>
<td class="nump">8,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes, net</a></td>
<td class="nump">39,480<span></span>
</td>
<td class="nump">59,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">16,758<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">29,188<span></span>
</td>
<td class="nump">30,977<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">311,992<span></span>
</td>
<td class="nump">476,431<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 60,000 shares authorized; 16,861 and 16,767 shares issued and outstanding at March&#160;31, 2022 and December&#160;31, 2021, respectively</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">325,368<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,031)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">468,838<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">793,192<span></span>
</td>
<td class="nump">821,159<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 1,105,184<span></span>
</td>
<td class="nump">$ 1,297,590<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CurrentPortionOfLiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CurrentPortionOfLiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LiabilityForContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LiabilityForContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412367336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (shares)</a></td>
<td class="nump">60,000<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (shares)</a></td>
<td class="nump">16,861<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (shares)</a></td>
<td class="nump">16,861<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799417851080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 45,693<span></span>
</td>
<td class="nump">$ 55,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostDirectMaterial', window );">Cost of Captisol</a></td>
<td class="nump">4,699<span></span>
</td>
<td class="nump">8,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization of intangibles</a></td>
<td class="nump">11,813<span></span>
</td>
<td class="nump">11,786<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">20,307<span></span>
</td>
<td class="nump">17,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">18,180<span></span>
</td>
<td class="nump">12,617<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="nump">54,999<span></span>
</td>
<td class="nump">50,435<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(9,306)<span></span>
</td>
<td class="nump">4,715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Gain (loss) from short-term investments</a></td>
<td class="num">(12,877)<span></span>
</td>
<td class="nump">13,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(789)<span></span>
</td>
<td class="num">(5,831)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">2,698<span></span>
</td>
<td class="num">(6,477)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (loss), net</a></td>
<td class="num">(10,834)<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income (loss) before income taxes</a></td>
<td class="num">(20,140)<span></span>
</td>
<td class="nump">5,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="nump">4,755<span></span>
</td>
<td class="nump">12,342<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (15,385)<span></span>
</td>
<td class="nump">$ 18,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income (loss) per share (USD per share)</a></td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="nump">$ 1.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in basic per share calculations (in shares)</a></td>
<td class="nump">16,824<span></span>
</td>
<td class="nump">16,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income (loss) per share (USD per share)</a></td>
<td class="num">$ (0.91)<span></span>
</td>
<td class="nump">$ 1.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in diluted per share calculations (in shares)</a></td>
<td class="nump">16,824<span></span>
</td>
<td class="nump">17,248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 45,693<span></span>
</td>
<td class="nump">$ 55,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">13,695<span></span>
</td>
<td class="nump">7,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">13,695<span></span>
</td>
<td class="nump">7,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">12,122<span></span>
</td>
<td class="nump">31,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,122<span></span>
</td>
<td class="nump">31,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">19,876<span></span>
</td>
<td class="nump">16,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 19,876<span></span>
</td>
<td class="nump">$ 16,766<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostDirectMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of material used for good produced and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostDirectMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27405-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(c),9(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412524760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss):</a></td>
<td class="num">$ (15,385)<span></span>
</td>
<td class="nump">$ 18,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized net loss on available-for-sale securities, net of tax</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income (loss)</a></td>
<td class="num">$ (15,499)<span></span>
</td>
<td class="nump">$ 18,051<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410134600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional paid in capital</div></th>
<th class="th">
<div>Additional paid in capital </div>
<div>Adjustment</div>
</th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th">
<div>Retained earnings </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (801)<span></span>
</td>
<td class="nump">$ 391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="nump">20,581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">20,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">8,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions', window );">Warrant and bond hedge unwind transactions</a></td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt', window );">Reacquisition of equity due to 2023 debt extinguishment, net of tax</a></td>
<td class="num">(9,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,086)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions', window );">Tax effect for 2023 Notes transactions</a></td>
<td class="num">(2,032)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,032)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">18,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2021</a></td>
<td class="nump">745,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">336,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(856)<span></span>
</td>
<td class="nump">410,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at beginning of period (shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2020</a></td>
<td class="nump">$ 709,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">318,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="nump">391,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2020-06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2021</a></td>
<td class="nump">$ 821,159<span></span>
</td>
<td class="num">$ (15,997)<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">372,969<span></span>
</td>
<td class="num">$ (51,130)<span></span>
</td>
<td class="num">(917)<span></span>
</td>
<td class="nump">449,090<span></span>
</td>
<td class="nump">$ 35,133<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes</a></td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss', window );">Unrealized net loss on available-for-sale securities, net of deferred tax</a></td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance at end of period (shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Mar. 31, 2022</a></td>
<td class="nump">$ 793,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 325,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,031)<span></span>
</td>
<td class="nump">$ 468,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123466103&amp;loc=SL6014347-161799<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410161624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">$ (15,385)<span></span>
</td>
<td class="nump">$ 18,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income (loss) to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights', window );">Change in estimated fair value of contingent liabilities</a></td>
<td class="num">(1,035)<span></span>
</td>
<td class="nump">1,684<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of intangible assets</a></td>
<td class="nump">13,655<span></span>
</td>
<td class="nump">12,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium on investments, net</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount and issuance fees</a></td>
<td class="nump">326<span></span>
</td>
<td class="nump">4,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights', window );">Amortization of commercial license rights</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss (gain) on debt extinguishment</a></td>
<td class="num">(1,532)<span></span>
</td>
<td class="nump">4,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="nump">8,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(16,180)<span></span>
</td>
<td class="num">(12,408)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_GainLossOnShortTermInvestments', window );">Loss (gain) from short-term investments</a></td>
<td class="nump">12,877<span></span>
</td>
<td class="num">(13,090)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="num">(80)<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="nump">43,638<span></span>
</td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(9,670)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(2,708)<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income tax receivable and payable</a></td>
<td class="nump">11,993<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(2,453)<span></span>
</td>
<td class="num">(5,695)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities</a></td>
<td class="num">(233)<span></span>
</td>
<td class="num">(3,768)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">52,011<span></span>
</td>
<td class="nump">10,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchase of short-term investments</a></td>
<td class="num">(38,190)<span></span>
</td>
<td class="num">(72,148)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfShortTermInvestments', window );">Proceeds from sale of short-term investments</a></td>
<td class="nump">132,866<span></span>
</td>
<td class="nump">109,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Proceeds from maturity of short-term investments</a></td>
<td class="nump">24,830<span></span>
</td>
<td class="nump">31,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Cash paid for equity method investment</a></td>
<td class="num">(750)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(4,875)<span></span>
</td>
<td class="num">(3,404)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(240)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">113,881<span></span>
</td>
<td class="nump">65,115<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repurchase of 2023 Notes</a></td>
<td class="num">(163,356)<span></span>
</td>
<td class="num">(108,822)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments under financing lease obligations</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(3,801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromHedgeFinancingActivities', window );">Proceeds from convertible bond hedge settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForHedgeFinancingActivities', window );">Payments to convertible bond holders for warrant purchases</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,459)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Net proceeds from stock option exercises and ESPP</a></td>
<td class="nump">347<span></span>
</td>
<td class="nump">26,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(5,862)<span></span>
</td>
<td class="num">(5,901)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity', window );">Payments to CVR Holders</a></td>
<td class="num">(1,416)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(121)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(170,421)<span></span>
</td>
<td class="num">(91,635)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(4,529)<span></span>
</td>
<td class="num">(15,766)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">19,522<span></span>
</td>
<td class="nump">47,963<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">14,993<span></span>
</td>
<td class="nump">32,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Taxes paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental schedule of non-cash activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued fixed asset purchases</a></td>
<td class="nump">2,574<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedInventoryPurchases', window );">Accrued inventory purchases</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized loss on AFS investments</a></td>
<td class="num">$ (114)<span></span>
</td>
<td class="num">$ (55)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedInventoryPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Inventory Purchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedInventoryPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Commercial License And Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_GainLossOnShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Short-term Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_GainLossOnShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHoldersFinancingActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders, Financing Activity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHoldersFinancingActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromHedgeFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 27<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3581-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromHedgeFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413517320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described our significant accounting policies in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 1, Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended March 31, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 is $341.1&#160;million which includes an unamortized discount of $2.2&#160;million.</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2022 and 2021, the amount recognized as revenue that was previously deferred was $3.7&#160;million, and $7.3&#160;million, respectively. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation&#160;of&#160;Revenue </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Investments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended March&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 13 positions which were in an unrealized loss position as of March&#160;31, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three months ended March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Credit Losses</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three months ended March&#160;31, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(0.1)&#160;million of allowance for credit losses, respectively, as of March&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 inventory consists of Captisol prepayments of $21.1 million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Other Identifiable Intangible Assets</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82,861)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">720,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,177)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5 million as of March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accrued Liabilities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,001&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,277&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2022, due to the net loss for the period, all of the 0.4&#160;million weighted average equity awards and 1.8&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413729080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASC 280, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, establishes annual and interim reporting standards for an enterprise&#8217;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed one reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#8220;Reorganization&#8221;) and, in connection therewith, will distribute (the &#8220;Distribution&#8221;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#8220;Merger&#8221;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the execution of the Merger Agreement, we have made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operate the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,559&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413683272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,157&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended March&#160;31, 2022, we adjusted the balance of the Metabasis CVR liability by $0.6&#160;million to mark to market.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the three months ended March&#160;31, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three months ended March&#160;31, 2022, management recorded $0.5 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of March&#160;31, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March&#160;31, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets Measured on a Non-Recurring Basis</span></div><div style="text-indent:22pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the organizational changes to the Company&#8217;s reportable segments, we re-allocated goodwill between the two identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At March 31, 2022, there were no indicators of impairment at either of the reporting units.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div>At March 31, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413675880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior Notes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.  The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $191.14. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or </span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of March 31, 2022 is 0.5%.  During the three months ended March 31, 2022 we recognized a total of $0.8&#160;million in interest expense which includes $0.5&#160;million in contractual interest expense and $0.3&#160;million in amortized issuance costs.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. After the repurchases, approximately $343.3&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended March 31, 2022, we repurchased $165.8&#160;million in principal of the 2023 Notes for $163.7&#160;million in cash, including accrued interest of $0.4&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $1.5&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended March 31, 2022, and a $0.9&#160;million reduction in debt discount.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Bond Hedge and Warrant Transactions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412441784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended March&#160;31, 2022 and 2021 was 23.6% and (214.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period. The variance from the U.S. federal tax rate of 21% for the three months ended March 31, 2021 was significantly impacted by the discrete tax benefit related to the net excess tax windfalls from the share based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413707336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 9, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,285)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(782)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,172,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, outstanding options to purchase 1.5 million shares were exercisable with a weighted average exercise price per share of $100.59.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2022, 44,360 shares were available for future purchases under the ESPP.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div>On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did not have any share repurchases during the three months ended March&#160;31, 2022. Authorization to repurchase $248.8 million of our common stock remained available as of March&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412441784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitment and Contingencies: Legal Proceedings</a></td>
<td class="text">Commitment and Contingencies: Legal Proceedings<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#8220;JPML&#8221;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#8220;MDL&#8221;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CyDex and Baxter Healthcare Corp. (&#8220;Baxter&#8221;) are parties to a license agreement relating to Ligand&#8217;s Captisol technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">overpaid royalties for several years, and seeks both refunds of those overpayment and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#8217;s Counterdemand. On June 30, 2021, the parties held a Preliminary Hearing before the arbitrator. The parties have completed fact discovery, exchanged expert witness statements and completed depositions of the expert witnesses. The arbitration hearing is currently scheduled for late May 2022.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799414654168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of March 31, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining nine months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of March 31, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining nine months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413787544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Standards Updates, Recently Adopted</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Standards Updates, Recently Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (&#8220;ASU 2020-06&#8221;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#8217;s own equity. Consequently, a convertible debt instrument, such as the Company&#8217;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended March 31, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 is $341.1&#160;million which includes an unamortized discount of $2.2&#160;million.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Captisol Sales</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Contract Revenue</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;D services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For R&amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Revenue</span></div>Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Credit Losses</a></td>
<td class="text">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. </span></div>We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 inventory consists of Captisol prepayments of $21.1 million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseRightsPolicyTextBlock', window );">Commercial License and Other Economic Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Commercial License Rights</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,177)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5 million as of March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><div style="padding-left:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for as financial assets in accordance with ASC 310, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Receivables, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">as further discussed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 1,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> of the Notes to Consolidated Financial Statements in our 2021 Annual Report. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 4, Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Note 6, Stockholders&#8217; Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseRightsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseRightsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799411858776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Revenue by Source</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kyprolis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Evomela</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Teriparatide injection </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rylaze </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,695&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Captisol</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - Core</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Captisol - COVID</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contract revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Service Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">License Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,089&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,844&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,876&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,766&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock', window );">Schedule of Short-Term Investments</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term investments consist of the following at March&#160;31, 2022 and December 31, 2021 (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:38.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.290%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized cost</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized gains</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross unrealized losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Estimated fair value</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,043)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(854)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,245&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168,861&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">189,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Bank deposits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63,381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Corporate equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,027)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Mutual fund</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">152,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,887&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;US government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">292,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,370)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Viking common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available-for-Sale Debt Securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,011&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">After one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,618&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,409&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Identifiable Intangible Assets</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other identifiable intangible assets consist of the following (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">181,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Definite lived intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Complete technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281,097&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">280,617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(82,861)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78,991)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Trade name</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,444)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,934)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Contractual relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">362,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43,460)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(36,217)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total goodwill and other identifiable intangible assets, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">720,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">732,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock', window );">Schedule of Commercial License Rights</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial license rights consist of the following (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aziyo and CorMatrix</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,456)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,461)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selexis and Dianomi</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,727)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,177)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(18,188)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5 million as of March&#160;31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,974&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts owed to former licensees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,677&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Royalties owed to third parties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Return reserve</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Subcontractor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplier</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">848&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total accrued liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,579&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock', window );">Schedule of Accounting for Share-Based Compensation</a></td>
<td class="text">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,914&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SBC - General and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,044&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Fair-Value Options Awarded to Employees and Directors</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,435&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dilutive potential common shares:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares used to compute diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Potentially dilutive shares excluded from calculation due to anti-dilutive effect</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,001&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,277&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Commercial License Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ScheduleOfShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Short-Term investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ScheduleOfShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413725784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of Reconciliation of Revenue from Segments to Consolidated</a></td>
<td class="text">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#8217;s internal financial information as used for corporate management purposes (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.376%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business revenue</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,559&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total OmniAb business revenue</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,178&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,559&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - Core </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Captisol - COVID</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Contract</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Total Ligand core business revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,515&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55,150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment operating income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OmniAb business </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6,189)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,604)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ligand core business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,446&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,842&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unallocated corporate items</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shared-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,657&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;Total unallocated corporate items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9,306)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413572584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Assets and Liabilities Measured at Fair Value</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.818%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.830%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Short-term investments, excluding Viking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">168,861&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,735&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">290,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Investment in Viking common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,145&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">162,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">280,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">409&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321,586&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">CyDex contingent liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Metabasis contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Icagen contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">xCella contingent liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">480&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts owed to former licensor</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,782&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,047&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,157&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#946; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended March&#160;31, 2022, we adjusted the balance of the Metabasis CVR liability by $0.6&#160;million to mark to market.  </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt">The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#8217;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the three months ended March&#160;31, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders.</span></div>4.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three months ended March&#160;31, 2022, management recorded $0.5 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Reconciliation of Level 3 Financial Instruments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the level 3 financial instruments as of March&#160;31, 2022 is as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.374%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of December&#160;31, 2021</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments to CVR holders and other contingent payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value adjustments to contingent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent liabilities from xCella asset acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">480</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of level 3 financial instruments as of March&#160;31, 2022</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,190&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799418003064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Values and Coupon Rates on Financing Arrangements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes information about the 2023 Notes (in thousands): </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:67.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.437%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.907%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal amount of the 2023 Notes outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">177,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unamortized discount (including unamortized debt issuance cost)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(987)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total long-term portion of notes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">176,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of the 2023 Notes outstanding (Level 2)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">172,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">341,801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%">(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413521368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Plan Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,285)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(782)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,172,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Activity</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our stock option and restricted stock activity and related information:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.795%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,199,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106.00&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">264,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">138.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,840&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Options exercised/RSUs vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(126,049)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,285)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(782)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">131.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of March&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,172,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">107.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">162,152&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799418303704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock', window );">Schedule of Operating and Finance Lease Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Finance Lease Assets and Liabilities (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.007%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finance lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,403&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,053&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current finance lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,099&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,699&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,651&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Maturity of Operating and Finance Lease Liabilities as of March 31, 2022 (in thousands): </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity Dates</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Remaining nine months ending December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,074&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,563&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,699&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AssetsAndLiabilitiesLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets and Liabilities Leases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AssetsAndLiabilitiesLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799409443768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>position </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">$ 39,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,095,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">793,192,000<span></span>
</td>
<td class="nump">$ 745,840,000<span></span>
</td>
<td class="nump">821,159,000<span></span>
</td>
<td class="nump">$ 709,525,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized that was previously deferred</a></td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="nump">$ 7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of positions in an unrealized loss position | position</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Credit losses related to available-for-sale debt securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease', window );">Additional allowance for credit losses recorded related to COVID-19</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 25,614,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="nump">6,001<span></span>
</td>
<td class="nump">4,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">$ 325,368,000<span></span>
</td>
<td class="nump">$ 336,621,000<span></span>
</td>
<td class="nump">372,969,000<span></span>
</td>
<td class="nump">318,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="nump">$ 468,838,000<span></span>
</td>
<td class="nump">$ 410,058,000<span></span>
</td>
<td class="nump">449,090,000<span></span>
</td>
<td class="nump">$ 391,952,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,997,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adjustment | Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,130,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember', window );">Adjustment | Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,133,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember', window );">Adjusted Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Adjustment | Additional paid in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Adjustment | Retained earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Stockholders' equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">$ 21,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares) | shares</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Performance period for awards</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent', window );">Payout range (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410081544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 45,693<span></span>
</td>
<td class="nump">$ 55,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">13,695<span></span>
</td>
<td class="nump">7,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember', window );">Kyprolis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">4,622<span></span>
</td>
<td class="nump">4,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember', window );">Evomela</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,701<span></span>
</td>
<td class="nump">2,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember', window );">Teriparatide injection</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">2,911<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RylazeMember', window );">Rylaze</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,649<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">1,812<span></span>
</td>
<td class="nump">476<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember', window );">Captisol</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">12,122<span></span>
</td>
<td class="nump">31,272<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">6,226<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,896<span></span>
</td>
<td class="nump">30,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">19,876<span></span>
</td>
<td class="nump">16,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember', window );">Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">5,146<span></span>
</td>
<td class="nump">5,462<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember', window );">License Fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">3,086<span></span>
</td>
<td class="nump">1,043<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember', window );">Milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">9,089<span></span>
</td>
<td class="nump">8,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 2,555<span></span>
</td>
<td class="nump">$ 1,844<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_KyprolisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_KyprolisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_EvomelaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_EvomelaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_TeriparatideInjectionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RylazeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RylazeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_RoyaltyOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412088952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 172,435<span></span>
</td>
<td class="nump">$ 292,225<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">531<span></span>
</td>
<td class="nump">842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(4,105)<span></span>
</td>
<td class="num">(2,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">168,861<span></span>
</td>
<td class="nump">290,697<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI', window );">Total short-term investments</a></td>
<td class="nump">189,006<span></span>
</td>
<td class="nump">321,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember', window );">Bank deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">6,231<span></span>
</td>
<td class="nump">63,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">6,181<span></span>
</td>
<td class="nump">63,381<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">4,899<span></span>
</td>
<td class="nump">29,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(84)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">4,815<span></span>
</td>
<td class="nump">29,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">36,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Corporate equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">5,807<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">344<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(3,043)<span></span>
</td>
<td class="num">(2,027)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">3,108<span></span>
</td>
<td class="nump">4,182<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember', window );">Mutual fund</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">152,253<span></span>
</td>
<td class="nump">152,136<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(854)<span></span>
</td>
<td class="num">(249)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">151,399<span></span>
</td>
<td class="nump">151,887<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">US government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">3,245<span></span>
</td>
<td class="nump">5,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">3,171<span></span>
</td>
<td class="nump">5,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross unrealized gains</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross unrealized losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated fair value</a></td>
<td class="nump">187<span></span>
</td>
<td class="nump">408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Viking common stock</a></td>
<td class="nump">$ 20,145<span></span>
</td>
<td class="nump">$ 30,889<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities, FV-NI</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_DemandDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412003288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis', window );">Within one year</a></td>
<td class="nump">$ 10,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis', window );">After one year through five years</a></td>
<td class="nump">6,523<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total</a></td>
<td class="nump">16,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue', window );">Within one year</a></td>
<td class="nump">10,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue', window );">After one year through five years</a></td>
<td class="nump">6,398<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total</a></td>
<td class="nump">$ 16,409<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62586-112803<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410086568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 181,206<span></span>
</td>
<td class="nump">$ 181,206<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwill', window );">Total goodwill and other identifiable intangible assets, net</a></td>
<td class="nump">720,913<span></span>
</td>
<td class="nump">732,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember', window );">Complete technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">281,097<span></span>
</td>
<td class="nump">280,617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(82,861)<span></span>
</td>
<td class="num">(78,991)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">2,642<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,477)<span></span>
</td>
<td class="num">(1,444)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">40,700<span></span>
</td>
<td class="nump">40,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(18,934)<span></span>
</td>
<td class="num">(18,267)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Contractual relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract', window );"><strong>Summary of Goodwill and Other Identifiable Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite lived intangible assets</a></td>
<td class="nump">362,000<span></span>
</td>
<td class="nump">362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">$ (43,460)<span></span>
</td>
<td class="num">$ (36,217)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412538664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details) - Commercial license rights - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">$ 28,298<span></span>
</td>
<td class="nump">$ 28,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(18,177)<span></span>
</td>
<td class="num">(18,188)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">10,121<span></span>
</td>
<td class="nump">10,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated amortization on finite-lived intangible assets</a></td>
<td class="num">(11,700)<span></span>
</td>
<td class="nump">11,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments', window );">Credit loss adjustments of finite-lived intangible assets</a></td>
<td class="num">(6,500)<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Aziyo and CorMatrix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">17,696<span></span>
</td>
<td class="nump">17,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(9,456)<span></span>
</td>
<td class="num">(9,461)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">8,240<span></span>
</td>
<td class="nump">8,235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Selexis and Dianomi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract', window );"><strong>Commercial License and Other Economic Rights</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross</a></td>
<td class="nump">10,602<span></span>
</td>
<td class="nump">10,602<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments', window );">Adjustments</a></td>
<td class="num">(8,721)<span></span>
</td>
<td class="num">(8,727)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 1,881<span></span>
</td>
<td class="nump">$ 1,875<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_CommercialLicenseAndOtherEconomicRightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commercial License and Other Economic Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_CommercialLicenseAndOtherEconomicRightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-lived Intangible Assets, Credit Loss Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_AziyoAndCorMatrixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=lgnd_SelexisAndDianomiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799409381368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract', window );"><strong>Accrued Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Compensation</a></td>
<td class="nump">$ 3,620<span></span>
</td>
<td class="nump">$ 6,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">3,974<span></span>
</td>
<td class="nump">2,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LicenseeAccrualCurrent', window );">Amounts owed to former licensees</a></td>
<td class="nump">2,677<span></span>
</td>
<td class="nump">630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties owed to third parties</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ReturnsAccrual', window );">Return reserve</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedAssetAcquisitionsCurrent', window );">Acquisition related liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSubcontractorExpensesCurrent', window );">Subcontractor</a></td>
<td class="nump">1,757<span></span>
</td>
<td class="nump">1,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_AccruedSupplierExpensesCurrent', window );">Supplier</a></td>
<td class="nump">1,697<span></span>
</td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Accrued interest</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,758<span></span>
</td>
<td class="nump">1,904<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 15,877<span></span>
</td>
<td class="nump">$ 17,579<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedAssetAcquisitionsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Asset Acquisitions, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedAssetAcquisitionsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSubcontractorExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Subcontractor Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSubcontractorExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_AccruedSupplierExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Supplier Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_AccruedSupplierExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LicenseeAccrualCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensee Accrual, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LicenseeAccrualCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ReturnsAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ReturnsAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799417104168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 9,044<span></span>
</td>
<td class="nump">$ 8,405<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">SBC - Research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">3,914<span></span>
</td>
<td class="nump">3,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">SBC - General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BasisOfPresentationLineItems', window );"><strong>Basis of Presentation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Share-based compensation expense</a></td>
<td class="nump">$ 5,130<span></span>
</td>
<td class="nump">$ 4,466<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BasisOfPresentationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BasisOfPresentationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413903304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility (as a percent)</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799409398088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Summary of computation of basic and diluted net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding (in shares)</a></td>
<td class="nump">16,824<span></span>
</td>
<td class="nump">16,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted income per share (in shares)</a></td>
<td class="nump">16,824<span></span>
</td>
<td class="nump">17,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)</a></td>
<td class="nump">6,001<span></span>
</td>
<td class="nump">4,277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesAbstract', window );"><strong>Dilutive potential common shares:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential common shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">701<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799405794616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 22, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,764<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,306)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Shared-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCostAndExpenseOperating', window );">Other corporate expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,257<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Total operating costs and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember', window );">Captisol - Core</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember', window );">Captisol - COVID</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember', window );">Contract revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb Technologies | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,178<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,189)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,604)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb Technologies | Royalties | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember', window );">OmniAb Technologies | Contract revenue | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Total segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,446<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Royalties | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,432<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Captisol - Core | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Captisol - COVID | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember', window );">Ligand Core Business | Contract revenue | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,207<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostAndExpenseOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostAndExpenseOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCoreMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_MaterialSalesCaptisolCOVIDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_ContractRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_ContractRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_OmniAbTechnologiesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandCoreBusinessSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799405270904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2010 </div>
<div>contingent_value_right </div>
<div>contingent_value_right_series</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfContingentValueRightsSeries', window );">Number of CVR Series | contingent_value_right_series</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember', window );">Transferred over Time | Phase 3 Clinical Trial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetGross', window );">Gross contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Transferred over Time | Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember', window );">Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare', window );">Number of CVRs issued per acquiree share | contingent_value_right</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries', window );">Number of CVRs issued from each CVR series | contingent_value_right</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders', window );">Frequency of cash payments to CVR holders</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember', window );">xCella | Earnout Rights for Partner Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency', window );">Earnout rights recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember', window );">Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueAdjustment', window );">Mark-to-market adjustment of CVR liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember', window );">Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities', window );">Payment for contingent consideration liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,006,000<span></span>
</td>
<td class="nump">$ 321,586,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,047,000<span></span>
</td>
<td class="nump">11,157,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,782,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,376,000<span></span>
</td>
<td class="nump">7,364,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">168,861,000<span></span>
</td>
<td class="nump">290,697,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,145,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,424,000<span></span>
</td>
<td class="nump">40,624,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,279,000<span></span>
</td>
<td class="nump">9,735,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;1 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,889,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,394,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,782,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,782,000<span></span>
</td>
<td class="nump">3,358,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162,394,000<span></span>
</td>
<td class="nump">280,553,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;2 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,190,000<span></span>
</td>
<td class="nump">7,713,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - CyDex</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">334,000<span></span>
</td>
<td class="nump">349,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Metabasis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - Icagen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,376,000<span></span>
</td>
<td class="nump">7,364,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Contingent liabilities - xCella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Amounts owed to former licensor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Liabilities, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,000<span></span>
</td>
<td class="nump">409,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring | Level&#160;3 | Investment in Viking common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Assets, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Number of Contingent Value Rights Issued per Acquiree Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfContingentValueRightsSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Contingent Value Rights Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfContingentValueRightsSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (ee)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_Phase3ClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_MetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=lgnd_XCellaBiosciencesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyIcagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyCydexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForContingentValueRightsCompanyXCellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799417157672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details) - Level 3<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of December&#160;31, 2021</a></td>
<td class="nump">$ 7,713<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToContingentValueRightHolders', window );">Payments to CVR holders and other contingent payments</a></td>
<td class="num">(1,545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments to contingent liabilities</a></td>
<td class="num">(458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition', window );">Contingent liabilities from xCella asset acquisition</a></td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair value of level 3 financial instruments as of March&#160;31, 2022</a></td>
<td class="nump">$ 6,190<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToContingentValueRightHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Contingent Value Right Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToContingentValueRightHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799417976552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>reporting_unit</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799409772952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>option </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,532,000<span></span>
</td>
<td class="num">$ (4,840,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsToUnwindWarrants', window );">Payments to unwind warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges', window );">Proceeds from unwinding convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges', window );">Number of options under convertible bond hedges | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">177,527,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts', window );">Proceeds from debt, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 733,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0040244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortized issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchaseAmount', window );">Repurchased amount of debt instrument</a></td>
<td class="nump">$ 20,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayments of notes</a></td>
<td class="nump">19,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_RepaymentsOfNotesPayableInterestPortion', window );">Accrued interest portion of repurchased amount of debt instrument</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 343,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_IncreaseDecreaseInDebtDiscount', window );">Increase (decrease) in debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued in public offering (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,018,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,559,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_PaymentsForConvertibleBondHedges', window );">Payments for convertible bond hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 315.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Adjustments to additional paid-in-capital from warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentIncreaseAccruedInterest', window );">Accrued Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Initial conversion rate (shares per $1,000)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0052317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Initial conversion price (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Stock price trigger to classify convertible debt as current (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember', window );">Convertible Notes | 2023 Convertible Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Consecutive trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger', window );">Maximum threshold of debt trading price trigger (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_IncreaseDecreaseInDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Debt Discount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_IncreaseDecreaseInDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_NumberOfOptionsUnderConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Options under Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_NumberOfOptionsUnderConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsForConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments for Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsForConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_PaymentsToUnwindWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Unwind Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_PaymentsToUnwindWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_ProceedsFromUnwindingConvertibleBondHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Unwinding Convertible Bond Hedges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_ProceedsFromUnwindingConvertibleBondHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_RepaymentsOfNotesPayableInterestPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments Of Notes Payable, Interest Portion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_RepaymentsOfNotesPayableInterestPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentIncreaseAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase for accrued, but unpaid interest on the debt instrument for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentIncreaseAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value amount of debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDebtNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDebtNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410098120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes - Notes Payable (Details) - Convertible Notes - 2023 Convertible Senior Notes - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract', window );"><strong>Notes Payable, Current and Noncurrent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount of the 2023 Notes outstanding</a></td>
<td class="nump">$ 177,527,000<span></span>
</td>
<td class="nump">$ 343,301,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount (including unamortized debt issuance cost)</a></td>
<td class="num">(987,000)<span></span>
</td>
<td class="num">(22,584,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Total long-term portion of notes payable</a></td>
<td class="nump">176,540,000<span></span>
</td>
<td class="nump">320,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of the 2023 Notes outstanding (Level 2)</a></td>
<td class="nump">$ 172,535,000<span></span>
</td>
<td class="nump">$ 341,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=lgnd_ConvertibleSeniorNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799413722456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate (as a percent)</a></td>
<td class="nump">23.60%<span></span>
</td>
<td class="num">(214.10%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410138568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (shares) | shares</a></td>
<td class="nump">2,199,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (shares) | shares</a></td>
<td class="nump">14,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (shares) | shares</a></td>
<td class="num">(17,689)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(23,285)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (shares) | shares</a></td>
<td class="nump">2,172,724<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 106.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">114.13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (USD per share) | $ / shares</a></td>
<td class="nump">19.61<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">54.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 107.31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (shares) | shares</a></td>
<td class="nump">264,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (shares) | shares</a></td>
<td class="nump">24,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSUs vested (shares) | shares</a></td>
<td class="num">(126,049)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (shares) | shares</a></td>
<td class="num">(782)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (shares) | shares</a></td>
<td class="nump">162,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 138.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share) | $ / shares</a></td>
<td class="nump">99.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">RSUs vested (USD per share) | $ / shares</a></td>
<td class="nump">121.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share) | $ / shares</a></td>
<td class="nump">131.95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (USD per share) | $ / shares</a></td>
<td class="nump">$ 145.60<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799411819720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 11, 2019</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding options that are exercisable (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Outstanding options that are exercisable, weighted average exercise price (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized stock repurchase amount</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Period in force of stock repurchase program</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock repurchased during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized stock repurchase amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 248,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_EmployeeStockPurchasePlanAbstract', window );"><strong>Employee Stock Purchase Plan</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate', window );">Share purchase price as percent of market price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod', window );">Shares available for future purchases (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_EmployeeStockPurchasePlanAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_EmployeeStockPurchasePlanAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate from fair value on purchase date that participants pay for shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=lgnd_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799418011464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies: Legal Proceedings (Details)<br></strong></div></th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>civil_complaint</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember', window );">US District Court for the Northern District of Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of civil complaints filed against entity</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410067528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Narrative (Details) - Maximum<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term of operating leases</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term of operating leases</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799410074568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Operating and Finance Lease Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">$ 15,783<span></span>
</td>
<td class="nump">$ 16,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease assets</a></td>
<td class="nump">15,620<span></span>
</td>
<td class="nump">16,207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseRightOfUseAsset', window );">Total lease assets</a></td>
<td class="nump">31,403<span></span>
</td>
<td class="nump">32,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">1,850<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current financing lease liabilities</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseLiabilityCurrent', window );">Current lease liabilities</a></td>
<td class="nump">1,902<span></span>
</td>
<td class="nump">2,099<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Noncurrent liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">16,758<span></span>
</td>
<td class="nump">15,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liabilities</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_lgnd_LeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 18,699<span></span>
</td>
<td class="nump">$ 17,651<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_lgnd_LeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">lgnd_LeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>lgnd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139799412341544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturity of Operating Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remaining nine months ending December 31, 2022</a></td>
<td class="nump">$ 1,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">2,712<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">2,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">2,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">2,727<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">8,074<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">22,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(3,864)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 18,699<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>lgnd-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:lgnd="http://www.ligand.com/20220331"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="lgnd-20220331.xsd" xlink:type="simple"/>
    <context id="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia08cf90d3d0749cba99e0a20f8f8db7f_I20220505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-05-05</instant>
        </period>
    </context>
    <context id="i4ed5b36e32c14d6ba6f922ef55910407_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6c4b67ce45734a1488e028d74424a3ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2871262664774e9c93e671bd91fbc05a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i28b08e6912b04510a2abbaffe52e8c52_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6af8f3a1ea1147389b4f58ce1a5ce5c3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id4bdb647ddf147bd84a8bb24e2666210_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icbd7481a03054f56837d5f2889064a3e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5f315420bac2445db97141e3eb94ecf8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id5b05cfdbed34186bc0ca0f9967ff690_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d9dead5c83f404093493fd89aedc1ef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f6c591ca6164e298b702b2e5838de27_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3f9217abff4940c09241816ada5b00d7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i745a10c5acc04c8abff6813d0fbcc32c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87c3f0f2b43c4a02a873a348ac60340e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2b8ad2425b94970836064433e1b9c36_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic54fc48630a943be8d51ab84bb6ec9e1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i04dfa09c315e4ea8937000c9fbcebd65_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i05239c6a6e534a8c889d6057c3a05746_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i29e36d3c6bfa46a3aabff2ac65a972b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ida954be77ff74c0bbe3dc1fe29aee07d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2349b019bea04c3f8818d90c8e36dfe4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib57655db6c244e568e24627c0da2b0e6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie23dddf73d564cccbeb38cedfbf213d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf1964f2dbc3421fbd584115f1a95eb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea088c6521ae42dabe8f16d54142f236_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40321155ca4046eba9b0de104f5ce8db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8542ff7045c84ed5bbfbe302627e05db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0adfb1eca5a640698b9228529cba9397_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i154f58555d7d4643b2e1f528903985d9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8c8f70bcb8544a2d8a2cb58c9207ff0b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3c66c5680f12470c9b06b7b32d2062a2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib7b75c9953264ac2b488a162bfbb1fa7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6fb955a30fcb449ca1b8aed8ec29365a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0211e1bbe9f44dfebcdf0ebe1dac694e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id709f7f89de844718660a4c1048c1cf3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5d1b66ab770745c8ad6850d6dfd97f30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42456cb257354b64b669494c1f8a43e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6bf4f2b14ab4ca4964ed5c7d1fde736_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d5f7c3225f742f2837effcd50bb3f07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iadcc8e71d6a1438fbd272741cd9b7d95_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i07fd099a96414912b8668ce47bea3ec2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:KyprolisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2ee81d901b6a492abb235b3119cc7898_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i24d5c0bc6f4744e0b51b5d1f8ae76c36_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:EvomelaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i04011d0026304dbebecfd23dce2351c2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8a2afd26bd6c45f79cf4af863d253176_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:TeriparatideInjectionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic21c8159caf94bc9a53b73d289bb1251_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic0175e6ce3cf48caadfd1f3b8bb97392_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RylazeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i11d5dea3dcd743feb47922ec6ed01b4b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7bf4fc09793f43a9a8d43f9a8f6a5199_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:RoyaltyOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia269861fa92141fcb3d9629f7e926de1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i4a539e9335924d0aabf0ec4d5b20b5b7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaedc31f3d0524728ab67dc0105f82c05_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i032d93aa682241bcb144bf6c5d387a4a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i356debce55094a5f8fb2dd9767f8a65e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9ebba23e98694d9baaebf57762ecde39_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7769789917214a24a4c7dfc52ac670e3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia0a615c256b74c3cad0d586a69d2c6d0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ief27a2dceccf46e7bb26272780283c82_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2873d3d891464c6596099d2f3ceccbc3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i10492cd31c0f473a8754fc4b06d6e667_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i84aa90196d9044c096cdc13634fd7385_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:LicenseFeesMilestonesAndProductOtherProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ida69113abe7847e8b5ed94bf90a72132_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i94ef9ec786694f06a63d2a1409816900_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic8ff3f576fac41e7b315329c76a8306c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2155f0c2705b4c408b646add63eb9071_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie11feec6336542d386a98bda4c8dbf00_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib7645756406646ca8f1ec3acc081a02c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56582b6df3664f7283828126f810559e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i98b2a53fb0eb405a93cded08866b0e8d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i285b0c923a6f42c2af32f25b9fb32381_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:DemandDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i774eff23634b4e6f9ce07e67955988f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic258a2744cc743da87ef38a3bdcf1222_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34da59c366e142fbbf562b813abcb5aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20bdb340507b4cc49042547bdf096356_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i992d4d8c76a5476194b7e457e109762c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i61db617747884bd480b2ae120011bf66_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7bdc3319eb85415ea312cb8a112c69ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34997f63ccf047658e1fca662ede1c9f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if7807a6ec9b74845a3590b8007c957ba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1c93540126b4a8dadf1d7a4085e4c3f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if722abdc75b34610b6fea0f9483cee81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i518fdba340374fd3a474af40b10ce796_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8c4e5dcb4e7746e5bc080a9c25e3bc3c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7464cb7c60b0446cbd43978b90d27c58_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i54b7531ec2484661a8f1a0b6c44bfdfe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f0ef9c25a614e018c39ce8e9e5101bd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7719a92b270b4a49ac3b46e3e2b46499_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1e39b01f1d4d45689cebd1037fe70f27_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ieb1ea6c6606c481a951f3cc3af50b136_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:AziyoAndCorMatrixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22a5e6b72c57405abf407349fa1f4137_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i457b420796584b0fb47f7e39b1055c47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">lgnd:SelexisAndDianomiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7080131f89e444529897ea3dc7448eb2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i14d8023b123a4c2faca1a22a3e115e11_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idfa8a3f9ab8545b981b3971997972972_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i11b4a8c686fc4648be49dc1b9c525045_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2ff20198dfd645f89511cf05d55fafd4_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2a3b49d1a88349509ccd11b907545d6d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8220447fce27459a888de6de4b101be1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9e532a1df4c44aa98fe74ecbd0a59126_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2fa0529885044a349ec209c5f5442871_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9bd6ab61611848b4af19ea870cad707f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8a1194575d634ee8956be0aa05025adc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3365559ab448481290ab043d14bce4fe_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2b33615ff4dc4786891d338a0cb87ea1_D20220101-20220322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-22</endDate>
        </period>
    </context>
    <context id="ib574058f498140e08306c67fbbc14b07_D20220323-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2022-03-23</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i300e1e912a0842718dbd2b3d456ac8e0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id431bc8ebbfc4087800d10ed11c19272_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic73cc7ba3d4a447d95e5cb30db52d28b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id34fb1dc5fc741d1b93bb6d1fad26056_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie50c79886ca04ee7b85538c7262e1e53_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2fb81ef4735243389f30ebb41fc5156c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:OmniAbTechnologiesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i598d08a1a5c64f9c9b4aae4b7fea0796_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if798cc5ddaad4b2a80521e5ef4181f09_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2096d791fd444431ae4e6423cf10a908_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic378cdb30a214a6e973eb163729ac9df_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCoreMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iccf94376ac9f41ba9db7e39a6ff00cd2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i44fcbfc7c1c64519a0a268ddd50005f9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:MaterialSalesCaptisolCOVIDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie0260450d8db471abd4488be4a3107e3_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id18be33f9e9e4ae7a764cb16fd2d9133_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:ContractRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70be0418e1f249f5998e0e0067145f1b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i19419d57f33740be82d4eb6147bb54a5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">lgnd:LigandCoreBusinessSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1e48006baa5e40e28df0dfb681b6ae97_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i76cb0239f16b43c4bd8d8c1d06dc5cd8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4c3151df873d468daa1bc191317f2131_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0a30df8c5d044c60a763185ed4b109ee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if634239711ec47bc8fb473be55d194c2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i78c295da60c54f4ba4c67de4f2b2fd6a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i919b865fc7e548288c960eb025fa16f6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f961cf3c57944a989b386a120a59e6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie56a23c988fb481eb3895b19408d8f68_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bcc5777b8c04572a90ff8c68c9be3d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8f9f85958a8e45c1999e50f7c31144df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i28df26f7a1f24146a45927ad3b6e2625_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2da3eb2118b64b948ace0d372c78e131_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i0024c5febbb84c33ba537d246bb26b0d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7e6326565a2e4955bf81bde2e03ac28b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia3ba69f089de4d0aa3b902eb1357efb6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a463045c0434ff28706f0fd5b252da7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5eb310903a3649db988222f2672883a4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id54984caedea4d4c829399ada8baf52c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia6e15e9ecb9c4bb9a73558b076d35394_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5112991c76244ad1b2e61a2afe8efa8b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c833df0e5124025a8cd7e1936222d95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c518e7be0004946a9276b77331674e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30c5a1b7c1bd4601ad0e07d638cfde90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i966883907ba441f5a4e24265299fe9b7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17df672b82eb4eff9d83b149a3113829_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8716ee2bef654ec887fa430172b5e0d3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i211899b611f340528eb396eab170056c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9b9d133c575a444b97ac9f108fea9d52_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3d7dc371fd8d4ba9b2de8e1a8d90ca31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i06393bae740d414fb55f36d4f43807b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3496b4825a99453d8e14a952b1c8bbf5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1aacb0ab6e8a482dbddfa6725169679d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyCydexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id8cd9489185040a7bb4e6b5151d8fb72_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i97def60ed00a4e26a90de87178d3202c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idfc8aa3e6e1c478c842cc795c7c3484c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifc9098fdefa544a68419972c21ec488c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic14bb82805cc494d8b56d377748e728c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1c0225f26f5a48b5b92459eaef9fd75e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic54f0bccced74dc6b12384a2e45705e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i12aa59424c6e4371bcaeafb801d99844_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f3a5031213d4a2aa5da82aaa404c742_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3a32dc635437486483a3be836ab04ada_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2055a011fa7a4a829cad038d7d64c6ae_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i90216ed11e8d4bc1b40442168089a1ad_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i80f9ef7fb8a04cb59bc97a74159c2874_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0690c7d860e439ab67baac1955afda1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6b92158554854b7599487fbbea4b32d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55dc9c881b384a888900e4e677032eef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i34e13f0ccb1840b38bbcc52a9b972a65_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idef14e6ec1314de598c64ef1cd3b8fdf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i065018e70379492b9ffac3ef63d44a78_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic7f207c7e7074abdbf50e9ac08b78310_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2d31d4856a7f4ecdac5cfa9487f3e54e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c2afa4c98a64c4a839dbfa0fd81f143_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6ec0e9d18f64f908b3d00d4d1706f84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if2069d01c1f64ca7a72f1f7662269e10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyXCellaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6e4d6cbded604d18851f0c907cacd012_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i465d2c5e70fe49d68072bca30f76eb6d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ied060cacedb645e8952913558fc4a323_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iac5865f4bf0c4476a1cdbb41799578ef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6854523039e846ca86b64f3d0452da62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ica6972566df3478a9c82f8db3f0f40d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a94d4a2b23c41cbb4633b169200cf02_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5dc1ab71740c4970bfbb9630883923ad_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:MetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="ib419e06b57b54f5c8f34756ee9797e58_D20100101-20100131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2010-01-01</startDate>
            <endDate>2010-01-31</endDate>
        </period>
    </context>
    <context id="i194dc7eb8286428aa943ce425971b4b8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i43db8217ff36458e87356cae1ff73eb4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">lgnd:Phase3ClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredOverTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i921ef3db471b47e886c3c26b72c7c384_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyMetabasisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iaafd9004e1524a9686d8306a396aa924_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">lgnd:LiabilityForContingentValueRightsCompanyIcagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icdfc9f4e909742e7b03c3eca98c41196_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">lgnd:XCellaBiosciencesIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">lgnd:EarnoutRightsForPartnerResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ica554f22c30d4304a7166e4a018118e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3d63dad091346d4b421cc89bf1e6cf2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i45c44217a7754fde9db2a176d420d07e_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i325334d147084fc3aa258bd786bbca4a_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="id01f6fee2fc241329c914948fff4bda7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i58d94099936a491687dbdd22e65b4761_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2b572383900440a9b8b357255d25c76_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2635945e42ab464987f287db2ac7954c_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="icf689c5950764536b68fadb81ab2aee0_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i87eb5ec96aa44c22872e02ee5f10ca53_D20180501-20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">lgnd:ConvertibleSeniorNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-05-01</startDate>
            <endDate>2018-05-31</endDate>
        </period>
    </context>
    <context id="i4ba9060814074f5b8b13493a50dcc9ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia2c459c7be754d97891d9360f85d4082_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i573a15b797f746cc9687adb9f4c7f519_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia72734fd1bc34d3f98100401134c40ef_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i1275fb9984434e01b87ce488fddf54ad_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">lgnd:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib33c801b49164b99a9d4646db3085406_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="i27f53be60bef4e978e550a0a4312773a_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="i9e0901d9e25c46e498905e04372debe7_D20191031-20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">lgnd:USDistrictCourtForTheNorthernDistrictOfOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-31</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="ia10c9da04455423daca5e24de07ee725_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000886163</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="position">
        <measure>lgnd:position</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>lgnd:segment</measure>
    </unit>
    <unit id="contingent_value_right">
        <measure>lgnd:contingent_value_right</measure>
    </unit>
    <unit id="contingent_value_right_series">
        <measure>lgnd:contingent_value_right_series</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>lgnd:reporting_unit</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="option">
        <measure>lgnd:option</measure>
    </unit>
    <unit id="civil_complaint">
        <measure>lgnd:civil_complaint</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV8yLTEtMS0xLTU5NTM1_febeb2f3-7da1-45fe-9adc-747d48652405">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV8zLTEtMS0xLTU5NTM1_bb887447-83be-451c-8a02-edbc7efc8540">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV80LTEtMS0xLTU5NTM1_5bc75c7e-c44e-454e-9966-980e47bb5f31">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV81LTEtMS0xLTU5NTM1_a8b70152-8a0e-477b-ab64-d70652f5378f">0000886163</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180L2ZyYWc6YTMxNjZjYWVkNmQxNGQxMTlmYWY2OWMxMmVhYWE5NmUvdGFibGU6OWQ5ZGQzZjJkODVkNDU4OGE3NTFiMzI4NmIzOWJiNWEvdGFibGVyYW5nZTo5ZDlkZDNmMmQ4NWQ0NTg4YTc1MWIzMjg2YjM5YmI1YV82LTEtMS0xLTU5NTM1_3a47411d-4c76-4381-b23e-ad12eaab5668">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0wLTEtMS03MDA0Mg_e2adfea4-35a8-4671-b333-781072ebc07b">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180Ni9mcmFnOjNjMzk5N2ZmZTI5ZTRmOTJhMDI3ZDYyY2ZjN2I2ODU4L3RhYmxlOjNiZTM1MjBhOGIwNzQ5MGQ4MjVmODY2YzQ3NTAzNWM1L3RhYmxlcmFuZ2U6M2JlMzUyMGE4YjA3NDkwZDgyNWY4NjZjNDc1MDM1YzVfMi0xLTEtMS01OTUzNQ_fe98e1fe-4d14-42a7-bc56-0b38f00a66e7"
      unitRef="number">0.0040244</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i87eb5ec96aa44c22872e02ee5f10ca53_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180Ni9mcmFnOjNjMzk5N2ZmZTI5ZTRmOTJhMDI3ZDYyY2ZjN2I2ODU4L3RhYmxlOjNiZTM1MjBhOGIwNzQ5MGQ4MjVmODY2YzQ3NTAzNWM1L3RhYmxlcmFuZ2U6M2JlMzUyMGE4YjA3NDkwZDgyNWY4NjZjNDc1MDM1YzVfNC0xLTEtMS03MzYyNg_99b2e5e2-808d-4e5f-9b7a-df265860a6db"
      unitRef="number">0.0052317</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8xNzI_b87f1627-cefd-4c14-ae03-700f9b750dff">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NTY4MjBmM2QyMjA5NDA1MGI4ZDliYzFmNmM4MDk3ODAvdGFibGVyYW5nZTo1NjgyMGYzZDIyMDk0MDUwYjhkOWJjMWY2YzgwOTc4MF8wLTAtMS0xLTU5NTM1_537f7ff8-9df1-49c3-96c6-9d94abbbea68">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yOTY_4e4101ca-e907-4625-bbbc-4bdfbe8fe09c">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NmNiNzU1ZWIxY2NhNGFlYTliY2QwYTY5OGFjMjdmODAvdGFibGVyYW5nZTo2Y2I3NTVlYjFjY2E0YWVhOWJjZDBhNjk4YWMyN2Y4MF8wLTAtMS0xLTU5NTM1_3436d683-bbb9-4e5d-a750-59ac40f44483">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg2_e18948e2-9907-44b3-af11-a21e8bbd1c2c">001-33093</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8zOTg_ea2eedfa-0b7f-4428-8934-900df0037e9a">LIGAND PHARMACEUTICALS INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y18wLTAtMS0xLTU5NTM1_3303d364-11c3-456c-a2ae-c06b24ded4fb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y18wLTEtMS0xLTU5NTM1_8186cf6f-8022-4c70-8a2f-f28a7540f0f0">77-0160744</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y18zLTAtMS0xLTU5NTM1_2f1f6936-9101-4a9c-a1f6-dcb8a69bc265">5980 Horton Street, Suite 405</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y180LTAtMS0xLTU5NTM1_cda7b7e3-8532-47c3-aa50-f9f4933777c4">Emeryville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y181LTAtMS0xLTU5NTM1_99aa19b4-1fda-408f-9e32-eec71468331f">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWQwZjkxODhkZGZkNGRlNzlmN2FjOGIxMjY4MGU2NGMvdGFibGVyYW5nZTo1ZDBmOTE4OGRkZmQ0ZGU3OWY3YWM4YjEyNjgwZTY0Y181LTEtMS0xLTU5NTM1_179ec2d0-dce7-45b4-ad1d-59bc01825cdf">94608</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg3_9fd27bed-4109-4069-a05c-194c6cfbf0e7">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg4_c0a3a1ce-7a25-4b3b-a610-55b6aadc0051">550-7500</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWVjNzYzZWQyNGY4NGJjNjkwN2M5YjFkMmRkZjZjNWUvdGFibGVyYW5nZTo1ZWM3NjNlZDI0Zjg0YmM2OTA3YzliMWQyZGRmNmM1ZV8xLTAtMS0xLTU5NTM1_df7615e0-1a92-49e3-a2b9-445a53808c28">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWVjNzYzZWQyNGY4NGJjNjkwN2M5YjFkMmRkZjZjNWUvdGFibGVyYW5nZTo1ZWM3NjNlZDI0Zjg0YmM2OTA3YzliMWQyZGRmNmM1ZV8xLTEtMS0xLTU5NTM1_b0e8a85a-be6b-4276-a306-8e67ca61e280">LGND</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NWVjNzYzZWQyNGY4NGJjNjkwN2M5YjFkMmRkZjZjNWUvdGFibGVyYW5nZTo1ZWM3NjNlZDI0Zjg0YmM2OTA3YzliMWQyZGRmNmM1ZV8xLTItMS0xLTU5NTM1_753b374d-67da-472d-ba03-30551650390e">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTg5_a403e4ba-fa0b-4e7f-bffa-d7fa60ac6566">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTkw_c4c4bff0-921c-40c1-89cf-7a2121274c92">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NjAzNDk5MDkwYTBkNDE3N2I3NTc4ZTY0YWRjMGUxZWUvdGFibGVyYW5nZTo2MDM0OTkwOTBhMGQ0MTc3Yjc1NzhlNjRhZGMwZTFlZV8wLTAtMS0xLTU5NTM1_a71f49ea-64c3-46c9-99a8-d176f9a10dd5">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NjAzNDk5MDkwYTBkNDE3N2I3NTc4ZTY0YWRjMGUxZWUvdGFibGVyYW5nZTo2MDM0OTkwOTBhMGQ0MTc3Yjc1NzhlNjRhZGMwZTFlZV8xLTQtMS0xLTU5NTM1_c33f6e98-5874-4001-acfc-fda348701cd9">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGFibGU6NjAzNDk5MDkwYTBkNDE3N2I3NTc4ZTY0YWRjMGUxZWUvdGFibGVyYW5nZTo2MDM0OTkwOTBhMGQ0MTc3Yjc1NzhlNjRhZGMwZTFlZV8yLTEtMS0xLTU5NTM1_aa67ae40-d6c9-4bb7-890a-4b514de5b92d">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTkx_a3e4fab6-b8b0-4c49-9ebc-eaa83c3ad4c0">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia08cf90d3d0749cba99e0a20f8f8db7f_I20220505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xL2ZyYWc6ZWViYTE3MWI0MzhhNDY5MDk4NWQxMzExYmViYzBkN2IvdGV4dHJlZ2lvbjplZWJhMTcxYjQzOGE0NjkwOTg1ZDEzMTFiZWJjMGQ3Yl8yMTQ5_224c3164-d26d-4f2f-936e-efb3fd0c9121"
      unitRef="shares">16861339</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMy0xLTEtMS01OTUzNQ_0925179b-c929-4069-b3b0-f09feb64f98e"
      unitRef="usd">14993000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMy0zLTEtMS01OTUzNQ_e3208043-c7b2-4ee3-bf42-ad9ab2624087"
      unitRef="usd">19522000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNC0xLTEtMS01OTUzNQ_2286d4af-6eb5-41da-ab62-f469be5d6fe9"
      unitRef="usd">189006000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNC0zLTEtMS01OTUzNQ_a576f3d3-17ae-49b1-90b1-bd13dd736eb6"
      unitRef="usd">321586000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNS0xLTEtMS01OTUzNQ_a3c829f0-0c47-4556-b560-d5c309c154e1"
      unitRef="usd">41797000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNS0zLTEtMS01OTUzNQ_69ccef75-3b59-41f1-8c3f-df325903ed4f"
      unitRef="usd">85453000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNi0xLTEtMS01OTUzNQ_11b6c294-b21f-4ed9-859a-aaef5fe58057"
      unitRef="usd">25614000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNi0zLTEtMS01OTUzNQ_00b76add-9057-49b7-9923-6d0d8802ac22"
      unitRef="usd">27326000</us-gaap:InventoryNet>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNy0xLTEtMS01OTUzNQ_7e8e30e0-6ef6-4fa0-899d-b74f6c523d43"
      unitRef="usd">0</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNy0zLTEtMS01OTUzNQ_8e4399f3-4f3e-415f-859e-47df2ac948dc"
      unitRef="usd">6193000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOC0xLTEtMS01OTUzNQ_64cce4a4-dde4-4d6d-97a1-dad4aac30a49"
      unitRef="usd">4656000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOC0zLTEtMS01OTUzNQ_a560e878-27b7-4840-8bfb-fbd9856a02b3"
      unitRef="usd">4671000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOS0xLTEtMS01OTUzNQ_307eb8de-f995-437b-af79-65bb0acf1e35"
      unitRef="usd">276066000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfOS0zLTEtMS01OTUzNQ_3a2b7e98-7a7d-47cf-bd89-1e7e03d827bd"
      unitRef="usd">464751000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTAtMS0xLTEtNTk1MzU_ed245256-2d68-4b23-94c5-3eb76fbd8bac"
      unitRef="usd">35655000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTAtMy0xLTEtNTk1MzU_606af54f-901b-4817-9c2e-54fcf819fa54"
      unitRef="usd">34482000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTEtMS0xLTEtNTk1MzU_95a6a1e5-73df-4728-be8f-70484b2c6189"
      unitRef="usd">539707000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTEtMy0xLTEtNTk1MzU_74a828b3-2fcf-469c-a191-667e68c24df2"
      unitRef="usd">551040000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTItMS0xLTEtNTk1MzU_43346c98-bee5-4c1a-8ff8-c702bb77dc3b"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTItMy0xLTEtNTk1MzU_cd61290c-76dc-4074-8070-6f32aa3d9404"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <lgnd:CommercialLicenseRights
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTMtMS0xLTEtNTk1MzU_69427ab1-f944-4523-9ac8-99b684d2536a"
      unitRef="usd">10121000</lgnd:CommercialLicenseRights>
    <lgnd:CommercialLicenseRights
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTMtMy0xLTEtNTk1MzU_4da0ecf3-a76e-4711-80a7-28e797d8371f"
      unitRef="usd">10110000</lgnd:CommercialLicenseRights>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTQtMS0xLTEtNTk1MzU_27ed2fee-940f-4756-9b1e-29d53f3acb77"
      unitRef="usd">24584000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTQtMy0xLTEtNTk1MzU_6881f94f-de53-40b3-b8d7-d359dcb6ad0c"
      unitRef="usd">20511000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTUtMS0xLTEtNTk1MzU_a8e49baa-2eef-46a6-a58c-a1c44a4de946"
      unitRef="usd">15783000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTUtMy0xLTEtNTk1MzU_eb10662d-fc5a-4191-bf94-7c23733742f5"
      unitRef="usd">16542000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTYtMS0xLTEtNTk1MzU_3e561f36-8ca5-442f-8678-047a79780339"
      unitRef="usd">15620000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTYtMy0xLTEtNTk1MzU_e2a3f820-9e20-40aa-ba73-4119ab483584"
      unitRef="usd">16207000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTctMS0xLTEtNTk1MzU_15b6928a-4e4e-4ec1-b984-0d2fbb5c6cea"
      unitRef="usd">6442000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTctMy0xLTEtNTk1MzU_013163f4-c780-4fba-811c-6800e77ed5b2"
      unitRef="usd">2741000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTgtMS0xLTEtNTk1MzU_e7def1c0-b2c8-4dd3-a2c3-fc8fcce31a3a"
      unitRef="usd">1105184000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMTgtMy0xLTEtNTk1MzU_a81dda23-b9c4-44d2-ac43-23bff84fe090"
      unitRef="usd">1297590000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjEtMS0xLTEtNTk1MzU_d5951dd3-04a4-47a2-b36c-2dbb2b65722d"
      unitRef="usd">6972000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjEtMy0xLTEtNTk1MzU_48e19e82-24bc-4cbd-91a3-dd9cb31c5980"
      unitRef="usd">8403000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjItMS0xLTEtNTk1MzU_677cf79e-6689-4d17-973d-df664f8b4f04"
      unitRef="usd">15877000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjItMy0xLTEtNTk1MzU_72bc1f8c-6d35-4aab-88aa-4cdae7ea4d3e"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMS0xLTEtNzM5Nzc_e049b28b-c4e6-49b9-9673-d223f9a72e2c"
      unitRef="usd">5800000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMy0xLTEtNzUzMjY_d1396c65-e69c-47e6-b6ff-ea1fc9c6b416"
      unitRef="usd">0</us-gaap:AccruedIncomeTaxesCurrent>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMS0xLTEtNTk1MzU_da753ba9-0f5a-47bf-8ad0-1c15185766fb"
      unitRef="usd">1524000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <lgnd:CurrentPortionOfLiabilityForContingentValueRights
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjMtMy0xLTEtNTk1MzU_17002867-c4e1-413b-9d90-b65c8bc6f548"
      unitRef="usd">2588000</lgnd:CurrentPortionOfLiabilityForContingentValueRights>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjQtMS0xLTEtNTk1MzU_f53d84ab-cf24-42ae-8c18-1c608aad5f83"
      unitRef="usd">10503000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjQtMy0xLTEtNTk1MzU_0f2d9826-6bb7-4c0e-815f-99b7fca80b39"
      unitRef="usd">10996000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjUtMS0xLTEtNTk1MzU_2996c09c-e579-44b3-968e-d90e9dc2b1a1"
      unitRef="usd">1850000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjUtMy0xLTEtNTk1MzU_8e705d13-85ee-4e7c-a41c-83191915832c"
      unitRef="usd">2053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjYtMS0xLTEtNTk1MzU_6bd5e283-3b18-45c1-92cb-714c3256e778"
      unitRef="usd">52000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjYtMy0xLTEtNTk1MzU_f5eb6a32-3a39-4c17-9e73-c07f603bd7f0"
      unitRef="usd">46000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjctMS0xLTEtNTk1MzU_6731568c-4e30-4a5b-943b-524798bfab79"
      unitRef="usd">42578000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjctMy0xLTEtNTk1MzU_83ea1a12-8b5e-427c-9cc4-f40311d84ba5"
      unitRef="usd">41665000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjgtMS0xLTEtNTk1MzU_9b01b405-ae91-4340-9e37-f099747dcddc"
      unitRef="usd">176540000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjgtMy0xLTEtNTk1MzU_bbba352d-ba11-474a-8219-d3f1cfa18aa0"
      unitRef="usd">320717000</us-gaap:ConvertibleDebtNoncurrent>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjktMS0xLTEtNTk1MzU_02fc7336-37d6-4639-9da7-8d7b1febe61e"
      unitRef="usd">7448000</lgnd:LiabilityForContingentValueRights>
    <lgnd:LiabilityForContingentValueRights
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMjktMy0xLTEtNTk1MzU_db1577cb-df4b-489b-9405-9915607a2d42"
      unitRef="usd">8483000</lgnd:LiabilityForContingentValueRights>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzAtMS0xLTEtNTk1MzU_a559031f-a446-4870-8ebb-f1633207b337"
      unitRef="usd">39480000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzAtMy0xLTEtNTk1MzU_a115e6e5-ca35-416b-b2f8-bb91fd5074aa"
      unitRef="usd">59095000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzEtMS0xLTEtNTk1MzU_893df428-4211-4e72-9501-743bc72ac685"
      unitRef="usd">16758000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzEtMy0xLTEtNTk1MzU_35dd2d70-6ec9-4142-8fde-b7e238144e52"
      unitRef="usd">15494000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzItMS0xLTEtNTk1MzU_a1a8863d-da7c-4473-85c1-a20e44503318"
      unitRef="usd">29188000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzItMy0xLTEtNTk1MzU_515feba1-7616-40ec-99df-e6e71ebd2e70"
      unitRef="usd">30977000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzMtMS0xLTEtNTk1MzU_69a052d4-8d5a-4ab8-8cb1-031777a7b5c9"
      unitRef="usd">311992000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzMtMy0xLTEtNTk1MzU_e65dc32a-93d7-4ce5-83df-19ff289e403b"
      unitRef="usd">476431000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzQtMS0xLTEtNTk1MzU_b9cc3268-26ee-47e8-b751-196b6d9908bd"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzQtMy0xLTEtNTk1MzU_5e957ab1-ffa7-4273-ac45-79135fd60ed3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8yNA_b2d4a385-4ce1-4a51-9812-23456d42cea0"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8yNA_b915bc0d-0f09-4342-ab13-5b196a70c1a1"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8zOA_2fb65cce-ca8e-4023-8a9c-a84a9a78d9eb"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF8zOA_f5f294a2-b738-4c0f-9aa2-61722eda43dc"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_02649cfa-e087-435f-9956-b4731f8c3fea"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_1409dec6-1049-4400-b33b-dba16c62b94b"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_b49bdff1-3af6-43c9-8cc1-2e7831a09729"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjpkYzFjYzFiNzRhMTQ0MGE1OWI3MTlmNmRiNWZlYjI4NF82MA_be8416e3-aae6-4ba3-b0f5-c624e3b845c4"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMS0xLTEtNTk1MzU_a9a97bd6-01a7-4fa9-a1b0-d053c6d92c7d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzYtMy0xLTEtNTk1MzU_31b9d08d-cf60-4ba1-a883-3018004b0c8a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8yMQ_29ae611a-0490-44ef-962c-859f9b49f6ea"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8yMQ_c6323c92-430a-4507-822b-3da30ef21397"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8zNQ_1a22fb23-68e1-4850-a32a-87dc3672b44b"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl8zNQ_ce870594-8a5f-4943-9f6e-b1f36a5e4e6a"
      unitRef="shares">60000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl81Nw_36dde462-6a4b-40c4-aa1e-fc90a33836db"
      unitRef="shares">16861000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl81Nw_e9dca2ce-1150-48a3-b552-e2cbbe328da3"
      unitRef="shares">16861000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl82NA_1fb77536-3234-4ba3-b2d1-4c67a0b560d5"
      unitRef="shares">16767000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMC0xLTEtNTk1MzUvdGV4dHJlZ2lvbjo1NDU5ZjBlYWJkOTA0OTI4YjE2ZjAxMzU2NThjYmQzYl82NA_9028f0db-f813-433b-a40b-64816654015d"
      unitRef="shares">16767000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMS0xLTEtNTk1MzU_ce4cfef7-a121-4bcf-bbb5-b2a1a22e4dde"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzctMy0xLTEtNTk1MzU_3ba6b5fc-9c21-4db8-b747-8cd821631f84"
      unitRef="usd">17000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzgtMS0xLTEtNTk1MzU_0172bdf7-3079-4fb8-add7-b95dca509f28"
      unitRef="usd">325368000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzgtMy0xLTEtNTk1MzU_0a49703f-6143-4890-a450-f2346d80bc22"
      unitRef="usd">372969000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzktMS0xLTEtNTk1MzU_5139dda8-b1b5-43e1-a47d-657f25f93172"
      unitRef="usd">-1031000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfMzktMy0xLTEtNTk1MzU_ef76113f-270a-42cf-b86c-d70346f36b0b"
      unitRef="usd">-917000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDAtMS0xLTEtNTk1MzU_3fb4e421-d4e4-4aee-829a-1e9643e5bb7c"
      unitRef="usd">468838000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDAtMy0xLTEtNTk1MzU_a363ea19-705a-4892-917d-e30a25209757"
      unitRef="usd">449090000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDEtMS0xLTEtNTk1MzU_a321faa7-cb3a-4348-81a7-bfa4ecb99fd7"
      unitRef="usd">793192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDEtMy0xLTEtNTk1MzU_a38b464d-69fa-4292-9b8b-57dfd30836a4"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDItMS0xLTEtNTk1MzU_f2575a3f-3a05-4ea8-8754-b5b13be78ebe"
      unitRef="usd">1105184000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xNi9mcmFnOjA0YzM2NjNiMmQ3ZTRiYWU4NzFmZGNhMzJlNTFhODI3L3RhYmxlOmQxOTUxMTI4YjUzYTQyMjNiNGExMjUyMDMzZjk1YjAyL3RhYmxlcmFuZ2U6ZDE5NTExMjhiNTNhNDIyM2I0YTEyNTIwMzNmOTViMDJfNDItMy0xLTEtNTk1MzU_6a61809a-1e50-46cb-8f2f-4563abdcad0e"
      unitRef="usd">1297590000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2871262664774e9c93e671bd91fbc05a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNC0xLTEtMS01OTUzNQ_ccd56c15-f742-4b05-bc17-f2dd1ec97392"
      unitRef="usd">13695000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28b08e6912b04510a2abbaffe52e8c52_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNC0zLTEtMS01OTUzNQ_85b04152-c09f-4536-a6ee-aff5003b8195"
      unitRef="usd">7112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6af8f3a1ea1147389b4f58ce1a5ce5c3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNS0xLTEtMS01OTUzNQ_d723f06c-fb1b-42f1-b0be-00fed675a5e7"
      unitRef="usd">12122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNS0zLTEtMS01OTUzNQ_86544294-ba61-44c5-a177-85637bf6833a"
      unitRef="usd">31272000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNS0zLTEtMS01OTUzNQ_f2d12651-5c23-4d07-946e-4f02c5b958b3"
      unitRef="usd">31272000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4bdb647ddf147bd84a8bb24e2666210_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNi0xLTEtMS01OTUzNQ_8d249bce-9f56-43f5-81df-818747defc38"
      unitRef="usd">19876000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbd7481a03054f56837d5f2889064a3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNi0zLTEtMS01OTUzNQ_3b9281e2-e5ac-44f5-9747-22034f341b56"
      unitRef="usd">16766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNy0xLTEtMS01OTUzNQ_2521d48a-6940-4c15-ae40-a541a61d84ea"
      unitRef="usd">45693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfNy0zLTEtMS01OTUzNQ_fd6b88a1-d19e-453b-bf93-cbe41412da84"
      unitRef="usd">55150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostDirectMaterial
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfOS0xLTEtMS01OTUzNQ_f9528704-f63b-470e-88b1-5e8bcea72b94"
      unitRef="usd">4699000</us-gaap:CostDirectMaterial>
    <us-gaap:CostDirectMaterial
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfOS0zLTEtMS01OTUzNQ_98c27444-571c-4300-8677-80836be345e5"
      unitRef="usd">8153000</us-gaap:CostDirectMaterial>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTAtMS0xLTEtNTk1MzU_058038a6-f371-48b6-a22c-f34d2dcb4421"
      unitRef="usd">11813000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTAtMy0xLTEtNTk1MzU_065a0f06-234e-451d-8b39-d0009785837e"
      unitRef="usd">11786000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTEtMS0xLTEtNTk1MzU_fd985838-d3b3-4204-b9f9-3126bdf47139"
      unitRef="usd">20307000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTEtMy0xLTEtNTk1MzU_82980605-7778-4187-8376-bfe2a485aa3c"
      unitRef="usd">17879000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTItMS0xLTEtNTk1MzU_32aa1f89-f220-47c1-b5c2-ec1f89fb419b"
      unitRef="usd">18180000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTItMy0xLTEtNTk1MzU_e7a5f942-b72e-49b9-a059-00c127bdc878"
      unitRef="usd">12617000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTQtMS0xLTEtNTk1MzU_dda246fa-8163-40c4-8ef7-cfee87a84f54"
      unitRef="usd">54999000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTQtMy0xLTEtNTk1MzU_a3fc28db-0d9b-4377-b111-a6c15e380528"
      unitRef="usd">50435000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTUtMS0xLTEtNTk1MzU_c3af6b9a-e756-4fe3-b0da-5f259ebab7df"
      unitRef="usd">-9306000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTUtMy0xLTEtNTk1MzU_30b1ad3f-ee28-431c-a7f0-fadd8fe9d307"
      unitRef="usd">4715000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTctMS0xLTEtNTk1MzU_99011954-6975-4c04-9f82-9d3896ab87a2"
      unitRef="usd">-12877000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTctMy0xLTEtNTk1MzU_30ed4b70-287a-4c80-adc9-99dfa833bbbc"
      unitRef="usd">13061000</us-gaap:GainLossOnInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTgtMS0xLTEtNTk1MzU_539af246-29a1-4a79-97cb-5ab4072ca693"
      unitRef="usd">134000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTgtMy0xLTEtNTk1MzU_ad267946-d5b6-4e00-9573-9ddf2245ab41"
      unitRef="usd">296000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTktMS0xLTEtNTk1MzU_f015af37-750f-4c2e-8b07-c39adef4a796"
      unitRef="usd">789000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMTktMy0xLTEtNTk1MzU_b41d12de-ff66-4b2a-96c4-de2f50a767ff"
      unitRef="usd">5831000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjAtMS0xLTEtNTk1MzU_284a6762-b186-4352-a120-4f8c1aeb41a8"
      unitRef="usd">2698000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjAtMy0xLTEtNTk1MzU_25782cc7-4dec-4434-946a-05bc40802eec"
      unitRef="usd">-6477000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjEtMS0xLTEtNTk1MzU_6a6c2140-fdff-46d3-8a15-78834f5c081d"
      unitRef="usd">-10834000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjEtMy0xLTEtNTk1MzU_bd33c05c-6c30-44ce-9377-d8bed22a0106"
      unitRef="usd">1049000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjItMS0xLTEtNTk1MzU_fcc0d40e-7c09-4ffd-b237-30a938317048"
      unitRef="usd">-20140000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjItMy0xLTEtNTk1MzU_7883873f-64ee-4252-8bb5-1b94f7861bac"
      unitRef="usd">5764000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjMtMS0xLTEtNTk1MzU_59398e9d-8e87-4e4d-b45e-d8c8e4dc5d44"
      unitRef="usd">-4755000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjMtMy0xLTEtNTk1MzU_db8e4978-e715-4869-84b9-6191f2fc01cf"
      unitRef="usd">-12342000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjQtMS0xLTEtNTk1MzU_63ff8a11-30d4-4db0-b8fe-0cb3db83849e"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjQtMy0xLTEtNTk1MzU_ca773ac4-6f0b-4448-9982-55d41784cd54"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjYtMS0xLTEtNTk1MzU_e56e4731-6feb-4bb9-9931-8519b1be15ea"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjYtMy0xLTEtNTk1MzU_fbbfa53f-2067-4b1d-8c94-eef9f9c81b0b"
      unitRef="usdPerShare">1.10</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjctMS0xLTEtNTk1MzU_b2ca69ee-39b8-4060-a705-db9b9cdbf339"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjctMy0xLTEtNTk1MzU_a3622068-02f9-4a57-b272-1a7f4c56659b"
      unitRef="shares">16435000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjktMS0xLTEtNTk1MzU_6d23377c-19fc-488a-8c80-4fe87c97b068"
      unitRef="usdPerShare">-0.91</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMjktMy0xLTEtNTk1MzU_863d389b-2d14-4b91-9c5b-0cb4817ce5f7"
      unitRef="usdPerShare">1.05</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMzAtMS0xLTEtNTk1MzU_a4041dc6-e49f-4502-b589-544e4b4e26ee"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18xOS9mcmFnOmFhZmVkMWRkMWY5NTQxZTE4ZTIyM2I0ODEzNDlkODY1L3RhYmxlOmNhODA2OTMzMmIyNDRkNjU5MWJjZGY3MGM1YmNkMjkzL3RhYmxlcmFuZ2U6Y2E4MDY5MzMyYjI0NGQ2NTkxYmNkZjcwYzViY2QyOTNfMzAtMy0xLTEtNTk1MzU_25535c20-31cf-43e6-9af0-eb462aa7de03"
      unitRef="shares">17248000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfMy0xLTEtMS01OTUzNQ_454f4199-e3c4-451d-80b4-c8c568dcfbad"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfMy0zLTEtMS01OTUzNQ_bc95796b-7d42-4e43-a0bd-6eb4724bc67a"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNC0xLTEtMS01OTUzNQ_f08ada80-33e9-4503-9b40-02f264d7fc2e"
      unitRef="usd">-114000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNC0zLTEtMS01OTUzNQ_28c0b150-717d-433d-8f5b-8be2299b6ea3"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNy0xLTEtMS01OTUzNQ_4d6a4865-060d-4ca3-843b-a712dbf1925c"
      unitRef="usd">-15499000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yMi9mcmFnOjVhNmNkZTg4YWE4MzQwZmY4ZDgyMDEzNDZkN2FjNzU4L3RhYmxlOjE0NzBmODhlNDMzOTQ4ZGQ5MWEyNTUyYThiNzUzNTBjL3RhYmxlcmFuZ2U6MTQ3MGY4OGU0MzM5NDhkZDkxYTI1NTJhOGI3NTM1MGNfNy0zLTEtMS01OTUzNQ_8fa94b05-caa6-42bb-a743-3e6683852339"
      unitRef="usd">18051000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i5f315420bac2445db97141e3eb94ecf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi0xLTEtMS01OTUzNQ_72d548e4-465f-4bf8-b4fe-7ed1821951ea"
      unitRef="shares">16767000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5f315420bac2445db97141e3eb94ecf8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi0yLTEtMS01OTUzNQ_ef723939-dac4-4390-9177-68d309e123c5"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id5b05cfdbed34186bc0ca0f9967ff690_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi0zLTEtMS01OTUzNQ_fd023280-40cc-44dd-9175-e4f2d2190b81"
      unitRef="usd">372969000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d9dead5c83f404093493fd89aedc1ef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi00LTEtMS01OTUzNQ_6fa0f172-5c07-4b03-847a-4e609d52cff9"
      unitRef="usd">-917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6f6c591ca6164e298b702b2e5838de27_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi01LTEtMS01OTUzNQ_8dffb38f-ba49-4bff-8f6b-1d330be462e8"
      unitRef="usd">449090000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMi02LTEtMS01OTUzNQ_11bb1299-e0d5-44dd-8203-8292eda62b41"
      unitRef="usd">821159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3f9217abff4940c09241816ada5b00d7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0zLTEtMS02OTIyNA_e96d474d-8d86-490d-a6b5-c303c2df7da1"
      unitRef="usd">-51130000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i745a10c5acc04c8abff6813d0fbcc32c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy01LTEtMS02OTI0OQ_637707a8-c224-4777-914f-72aaf8468f36"
      unitRef="usd">35133000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i87c3f0f2b43c4a02a873a348ac60340e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy02LTEtMS02OTIzMA_06f83863-3cb4-4064-ab38-ea1eec17ce94"
      unitRef="usd">-15997000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia2b8ad2425b94970836064433e1b9c36_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0xLTEtMS01OTUzNQ_6a4755ef-9c41-4da2-8528-e14ad5edf7af"
      unitRef="shares">94000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ic54fc48630a943be8d51ab84bb6ec9e1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy0zLTEtMS01OTUzNQ_d8136749-c072-466a-b70b-5451913ea05e"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMy02LTEtMS01OTUzNQ_4e3924f2-586b-43fb-ba4a-5341f4e2bbdc"
      unitRef="usd">-5515000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic54fc48630a943be8d51ab84bb6ec9e1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNC0zLTEtMS01OTUzNQ_0e623fb8-f715-42e2-be8f-dbc538731f44"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNC02LTEtMS01OTUzNQ_fc5f53cd-f733-42ed-8a08-f64067253cf5"
      unitRef="usd">9044000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i04dfa09c315e4ea8937000c9fbcebd65_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNS00LTEtMS01OTUzNQ_01eba2d6-5326-4eab-b3cd-96de0bef6cc9"
      unitRef="usd">-114000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfNS02LTEtMS01OTUzNQ_595a65e2-2f65-4964-934a-84eafdce9130"
      unitRef="usd">-114000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i05239c6a6e534a8c889d6057c3a05746_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfOS01LTEtMS01OTUzNQ_18c655db-b216-46bd-bb7d-998f4988e4ae"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfOS02LTEtMS01OTUzNQ_77f60b8f-3e69-4b91-b620-521e0190276f"
      unitRef="usd">-15385000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i29e36d3c6bfa46a3aabff2ac65a972b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtMS0xLTEtNTk1MzU_b0864a3f-5c14-4d29-b821-d4f10f812af4"
      unitRef="shares">16861000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i29e36d3c6bfa46a3aabff2ac65a972b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtMi0xLTEtNTk1MzU_0e9d021e-38dc-4ee8-b935-b85ac4838274"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ida954be77ff74c0bbe3dc1fe29aee07d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtMy0xLTEtNTk1MzU_154f2dbb-e32b-4df5-bf69-63dd00d0b515"
      unitRef="usd">325368000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2349b019bea04c3f8818d90c8e36dfe4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtNC0xLTEtNTk1MzU_f0cec5ae-4b47-480a-8b5c-f0247b23304f"
      unitRef="usd">-1031000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib57655db6c244e568e24627c0da2b0e6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtNS0xLTEtNTk1MzU_c6a33098-b620-4fba-b470-3b7717a0f8ab"
      unitRef="usd">468838000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOmQ2MGM1MGQ1MDNkZTQ0MDVhZTY1OTM4YjA5YTU1NGM1L3RhYmxlcmFuZ2U6ZDYwYzUwZDUwM2RlNDQwNWFlNjU5MzhiMDlhNTU0YzVfMTAtNi0xLTEtNTk1MzU_97146666-7e9a-4df3-8940-6e12f97dfba0"
      unitRef="usd">793192000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ie23dddf73d564cccbeb38cedfbf213d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi0xLTEtMS01OTUzNQ_c1710298-adcf-4d31-a4a7-7b1df5f1bcda"
      unitRef="shares">16080000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ie23dddf73d564cccbeb38cedfbf213d4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi0yLTEtMS01OTUzNQ_15e74ed5-3dd4-48f8-bd0d-c96f049a01b8"
      unitRef="usd">16000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf1964f2dbc3421fbd584115f1a95eb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi0zLTEtMS01OTUzNQ_459f4790-07ef-4535-82a9-e3606baae8ab"
      unitRef="usd">318358000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iea088c6521ae42dabe8f16d54142f236_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi00LTEtMS01OTUzNQ_e714005d-f04d-4c96-afaa-79364b0db731"
      unitRef="usd">-801000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i40321155ca4046eba9b0de104f5ce8db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi01LTEtMS01OTUzNQ_e4a716f9-0816-49b2-9c8c-087003cd8c95"
      unitRef="usd">391952000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8542ff7045c84ed5bbfbe302627e05db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMi02LTEtMS01OTUzNQ_c3ccdee3-4446-4dcb-95ff-26feb1375f1a"
      unitRef="usd">709525000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i0adfb1eca5a640698b9228529cba9397_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy0xLTEtMS01OTUzNQ_860a8e46-7afa-4c78-bed8-ad5be55614c0"
      unitRef="shares">572000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0adfb1eca5a640698b9228529cba9397_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy0yLTEtMS01OTUzNQ_ff0351f9-d82f-44ce-b879-2d01faca67b1"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy0zLTEtMS01OTUzNQ_4d49953d-881c-4cd6-8e2a-9dcdc48f65a9"
      unitRef="usd">20580000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMy02LTEtMS01OTUzNQ_99ff4d7b-5c4c-40ae-9a17-abd308fd57ce"
      unitRef="usd">20581000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNC0zLTEtMS01OTUzNQ_cd2cd2a3-9b26-4087-844d-c3d218b0d638"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNC02LTEtMS01OTUzNQ_400efa6c-f287-4f9a-97c0-477a035ca79d"
      unitRef="usd">8405000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="i154f58555d7d4643b2e1f528903985d9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNi00LTEtMS01OTUzNQ_9e2f38d0-0e1d-46eb-b984-6fdd38404b1d"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNi02LTEtMS01OTUzNQ_02ed1642-7e2e-4e56-99f2-347d31470dde"
      unitRef="usd">-55000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNy0zLTEtMS01OTUzNQ_c63da47c-9fa5-4c6a-8a12-61e23dafab80"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfNy02LTEtMS01OTUzNQ_6307ca06-8cc6-4f9e-8f52-5ccdd5cfcfbd"
      unitRef="usd">396000</lgnd:AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOC0zLTEtMS01OTUzNQ_0e5ba9cb-4091-4540-bde6-6ae7fc53f018"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOC02LTEtMS01OTUzNQ_7be46f41-c6c1-4860-8279-7a11130bff7a"
      unitRef="usd">-9086000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="i873d03ab0a2c474f97082d96f9b05cf2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOS0zLTEtMS02MDIyMA_ce63024a-594f-476e-acd6-849502d013e5"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfOS02LTEtMS01OTUzNQ_5e1c775b-6aea-485a-867b-df19d6d6e0e5"
      unitRef="usd">2032000</lgnd:AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions>
    <us-gaap:NetIncomeLoss
      contextRef="i8c8f70bcb8544a2d8a2cb58c9207ff0b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTAtNS0xLTEtNTk1MzU_8162255e-4209-4013-baf8-4f32a1d14093"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTAtNi0xLTEtNTk1MzU_eab7726c-880f-4aff-aeaf-cb788cbb7a70"
      unitRef="usd">18106000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i3c66c5680f12470c9b06b7b32d2062a2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtMS0xLTEtNTk1MzU_9f341f50-3fe7-4b5d-a8a9-28bb1db5e043"
      unitRef="shares">16652000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3c66c5680f12470c9b06b7b32d2062a2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtMi0xLTEtNTk1MzU_c82c3b9d-6e83-4c0c-bc0a-acb70c883de1"
      unitRef="usd">17000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib7b75c9953264ac2b488a162bfbb1fa7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtMy0xLTEtNTk1MzU_8c78cc15-c922-4351-b88d-370eb1ff56f5"
      unitRef="usd">336621000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fb955a30fcb449ca1b8aed8ec29365a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtNC0xLTEtNTk1MzU_4b57c46c-5e93-4bb4-893a-96b6c4423ce4"
      unitRef="usd">-856000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0211e1bbe9f44dfebcdf0ebe1dac694e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtNS0xLTEtNTk1MzU_9635f0eb-5a27-4cf0-9a26-17b3aec6e406"
      unitRef="usd">410058000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id709f7f89de844718660a4c1048c1cf3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yNS9mcmFnOmQ2YTlmZDM5NWE0ZDQyMTRhNjBmZjhhOTQyNzY4ZWIxL3RhYmxlOjAwYWVmNDY1N2U5ZTRmYzA5ODk1OGE1YTdiYjQ1NThmL3RhYmxlcmFuZ2U6MDBhZWY0NjU3ZTllNGZjMDk4OTU4YTVhN2JiNDU1OGZfMTEtNi0xLTEtNTk1MzU_33653d4a-0f26-40c7-868c-981545da94b4"
      unitRef="usd">745840000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNC0xLTEtMS01OTUzNQ_c9307c6d-bc7d-4894-84fa-8a8ad3650c7f"
      unitRef="usd">-15385000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNC0zLTEtMS01OTUzNQ_0a927ae9-d973-469c-95a1-60360428f9de"
      unitRef="usd">18106000</us-gaap:ProfitLoss>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNi0xLTEtMS01OTUzNQ_7e1f8804-6e70-4104-8a41-40b4ae9bfece"
      unitRef="usd">1035000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNi0zLTEtMS01OTUzNQ_1835277d-6ba1-4ba8-83f8-4b68f68f2bbc"
      unitRef="usd">-1684000</lgnd:NonCashChangeInEstimatedFairValueOfContingentValueRights>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNy0xLTEtMS01OTUzNQ_97435651-0bb6-447a-8036-125fae613d29"
      unitRef="usd">13655000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNy0zLTEtMS01OTUzNQ_2792305e-a79e-4acf-b844-d179dc33b4a7"
      unitRef="usd">12565000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOC0xLTEtMS01OTUzNQ_cea00978-b839-446b-892d-a56a47e77879"
      unitRef="usd">-51000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOC0zLTEtMS01OTUzNQ_441fccd0-647c-42c1-ba5e-d18421d5cc5c"
      unitRef="usd">-150000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOS0xLTEtMS01OTUzNQ_2aeb71e6-d3ae-4f1d-9df0-4ec40d3fa1ff"
      unitRef="usd">326000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfOS0zLTEtMS01OTUzNQ_ad3172e9-9adf-4ea4-b557-1b3a6043fb97"
      unitRef="usd">4916000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTAtMS0xLTEtNTk1MzU_c41271e8-255d-4278-9198-7091e279edda"
      unitRef="usd">-11000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTAtMy0xLTEtNTk1MzU_bfdf1ca2-09fd-4582-ad20-5eb88c2c05b3"
      unitRef="usd">528000</lgnd:AmortizationOfCommercialLicenseAndOtherEconomicRights>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTEtMS0xLTEtNTk1MzU_0e99b910-5fde-4332-8a7c-e7d37fd6cdf1"
      unitRef="usd">1532000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTEtMy0xLTEtNTk1MzU_784e6ebb-8da0-4afe-8c67-f295cf2946e6"
      unitRef="usd">-4840000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:ShareBasedCompensation
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTItMS0xLTEtNTk1MzU_627a0547-6655-4ec6-951c-3917f5c95f7e"
      unitRef="usd">9044000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTItMy0xLTEtNTk1MzU_f605a571-cdf6-4758-8ca2-23f5e549bb5c"
      unitRef="usd">8405000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTMtMS0xLTEtNTk1MzU_00f315de-7b91-4b86-9ff5-44fc71426886"
      unitRef="usd">16180000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTMtMy0xLTEtNTk1MzU_5a1b3bde-951b-48c8-9b7b-c395cdaa8158"
      unitRef="usd">12408000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTQtMS0xLTEtNTk1MzU_1952efef-3d7e-4a76-9dff-de6c4c60d566"
      unitRef="usd">-12877000</lgnd:GainLossOnShortTermInvestments>
    <lgnd:GainLossOnShortTermInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTQtMy0xLTEtNTk1MzU_ee852cb9-9466-4570-975f-24b5b00821b8"
      unitRef="usd">13090000</lgnd:GainLossOnShortTermInvestments>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTUtMS0xLTEtNTk1MzU_0425d4a4-9935-4d9e-a553-52f004f65ccf"
      unitRef="usd">-80000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTUtMy0xLTEtNTk1MzU_b66a0f20-1aa1-4cfe-97a3-8e6e377e1875"
      unitRef="usd">238000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTctMS0xLTEtNTk1MzU_8c186891-1d3a-49a3-9c69-e9e43273a201"
      unitRef="usd">-43638000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTctMy0xLTEtNTk1MzU_6033ed4f-b49b-46e7-9fb3-e65722a2b56c"
      unitRef="usd">-2411000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTgtMS0xLTEtNTk1MzU_5479aa00-6b78-4337-8956-58ed265cacb8"
      unitRef="usd">-44000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTgtMy0xLTEtNTk1MzU_cc43342b-c279-4645-a567-5c28f4177798"
      unitRef="usd">9670000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTktMS0xLTEtNTk1MzU_42c1733e-5602-431d-b268-1b477b143a48"
      unitRef="usd">-2708000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMTktMy0xLTEtNTk1MzU_72d8fb90-5ce1-43d3-8f74-28221bfd095e"
      unitRef="usd">470000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjAtMS0xLTEtNTk1MzU_6c7b374a-0e2f-484a-a1ae-2a5ecf36aa14"
      unitRef="usd">11993000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjAtMy0xLTEtNTk1MzU_c1ed677b-2f3a-47c6-9a22-bd0ef7980361"
      unitRef="usd">1072000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjEtMS0xLTEtNTk1MzU_713f3a6e-b0c5-4ab2-9007-8096d5d961ec"
      unitRef="usd">-2453000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjEtMy0xLTEtNTk1MzU_2a31e8e8-bde0-467e-af82-a52ba9e02683"
      unitRef="usd">-5695000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjMtMS0xLTEtNTk1MzU_98214773-c218-4262-92cb-1ebd0682be4c"
      unitRef="usd">233000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjMtMy0xLTEtNTk1MzU_0540e126-d4ba-4704-9971-68a958bb2ebd"
      unitRef="usd">3768000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjQtMS0xLTEtNTk1MzU_405bc98d-b054-4dba-8ff5-a042750bbb4c"
      unitRef="usd">52011000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjQtMy0xLTEtNTk1MzU_5d3a0b62-ab1e-4455-9f3f-f633ccc9f44b"
      unitRef="usd">10754000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjctMS0xLTEtNTk1MzU_77cd7d04-c563-41d4-933f-988744d27496"
      unitRef="usd">38190000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjctMy0xLTEtNTk1MzU_18e20233-bffa-4e2b-a69b-22204df2320e"
      unitRef="usd">72148000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjgtMS0xLTEtNTk1MzU_f9349276-275e-43c3-af41-7e6078f02706"
      unitRef="usd">132866000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromSaleOfShortTermInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjgtMy0xLTEtNTk1MzU_f3cb7b49-b704-4077-875c-d594a26fc208"
      unitRef="usd">109407000</us-gaap:ProceedsFromSaleOfShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjktMS0xLTEtNTk1MzU_fad6cce2-b0e4-4479-8b10-e86e0525a9f9"
      unitRef="usd">24830000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMjktMy0xLTEtNTk1MzU_cbc3b7a2-b574-4012-81de-dd2450ac3537"
      unitRef="usd">31500000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzEtMS0xLTEtNTk1MzU_21a3e377-ec9e-4d9f-88a6-f30fe7b4b4ec"
      unitRef="usd">750000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzEtMy0xLTEtNTk1MzU_9ea033af-acb3-408e-98f0-730ed961bdd9"
      unitRef="usd">0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzItMS0xLTEtNTk1MzU_cebf5b76-6d9e-451b-b768-fa6ac45a9fc1"
      unitRef="usd">4875000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzItMy0xLTEtNTk1MzU_1972165a-8188-4a21-8b67-16d9978fa57b"
      unitRef="usd">3404000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzMtMS0xLTEtNTk1MzU_0fb0e64e-6608-47bb-9ff9-e763425c5b1a"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzMtMy0xLTEtNTk1MzU_d67db43d-2edc-4f1e-97ee-fe09db974241"
      unitRef="usd">240000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzQtMS0xLTEtNTk1MzU_09a783db-4423-415f-a32e-a539f0b1f77e"
      unitRef="usd">113881000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzQtMy0xLTEtNTk1MzU_47b14da6-7478-4361-8477-ce5d5ea29691"
      unitRef="usd">65115000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzctMS0xLTEtNTk1MzU_44193261-05d5-40f6-a9ad-94c476e86ace"
      unitRef="usd">163356000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzctMy0xLTEtNTk1MzU_7b4279b9-5eed-46b1-8a30-c588df44b7b3"
      unitRef="usd">108822000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzgtMS0xLTEtNTk1MzU_971f4fa8-2714-42ca-9901-cf39d4e23296"
      unitRef="usd">13000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzgtMy0xLTEtNTk1MzU_75281507-f5b5-4758-b1e7-170675fb1b1f"
      unitRef="usd">3801000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzktMS0xLTEtNTk1MzU_4dc0b7cc-fa5a-4993-afee-1b59013f51e7"
      unitRef="usd">0</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:ProceedsFromHedgeFinancingActivities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfMzktMy0xLTEtNTk1MzU_7f22bb7a-e153-4bdf-8ac2-74e1b75e875b"
      unitRef="usd">16855000</us-gaap:ProceedsFromHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDAtMS0xLTEtNTk1MzU_4efb6b63-4575-45ea-8322-02ee2b1708f5"
      unitRef="usd">0</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:PaymentsForHedgeFinancingActivities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDAtMy0xLTEtNTk1MzU_3732ce05-7f6a-4d73-82aa-b4cde8df52ff"
      unitRef="usd">16459000</us-gaap:PaymentsForHedgeFinancingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDEtMS0xLTEtNTk1MzU_8b804aaa-44ef-4cb1-8965-55c96f310427"
      unitRef="usd">347000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDEtMy0xLTEtNTk1MzU_91d6c66a-0dcf-4369-a4ec-643bcdb5394a"
      unitRef="usd">26493000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDItMS0xLTEtNTk1MzU_97ec9989-ee67-4b76-bc5c-e36e9907ee72"
      unitRef="usd">5862000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDItMy0xLTEtNTk1MzU_0a7e2feb-0b86-4332-91d6-edc83ea9a1e7"
      unitRef="usd">5901000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDQtMS0xLTEtNTk1MzU_d5998413-6301-4d4b-a80c-13dc6d8672ce"
      unitRef="usd">1416000</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <lgnd:PaymentsToContingentValueRightHoldersFinancingActivity
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDQtMy0xLTEtNTk1MzU_ab37a1d4-8876-4e7d-869e-79bd44fd7a40"
      unitRef="usd">0</lgnd:PaymentsToContingentValueRightHoldersFinancingActivity>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDUtMS0xLTEtNTk1MzU_b8ce65f9-2e7d-47a5-9dcf-e8a251f947f8"
      unitRef="usd">-121000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDUtMy0xLTEtNTk1MzU_d8786692-ba02-4e9e-923e-2e9e08b4854b"
      unitRef="usd">0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDYtMS0xLTEtNTk1MzU_a290c33e-03af-400c-96e8-b1d6435c1eca"
      unitRef="usd">-170421000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDYtMy0xLTEtNTk1MzU_f50e6ce6-e82d-4665-bead-6798e1b3dbe5"
      unitRef="usd">-91635000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDgtMS0xLTEtNTk1MzU_b6240f4b-a936-427b-a7f5-fb9158a4bce6"
      unitRef="usd">-4529000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDgtMy0xLTEtNTk1MzU_5663e044-14c8-457d-86e7-f77879e6b0dd"
      unitRef="usd">-15766000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDktMS0xLTEtNTk1MzU_f4f7614c-fd2a-477f-af7a-87acb221d304"
      unitRef="usd">19522000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8542ff7045c84ed5bbfbe302627e05db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNDktMy0xLTEtNTk1MzU_57279c1e-7b35-4bdc-ac6e-4ce5224ac4f1"
      unitRef="usd">47963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNTAtMS0xLTEtNTk1MzU_849fd640-c91b-46d1-9312-2620541a29f7"
      unitRef="usd">14993000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id709f7f89de844718660a4c1048c1cf3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOmY2M2FmZWE3NjU2ZDQzOGI4Y2M0YTZmZGJhNWJiMWQwL3RhYmxlcmFuZ2U6ZjYzYWZlYTc2NTZkNDM4YjhjYzRhNmZkYmE1YmIxZDBfNTAtMy0xLTEtNTk1MzU_442233e3-4132-49d7-8516-1afd6efa4c29"
      unitRef="usd">32197000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMS0xLTEtMS01OTUzNQ_75495cc2-6e5c-4533-afe5-10c637ee9154"
      unitRef="usd">359000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMS0zLTEtMS01OTUzNQ_097c3843-799e-4b32-8431-1009c6ab56d8"
      unitRef="usd">241000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMi0xLTEtMS01OTUzNQ_064c1804-1d59-4121-93ba-37b3a5dc3bdf"
      unitRef="usd">0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMi0zLTEtMS01OTUzNQ_9583f80c-c847-447c-8f17-1af97e7198a4"
      unitRef="usd">344000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfOS0xLTEtMS01OTUzNQ_2a9fc8f8-e797-4b55-b282-795aea61eaea"
      unitRef="usd">2574000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfOS0zLTEtMS01OTUzNQ_26ae9d1d-f984-47e9-9411-8d36f68a97e0"
      unitRef="usd">87000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <lgnd:AccruedInventoryPurchases
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTAtMS0xLTEtNTk1MzU_3d332873-b96b-4b65-a62a-12f523324eed"
      unitRef="usd">306000</lgnd:AccruedInventoryPurchases>
    <lgnd:AccruedInventoryPurchases
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTAtMy0xLTEtNTk1MzU_9aa18efd-26f6-43a9-aeb5-70895834d9e1"
      unitRef="usd">775000</lgnd:AccruedInventoryPurchases>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTItMS0xLTEtNTk1MzU_3ba0faf2-95ac-4828-876e-9044e11de3ff"
      unitRef="usd">-114000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18yOC9mcmFnOjE3M2ViOWNjYWU4MjQxN2Q5ODY2MTY0NmRmNTRkZWY4L3RhYmxlOjQ4OGUwZjE3YTI4NDRmOWFhYzNmZDkyMTgxZWE3NjQ5L3RhYmxlcmFuZ2U6NDg4ZTBmMTdhMjg0NGY5YWFjM2ZkOTIxODFlYTc2NDlfMTItMy0xLTEtNTk1MzU_6610d4ce-58e9-4e0a-855c-80bc690f53eb"
      unitRef="usd">-55000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzI_663eefe9-0aac-423b-96fd-d71f6fab3ec3">Basis of Presentation and Summary of Significant Accounting Policies&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have described our significant accounting policies in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 1, Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Updates, Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended March 31, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 is $341.1&#160;million which includes an unamortized discount of $2.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue. During the three months ended March&#160;31, 2022 and 2021, the amount recognized as revenue that was previously deferred was $3.7&#160;million, and $7.3&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation&#160;of&#160;Revenue &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-term Investments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at March&#160;31, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gain (loss) from short-term investments in our condensed consolidated statements of operations includes both realized and unrealized gain (loss) from our short-term investments in public equity and warrant securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Allowances are recorded for available-for-sale debt securities with unrealized losses. This limits the amount of credit losses that can be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. The provisions of the credit losses standard did not have a material impact on our available-for-sale debt securities during the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment policy is capital preservation and we only invest in U.S.-dollar denominated investments. We held a total of 13 positions which were in an unrealized loss position as of March&#160;31, 2022. We believe that we will collect the principal and interest due on our debt securities that have an amortized cost in excess of fair value. The unrealized losses are largely due to changes in interest rates and not to unfavorable changes in the credit quality associated with these securities that impacted our assessment on collectability of principal and interest. We do not intend to sell these securities and it is not more-likely-than-not that we will be required to sell these securities before the recovery of the amortized cost basis. Accordingly, no credit losses were recognized for the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers. During the three months ended March&#160;31, 2022, we considered the current and expected future economic and market conditions including, but not limited to, the anticipated unfavorable impacts of the COVID-19 pandemic on our business and recorded an adjustment of $(0.1)&#160;million of allowance for credit losses, respectively, as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 inventory consists of Captisol prepayments of $21.1 million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Other Identifiable Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;720,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5 million as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2022, due to the net loss for the period, all of the 0.4&#160;million weighted average equity awards and 1.8&#160;million of potentially dilutive shares in connection with the adoption of ASU 2020-06 were anti-dilutive. Under the new standard, we are required to reflect the dilutive effect of the 2023 Notes by application of the if-converted method.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMjM_679ba35d-eb7b-44a5-91e4-565c5284b178">Basis of PresentationOur condensed consolidated financial statements include the financial statements of Ligand and its wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. We have included all adjustments, consisting only of normal recurring adjustments, which we considered necessary for a fair presentation of our financial results. These unaudited condensed consolidated financial statements and accompanying notes should be read together with the audited consolidated financial statements included in our 2021 Annual Report. Interim financial results are not necessarily indicative of the results that may be expected for the full year.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTA_984db0cd-3615-422a-89fb-a3dd34c20082">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and the accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNzM_5ddfeedc-d8e1-4c48-8c7a-b7ad5e04f0b1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Standards Updates, Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; (&#x201c;ASU 2020-06&#x201d;). The guidance simplifies the complexity associated with applying U.S. GAAP for certain financial instruments with characteristics of liabilities and equity. More specifically, the amendments focus on the guidance for convertible instruments and derivative scope exception for contracts in an entity&#x2019;s own equity. Consequently, a convertible debt instrument, such as the Company&#x2019;s 2023 Notes, will be accounted for as a single liability measured at its amortized cost, if no other features require bifurcation and recognition as derivatives. The new guidance also requires the if-converted method to be applied for all convertible instruments and requires additional disclosures. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We adopted this guidance effective January 1, 2022 under the modified retrospective approach and the comparative information has not been restated and continues to be presented according to accounting standards in effect for those periods. The cumulative effect of the change was recognized as an adjustment to the opening balance of retained earnings at the date of adoption and our 2023 Notes are no longer bifurcated into separate liability and equity components. The principal amount of the 2023 Notes is classified as a single liability measured at amortized cost in the condensed consolidated balance sheet for the period ended March 31, 2022. Upon adoption of ASU 2020-06 on January 1 2022, we recorded an adjustment to the 2023 Notes liability component, deferred tax liabilities, additional paid-in-capital and retained earnings. This adjustment was calculated based on the carrying amount of the 2023 Notes as if it had always been treated as a single liability measured at amortized cost. Furthermore, we recorded an adjustment to the debt issuance costs contra liability and equity (additional paid-in-capital) components under the same premise, as if debt issuance costs had always been treated as a contra liability only. Under this transition method, the cumulative effect of the accounting change increased the carrying amount of the 2023 Notes by $20.4&#160;million, reduced deferred tax liabilities by $4.4&#160;million, reduced additional paid-in capital by $51.1&#160;million and increased retained earnings by $35.1&#160;million. The net balance of the 2023 Notes at January 1, 2022 is $341.1&#160;million which includes an unamortized discount of $2.2&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i5d1b66ab770745c8ad6850d6dfd97f30_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzYyMg_dae0a0f5-fee4-4d31-91a2-04550b47b890"
      unitRef="usd">20400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5d1b66ab770745c8ad6850d6dfd97f30_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzY0Mw_bcecc1dc-12da-407f-9113-2c26be0d97d6"
      unitRef="usd">-4400000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:StockholdersEquity
      contextRef="i42456cb257354b64b669494c1f8a43e9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzY5Mw_2856c1fb-1384-46f5-9f56-739473c66d83"
      unitRef="usd">-51100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic6bf4f2b14ab4ca4964ed5c7d1fde736_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzczNg_9023d639-505e-4097-b0b5-c242ed42efa9"
      unitRef="usd">35100000</us-gaap:StockholdersEquity>
    <us-gaap:ConvertibleNotesPayable
      contextRef="i6d5f7c3225f742f2837effcd50bb3f07_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyMzc1Nw_f82abf1e-d775-4fe7-b2a0-442b07d827c4"
      unitRef="usd">341100000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i6d5f7c3225f742f2837effcd50bb3f07_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIyNDY1OQ_25ab67eb-95e0-443f-a462-b04a75ff9e67"
      unitRef="usd">2200000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNzA_638d34de-17a8-4d02-b712-965c63cc5f48">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenue is generated primarily from royalties on sales of products commercialized by our partners, Captisol material sales, and contract revenue for services, license fees and development, regulatory and sales based milestone payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply the following five-step model in accordance with ASC 606, Revenue from Contracts with Customers, in order to determine the revenue: (i) identification of the promised goods or services in the contract; (ii) determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii) measurement of the transaction price, including the constraint on variable consideration; (iv) allocation of the transaction price to the performance obligations; and (v) recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive royalty revenue on sales by our partners of products covered by patents that we or our partners own under contractual agreements. We do not have future performance obligations under these license arrangements. We generally satisfy our obligation to grant intellectual property rights on the effective date of the contract. However, we apply the royalty recognition constraint required under the guidance for sales-based royalties which requires a royalty to be recorded no sooner than the underlying sale occurs. Therefore, royalties on sales of products commercialized by our partners are recognized in the quarter the product is sold. Our partners generally report sales information to us on a one quarter lag. Thus, we estimate the expected royalty proceeds based on an analysis of historical experience and interim data provided by our partners including their publicly announced sales. Differences between actual and estimated royalty revenues, which have not been material, are adjusted in the period in which they become known, typically the following quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Captisol Sales&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from Captisol sales is recognized when control of Captisol material is transferred or intellectual property license rights are granted to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or rights. A performance obligation is considered distinct from other obligations in a contract when it provides a benefit to the customer either on its own or together with other resources that are readily available to the customer and is separately identified in the contract. For Captisol material or intellectual property license rights, we consider our performance obligation satisfied once we have transferred control of the product or granted the intellectual property rights, meaning the customer has the ability to use and obtain the benefit of the Captisol material or intellectual property license right. We recognize revenue for satisfied performance obligations only when we determine there are no uncertainties regarding payment terms or transfer of control. Sales tax and other taxes we collect concurrent with revenue-producing activities are excluded from revenue. We have elected to recognize the cost of freight and shipping when control over Captisol material has transferred to the customer as an expense in Cost of Captisol. We expense incremental costs of obtaining a contract when incurred if the expected amortization period of the asset that we would have recognized is one year or less or the amount is immaterial. We did not incur any incremental costs of obtaining a contract during the periods reported.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Contract Revenue&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Our contracts with customers often include variable consideration in the form of contingent milestone payments. We include contingent milestone payments in the estimated transaction price when it is probable a significant reversal in the amount of cumulative revenue recognized will not occur. These estimates are based on historical experience, anticipated results and our best judgment at the time. If the contingent milestone payment is based on sales, we apply the royalty recognition constraint and record revenue when the underlying sale has taken place. Significant judgments must be made in determining the transaction price for our sales of intellectual property. Because of the risk that products in development with our partners will not reach development milestones or receive regulatory approval, we generally recognize any contingent payments that would be due to us upon the development milestone or regulatory approval. Depending on the terms of the arrangement, we may also defer a portion of the consideration received if we have to satisfy a future obligation, which typically occurs with our contracts for R&amp;amp;D services.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For R&amp;amp;D services we recognize revenue over time and we measure our progress using an input method. The input methods we use are based on the effort we expend or costs we incur toward the satisfaction of our performance obligation. We estimate the amount of effort we expend, including the time it will take us to complete the activities, or the costs we may incur in a given period, relative to the estimated total effort or costs to satisfy the performance obligation. This results in a percentage that we multiply by the transaction price to determine the amount of revenue we recognize each period. This approach requires us to make numerous estimates and use significant judgement. If our estimates or judgements change over the course of the collaboration, they may affect the timing and amount of revenue that we recognize in the current and future periods.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customer contracts are sublicenses which require that we make payments to an upstream licensor related to license fees, milestones and royalties which we receive from customers. In such cases, we evaluate the determination of gross revenue as a principal versus net revenue as an agent reporting based on each individual agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Revenue&lt;/span&gt;&lt;/div&gt;Depending on the terms of the arrangement, we may also defer a portion of the consideration received because we have to satisfy a future obligation. The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (contract liabilities) on the consolidated balance sheet. Except for royalty revenue and certain service revenue, we generally receive payment at the point we satisfy our obligation or soon after. Therefore, we do not generally carry any contract asset balance. Any fees billed in advance of being earned are recorded as deferred revenue.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzI3NTk0Nw_a4934969-4517-4af9-8dc5-96fd5012e441"
      unitRef="usd">3700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzI3NTk1MA_8f7363bd-565d-4e4b-a104-3a6191b1613d"
      unitRef="usd">7300000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzU_fb1ec2f8-0466-4926-85b3-627de32802a7">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents disaggregation of royalties, Captisol and contract revenue (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Kyprolis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Evomela&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Teriparatide injection &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Rylaze &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Captisol&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - Core&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contract revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;License Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Milestone&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"&gt;(1) Captisol - COVID represents revenue on Captisol supplied for use in formulation with remdesivir, an antiviral treatment for COVID-19.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iadcc8e71d6a1438fbd272741cd9b7d95_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNC0yLTEtMS01OTUzNQ_ab3314c5-1a73-4c76-9545-04529fa8559b"
      unitRef="usd">4622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07fd099a96414912b8668ce47bea3ec2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNC00LTEtMS01OTUzNQ_9873bcab-2602-4fce-b364-735ad24e4a9d"
      unitRef="usd">4287000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ee81d901b6a492abb235b3119cc7898_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNS0yLTEtMS01OTUzNQ_8c42ca9b-c346-46a0-8919-a9b52c7dbb85"
      unitRef="usd">2701000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24d5c0bc6f4744e0b51b5d1f8ae76c36_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNS00LTEtMS01OTUzNQ_05c2f955-5864-4ab4-b90f-9fb888e79995"
      unitRef="usd">2333000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04011d0026304dbebecfd23dce2351c2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi0xLTEtMS03MjQwMw_00e87fad-a7b0-4bf7-b00e-a292b8a0b754"
      unitRef="usd">2911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a2afd26bd6c45f79cf4af863d253176_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi0zLTEtMS03MjQ1OA_993181a4-0c85-4289-bb4e-02a955481a23"
      unitRef="usd">16000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic21c8159caf94bc9a53b73d289bb1251_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy0xLTEtMS03MjQwMw_0af034b8-f52f-4e76-bdc8-750f05162f2d"
      unitRef="usd">1649000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0175e6ce3cf48caadfd1f3b8bb97392_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy0zLTEtMS03MzU3Nw_aad16230-8ee8-4a46-be91-aa29531533c9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11d5dea3dcd743feb47922ec6ed01b4b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi0yLTEtMS01OTUzNQ_7fd0ba69-21e0-43d4-8250-400c2f208a21"
      unitRef="usd">1812000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bf4fc09793f43a9a8d43f9a8f6a5199_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNi00LTEtMS01OTUzNQ_5f5d3284-0627-487f-82d4-23b8740d191a"
      unitRef="usd">476000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2871262664774e9c93e671bd91fbc05a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy0yLTEtMS01OTUzNQ_f765b1b1-036c-4d75-99b5-6b3821766e2f"
      unitRef="usd">13695000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28b08e6912b04510a2abbaffe52e8c52_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfNy00LTEtMS01OTUzNQ_6a7cde8e-7088-42ff-8eb0-3f917df24e3a"
      unitRef="usd">7112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia269861fa92141fcb3d9629f7e926de1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItMS0xLTEtNzUxNzY_23273650-3b6c-4682-81bb-380f098ad0f9"
      unitRef="usd">6226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a539e9335924d0aabf0ec4d5b20b5b7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItMy0xLTEtNzUxODc_655b097e-f210-4962-84b0-48b4a13f8b84"
      unitRef="usd">1253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaedc31f3d0524728ab67dc0105f82c05_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtMS0xLTEtNzUxNzk_0e70029b-bdee-4071-9936-5fe6a49e2e91"
      unitRef="usd">5896000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i032d93aa682241bcb144bf6c5d387a4a_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtMy0xLTEtNzUxODc_2612711f-e324-44c2-a714-e303df1ac4e8"
      unitRef="usd">30019000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6af8f3a1ea1147389b4f58ce1a5ce5c3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfOS0yLTEtMS01OTUzNQ_004ae346-32f5-4ad2-951f-e010d8ca5d2d"
      unitRef="usd">12122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9a7cc6e6e0a4026a692cb207fc352f9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfOS00LTEtMS01OTUzNQ_3112da10-b178-4cee-bcb2-3ae8416c7b23"
      unitRef="usd">31272000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i356debce55094a5f8fb2dd9767f8a65e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItMi0xLTEtNTk1MzU_d8694ce1-2e6b-435e-8fb6-7c0d9e7ed017"
      unitRef="usd">5146000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ebba23e98694d9baaebf57762ecde39_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTItNC0xLTEtNTk1MzU_27f46d62-a36d-45de-8ac7-9e648c3092b7"
      unitRef="usd">5462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7769789917214a24a4c7dfc52ac670e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtMi0xLTEtNTk1MzU_40c19776-41e1-48cb-93b1-220e7b04575f"
      unitRef="usd">3086000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia0a615c256b74c3cad0d586a69d2c6d0_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTMtNC0xLTEtNTk1MzU_681566f1-a5d1-4e00-a90c-a10eb5a9d3a7"
      unitRef="usd">1043000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief27a2dceccf46e7bb26272780283c82_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTQtMi0xLTEtNTk1MzU_c06b4048-e6ac-4170-9f8a-00c0966045a4"
      unitRef="usd">9089000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2873d3d891464c6596099d2f3ceccbc3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTQtNC0xLTEtNTk1MzU_80944ddc-9a3a-40ad-9908-d86c9e5aa105"
      unitRef="usd">8417000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i10492cd31c0f473a8754fc4b06d6e667_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTUtMi0xLTEtNTk1MzU_9fabdac8-bd3a-4ffe-ad0a-05e7d20af2c4"
      unitRef="usd">2555000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84aa90196d9044c096cdc13634fd7385_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTUtNC0xLTEtNTk1MzU_c5f2acab-adda-4e2e-918f-cd74c71c7ed0"
      unitRef="usd">1844000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4bdb647ddf147bd84a8bb24e2666210_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTYtMi0xLTEtNTk1MzU_8c1d2513-1c91-4f9a-a12d-99423ddf3b6a"
      unitRef="usd">19876000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbd7481a03054f56837d5f2889064a3e_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTYtNC0xLTEtNTk1MzU_7eae139c-f64c-4253-b89f-47edf6bcfeee"
      unitRef="usd">16766000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTgtMi0xLTEtNTk1MzU_c6eacb9b-9495-47b5-a573-07b2aab073c5"
      unitRef="usd">45693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOmMwZmQ1MmFiMWZmZTQzMDhhODdlZDc0MDYwZTViOTU5L3RhYmxlcmFuZ2U6YzBmZDUyYWIxZmZlNDMwOGE4N2VkNzQwNjBlNWI5NTlfMTgtNC0xLTEtNTk1MzU_f4ad0cb3-7300-48aa-aa9f-4a9d3d9dd72f"
      unitRef="usd">55150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <lgnd:ScheduleOfShortTermInvestmentsTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTI_523b3ff6-4aee-41f4-951f-b41a57085b57">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our short-term investments consist of the following at March&#160;31, 2022 and December 31, 2021 (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.290%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross unrealized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,043)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(854)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;189,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Bank deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Corporate equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,027)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Mutual fund&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;152,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;151,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;US government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;292,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,370)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleOfShortTermInvestmentsTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy0xLTEtMS01OTUzNQ_215870ea-f492-4036-9dd3-36f3cf208f52"
      unitRef="usd">6231000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy0zLTEtMS01OTUzNQ_b6d57447-bba4-4df1-a370-dba52887033d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy01LTEtMS01OTUzNQ_ca93b29d-a7d5-4fac-9293-e8c1af50d2cb"
      unitRef="usd">50000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ida69113abe7847e8b5ed94bf90a72132_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMy03LTEtMS01OTUzNQ_b427c31c-bea8-4ee1-82f0-0ef86dfe6def"
      unitRef="usd">6181000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC0xLTEtMS01OTUzNQ_6325ef97-16d3-49f9-a804-8782bcd68933"
      unitRef="usd">4899000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC0zLTEtMS01OTUzNQ_3736c76f-a0bc-485a-b469-2e5bb0c0473a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC01LTEtMS01OTUzNQ_47577def-a8d1-478b-9914-817b2373ba12"
      unitRef="usd">84000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i94ef9ec786694f06a63d2a1409816900_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNC03LTEtMS01OTUzNQ_8bce40ca-8f95-4b02-a6ea-9ec3f55551cf"
      unitRef="usd">4815000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi0xLTEtMS01OTUzNQ_870039fa-6631-4c56-a03d-48aaafca0f26"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi0zLTEtMS01OTUzNQ_d9f2d03c-5e34-4cc8-8f3e-47feef1c4f42"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi01LTEtMS01OTUzNQ_961dd8c9-f231-4d13-9018-5b9d50b3e5ec"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8ff3f576fac41e7b315329c76a8306c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNi03LTEtMS01OTUzNQ_ba0c5ae9-0bd5-4d78-8874-8882c839946b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy0xLTEtMS01OTUzNQ_c889619e-617a-4488-9155-c5b45b95c49e"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy0zLTEtMS01OTUzNQ_4fcb74a5-2d01-4479-8f61-c84e4b2869f6"
      unitRef="usd">344000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy01LTEtMS01OTUzNQ_a03671bc-e92a-4a3b-9dae-798bccc46c80"
      unitRef="usd">3043000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2155f0c2705b4c408b646add63eb9071_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfNy03LTEtMS01OTUzNQ_7cbf6ea3-55c1-409e-a5b9-a712deddb19d"
      unitRef="usd">3108000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC0xLTEtMS01OTUzNQ_31a68c8b-e1b7-433d-a1c6-83074c392bbc"
      unitRef="usd">152253000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC0zLTEtMS01OTUzNQ_ec3be043-484f-4eb8-8d9e-f7d01f3d66ff"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC01LTEtMS01OTUzNQ_6eef6e84-9671-48cc-ae55-f311fa0c2e69"
      unitRef="usd">854000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie11feec6336542d386a98bda4c8dbf00_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOC03LTEtMS01OTUzNQ_393f0507-4288-43a2-96d3-626891ed5cca"
      unitRef="usd">151399000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS0xLTEtMS01OTUzNQ_c74169d9-9ef1-4022-96d5-f9f7ca605238"
      unitRef="usd">3245000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS0zLTEtMS01OTUzNQ_0765d443-3663-4cbc-aca0-4ba23c95748d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS01LTEtMS01OTUzNQ_143e28e5-8a8f-47b8-8181-8974f8cedc20"
      unitRef="usd">74000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7645756406646ca8f1ec3acc081a02c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfOS03LTEtMS01OTUzNQ_b413cfad-256c-4af7-9b93-08a74afd8c3c"
      unitRef="usd">3171000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i56582b6df3664f7283828126f810559e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtMS0xLTEtNTk1MzU_0cf39e90-7fb7-462d-80b0-02a1ebddb058"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i56582b6df3664f7283828126f810559e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtMy0xLTEtNTk1MzU_4fb6ddb7-5d93-4d20-88d8-2ffe29aee1f4"
      unitRef="usd">187000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i56582b6df3664f7283828126f810559e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtNS0xLTEtNTk1MzU_28767e3d-c00b-4a56-8d17-61c3ebcc1d5f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56582b6df3664f7283828126f810559e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTAtNy0xLTEtNTk1MzU_6dd83770-2c65-4ac1-b343-f30344372a54"
      unitRef="usd">187000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtMS0xLTEtNTk1MzU_03015042-fd0a-4dc4-8037-09730d6240c7"
      unitRef="usd">172435000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtMy0xLTEtNTk1MzU_9e101075-8fb2-4896-8347-bb895b7ebc79"
      unitRef="usd">531000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtNS0xLTEtNTk1MzU_ceca2248-de20-4264-879f-7b5ec6e5782b"
      unitRef="usd">4105000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTEtNy0xLTEtNTk1MzU_0099b1ea-660e-4561-9b46-d5b4130fef58"
      unitRef="usd">168861000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i98b2a53fb0eb405a93cded08866b0e8d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTItMTAtMS0xLTcyMjQ4_7ba20d5b-ee9c-4d0d-b6a2-704656ab8bb0"
      unitRef="usd">20145000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTItMTAtMS0xLTczNTg3_3c02fcef-4e78-4398-9dd2-a97da8a87e56"
      unitRef="usd">189006000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtMS0xLTEtNjk2MTA_3b60b517-8268-4cd6-bb74-a050d1b83761"
      unitRef="usd">63389000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtMy0xLTEtNjk2MjQ_a3123c58-7819-4de1-a84b-2c2a6e534f1d"
      unitRef="usd">13000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtNS0xLTEtNjk2MjQ_9c769fce-0593-4f4c-b301-2a0a967d59e0"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i285b0c923a6f42c2af32f25b9fb32381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTQtNy0xLTEtNjk2MjQ_fd17832a-26df-45e9-a290-06ed2112a388"
      unitRef="usd">63381000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtMS0xLTEtNjk2MjQ_3cc89d26-684f-4aea-8bf2-2952d68205f5"
      unitRef="usd">29308000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtMy0xLTEtNjk2MjQ_a6259d70-d208-43de-9d24-7bb1085d6c5f"
      unitRef="usd">17000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtNS0xLTEtNjk2MjQ_5cd6d1d5-2f3a-41c2-92f4-942a8fe25088"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i774eff23634b4e6f9ce07e67955988f2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTUtNy0xLTEtNjk2MjQ_6afd5807-db44-4d30-a90b-30690aa36ae1"
      unitRef="usd">29287000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctMS0xLTEtNjk2MjQ_894190e8-c1e2-4db3-b7f1-bebc5fe275ba"
      unitRef="usd">36008000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctMy0xLTEtNjk2MjQ_c0901ee8-3962-4b07-b133-be4892edfda8"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctNS0xLTEtNjk2MjQ_3905a028-644a-4060-8817-bc20c178099b"
      unitRef="usd">12000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic258a2744cc743da87ef38a3bdcf1222_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTctNy0xLTEtNjk2MjQ_1032d906-6f40-4a49-a84e-db1e572c6b33"
      unitRef="usd">35998000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtMS0xLTEtNjk2MjQ_2c4627df-b36e-4c7a-9009-3586173ecaad"
      unitRef="usd">5807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtMy0xLTEtNjk2MjQ_689010e2-a25d-4fd3-aead-348cfa4bd492"
      unitRef="usd">402000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtNS0xLTEtNjk2MjQ_7dc43677-4faf-410a-a68a-a9e0ce3b93a3"
      unitRef="usd">2027000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i34da59c366e142fbbf562b813abcb5aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTgtNy0xLTEtNjk2MjQ_ef7a5b21-40b9-462d-a10e-41782627fddd"
      unitRef="usd">4182000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i20bdb340507b4cc49042547bdf096356_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktMS0xLTEtNjk2MjQ_37781b73-c902-42b6-8abb-043570bfa6ce"
      unitRef="usd">152136000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i20bdb340507b4cc49042547bdf096356_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktMy0xLTEtNjk2MjQ_cbd80c01-6c77-4c7f-aaa3-4c7aca96a1b6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i20bdb340507b4cc49042547bdf096356_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktNS0xLTEtNjk2MjQ_bfd6e13b-6a5d-49de-ba7c-5fbc1f00d65e"
      unitRef="usd">249000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20bdb340507b4cc49042547bdf096356_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMTktNy0xLTEtNjk2MjQ_731c8f40-a861-4d74-a279-ffb0041385d6"
      unitRef="usd">151887000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtMS0xLTEtNjk2MjQ_1fb137ff-2916-484b-8759-c2aa913084b1"
      unitRef="usd">5577000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtMy0xLTEtNjk2MjQ_a34957c6-70dd-415c-a7d1-8f8993c15a6f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtNS0xLTEtNjk2MjQ_f4be4a48-4c18-4dea-b622-bd9f7a5a22a9"
      unitRef="usd">23000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i992d4d8c76a5476194b7e457e109762c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjAtNy0xLTEtNjk2MjQ_0cb0bdbc-fb83-4754-b29b-d5ed219cbd04"
      unitRef="usd">5554000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i61db617747884bd480b2ae120011bf66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtMS0xLTEtNjk2MjQ_6e8bb772-5b3c-4f52-bcc4-8ad8d65dc79d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i61db617747884bd480b2ae120011bf66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtMy0xLTEtNjk2MjQ_e602649d-3a62-43f1-8b01-2944b5199e9e"
      unitRef="usd">408000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i61db617747884bd480b2ae120011bf66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtNS0xLTEtNjk2MjQ_71fdad85-0299-4ad2-8e5e-bda23f7206c6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i61db617747884bd480b2ae120011bf66_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjEtNy0xLTEtNjk2MjQ_f2378f73-0ea3-463a-b80a-a7e11d5f1ea3"
      unitRef="usd">408000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItMS0xLTEtNjk2Njc_739823ec-cbb0-4565-84c6-5fc126faa537"
      unitRef="usd">292225000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItNC0xLTEtNjk2Njg_592316e2-40e1-47fb-846c-49ba59736a6c"
      unitRef="usd">842000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItNy0xLTEtNjk2NzE_cf00ba94-8d93-4f6a-9915-1f2bbd4b0ad3"
      unitRef="usd">2370000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjItMTAtMS0xLTY5Njcz_964e6ded-bb05-467d-bd35-fe5062b74e35"
      unitRef="usd">290697000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7bdc3319eb85415ea312cb8a112c69ea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjUtMTAtMS0xLTcyMjcw_e4be8be1-a1a6-4bba-b333-71e4b4770b2f"
      unitRef="usd">30889000</us-gaap:EquitySecuritiesFvNi>
    <lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjZmYThmYzZjMzYwMzQ1Yzk5N2Q5NDMzYjRjM2E3YTE2L3RhYmxlcmFuZ2U6NmZhOGZjNmMzNjAzNDVjOTk3ZDk0MzNiNGMzYTdhMTZfMjUtMTAtMS0xLTczNTkw_a9fdabf1-91e1-4a2d-af3c-2a05bec53d38"
      unitRef="usd">321586000</lgnd:DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzM_68a82262-c156-4760-bfd2-514852e583be">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our available-for-sale debt securities by contractual maturity (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;After one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMi0xLTEtMS01OTUzNQ_e73ed739-6da6-46f0-8c62-b3e40d973db0"
      unitRef="usd">10095000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMi0zLTEtMS01OTUzNQ_11e20436-0dd5-45bb-83df-615b129d6fdf"
      unitRef="usd">10011000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMy0xLTEtMS01OTUzNQ_a03857a0-cc7d-4e9e-9159-724779a06608"
      unitRef="usd">6523000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfMy0zLTEtMS01OTUzNQ_e1b3988d-f433-4314-880a-e47c192f6238"
      unitRef="usd">6398000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue>
    <us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfNC0xLTEtMS01OTUzNQ_901777d0-e3bb-481a-a8d4-18cdb88a8789"
      unitRef="usd">16618000</us-gaap:HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjQzMWQ0MzBkMmIyMDQ0Nzk4Y2IzYjQxYmM3MjY4ZmY2L3RhYmxlcmFuZ2U6NDMxZDQzMGQyYjIwNDQ3OThjYjNiNDFiYzcyNjhmZjZfNC0zLTEtMS01OTUzNQ_14b29458-dea5-4426-8a5d-4303aff2658d"
      unitRef="usd">16409000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTAxODQ_f5f37383-af9a-4d7b-bec5-2f4615f8ce7b"
      unitRef="position">13</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTA4MDQ_023b3914-12e7-4cc4-a29f-f3f600f59cf7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTc_e0a8e23c-0836-4823-82c9-5c3563d3498c">Accounts Receivable and Allowance for Credit LossesOur accounts receivable arise primarily from sales on credit to customers. We establish an allowance for credit losses to present the net amount of accounts receivable expected to be collected. The allowance is determined by using the loss-rate method, which requires an estimation of loss rates based upon historical loss experience adjusted for factors that are relevant to determining the expected collectability of accounts receivable. Some of these factors include macroeconomic conditions that correlate with historical loss experience, delinquency trends, aging behavior of receivables and credit and liquidity quality indicators for industry groups, customer classes or individual customers.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTE4Mzk_7ceb7574-0caf-4f63-acf9-3b8bd5dbaf18"
      unitRef="usd">-100000</lgnd:COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNjU5NzA2OTgwNTM1NA_a21e8dc3-e06b-4529-aa59-dd1496c225c6">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, which consists of finished goods, is stated at the lower of cost or net realizable value. We determine cost using the first-in, first-out method or the specific identification method. &lt;/span&gt;&lt;/div&gt;We analyze our inventory levels periodically and write down inventory to net realizable value if it has become obsolete, has a cost basis in excess of its expected net realizable value or is in excess of expected requirements. There were no write-downs related to obsolete inventory recorded for the three months ended March&#160;31, 2022 and 2021. As of March&#160;31, 2022 inventory consists of Captisol prepayments of $21.1 million, and as of December 31, 2021 inventory consists of Captisol prepayments of $24.6&#160;million.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryNet
      contextRef="i34997f63ccf047658e1fca662ede1c9f_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIwNDkwOQ_f67663c7-b8ca-4387-9ce9-2cef8be61a4e"
      unitRef="usd">21100000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="if7807a6ec9b74845a3590b8007c957ba_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODIwNTEwMw_41bc040c-fc9e-4042-b02b-246ce97b49ea"
      unitRef="usd">24600000</us-gaap:InventoryNet>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMzc_fd8d05cc-37a5-46cf-88f8-cfc7abfdde73">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other identifiable intangible assets consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;181,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Definite lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Complete technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;280,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(82,861)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(78,991)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;40,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,934)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,267)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Contractual relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;362,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43,460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(36,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total goodwill and other identifiable intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;720,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;732,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMy0xLTEtMS01OTUzNQ_43346c98-bee5-4c1a-8ff8-c702bb77dc3b"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMy0zLTEtMS01OTUzNQ_86159b2e-3634-4bae-9c54-7ac85b5b78f8"
      unitRef="usd">181206000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic1c93540126b4a8dadf1d7a4085e4c3f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNS0xLTEtMS01OTUzNQ_5f80841b-a2ce-4187-9ba3-8d3d64e9ef20"
      unitRef="usd">281097000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if722abdc75b34610b6fea0f9483cee81_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNS0zLTEtMS01OTUzNQ_42654a36-939a-42ed-95e9-25e2d4db847e"
      unitRef="usd">280617000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic1c93540126b4a8dadf1d7a4085e4c3f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNi0xLTEtMS01OTUzNQ_82bc1e29-d434-44bc-a19a-cf3815dd43f0"
      unitRef="usd">82861000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if722abdc75b34610b6fea0f9483cee81_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNi0zLTEtMS01OTUzNQ_0bce75a6-7bb9-41d9-bc9e-8e1112935f96"
      unitRef="usd">78991000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i518fdba340374fd3a474af40b10ce796_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNy0xLTEtMS01OTUzNQ_d3429b58-0331-43de-8041-7626308c8a4f"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8c4e5dcb4e7746e5bc080a9c25e3bc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfNy0zLTEtMS01OTUzNQ_284465e0-7c73-48b5-860d-07ca96edf90a"
      unitRef="usd">2642000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i518fdba340374fd3a474af40b10ce796_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOC0xLTEtMS01OTUzNQ_2f13d378-f71c-4213-a6a7-8964341b8031"
      unitRef="usd">1477000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8c4e5dcb4e7746e5bc080a9c25e3bc3c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOC0zLTEtMS01OTUzNQ_0ff4609c-e821-4f6e-9e6c-7a46850fa49f"
      unitRef="usd">1444000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7464cb7c60b0446cbd43978b90d27c58_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOS0xLTEtMS01OTUzNQ_7afd4a29-6e44-499b-ab83-f14ef29a354d"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i54b7531ec2484661a8f1a0b6c44bfdfe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfOS0zLTEtMS01OTUzNQ_b62a01d0-1d33-4a4e-80f5-ee9410317ae9"
      unitRef="usd">40700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7464cb7c60b0446cbd43978b90d27c58_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTAtMS0xLTEtNTk1MzU_269c1f08-9eca-4632-9186-63b611ca5358"
      unitRef="usd">18934000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i54b7531ec2484661a8f1a0b6c44bfdfe_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTAtMy0xLTEtNTk1MzU_b1534d8a-c25d-47e4-a66e-081ff516c0b3"
      unitRef="usd">18267000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5f0ef9c25a614e018c39ce8e9e5101bd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTEtMS0xLTEtNTk1MzU_924e7fb7-5614-4f56-b95b-8a8495208597"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7719a92b270b4a49ac3b46e3e2b46499_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTEtMy0xLTEtNTk1MzU_1a584f2b-c48c-4627-b5ba-e12f90f2d06d"
      unitRef="usd">362000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5f0ef9c25a614e018c39ce8e9e5101bd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTItMS0xLTEtNTk1MzU_f68e5aea-e44d-42e0-ae08-0a554750f1d7"
      unitRef="usd">43460000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7719a92b270b4a49ac3b46e3e2b46499_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTItMy0xLTEtNTk1MzU_1c1b3ee1-4736-46d3-9bbb-93aa279fe0e4"
      unitRef="usd">36217000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTMtMS0xLTEtNTk1MzU_2cc3b243-9847-4a48-a749-fa31a469e228"
      unitRef="usd">720913000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <us-gaap:IntangibleAssetsNetIncludingGoodwill
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjg4ZWNmZmI2YTE4ZjQ1OWI5ZmI1YWE4YmFlNGVkMDk5L3RhYmxlcmFuZ2U6ODhlY2ZmYjZhMThmNDU5YjlmYjVhYThiYWU0ZWQwOTlfMTMtMy0xLTEtNTk1MzU_aad61d7a-3359-464a-bffc-4d02e6fbb515"
      unitRef="usd">732246000</us-gaap:IntangibleAssetsNetIncludingGoodwill>
    <lgnd:CommercialLicenseRightsPolicyTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNjU5NzA2OTgwNTM1Ng_073dce2c-e553-4a4d-bb86-a88f8b7ab9da">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Commercial License Rights&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5 million as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Commercial license rights represent a portfolio of future milestone and royalty payment rights acquired from Selexis, S.A. (Selexis) in April 2013 and April 2015, CorMatrix Cardiovascular, Inc. (CorMatrix) in May 2016, which was later acquired by Aziyo in 2017, and Dianomi Therapeutics, Inc. (Dianomi) in January 2019. Commercial license rights acquired are accounted &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;for as financial assets in accordance with ASC 310, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Receivables, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;as further discussed in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 1,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; of the Notes to Consolidated Financial Statements in our 2021 Annual Report. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We estimated the credit losses at the individual asset level by considering the performance against the programs, the company operating performance and the macroeconomic forecast. In addition, we have judgmentally applied credit loss risk factors to the future expected payments with consideration given to the timing of the payment. Given the higher inherent credit risk associated with longer term receivables, we applied a lower risk factor to the earlier years and progressively higher risk factors to the later years. During the three months ended March&#160;31, 2022, we further considered the current and expected future economic and market conditions surrounding the novel coronavirus (COVID-19) pandemic and concluded no further adjustment was needed on the allowance for credit losses as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</lgnd:CommercialLicenseRightsPolicyTextBlock>
    <lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDQ_9bc8da58-de2e-45c5-9e21-d992e5cbe3de">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial license rights consist of the following (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.777%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Aziyo and CorMatrix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,456)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,461)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Selexis and Dianomi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,177)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;28,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(18,188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5 million as of March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(2) Amounts represent accumulated amortization to principal of $11.7&#160;million and credit loss adjustments of $6.5&#160;million as of December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1e39b01f1d4d45689cebd1037fe70f27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0yLTEtMS03Mjg4MA_d1f62529-7bb7-4917-b553-a536ede810c4"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i1e39b01f1d4d45689cebd1037fe70f27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi00LTEtMS03MjkwMg_eded4634-67ee-48c3-a422-df3f135dfdb9"
      unitRef="usd">9456000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1e39b01f1d4d45689cebd1037fe70f27_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi02LTEtMS03MzY1NA_3f786bf8-769d-4114-99e0-99653448a04a"
      unitRef="usd">8240000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ieb1ea6c6606c481a951f3cc3af50b136_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi04LTEtMS03MjgzNQ_57209a3d-bf77-425c-86c4-d9f6f949501a"
      unitRef="usd">17696000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ieb1ea6c6606c481a951f3cc3af50b136_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMC0xLTEtNzI4NDE_4d43616c-52c8-4bb1-a5c1-39fcced6cc63"
      unitRef="usd">9461000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ieb1ea6c6606c481a951f3cc3af50b136_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMi0xLTEtNzM2NTQ_4432b51d-e9cb-4314-be66-7b5d4fc257d8"
      unitRef="usd">8235000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i22a5e6b72c57405abf407349fa1f4137_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0yLTEtMS01OTUzNQ_7295dd91-e096-4e7c-867a-80911cf6e263"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i22a5e6b72c57405abf407349fa1f4137_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi00LTEtMS01OTUzNQ_0b5767ec-9aad-434d-8a13-84680f8dd9b7"
      unitRef="usd">8721000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i22a5e6b72c57405abf407349fa1f4137_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi02LTEtMS01OTUzNQ_cbfcc68d-7cfd-41e1-8aa6-4856c5a2b9db"
      unitRef="usd">1881000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i457b420796584b0fb47f7e39b1055c47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi04LTEtMS01OTUzNQ_f5bc1df5-af8a-4cc0-8127-40207cd3d58c"
      unitRef="usd">10602000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i457b420796584b0fb47f7e39b1055c47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMC0xLTEtNTk1MzU_0d808498-be3d-4eb6-8cba-664974d90e10"
      unitRef="usd">8727000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i457b420796584b0fb47f7e39b1055c47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfMi0xMi0xLTEtNTk1MzU_d04c00c7-f15f-47a0-b410-a70f0424f404"
      unitRef="usd">1875000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC0yLTEtMS03MzY1NA_59a05808-0aec-49c7-ac18-68cb5de1e163"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC00LTEtMS03MzY1NA_1383366d-2202-42a2-b589-bbd9891a78fb"
      unitRef="usd">18177000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC02LTEtMS03MzY1NA_7f27d777-cdd6-41a6-84a7-4ee90efb08fc"
      unitRef="usd">10121000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC04LTEtMS03MzY1NA_439c6c80-3ef8-47a9-93c6-13e422b31722"
      unitRef="usd">28298000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments
      contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC0xMC0xLTEtNzM2NTQ_c7cb2c14-9a07-4108-8051-9bbd5f1f7986"
      unitRef="usd">18188000</lgnd:FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjhiNGY3ZTEzY2U0MTQzZjhiNzkyNjlkZjUwNjUxNjYxL3RhYmxlcmFuZ2U6OGI0ZjdlMTNjZTQxNDNmOGI3OTI2OWRmNTA2NTE2NjFfNC0xMi0xLTEtNzM2NTQ_fb2016c3-915e-4d21-a7b8-904f7d7a6f6a"
      unitRef="usd">10110000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNTQ5NzU1ODE4NzU4Mg_20db39c4-f944-4e19-85b5-b1c4c681c6e6"
      unitRef="usd">11700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTI3ODk_68b3e85f-63e1-4eda-8180-9064c12eca90"
      unitRef="usd">6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzI3NjAzNw_3dccb52c-d3e2-4807-b2a4-19581aa30824"
      unitRef="usd">-11700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments
      contextRef="ib0c60b91c8e64dfcb975d1a8c0c61ad0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfNjU5NzA2OTgwNTM3Mg_095ee713-ca59-4240-b143-545a1b634696"
      unitRef="usd">-6500000</lgnd:FiniteLivedIntangibleAssetsCreditLossAdjustments>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDE_8917a497-763d-4279-89ee-f15215f57f2f">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Royalties owed to third parties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Return reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Acquisition related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Subcontractor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Supplier&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMi0xLTEtMS01OTUzNQ_2b639210-33a1-4ffa-a974-b3b014842f2f"
      unitRef="usd">3620000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMi0zLTEtMS01OTUzNQ_81c7d6e3-faa4-41d1-bee0-580e30fa14e7"
      unitRef="usd">6532000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMy0xLTEtMS01OTUzNQ_4ebdb9ec-6fa1-414d-b099-09106d32d97d"
      unitRef="usd">3974000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMy0zLTEtMS01OTUzNQ_9bf660e9-4b89-4d5b-8fb5-bf2c5182d033"
      unitRef="usd">2046000</us-gaap:AccruedProfessionalFeesCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNC0xLTEtMS01OTUzNQ_2205fc55-0660-4be9-acac-2e924b42efc4"
      unitRef="usd">2677000</lgnd:LicenseeAccrualCurrent>
    <lgnd:LicenseeAccrualCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNC0zLTEtMS01OTUzNQ_73cdcf17-8be8-460e-9048-616fed42d5e8"
      unitRef="usd">630000</lgnd:LicenseeAccrualCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNS0xLTEtMS01OTUzNQ_8e16b3be-2560-4c1c-8a98-8bbe8c893760"
      unitRef="usd">0</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNS0zLTEtMS01OTUzNQ_6180445d-cbdb-41b6-afa1-737dea987d1e"
      unitRef="usd">149000</us-gaap:AccruedRoyaltiesCurrent>
    <lgnd:ReturnsAccrual
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNi0xLTEtMS01OTUzNQ_4756ee66-e065-480c-9836-dda343e9bdce"
      unitRef="usd">0</lgnd:ReturnsAccrual>
    <lgnd:ReturnsAccrual
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNi0zLTEtMS01OTUzNQ_ef0783ab-9675-43b5-bc64-6c916236cd09"
      unitRef="usd">2420000</lgnd:ReturnsAccrual>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNy0xLTEtMS01OTUzNQ_e37e3f18-af72-4109-b893-e70ebcae0119"
      unitRef="usd">0</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedAssetAcquisitionsCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfNy0zLTEtMS01OTUzNQ_a448cfd4-5d83-4b34-b76e-b5bc490635b6"
      unitRef="usd">1000000</lgnd:AccruedAssetAcquisitionsCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOC0xLTEtMS01OTUzNQ_ac12470f-ffb0-4c4e-a390-a328a314d1c8"
      unitRef="usd">1757000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSubcontractorExpensesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOC0zLTEtMS01OTUzNQ_636c5220-5d53-4e41-8938-45bfaef8aff8"
      unitRef="usd">1759000</lgnd:AccruedSubcontractorExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOS0xLTEtMS01OTUzNQ_8faf7a1a-bc87-45df-a47a-4a8fb4f114ca"
      unitRef="usd">1697000</lgnd:AccruedSupplierExpensesCurrent>
    <lgnd:AccruedSupplierExpensesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfOS0zLTEtMS01OTUzNQ_2dfdc42b-0434-49ac-855a-2390bb1b2891"
      unitRef="usd">848000</lgnd:AccruedSupplierExpensesCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTAtMS0xLTEtNTk1MzU_1f5e9245-d71e-4f24-85ca-93fb4818db53"
      unitRef="usd">394000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTAtMy0xLTEtNTk1MzU_daa1303c-1ce1-4440-94be-79391380a180"
      unitRef="usd">291000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTEtMS0xLTEtNTk1MzU_78a92c13-fde7-4191-a4c9-e93cfb5f99ec"
      unitRef="usd">1758000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTEtMy0xLTEtNTk1MzU_8392c652-e9ed-4d9c-8dde-e930d37c8c07"
      unitRef="usd">1904000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTItMS0xLTEtNTk1MzU_5e6adc9b-6d6a-4ccf-ae05-b5fb46201355"
      unitRef="usd">15877000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjY3OThmNWEzODliMzRjZThiNzNlMDcxOWE2MTA4NTIwL3RhYmxlcmFuZ2U6Njc5OGY1YTM4OWIzNGNlOGI3M2UwNzE5YTYxMDg1MjBfMTItMy0xLTEtNTk1MzU_414c8e6d-d2f0-4c3d-8d2c-259d98bc028b"
      unitRef="usd">17579000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNjY_ce0da8a5-4b8f-4c83-9d33-bd2bf3b6ca89">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for awards to employees and non-employee directors is a non-cash expense and is recognized on a straight-line basis over the vesting period. The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited amount of performance-based restricted stock units (PSUs) contain a market condition based on our relative total shareholder return ranked on a percentile basis against the NASDAQ Biotechnology Index over a three-year performance period, with a range of 0% to 200% of the target amount granted to be issued under the award. Share-based compensation cost for these PSUs is measured using the Monte-Carlo simulation valuation model and is not adjusted for the achievement, or lack thereof, of the performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDg_bdcf1bb9-0b1e-47e4-b7ef-bd1fc6a3183b">The following table summarizes share-based compensation expense recorded as components of research and development expenses and general and administrative expenses for the periods indicated (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;SBC - General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</lgnd:ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i7080131f89e444529897ea3dc7448eb2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfMy0xLTEtMS01OTUzNQ_beb7e667-1479-48fb-b3c7-76745d77ed05"
      unitRef="usd">3914000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i14d8023b123a4c2faca1a22a3e115e11_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfMy0zLTEtMS01OTUzNQ_31b57aed-489c-4749-85a0-c948d48e1807"
      unitRef="usd">3939000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="idfa8a3f9ab8545b981b3971997972972_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNC0xLTEtMS01OTUzNQ_efbfbf40-668c-47dd-8dbc-da25a6d52936"
      unitRef="usd">5130000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="i11b4a8c686fc4648be49dc1b9c525045_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNC0zLTEtMS01OTUzNQ_0f49c6f0-9e88-4829-ac01-af02abc81676"
      unitRef="usd">4466000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNS0xLTEtMS01OTUzNQ_88e8660d-f23c-47d7-ad99-ed56c44900cf"
      unitRef="usd">9044000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjJiYjZhZDcwMzEzMDQxNWY4ZDEyZGEwM2JiZjk2NDUxL3RhYmxlcmFuZ2U6MmJiNmFkNzAzMTMwNDE1ZjhkMTJkYTAzYmJmOTY0NTFfNS0zLTEtMS01OTUzNQ_8c790eb5-4c42-4248-aba4-abac9d66d8e8"
      unitRef="usd">8405000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzMjg_66a83d2a-bc7a-4344-982b-6380aff06d28">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair-value for options that were awarded to employees and directors was estimated at the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfMy0xLTEtMS01OTUzNQ_4b1636bf-498f-4cc7-a228-5d4438c78276"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfMy0zLTEtMS01OTUzNQ_10ac47f5-24aa-45ae-91b7-e65591f97f18"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNC0xLTEtMS01OTUzNQ_53ac0d7b-8692-4753-97ad-c4f1a6459ff8"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNC0zLTEtMS01OTUzNQ_86f6fa68-a5c7-445c-a8ca-5298bfbd0989"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNS0xLTEtMS01OTUzNQ_5ccc5426-cb58-4429-a96e-3d517551daf8"
      unitRef="number">0.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNS0zLTEtMS01OTUzNQ_3b5dcb5d-0d0b-454d-8d44-e2d6b4c3708d"
      unitRef="number">0.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNi0xLTEtMS01OTUzNQ_c3aa6fa9-b147-46bc-9680-cba30b56f118">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjE5NWUwNjEzNGFjMzRlOTE5YjdhOGRmZWUzOTY3NGIyL3RhYmxlcmFuZ2U6MTk1ZTA2MTM0YWMzNGU5MTliN2E4ZGZlZTM5Njc0YjJfNi0zLTEtMS01OTUzNQ_5b9a1ca3-7092-456e-9c19-e35d24cbb91e">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDA_292ed8eb-3afb-4c9f-a56d-4378cf74b8bf">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i2ff20198dfd645f89511cf05d55fafd4_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTczMjM_1c458157-d24a-4efe-b4e5-18b03c0e436b"
      unitRef="number">0</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent
      contextRef="i2a3b49d1a88349509ccd11b907545d6d_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTczMjk_c521ea5b-e93b-41e7-bf5b-1958434b98ae"
      unitRef="number">2</lgnd:ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNTk_1a6f86ed-f236-4501-9439-e61b39808bb1">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is computed based on the sum of the weighted average number of common shares and potentially dilutive common shares outstanding during the period. Diluted net loss per share is computed based on the sum of the weighted average number of common shares outstanding during the period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Potentially dilutive common shares consist of shares issuable under the 2023 Notes, stock options and restricted stock. The 2023 Notes have a dilutive impact when the average market price of our common stock exceeds the maximum conversion price.  It is our intent and policy to settle conversions through combination settlement, which involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion. Potentially dilutive common shares from stock options and restricted stock are determined using the average share price for each period under the treasury stock method. In addition, the following amounts are assumed to be used to repurchase shares: proceeds from exercise of stock options and the average amount of unrecognized compensation expense for the awards. See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 4, Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Note 6, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkzNDI_39867695-2aa0-4bba-b54c-c3780f5f4d52">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of weighted average shares used to calculate basic and diluted earnings per share (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dilutive potential common shares:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Potentially dilutive shares excluded from calculation due to anti-dilutive effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfMy0xLTEtMS01OTUzNQ_e7595ab9-875f-40dc-940d-045120424375"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfMy0zLTEtMS01OTUzNQ_90ecd1ad-0f8c-4e9c-839f-d820d5aa8e0e"
      unitRef="shares">16435000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8220447fce27459a888de6de4b101be1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNS0xLTEtMS01OTUzNQ_dd936ad0-bef0-4e3d-bafa-34d4c3f1eedf"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9e532a1df4c44aa98fe74ecbd0a59126_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNS0zLTEtMS01OTUzNQ_29c30c6b-b34a-4bdd-ab9c-db416432bbc3"
      unitRef="shares">112000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i2fa0529885044a349ec209c5f5442871_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNi0xLTEtMS01OTUzNQ_2a9fcf2d-6a3f-445d-859a-90e7c6e10e56"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9bd6ab61611848b4af19ea870cad707f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNi0zLTEtMS01OTUzNQ_4aded017-e236-46f0-ae12-0814d5fa9984"
      unitRef="shares">701000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNy0xLTEtMS01OTUzNQ_f1f93cf0-6d21-446c-b503-bb7b85ec0999"
      unitRef="shares">16824000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfNy0zLTEtMS01OTUzNQ_0a58c75f-3b39-4b5f-89af-23532ac190b5"
      unitRef="shares">17248000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfOC0xLTEtMS01OTUzNQ_980a9707-0426-45ca-8623-a11f48b2de8b"
      unitRef="shares">6001000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RhYmxlOjVkMTFkMDY4ZTI1MTQxZTBiNmNlNmMyZDE2NjExYzIzL3RhYmxlcmFuZ2U6NWQxMWQwNjhlMjUxNDFlMGI2Y2U2YzJkMTY2MTFjMjNfOC0zLTEtMS01OTUzNQ_45566a85-5577-4bc8-888e-0ea6aed0d388"
      unitRef="shares">4277000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8a1194575d634ee8956be0aa05025adc_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMTkxODI_3e1d083c-8cf9-4164-b92a-0b4731b5448d"
      unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3365559ab448481290ab043d14bce4fe_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNC9mcmFnOjFlMjllNTllODgxMTQ4ZGI5ZDRkNjJmNmFlNjZjNjY3L3RleHRyZWdpb246MWUyOWU1OWU4ODExNDhkYjlkNGQ2MmY2YWU2NmM2NjdfMjE5OTAyMzMzNjE1NA_39c97801-e971-4e59-8c81-1d6716331438"
      unitRef="shares">1800000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzMjQ_c81d221d-be39-4803-be76-03ced646d405">Segment Information&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASC 280, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, establishes annual and interim reporting standards for an enterprise&#x2019;s operating segments and related disclosures about its products, services, geographic areas and major customers. An operating segment is defined as a component of an enterprise that engages in business activities from which it may earn revenue and incur expenses, and for which discrete financial information is regularly evaluated by the chief operating decision maker in deciding how to allocate resources and assess performance. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our operating segments are identified in the same manner as they are reported internally and used by our chief operating decision maker for the purpose of evaluating performance and allocating resources. Historically, we have disclosed one reportable segment. On March 23, 2022, we entered into the Merger Agreement, pursuant to which APAC will combine with OmniAb, and acquire the OmniAb Business, in a Reverse Morris Trust transaction. Immediately prior to the Merger and pursuant to the Separation Agreement, we will, among other things, transfer the OmniAb Business, including but not limited to the equity interests of Ab Initio Biotherapeutics, Inc., Crystal Bioscience, Inc., Icagen, LLC, Taurus Biosciences, LLC and xCella Biosciences, Inc. to OmniAb (the &#x201c;Reorganization&#x201d;) and, in connection therewith, will distribute (the &#x201c;Distribution&#x201d;) to Ligand stockholders 100% of the common stock of OmniAb. Immediately following the Distribution, Merger Sub will merge with and into OmniAb (the &#x201c;Merger&#x201d;), with OmniAb continuing as the surviving company in the Merger and as a wholly owned subsidiary of APAC.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the execution of the Merger Agreement, we have made organizational changes to better align our organizational structure with our strategy and operations, and management has reorganized the reportable segments to better reflect how the business is evaluated by the chief operating decision maker. Beginning in the first quarter of 2022, we operate the following two reportable segments: (1) OmniAb business and (2) Ligand core business. The OmniAb business segment is focused on enabling the discovery of therapeutic candidates for our partners by pairing antibody repertoires generated from our proprietary transgenic animals with our OmniAb business platform screening tools. The Ligand core business segment is a biopharmaceutical business focused on developing or acquiring technologies that help pharmaceutical companies deliver and develop medicines. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our chief operating decision maker relies on internal management reporting processes that provide revenue and operating income by reportable segment for making financial decisions and allocating resources. Segment operating income (loss) represents income (loss) before income taxes, interest income, interest expense, other income (expense), net, unallocated share-based compensation, and unallocated corporate overhead. Our management does not evaluate, manage or measure performance of segments using asset information; accordingly, asset information by segment is not prepared or disclosed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - Core &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shared-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i2b33615ff4dc4786891d338a0cb87ea1_D20220101-20220322"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzNDE_30d65455-d073-49b4-addc-9e0803bb21b8"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="ib574058f498140e08306c67fbbc14b07_D20220323-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzNDk_9fcf0350-ac47-4375-beac-f3d9c42cb7f1"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90ZXh0cmVnaW9uOjJiMzhmMTY0YWIzMzQxZTFiZjMwYTlkYTY3ZWQ4Yzc0XzY1OTcwNjk3NzkzNDA_6210e946-7c6f-4e3f-9e95-13d4b15e1841">The following table provides a reconciliation of revenue and operating income by reportable segment to consolidated results and was derived from each segment&#x2019;s internal financial information as used for corporate management purposes (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total OmniAb business revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - Core &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Captisol - COVID&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;Total Ligand core business revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;46,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;45,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;55,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Segment operating income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;OmniAb business &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6,189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ligand core business&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Shared-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,657&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Total unallocated corporate items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i300e1e912a0842718dbd2b3d456ac8e0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtMS0xLTEtNzMyOTQ_76de5eb1-4c61-42f9-9455-c7728676a3a7"
      unitRef="usd">263000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id431bc8ebbfc4087800d10ed11c19272_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtMy0xLTEtNzM2MDU_1126754a-3a59-45d4-a0ab-8a20e4d987d0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic73cc7ba3d4a447d95e5cb30db52d28b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtMS0xLTEtNzMyOTQ_67817445-5773-4292-9a92-3290bbd89415"
      unitRef="usd">8915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id34fb1dc5fc741d1b93bb6d1fad26056_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtMy0xLTEtNzMzMzc_eb7c1f48-afd8-43b8-9c30-df95f8b7baf4"
      unitRef="usd">8559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie50c79886ca04ee7b85538c7262e1e53_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtMi0xLTEtNzA1MTQ_e44879ad-bae5-43fe-9d5d-993248ee7ae2"
      unitRef="usd">9178000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fb81ef4735243389f30ebb41fc5156c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzMtNC0xLTEtNzA1MTQ_2890e464-73df-49f2-85f2-47b61a811f23"
      unitRef="usd">8559000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i598d08a1a5c64f9c9b4aae4b7fea0796_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzctMS0xLTEtNzMzMDE_ce806d74-5242-45a7-b364-558d453c6145"
      unitRef="usd">13432000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if798cc5ddaad4b2a80521e5ef4181f09_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzctMy0xLTEtNzMzMTE_ab1708be-2681-4dc4-98e7-2a76861cc3e2"
      unitRef="usd">7112000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2096d791fd444431ae4e6423cf10a908_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtMS0xLTEtNzQ1NTU_fd56629a-d170-4028-8e49-661b83fd8baa"
      unitRef="usd">6226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic378cdb30a214a6e973eb163729ac9df_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtMy0xLTEtNzQ1NjI_cd318d3c-9bea-45d5-8760-b75a3ebb4591"
      unitRef="usd">1253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccf94376ac9f41ba9db7e39a6ff00cd2_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtMi0xLTEtNzA1MTQ_861598f1-f258-42b8-a596-df184c3ee386"
      unitRef="usd">5896000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44fcbfc7c1c64519a0a268ddd50005f9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzQtNC0xLTEtNzA1MTQ_3b9411e5-1230-4dc1-a9c7-932e63a62e1b"
      unitRef="usd">30019000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0260450d8db471abd4488be4a3107e3_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzUtMS0xLTEtNzExNjE_9d522233-9927-45fe-8c4b-6bdbd85d61f3"
      unitRef="usd">10961000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id18be33f9e9e4ae7a764cb16fd2d9133_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzUtMy0xLTEtNzExNjE_ba9456b9-2974-459c-bf7b-42ecd6562283"
      unitRef="usd">8207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70be0418e1f249f5998e0e0067145f1b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTEtMS0xLTczNjAx_1521c869-907c-4aae-a426-4be4d4336216"
      unitRef="usd">36515000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19419d57f33740be82d4eb6147bb54a5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTMtMS0xLTczNjAx_a044aaa2-bd1a-4dd8-bfec-5b266a701bf0"
      unitRef="usd">46591000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e48006baa5e40e28df0dfb681b6ae97_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzExLTEtMS0xLTczNjAz_2e0ac865-07b9-462d-b6d3-44237fc69931"
      unitRef="usd">45693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i76cb0239f16b43c4bd8d8c1d06dc5cd8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzExLTMtMS0xLTczNjAz_8ab97664-545c-4cf4-a8fa-5948a24ef59a"
      unitRef="usd">55150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie50c79886ca04ee7b85538c7262e1e53_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE1LTEtMS0xLTczMTMx_ee732b77-d0fb-4c31-9dfe-c9b61e505756"
      unitRef="usd">-6189000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2fb81ef4735243389f30ebb41fc5156c_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE1LTMtMS0xLTczMTMx_d51e65fa-d081-48eb-8335-dadfa502afb9"
      unitRef="usd">-4604000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i70be0418e1f249f5998e0e0067145f1b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtMi0xLTEtNzA1MTQ_181d9b95-312b-4cf7-bdf0-4045ff835f97"
      unitRef="usd">9991000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i19419d57f33740be82d4eb6147bb54a5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzgtNC0xLTEtNzA1MTQ_2fff4de4-3d69-436d-8f46-c2f057d7e208"
      unitRef="usd">18446000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i1e48006baa5e40e28df0dfb681b6ae97_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTEtMS0xLTcxMTYx_d77ebaaf-f2ea-4b9a-8f49-7cd9518c8646"
      unitRef="usd">3802000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i76cb0239f16b43c4bd8d8c1d06dc5cd8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEwLTMtMS0xLTcxMTYx_b6eaaa21-475d-4569-be16-252e7f792fef"
      unitRef="usd">13842000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4c3151df873d468daa1bc191317f2131_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEzLTItMS0xLTcwNTE0_d112dc13-a926-46b2-ac1f-98bd67bded4a"
      unitRef="usd">5657000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzEzLTQtMS0xLTcwNTE0_111d844b-d019-4dc4-a5cb-567b6753fb94"
      unitRef="usd">4870000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="i4c3151df873d468daa1bc191317f2131_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE0LTItMS0xLTcwNTE0_0961c369-6c3a-40c2-aa07-1115660a6907"
      unitRef="usd">7451000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OtherCostAndExpenseOperating
      contextRef="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE0LTQtMS0xLTcwNTE0_192a6f63-a720-4076-bcad-bb0ff42dee02"
      unitRef="usd">4257000</us-gaap:OtherCostAndExpenseOperating>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i4c3151df873d468daa1bc191317f2131_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE2LTEtMS0xLTcxMTYx_20ddb69e-1adf-4103-a056-777d02f38a1b"
      unitRef="usd">13108000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="ia1c9c1b679ab41c1b1c5f17e176032c3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE2LTMtMS0xLTcxMTYx_b79bd949-596a-41e9-a2a0-6818d08210f6"
      unitRef="usd">9127000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE4LTItMS0xLTcwNTE0_a9f7f08b-a0ee-425e-b676-1c8abeca0c94"
      unitRef="usd">-9306000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181MTUvZnJhZzoyYjM4ZjE2NGFiMzM0MWUxYmYzMGE5ZGE2N2VkOGM3NC90YWJsZTplMTMzMTA3MzAzOGE0ODViYjZhNzlhYjg1NmIzMDFlNC90YWJsZXJhbmdlOmUxMzMxMDczMDM4YTQ4NWJiNmE3OWFiODU2YjMwMWU0XzE4LTQtMS0xLTcwNTE0_1f18c3da-ca60-4e57-a4c3-5c516e63b589"
      unitRef="usd">4715000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjYwMw_6a55196b-17c6-4dba-9cf6-5d534a409719">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;189,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended March&#160;31, 2022, we adjusted the balance of the Metabasis CVR liability by $0.6&#160;million to mark to market.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the three months ended March&#160;31, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three months ended March&#160;31, 2022, management recorded $0.5 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of March&#160;31, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets Measured on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We apply fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to our goodwill, indefinite-lived intangible assets and long-lived assets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate goodwill and indefinite-lived intangible assets annually for impairment and whenever circumstances occur indicating that goodwill might be impaired. We determine the fair value of our reporting unit based on a combination of inputs, including the market capitalization of Ligand, as well as Level 3 inputs such as discounted cash flows, which are not observable from the market, directly or indirectly. We determine the fair value of our indefinite-lived intangible assets using the income approach based on Level 3 inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the organizational changes to the Company&#x2019;s reportable segments, we re-allocated goodwill between the two identified reporting units (OmniAb business and Ligand core business). We performed a goodwill impairment analysis immediately before and after the allocation of goodwill and concluded no impairment. At March 31, 2022, there were no indicators of impairment at either of the reporting units.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;At March 31, 2022, there were no indicators of impairment of our indefinite-lived intangible assets, or long-lived assets.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjYwMA_819df2c7-3c0c-4edd-9015-23518312e7aa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the hierarchy for our assets and liabilities measured at fair value (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.671%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.818%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.830%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Short-term investments, excluding Viking&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;168,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;290,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Investment in Viking common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;20,145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;30,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;26,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;162,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;189,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;40,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;280,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;321,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;CyDex contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Metabasis contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Icagen contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;xCella contingent liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts owed to former licensor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;9,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;Excluding our investment in Viking, our short-term investments in marketable debt and equity securities are classified as available-for-sale securities based on management's intentions and are at level 2 of the fair value hierarchy, as these investment securities are valued based upon quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Short-term investments in mutual funds are valued at their net asset value (NAV) on the last day of the period. We have classified marketable securities with original maturities of greater than one year as short-term investments based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations. In addition, we have investment in warrants resulting from Seelos Therapeutics Inc. milestone payments that were settled in shares during the first quarter of 2019 and are at level 3 of the fair value hierarchy, based on Black Scholes value estimated by management on the last day of the period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;In connection with our acquisition of Metabasis in January 2010, we issued Metabasis stockholders four tradable CVRs, one CVR from each of four respective series of CVR, for each Metabasis share. The CVRs entitle Metabasis stockholders to cash payments as frequently as every six months as cash is received by us from proceeds from the sale or partnering of any of the Metabasis drug development programs, among other triggering events. The liability for the CVRs is determined using quoted prices in a market that is not active for the underlying CVR. The carrying amount of the liability may fluctuate significantly based upon quoted market prices and actual amounts paid under the agreements may be materially different than the carrying amount of the liability. Several of the Metabasis drug development programs have been outlicensed to Viking, including VK2809. VK2809 is a novel selective TR-&#x3b2; agonist with potential in multiple indications, including hypercholesterolemia, dyslipidemia, NASH, and X-ALD. Under the terms of the agreement with Viking, we may be entitled to up to $375 million of development, regulatory and commercial milestones and tiered royalties on potential future sales including a $10 million payment upon initiation of a Phase 3 clinical trial.  During the three months ended March&#160;31, 2022, we adjusted the balance of the Metabasis CVR liability by $0.6&#160;million to mark to market.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:12pt"&gt;The fair value of Icagen contingent liabilities was determined using a probability weighted income approach. Most of the contingent payments are based on certain revenue milestones as defined in the asset purchase agreement with Icagen. The fair value is subjective and is affected by changes in inputs to the valuation model including management&#x2019;s estimates regarding the timing and probability of achievement of certain developmental and regulatory milestones. Changes in these estimates may materially affect the fair value. During the three months ended March&#160;31, 2022, we paid $1.5&#160;million contingent liability based on revenue milestones to former Icagen shareholders.&lt;/span&gt;&lt;/div&gt;4.The fair value of xCella contingent liabilities is determined when it is probable that the earnout liability will occur and the amount can be reasonably estimated. Management concluded that no earnout liability would be recognized at the acquisition date in September 2020.  During the three months ended March&#160;31, 2022, management recorded $0.5 million of earnout liability to be allocated to the cost of the acquired assets due to contingencies being met as part of the acquisition agreement.</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0a30df8c5d044c60a763185ed4b109ee_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0yLTEtMS01OTUzNQ_13401a5a-508d-4111-adf1-2da0fa6bdc69"
      unitRef="usd">6279000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if634239711ec47bc8fb473be55d194c2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy00LTEtMS01OTUzNQ_0c5d98a4-4512-4b24-a7d8-6349743d68ee"
      unitRef="usd">162394000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i78c295da60c54f4ba4c67de4f2b2fd6a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy02LTEtMS01OTUzNQ_86cdd8a7-d797-45c6-b602-7388e4607211"
      unitRef="usd">188000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i919b865fc7e548288c960eb025fa16f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy04LTEtMS01OTUzNQ_49b79954-e795-4bf8-92f7-76ff4c002d95"
      unitRef="usd">168861000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3f961cf3c57944a989b386a120a59e6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xMC0xLTEtNTk1MzU_046d82df-4537-4a09-b551-5eaa61b9533e"
      unitRef="usd">9735000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie56a23c988fb481eb3895b19408d8f68_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xMi0xLTEtNTk1MzU_8ddaa66c-3960-438e-a71f-3e92f977d778"
      unitRef="usd">280553000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5bcc5777b8c04572a90ff8c68c9be3d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xNC0xLTEtNTk1MzU_f497ccfb-6c10-4204-a586-fd9cbaf353d5"
      unitRef="usd">409000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8f9f85958a8e45c1999e50f7c31144df_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMy0xNi0xLTEtNTk1MzU_5d480e9e-2d63-4134-9ce6-fda64f1c4d00"
      unitRef="usd">290697000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i98b2a53fb0eb405a93cded08866b0e8d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0yLTEtMS01OTUzNQ_7ba20d5b-ee9c-4d0d-b6a2-704656ab8bb0"
      unitRef="usd">20145000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i28df26f7a1f24146a45927ad3b6e2625_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC00LTEtMS01OTUzNQ_109a31db-bcf0-40e4-a682-c93556b7eb3b"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2da3eb2118b64b948ace0d372c78e131_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC02LTEtMS01OTUzNQ_b1fc78ad-c8b0-419d-8c05-bdcfe371ef66"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0024c5febbb84c33ba537d246bb26b0d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC04LTEtMS01OTUzNQ_e4600ac1-7190-411d-b459-0f139773d0e9"
      unitRef="usd">20145000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7e6326565a2e4955bf81bde2e03ac28b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xMC0xLTEtNTk1MzU_c904fd21-aedb-402f-8f2f-5a239bc1bfd9"
      unitRef="usd">30889000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia3ba69f089de4d0aa3b902eb1357efb6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xMi0xLTEtNTk1MzU_d2fa7661-01d8-4a01-9aee-2bcc756a2604"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9a463045c0434ff28706f0fd5b252da7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xNC0xLTEtNTk1MzU_5ecd47b3-e02d-4df6-8170-83c787b7cfa1"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7bdc3319eb85415ea312cb8a112c69ea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNC0xNi0xLTEtNTk1MzU_e4be8be1-a1a6-4bba-b333-71e4b4770b2f"
      unitRef="usd">30889000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5eb310903a3649db988222f2672883a4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0yLTEtMS01OTUzNQ_209da095-c348-4d4d-babf-b003761398d1"
      unitRef="usd">26424000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="id54984caedea4d4c829399ada8baf52c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi00LTEtMS01OTUzNQ_a7bc40b5-1a66-43ef-9d4b-7bfa75e8398f"
      unitRef="usd">162394000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia6e15e9ecb9c4bb9a73558b076d35394_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi02LTEtMS01OTUzNQ_24818f8e-a646-4e47-9647-7a8da1682b21"
      unitRef="usd">188000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5112991c76244ad1b2e61a2afe8efa8b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi04LTEtMS01OTUzNQ_b2581eb3-4b10-4ac8-9d06-505065918983"
      unitRef="usd">189006000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4c833df0e5124025a8cd7e1936222d95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xMC0xLTEtNTk1MzU_c2103317-c6f8-45f9-8629-cf32c72bb89b"
      unitRef="usd">40624000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8c518e7be0004946a9276b77331674e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xMi0xLTEtNTk1MzU_31010d26-6d08-4789-bfde-f53e771c5854"
      unitRef="usd">280553000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i30c5a1b7c1bd4601ad0e07d638cfde90_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xNC0xLTEtNTk1MzU_07a7398d-aea8-41e0-a253-99b774a3b325"
      unitRef="usd">409000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i966883907ba441f5a4e24265299fe9b7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfNi0xNi0xLTEtNTk1MzU_a450d5bb-de1e-4644-9a49-2240051fb742"
      unitRef="usd">321586000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i17df672b82eb4eff9d83b149a3113829_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0yLTEtMS01OTUzNQ_6590ec57-c581-4e8a-958f-c2fd87a5f408"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8716ee2bef654ec887fa430172b5e0d3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS00LTEtMS01OTUzNQ_c16c8f79-2da8-42f6-8ef9-bb82a5a4735d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i211899b611f340528eb396eab170056c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS02LTEtMS01OTUzNQ_69c5aaa9-c6a7-4610-883d-a87ec6929404"
      unitRef="usd">334000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i9b9d133c575a444b97ac9f108fea9d52_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS04LTEtMS01OTUzNQ_a5cc078c-de47-4fff-b5e8-2d422fab87ff"
      unitRef="usd">334000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3d7dc371fd8d4ba9b2de8e1a8d90ca31_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xMC0xLTEtNTk1MzU_d553da34-718b-432d-9736-abbc81ba290c"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i06393bae740d414fb55f36d4f43807b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xMi0xLTEtNTk1MzU_4c03029d-ffad-4662-834d-7fe236a4cc29"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3496b4825a99453d8e14a952b1c8bbf5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xNC0xLTEtNTk1MzU_79ca37cd-635c-415a-bcdf-13f54f6af457"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1aacb0ab6e8a482dbddfa6725169679d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfOS0xNi0xLTEtNTk1MzU_88527970-603b-469f-b30c-4171982f986b"
      unitRef="usd">349000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id8cd9489185040a7bb4e6b5151d8fb72_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMi0xLTEtNTk1MzU_e9dd7bea-35a2-447c-805f-d5ec19baee66"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i97def60ed00a4e26a90de87178d3202c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtNC0xLTEtNTk1MzU_6a7fc369-179d-446f-90ad-2b367827c3a2"
      unitRef="usd">2782000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idfc8aa3e6e1c478c842cc795c7c3484c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtNi0xLTEtNTk1MzU_298aed38-a2f9-40f6-bfa8-855d833ef170"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifc9098fdefa544a68419972c21ec488c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtOC0xLTEtNTk1MzU_4bbab36e-88df-42b0-b326-bb5ea125315c"
      unitRef="usd">2782000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic14bb82805cc494d8b56d377748e728c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTAtMS0xLTU5NTM1_bb09fc86-ba15-4a1c-b90a-2ba5f3f238f3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i1c0225f26f5a48b5b92459eaef9fd75e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTItMS0xLTU5NTM1_a49ee049-c752-482c-9c03-ac07c81cc8d6"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic54f0bccced74dc6b12384a2e45705e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTQtMS0xLTU5NTM1_af1049e8-9549-48cf-bb86-b3cdaa646ab6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i12aa59424c6e4371bcaeafb801d99844_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTAtMTYtMS0xLTU5NTM1_208db8db-1baa-4ecd-9f1e-5f704bce9e0d"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4f3a5031213d4a2aa5da82aaa404c742_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMi0xLTEtNTk1MzU_6135dd68-c51b-4e6a-8c99-8149deaae559"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i3a32dc635437486483a3be836ab04ada_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtNC0xLTEtNTk1MzU_6708f7bc-7874-4dea-9194-3c4f4dfe5ff6"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2055a011fa7a4a829cad038d7d64c6ae_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtNi0xLTEtNTk1MzU_fede6773-e2e2-409b-b7d6-efe80e6f78c3"
      unitRef="usd">5376000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i90216ed11e8d4bc1b40442168089a1ad_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtOC0xLTEtNTk1MzU_613843f4-fbc4-4f93-8f8d-986b5fa06acc"
      unitRef="usd">5376000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i80f9ef7fb8a04cb59bc97a74159c2874_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTAtMS0xLTU5NTM1_6d4a22f7-3feb-4a3c-9b7c-f07c1f3f0257"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic0690c7d860e439ab67baac1955afda1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTItMS0xLTU5NTM1_5cda2437-119c-446a-9189-9e296a8f4bd2"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6b92158554854b7599487fbbea4b32d3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTQtMS0xLTU5NTM1_c09c8357-26d7-48f6-8603-9fbea1cbd6a7"
      unitRef="usd">7364000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i55dc9c881b384a888900e4e677032eef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTEtMTYtMS0xLTU5NTM1_8b2d1323-6833-4d92-b51e-4c24c5685a7b"
      unitRef="usd">7364000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i34e13f0ccb1840b38bbcc52a9b972a65_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMi0xLTEtNTk1MzU_2449d44f-1976-4c8b-b8a9-624bca178b5d"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idef14e6ec1314de598c64ef1cd3b8fdf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtNC0xLTEtNTk1MzU_45d6e2a8-40f7-4015-ad4b-2e0d54700fa8"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i065018e70379492b9ffac3ef63d44a78_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtNi0xLTEtNTk1MzU_fadccdc4-a90e-44e7-b4f8-df7f2e630a41"
      unitRef="usd">480000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic7f207c7e7074abdbf50e9ac08b78310_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtOC0xLTEtNTk1MzU_2360775e-2e27-4039-b269-61191026fe39"
      unitRef="usd">480000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i2d31d4856a7f4ecdac5cfa9487f3e54e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTAtMS0xLTU5NTM1_6e3e4558-a6c8-413a-a805-552a31d1ef68"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8c2afa4c98a64c4a839dbfa0fd81f143_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTItMS0xLTU5NTM1_d662a1d9-8ac1-43c3-9093-facb00b61e1e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if6ec0e9d18f64f908b3d00d4d1706f84_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTQtMS0xLTU5NTM1_e1408f04-4292-449d-b1f0-84ef3bd678bd"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="if2069d01c1f64ca7a72f1f7662269e10_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTMtMTYtMS0xLTU5NTM1_4c0c4bbc-9964-4653-8c0b-01a54c4f90d7"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6e4d6cbded604d18851f0c907cacd012_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMi0xLTEtNTk1MzU_eefe57ad-3681-4735-a1da-b0b22bef554a"
      unitRef="usd">75000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i465d2c5e70fe49d68072bca30f76eb6d_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtNC0xLTEtNTk1MzU_f23df037-a645-4520-adef-bdbbdca3175e"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ied060cacedb645e8952913558fc4a323_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtNi0xLTEtNTk1MzU_511a8c9d-87e2-489e-9839-b12963f38bed"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iac5865f4bf0c4476a1cdbb41799578ef_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtOC0xLTEtNTk1MzU_22c3e2f4-86b9-4a61-89ed-50a87cadf989"
      unitRef="usd">75000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i6854523039e846ca86b64f3d0452da62_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTAtMS0xLTU5NTM1_63ce52e1-53a5-4e2a-ae63-792a2933d91d"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ica6972566df3478a9c82f8db3f0f40d1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTItMS0xLTU5NTM1_dcf6ff26-f332-4f85-a716-e6a2dfa98fff"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4a94d4a2b23c41cbb4633b169200cf02_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTQtMS0xLTU5NTM1_6f93de02-4a9b-420c-b089-05a2ef3a45bb"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5dc1ab71740c4970bfbb9630883923ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTQtMTYtMS0xLTU5NTM1_4e4c06ee-1460-4db7-b50d-8c5d8acf9fe3"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5eb310903a3649db988222f2672883a4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMi0xLTEtNTk1MzU_21912544-c0ea-4bf1-a279-48fb8774446b"
      unitRef="usd">75000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="id54984caedea4d4c829399ada8baf52c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtNC0xLTEtNTk1MzU_83b4c46f-af84-4632-960c-cc32383ccd48"
      unitRef="usd">2782000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia6e15e9ecb9c4bb9a73558b076d35394_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtNi0xLTEtNTk1MzU_f7c04beb-2d99-4f7c-8a32-6b03cd218323"
      unitRef="usd">6190000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5112991c76244ad1b2e61a2afe8efa8b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtOC0xLTEtNTk1MzU_58c72dc0-5d6f-49e3-a80b-dba6d5c4d483"
      unitRef="usd">9047000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4c833df0e5124025a8cd7e1936222d95_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTAtMS0xLTU5NTM1_a1229f86-9ed7-44e7-98df-c270be3290e5"
      unitRef="usd">86000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8c518e7be0004946a9276b77331674e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTItMS0xLTU5NTM1_0d511499-56fb-4a01-bca2-54ae0e171488"
      unitRef="usd">3358000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i30c5a1b7c1bd4601ad0e07d638cfde90_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTQtMS0xLTU5NTM1_f842b271-2933-4c43-aa13-c3e108125740"
      unitRef="usd">7713000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i966883907ba441f5a4e24265299fe9b7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOjViZDc2ZjBlYTFlZDQxZjJiNzYwOGEyOTc2NzM5OTQ3L3RhYmxlcmFuZ2U6NWJkNzZmMGVhMWVkNDFmMmI3NjA4YTI5NzY3Mzk5NDdfMTUtMTYtMS0xLTU5NTM1_c8fb17a0-a74f-4bdd-84f9-552c2ee97d98"
      unitRef="usd">11157000</us-gaap:LiabilitiesFairValueDisclosure>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare
      contextRef="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjQ5Nw_45864de6-0a2c-4ddb-b631-858544931619"
      unitRef="contingent_value_right">4</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare>
    <lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries
      contextRef="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjUxNQ_5dc1cc68-1e37-469f-a0aa-e70125cc2049"
      unitRef="contingent_value_right">1</lgnd:BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries>
    <lgnd:NumberOfContingentValueRightsSeries
      contextRef="ib419e06b57b54f5c8f34756ee9797e58_D20100101-20100131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjUzNQ_90902a5a-8a03-44ec-a3bf-23a01997625e"
      unitRef="contingent_value_right_series">4</lgnd:NumberOfContingentValueRightsSeries>
    <lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders
      contextRef="icb358b5c4cb4458bb5b6d71aa4e487c2_D20100101-20100131"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMjY3MA_53a5cabd-cae3-45e6-84de-a8dda2069d67">P6M</lgnd:BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders>
    <us-gaap:Investments
      contextRef="i194dc7eb8286428aa943ce425971b4b8_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMzQ3Mg_6c917e04-debc-4c1c-b9af-a6c75092f5a6"
      unitRef="usd">375000000</us-gaap:Investments>
    <us-gaap:ContractWithCustomerAssetGross
      contextRef="i43db8217ff36458e87356cae1ff73eb4_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfMzU4Nw_37c7c8a0-6f43-4096-892a-87cc17199e83"
      unitRef="usd">10000000</us-gaap:ContractWithCustomerAssetGross>
    <us-gaap:LiabilitiesFairValueAdjustment
      contextRef="i921ef3db471b47e886c3c26b72c7c384_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjU5NzA2OTc3OTcxNA_aac60f24-1960-4560-b6e1-b46d9d5c6e5f"
      unitRef="usd">600000</us-gaap:LiabilitiesFairValueAdjustment>
    <us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities
      contextRef="iaafd9004e1524a9686d8306a396aa924_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNDE5OA_cd754d7c-b29a-4496-9734-f2c64eb92de5"
      unitRef="usd">1500000</us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities>
    <lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency
      contextRef="icdfc9f4e909742e7b03c3eca98c41196_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNTE0Nw_8b1c5048-960d-42e4-a1d9-177adb1ace4d"
      unitRef="usd">500000</lgnd:BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjYwMQ_0dc7919d-41ec-46f6-8cd3-ca65a1983c51">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the level 3 financial instruments as of March&#160;31, 2022 is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Payments to CVR holders and other contingent payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value adjustments to contingent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Contingent liabilities from xCella asset acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;480&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of level 3 financial instruments as of March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,190&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ica554f22c30d4304a7166e4a018118e6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMC0xLTEtMS01OTUzNQ_54ffd7b8-ec06-4556-9ef6-5208f66eaee8"
      unitRef="usd">7713000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <lgnd:PaymentsToContingentValueRightHolders
      contextRef="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMS0xLTEtMS01OTUzNQ_d8e47a81-9a57-4c80-8ad0-62ffcbbaa9ba"
      unitRef="usd">1545000</lgnd:PaymentsToContingentValueRightHolders>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMi0xLTEtMS01OTUzNQ_8a37df83-2c18-49a3-bb34-f773043079a4"
      unitRef="usd">-458000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition
      contextRef="ie853cb73eb70437a97584c1d5ca7f285_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfMy0xLTEtMS01OTUzNQ_fe318901-f3e5-48a8-af9b-cc1d4e032eab"
      unitRef="usd">480000</lgnd:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ic3d63dad091346d4b421cc89bf1e6cf2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RhYmxlOmY0NThjYjBiNjA4NDQ0OWVhOGNiYWUwN2U5MWY2ZGNiL3RhYmxlcmFuZ2U6ZjQ1OGNiMGI2MDg0NDQ5ZWE4Y2JhZTA3ZTkxZjZkY2JfNC0xLTEtMS01OTUzNQ_c7d3fbcd-dac2-4763-813b-41bcc9b6d109"
      unitRef="usd">6190000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:NumberOfReportingUnits
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M18zNy9mcmFnOjg0MTE0ZTQ4MTY0MDQ3OTQ5NzQ2NTkzNTBiZGNlYzA1L3RleHRyZWdpb246ODQxMTRlNDgxNjQwNDc5NDk3NDY1OTM1MGJkY2VjMDVfNjU5NzA2OTc3OTcyNw_07029b45-5096-4bca-9ed1-df6216f1cf42"
      unitRef="reporting_unit">2</us-gaap:NumberOfReportingUnits>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU0Mw_1ef25279-fd11-4492-9937-c10a6be038a8">Convertible Senior Notes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;0.75%&#160;Convertible&#160;Senior&#160;Notes&#160;due 2023&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we issued&#160;$750.0&#160;million&#160;aggregate principal amount of&#160;0.75%&#160;convertible&#160;senior&#160;notes. The net proceeds from the offering, after deducting the initial purchasers' discount and offering expenses, were approximately $733.1 million. The 2023 Notes will be convertible into cash, shares of common stock, or a combination of cash and shares of common stock, at our election, based on an initial conversion rate, subject to adjustment, of&#160;4.0244&#160;shares per $1,000 principal amount of the 2023 Notes which represents an initial conversion price of approximately&#160;$248.48 per share.  The maximum conversion rate of the 2023 Notes is 5.2317 per $1,000 principal amount of the 2023 Notes which represents a maximum conversion price of approximately $191.14. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2023 Notes may convert the notes at any time prior to the close of business on the business day immediately preceding November 15, 2022, under any of the following circumstances: &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) during any fiscal quarter (and only during such fiscal quarter) commencing after September 30, 2018, if, for at least 20 trading days (whether or not consecutive) during the 30 consecutive trading day period ending on the last trading day of the immediately preceding fiscal quarter, the last reported sale price of our common stock on such trading day is greater than 130% of the conversion price on such trading day; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) during the five business day period immediately following any 10 consecutive trading day period, in which the trading price per $1,000 principal amount of notes was less than 98% of the product of the last reported sale price of our common stock on such trading day and the conversion rate on each such trading day; or &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3) upon the occurrence of certain specified corporate events as specified in the indenture governing the notes. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The notes will have a dilutive effect to the extent the average market price per share of common stock for a given reporting period exceeds the conversion price of $248.48. In connection with the issuance of the 2023 Notes, we incurred $16.9 million of issuance costs, which primarily consisted of underwriting, legal and other professional fees, is amortized to interest expense using the effective interest method over the five year expected life of the 2023 Notes, and the effective interest rate as of March 31, 2022 is 0.5%.  During the three months ended March 31, 2022 we recognized a total of $0.8&#160;million in interest expense which includes $0.5&#160;million in contractual interest expense and $0.3&#160;million in amortized issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;It is our intent and policy to settle conversions through combination settlement, which essentially involves payment in cash equal to the principal portion and delivery of shares of common stock for the excess of the conversion value over the principal portion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During 2021, we repurchased $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million. After the repurchases, approximately $343.3&#160;million in principal amount of the 2023 Notes were outstanding as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the three months ended March 31, 2022, we repurchased $165.8&#160;million in principal of the 2023 Notes for $163.7&#160;million in cash, including accrued interest of $0.4&#160;million. We accounted for the repurchase as a debt extinguishment, which resulted in a gain of $1.5&#160;million reflected in other income (expense), net, in our condensed consolidated statement of operations for the three months ended March 31, 2022, and a $0.9&#160;million reduction in debt discount.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Convertible Bond Hedge and Warrant Transactions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the 2023 Notes, in May 2018, we entered into convertible bond hedges and sold warrants covering 3,018,327 shares of our common stock to minimize the impact of potential dilution to our common stock and/or offset the cash payments we are required to make in excess of the principal amount upon conversion of the 2023 Notes. The convertible bond hedges have an exercise price of $248.48 per share and are exercisable when and if the 2023 Notes are converted. We paid $140.3 million for these convertible bond hedges. If upon conversion of the 2023 Notes, the price of our common stock is above the exercise price of the convertible bond hedges, the counterparties will deliver shares of common stock and/or cash with an aggregate value approximately equal to the difference between the price of common stock at the conversion date and the exercise price, multiplied by the number of shares of common stock related to the convertible bond hedge transaction being exercised. The convertible bond hedges and warrants described below are separate transactions entered into by us and are not part of the terms of the 2023 Notes. Holders of the 2023 Notes and warrants will not have any rights with respect to the convertible bond hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the convertible bond hedge transactions, we entered into warrant transactions whereby we sold warrants covering approximately 3,018,327 shares of common stock with an exercise price of approximately $315.38 per share, subject to certain adjustments. We received $90.0 million for these warrants. The warrants have various expiration dates ranging from August 15, 2023 to February 6, 2024. The warrants will have a dilutive effect to the extent the market price per share of common stock exceeds the applicable exercise price of the warrants, as measured under the terms of the warrant transactions. The common stock issuable upon exercise of the warrants will be in unregistered shares, and we do not have the obligation and do not intend to file any registration statement with the SEC registering the issuance of the shares under the warrants.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, in connection with the repurchases of approximately $20.3&#160;million in principal of the 2023 Notes for approximately $19.1&#160;million in cash, including accrued interest of $0.1&#160;million, during the quarter ended December 31, 2020, we entered into amendments with Barclays Bank PLC, Deutsche Bank AG, London Branch, and Goldman Sachs &amp;amp; Co. LLC to the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. The &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;amendments provide that the options under the convertible note hedges corresponding to such repurchased 2023 Notes will remain outstanding notwithstanding such repurchase.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, in connection with the repurchases of $152.0&#160;million in principal of the 2023 Notes for $156.0&#160;million in cash, including accrued interest of $0.3&#160;million, we entered into Warrant Early Unwind Agreements and Bond Hedge Unwind Agreements with Barclays Bank PLC, Deutsche Bank AG, and Goldman Sachs &amp;amp; Co. LLC to unwind a portion of the convertible note hedges transactions we initially entered into in connection with the issuance of the 2023 Notes. We paid $18.4&#160;million as part of the Warrant Early Unwind Agreements reducing the number of shares covered by the warrants from 3,018,327 to 2,559,254. We received $18.9&#160;million as part of the Bond Hedge Early Unwind Agreements reducing the number of options under the convertible bond hedges to 598,021. These unwind transactions resulted in a $0.5&#160;million net increase in additional paid-in-capital in our condensed consolidated balance sheet as of December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzg0ODI5MDcxNTM3NA_23b94f7f-f0f5-4f75-ba28-dee7b06e53d1"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfOTk_70445273-39b6-46d9-b089-b7f53591cd2b"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTMy_1e2516f1-2f0c-4d9b-a8d7-34424440a027"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromDebtNetOfIssuanceCosts
      contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMjg4_a9d7aea3-5bc3-41fb-9922-9258b3f3e8c5"
      unitRef="usd">733100000</us-gaap:ProceedsFromDebtNetOfIssuanceCosts>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjA5_705fec65-563d-4f47-8cdb-6e63c0d6f8e2"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i325334d147084fc3aa258bd786bbca4a_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4NDY3Nw_480fb869-3e5e-45bb-b984-568904024330"
      unitRef="usdPerShare">191.14</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfOTQy_5ca935f2-bdb2-48bc-9983-fc221df48af4"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfOTk4_c47db030-80d3-47df-85cd-7a1699fd4a66"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="idecb9c8b609f480f9fc0ad8eb1f5539d_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTE5Mw_8b25dd8c-b9a3-4112-92ac-f30e771a50ad"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTI1OA_1508c33b-07da-41f3-ac31-9e4236dbab5b"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTMwNw_f8b5e58e-ef2a-481b-9fd6-74714be5a81d"
      unitRef="d">10</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger
      contextRef="i552a7a5cda3441c59d3a9b54db0b82ad_D20180501-20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTQxNg_2ecd724d-49d9-48b2-bd04-7e1f8d407509"
      unitRef="number">0.98</lgnd:DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1NjUyMw_613df7ce-879a-45b5-b641-2699e46c7e28"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMTk5Nw_66131259-a6df-4201-938d-fd4d1cf12e18"
      unitRef="usd">16900000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentTerm
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzg0ODI5MDcxMzIwMg_ec8bc548-87f1-4518-b067-e44421bc6144">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ0NA_7ad6da96-8c1d-4268-90f7-f91037ab2349"
      unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ1MA_f121d9e5-4ed6-49ae-a88f-0a1b378f827e"
      unitRef="usd">800000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebtExcludingAmortization
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ2NA_289663ad-12b8-434b-80c2-1fea2a800757"
      unitRef="usd">500000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ3OA_4a68aa10-b241-4740-a4e3-291c6c1567e7"
      unitRef="usd">300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjQ5Mg_e966307c-8eab-4d48-9838-975df90474f0"
      unitRef="usd">152000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjUwOA_d06a05ca-d0b6-4d5a-8a0c-6cd354cd2269"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjUyNA_20bbef93-7923-4451-8bb5-175415083c31"
      unitRef="usd">300000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjUzOA_1cf0597e-5a30-4553-8090-58fe9c8e29e6"
      unitRef="usd">343300000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjU1NA_679812c8-f1a7-4634-af4c-dbfc4164884f"
      unitRef="usd">165800000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjU3MA_ee64cb38-5ab0-4863-b364-6fa60168fb02"
      unitRef="usd">163700000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjU4Ng_1380ffe0-eb4d-4800-945b-02f7ed9f685c"
      unitRef="usd">400000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjYwMA_771c721a-d51e-45b5-9483-b10fd0c69d16"
      unitRef="usd">1500000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <lgnd:IncreaseDecreaseInDebtDiscount
      contextRef="idde211844aaa43798ec3f99ee9371f33_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU5NzA2OTc4MjYxNA_916acc4c-d2c2-48e5-9f42-853a44d1fd4d"
      unitRef="usd">-900000</lgnd:IncreaseDecreaseInDebtDiscount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzI1NQ_1140bfff-097c-44ba-8de1-137d6a1dcad0"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzUyOQ_c946fce2-fa8e-4107-a55c-c705bb1e57bc"
      unitRef="usdPerShare">248.48</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <lgnd:PaymentsForConvertibleBondHedges
      contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfMzYxMg_5329b2d4-741c-42fb-8b05-f19b29fd72db"
      unitRef="usd">140300000</lgnd:PaymentsForConvertibleBondHedges>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNDUxMg_3fc993c6-aeee-4f90-af2f-7945940bd6de"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNDU3OA_6ee3b968-303b-4a60-8ef8-670490ce13d6"
      unitRef="usdPerShare">315.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i284e06f8d557412997e0baa7f330a5a8_D20180501-20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNDYzNg_053a6c5c-4ead-4fff-a9c8-8430dd5ad701"
      unitRef="usd">90000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i2635945e42ab464987f287db2ac7954c_I20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1Mzk4Mg_f940f855-ce6f-4a3f-aeed-824c9cdaa5ec"
      unitRef="usd">20300000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="icf689c5950764536b68fadb81ab2aee0_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1Mzk1Mw_d237aa45-a621-4757-81a4-8baea367d060"
      unitRef="usd">19100000</us-gaap:RepaymentsOfNotesPayable>
    <lgnd:RepaymentsOfNotesPayableInterestPortion
      contextRef="icf689c5950764536b68fadb81ab2aee0_D20210101-20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTQ5NzU1ODE1Mzk2OA_e63f2363-0226-4a58-a940-4641fe41345f"
      unitRef="usd">100000</lgnd:RepaymentsOfNotesPayableInterestPortion>
    <us-gaap:DebtInstrumentRepurchaseAmount
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTY3OA_2b62f16c-5af9-4194-8b8a-7e6de6d2256c"
      unitRef="usd">152000000</us-gaap:DebtInstrumentRepurchaseAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTcxNg_21b3fc26-0969-4180-b703-04c9df2cad47"
      unitRef="usd">156000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="ia2b572383900440a9b8b357255d25c76_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNTc1OA_5fbda0d9-23ae-4459-8cfe-29ac2403888e"
      unitRef="usd">300000</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <lgnd:PaymentsToUnwindWarrants
      contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjA2Mg_f045084d-3f8f-453a-9b99-05dca1861ecf"
      unitRef="usd">18400000</lgnd:PaymentsToUnwindWarrants>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i45c44217a7754fde9db2a176d420d07e_I20180531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjE3MQ_1140bfff-097c-44ba-8de1-137d6a1dcad0"
      unitRef="shares">3018327</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjE3Nw_c5d8bc2d-a711-4845-8795-c349f6420ab5"
      unitRef="shares">2559254</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <lgnd:ProceedsFromUnwindingConvertibleBondHedges
      contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjE5Mw_228c891d-b55e-4e02-bd77-c95c5617b12f"
      unitRef="usd">18900000</lgnd:ProceedsFromUnwindingConvertibleBondHedges>
    <lgnd:NumberOfOptionsUnderConvertibleBondHedges
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjMxNA_bcaad7e8-f55a-4b35-9b98-0bb011e2512a"
      unitRef="option">598021</lgnd:NumberOfOptionsUnderConvertibleBondHedges>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjM1OA_fe5f141b-b6d3-4544-b1eb-ff34c7214769"
      unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RleHRyZWdpb246MGUzNzNjY2ZlYTQ0NGYyMGJmZmFjYThmN2ZmYjM3MDFfNjU0MQ_c2148513-10e8-4ced-959a-3d3146767eed">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes information about the 2023 Notes (in thousands): &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.437%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.907%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal amount of the 2023 Notes outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;177,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;343,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unamortized discount (including unamortized debt issuance cost)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(987)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total long-term portion of notes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;176,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fair value of the 2023 Notes outstanding (Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;172,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;341,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:115%"&gt;(1) - Balances as of December 31, 2021 reported before the adoption of ASU 2020-06.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMS0xLTEtMS01OTUzNQ_684135a3-2e8c-4feb-bb12-1da78e0e3418"
      unitRef="usd">177527000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMS0zLTEtMS01OTUzNQ_be2f3bd4-aaf4-43a3-8c1a-0ae2f959648a"
      unitRef="usd">343301000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMi0xLTEtMS01OTUzNQ_6d2ce240-49b7-4156-9b40-d0961e2dd189"
      unitRef="usd">987000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMi0zLTEtMS01OTUzNQ_d2033fd3-b075-4d6b-87b6-b78223b43823"
      unitRef="usd">22584000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermNotesPayable
      contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMy0xLTEtMS01OTUzNQ_c6f0d62b-f540-4a2d-8ffa-5743b2fe37ff"
      unitRef="usd">176540000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfMy0zLTEtMS01OTUzNQ_b54b8c6c-036f-4b85-9e2a-7866ec6d1214"
      unitRef="usd">320717000</us-gaap:LongTermNotesPayable>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="id01f6fee2fc241329c914948fff4bda7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfNi0xLTEtMS01OTUzNQ_d65c5b92-93c6-4cff-bb5f-22ede63a01a7"
      unitRef="usd">172535000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i58d94099936a491687dbdd22e65b4761_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180My9mcmFnOjBlMzczY2NmZWE0NDRmMjBiZmZhY2E4ZjdmZmIzNzAxL3RhYmxlOjk1YmMyOGU4ODYyZDQ3YTU5ZTBhNzk2MTAwODFiMGE5L3RhYmxlcmFuZ2U6OTViYzI4ZTg4NjJkNDdhNTllMGE3OTYxMDA4MWIwYTlfNi0zLTEtMS01OTUzNQ_c3cfe66e-56f5-4b91-9a24-ee4ed5f2fbe6"
      unitRef="usd">341801000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180OS9mcmFnOjkyMjNiODljMWJhZjRlZGQ5ODBhNWUxN2Q4ZjU2YjI5L3RleHRyZWdpb246OTIyM2I4OWMxYmFmNGVkZDk4MGE1ZTE3ZDhmNTZiMjlfMTUzOA_15d088b6-71b0-4766-8ae9-932bb61605e8">Income TaxOur effective tax rate may vary from the U.S. federal statutory tax rate due to the change in the mix of earnings in various state jurisdictions with different statutory rates, benefits related to tax credits, and the tax impact of non-deductible expenses, stock award activities and other permanent differences between income before income taxes and taxable income. The effective tax rate for the three months ended March&#160;31, 2022 and 2021 was 23.6% and (214.1)%, respectively. The variance from the U.S. federal statutory tax rate of 21% for the three months ended March&#160;31, 2022 was due primarily to the tax deductions related to foreign derived intangible income tax credit as well as the research and development tax credits, which were partially offset by Section 162(m) limitation during the period. The variance from the U.S. federal tax rate of 21% for the three months ended March 31, 2021 was significantly impacted by the discrete tax benefit related to the net excess tax windfalls from the share based compensation resulting from increased stock option exercise activity, stock award vesting and appreciation of our stock price during the period.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180OS9mcmFnOjkyMjNiODljMWJhZjRlZGQ5ODBhNWUxN2Q4ZjU2YjI5L3RleHRyZWdpb246OTIyM2I4OWMxYmFmNGVkZDk4MGE1ZTE3ZDhmNTZiMjlfNDI5_63a4c35f-1208-4727-95ca-ad51c68f9c78"
      unitRef="number">0.236</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if28278f3235c40f2a7fceac243bf29a6_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M180OS9mcmFnOjkyMjNiODljMWJhZjRlZGQ5ODBhNWUxN2Q4ZjU2YjI5L3RleHRyZWdpb246OTIyM2I4OWMxYmFmNGVkZDk4MGE1ZTE3ZDhmNTZiMjlfMTY0OTI2NzQ1NDA2Mw_9343f552-c1f1-4ad6-8ba3-43c05321c31c"
      unitRef="number">-2.141</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTU1OQ_84f9b1e6-ceff-4e62-a583-cc403c1a0c02">Stockholders&#x2019; Equity&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant options and awards to employees and non-employee directors pursuant to a stockholder approved stock incentive plan, which is described in further detail in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Note 9, Stockholders&#x2019; Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, of the Notes to Consolidated Financial Statements in our 2021 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(782)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,172,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, outstanding options to purchase 1.5 million shares were exercisable with a weighted average exercise price per share of $100.59.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price at which common stock is purchased under the Amended Employee Stock Purchase Plan, or ESPP, is equal to 85% of the fair market value of the common stock on the first or last day of the offering period, whichever is lower. As of March&#160;31, 2022, 44,360 shares were available for future purchases under the ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;On September 11, 2019, our Board of Directors approved a stock repurchase program authorizing, but not obligating, the repurchase of up to $500.0 million of our common stock from time to time over the next three years. We expect to acquire shares primarily through open-market transactions and may enter into Rule 10b5-1 trading plans, to facilitate open-market repurchases. The timing and amount of repurchase transactions will be determined by management based on our evaluation of market conditions, share price, legal requirements and other factors. We did not have any share repurchases during the three months ended March&#160;31, 2022. Authorization to repurchase $248.8 million of our common stock remained available as of March&#160;31, 2022.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTU1OA_77d22084-1226-4a0e-ac60-0a43ed67e4b2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(782)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,172,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTU2MQ_e71074a6-25cb-4a85-908e-a488ac60f399">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our stock option and restricted stock activity and related information:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.151%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,199,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;264,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;138.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;14,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Options exercised/RSUs vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;19.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(126,049)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23,285)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(782)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;131.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance as of March&#160;31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,172,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;107.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;162,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;145.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i4ba9060814074f5b8b13493a50dcc9ab_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi0xLTEtMS01OTUzNQ_3ac2d0cb-2675-48cb-8c0b-efe36716ae5d"
      unitRef="shares">2199598</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i4ba9060814074f5b8b13493a50dcc9ab_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi0zLTEtMS01OTUzNQ_93017605-9900-40bf-b229-2835ad7eda6d"
      unitRef="usdPerShare">106.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia2c459c7be754d97891d9360f85d4082_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi01LTEtMS01OTUzNQ_cf8665fa-0cb9-4eec-8844-096bf1757ee5"
      unitRef="shares">264143</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia2c459c7be754d97891d9360f85d4082_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMi03LTEtMS01OTUzNQ_6c58252b-28c9-474a-ab11-f677fd6647a5"
      unitRef="usdPerShare">138.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy0xLTEtMS01OTUzNQ_718d4ae7-7711-4502-a0bb-5e5c4be89447"
      unitRef="shares">14100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy0zLTEtMS01OTUzNQ_90f05c93-97ba-494e-be13-69ef48978c46"
      unitRef="usdPerShare">114.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy01LTEtMS01OTUzNQ_01f62687-f2a4-4cb9-9c42-b4dd62a68166"
      unitRef="shares">24840</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfMy03LTEtMS01OTUzNQ_60c3ce5a-067e-4e5a-8634-e54b20f7b74a"
      unitRef="usdPerShare">99.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC0xLTEtMS01OTUzNQ_7bbafcce-40de-4e99-93f0-c1ce5b60e54a"
      unitRef="shares">17689</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC0zLTEtMS01OTUzNQ_516d895d-68bb-4f70-a425-fbe405edc714"
      unitRef="usdPerShare">19.61</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC01LTEtMS01OTUzNQ_465250e9-eafa-46c1-8105-1344a7fddd9b"
      unitRef="shares">126049</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNC03LTEtMS01OTUzNQ_a7cc24b3-4045-4adf-8d82-8c6eda775acf"
      unitRef="usdPerShare">121.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS0xLTEtMS01OTUzNQ_933314c1-d185-4a80-b728-7fef0564ac95"
      unitRef="shares">23285</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i459bd23987a24514bec979294a7eaa9e_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS0zLTEtMS01OTUzNQ_450d2b50-9077-44fd-9101-f24295e71bf0"
      unitRef="usdPerShare">54.49</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS01LTEtMS01OTUzNQ_539feaaa-232d-49bf-839b-f73454512f94"
      unitRef="shares">782</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i42d675f7c0e04cb3837e54cb5fa992c8_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNS03LTEtMS01OTUzNQ_fe6b8880-7111-455b-a493-ad0833e0be76"
      unitRef="usdPerShare">131.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i573a15b797f746cc9687adb9f4c7f519_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi0xLTEtMS01OTUzNQ_56d5cbc7-89ba-46e2-87d0-ecf574983321"
      unitRef="shares">2172724</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i573a15b797f746cc9687adb9f4c7f519_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi0zLTEtMS01OTUzNQ_602a876a-190b-43ae-943d-1123a348feae"
      unitRef="usdPerShare">107.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia72734fd1bc34d3f98100401134c40ef_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi01LTEtMS01OTUzNQ_ac2490ad-4f5d-4f9a-8bd8-346a422d0650"
      unitRef="shares">162152</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ia72734fd1bc34d3f98100401134c40ef_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RhYmxlOjk5NmY2NzQ5YWRmZDQzMjk5OWU4YmI2NjYwNmQyODRiL3RhYmxlcmFuZ2U6OTk2ZjY3NDlhZGZkNDMyOTk5ZThiYjY2NjA2ZDI4NGJfNi03LTEtMS01OTUzNQ_6bb47914-0e4e-436e-b93a-678c3acd6ae7"
      unitRef="usdPerShare">145.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNDUw_4e9f2f09-adba-4846-a42e-569e58a83014"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNTQ5NzU1ODE0MDQ1Mw_ef9e13e4-1a01-44e8-9df5-ee58bf2cb645"
      unitRef="usdPerShare">100.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate
      contextRef="i1275fb9984434e01b87ce488fddf54ad_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNjc4_95158607-f00c-4937-81d0-1fa595c937f0"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate>
    <us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod
      contextRef="i1275fb9984434e01b87ce488fddf54ad_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfODA1_b8565d0e-b161-48d8-baab-68202cbda26c"
      unitRef="shares">44360</us-gaap:EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib33c801b49164b99a9d4646db3085406_I20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTA4Mw_9f053c23-3999-4f95-8613-fc80bcf65964"
      unitRef="usd">500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i27f53be60bef4e978e550a0a4312773a_D20190911-20190911"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTEzOA_fdeeca49-0ebd-4a83-a507-667288b929d4">P3Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfNjU5NzA2OTc2ODYxNg_955b16ff-388f-4ac2-9ca1-3f2ada6c8b52"
      unitRef="usd">0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181Mi9mcmFnOmE0OTI1YTJiMGI3YjRjNDFiY2E0YmQ4MDhjMjdhYmRkL3RleHRyZWdpb246YTQ5MjVhMmIwYjdiNGM0MWJjYTRiZDgwOGMyN2FiZGRfMTUwNQ_f764817e-f2b2-4a00-8155-3a9ada990292"
      unitRef="usd">248800000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181NS9mcmFnOjIzYjA5OWQwYjcyZjQwYzI4ODE0MWJlMjBhYmZlNzEwL3RleHRyZWdpb246MjNiMDk5ZDBiNzJmNDBjMjg4MTQxYmUyMGFiZmU3MTBfMjI4Mw_712a40e4-a39b-4ce5-9d8c-81adfc14391d">Commitment and Contingencies: Legal Proceedings&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an estimate of a loss when the loss is considered probable and estimable. Where a liability is probable and there is a range of estimated loss and no amount in the range is more likely than any other number in the range, we record the minimum estimated liability related to the claim in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As additional information becomes available, we assess the potential liability related to our pending litigation and revises our estimates. Revisions in our estimates of potential liability could materially impact our results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 31, 2019, we received three civil complaints filed in the U.S. District Court for the Northern District of Ohio on behalf of several Indian tribes. The Northern District of Ohio is the Court that the Judicial Panel on Multi-District Litigation (&#x201c;JPML&#x201d;) has assigned more than one thousand civil cases which have been designated as a Multi-District Litigation (&#x201c;MDL&#x201d;) and captioned In Re: National Prescription Opiate Litigation. The allegations in these complaints focus on the activities of defendants other than the Company and no individualized factual allegations have been advanced against us in any of the three complaints. We reject all claims raised in the complaints and intend to vigorously defend these matters.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CyDex and Baxter Healthcare Corp. (&#x201c;Baxter&#x201d;) are parties to a license agreement relating to Ligand&#x2019;s Captisol technology and, more specifically, relating to Captisol-enabled Nexterone (amiodarone HCl premixed injection). Baxter contends that it has&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;overpaid royalties for several years, and seeks both refunds of those overpayment and a reduced royalty going forward. CyDex contends that Baxter has not paid the royalties due to CyDex under the terms of the license agreement. On April 6, 2021, Baxter initiated an arbitration with the American Arbitration Association pursuant to the arbitration provision of the license agreement. On April 21, 2021, CyDex filed an Answering Statement and Counterdemand. On May 5, 2021, Baxter filed an Answering Statement in response to CyDex&#x2019;s Counterdemand. On June 30, 2021, the parties held a Preliminary Hearing before the arbitrator. The parties have completed fact discovery, exchanged expert witness statements and completed depositions of the expert witnesses. The arbitration hearing is currently scheduled for late May 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i9e0901d9e25c46e498905e04372debe7_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181NS9mcmFnOjIzYjA5OWQwYjcyZjQwYzI4ODE0MWJlMjBhYmZlNzEwL3RleHRyZWdpb246MjNiMDk5ZDBiNzJmNDBjMjg4MTQxYmUyMGFiZmU3MTBfMzg0ODI5MDcxOTMwNQ_f96699f1-0945-412a-874c-fdd64a1b0246"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i9e0901d9e25c46e498905e04372debe7_D20191031-20191031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181NS9mcmFnOjIzYjA5OWQwYjcyZjQwYzI4ODE0MWJlMjBhYmZlNzEwL3RleHRyZWdpb246MjNiMDk5ZDBiNzJmNDBjMjg4MTQxYmUyMGFiZmU3MTBfMzg0ODI5MDcxOTMxNQ_b0940f9a-c85b-48b3-81e5-e130ee10042d"
      unitRef="civil_complaint">3</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5Mw_abd7c03c-df1b-42dc-b55d-d4abf0b30032">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of March 31, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining nine months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5Mw_eb4cfe7a-8551-4e33-b8cc-169841c9ff08">Leases&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We lease certain office facilities and equipment primarily under various operating leases. Our leases have remaining contractual terms up to ten years, some of which include options to extend the leases for up to five years. Our lease agreements do not contain any material residual value guarantees, material restrictive covenants, or material termination options. Our operating lease costs are primarily related to facility leases for administration offices and research and development facilities, and our finance leases are immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists. Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease. These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable. Lease assets also include any upfront lease payments &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;made and adjusted for lease incentives and other items as prescribed by ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to base rent, certain of our operating leases require variable payments, such as insurance and common area maintenance. These variable lease costs, other than those dependent upon an index or rate, are expensed when the obligation for those payments is incurred. Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of March 31, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining nine months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm
      contextRef="ia10c9da04455423daca5e24de07ee725_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMTU3_0b05d11d-81cb-40ee-864a-ea0a1160ab78">P10Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ia10c9da04455423daca5e24de07ee725_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjIy_ae795a6c-e40a-495c-b840-e157ada2a93e">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <lgnd:AssetsAndLiabilitiesLeasesTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5NA_07b58f05-8ab3-43dd-9eec-f2f2879d89b9">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Finance Lease Assets and Liabilities (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finance lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;31,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Long-term finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</lgnd:AssetsAndLiabilitiesLeasesTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMS0xLTEtMS01OTUzNQ_2909d7e7-9f74-4a78-9c7e-5895c4d778cd"
      unitRef="usd">15783000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMS0zLTEtMS01OTUzNQ_0c97e4e1-039a-42d0-9cfa-116e68d2131c"
      unitRef="usd">16542000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMi0xLTEtMS01OTUzNQ_e771b899-7fac-41a8-9f9c-d8d39f24569e"
      unitRef="usd">15620000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMi0zLTEtMS01OTUzNQ_35e7c02a-240d-4cbe-918d-0a590c955680"
      unitRef="usd">16207000</us-gaap:FinanceLeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMy0xLTEtMS01OTUzNQ_b44f8344-ea4e-4d03-8702-dd9a4b5dceab"
      unitRef="usd">31403000</lgnd:LeaseRightOfUseAsset>
    <lgnd:LeaseRightOfUseAsset
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMy0zLTEtMS01OTUzNQ_6cc4cad8-1224-4382-8d49-6cfe9867f21e"
      unitRef="usd">32749000</lgnd:LeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNi0xLTEtMS01OTUzNQ_42f57636-14e9-4f13-ac2a-5427143e3b4a"
      unitRef="usd">1850000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNi0zLTEtMS01OTUzNQ_781da294-d17b-4775-adba-5ffad06e4da6"
      unitRef="usd">2053000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNy0xLTEtMS01OTUzNQ_118ad398-0f0e-4d08-aed4-7b23ce7d4076"
      unitRef="usd">52000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfNy0zLTEtMS01OTUzNQ_6dd6825a-e135-4e2e-89a3-35420a5a3147"
      unitRef="usd">46000</us-gaap:FinanceLeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOC0xLTEtMS01OTUzNQ_a051a78e-cf78-4ab2-860c-05346d4554a9"
      unitRef="usd">1902000</lgnd:LeaseLiabilityCurrent>
    <lgnd:LeaseLiabilityCurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOC0zLTEtMS01OTUzNQ_9373d54d-9562-4cf3-88d0-a636f04826a6"
      unitRef="usd">2099000</lgnd:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOS0xLTEtMS01OTUzNQ_9e1a8677-bc4a-4b61-b616-a3d55fd03e5f"
      unitRef="usd">16758000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfOS0zLTEtMS01OTUzNQ_646ce963-7819-4ed4-bead-338a072d3681"
      unitRef="usd">15494000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTAtMS0xLTEtNTk1MzU_0d0d65c9-02ac-4ae3-acde-871ed6f2522f"
      unitRef="usd">39000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTAtMy0xLTEtNTk1MzU_f5c4e99d-de86-4097-9d72-184c17a2d4d4"
      unitRef="usd">58000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <lgnd:LeaseLiability
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTEtMS0xLTEtNTk1MzU_ef510aee-be56-419f-aada-f3852a34d7a1"
      unitRef="usd">18699000</lgnd:LeaseLiability>
    <lgnd:LeaseLiability
      contextRef="i6c4b67ce45734a1488e028d74424a3ad_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOjkyZjFiN2Y5M2RiYzQxMzI5OGQ1Yzk0NDM2ZWIwMjVhL3RhYmxlcmFuZ2U6OTJmMWI3ZjkzZGJjNDEzMjk4ZDVjOTQ0MzZlYjAyNWFfMTEtMy0xLTEtNTk1MzU_90ddabbd-4fa2-4e0a-bc35-6b971e92f472"
      unitRef="usd">17651000</lgnd:LeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RleHRyZWdpb246MWU1OTI3YmE3OGNiNDlkNmEzOWM2OWFjYjA5YWFhZTNfMjU5Mg_2a80b417-e8de-4d89-9f81-a95517a00602">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Maturity of Operating and Finance Lease Liabilities as of March 31, 2022 (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity Dates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Remaining nine months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfMS0xLTEtMS01OTUzNQ_3ffb2743-d6b1-47d9-ba98-26781e5ecf58"
      unitRef="usd">1020000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfMi0xLTEtMS01OTUzNQ_4b2f1ff9-8904-4e3f-a95b-0a64e8847459"
      unitRef="usd">2712000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfMy0xLTEtMS01OTUzNQ_a0e6fec1-c56c-4659-be67-72b7021b4beb"
      unitRef="usd">2716000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNC0xLTEtMS01OTUzNQ_db17a3d4-76df-4b9a-b105-9e6087ccb901"
      unitRef="usd">2614000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNS0xLTEtMS01OTUzNQ_ae58ca5a-8dc0-40b3-8169-699ab554609c"
      unitRef="usd">2700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNi0xLTEtMS03MTI5Mg_3a96e7bd-759d-4f8c-ba95-a41331c92e94"
      unitRef="usd">2727000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNi0xLTEtMS01OTUzNQ_c7415568-e776-4111-ac29-2e2dd0146b18"
      unitRef="usd">8074000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfNy0xLTEtMS01OTUzNQ_2a866d55-fabf-463b-a110-fb23f17b4a61"
      unitRef="usd">22563000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfOC0xLTEtMS01OTUzNQ_99c2b8b8-c6ee-49b4-8593-687be54bb418"
      unitRef="usd">3864000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i4ed5b36e32c14d6ba6f922ef55910407_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjI0YWFjNDQwOTQ5NjRkNDE4NGVhOGQwYzc3YmJmMDczL3NlYzoyNGFhYzQ0MDk0OTY0ZDQxODRlYThkMGM3N2JiZjA3M181OC9mcmFnOjFlNTkyN2JhNzhjYjQ5ZDZhMzljNjlhY2IwOWFhYWUzL3RhYmxlOmU5NDE4ZTRhNGRlOTQzYjU5ZTY2MTVhODI1OGI3NzMxL3RhYmxlcmFuZ2U6ZTk0MThlNGE0ZGU5NDNiNTllNjYxNWE4MjU4Yjc3MzFfOS0xLTEtMS01OTUzNQ_9ec5855b-0732-47c9-8469-68482e261425"
      unitRef="usd">18699000</us-gaap:OperatingLeaseLiability>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>57
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MLZJ%@<>B-F]850/K=F'/W]8 %M7YLXF+XW.<T/'K(9^L" 69#=1F<6I_ED;
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M.RN&H1\8B8ZT2J(KT7&R7[^CK$J61,ENUW7]8DO6W?$YWMM#ZV3+TT]9P)A
MCW&49*>#0(CUZ]$H\P(6T^P57[,$GJQX&E,!M^G]*%NGC/JY4AR-B*99HYB&
MR6!\DO_V/AV?\(V(PH2]3U&VB6.:/DU8Q+>G SSX\L-->!\(^<-H?+*F]VS!
MQ.WZ?0IWH]**'\8LR4*>H)2M3@=O\.LY<:1"+O%[R+;9WC62KMQQ_DG>S/W3
M@281L8AY0IJ@\/7 SE@424N XW-A=%"N*17WK[]8/\^=!V?N:,;.>/0A]$5P
M.G &R&<KNHG$#=]>LL(A4]KS>)3EGVA;R&H#Y&TRP>-"&1#$8;+[IH_%1NPI
MZ%:' BD42$,!ZQT*>J&@'ZM@% I&0X'8'0IFH6 V?>A2L H%ZU@%NU"PFSXX
M'0I.H> T?>A2< L%-T^'7?SRX$^IH..3E&]1*J7!FKS(,RC7AIB'B4SVA4CA
M:0AZ8GQV?36=72UF4P17B^NW\^F;)=PLEO#U;G:U7*#K<[B[/OOU\OKM=':S
M^ 7-?KN=+_] 0W2[F*+GSUZ@+* IRU"8H&7 -QE-_.PE>E:[/QD) "N7''D%
ML,D.&.D MN2"1@JULWZU-_Y?L&E0C4*A.^W7/>-Q#/6W$-S[I-">'5K9#V7]
MT@BM:>A+]SVZ#M5>G'^KK5[_+@Y8];Q-O(FH8#[B(F I\G@,+3*0O>N!H8AG
MJD!=]EN]80)Z*IAD-$W"Y%YE8OZ5)KJ\'$%VERE.RA0GN76CP_J$1C3Q&*("
MW;'[,)$K(+Y":Y:&W$?/=^G[0CZ?,N\5TO%+1#2BJ1)HMY*9KR3GR,,86YH#
MH@\*@'H)4/\W (_ -=DM8.WALC77)&8); >_+8:MNLBL+:)C1S>=NMA%6VSH
M:+@N=*FPY6* I=XNH]PN(]?3.[9KGG@PUC.&GL.VY%<O9('D91OPR&=I!DWJ
M\R843^C/&QY%",;BEJ;^QYYD,LO%S=Y8S;-LDP<+XN/M^D4F%T:;!!9&+%Y'
M_(FQXD=97U!<-)_K:X@R-,8$& PH%TUS&XH@8)&/@+= K3^E$J^@C_#H2V*J
M\M!LY:%I=VRK57IF_22>J1+8:CE$---I)-34:N=O(WW5=CH*U"ZWQN[=FH7T
M:"@YE5]S7.6(W0+@&%JC#F<'A&H@G1*DTPOR-H%:B,*_ :,,A&SF2++)!QI&
M]"YB0XC#,*,11)!YFQ3F"ZMB!O20I2FH0H!47CDMP$.SX=1%OTS-)[?TR>WU
MZ0--4YH(!!0"W7'X")A_SR CMR'<"'B6T9PT*W/*;0'2W6:[ZY>I@<9:Q:FT
M7M@WC'K0?[)\ALOM9;MNY&\8$EPV<1UV_$X@]BB@UX-D(&==&8V.(!2KUG;8
MU9RF2P?%ZE[M,47<Z]62/B*V6L$I)2_IW(LK+J#4#P6B,%Q#1#2=-($?$JL#
MK^8_[B< 5["K80*%"R-#EH6JHTZP8K0[6&ML[N5!L3K&B@+@HSD @]16TY-W
M-"UI %;R6UW!3ZRN@8NKB8N-;T-W!*A)87L?E&V8T/ :S;V0JW5WNYDB;5NZ
M;EFD,08N%')#QVP%LRUE8$W;(SOU_:I( NYG"=^3<N+VK._AG+@:][A_WG\'
MUHG;\UA).Q5R+=Z)VY-;23P5<@KFJ;+60SUQQ02P_>/))ZYF/.X?\G"$XYM$
M#@U8$J8B&,[0[=J',QWZ<_8HY$D.9CUZ&V;BHS)DWVY?9L%0=KIN/ZJYCOL'
M^U'M;C__U.VN/;VQ95NV.LBDFM^D?W[WM;M#H":%[?UD=PC&IEM/T3.%W!"D
MW$;+FRKD6FV1M$>^;A/7:JQYKEK3Q%AOM.(+A;VAVUSU4B%E&*[F-JS-%:OJ
M)M;UCC!5A(3@'U^+9.]OA7Y:\9,<!4F;D;A&Q]96=(3TTY'_]S!(VC0&CA*X
M>8HZ*%9WOF([I)_M?,UQC[0IA*L91A/I :DZT(IFD'Z:\9\>^4B;=PPQ-IJ=
MXH!4W;.*G)!^<G(492<**H!-W3&;?>J@7!UE109(__\"7TW:B;* V_\&8,NQ
M< >ZBBN0_EE^+&E7@9H4MFO4SM6Q2YK3J2W7GDYM&9V8NM6D=@JY(=;T)K=3
MB!F6X^A-UC[:>RLB7]R!ST!S,Q2Q%2AJKVS8\73W+FQW(_@Z?U%RQX7@<7X9
M, K]3@K \Q6'TVYQ(]^]E&\DQ_\ 4$L#!!0    (  R!J52=0QSHJ @  +\D
M   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULG9IM4]LX$,>_BH:Y%^U,
M::P'.TX'F*% IYUI@6GHW6MC*\17Q\[)#@_WZ6\EA\BQ5@+N#23.2OKO>K4_
M2?;10Z-^MTLI._*XJNKV^&#9=>M/DTF;+^4J:S\V:UG#+XM&K;(.OJJ[2;M6
M,BM,HU4U85&43%9961^<')EKU^KDJ-ET55G+:T7:S6J5J:?/LFH>C@_HP?.%
MG^7=LM,7)B='Z^Q.SF7W:WVMX-MDUTM1KF3=EDU-E%P<'YS23V>Q:6 L_BSE
M0SOX3+0KMTWS6W_Y5AP?1%J1K&3>Z2XR^'<OSV15Z9Y QS_;3@]V8^J&P\_/
MO7\QSH,SMUDKSYKJK[+HEL<'Z0$IY"+;5-W/YN&KW#H4Z_[RIFK-7_*PM8T.
M2+YINV:U;0P*5F7=_\\>MX$8-(!^\ 9LVX"-&PA/ [YMP(VCO3+CUGG692='
MJGD@2EM#;_J#B8UI#=Z4M;Z-\T[!KR6TZT[.KB[/+R[G%^<$/LVOOG\[/[V!
M+_,;^/?CXO)F3JZ^D+/3^5?RY?O57W-R2'[-S\F[/]Z3/TA9DYMELVFSNFB/
M)AVHT7U.\NW(G_N1F6=D3GXT=;=LR45=R&*__02\V+G"GEWYS((=_LC41\+I
M!\(BQA ]9Z]O3@-R^"ZRW/3'?9'-VB59P#1IR4(U*P(S3V5=6=_UJ5MVI6P_
M!<81NW&$&4=XQKF$N5[6>;.2Y%W5M.U[[%;T722F"SVS[T\.:<S3^&AR/XR0
M:T93&B4[JSV!\4Y@' S$:?$WY#%,_:XE70-S/V_JO*PDJ<?*]<_Z8JY#MU;-
M?0F906Z?WAR[9"<M"<;N;)G5=U(GLFR[$HH"#+?(2D7NLVHC2;,@H%6/"^))
M56:W967&QD+<CQ3OA3CBXPB[5C1)!1[@Z<Z+:="+<PD5/"^SOB[6!<E6C>K*
M?_L+X$19=^!G>0LQS]I6=JC^J:N,)_%8/V+%XB3&'4AW#J1!!TY'>L&=5;F!
M*5.#]'NY39X/.C<PY:FC*:8CV:X)C2-<]&PG>O8FT86\[4A1MGFS@631MZ%L
MVTU6YY(L))XR,T<59\E(N6LC9M0S(VEDJW[T)O$P"5=200Y5D.8Y4%H2I0&(
MU_4(2?5QQ!&CF*4>W0-:T:#N[U FR+L[6)Z\U]EA8BX?]0S=E.U2IPDJF"*"
M8\[&DETSD0I/FE!F-;.@YODR4_)0KS4*'6=8@+4F[JA2YDB814*,A;I6H-,S
M":D%%N4OU)&%5 I4;HMRESWB>;OM9S^>"4VCL4[,CHG(EP86>33,O&$:&+BV
M2\CGPTZJU;!BH-H%4L'2Z70LW34[I#R:^;+!PI#&0>E7W5(J5%CLCNA&U#5B
MW!=.2T&:A)<J!H.MYN" M(84II -R!>B+K7 HF%BG>:F2K9Z,2#+^PS(Y*WN
MU$6.X,G Z6UD7#,F!E5I7ZDE$PVCZ1MD4]TUZ@F5YF+%G:NNS>$LF?KRR-*'
MOH"?YQ"NLZ?,D%V#/\_51A8O+56H"Y5#-HV<D"+L\0EG%CTLC)YON^(RN/M&
M_=833#%S:4+I;,9'BC&S:,H\DBUU6)@ZN\*H)&3#!E>(,(:)V%&(F,7)S%.[
MF84,"T/&E!7/G$7EN@@Y9-Q1BUCQ:>(I.,R2AH5)<_G:13XJW:5*S")G 8*8
M02[$GK4VL^QAXDW[NIXWK]^;,(L*%D;%]4;E2U@VZ 7:ZP''$([PE,[&*,'L
MIHP*W\VU-&'A3=6U:G(IBVUXVJQZJP/('HFS-!FOC#&[:":BJ<<!2R<6IM.^
M [ KW*BR>WJC$QB.4N[<!->,P\[$5V0MME@86R9)UUD)V]E&$?G/1CNPDMVR
M*0;*4>$(KZ:QH]NU\FFV1&-AH@W3'>H"5 /0K$N9EK_VZD58)M+I>-^*F7$1
M>:H!MS3C89IYEW/<1=$XB(@)(,,31VYIQ<.T0HLK5J50V2Z?*.5I.JZNB%T2
M4^KA&+<<X^Q-U751UK"%?GUUY8/CN3"#?LKU(.%8Q#BY;#I/5- -#^?QN":A
MAE&:,L\:A%OL\/"6YSI[ZH_0-G4!I+=QJ:1QX;8J[\RV$G< W<Z,Q2-&/(T\
M:VAN.<9?X-A>/<T;2$75F=.HVP:F]U(6=Y+ PJ6KI&^6<Q=6SFQR36B2QKZ,
MM#CC+^#L.?!=@VAO*K@;K:FR#YE26=V1Y[3";X0++<<1["0Q$?',XXGE&@]S
M31>&]3Z<NR;_#0LO<PPD'_4)$.@V1?=B?GV-.H 02XQWSX@12\1@N;[O@<4:
M#V/M1I](]%Q3LC+'M=LCXU8?L@R22,_I+?8RN#'X PJ.L"Y.D_&Y$&HV\\X+
M"SS^ O &F77VYT_RM4\F5"F"+RJH4WY<,P].A"6<^)^$$]@Q(!N# K'R2;*$
M$Z\DW*8UIU4H)5#)V$'@-!*N:L1P!A7?4TV$Y9L([].T]$+FRA1M4*[=^- [
MH]/U'E;+]78'IP#8JLQUDNO?47^0_9F(V6SL#6)&XVGB.486EJ$BS-"S5ZLG
M64=NY5U9U_HNZ16>5&53H$XA&[=9S,:S$C$3TUGBJ3%B\#@M#-JW^23A<M@;
MY+Q1N"<7B!EG=.;9RPC+7A%^^#;?K-=]1<PJ\W2B:MJ-ZA]M/2^U( _[]P&
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MUEZS&EV"7'##WI>04CA&QYVD)DXLDT%SWYO0>Z9,UPK9=X9JG0B*-1<+##X
MCL]ML775C(<$ ;@LF5;DC8323EF0-8?G1(C4VC^3\3".&NLG,#K-V#CE[K0X
M,P[S"LUCE2/O[&Q2_<&XAD%X:64$3P0TQ/97=!@'7CYC[\R8+,8V+E1XM OO
MGS F$1@8]B,5L(3<K'+GNEM0E<YEKI*3*:2'"=Q.!EY6@R;!'E-MTZBU9.O)
M\4H>DKQ@FW<Z.PM$XZ)22J<;-Z*3;34J\C4E ,^(_D@J1V&-0X3M,F*M'22Q
M)I_)9-]#Q@J8,-1(@,2Q$65_/F(5(O(D2N<A6'QL3#+,1B*LJD1O5$O.(]);
M2RNS_%]%2=]8<)&OKM/J<'#-@G)QB?GHH+MN(:D-R4&0GN+L)UL#.+B)I%R,
M%ZMH$#.[Q:U)^Q-N^T8]4)3#VQ>W+?E ]HL(R9NCKZFJQ<$R\:+91$](PB$6
M&5V32:TYL2D%((D&Y'-?6..JOJ@!CQGAPH81OJJY'B\^^B;?[8Q7&6@F6/$+
M-&'2!CQT)@H<])#V( *!TB_-BG8J!M*_3\4+30H3XE)%CEF$-WTJZX*EC.+C
MCD$S(99POM'N-HAM&MTZC^S )3C&46B>&S:AE 4D.H)@0D]7/*$O\JU%@KAI
M><;FAF%2Y'D^?C/9OK8R8[.2MCC3=R%,)R9,NW&-5\'5JA7$</'WLE=N51!)
M@.5-K$_<=B4FL_-]]$L[K;?-YUZ^5=' 'WAYR; EG:(?\6[=<$$A1#B!Z?,2
M5JA#,TK)="( ^VZV8!M4Q2@/;MV:BWX,1;MM3HE!]BML<=3D(I>82OU]GZU9
MQDWF$I-#RG[P3N\UY-"&W>HFMOX<C]AF[>NL&_%<<EY9))/W>+LKDE1W*[%V
M!XW:4@D-?O$VR5@PK;:SG'A.O)6)7YSW>U$;]]4+G2:F*LE;RYOW(G#.$^#E
M7); V-O04734K#EJ"S]VN!6'PH9J09Z!,NP/Y.L==,=QMHJ/A#,@EN-?40JV
M*)_MM?&I]SL3[%P$0Z X6QTNK(92RZ1E03 JAL'H(1^7,:!4)N52"V?"(!0D
M_T'$W)5@LVW6?,Z45RZB2VRDZ&V;]8N](RM!CD>^URE$Z+=_2[:[+U^Y5(3X
M*:=/;;:T:VO95I!L,-_2YB2_(#2N*P2XT*C[AM4@J:/=OC4I2,F\A4]X#787
M0@DVL2>%0L8[+=DS%D5[T$8/M]4!UMDD50DWAJ%-H\>U;,"[DTC)*Z'3-4^S
M(KSKO!4&)BDD!@)EI,1JIW/&.[)VQ<%-?""PLW.[!I6M":-LFE& QLP&JK8B
M,V.@<W@(6.)Z<L4DZ*W"XV7Q)97=D[5VIA+*M\U)72V/UU,XW4R:1YM36B&[
MV(1,+F2G(H$MCKDH7K"W)426>UBX"@^ZK0[$&LV)AF.Q8L5,5/;? S'N=6.3
MV,*M3 /(0Y##*.#=5[61'HX)64A])T5+/4UK:;@XVZK%F]^O]?R-9T?#?$)'
M*G#W%'(ZY\E+)/%^P\$R^4DGN0Y/(D*35V<5YYMW#94%ML9)9F55&);IY&ZC
M4+.RO3G)K!Q\8HR]3.=T4&^1%+U3B*=)-$ %[JWXG&4_UW75- Y37*[P13FR
M_Z R9=_#+\"6K*[%,Y+:HE$&S$C4L82PKY-!(R5L'%/K/?U+M/+26,#'J6;1
M>8:9 @X*?(%(+:DTP$532LDGS<8&"QRW!,)+'YI2L&GS(:#(TXK@*IBW_F&C
M;IP?RKYQ<VO2_LZ%SQX2SL-(<G]7-10S^U%!M>;6E?&NUCO[ZEMNPF C<YI@
MY75-:XDQ,?;=N35G3K3^E7'(=A5Y2P=]+;=)06!%>:T5)VV"_-[!95K](ES0
M<NZ"1Y'=45_=X1T7/@Q>27D*NHB02TT4I2H3$:0."XN-KWBY:.V5#P/:#3A8
M;:7K]U))F%$EK0V!INT6YKN:*"&76S_DT*#8FEN=GC\=]6>^P$8S/YWU1V')
MS;8O4 7Q5=XDZS7%O582K&S]VDF-M>S=0URE/:&A;,[)0*=B@A+4Q9+3C71H
M[!N\;6Z?8Z5/X8?[\WQ6_S^.L"P%%>C4.)KB/?V,YS/U[0.8O$A4',T&0_P[
M&HW4KU#'TI/!KO'?34M\'"V&0S6<JK?'(OF3>A"GXX7BUI[X2]-*-HSFPUB-
M9U,L,!Q%T\4$O\RB(1ZZ';I?J(,,7/%43:,XYA%1/!EUWO_R^P^OU,WP5DVB
M^6*J1H-H,%S0EW$TY%U@P_$L]E&BQ=B]$1]+FZ>883B>\L_Q-%8_&M7_FKAW
M% WF4ZP^&(_43\ZQ7>#I0LVC\7!F=A='D\F$]C@>$PR+:"X;G4:SZ53]RCX(
M$#O!OD>T$I:<#!C\LST%?!&45WRF=!^T$NTE=4"^"T> E)*4M,@VTPVT?AU)
MIIK<*HBN%,)9+W!W'2W8&RY@7C=0WSW2^#!9#]IT"W-$W?A7>?#*-!Y;?>^Y
M&R)U02)=YY%Y.CSCW+MNI\AW; GW)0"6RL$:NJ\Y?US@;Q#J6^?P<?,R&5E]
M"L>+I'SO]30SUVB(GY91GZJ;R>"67PSG0V+!7<7-,\L*($(LY@O/U3?S\2T]
M&DZHHF9*'-"Z\%C<-]=^^IE-)T1#O=J2M ([#V9J!#ZZ&1';W8('AX.Y^FG/
MP>0*0:T:3F*6!P_+!, ,)\-H! A_NU=K<MU*IG,P]2B*QQ,_:#;FN6=#]8ZM
M.W!BWPTA_^'OX.19'(U')+,3QMG-&%!-;IG'Y]%\.E2_Y^^Y 0+(H%"^K=+W
M0#M$:V+X_PHC888Y!&HPO< C9Q0;1:,Y2SE)T4T\O+4/S\D5+Z(1\ 81O1G-
M;^E/TFIGM!I-L?9<Q1#&&/B81(O%_!$$&@\P(HX&\8RX8#B/SP@T'$T]KN/Q
M0@@T!PQ7"32))K-9,&A$VFTR&9\3: R0P]^?8G_@B9@(-!_'C)QH-&-NCA<#
MJ)W910)!;<Z!T$\0: 1K.H$>_([<CQN2N%OQ=*^,,)W@5[J\ND<M*#?BBA:F
M&V19L0XS$LZQ3%</=("HKBLI?"F5-$M'#KL%F0'B^1@' N+2=A8X=X3[-6TY
MHX>_>IQ)XIZC@'"L=,^4DHG=Z("'J1X%.3NX&(B&C?9B1P1!FBW'&E?ED:N;
MF-=,OCR:L,1U'8DRI!9?*F$&^K'3;6H[/#C'R!5<YQ,%('7ASE?A=+:1R'43
M5@]Y(]4#$Q1T!MO>2Y<AYH@@"<I[VQT9[DJXZ1&(R#[#3^Q?=,KD3"%VVCQV
MS:7W@4G\M]1AS,UM)^;MQ!9Y:\=Y_]>$Q=\9B^^D[=;EV:'LX-NPNT2_P-&Z
MXUY>]P&V6NW7&^X%,GV_TV@2C_#O"+K,.A_P1:;#N?PR'BS8MGM9D8,D1RXS
MFF8Q=D/J!]\=38T:)1^!H5$D7-3[WLLH'U #,67E3S(Y&91:BRX@QR87 V:
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M/DWJMHUIUX2Y)0*10X<J8'(<?3@J("ZON5H ST;&1@AF4PM3[-@-LMXH'G/
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M^-B&)"QW83*5GP<^Q%1RH^)5NBGUESIRVFXT<%/F.=BL2Y@ME1 9%JR+*IH
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MNNR:[@]91?C0V[8N7"HH->\%-)?=B>8[[^[S9VMU&Q#9FB\,F4=I>+8<0JD
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M5#_G36UMX!3?E,3[0(K_D#(5_M,14$MVUX*,Y%K3.0-6).JO0MK7JZ"1$W;
M=&<IOE?4OPI%_:NGM,I8[HHQ=X)AP*]KJ@F$&M4--H4?^!4'W=UG];=O0K@P
M- XVR30$8+U]8>!B.$"&+$$N*LI3_!]F&[M@SO=V=5-*WI5FNKMOEC6)+1K#
M+GH"2I>ZG,MYM'/]<2MCHSOA4I($#-J$MA[R7;._,]LN_E7>ZIW&E:QP[ 1$
M;3BH)SB0!Z1%+5\CXD8'&&'=]&H )31<KB.W@5,XGSM9N/K;R0YG\^)TR!3=
M5AYR+[.\J>%"JGII<K[,-DG/&Q"AF+.$\<?/0Y?)T#'JGLDW=$=9%72]PSU4
M4PW\8.I&O)<G3)R DS5]+ V86]!)_H21T4_7TDCDSC@Y+\ R8""8-]S.('%D
M=(TO_C<QTZAP>ZSR>;#*YWL-YI<*]DT(;)>M[9U*;P.\L"M Y=<'K,G-G3Z(
MZZGPR6N9:YUE*#>#W.W"W]T,N.SCFD1:IZIK7P&P')G%KU&=F*V!_*1DZC%V
M\M"H[3/3V'9H$(3D4QVPD4</OFUK^[K*8ZH]_)V,8_O\>"^';T*)6_WJ+Q="
M]]X/7D/Y98>=#N_KEY>U5/)DJ\3I).%#=BS+'DHS46=!H3UZL=7*$7N3W#<3
M]1-'I.O8\*P.)T?J=\AJQY,3>7+]E]G4KCVP^2UK&W.OGJG)Y>#B^04^'#X?
MG)U?'.'3U>#D;+S]Z&+B'IV>JUM-G7]B<6]-1IQ4D_'@8GRB#J\&ER<8.AE<
M74UZ7U[REY?GZ@_&?L_4"19[?D7+3ZX&D\M+6A\3)CC>]L.K*_]P,N:37L>.
M6>?,X:LDX=ZNI[##]\&:+LTGD]%E[Y8_"1!I#SD/OAB=Q['\U7:;#;'W_Y&<
M![HQVJ. "7V<L$$#3<U^08!=S!(CHMJ$HH OU.?NNHLCL].%@;H=78,9[M<C
M0H_7.&@)FB:G@@7\K^>#1 -OJ!R)#-12:T\S@/O*L4QXS@O]!AR+>1>AJQ]'
M)]8VD1;$6]%O#,?0RT%/.>EB+%OICII*_1;N&6_@FS(P\_D^_H7M^%IFNP4S
M-K9RU<X^=N]_"D5.@)+E=IV9]!-Q?T=GK53>J6N$.D7^EG>!G->13A2HX4W:
M7[;SW9@]+Q-\ZF5SE";T4):+)BG(Y4)F224)$I:O#R2%Q)#K9?.,&C]]57_>
M9$L[B'V/U88Z!2G1H2IV.L]U1_8Q"-V' NCS"Q"A 6@0RA"^PL0U!M^+FIH@
MUX,"HI)$UIE+@$XAB9'R9J_V(2FQF^A2,']E(=-&ZB<9@Z\64#1-L(-*^!"D
MHX2)V.ZS=HV-%(93(!1*==R&Z")Z<HJ0C6<-AC2N'Y:8YVL=H ;,<*3L.K\8
MG^MX?1O+P>T"F8Q:RFMCN[H2F3:OZLG-V7:B&=\K<9SVTJ2'4/C/NDW!I<54
MZ'LH:U0UJ1DLKZX %1ND9X<W[_[UR]OAY/D1N ["_%IT=2%7$54="-OJ.ZRT
M+F(99U]RL3-"[$,SR<N D[UPXW8!ES-\P[D ]8K *SWZ<MDW+J7D@>0;>?K
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MKN4OF<3A\@=A )3FB/A(YF>8.AY=GA](@<3_TM8K_KLFT[IMZR5_7.@,E-(
M/)_5.(3[A38(?^GF^_\!4$L#!!0    (  R!J51D\1D Z0H  ) =   9
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M.P/ZOE:4H_W&.>A^*K-?4$L#!!0    (  R!J51AL<.,,P,   L)   9
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M:B_5_2^B#"AR]F*5FN)_=%^.[7=0O#969>5D\""3^>8O?RB%V)I HY8)I)Q
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MX.N:;Z6>1$X&2B^BD#*(*\&W>\&H0_!G*JX AN\!"A!RN,_\[G<LKMWAH?M
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MAHD-6DK.,@8:7:$/4N9[QKE#_F4*4.@^M^XLBCYP0/?6L]BP:GBK-1B-WB[
M4,;U.XO^NEJ@MV_>H3>("?2ED#MMW>B);VR %4T_JX.Y.P1#+@3S)U77*,3O
M$0D(Z8'/A^$+R!HX/H;[5M9&6])H2YR_\(*_CH+_6Y^!Y<-F^= M'UU8_FG-
M/AT/R-@AJR_]<8933()XXC]V]7K6[(A8U!"+!HE]D89RM.E*(ITDK"L):R6A
M3I+W2(#I"^:PVJC#,B'!&(<GP?28A81$%X(9-<&,!H.9RW++P0 RD!5"<KGY
M,9"[N/$:OT;I),WRR6!0"U@SP6Q0W/;8_#P5?5E(SN0E*0[&R4D6^LR"&"?]
M64@;PND@X4^@]8W=$[)=N>/46,ZTE,JPGZZ?]=%-SWA<I22-\0G='K,D'8]Q
M/]UQ0W<\_ 4HF@,2M(2!9.&@[>'!:U0+[FPB^,7KI79Y5 EQ1$[T?\[JF'#;
MF3%YX7JI'1Y5 HZ2T_+N-XNB"X3;7HZ'F_G<'05L-A5PQU$7;#N8O+8;X^A5
MJJ?MH'BXA?Y6]8S.=(Z") A.T_&<V3'EMCWC^*7K)^XIC'0<1J>,>^U(?*%!
MXK:EX^&>/I?"*'MJWMF]]Y>+J.V_.'V5(FH[*AYNJ;]51.,SK</87H#.JNA9
MN^/S8=NX2?#"950[[![)KJ(PBD\I]]E9SF?[K-^Y.E3W-GN$WC"A$8>U!0;7
MB0U:':Y"AXF16W>;>)#&-B0W+.SU$51E8-^OI31/D^J"TEQ(9_\!4$L#!!0
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M?;.P9FY/3HSD),-,H?LLXS53A)W0CE.2$9#HDQD5-1S19X(/A!)E1HV3+ZH
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M"D : [S/A-"[C7'0?F?$?P%02P,$%     @ #(&I5/>=CTC= @  *0@  !D
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MKV0Z9BU\EW5SU"M?C SX]%@FHWJTKG<3G^8_C$^I#I9EZXVF+**4:E:<LJ?
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M/9;8/(*R!OB^D,BH&]@%?#NZ_@U02P,$%     @ #(&I5-&V!4?.!0  2B$
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M+'8MNKD >1>'O*G;QS2?5VO9_$4'32]HJTTCO5!,XK',BEQA80%0NX/,F[B
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M)^*+^!^@#(VR0$H@%L>)=CA+T8HE\=LD?QNQ5:+@>BY%AM8ZPV&L[7"##L3
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M'KL)_Q.7V4:X4=*RB!6%VU* 'CF33DXS5(_=7/]N/N=59P60GD4^TSV&O>/
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M0]4O1[TPLJAZZ5H:[,S5=(>/+2AK@.<;B:*:A6W/[?,]^P=02P,$%     @
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M'O\AS80F2B^A.:^^P;%IZUH@V7-!BZ:S)"BRLO[%3TT@3CIX0QU0TP%5W/5
M%>4-%G@^9?0(F&HMU=1!-=6JMX3+2G575H+)?S/93\Q7@B:/6YJGA/&_P.W/
M?29^@2M070;_[:K(+7,LPU>FX(YPP;)$D+1I<*UBJGJ\OR$"9SG_,'6$I%+:
M3M(0+&H"-$#@@6^T%%L.;LN4I-W^CIQ-.R7T/*4%,@I^P\P&'OP(D(O0.^
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M-6-&9Y\8[/H&[P.R76RJM25NT3AM^9^ +B3P?FTMO0:A3X>_3/$"4$L#!!0
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M94//!K@00/NUM7@RPBB/#U'Y"E!+ P04    "  ,@:E4=B(RDP4#  "%"@
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M]<G+/4\YD&QMM@TS)M4FQ!RNU#X1<UV@YA>,R=U [T3JG>?X/U!+ P04
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MV*F>AW6E&<UK<"I%V(^B)"PIEV0\DLORNC1U,%-+:3)RT9D"=_N29Z277)#
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M':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04
M"  ,@:E4N4S D<\#  !+'@  #P   'AL+W=O<FMB;V]K+GAM;,696T_;,!2
M_XJ5E[$'UN9"N6B=!+1LE4J+".(5F>246B1V9SN%\>OG)'2<:NW17KP\);XT
M^>+:_NSCKR]*/S\J]<Q>RT*:8;"T=G76ZYEL"24W7]0*I"M9*%URZY+ZJ6=6
M&GANE@"V+'I1OS_HE5S(X-O7S;-N= \GE(7,"B5=9IUQ+^#%?)372;861CR*
M0MA?PZ"Y+R!@I9"B%&^0#X-^P,Q2O?Q06KPI:7F19EH5Q3 (VX)[T%9D?V6G
M->0=?S1-CN6/M]R!#(-!WSUP(;2Q38WF^=PQKL%5;E.555>BL*!'W,)WK:J5
MD$_U8]Q7]-!G-.VPN;:->*;_I1G58B$R&*FL*D':MATU%#6@-$NQ,@&3O(1A
M<*G6H.OO<2^8Y.VW60>%6DJ?"5>@)WF#YQ%E/AN-9^EXQ-Q=.I].1N=W+G%Q
M/CV?78X9@HP(R*A#R(<(0<8$9-P)9'KG+M?C&8),",BD0\BMECPB((^ZA(P1
MY(" ''0)F2#(8P+RV"_D!3?",+5@-QJ,J]K48%SF+*W*DB/($P+RQ"]D"D]U
M#3:1[<]=.0([)<!._8)=<:'9/2\J8-? 3:6A_H'!$W>?FKG[GGN@DNM:DNZM
M+ 4IE&8S)^8M/M(LGM4RD9DJ@=WQ5TQ$:23T[)'4JNQYJ8H<M/G$QC\KMSK!
M;)0]0M_Z4&4I;#,0ZO'I_ESKEB<@,P'F@4TQ)N6/T+- IFX@;'<Q2A2A9U.0
M\]N6SD)*%:%G5]"86&@A)8O0LRTV$_$MK)2N>Q\[<(OG LQG3$B9(O2LBCTS
M\H838U+>"#V+8]_,_,Z)%]640"+/ MDU'>[ZRR/*(I%GB[03SDXL<D?B627T
MD,;+OXBR2N39*C3F$<:DK!)YM@J-.<"8E&ZB3G5SC#$IW42=ZN8$8U*ZB;K<
MG#R<8DS*.9%GYU"8#\T&X \FY9S(LW-HS!#'2"CGQ)Z=0V-NA7(HZ\2>K4-C
MXA5;3%DH]KVA^7OKS Y&8+DHME09DW$QSP[:MV@[9.?&@,68E(-BSP[:CWD+
MV59((J8<%'MVT'[,&=<:AW1BRD&Q[_#8OB5PRXDQ*0?%GAU$8;HKQJ0<%'MV
MT$<H9??PIL03>Q;/SEW$(6NRV7R%X]Z4>)(N-COO@\:*-<:DQ)/X/H^APD!;
M$8V$$D_B63SON[*/]H.='3.AO)-X]LX?QOD*:D;YU#3IE9!<9H"/MA+R1.:_
M1-0<YC6WE:Y[I5MV?"!C3,H[2>.=WN;P,H>%D)#/W"N,R\]XD=UH5E_:*&QR
M5$=(%E517+J\N9PJGF_.0C?GN-]^ U!+ P04    "  ,@:E4N#;$W*D!   N
M&P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=F[;L) $(7A5T%^
M ):966X14*6AC7@!"Y:+,-CR;A1X^R HX%@ITJ ]E;6V//X;?[+6LZ]0E>E0
MG^/^T,3>Y52=X[S8I]1\.!?7^W J8[]NPOEV95NWIS+=ENW.->7Z6.Z"T\%@
MY-K7&<5B]CJSM[HVX3\3Z^WVL Z?]?K[%,[IC\'NIVZ/<1]"*GJKLMV%-"_<
MI7J>CNY^D/YM<M%;;N9%N]Q(X7('*01I_B"#(,L?Y"'(YP\:0M P?] (@D;Y
M@\80-,X?-(&@2?Z@*01-\P?) &4<$"1UL";06I!K(?!:$&PA$%N0;"$P6Q!M
M(5!;D&TA<%L0;B&06Y!N(;!;$&\AT%M1;R706U%O)=!;.Q_;!'HKZJT$>BOJ
MK01Z*^JM!'HKZJT$>BOJK01Z*^JM!'HKZJT$>AOJ;01Z&^IM!'H;ZFT$>EMG
MLX1 ;T.]C4!O0[V-0&]#O8U ;T.]C4!O0[V-0&]#O8U ;X]Z>P*]/>KM"?3V
MJ+<GT-NCWIY ;]_9[";0VZ/>_IUZQW2M0GSV/-;X_'=2G6[WAN?C[\O'R<X+
M=<?9P>^QQ2]02P,$%     @ #(&I5%/9*RFR 0  4QL  !,   !;0V]N=&5N
M=%]4>7!E<UTN>&ULS9G-;L(P$(1?!>6*B+&=TA\!E[;7ED-?P$TV)"*)+=M0
M>/LZX4=J1:,B*G4NL1+OSHR]TG?)]&UGR VV==6X651X;QX8<VE!M7*Q-M2$
MG5S;6OGP:I?,J'2EEL3$>#QAJ6X\-7[D6XUH/GVB7*TK/WC>AL^NU,TLLE2Y
M:/"X+VR]9I$RIBI3Y<,^VS39-Y?1P2$.G5V-*TKCAJ$@8F<=VIV?#0Y]KQNR
MMLQHL%#6OZ@Z5+%MQ9S?5>3B?HDS&76>EREE.EW7H25VQI+*7$'DZRK>BP[[
MG7VX8=H_^=7^G4R?8:A<6&U<F)BER^V.(VF[1R8(D?5E_Q%/CD'ZZO-1.^V,
MLE]ZA^O]T';5S<.Q;KG^CK_.^*1_80X!DD."Y$A <MR Y)B Y+@%R7$'DN,>
M) <?HP1!(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M (:M
M(:M (:M (:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$
M(6N"0M8$A:P)"ED3%+(F*&1-_I.L[UJO_OHW3[O&M2J;HS_K_J7-/P%02P$"
M% ,4    "  ,@:E4!T%-8H$   "Q    $               @ $     9&]C
M4')O<',O87!P+GAM;%!+ 0(4 Q0    (  R!J53_3%-6[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  R!
MJ5297)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ #(&I5/P7GD5+!0  >14  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  R!
MJ51W=6];)P<   T?   8              " @8X-  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    "  ,@:E4*VB7ON$"  !O"0  &
M        @('K%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ #(&I5"LV AC@!0  *1H  !@              ("! A@  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (  R!J51QTQ<MQP(  +(&   8
M              " @1@>  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    "  ,@:E4/S82,(0&  "='   &               @($5(0  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ #(&I5)U#'.BH"
MOR0  !@              ("!SR<  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    (  R!J51\I?VX:"   !9@   8              " @:TP
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    "  ,@:E4!3#\
M=Y0(   7%0  &               @(%+40  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ #(&I5';(DG=O"P  LAT  !D
M ("!%5H  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    "  ,
M@:E4@Z#DW\4+   3(P  &0              @(&[90  >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (  R!J52;40.6UP,  -$(   9
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M970Q-BYX;6Q02P$"% ,4    "  ,@:E49/$9 .D*  "0'0  &0
M    @(&,H   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M  R!J53\D">TT@,  %,(   9              " @:RK  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ #(&I5(6+AU)*"0  IQ<  !D
M             ("!M:\  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    "  ,@:E4E%V2%1(#  !@!@  &0              @($VN0  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    (  R!J51AL<.,,P,
M  L)   9              " @7^\  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ #(&I5!R) B95 P  9P@  !D              ("!
MZ;\  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    "  ,@:E4
M*U!%NQP'  #O(@  &0              @(%UPP  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    (  R!J52Q,^V@T00  ",8   9
M      " @<C*  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ #(&I5-Y.YH8"!@  'R   !D              ("!T,\  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  ,@:E4LGU7")T"  #:!@
M&0              @($)U@  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    (  R!J526AP<0K@,  )P.   9              " @=W8  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ #(&I5'/;]Q.+
M P  L0P  !D              ("!PMP  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    "  ,@:E4/16YUFH#    "P  &0
M@(&$X   >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    (  R!
MJ53/1W<@W (  ',(   9              " @27D  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ #(&I5/>=CTC= @  *0@  !D
M         ("!..<  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4
M    "  ,@:E4'T:>NV8#  ":"@  &0              @(%,Z@  >&PO=V]R
M:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (  R!J531M@5'S@4  $HA
M   9              " @>GM  !X;"]W;W)K<VAE971S+W-H965T,S,N>&UL
M4$L! A0#%     @ #(&I5'&[+&_?"0  \TL  !D              ("![O,
M 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"% ,4    "  ,@:E4N%J(
M8_ "  !Y!P  &0              @($$_@  >&PO=V]R:W-H965T<R]S:&5E
M=#,U+GAM;%!+ 0(4 Q0    (  R!J53$!;P0$0(  &8$   9
M  " @2L! 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
M#(&I5$F+BQDS!P  82   !D              ("!<P,! 'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    "  ,@:E4PG!)J>("  #*!P  &0
M            @('="@$ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    (  R!J52$W\%-(@(  "8%   9              " @?8- 0!X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ #(&I5![:!/ G!
M=Q$  !D              ("!3Q ! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    "  ,@:E4?;?VIF,#   <"@  &0              @(&M
M% $ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    (  R!J500
MVJ#*) (  '$$   9              " @4<8 0!X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ #(&I5)%-ZBS^ 0  E 0  !D
M     ("!HAH! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
M"  ,@:E4=B(RDP4#  "%"@  &0              @('7' $ >&PO=V]R:W-H
M965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (  R!J500;ZZ&R@(  !4(   9
M              " @1,@ 0!X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L!
M A0#%     @ #(&I5+5(4?<@ P  &A(   T              ( !%",! 'AL
M+W-T>6QE<RYX;6Q02P$"% ,4    "  ,@:E4EXJ[',     3 @  "P
M        @ %?)@$ 7W)E;',O+G)E;'-02P$"% ,4    "  ,@:E4N4S D<\#
M  !+'@  #P              @ %()P$ >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ #(&I5+@VQ-RI 0  +AL  !H              ( !1"L! 'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ #(&I5%/9*RFR 0
M4QL  !,              ( !)2T! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2     #4 -0!J#@  ""\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>228</ContextCount>
  <ElementCount>315</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>72</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2114102 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2117103 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2122104 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2126105 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2128106 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2132107 - Disclosure - Commitment and Contingencies: Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2134108 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2315302 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/FairValueMeasurements</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2329305 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/StockholdersEquity</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2335306 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ligand.com/role/Leases</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2416411 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/SegmentInformation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2419412 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2420413 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2421414 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2424415 - Disclosure - Convertible Senior Notes - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails</Role>
      <ShortName>Convertible Senior Notes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2425416 - Disclosure - Convertible Senior Notes - Notes Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails</Role>
      <ShortName>Convertible Senior Notes - Notes Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2427417 - Disclosure - Income Tax (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/IncomeTaxDetails</Role>
      <ShortName>Income Tax (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/IncomeTax</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails</Role>
      <ShortName>Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2433420 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails</Role>
      <ShortName>Commitment and Contingencies: Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails</Role>
      <ShortName>Leases - Operating and Finance Lease Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="lgnd-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturity of Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="lgnd-20220331.htm">lgnd-20220331.htm</File>
    <File>lgnd-20220331.xsd</File>
    <File>lgnd-20220331_cal.xml</File>
    <File>lgnd-20220331_def.xml</File>
    <File>lgnd-20220331_lab.xml</File>
    <File>lgnd-20220331_pre.xml</File>
    <File>lgnd_33122exhibit311.htm</File>
    <File>lgnd_33122exhibit312.htm</File>
    <File>lgnd_33122exhibit321.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>lgnd-20220331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="694">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>63
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "lgnd-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 25,
   "contextCount": 228,
   "dts": {
    "calculationLink": {
     "local": [
      "lgnd-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lgnd-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "lgnd-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "lgnd-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lgnd-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "lgnd-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 507,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 3,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 8
   },
   "keyCustom": 42,
   "keyStandard": 273,
   "memberCustom": 30,
   "memberStandard": 38,
   "nsprefix": "lgnd",
   "nsuri": "http://www.ligand.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.ligand.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117103 - Disclosure - Fair Value Measurements",
     "role": "http://www.ligand.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122104 - Disclosure - Convertible Senior Notes",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126105 - Disclosure - Income Tax",
     "role": "http://www.ligand.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128106 - Disclosure - Stockholders' Equity",
     "role": "http://www.ligand.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132107 - Disclosure - Commitment and Contingencies: Legal Proceedings",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings",
     "shortName": "Commitment and Contingencies: Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134108 - Disclosure - Leases",
     "role": "http://www.ligand.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315302 - Disclosure - Segment Reporting (Tables)",
     "role": "http://www.ligand.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329305 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://www.ligand.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335306 - Disclosure - Leases (Tables)",
     "role": "http://www.ligand.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredIncomeTaxLiabilitiesNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Revenue by Source (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "iadcc8e71d6a1438fbd272741cd9b7d95_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Investment Categories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "lgnd:ScheduleOfShortTermInvestmentsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Available-for-Sale Debt Securities by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Goodwill and Other Identifiable Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetIncludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Commercial License Rights (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:ScheduleOfCommercialLicenseRightsTableTextBlock",
       "lgnd:CommercialLicenseRightsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i15f31f56d8fa4583b0ccb100f5a2fb11_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410407 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accrued Liabilities and Other Long-Term Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411408 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Accounting for Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412409 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Fair Value Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413410 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies - Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i8220447fce27459a888de6de4b101be1_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ib574058f498140e08306c67fbbc14b07_D20220323-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416411 - Disclosure - Segment Information (Details)",
     "role": "http://www.ligand.com/role/SegmentInformationDetails",
     "shortName": "Segment Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ib574058f498140e08306c67fbbc14b07_D20220323-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ib419e06b57b54f5c8f34756ee9797e58_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419412 - Disclosure - Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ib419e06b57b54f5c8f34756ee9797e58_D20100101-20100131",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "lgnd:NumberOfContingentValueRightsSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contingent_value_right_series",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ica554f22c30d4304a7166e4a018118e6_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420413 - Disclosure - Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ica554f22c30d4304a7166e4a018118e6_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421414 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportingUnits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "reporting_unit",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424415 - Disclosure - Convertible Senior Notes - Narrative (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
     "shortName": "Convertible Senior Notes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i8cfdef1052f742c2a3e679d1385ce407_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "id01f6fee2fc241329c914948fff4bda7_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425416 - Disclosure - Convertible Senior Notes - Notes Payable (Details)",
     "role": "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails",
     "shortName": "Convertible Senior Notes - Notes Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "id01f6fee2fc241329c914948fff4bda7_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427417 - Disclosure - Income Tax (Details)",
     "role": "http://www.ligand.com/role/IncomeTaxDetails",
     "shortName": "Income Tax (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostDirectMaterial",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ba9060814074f5b8b13493a50dcc9ab_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails",
     "shortName": "Stockholders' Equity - Stock Option Plan and Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ba9060814074f5b8b13493a50dcc9ab_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "role": "http://www.ligand.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i9e0901d9e25c46e498905e04372debe7_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433420 - Disclosure - Commitment and Contingencies: Legal Proceedings (Details)",
     "role": "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails",
     "shortName": "Commitment and Contingencies: Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i9e0901d9e25c46e498905e04372debe7_D20191031-20191031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNewClaimsFiledNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "civil_complaint",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ia10c9da04455423daca5e24de07ee725_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Leases - Narrative (Details)",
     "role": "http://www.ligand.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ia10c9da04455423daca5e24de07ee725_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails",
     "shortName": "Leases - Operating and Finance Lease Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "lgnd:AssetsAndLiabilitiesLeasesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "lgnd:LeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Leases - Maturity of Operating Lease Liabilities (Details)",
     "role": "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturity of Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i4ed5b36e32c14d6ba6f922ef55910407_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "ie23dddf73d564cccbeb38cedfbf213d4_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "i0adfb1eca5a640698b9228529cba9397_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "role": "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114102 - Disclosure - Segment Information",
     "role": "http://www.ligand.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "lgnd-20220331.htm",
      "contextRef": "icdafd1a0ce38408badf3484e39547f5f_D20220101-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 72,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.ligand.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "lgnd_AccruedAssetAcquisitionsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Asset Acquisitions, Current",
        "label": "Accrued Asset Acquisitions, Current",
        "terseLabel": "Acquisition related liabilities"
       }
      }
     },
     "localname": "AccruedAssetAcquisitionsCurrent",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedInventoryPurchases": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Inventory Purchases",
        "label": "Accrued Inventory Purchases",
        "terseLabel": "Accrued inventory purchases"
       }
      }
     },
     "localname": "AccruedInventoryPurchases",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSubcontractorExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Subcontractor Expenses, Current",
        "label": "Accrued Subcontractor Expenses, Current",
        "terseLabel": "Subcontractor"
       }
      }
     },
     "localname": "AccruedSubcontractorExpensesCurrent",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AccruedSupplierExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Supplier Expenses, Current",
        "label": "Accrued Supplier Expenses, Current",
        "terseLabel": "Supplier"
       }
      }
     },
     "localname": "AccruedSupplierExpensesCurrent",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "label": "Adjustments to Additional Paid in Capital, Tax Effect of Convertible Senior Notes Transactions",
        "negatedTerseLabel": "Tax effect for 2023 Notes transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalTaxEffectOfConvertibleSeniorNotesTransactions",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "label": "Adjustments to Additional Paid in Capital, Warrant and Bond Hedge Unwind Transactions",
        "terseLabel": "Warrant and bond hedge unwind transactions"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantAndBondHedgeUnwindTransactions",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AmortizationOfCommercialLicenseAndOtherEconomicRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization Of Commercial License And Other Economic Rights",
        "label": "Amortization Of Commercial License And Other Economic Rights",
        "verboseLabel": "Amortization of commercial license rights"
       }
      }
     },
     "localname": "AmortizationOfCommercialLicenseAndOtherEconomicRights",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_AssetsAndLiabilitiesLeasesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets and Liabilities Leases",
        "label": "Assets and Liabilities Leases [Table Text Block]",
        "terseLabel": "Schedule of Operating and Finance Lease Assets and Liabilities"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLeasesTableTextBlock",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_AziyoAndCorMatrixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aziyo and CorMatrix",
        "label": "Aziyo and CorMatrix [Member]",
        "terseLabel": "Aziyo and CorMatrix"
       }
      }
     },
     "localname": "AziyoAndCorMatrixMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_BasisOfPresentationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of presentation.",
        "label": "Basis of Presentation [Line Items]",
        "terseLabel": "Basis of Presentation [Line Items]"
       }
      }
     },
     "localname": "BasisOfPresentationLineItems",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BasisOfPresentationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation.",
        "label": "Basis of Presentation [Table]",
        "terseLabel": "Basis of Presentation [Table]"
       }
      }
     },
     "localname": "BasisOfPresentationTable",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "label": "Business Combination, Contingent Consideration, Gain (Loss) Recognized on Contingency",
        "terseLabel": "Earnout rights recognized"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationGainLossRecognizedOnContingency",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "label": "Business Combination, Frequency of Cash Payments to Contingent Value Rights Holders",
        "terseLabel": "Frequency of cash payments to CVR holders"
       }
      }
     },
     "localname": "BusinessCombinationFrequencyOfCashPaymentsToContingentValueRightsHolders",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "label": "Business Combination, Number of Contingent Value Rights Issued from Each Contingent Value Right Series",
        "terseLabel": "Number of CVRs issued from each CVR series"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedFromEachContingentValueRightSeries",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "label": "Business Combination, Number of Contingent Value Rights Issued per Acquiree Share",
        "terseLabel": "Number of CVRs issued per acquiree share"
       }
      }
     },
     "localname": "BusinessCombinationNumberOfContingentValueRightsIssuedPerAcquireeShare",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "label": "COVID-19, Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)",
        "terseLabel": "Additional allowance for credit losses recorded related to COVID-19"
       }
      }
     },
     "localname": "COVID19AccountsReceivableAllowanceForCreditLossPeriodIncreaseDecrease",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseAndOtherEconomicRightsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License and Other Economic Rights",
        "label": "Commercial License and Other Economic Rights [Abstract]",
        "verboseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseAndOtherEconomicRightsAbstract",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_CommercialLicenseRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial License Rights",
        "terseLabel": "Commercial license rights, net"
       }
      }
     },
     "localname": "CommercialLicenseRights",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_CommercialLicenseRightsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial License Rights",
        "label": "Commercial License Rights [Policy Text Block]",
        "terseLabel": "Commercial License and Other Economic Rights"
       }
      }
     },
     "localname": "CommercialLicenseRightsPolicyTextBlock",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ContractRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue",
        "label": "Contract Revenue [Member]",
        "terseLabel": "Contract revenue"
       }
      }
     },
     "localname": "ContractRevenueMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ContractRevenueServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Revenue, Service",
        "label": "Contract Revenue, Service [Member]",
        "terseLabel": "Service Revenue"
       }
      }
     },
     "localname": "ContractRevenueServiceMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ConvertibleSeniorNotesDue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Convertible Senior Notes due 2023",
        "label": "Convertible Senior Notes due 2023 [Member]",
        "terseLabel": "2023 Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleSeniorNotesDue2023Member",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_CurrentPortionOfLiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentPortionOfLiabilityForContingentValueRights",
        "verboseLabel": "Current contingent liabilities"
       }
      }
     },
     "localname": "CurrentPortionOfLiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
        "terseLabel": "Maximum threshold of debt trading price trigger (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleMaximumThresholdPercentageofDebtTradingPriceTrigger",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "label": "Debt Securities, Available-For-Sale And Equity Securities, FV-NI",
        "totalLabel": "Total short-term investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties [Member]",
        "terseLabel": "Development, Regulatory, &amp; Commercial Milestones and Tiered Royalties"
       }
      }
     },
     "localname": "DevelopmentRegulatoryCommercialMilestonesAndTieredRoyaltiesMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EarnoutRightsForPartnerResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnout Rights for Partner Research and Development",
        "label": "Earnout Rights for Partner Research and Development [Member]",
        "terseLabel": "Earnout Rights for Partner Research and Development"
       }
      }
     },
     "localname": "EarnoutRightsForPartnerResearchAndDevelopmentMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EmployeeStockPurchasePlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan [Abstract]",
        "label": "Employee Stock Purchase Plan [Abstract]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanAbstract",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "lgnd_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "EmployeeStockPurchasePlanMember",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_EvomelaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Evomela",
        "label": "Evomela [Member]",
        "terseLabel": "Evomela"
       }
      }
     },
     "localname": "EvomelaMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Contingent Consideration from Acquisition",
        "terseLabel": "Contingent liabilities from xCella asset acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityContingentConsiderationFromAcquisition",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization &amp; Credit Loss Adjustments",
        "negatedTerseLabel": "Adjustments"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortizationCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_FiniteLivedIntangibleAssetsCreditLossAdjustments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "label": "Finite-lived Intangible Assets, Credit Loss Adjustments",
        "negatedLabel": "Credit loss adjustments of finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsCreditLossAdjustments",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_GainLossOnShortTermInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Short-term Investments",
        "label": "Gain (Loss) on Short-term Investments",
        "negatedLabel": "Loss (gain) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnShortTermInvestments",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_IncreaseDecreaseInDebtDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) in Debt Discount",
        "label": "Increase (Decrease) in Debt Discount",
        "negatedLabel": "Increase (decrease) in debt discount"
       }
      }
     },
     "localname": "IncreaseDecreaseInDebtDiscount",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_KyprolisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kyprolis",
        "label": "Kyprolis [Member]",
        "terseLabel": "Kyprolis"
       }
      }
     },
     "localname": "KyprolisMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability",
        "label": "Lease, Liability",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiability",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Current",
        "label": "Lease, Liability, Current",
        "totalLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilityCurrent",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Right-Of-Use Asset",
        "label": "Lease, Right-Of-Use Asset",
        "totalLabel": "Total lease assets"
       }
      }
     },
     "localname": "LeaseRightOfUseAsset",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LiabilityForContingentValueRights",
        "verboseLabel": "Long-term contingent liabilities"
       }
      }
     },
     "localname": "LiabilityForContingentValueRights",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyCydexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Cydex",
        "label": "Liability For Contingent Value Rights Company, Cydex [Member]",
        "verboseLabel": "Contingent liabilities - CyDex"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyCydexMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyIcagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Icagen",
        "label": "Liability For Contingent Value Rights Company, Icagen [Member]",
        "terseLabel": "Contingent liabilities - Icagen"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyIcagenMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyMetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, Metabasis",
        "label": "Liability For Contingent Value Rights Company, Metabasis [Member]",
        "terseLabel": "Contingent liabilities - Metabasis"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyMetabasisMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForContingentValueRightsCompanyXCellaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Contingent Value Rights Company, xCella",
        "label": "Liability For Contingent Value Rights Company, xCella [Member]",
        "terseLabel": "Contingent liabilities - xCella"
       }
      }
     },
     "localname": "LiabilityForContingentValueRightsCompanyXCellaMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "label": "Liability for Restricted Investments Owed to Former Licensees [Member]",
        "terseLabel": "Amounts owed to former licensor"
       }
      }
     },
     "localname": "LiabilityForRestrictedInvestmentsOwedToFormerLicenseesMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees",
        "label": "License Fees [Member]",
        "terseLabel": "License Fees"
       }
      }
     },
     "localname": "LicenseFeesMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseFeesMilestonesAndProductOtherProductOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License Fees, Milestones, and Product, Other, Product, Other",
        "label": "License Fees, Milestones, and Product, Other, Product, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "LicenseFeesMilestonesAndProductOtherProductOtherMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_LicenseeAccrualCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensee Accrual, Current",
        "label": "Licensee Accrual, Current",
        "terseLabel": "Amounts owed to former licensees"
       }
      }
     },
     "localname": "LicenseeAccrualCurrent",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_LigandCoreBusinessSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ligand Core Business Segment",
        "label": "Ligand Core Business Segment [Member]",
        "terseLabel": "Ligand Core Business"
       }
      }
     },
     "localname": "LigandCoreBusinessSegmentMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCOVIDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, COVID",
        "label": "Material Sales, Captisol, COVID [Member]",
        "terseLabel": "Captisol - COVID"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCOVIDMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolCoreMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol, Core",
        "label": "Material Sales, Captisol, Core [Member]",
        "terseLabel": "Captisol - Core"
       }
      }
     },
     "localname": "MaterialSalesCaptisolCoreMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MaterialSalesCaptisolMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Material Sales, Captisol",
        "label": "Material Sales, Captisol [Member]",
        "terseLabel": "Captisol"
       }
      }
     },
     "localname": "MaterialSalesCaptisolMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MetabasisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Metabasis",
        "label": "Metabasis [Member]",
        "terseLabel": "Metabasis"
       }
      }
     },
     "localname": "MetabasisMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_MilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone",
        "label": "Milestone [Member]",
        "terseLabel": "Milestone"
       }
      }
     },
     "localname": "MilestoneMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_NonCashChangeInEstimatedFairValueOfContingentValueRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
        "negatedLabel": "Change in estimated fair value of contingent liabilities"
       }
      }
     },
     "localname": "NonCashChangeInEstimatedFairValueOfContingentValueRights",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_NumberOfContingentValueRightsSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Contingent Value Rights Series",
        "label": "Number of Contingent Value Rights Series",
        "terseLabel": "Number of CVR Series"
       }
      }
     },
     "localname": "NumberOfContingentValueRightsSeries",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_NumberOfOptionsUnderConvertibleBondHedges": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Options under Convertible Bond Hedges",
        "label": "Number of Options under Convertible Bond Hedges",
        "terseLabel": "Number of options under convertible bond hedges"
       }
      }
     },
     "localname": "NumberOfOptionsUnderConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "lgnd_OmniAbTechnologiesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "OmniAb Technologies Segment",
        "label": "OmniAb Technologies Segment [Member]",
        "terseLabel": "OmniAb Technologies"
       }
      }
     },
     "localname": "OmniAbTechnologiesSegmentMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_PaymentsForConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments for Convertible Bond Hedges",
        "label": "Payments for Convertible Bond Hedges",
        "terseLabel": "Payments for convertible bond hedges"
       }
      }
     },
     "localname": "PaymentsForConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders",
        "label": "Payments to Contingent Value Right Holders",
        "negatedTerseLabel": "Payments to CVR holders and other contingent payments"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHolders",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToContingentValueRightHoldersFinancingActivity": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Contingent Value Right Holders, Financing Activity",
        "label": "Payments to Contingent Value Right Holders, Financing Activity",
        "negatedLabel": "Payments to CVR Holders"
       }
      }
     },
     "localname": "PaymentsToContingentValueRightHoldersFinancingActivity",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_PaymentsToUnwindWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Unwind Warrants",
        "label": "Payments to Unwind Warrants",
        "terseLabel": "Payments to unwind warrants"
       }
      }
     },
     "localname": "PaymentsToUnwindWarrants",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_Phase3ClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 Clinical Trial",
        "label": "Phase 3 Clinical Trial [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrialMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ProceedsFromUnwindingConvertibleBondHedges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Unwinding Convertible Bond Hedges",
        "label": "Proceeds from Unwinding Convertible Bond Hedges",
        "terseLabel": "Proceeds from unwinding convertible bond hedges"
       }
      }
     },
     "localname": "ProceedsFromUnwindingConvertibleBondHedges",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RepaymentsOfNotesPayableInterestPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments Of Notes Payable, Interest Portion",
        "label": "Repayments Of Notes Payable, Interest Portion",
        "terseLabel": "Accrued interest portion of repurchased amount of debt instrument"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayableInterestPortion",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_ReturnsAccrual": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Returns Accrual",
        "label": "Returns Accrual",
        "terseLabel": "Return reserve"
       }
      }
     },
     "localname": "ReturnsAccrual",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "lgnd_RoyaltyOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty, Other",
        "label": "Royalty, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "RoyaltyOtherMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_RylazeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rylaze",
        "label": "Rylaze [Member]",
        "terseLabel": "Rylaze"
       }
      }
     },
     "localname": "RylazeMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlock [Table Text Block]",
        "verboseLabel": "Schedule of Accounting for Share-Based Compensation"
       }
      }
     },
     "localname": "ScheduleForShareBasedCompensationExpenseForAwardsToEmployeesAndDirectorsTableTextBlockTableTextBlock",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfCommercialLicenseRightsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Commercial License Rights",
        "label": "Schedule of Commercial License Rights [Table Text Block]",
        "terseLabel": "Schedule of Commercial License Rights"
       }
      }
     },
     "localname": "ScheduleOfCommercialLicenseRightsTableTextBlock",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_ScheduleOfShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Short-Term investments",
        "label": "Schedule of Short-Term investments [Table Text Block]",
        "terseLabel": "Schedule of Short-Term Investments"
       }
      }
     },
     "localname": "ScheduleOfShortTermInvestmentsTableTextBlock",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "lgnd_SelexisAndDianomiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selexis and Dianomi",
        "label": "Selexis and Dianomi [Member]",
        "terseLabel": "Selexis and Dianomi"
       }
      }
     },
     "localname": "SelexisAndDianomiMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "label": "Share-Based Compensation, Achievement of Performance Criteria, Payout Range, Percent",
        "terseLabel": "Payout range (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationAchievementOfPerformanceCriteriaPayoutRangePercent",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "lgnd_TeriparatideInjectionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Teriparatide Injection",
        "label": "Teriparatide Injection [Member]",
        "terseLabel": "Teriparatide injection"
       }
      }
     },
     "localname": "TeriparatideInjectionMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_USDistrictCourtForTheNorthernDistrictOfOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US District Court for the Northern District of Ohio",
        "label": "US District Court for the Northern District of Ohio [Member]",
        "terseLabel": "US District Court for the Northern District of Ohio"
       }
      }
     },
     "localname": "USDistrictCourtForTheNorthernDistrictOfOhioMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "lgnd_XCellaBiosciencesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "xCella Biosciences, Inc.",
        "label": "xCella Biosciences, Inc. [Member]",
        "terseLabel": "xCella"
       }
      }
     },
     "localname": "XCellaBiosciencesIncMember",
     "nsuri": "http://www.ligand.com/20220331",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r124",
      "r173",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r195",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r293",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r124",
      "r173",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r191",
      "r195",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r290",
      "r291",
      "r293",
      "r295",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r52",
      "r54",
      "r122",
      "r123",
      "r304",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember": {
     "auth_ref": [
      "r2",
      "r129",
      "r136",
      "r231",
      "r440",
      "r441",
      "r442",
      "r458",
      "r459",
      "r488",
      "r493",
      "r494",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjusted Balance [Member]",
        "terseLabel": "Adjusted Balance"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r129",
      "r136",
      "r142",
      "r231",
      "r440",
      "r441",
      "r442",
      "r458",
      "r459",
      "r488",
      "r491",
      "r493",
      "r494",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r129",
      "r136",
      "r142",
      "r231",
      "r440",
      "r441",
      "r442",
      "r458",
      "r459",
      "r488",
      "r491",
      "r493",
      "r494",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r129",
      "r136",
      "r142",
      "r231",
      "r440",
      "r441",
      "r442",
      "r458",
      "r459",
      "r488",
      "r491",
      "r493",
      "r494",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r303",
      "r344",
      "r401",
      "r403",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r574",
      "r626",
      "r628",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r303",
      "r344",
      "r401",
      "r403",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r574",
      "r626",
      "r628",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r198",
      "r380",
      "r383",
      "r577",
      "r625",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r198",
      "r380",
      "r383",
      "r577",
      "r625",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r303",
      "r344",
      "r391",
      "r401",
      "r403",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r574",
      "r626",
      "r628",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r303",
      "r344",
      "r391",
      "r401",
      "r403",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r574",
      "r626",
      "r628",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r53",
      "r54",
      "r122",
      "r123",
      "r304",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r130",
      "r131",
      "r132",
      "r133",
      "r208",
      "r209",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r282",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r458",
      "r459",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r540",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r36",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r9",
      "r25",
      "r203",
      "r204"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of premium on investments, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r21",
      "r587",
      "r611"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes liability"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAndNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities [Abstract]",
        "verboseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAndNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "verboseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties owed to third parties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r58",
      "r59",
      "r60",
      "r613",
      "r636",
      "r640"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r57",
      "r60",
      "r66",
      "r67",
      "r68",
      "r126",
      "r127",
      "r128",
      "r479",
      "r631",
      "r632",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r443",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r440",
      "r441",
      "r442",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r130",
      "r131",
      "r132",
      "r133",
      "r142",
      "r208",
      "r209",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r282",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r456",
      "r457",
      "r458",
      "r459",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r540",
      "r579",
      "r580",
      "r581",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt",
        "verboseLabel": "Reacquisition of equity due to 2023 debt extinguishment, net of tax"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r404",
      "r406",
      "r446",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r298",
      "r358",
      "r366"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "verboseLabel": "Adjustments to additional paid-in-capital from warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net income (loss) to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r406",
      "r432",
      "r445"
     ],
     "calculation": {
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Shared-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, after Tax",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r75",
      "r104",
      "r323",
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortized issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r104",
      "r323",
      "r334",
      "r335",
      "r527"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount and issuance fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive shares excluded from calculation due to anti-dilutive effect (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r118",
      "r181",
      "r187",
      "r193",
      "r227",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r296",
      "r297",
      "r475",
      "r480",
      "r508",
      "r541",
      "r543",
      "r585",
      "r610"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r51",
      "r118",
      "r227",
      "r283",
      "r284",
      "r285",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r296",
      "r297",
      "r475",
      "r480",
      "r508",
      "r541",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "verboseLabel": "Assets, fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross unrealized gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross unrealized losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r212",
      "r239"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Fair Value, Rolling Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Fair Value",
        "terseLabel": "Within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Amortized Cost",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security, measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next rolling fiscal year through fifth year following latest fiscal year. For interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling after One Through Five Years, Fair Value",
        "terseLabel": "After one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r217",
      "r218",
      "r603"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r210",
      "r213",
      "r239",
      "r592"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Estimated fair value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r408",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "verboseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r400",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r400",
      "r402",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r108",
      "r109",
      "r110"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accrued fixed asset purchases"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r33",
      "r106"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r98",
      "r106",
      "r111"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r98",
      "r517"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "verboseLabel": "Warrant exercise price (USD per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "verboseLabel": "Warrants issued in public offering (shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r44",
      "r269",
      "r594",
      "r617"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r277",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitment and Contingencies: Legal Proceedings"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r126",
      "r127",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock authorized (shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock issued (shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock outstanding (shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock, $0.001 par value; 60,000 shares authorized; 16,861 and 16,767 shares issued and outstanding at March\u00a031, 2022 and December\u00a031, 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r72",
      "r597",
      "r621"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetGross": {
     "auth_ref": [
      "r205",
      "r236",
      "r368",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration in exchange for good or service transferred to customer, when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, before Allowance for Credit Loss",
        "terseLabel": "Gross contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r368",
      "r369",
      "r381"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized that was previously deferred"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Contractual relationships"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "verboseLabel": "Fair value of the 2023 Notes outstanding (Level 2)"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "2023 convertible senior notes, net"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayable": {
     "auth_ref": [
      "r22",
      "r588",
      "r612",
      "r642"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable",
        "terseLabel": "Convertible notes payable"
       }
      }
     },
     "localname": "ConvertibleNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleNotesPayableMember": {
     "auth_ref": [
      "r19",
      "r586",
      "r607",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.",
        "label": "Convertible Notes Payable [Member]",
        "terseLabel": "Convertible Notes"
       }
      }
     },
     "localname": "ConvertibleNotesPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r392",
      "r399",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r195",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostDirectMaterial": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of material used for good produced and service rendered.",
        "label": "Cost, Direct Material",
        "terseLabel": "Cost of Captisol"
       }
      }
     },
     "localname": "CostDirectMaterial",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r114",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r317",
      "r324",
      "r325",
      "r327",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r19",
      "r21",
      "r22",
      "r117",
      "r124",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r332",
      "r333",
      "r334",
      "r335",
      "r529",
      "r586",
      "r588",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r22",
      "r328",
      "r588",
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal amount of debt"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r302",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Initial conversion price (USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r41",
      "r302",
      "r359",
      "r362",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Initial conversion rate (shares per $1,000)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Consecutive trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Stock price trigger to classify convertible debt as current (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r300",
      "r332",
      "r333",
      "r526",
      "r529",
      "r530"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal amount of the 2023 Notes outstanding",
        "verboseLabel": "Aggregate principal amount outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentIncreaseAccruedInterest": {
     "auth_ref": [
      "r117"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.",
        "label": "Debt Instrument, Increase, Accrued Interest",
        "terseLabel": "Accrued Interest"
       }
      }
     },
     "localname": "DebtInstrumentIncreaseAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r40",
      "r330",
      "r526",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r40",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r42",
      "r117",
      "r124",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r332",
      "r333",
      "r334",
      "r335",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchaseAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value amount of debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchase Amount",
        "terseLabel": "Repurchased amount of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentRepurchaseAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r42",
      "r117",
      "r124",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r313",
      "r314",
      "r315",
      "r316",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r326",
      "r332",
      "r333",
      "r334",
      "r335",
      "r359",
      "r363",
      "r364",
      "r365",
      "r525",
      "r526",
      "r529",
      "r530",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r313",
      "r525",
      "r526",
      "r527",
      "r528",
      "r530"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermNotesPayable",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedTerseLabel": "Unamortized discount (including unamortized debt issuance cost)",
        "terseLabel": "Unamortized discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r214",
      "r239",
      "r243",
      "r244"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Allowance for Credit Loss",
        "terseLabel": "Credit losses related to available-for-sale debt securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Available-for-Sale Debt Securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized net loss on available-for-sale securities, net of deferred tax"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r222",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of positions in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtSecuritiesAvailableforsaleAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableforsaleAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r449",
      "r450"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes, net",
        "verboseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DemandDepositsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts that may or may not bear interest and that depositor is entitled to withdraw at anytime without prior notice. Checking and negotiable order of withdrawal (NOW) accounts are the most common forms of demand deposits.",
        "label": "Demand Deposits [Member]",
        "terseLabel": "Bank deposits"
       }
      }
     },
     "localname": "DemandDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r104",
      "r176"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of intangible assets"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DilutiveSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share [Abstract]",
        "terseLabel": "Dilutive potential common shares:"
       }
      }
     },
     "localname": "DilutiveSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Revenue by Source"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r143",
      "r145",
      "r150",
      "r151",
      "r152",
      "r155",
      "r156",
      "r494",
      "r495",
      "r598",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Summary of computation of basic and diluted net income (loss) per share",
        "verboseLabel": "Earnings Per Share, Basic and Diluted:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r145",
      "r150",
      "r151",
      "r152",
      "r155",
      "r156",
      "r494",
      "r495",
      "r598",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income (loss) per share (USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r153",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "verboseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTaxDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares to be repurchased in accordance with a policy to use treasury stock to satisfy share-award conversions.",
        "label": "Share-based Payment Arrangement, Shares Expected to be Repurchased, Next Fiscal Period",
        "verboseLabel": "Shares available for future purchases (shares)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationEstimatedQuantityOfSharesToBeRepurchasedInFollowingPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r66",
      "r67",
      "r68",
      "r126",
      "r127",
      "r128",
      "r131",
      "r139",
      "r141",
      "r158",
      "r231",
      "r358",
      "r366",
      "r440",
      "r441",
      "r442",
      "r458",
      "r459",
      "r493",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r631",
      "r632",
      "r633",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_DebtSecuritiesAvailableForSaleAndEquitySecuritiesFVNI",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r16",
      "r20",
      "r223",
      "r608",
      "r644",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Corporate equity securities",
        "verboseLabel": "Investment in Viking common stock"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails",
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r496",
      "r497",
      "r498",
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "verboseLabel": "Schedule of Assets and Liabilities Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r496",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r315",
      "r332",
      "r333",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r497",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r503",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r496",
      "r497",
      "r499",
      "r500",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r315",
      "r392",
      "r393",
      "r398",
      "r399",
      "r497",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r315",
      "r332",
      "r333",
      "r392",
      "r393",
      "r398",
      "r399",
      "r497",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r315",
      "r332",
      "r333",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r497",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3",
        "verboseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Financial and Nonfinancial Liabilities, Fair Value Disclosure [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r501",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Level 3 Financial Instruments"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments to contingent liabilities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r501"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Fair value of level 3 financial instruments as of March\u00a031, 2022",
        "periodStartLabel": "Fair value of level 3 financial instruments as of December\u00a031, 2021"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r315",
      "r332",
      "r333",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r547",
      "r548",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails",
      "http://www.ligand.com/role/FairValueMeasurementsReconciliationofLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r503",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "verboseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current financing lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r533",
      "r537"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedTerseLabel": "Payments under financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r531"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Financing lease right-of-use assets",
        "verboseLabel": "Finance lease assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r220",
      "r221",
      "r224",
      "r225",
      "r226",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r241",
      "r242",
      "r245",
      "r246",
      "r326",
      "r356",
      "r484",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r258"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization",
        "negatedTerseLabel": "Accumulated amortization on finite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r254",
      "r255",
      "r258",
      "r259",
      "r578",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r258",
      "r582"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      },
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "netLabel": "Gross",
        "verboseLabel": "Definite lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r254",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r258",
      "r578"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnInvestments": {
     "auth_ref": [
      "r80",
      "r104",
      "r211"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) on investment.",
        "label": "Gain (Loss) on Investments",
        "verboseLabel": "Gain (loss) from short-term investments"
       }
      }
     },
     "localname": "GainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r104",
      "r336",
      "r337"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Loss (gain) on debt extinguishment",
        "terseLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "verboseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "verboseLabel": "SBC - General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r250",
      "r251",
      "r543",
      "r584"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r219",
      "r602"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity) with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAvailableforSaleDebtSecuritiesbyContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r181",
      "r186",
      "r189",
      "r192",
      "r195",
      "r583",
      "r595",
      "r600",
      "r623"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Total segment operating income",
        "totalLabel": "Income (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r261",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r119",
      "r453",
      "r454",
      "r455",
      "r460",
      "r462",
      "r464",
      "r465",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r140",
      "r141",
      "r179",
      "r451",
      "r461",
      "r463",
      "r624"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r100",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r47",
      "r593",
      "r619"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income taxes receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income tax receivable and payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r152"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive potential common shares (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r253",
      "r256"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "verboseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.",
        "label": "Intangible Assets, Net (Including Goodwill)",
        "totalLabel": "Total goodwill and other identifiable intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetIncludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Including Goodwill) [Abstract]",
        "verboseLabel": "Summary of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetIncludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r69",
      "r175",
      "r524",
      "r527",
      "r599"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r82",
      "r321",
      "r331",
      "r334",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Total interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "auth_ref": [
      "r84",
      "r322",
      "r334",
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "terseLabel": "Contractual interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebtExcludingAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r95",
      "r99",
      "r107"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Interest Payable, Current",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "InterestPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r8",
      "r48",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r49",
      "r112",
      "r157",
      "r247",
      "r248",
      "r249",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r79",
      "r174"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r618"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remaining nine months ending December 31, 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "terseLabel": "Remaining lease term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term of operating leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r37",
      "r118",
      "r188",
      "r227",
      "r283",
      "r284",
      "r285",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r296",
      "r297",
      "r476",
      "r480",
      "r481",
      "r508",
      "r541",
      "r542"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r118",
      "r227",
      "r508",
      "r543",
      "r589",
      "r615"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r118",
      "r227",
      "r283",
      "r284",
      "r285",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r296",
      "r297",
      "r476",
      "r480",
      "r481",
      "r508",
      "r541",
      "r542",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "netLabel": "Current liabilities:",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which a liability could be incurred (settled) in a current transaction between willing parties.",
        "label": "Liabilities, Fair Value Adjustment",
        "terseLabel": "Mark-to-market adjustment of CVR liability"
       }
      }
     },
     "localname": "LiabilitiesFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "verboseLabel": "Liabilities, fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Noncurrent liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Commercial license rights"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "totalLabel": "Total long-term portion of notes payable"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r42",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails",
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermNotesPayableCurrentAndNoncurrentTotalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes Payable, Current and Noncurrent [Abstract]",
        "terseLabel": "Notes Payable, Current and Noncurrent [Abstract]"
       }
      }
     },
     "localname": "LongtermNotesPayableCurrentAndNoncurrentTotalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNotesPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of civil complaints filed against entity"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CommitmentandContingenciesLegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual fund"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r98",
      "r101",
      "r105"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r6",
      "r61",
      "r63",
      "r68",
      "r71",
      "r105",
      "r118",
      "r130",
      "r134",
      "r135",
      "r136",
      "r137",
      "r140",
      "r141",
      "r149",
      "r181",
      "r186",
      "r189",
      "r192",
      "r195",
      "r227",
      "r283",
      "r284",
      "r285",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r296",
      "r297",
      "r495",
      "r508",
      "r596",
      "r620"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss):"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Standards Updates, Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental schedule of non-cash activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (loss), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      },
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "totalLabel": "Total operating costs and expenses"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "verboseLabel": "Operating costs and expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r181",
      "r186",
      "r189",
      "r192",
      "r195"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Income (loss) from operations",
        "totalLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/LeasesMaturityofOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "lgnd_LeaseLiabilityCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "lgnd_LeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r531"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "lgnd_LeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Operating lease right-of-use assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/LeasesOperatingandFinanceLeaseAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r38"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccruedLiabilitiesandOtherLongTermLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r50",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r55",
      "r56",
      "r58"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "verboseLabel": "Unrealized net loss on available-for-sale securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostAndExpenseOperating": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.ligand.com/role/SegmentInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.",
        "label": "Other Cost and Expense, Operating",
        "terseLabel": "Other corporate expenses"
       }
      }
     },
     "localname": "OtherCostAndExpenseOperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "verboseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentedTechnologyMember": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patented technology to exploit the technology for a period of time specified by law.",
        "label": "Patented Technology [Member]",
        "verboseLabel": "Complete technology"
       }
      }
     },
     "localname": "PatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityOperatingActivities": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability exceeding amount recognized at acquisition date. Includes, but is not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Operating Activities",
        "terseLabel": "Payment for contingent consideration liabilities"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForHedgeFinancingActivities": {
     "auth_ref": [
      "r94",
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Payments for Hedge, Financing Activities",
        "negatedTerseLabel": "Payments to convertible bond holders for warrant purchases"
       }
      }
     },
     "localname": "PaymentsForHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r85",
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedTerseLabel": "Cash paid for equity method investment"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Payments to Acquire Short-term Investments",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r408",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock authorized (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock outstanding (shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized; zero issued and outstanding at March\u00a031, 2022 and December\u00a031, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.",
        "label": "Proceeds from Debt, Net of Issuance Costs",
        "terseLabel": "Proceeds from debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromDebtNetOfIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromHedgeFinancingActivities": {
     "auth_ref": [
      "r91",
      "r102"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a financial contract that meets the hedge criteria as either cash flow hedge, fair value hedge or hedge of net investment in foreign operations.",
        "label": "Proceeds from Hedge, Financing Activities",
        "terseLabel": "Proceeds from convertible bond hedge settlement"
       }
      }
     },
     "localname": "ProceedsFromHedgeFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "auth_ref": [
      "r85",
      "r88"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-term Investments",
        "terseLabel": "Proceeds from maturity of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r91",
      "r94"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfShortTermInvestments": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.",
        "label": "Proceeds from Sale of Short-term Investments",
        "verboseLabel": "Proceeds from sale of short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r89",
      "r435"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Net proceeds from stock option exercises and ESPP"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r6",
      "r61",
      "r63",
      "r68",
      "r97",
      "r118",
      "r130",
      "r140",
      "r141",
      "r181",
      "r186",
      "r189",
      "r192",
      "r195",
      "r227",
      "r283",
      "r284",
      "r285",
      "r288",
      "r289",
      "r290",
      "r292",
      "r294",
      "r296",
      "r297",
      "r474",
      "r477",
      "r478",
      "r482",
      "r483",
      "r495",
      "r508",
      "r600"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r260",
      "r543",
      "r604",
      "r616"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r32",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Credit Losses"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "auth_ref": [
      "r185",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r185",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Revenue from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repurchase of 2023 Notes"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "terseLabel": "Repayments of notes"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r448",
      "r576",
      "r650"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingCostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "verboseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "verboseLabel": "SBC - Research and development expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesAccountingforShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock Awards",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r366",
      "r443",
      "r543",
      "r614",
      "r635",
      "r640"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r126",
      "r127",
      "r128",
      "r131",
      "r139",
      "r141",
      "r231",
      "r440",
      "r441",
      "r442",
      "r458",
      "r459",
      "r493",
      "r631",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r172",
      "r173",
      "r185",
      "r190",
      "r191",
      "r198",
      "r199",
      "r201",
      "r379",
      "r380",
      "r577"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "verboseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalties",
        "verboseLabel": "Royalties"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesRevenuebySourceDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "verboseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Carrying Values and Coupon Rates on Financing Arrangements"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Schedule of Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r254",
      "r257",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesCommercialLicenseRightsDetails",
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "verboseLabel": "Schedule of Goodwill and Other Identifiable Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r34",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r408",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r412",
      "r423",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Stock Option Plan Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "verboseLabel": "Schedule of Fair-Value Options Awarded to Employees and Directors"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r45",
      "r115",
      "r159",
      "r160",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r347",
      "r351",
      "r356",
      "r359",
      "r360",
      "r361",
      "r363",
      "r364",
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r168",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r201",
      "r264",
      "r265",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r168",
      "r170",
      "r171",
      "r181",
      "r184",
      "r189",
      "r193",
      "r194",
      "r195",
      "r196",
      "r198",
      "r200",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Performance period for awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount rate from fair value on purchase date that participants pay for shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date",
        "terseLabel": "Share purchase price as percent of market price (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested at end of period (shares)",
        "periodStartLabel": "Nonvested at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested at end of period (USD per share)",
        "periodStartLabel": "Nonvested at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSUs vested (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "RSUs vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate (as a percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Outstanding options that are exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Outstanding options that are exercisable, weighted average exercise price (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r414",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "verboseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (USD per share)",
        "periodStartLabel": "Balance at beginning of period (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r405",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Options exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r408",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "verboseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r427",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesFairValueValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance at end of period (shares)",
        "periodStartLabel": "Balance at beginning of period (shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r20",
      "r590",
      "r591",
      "r609"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r643",
      "r644",
      "r645",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "verboseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r5",
      "r168",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r195",
      "r201",
      "r252",
      "r262",
      "r264",
      "r265",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/SegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r46",
      "r66",
      "r67",
      "r68",
      "r126",
      "r127",
      "r128",
      "r131",
      "r139",
      "r141",
      "r158",
      "r231",
      "r358",
      "r366",
      "r440",
      "r441",
      "r442",
      "r458",
      "r459",
      "r493",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r631",
      "r632",
      "r633",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r128",
      "r158",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r358",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r358",
      "r366",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Options exercised (shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityStockOptionPlanandRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r366",
      "r407",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under employee stock compensation plans, net of shares withheld for payroll taxes"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Period in force of stock repurchase program"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized stock repurchase amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r23",
      "r24",
      "r358",
      "r366"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock repurchased during period"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r118",
      "r207",
      "r227",
      "r508",
      "r543"
     ],
     "calculation": {
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Stockholders' equity",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r343",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r366",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "verboseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "verboseLabel": "Supplemental disclosure of cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r380",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r380",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesGoodwillandOtherIdentifiableIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredOverTimeMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred over time.",
        "label": "Transferred over Time [Member]",
        "terseLabel": "Transferred over Time"
       }
      }
     },
     "localname": "TransferredOverTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/FairValueMeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r220",
      "r221",
      "r224",
      "r225",
      "r226",
      "r326",
      "r356",
      "r484",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r130",
      "r131",
      "r132",
      "r133",
      "r142",
      "r208",
      "r209",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r282",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r456",
      "r457",
      "r458",
      "r459",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r540",
      "r579",
      "r580",
      "r581",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r121",
      "r392",
      "r399",
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "US government securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r104"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "verboseLabel": "Unrealized loss on AFS investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesInvestmentCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r144",
      "r152"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in diluted per share calculations (in shares)",
        "totalLabel": "Shares used to compute diluted income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r143",
      "r152"
     ],
     "calculation": {
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in basic per share calculations (in shares)",
        "verboseLabel": "Weighted average shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.ligand.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesEarningsLossPerShareDetails",
      "http://www.ligand.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3581-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27405-111563"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466103&loc=SL6014347-161799"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130533-203044"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(13))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r651": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r652": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r653": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r654": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r655": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r656": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r657": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r658": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r659": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r660": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r661": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r662": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r663": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(c),9(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "8",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(ee)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>64
<FILENAME>0000886163-22-000049-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000886163-22-000049-xbrl.zip
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M+I:WKK1,Y^BOI=#)WNTO >*#\:_^;(>^J:5O9N&?0?[YKZ6U;J</>IPUAZ<
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ME;8L<N4"-MP%[NA<ZU^BH"MU&)DB-ZU]TPJ]-7/:!VO96D15C-I(YT000.S
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MIM8*CZ/Q1" ^#R'4"KXS =_I',O"D9,:L.0,8B%(JSBGRDDB"#!A/@\'(U6
MFB5[2*)5.*1#1CAAX/SK2!&PTG24+,=<N#FPAQ6@9LE"<:T\4@8;[@2+VFG+
MC G,RE1 )%6B6"P+M9,?F7)C5[AQ4^79S)LIC#"Q.L>]-\8S2XQ"G,"<"L81
M*QS1/!P@62%WVLB=3A( TL)+C:-G\(=BL+=!,$)=Q,AH- _9HH]T:OC\:,RL
M 7DJ)MA1J9RW%)ET[JL(6M)@ 6&2:..TGX>TA0K(,P;DZ41)7=2,2@&H!?I@
MC?8V[8LV(D:$G)^G/3U3!]1CG%8_ETB>BDEF+#H;G708_#F.M0';+)3WG@/:
M>*Q8<87D.;') 1&!&$=>><LD-A;8LDI;\0S%2"["H?)3#/T_*THQG94K#%BE
M-.J@ ;)!&IE*5&(1/?$:TP4XTKN"[P);7XEL0 RG$OF$Z<BU5@$%A(3$C$<\
M#WD#%:!FR1YBS;#V7$9*)0-P*>)9L (S:2UG9I[VU%> F@4+A0-38(^L,3PP
M%(CR$?EHA<)6F*#E'%BH693E5(R#%,XB0G7$PC+JF 72KQSV2'C'G5=S8!QF
M4993T4OF*.;81R6I9T)Y8[!U&"@OEI' WPNBEY<'73:ZG?N9]KG43(.==F!1
M9=ILA.$G[(#^R8"E0)2X>7%C9D^:4]%-9"C,D<IQCQAS H%32K'BP:<J!3K,
MP_'9)B_>F]8@O![61_MUT@,VB_#/('3<\+I4+V^^<FMO+VT>+, (3\IAO=*D
MLF[A'?4*]X^[1;\9BO9VYW,8[W9[A-=?_O@?&.-4E&VXDTJR?6-0MCNG@WZO
MO -/'NR/<\Z1H(RD:FLX.' <G$HE;*D-G'OP+QRI\/L\\4OF!+]2.:*Y-P(Y
MSB*S!HRP](%%8DGTPE3X?9[XI7."7XVU52)MQ@B<*:*4TP(%<-UX-%C$>3BW
M[+G@=U8@0Z,6V$7JN-2,&:VTI4H83%(1I"!F^'S/9P>9!:*<DRO8';@PA#JM
M$M=4. !Z-;? -I'R*@I5X?=YXO=Q*><$#VVS#DROE%8YQ+@D1J,84VUCIVV@
MGE3X?9[X?5S*.3G\JJBCXIHKHP+C#FNM T=1.HHQ8SY6^)T9_,X*9-)2(!%1
MFI2[@)DPC&LBC:=6!"((K[R4&9TS)XG?C7\&(-&OE>+FQ%TBWM!@P: I*YC5
M3!D7D*>2.*E"6CVKL#N;\V6%W1PAPAR/P5JKF*/4&DZE)TQ82X1%\W ^\$QC
M=\'@(H.@1'#!#0E,<VZCPM8'$A U+I4FJIC=;(9FYA:[DZ.8!HR;T!$I[0/S
MR,#O&I%@,>4R1#L/9_$N)G87EF).#KO:,$$1^-*(418C41*)B*+GEG"@G_-P
M"NQB8G=A*>8$HYG!4HPT, 0JF/96*T4( 6]?$J6H817%G%'.,"NDTW.FP3DQ
MP0?#/'.*:*JU\499$SEQ%8!F=.*>%0 9$3 /.CBK';-6&TDY5Q9)X2FGNK)
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M G9,*J<8<4YJ[J2C3+$*W17%G6-T1Z>15A$,N.&,&:$8UEH21U(Y1:4J=%>
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M_9U@CJX16A(NA(^4266T4R0J;VE$D2%?Y>A6]'<Z5GR"&XB-9FGGL"74,>R
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MMS90X^03M/4('ZYOG->;FSE</ZEOO:4'+776.-_^"%Y;Q(+(S(7H,^8PRTR
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M,E5 8E:9Q ^5MZ(4OZ3!-RF%"HQJ'2DH+PT9PSPF5P!^DCX"G]!,>;?T2KS
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M\#GTST)Q<BS9R9'I*'_=N^[X^,79*#UZ&%[25?%WU,Y.\X4Q(Z=>,6/!1<*
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M82W%T\1B3L AG<_TJ  C0H TQQPA:A76?&-3MC&N*[AV>:2U!LJVR0;8G9O
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MX,9/\SF;"',3J03)44SV'@F@+)+@DL+Q(69I(S8VI9H/JBLNFW4 Z!)4S Q
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MEG)*:2\0EXZ:])/=)4?E%M&<]L!)8]V)(BY'(/7(Y?V#N4IK6#G!N;=@"1;
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M"2LM)9X@00RI6B?>I0)\=?%)"?C"M/4Q;>6MN\:T.E*&(T= 8Y# +/=@E-%
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MM 6NG<]JTRQ36_OJW*3?>R'_LM7W6U>FJ+!6;:QU/B=1M&24"XX!62N ,6E
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M&_ 4WKD7[[R==V0PPCTS#+2F')C7 0SG%#B)"+$HN'-Q8[,X,58(PH_IPRC
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MUTWJHTJKWSEX]:HX1QZE"G*>E/UJ3D8[%W/B"R/=BY'F:_4HJQ SB8)8DAW
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ME3:!F3N-=KA99'-QH6\!&5H/^;RF:OFNGEZ+3GT3=*8"%@!4AUT'$Y97R:)
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M[MQI]5_7"/X4@3@IK5,*JWR\H0U2"QQD2,&HQ/ E!Y^*E03RN:HL[?C+GN9
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M:@TA/A=FW^BD/W(DZ<JD7W&6.XLYA#6Z73RP4T:7<32S_R;C:G%A+2S"114
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M2Y;*0X"!-]D#-:/V<US+XCDJOK/,XI=<G_-5E&=RKA0&)?;H>)2C^X\:$ZY
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MXDQ8^%#[\S-T9(<'T*-F;@DM5.J.%/.EDJ8NG+4WAX/A&,%$'%4O^U_BJ,C
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M#VCK,]L[L:>CC7^=ZQ(PB>G#LP&RW/,?3(&Z6C+$XH36LH:%IE$3)D0@''!
MAQ@Q)9P)"Q]J7P,(W!/#=I;<J'34-&%FN.;)1<,,U21$E@0%12GO.'R_//%9
M)G%=_^WP3[I@N]U5 LC?T<?NEPQ\H_VA#3E9_Q4(W###\P08XOS[143< 08_
M3I/>]*J_"C]]<MCW^6QOWW^,V.I(F4=8,XFXI@QIZ@T2G@G) N-F=0TRZIPV
M@F"%"=?>.6MIB%)YP$D"T[F<4#(=Z&H^'T6/SR:E(&6MJ*K_%"Q=S5Y<_WRX
MBP7\NX-5S"4[':+APA -NZ-",G/^"["\.L$1-/6HD*MZN#+MFXP UN.P-HB
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MABUTZEQ)CJLSLC)*N7+>9K5]F999>,NB>#RWQ^,NM".;%L?V=%94Y;^N087
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M@AM@NV[@D$*Q6<86ZI[4VG-?4FO_.'XJ/>(ZG9.6.SSLM--%@ZC?'GQN953
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MQJ4H#'%H#Q&@61&?G2%&RFB$2)EI6B?DIP_C'"RU)N.L["2 4P:8M9H'SE(
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MR7N#8.AUM]T93(KN58U1&=;B\6 [D=W&"6)A"L&,[WK=Z[3A-M?CD /0A..
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M4_Z"_DK=/VY"JU6)YL^.5AA\!C^MBZ$M(6A#M]Y>XRS=:[_0W39<UML W%T
MKIX#.*F+R@59$&:I)%SI@AB#)SM5!02]R"NE^9-G?$%%H=7A;</([K*!GR\$
ML13ZVAQEI//N";?G%S4XNGUJ'ARX?3<FMF8\6W)Z@:DQ.^-5W6#;7;#M>@[;
M@B^H5+# H?""<*DET4$98D$,N,\+YK4!;)/S,7-3^VGCTKN#2_K+_'DW%O!8
M7KWC)_ #KF5F?A1,MX4K"P?VEZ(%+QTWG%%KI3*!^M(&MFHI]8W_\$%#^<&\
M_]!6K@C&.N*T981794$D+0SAU%BK3.EHKKYA2XL5-]X:JPG-%IM8K>S!/9QO
MQCL^K?LP;CNUNZO%)Y[I0']XN(UA7CH[Z+3):"ME<2_=?![9Q&4Q-@K+^M:O
M?>.Q[KL8YMJZG@P\FBB*$]\9%H]T1^^<XM^!QW= M6)01(Q4Q6_BIQ-I21>7
M<,L8A],"^S=&D;:&4118E>"TTW$8A82)2C$JMNY[THH)='6[K]NG-<IL$U:!
M3MU6!^.LX@7IK]MW.R?^;C/L4]BM'[UR4RQGA;=N#V*X:RR#-)Y0_#K&>V%R
M6F;KKAU<]/J8J-!K0KJ&>6 Q=DKWQP^^P)%A4$NZFT]%A$9A9+-%:9K".UU_
MV>G&NZ&*&X<]8FC:**X)+T[1QI.I9^/R2)G5EW'S?1Y=_F=]"J\2"T5=>9R6
M7O9G0]Z:N.7>  LR]3)7]RQ&I\%S8[IEP+"!K6'!IJ;>TT1AIE&Z97KV%MP
M1!BS##MI=M)O*[W]"@N5PLGQZS.QX^.YFGZQ1R&Z"\J)X"MVNK!JS2K"1A\&
MFS?!4<\[(%GMZU$4>9*=IN#3:>3@,>BZZ\DXL&HDG\;WKS!U$N^TE%Z-Q/$$
M_S07O_<%,4XW9A(.$_M?#Q_[%IZZR>5?(:GF^N#J)*]RI@P71&#B%S=68U,%
M2EPH&2T#M8&S)\_Z5YWYV+Q4^"V6-9M&H%[VR^%%N]XQF6GB*R,D)C@!<<!T
MC.:#7^,6O_3=&(P-FF,L:U. JEO7L2+.!5R$>@WSD7W .\6TX] ?IA@GF6T
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M:\V+2DEOBP [QJNB O.F6#%H>XQE1[Y[\7!;%W[7H-/]SWM7^Z<GWDIC!9>
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MGJG5GR"$V&;X[DD(&T!> 9"OYPB6+4/N2F9($,BR-',$%DT34?'"L."+*F
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M>)]F>; ?P(:!K1V/WLPYGE0!:\J!=SDJ$8]D3DS%)*F"#[DHN;8*([N++;;
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M'^!'L#QMM*QZPS=)4#F^@_/#<,&17$Q_=4C()I?KK!DP^@0&W2[<%I"V9\]
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MO U"8H!V_O4U4!]PW-.:H?_Q!6; 'BXVD1</ 0)W!_X GGQTY5L?_7Y4P1L
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MK(;"[O#Y49; K26T*BRCGXKW*.0.B3G#_M*(WCMWYJD/O+>A_AZ+:Q%F\L8
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MFI=VW*D/C\*^7+=80#YL&1? ?CR6&&:^7P0DTZ83C_R4D=,TT,\PD8@:(WM
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M)K]'DD8Q?!# :*HES&#!8@(D!MH&ZA0!6T^O9#203 BD/YVV6)&AF VHX$Y
MC#I7MU1@PI0T";:*HPD;6DW: *"5^^CNC$*AQ9J4;UA5#Y5"-QP!86:B6JWK
MSHPU^B2K/XG 0 60!BI 60S*.ZMV3 5$P2-:%01,"->.BBZ>486J9)QFQ?#U
M*7 LN2+M2NX6A6VNT^"*2R)WE1]L@'7?VSWVZYSC-:$>L;TJ0KF?XPCC;<>I
MH 'J?01<(^:/ V<(CS"RBO$[C]1HP@$0([ A 68F$,T\0.S%WM;CDO$Q$D!&
M*%0P-.8Y >+]/!L%-(%"J2&A' W0:G,;;/HB\5PN#>% P0=!8NE,^3M,1F@'
MS>1(&A1GG\_.6?#!ZB,,M9(ZP?MA5&;+1NB0_5GJ0!RX,"X%!S,_1#'H4\:7
M&%0P/=@,U#E#OP)K!D!T&)(H[9'4&VUS');+T4<[@@R,E"QO#-:$$PXAA<E8
MQ@ K]JI2.C!"@T&/P)_Y,F4"WQ!PT'21U]80[X,5+D(D5.-GGS[FS$F]@O4N
M0M<RC?-XD6 Y(_PL/6+JEPL7A$QH&N_?GYO&%R>#:]&>2N@'.OFW<Q$$3ODW
M7 +W)4]QHH4.+H4>[9*A@5-<B> ![#2404Y*:T" F@QCX(K2*U1:\(WZL[X<
M?%M&&4JV!0H_I70CPT='(/Y.656T5\LH@9N3(#B11ACZITP%_:MLI#(IT$]
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M. 5B<PQ +M QE3]D[,=)6G*'2+,OFC>H$DI5^>0>%7@1YP:5=C/.8JZ*R-*
M;)K53>5).2F;7;#,&%F"%I:2Y0D4]N*OM*2O-;V)%+?6']*]/%R:QM6,E*^'
M:1S^-77^XT]:.H2PVA!5<R:P@JY &_\;EO' SD  ?.#S O\)'?90+>4$8NJ(
M+-M2'UNY^SGLMLC^7('$D=+4V3P5UQ%:P;GXU9"6TWK4U?#-H%";@Q'Z$NSV
MF"I;%\"OT'LY6P!T?,\(1/95S.#FRC?/-VZ/Y)7+*D*B6TR>0 $ _#K!TED7
MZX!(\B"&IK+^B]_ I<X^__:IT^YQ1@@F:F!XA#Q1(%-!I+CX$J5LI-)Q/,*
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MVIWFH10ZUN6Z=;EN91Y[O]>IZ\YK1#YT1*:Z\^:]D]+J](#:P-U "01]#S1
M<L$=985&Q^QWNW6%QH'"=.WPU/8=M6KUS=Y/YO3-[N ):E_VC]'7KH4=N!8H
MG4S.Y(G"VJUPY'KLNN**KMD>= ]%CZVML=H:J](Y!J;=O+WG38W)-28? ":?
MM-MF9[A])X[:KU#[%39 K[?C,8]<(=<"SG?9I M1@5NW# T^'#NJU;;ND!4;
M'_@>U/0$!]YD;NLV?76.#!].6G;'6L]R:V2X58_9Z'HV6&C_V/[35K =TI!?
M2AO]75#B<98*JE4I4A9P8..UGV 2\6AA./-YL%!E 2))_1D-''/",',"0ZP(
M*$QBEFLM>2SD++*\D(;?I>H-G%&)Y2BQ2/7D"1YF5DR2E%4O7!W%-3(5&]BN
MU(9V1?/NL,H&9<V/]"?)97Y<'HV('[UV8I\**^B$^*U?K2O+& N/9JXEJ9-F
M:10OBCW!&5OVC]MN3=5_%9GL\@9P70_K>?AB\UE[$7X!@!S"KUA4Z.G#9+5[
MA8OV_!0SYV]$$,B9M7A0@;N@\WL"SAO-*5&\>"51<S)I=MS< 39),T&C\3@1
M*>++E> )?G:O=3([-0)_YLNJ'*\H+]$A^&B7:<A[9,B6BZ'\V=QQ4ZXHR!%/
M"]\DJGK3B45C1+4'2"PB3/@L<%4X-A6.0\\5%0I4@6G(JBSQ3<2NGP@UAG1A
MRM^=&R?V#"S9XPI-#\DL!BS/J\JHOH^>!> 7)3S:Y>THO?UVEN5[?_W!;W4<
MQ^UTFL/.L-?Q.O:@(YR!UW3[_=%HW.RW_]UO_["RXN.QL^HL>..]_T?F XHN
MZ#[/G3DFT!N7(H&K=+4JKUOOJ],],"Y^1ORSLC8+40C+&DVNA!1P/==.@*41
M//AV36ERBHV!L):KU>Q8S6*..]-],6T<:W'L=G]I3F1!Q4")N+7 25)C 7Q%
M5>&,@1BB&!B; ++S1SS7$U_8K^J2<[RS=T%THRH)G[)*$-@2[(1G)[,P6!B,
MUW3%"O--V<\IG3I<@#J- A2WA"/;HX)I3)V$1YC3:V/80[(LU7E3SL@/D/0
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MZNWY7_YKT++[K^$+!&9J 0%GE,TL:.MDC^E'QQ&W+AAU62#[5U%'GUD64DL
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M;&064EB"[2H;2= 1%R7X 7M%5V@1VYH',FJ&S^7> #G-1.N^'HT"^)PT*EV
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M&FA_MODF]N'DF]3)$+MSM%.BRVP>1 LA$N585%-8M5&F<IH@4 ]HU-)FC:-
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M<P''J1'<UA=$RV];40T>63/0RN3-6@/8]_/4&L"!'8V8>:T!U!K 1@*PK32
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M8OPUFDU\G/W9S3X?G$YG:+$GM_C*0=@4E"$@D*52)87N(-5$\2#!L)0L;W-
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M^W(WFV<O>H_C#DP3.C\EBI(1SS4K79@U2USA(+0I 7&)H4\IHXUXLF+.;**
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M@W=2VUB:!#N*7U!2BT")XTD;)44&6+-;S,,OZU-[W78$J#;<E4GPY<NP@UN
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M__WM9/335YS.AI/QWW[F?V$__X3C-,G#\:>__?S'Q]_ _?R__^U__:]__7\
M_O/7]Z]_>C%)IR<XGO_T?(IACOFG/X?SSS_](^/LOW\JT\G)3_^83/][^#4
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MJ[0;Z?]M^?MDDNMB/^#TZS#A[,-DE)^=3*;SX3\7ONV I:*9HCV3NZ1 !1[
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M.R04[7G>L](F)_4N9/OOHHO/6V8J7^\AO<QD)O$_F\V0_LL?P[=!$$F2U^J
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M]>O9[^&_)M/GHS!;SJT2ROLHZX*L%[6,H]1+S@"V)&-8<*Z$-@E7.X \_I3
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M[.A+&PVBE.NV:*=A]'[XZ?-Y4KL6PMJ@)3A,<=DS-B#30-"*U#IY&=J$(K<
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M#(CT=J;"59121]]F[]H1Z).A6$L%-=C8]K0\GYU4/VV0A*%7PM;VWHZ!<L5
M1)M *DYGN!0RA ?I^BSA/\W#]/":;5#@?I%PO>=REG=Z!>G-5H)>;"OIQ:YY
ME9[>9\A)\(0Z)UG:W%?TNXY#E:,^"+?TB!1X*!?Y>R[\U[.;/V!Q-T5+SG2V
M%=""WG)5QV^XI#C4U)1B4972: 9/PT4=OSSD\%3M=_?OC3(-3.";D5W.MNV
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MF2BE="QBW0?%#_X=0YT-PD;K.MQ%;[O94H?5!>/,*\S(P&IM:K/N D&P2#9
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M08CEJ8MEBQ3!'E"K#+A8]W$18+_T00^*W&42NH'6DEPZRZ_2[&$WI1I =.M
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M^B^6:3ZUT^(#(3,1%OH13E,*)T]_I#+Z*ZU)ZZ4TJZQ#;UYR8WR7C=/!N<%
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M\@N,.;NF8"L"TQ,)/:WC,D3T@\#&1ZE.G_J.I@IT613/W4!?!]ZKQ,O]*F@
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M#<1_]WL]@ X56X@+53UZHL%\7ZPWJO6+QD<7!=WR#C55-Q?';AW*<T9?@7S
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MV]_VO"S#0 D(.<MKD)*0CMI39P/7:V/I9NU![49"*4^0FDN.2D2^=B\%':U
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M:,)/_- @+X>/XCSA,?OK;7'ZNLO1$<3- =EI^XAZ@N#UN6FM@50%"SMH>RU
MT#DB^:+I&9,OK2%,,<Z9[V@ U&;3J7#A8)9XS_O;/D4O:S[6/'A969&E+'79
ML"[6\'+])58FL2IL*PZ4RR/SQ:)^!#FB#H*&XS^7ZD0>X;3])=TN%4_)Z%ZX
M<)&GR[RZY91ISW5$W.^;\_^[;=#_#S.)7WO&HTQH0+L>$DH#1HUHP$4;J\U
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MO?L78L@\8XVS<_50%@^K2DNEI:7S7W'VT=RMV>1B5;*?R[IBX:W?7B_M9BL
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MMLC'EU-6^$S.+5GK[&4 D $5&SCG+=#LKNXR]8[I*N[E DAE)%6>(+9U@_.
M*6R$@;@IM['5V#',,P%O-K-U99H$![O9):[6#3V\<PU-LCUD#IXL(Q[2.'GY
M]X8Y<?("3SM#3(13P_U0BA;6[_S2:I<DAJO/BIV]GI2A( 2ANRMA4WN*6/DD
M:!+-]MA;9-$($(:8*S.T.P=[RG2M^+M>2Y^\7AJ@NA&O+:JQ$]_\0*L).SPV
MOM9@9J?8VB1]D.\&J8\@#W5[ ;T@*#  S>$BFJ/RKBV^ 5>]39GI<661#'XO
MG"1'+YB*C$-VHG!6U8YIR:T3B<'3R5<8HXRLM@V5[*6F;ECV<+MW/Y7#R;=
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M1MBFU^<Z\0='YV=;G23>+IC3F7CFDY][0JNSSY7&Y[\!IY#]@)R\M&A[0&)
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MV7^,Q9\;BUS;QH"UV$O4VP4Q=*S03F!Y+G"WHS@7-(=NTJY=LSQ[0)Q:J<,
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MABD)R=N_8G),2R$ B!UC*QPXYRT"@C@VZ;9_S$UV7KZ#[J[J:67QV1!K&%9
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MX- 5R3=+#\F;EX=JX%YGVF==TDK*=[ZLDAFI,U+Q5OCFZ2U;YM&1>=I-GI\
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MXXV=%]XFU*-WPCQ"IX^BG-?.P%"2O84RGVQHW@>7%DG$DHPCIB?E<:P]>)I
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M0))B8;*\A"HD7"*:N?@M%FW.S85I(>NO2!7E/;5/?N#"LYT8>69O9"7JB-O
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M2$$(Y QSB%"&(9%<09XF.,(T9DELE672I=&Y25:##N0KH R^.HZOCB(I-W:
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M?U"#.ZGAV8Q>"=R\$OTY@UYHUW*"5[R5^&_ZR,'UILY;J2UN&:Z ;7 WY '
ML2*K.^3>]I&KS:&WWI&SN&7QA^!(=R4W(6EWTV&&S>!]Q94AQKMU,-/EX.[
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M5'(<82EA+D@.49Q@6&:R@%BFA,4R%G%NE=QA.?_4'/ 7?!1]'?X7Z)HS:3U
MJXCES:+M,ID=O0*"_S)>MEMP=RAOX(2>YZH'=C*,7 S!":#3&@ENP[@WPW@_
MKQA9_(<@Z_?J?ZH9SE"2)ED=FXH@RN,4$B:16@R,XR23C!"C(BH#<TR-V';=
M'AHY@184U)+:=\,XAG.8G#R!%-K+8X^/4SN,"PC<W [C>-S1VV%<4.Q<.XQ+
M'W6,GM(-/U_K?I]O5C]U68/F6).619916L"8( 81CW)8XB2#,B]2GO)89(55
M];/STTSM->]W/V4].2WCGLY#:F:$W Y4X%?]:H?83^I;3ZH?7?EHCY%,@]#X
M#5DZ/]6XL4F#ZIX$(0U_VG/M^5G!4B2S2$ 291PB$9?JS,,*6&01XEQD N'$
MJ4[ \4Q6%#%"M8 '/4<OPNBTVKRG8O.W%IF?$&4,%9<?H:)\V&"BD]FF44'^
M:@C1Q0<<[[7/.V^Z[DAE621%'JM]0Q?!2*-,$4>*8"D3)"0N(A$;]<\SFFUJ
M5D7/)?K4ND19(Z_E-?0@Q(;7R[Z "WY_<.!&AGLW<H!BK$:@^+W?'9QQW'M;
M$^5/[F.-'G(LQ:R,1\5+^B_MS?A%%MH]?+]Y0];K9T5<=4KN3"9%C"16X+(R
MA2@N,20D+=4_12(1$DP45IY7HUFGQBQ:VGHWK0UNL9?;LGZS$>)F!.,=Q\!$
MLX.P_J$G\AT@&]!)W505\%C^V08EOR6AC68>MTRT#1@GI:.M'G9CI(^KY:-N
M%J"C3A[4$&W7:D)$(1-UZ$EI%$%$L(!EAB@LXR+A6.8TR:V*,IZ?9FJ<HZ5L
M6B=H.>^ EM2R%_@57,V(YG:T C.+&U#65#*,@U?NN##5J&0QK.XQ.USYM*]+
MXK="BO5:\*:NV /YK8[O0F1Q7.081H)F$$5)#BE31YZ,H3PF,H\C2>Q"=(WF
M=8C8"GUWT@K9U9/>:#%OO>\]A[CK+:\KBB^<0=&BVM8/?!A$U<-M[@!*@>]P
MS\W\PC>W V!<OZ\=>M@A-+5UPE</J^_+O^9+_@^BO?&;:A8KSI%,D4^6IARB
M$N40QY) FN(2TS(I<82-RPA>FF5JYDDGIXY%V]:2@K]:42VB!B]B.LPQWI *
MS"E]D!HAP3\\@F01(>D#K)$"'5U LXM2O ;&8+#AQ8?'BQF\)O]!Z-_5#SM0
M89L(^T57S%XM/\M=ANS[U?ILV;=9R6,J$R)AFB=,66DL@1@S 4F9H#**RQS1
MQ*SGAYL -M_S<7I_=$GT;%]2T3I_WG$Q#,@U*,"A74VVLGNB%6?,!OG&?M3Q
MB,A9XP.&<A_%^5S9V8/:JSXCJ$R+HDQ@P60"48PE+$D:P3S.<)*)@B2(6P87
M]\>?FN56"U;?D%D?#@]@,SX&NH(1_L"W.]#5EU]>3W7GE/9]?CN88^R3VCD%
MSYS)SG[,\<)J0:KJLVP-F,_KF@RZ:K/[+,4W9+$0_/5S9^BT']3QM#2A-"E@
M@7D,$9:1[C2:0I03EC"2,<JY7=^Q&R6:GE'22=B5=9\OP=.6+N8,K*0Z3.L;
MFE>5CH ::*$09.T,+\7&6X_0-HS61&=OM3*J%Z6IM=TOV[W7"#0J ?J\.ROM
MGO#HK?*$K]^+MAME&O<*S@^ )Y=SGH:]R2MVSE3[MR9;8E:FK,BSG$#U9ZFH
MEQ6PU+&,9<00+Q#53:!MD["-9G9PTX^16-WW<>B&&6U627U!OJH[&O:.A4_M
MAYU<1D.K8N5DNQ7D\3UN%YH5M$)[1]/)&^<)U1=PS3FBZ^JI,P#*T&TW--)+
M^/ ,-+O@T#-Y,D0GWUF$2I;SDL(XEQE$12I@F6<Q+'D>TRPC618QGQU\IV<H
MG^_<>P>6PK#,FB'29G:O/_0"T[-!M]ZQ6O0&,4:O3#FAEKR73$G#IQPLQ<-:
MFK,TD3EGBCXRA'*(*">*0Q*LCN1%FK,2XSRC)IDM9\:V\KB-ELOB6"/W''8&
MAIL[(H$IX+CFK3L*%@:7.QHC65;&J-C93^?U'C24CAX9SR(Z+^N!Z7/A(VXV
M3F='O5^MOZQ73 A>Z;Y4-0%^6/X2E6:_>[:9_ZK?UEE4E*@4)8(R23A$)).0
MZ,8K42+R7'*91S&R.,,ZBC'1 VTMKIWE8XN_F2D4 LZ1CZZZU-JK3OBZ^=[?
M0&,X[10 >PW\V4N.T'DUH&QE&-6B<@3HV,1R'>8VFGM8W;-_;N=K<;%[U2PB
M-&.$YI"4ND"B.LE!G&($LY+$A!5$WX?>P'#7)9@HN7WIVB&MI.XH5<O>I")W
M@KLQG\&2V)&>)X3'=]6U8A^W'KP[;)/GG^K, 0O"<@;3OPC!F<-RB=LL1G"\
M#-[YOM1/U9RW;>]?/^OT@_O?<VVOY21AK(2<$MW:DQ&(BY)!SA!.HTC76K'+
M7+PVX]0"/7H>V@.)]2UADR2CI;;,);J.N^%5K4\T0U_&W@BD_3VK*3A^;U*O
MSCKN7:DI"">WH<8/VE%/M=[,_B"_YS^W/]M: %B6/,LDA@6B.CE:EI DI82)
M+%!1DH1+'IE0S,G(4Z.25C@SJCC%:9@2;M(^\*O?RN6Q&,)%;8?>9?50[SU6
M_SI^AT]''>5=O:A,]TY>_H!CBO#>?:K>/A&5*.)0(+7+HU0FL.1)"?,BQ5F<
M\3Q%TJ8V4F_LB7J07?NK]5$SVYX=L0CM.S8 P#ZQ]U15O]F\O?''3>$]5>PD
M;_?,1QSK&XI';=5_%4\ZC'OY^%7\$LNM^"JTL&J*Y:-NR_AQUX:41HRA*$:0
M%7KKI F#)17*1&=4V^L)C:G1UNDX_]0VV%9\L)/_#K0:@)X*==/26SK%6BZ2
M&5<$A#XPGWA'W;[6HAMV?HLP6LHP;G5&-X!.RC8Z#N-PS_U_GI^4@O.JM7VS
MHD187Q9QC@E$>9% 6A98A\YP*G*!>6E$=&?&GAJ)==)97.D>@35,.#="$)A,
M.L&NGQ6NPF!QL^T.QT@WVU>_%'8WVN?U';S1/GIDO!OM\[(>W&A?^(CC54_O
M-ND/LFFCOK^L11=!7!=P6BRJS_+;#\6#NF)+<^%4_W:&LI31,HU@DN=2':A0
M#,M88,AS[4G-8JS^MK');I1G:O1V<"4+?C8*/>M+H4I+W]0@FN_EM[P4NG'Q
M#&^*QEN2T-='!ZNQU^4.]+1I*\XI?>I\F?TR?3!8)OM;)3_@^KUJNE&F<>^?
M_ !X<BGE:5C'DS'[(?AV(3[+>\;66\%[A^X'W6OQ0?S>O%8P_-=,,IS10AF'
M64:Q+M]+(27*8(PEC5#*291&PBZNVGQRFU=[G!CK3G;]ZK;2 Q,/T*VK8'CJ
M#8)LZ /O,*3@SUIRH$4'M>P^C[K6@/D]Y9I//^X!UQJ6D[.M_0B.M<=UHZ/=
M/6_*RU314@DIETB1%5$_E:DZV&9"TCR1BJ]2JUKC_=&G9OO5PKG?FA\B9T8P
MSG@$YA!S*.P+A)]3V6]!\(,9QBT ?DZYDX+?9S_DL^50KX=,]?IY_YDV<J<6
MX/-3W>3Q[W66\(?E%[&>K_@_A,XO$_Q>[?[D4;S[+=9L7HDOZSD3,XX(23 B
M4&:Y@"A3C$#+.(%2QIEBB31*A*WE,I[TTS-]:MG5WOSJ^[>WX$FL05UTP;+F
MPICK;V@S37--0QM=O4Y.?;W[[9PJ'4MTMN63UOX.M/K?@;^W]3F6H,'@#G0H
M@!8&T.$ :B!"]X4*NGHC-)L*(_\$.E@%71BSMEAA17#;%3^)C2YB_V6]^C7G
MNAK&]TJ7B'T_7Y(E.PB\OZ?59DW89B9X&L4%89 ((72Z<PQ)FN00YP5*41(G
M,<_L-C=[(::W1]6-'.1B]5?K@I.=\(#LI/_?=CN6P]J8;3QA\0Z\?RCAFZX9
MG?AZKWBE-5#;P-_ 3HE>4I"RS%L]/%KG[B!ZI7$',49E8W>8CDGUAI$<H^M$
M50FQ:UUVF&[9>DZ?C[QE*:<H80F'.-*71K+0S<=( 7.,TPQGN<2TL.K.82_#
MU)P%?2_;'[UKHGU_OEHK=V>FRSJ9$65@] ,S92/]W3'0O;SJN_V"A/1UW@"C
MW]A#!SG&C5%T!^HDEO&&H>P3 71JP6HQY[6=6\<,U:X]C).""(YADG$"491R
M6'*10YJR@J-"9&ELE'1T>8JID=V!E$U\G)6+= #,8<KR U%@1G) QRJ38!B
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M2EA&96Z5R7AYJJD9!SM)?;## ,)F!.$'M\ <L8?L@":\L\1U,#Q'F5^<;N0
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M75?[>G"9KRR[U?)1EQC[M-J(SJG[9KO6*WZ_Y)^4/LT_ZL#KW2O 4)2565S
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MM50_LJ8H;%WFB2=QF7)$H."RT!4$E?69Z3@9$9<L05$LI5&"G-/L4^.CGO!
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M(.$D5CM_EG"&K<)P+\TTM1U?U]7379C4EK^H919@K9LTV;:NN(BLV3ON!:_
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M]UJUB1\;\AO01D8[>KH$J1D5W0+3J(DQ2D30R@A>M5)Z;$)^!8< F3&G<[U
M9LQ%A<]GQES^N!L=M.Z(ZJM@8EY?4G\2FS?;]5I98C-2$DD%B6#,N#[@$YT1
M$R.8IRSG,>=Y$DL;(V=HLJE9-9VL8+T3UJ(JG!&\9OS@"[3 )+'#ZVL/+R+5
M4H'[Q6+U%U'O1%UM^<U:\/D&Z**&=Z#5PQ^+F*#EE4H&)QR53TQ4/R85HV?L
MTUKNU4&.Z\/<^P5YG$4)YTD6,T@3%NM,<@E+DA6P2(1$C)1QE!G5\#D9>7*<
MT0D'M'3F"2R'< W3PDT@A.8 ,_VM4E7.ZNJ<HW(XVFC)*6>5Z&>EG/^ 0_48
M]4*OM_H0\4L-MEH_?U%K^T/W_I@E9:P,>O4"4E+H2EIE JF,),R*HD 1Q0G%
M1EEEP]-,[I5L!*T#,6I)P5,GJD65E<NH#K^L_K *OWO7,.V$!%^\PF11F,8+
M7",5J7&!S:YPS54T!HO87'YZO((V5S4X*&YS_=,W-JIMVGMJ?_1JJ3W0M=,P
MD;S,>2F479(0?=!)85DJEHP+]15@B<@2:E7K9G"VJ5%DVZQV+Z23CW888,,K
M0E^P!69+:\3<N_P.(1&FN^_9&5^FJ^^0\A>[^0X^Y)JA_T!^?^!JM#J(0^\I
MG[9->=*"9%&)"BABQ1DHEPC23'"(62YR1C-%)\(N5?_"3),CC28[7?L$#\4%
MC;RVV?N7 +Y^&/(&6VC2<$7,(;/_"AHWIOA?&GWD7/\K2IXF_5][P.&X]7I;
MS9>BJA3=T/FR'O3]6OQS*Y;L^;-\0ZH?[:UVTR93AWVI?]2Y0TWM_W]KFHXK
M(DE2R5@.8ZE3_8M,IW,6.<P0RK*T$%&9&H7#>I5J:J2S4T+'7S*E!GAJ]:B[
MT_[[5]#V<+<XLWA;08.3X$NL2V!6ZU0"/9WNP,%":;VZ:*:NC7"K6ENDH5$.
M_-O++9[%^?0E%G&DX^R8BVEW#/8-^N"IV=MDXQVR?>-S<";W/OB-M13>SBNV
M6.ELVVI7A))PS#A*$MW #D&4XASBG"50<%[$E!,D2ZOLUJ'))K<M[LO=]*0U
M*5]IC[/90=X7>H$W+W?@W"L!#" 2)J/_W(0ODYD_H/K%#/NA9QPC'A1!\?EB
MNYG_$OL*N>]^L\66"ZZ38[7O8+MI.]Z_(VO=+;KZ(MH.G\_G!ZC=7&6&11(C
M!$4N&40T09#B2,)4%IBS),Y$8974%E#6J9%87]*#2M(.OLB02VQ&@!-9N-"W
M1FYK9A_4$1Y-OS$A >4=-Z0D// G$2DC3&GO!7[;'L#>J^V(+)I,A/?J_ZH9
M05F62Q1!SG)%^8P@2'B6P2*2@L<"DY@9%3@8G&5J9-T)"AI)VR0D4,MJ[OF]
M#.IUKZ\7J +3HQ-*5M[>JR@X>WHOCSR:E_>J<GT/[_4/.UJ+=0Q^%[$9\Z04
M5!*8)EAW0TVX.F7&#(J""D%0(B3/9YO5ABP,[;O^Z%8O^6Z.<%_?!ST'8(UP
M@-2B6MIA!^ 96DZND(2V=6JY0D2LGE/8KSER,,.X!L0YY4ZV_+,?<GM?/PHU
MF/C\)-9$^Z$^"E+MJK0]=VZJMUNABVBFB*4<QG%<0H2X@%BF$:0<H31.>!I'
MV.95-IUXFF_Y0HN[NTVQ>\N-(3<C@!! !N:&1F2=H]T*#6JI]V4JG^^TJYP*
M\(7,/=9#LX7**ZL83SXJX=A"<LQ%UL^[T=3;>44>']<ZO:T^QGP5O\1R*^I2
MI+.BR"-.: 0QSA0U16D,J53VALAH&F>I*,LRLO$B#4TVN9/%@:Q-M=Y:VK9.
MJZ4G:!!G,S[RA5[HPX8S<-:T8X*(5ZH9G'!4>C%1_9A2C)X)5/+G4GV%)DBN
M5^3Z\^:'6#_\(,O#R@LZ$K<Y3,VH3!"6N3:8<*0C5 I(9)'"5):RC!!."HGL
M$H1'E-[H11TUZ;A7[*<N\E/YKO+C<>G-B')JRSF=VCY72ONTX<0] $"- -@H
M"$X*_]3)+*TO:<2J/OX7;]R"/A[EGU8M'_\+8UW&)X (KL4MVK213V(SXRQ!
M+.,,9EG*U D_JBO3"1BS.)(\CW&<X-DOL:8K4T.Z/[P-!?4G"<=$.^ELJU?T
M,$LE+5"I*QH)ED,DLPB6(L4PS1)<%IAF$;=*A'%%;(RCA@^\S'9&5Q0";UT[
ML>[ IX'"!@Z5/$[5]5R^HS?!R#4[3E4[+=1QYC,NJ;RU6_1^R7M=)FI_1%4?
M'?;U=W'$!<D9A4FLB4[F!:0YB2'FDB%EMF,IF'EFK^&L4WN;^PU^]GXX79>W
M:>HC&I]<5RM+_Z*GH4V2J^FR#'-#,+!'N0<YQJ\!M[)IIG,#LC;9Q $0'BNY
M> AI7^G%EO ,9QN;#C9B\K&E?H>YR+8/.SIQ6N;Z+.NN'*^?ZU)OC8LR3C)E
M=N4$\D(G)F<(0U)$%$9%DN8%BO.\3*T2DR_/-65";SK+J%-T6]G0Q14\!+.A
M@\,/>*$=$NZXV7L-KB/B]Y0_,-^XI_+KBI^<H@T><2.0!W40KZ18Z^YCZJCY
M,/\I_A!U]FS"8Y$G D,N=3QR5":*/E@*)28E$CE+.;*BCXLS38T\>H*"E9(4
M:%'M^.(RJF9LX06KP%QQ%B;P9R.G1YZXBH57EK@\VZ@<<57I8X:X_H!K[1/%
M-U]%5_B(O]WJ[H2-PZU.LIC%91&AJ.!02)1!Q'(.:<Q**",:$R2D5/]M5__D
MRHQ3XXMFHUSO)0:\%EDW81CRLSOB;6AO^$0QM-51 ]@3%C32[OH3U +[+)!B
MB(WG(BG79AVY4(HA"*?%4DP?=(R:Y?^Y;7N,/:SN.9_KDS)9Z.BG#\LWY&F^
M(8M_$'V!L/E055O!9QCEF#)%.4+3$.(%A31**<Q(*0N<JM-.QNV<]=8R3,^C
MWU-!QX^1G1+@26D!YTO(&CV:_IM_-=K8!NE:KY49>P7%/[23ZQ#XO?1U )^^
M?VT5N .M"J#1P6-8L"M\?D.'K:48-[S8%:23$&3G@7P&[C2WHO=+-2?3=6I^
MB2_J:UG5C<*>9XR+0B9IK(PTD4)$<@IQB7*810)E)"8%9:4=13I(,3V2; (K
M7I\$8/@(IQE>$$,K+BS(H>VZ<V$KO<B6/QN)C3S^GH)2C* ;(;AD6(X)!(D8
M 646[&$VU(UU/<[YV_\01"?_\\_+KSJ74YNIZ@.?5LMU]\^ZX^+'^5)\V(B?
MU2P25& 9,1BS#$.$HQS2#!'(L[PHXR2+8VK7F,FG=%,[]NX+8-Q=N!@%G8I@
MM00[)>M/]=4$35O4/[6FH%;5M>B(ER^!&3._V-(&YNP7657WBB@^T0]30L6+
MA"]3<\4GN!>+M'B=Y,;ZSI]E$^\Q5];[JJKM>,OB129#3>AMWXFK+_QV H-.
MXB#5C&P@"E.E>&CBERE6; #%Q9K%)L\Z1)#]H89?JS&_D86HU"EV,Z]6BS>K
M=7>112)68AY1B'+$=$H'A91E!<QSFJ.LR 0MC*X'32:;FNG320@@T$):A"E=
M0W6897QC%9A=.DE!+>H=Z(2]JU&[?E5H#Y]%<)='&$>*Z1J&TU-0ER$L@[%<
MU\88+X3+4)N#R"W39\+6&+C7W<_^0Y#U>W5>GB&9DXAG!#)!"H@25M^Q$AAQ
MDN:%2%%A1K8W23$U%G[X(=:B[A(7IN; X1*8V7_!@0U,V7;5"+HF?5H1H#49
MOSS!62!?I%;!H223+%QP%BS7*@;G![-CQ6J]F7U9K_B6;3ZOOXGUKSD335,=
M7N818Q)F6$2Z6%(*R[20,,KC)(V30N+<*)?HT@13X[)6QMJ+THII5;WR(I##
MM.4#GL",Y(",,=E<4W^(1]2S/0Y1_SKFCXN#CT(-UU3KWOJKGW,S<[XHY.I@
MM#I:Y M9J\'U@;6)$.D*+LXRAI@H)84EBTKUFA<%Q#R3,.52R#)FM,16U4K,
MIIW>R]]*#2HM]AUX4MOIK[JT]*OOW][J.#)0Y_E;IOD;+H*99>,?VN#$T:'Z
MK4%5R:R^PZ"1NBW=K>1NLNO]62YV0'DU50RG'M4VL8/CV!BQ?-J-K(ZZ?KU=
M_23SY8P(S'&4,YCD.(<H0@4DB&80TR@J8HEI%AME1@[.,C4J.NY.!_YLY+2\
MD3N/J!G1W(Q38%ZQA\B:0@8A\,H8YV<:E2 &E3WF@^$/^W)SM][$2.1E+LH2
M<H$SB'1S+1QQ G&9$)9B',>$W^;BGK9[^U;'[(T^[?\Q_FQOGFQ/7NS_<1[L
MD+[K6_W6T_!9V_JK_>7^-"&K_2#_VN2JSL=Z*:LIPGDJ$Q@GI8 (*?;$2$BU
M]4B41449\:RTS@:RDV%J=*JEKXM(Z,:#JY\_5\OFG >V2[460/Q\6JR>A6C_
MD_7K@#WI0+D[L!3U!7U3ZPW\-=_\^"$6'$AUFGDBSTJ1!=B0W^I7CN7@'-;9
MS)8+O'J!^;X1LXW.OVO.B=7=^6IL^[#6SBG>UJ?:^CQ;WH"G_UPF2SG&SVYR
M ^ILOI/C4(X%?@7=]+J/_"+SA<[T5E\HS?'?EVM!%O/_%OSORO;]N*JJ69FG
M.$L*"DE19#H6 T,JR@06F"#$8U%0LSXBK@),C7'W$M;4N5 BZF!%TBD"%7/"
M2JD"JIV6.Y;EG=M(4:IEP6#;=3,CT9"K$9A!M>B]YDYWX/YD">Y ;[6T"N"5
M5N+R%F9?<M@1/[]EB&V%&+<TL2-$)^6*7<<)&TSQ2?S>//PE%K_$'ZOEYD<U
M$UDJ,H$Q9(C%$"6"PK)@ZDN9ER55 "H+UBK0WU60J1&G^O*F88(I3I; C/O&
M #8P!]J&5-3!%)^7+Q!+<0G$%PFG.!%FDA$5ER!S#:JX.)Z#:_/35OL /LNS
M;96_*2-65#.>29F6M("8J:5"M,P@12R'!<\SF65)6D9&1&@ZX=0(KQ&Y;D[^
M[U]!(Z.%%\\$8@/WIV?@ A-:#[,+_=N#X&CA%?6,YTC>T9MQM?.66H TZ#4U
M&6<\[ZF%5@=>5)OG7$_US;FR+2G[9E5MJK^O]3&0<\'S.!6P$(A A,M2'=\)
MA2RADB99(H7=3?/%F:;&OO7Q<-ZY1YF6T_;$?0E3TZ.U!Z3&.$/O?,BUB'>@
M%M+G$?D*#I[/PI=F&_G0>T7IT]/MM0?<F$%QSB^QWLS525DO]B<E?MOV$O,R
M3Y%,(*<RA0BE&.($E[",:8PH36(BK6Y3+LXT-6;0!U%%"#MI0266\]4:+%>;
MUE5G1Q27(38C"B_ !2:*GHQ "WD']F+ZHXJK2'BEBLNSC4H55Y4^IHKK#]R8
MJOQQ5Z\@9X0F1!WA(E9(B%B405P(!@6-8\;2)$V%L+MQ/9YB:N2PSUIVKQEQ
M!DC3*\U;X E]8VF'C'ON]HGR83*U/[Y,!83+:E[,PC[]I'TFS,?Y9MXT^GM#
MJB9](XZS.$KS$A:$9!"E20)Q%,=0D(BE48%9S(P2_\X//[47>R\AT"):9\"<
M 7#XI;X=EM#.8SM$K#)?+BM^<][+F:%'RWJYK%8_YV7@4PZNUC>?__W#VQC?
M,[;:+C?55\'$_)>^^;I?+%9_Z</"^]7ZC3HZS#?ZVJN)(/BP9&OM!WXKFK]G
M:1[G"4L1E$ABB+@H=.]>!B,BHHP6DJ#<O*2"%Y&F1A"]8IJD4Z,.@V*U(O5-
MOZC 6C"]=%S]L*B3/38K4.,!8VSAE?2SJ@;^W]'7*O1)I,7Z#G0J@;U.ZC\/
MEJ[1"VC%[MJ*SZ#3#;SJM#,,:?.X;A;^YM'7;R2/]*CK:.>]]@KYH'_;STSC
M><"](G/@(_<[\LA=J]NNH9^WFVI#EGR^?/R'T,Y]P>_529T\BG>_Q9K-*_%E
M/6?BZVJQ4%]J_>!,1D6:%)+#F*=J6Y8\AV524I@6"<D3$I,4(:L#]N@J3&T;
M[\2&K=R@$QS4DH_4S-K]&V'H*9CT.H?V1-S>VGK7O+H'Q!WHH #GOSMA2M:]
MV$I.H\^UNQH3J&0\QC)YZWI]NR3NS:_;&O:S)&&<QC2%*44((JS^H#KQF8LR
MR]09E#!NY5#NC3VUC:@GFGTCYPXOL]W $87 -&T"@%,/YR-5O;=P[L8?O8/S
MD6+G&C@??\1K]ET=EG(A*2MG/,H+*B&G7"<L%QG$$B=0<,$29:5B$5OE@=B+
M,+D7?+3<.R\I=T.+:WH]%7+)QC :]PEW;1GRZ>7;&: Y1KK=D!A3R+8S@,DP
MV<YD),<4DGW5\5VI;ZZ[%E+.(<$H@J@D)21QKL[_(I>RE%)QJ555JC-S3(TG
MK=O9#^%GQE0WHA+\XFW?\"#$D7) >[_I%F?F&3>3XK*B)TD2 Q]U["5XE(&V
MSTT[S%2;I4APFJB33D%S E%:<EA&N(0R+;-$O>\B(E8%=DTGGAH/O*LV\Y_U
ME9G4C4!^#3;>O UR,Y8( 61@ZC!(>O78ZL\2'[\=_DPG'[>QGR4D)_W\;)]W
M"!AXUQX\FK)V;2M5W19KMXGJ(BJB0!D4B IEA!0Q+#DI8$19$G.41RQ/C(,!
MKDXW.1[J#F9-;^!.9*!EMK@)O@ZSP>V\5_ "<\\0;B9VC N$%A?E7J$<Z1+\
M5DCM[K6-$1J\L[X^RGCWT<8:'=PUFS_E>H^\6F\>Q/IGSV'7=;;)$AP71&UX
M)2MU&!:#)1893+F(BDCR.$V%;:_42Y/9?-_':HFJ9(6*XW^"N:MW? !<TZM3
M'X %]U;MD.J)>;T8H,/UXS4T/%\37IQNY.N\:VJ?7KM=?<(^*GO?ZO[^<2UJ
ME^,;'?\BUD]DO7G^I+XA;7W;,F6XB*-"'R(3B!*,8)E''$HA,L)37N(\,PW6
M-IYU:I9;7TJ@Q;0L(6P'^3"=! ,R,+,X8&@5^6V-R<T!X>8SCA8G;@U"/WS<
M_F$OJ:&[KIEOYQ5;K'23S&H6,1[+I)20,Z)HIU0$1**"P;@0%"N+I4 BLK-7
M#&:=GN'R?N>PTO=UFQ\"U$FDGW3&*%CM RK JX_BEX(ZL:R2:;(49M:-9WB#
MD]%Q6NF^1S#HB1PLQ70(GY#)IF?G?<FTTR$@KB2@#CX:MOA:W2)*?1MGG"HZ
MDIQ!1 A7/"41I%F>0LIRB2*J&S[97:M9"C U2TE]"_,PQ=9VD!O>Q 4$,O0U
MG4MQ-:W#^-75CM%[D:IJ.R$F64WM&"+7*FHGX[C7X=WSI>7U]OF')_3JU-=4
M>PF#W'(/@^"]P.J9J48OHWI9W7/%4@<^[?:=;6O3'+X:;]I:)RB)8B(273^F
M1! AW7@M21(8YRC*L@R)5,8V._#09%/;;5NQ@&R:I:N=8E%GIBU<(U\&D3;C
M"%_X!6:*5LPS6^L;W]5E3!#Q2AN#$XY*'B:J'U.(T3,.U].[L71"W[F*>#H"
MCRR?WSQS\;OU[+.8DI1$% HB=2G1B$,<9[D"'L>QB%"9T<+,#>$JPO1\$KU"
MCCV> 1"\>7XK#*O+.R^(P=5V8)!#&_^=]#KV]V+1S%8%159:"9=>32[@6UR*
M!UZ$D:[)71;#TYWY#0 .WJ*[C#O>O?H-6A_<M-\RCL/6\G7U3!:;Y\^;'V+=
MOBLE$V7"20:CI.00%6KGH'D6P1QG4B!$"XZ-JAQ>&']JEF@MF@7]G$',@-IO
MPR$P<[?"W8%:/!=./@.*!>7>!LY(C'H(DB>NO*SY(!6>>6P\IKLL\P&1#7S,
M[2R]+W!1/:P)%_=+7@\^7 #C[6I+-W*[Z#[U9;68L^=9%B,4Z=+Z<9%0B%B,
M("7*/!9(%CG+<10CJR+//H6;&D.>J38#R))?+CAC>W;WNK)F9_V76J_03+Y7
MZP[4BM4KU?"Z0=6@3L'=9^] HR/XL_W[0?S>@->*#/[+HV,RQ&IX]4MX%7!4
M/T8(:(_]'D'F<*V<P%8_A2:A]PJ*QH#>*ANZO:58+:O70GW11?.Y!YTJ_.[W
M9DW4'/,E63_714-U?6#UI,XF5H]^T'$DHMK,"HRIX%29PR16>T8N$<18]ZIB
M2*H-6A(9H=EFM2$+LSTCH*Q66\A.XG"\U*@ 7NF*@'\#M%8+S)O_=,C7#KG*
M6<:H0)Q"RM2A!PE1PC*2,<PD9H7 C%%L91E,995',!0>]#<)5.*Q3@I?[2Z!
MFX6>SA*;F0@36;C %D/W9M9='H'>/\!>5;#7M7MIV\_7ZC8E[??J@4X_G\5+
M@B^"YV(HX>0=N;A*<.!/B[6$G]+Q&K>+U_JP?-INJCIB,6G]'%E&)*9)!LLT
M)A 5>0I+FJB#9:R.F)*C(N/8+MYS8+;IW:G4TOW?_U><1_]/8GEC.P"JX86M
M'Z!"W]?NXC/O0"/H'6AC7@-DIQA@XO?&=F"^<2]LKRM^<E]K\(@;83RHQS[+
M>[ZJ"\AUF6R1*&2>$BA+DD(4HPB6&8T@+P7)229C@G(;R_+<)),S"=6(.@"\
MD](R_6003S.2N!6EP.S0GGZU]?1-A\23-:_ ]R=.-C[33$S \$H+9R<:E0^&
M5#TF@L'/.F:TLA^";Q=J6&6#J 77H=_W524VU?V2_WVUXG_-%XL'[1/1'K7:
MH3:+LU3D/*&PR.)$'3U+!DF21C!%.,7J^,GUT=,NU=5>BNF9&)T2FD<ZF7MN
MS0]<G3;G<E[[I?=J@D9/RU19AU4SHZ' *Q&8I?I+< )QO1:[A?FS5B*,G_@&
M$/WFY#K(,6ZRKCM0)UF\-PSEZL-M#FWO?NNR<G7"S+O?;+'5Z6+W/U?KS?R_
MFTOEF$HAE D%(T*)K@Q'U2$L2V%1D++$J:+3Q*A=MNW$4S.R]%%9!RMOB0*S
MU0&(1@E;KYLA]*8N-/^ !O>'M?BU,M^U678[N4%?<)^.+CNH/'NM#"<?V05E
M!\FI/\GR>=>DX/73:JWL]4^KY;?&]]T>4-1YC^6",LCRF"M[3IWUJ"01+%B:
MQ;$H2TFM^.GB3-,CI%;0VD,,6UEM$WPOP6K&/5[ "DPVYW$*X!6Z"H;GS-U+
MLXV<KWM%Z=,LW6L/.)X%F[&^BB=-.HI\['+7+CT^H2]R]\W=R1BF\<<5(/S:
M^)<F&]>0OZ+RB;5^[?-^*K<>EEYL-U-=";K:O";5O)K1J$BY,L AQ;H*1L13
M2$J6PPS%<8ZE*#"E-K$2M@),+0!B)R%@JX'[43_@F]%*2$@#TXU!3=<[L(?\
MS1#D-]=X-<4M:*W7JT*\:,U74XBNU7XU'L>-Y;J<]8?5/?OG=KX6YRJ8S8HH
MIIP7",82Q1!ASB!F90;S')=E+-,X+=AL*1YUW>8'<^/>:'*C=Q W[^")".'>
MQUT5SKHUQ^T5"\T6PHSF_.$Z#K=U\NI"&:W$X'QM0W^49H615QXSFWE4\K("
MXYBQ[!YVHZGOE?@LN]+PU0SCB,1Q)A4?98J/.)&PC",$&8TBFA>(9=*JD,_A
M\%-S+7QO6&8GGQVQ'$%GQB#N@ 2FBF,LQ@G6/P^'5U8XFF+4U_^\>L?O^85/
MO4P7W;^K#VZJ#\NF.\_?UZNJFI4B%[R,F2X^6$#$$MU\K$QA'(D$4Y*C5!CF
M_P>4<GIWS;60ZLCPJNDP9EF4,,1"&OJ(7G9Q0KN7/+:O;315MFG;%5W_C])V
M.NUI!Y9B4OUGS\GY/ZK![ #0OCO(#DUU:WS1.[)>SI>/NL%[)\.<W2_YV_EB
MJ\]_A]$J95RF>2IR&"/,E+4824BRK%0[!"MI@F7.!76-,;*29'K<WP]RT<N\
M;5+*]3]K3>HXEU87T.D*GL2ZX1W72".[]3/<#L*O26C*[RW&#NLO'=9W9U9D
MG, C)SP#!1_9R?)" 4A.@%T.0G(;SKWBY(=EM5EOFXKBNQJ^#VI!JQ^K!=?I
MKDJ:M^2YFI$BS2FE.60)2B!"20YIC')8,L:R5)W2B\3J'&XU^]2.Z3L9P:81
M$G EI1U%VL%O1HS!0!WCQF,O^!WHB7X']FBWTH.W0V@[%0ZU1LU[/5%S"48O
M,VH-SKGJH_:#W)C-]OJY#N1\LR!5=?][7LVR-(DC20F,J2QU[K-NF<(E+!.$
MLCB)$UQ8Y3Y?G&EJ=%5+!VKQP)]:0,O\E,N0FM&2%Z "4Y %1NY9:Y?T#Y.S
M=C+;RV2L75+Z8K[:Q0?L"(&+^:R]3GV.$_HPWRS$#&>$X1(7L(C*%"+*(UCB
M"&LL92P%29.<FG# N<&G]MK70ND31IR\HG_K(@J>S=[]L^@-O^ZW8A+X#;>%
MP_@U']+[S)M="?8OCZM?_ZH>JU_J?R+](VQ^K-_DLP..\O(.J=*]KX.?<0S
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M25Y+,UY%Q'=MQLL3CEV<\:KJ9ZHS7G_&C49J![14K^7]DG\3ZU]S73UDU].
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M0%?/9FO<[*\]-5;)_,@V$R$:%4P(JR/;NKW>*W,.\GJ;=A-FCNRBVP#(A_9
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M]X4^)L& /__U"3?DN<_5[AO[0?_MO_ZC^Q?]AUDI__4?_P-02P,$%     @
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M6J;;[,7.(J(T*:-!B.0?@=)<0\PQ $>I153&9Y$' LT=).P%%]<[7(:0;Q=
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MU$/D-$A29R"Q=V!A7I("YA^GM)>>L_#\:YJ=UHJ=ORP6^??I;#91W =T@N)
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MM#WR=)&W&WU\PO4TD==]A9FA1HU<?<2CS!VYAZO''$(BLK"R,$?F"LE<L63
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M:B=<"DOKA;5<IRZ*VOM2:4W;<6%[X80>< DC]--U?-Q%02<I]0.TN1A0M'U
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M4O++Z?KU8OV?N-ZNJ6A<8$*"YZGV6G & E,".$\IHS EQS;)]7TI'+E&L@U
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M5!NCTL7IT[/I*GS\N*S]'C:/VN5"-EJ[E/(H'*4D%\@:6KL*C047M /CLJ
MSWA:V$UDM!=Y/\+9TT-0>-W\#J_#L<.F]^D3YM.[1M!<8TQF@4+F6-N(8KUS
M8"$Z$:%PP8S4.4B9]PJ>'O+4'^$$ZA#,M55/!X%4[5'['M-N@,R3+V$ZJ_S4
MKE!A=GU-Y2#JP45M8RLW'K:"P)@#S[+V60=-/[2QBP^@\D<XE#K*/+;2: =H
MO5B)+TF.\X_3FK1=K7 S[^@OBT7^?3J;76-18V;DXRO:""@B5*@9>>->@/8^
M%X8L.=7F-/4 8G^$HZECL-M:OZ.&_=?VDCL2<]>X\TEJ%[D"8TL I7B B$*
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MZX'5>=D?E[C=7G9G4UP*@3$'$"@2*%7[4@6?0'J=,D>F#6O3^/M.DKH%W/%
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M[^9[ +KU.7MAQ_TPV#E>UAUXQ2]KC2NNUF_#MUIS>,9%CB9G$0O1;BT%?]*
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MNX;N=.PO-C(3A .=LJDU[ 8<,03%!BV*# JQ32#_(\I&[FW3"X1V@O:!^NP
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MWLX75PT./I-VUO+Y6(=;+^NM\3#[_N9[QK\W>Q%Y/JQ8QF@_,]49"K7Q5M&
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M2!R1&?X=9]/YXM?Y"@\R.D\\:0 KLPN- YF5GS"N;K%S QT3A6?<6Y *.>V
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M\#$.V+9YNSEB(UHV0J]?(OWQ__Y?_Q]02P,$%     @ #(&I5(F$I\JX"
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M[VJ^O-W]#U!+ 0(4 Q0    (  R!J50-3_#>_-<! %<P%0 1
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M+3(P,C(P,S,Q7W!R92YX;6Q02P$"% ,4    "  ,@:E4B82GRK@(  #".@
M&               @ %\:00 ;&=N9%\S,S$R,F5X:&EB:70S,3$N:'1M4$L!
M A0#%     @ #(&I5)%4;CJJ"   JSL  !@              ( !:G($ &QG
M;F1?,S,Q,C)E>&AI8FET,S$R+FAT;5!+ 0(4 Q0    (  R!J529-T9FM08
M -0K   8              "  4I[! !L9VYD7S,S,3(R97AH:6)I=#,R,2YH
8=&U02P4&      H "@"> @  -8($

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
